PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chopra, HD; Wuttig, M				Chopra, Harsh Deep; Wuttig, Manfred			Non-Joulian magnetostriction	NATURE			English	Article							FE-GA ALLOYS; PHASE; MAGNETOELASTICITY	All magnets elongate and contract anisotropically when placed in a magnetic field, an effect referred to as Joule magnetostriction(1). The hallmark of Joulian magnetostriction is volume conservation(2), which is a broader definition applicable to self-accommodation of ferromagnetic, ferroelectric or ferroelastic domains in all functional materials(3-10). Here we report the discovery of 'giant' non-volume-conserving or non-Joulian magnetostriction (NJM). Whereas Joulian strain is caused by magnetization rotation, NJM is caused by facile (low-field) reorientation of magnetoelastically and magnetostatically autarkic (self-sufficient) rigid micro-'cells', which define the adaptive structure, the origin of which is proposed to be elastic gradients ultimately caused by charge/spin density waves(11-13). The equilibrium adaptive cellular structure is responsible for long-sought non-dissipative (hysteresis-free), linearly reversible and isotropic magnetization curves along all directions within a single crystal. Recently discovered Fe-based high magnetostriction alloys(14,15) with special thermal history are identified as the first members of this newly discovered magnetic class. The NJM paradigm provides consistent interpretations of seemingly confounding properties of Fe-based alloys, offers recipes to develop new highly magnetostrictive materials, and permits simultaneously large actuation in longitudinal and transverse directions without the need for stacked composites.	[Chopra, Harsh Deep] Temple Univ, Dept Mech Engn, Lab Quantum Mat & Devices, Mat Genom Lab, Philadelphia, PA 19122 USA; [Chopra, Harsh Deep] Temple Univ, Temple Mat Inst, Philadelphia, PA 19122 USA; [Wuttig, Manfred] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Maryland; University of Maryland College Park	Chopra, HD (corresponding author), Temple Univ, Dept Mech Engn, Lab Quantum Mat & Devices, Mat Genom Lab, Philadelphia, PA 19122 USA.	chopra@temple.edu; wuttig@umd.edu			National Science Foundation DMR-Metals grant [1206397]; National Science Foundation DMR-Condensed Matter Physics grants [1541236, 0964830]; Direct For Mathematical & Physical Scien [1541236, 1206397] Funding Source: National Science Foundation	National Science Foundation DMR-Metals grant; National Science Foundation DMR-Condensed Matter Physics grants; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors appreciate the donation of single crystals by T. A. Lograsso. We thank S. Fahler for discussions. We thank S. Z. Hua for discussions, input on experimental design and help with magnetic and temperature dependent measurements. We thank J. Steiner, T. Ren, E. Gande and J. N. Armstrong for help with vibrating sample magnetometry and magnetostriction measurements, and assistance in collation of some images, experiments and sample preparation. M.W. acknowledges support from the National Science Foundation DMR-Metals grant 1206397 and H.D.C. acknowledges support from the National Science Foundation DMR-Condensed Matter Physics grants 1541236 (previously 1309712) and 0964830.	Chopra H. D., 2014, P MSE C S 23 25 SEP; Chopra HD, 2000, PHYS REV B, V61, P14913, DOI 10.1103/PhysRevB.61.R14913; Chopra HD, 1996, ACTA MATER, V44, P747, DOI 10.1016/1359-6454(95)00183-2; CLARK AE, 1972, PHYS REV B, V5, P3642, DOI 10.1103/PhysRevB.5.3642; Clark AE, 2003, J APPL PHYS, V93, P8621, DOI 10.1063/1.1540130; Clark AE, 2000, IEEE T MAGN, V36, P3238, DOI 10.1109/20.908752; du Tremolet de Lacheisserie E., 2002, MAGNETISM, P79; Fu JY, 2007, FERROELECTRICS, V354, P238, DOI 10.1080/00150190701455005; Guruswamy S, 2000, SCRIPTA MATER, V43, P239, DOI 10.1016/S1359-6462(00)00397-3; Jin YM, 2003, J APPL PHYS, V94, P3629, DOI 10.1063/1.1599632; Joule JP, 1847, PHIL MAG 3, V30, P76, DOI DOI 10.1080/14786444708645656; Kaufmann S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.145702; KHACHATURYAN AG, 1969, SOV PHYS JETP-USSR, V29, P557; Lisfi A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/41/415702; Lisfi A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866183; Pirc R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214114; Rafique S, 2004, J APPL PHYS, V95, P6939, DOI 10.1063/1.1676054; Roytburd AL, 1998, J APPL PHYS, V83, P228, DOI 10.1063/1.366677; Sozinov A, 2002, APPL PHYS LETT, V80, P1746, DOI 10.1063/1.1458075; SULLIVAN M, 1980, REV SCI INSTRUM, V51, P382, DOI 10.1063/1.1136225; Sullivan MR, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.094427; Wuttig M, 2002, APPL PHYS LETT, V80, P1135, DOI 10.1063/1.1450045; Xing Q, 2008, ACTA MATER, V56, P4536, DOI 10.1016/j.actamat.2008.05.011	25	84	88	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					340	+		10.1038/nature14459	http://dx.doi.org/10.1038/nature14459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993965				2022-12-28	WOS:000354816500053
J	Han, BW; Wang, W; Li, CJ; Weng, ZP; Zamore, PD				Han, Bo W.; Wang, Wei; Li, Chengjian; Weng, Zhiping; Zamore, Phillip D.			piRNA-guided transposon cleavage initiates Zucchini-dependent, phased piRNA production	SCIENCE			English	Article							INHERITED PIRNAS; ELEGANS PIRNAS; BIOGENESIS; DROSOPHILA; GERMLINE; PATHWAY; ARABIDOPSIS; CHROMATIN; PROTEIN; PIWI	PIWI-interacting RNAs (piRNAs) protect the animal germ line by silencing transposons. Primary piRNAs, generated from transcripts of genomic transposon "junkyards" (piRNA clusters), are amplified by the "ping-pong" pathway, yielding secondary piRNAs. We report that secondary piRNAs, bound to the PIWI protein Ago3, can initiate primary piRNA production from cleaved transposon RNAs. The first similar to 26 nucleotides (nt) of each cleaved RNA becomes a secondary piRNA, but the subsequent similar to 26 nt become the first in a series of phased primary piRNAs that bind Piwi, allowing piRNAs to spread beyond the site of RNA cleavage. The ping-pong pathway increases only the abundance of piRNAs, whereas production of phased primary piRNAs from cleaved transposon RNAs adds sequence diversity to the piRNA pool, allowing adaptation to changes in transposon sequence.	[Han, Bo W.; Wang, Wei; Li, Chengjian; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA; [Han, Bo W.; Wang, Wei; Li, Chengjian; Weng, Zhiping; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wang, Wei; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 368 Plantat St, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; phillip.zamore@umassmed.edu		Han, Bo/0000-0001-9501-8702; Zamore, Phillip/0000-0002-4505-9618	National Institutes of Health [HG007000, GM62862, GM65236]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R01GM062862, R37GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Boucher, C. Tipping, G. Farley, and E. Kittler for technical assistance; R. Fukunaga and E. Sontheimer for discussions; J. Brennecke for sharing reagents and unpublished data; and members of the Weng and Zamore laboratories for advice and comments on the manuscript. This work was supported in part by National Institutes of Health grants HG007000 to Z.W. and GM62862 and GM65236 to P.D.Z. Sequencing data are available from the National Center for Biotechnology Information Sequence Read Archive using accession number SRP045930.	Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin VV, 2013, RNA, V19, P1064, DOI 10.1261/rna.039669.113; Voigt F, 2012, RNA, V18, P2128, DOI 10.1261/rna.034967.112; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	28	228	233	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					817	821		10.1126/science.aaa1264	http://dx.doi.org/10.1126/science.aaa1264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977554	Green Accepted			2022-12-28	WOS:000354428700048
J	Sedgwick, P				Sedgwick, Philip			Controlled trials: allocation concealment, random allocation, and blinding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Berlin Ivan, 2014, BMJ, V348, pg1622, DOI 10.1136/bmj.g1622; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3434; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1635; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345	4	6	7	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2015	350								h2633	10.1136/bmj.h2633	http://dx.doi.org/10.1136/bmj.h2633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CN	25979365				2022-12-28	WOS:000354770600003
J	Shamseer, L; Sampson, M; Bukutu, C; Schmid, CH; Nikles, J; Tate, R; Johnston, BC; Zucker, D; Shadish, WR; Kravitz, R; Guyatt, G; Altman, DG; Moher, D; Vohra, S				Shamseer, Larissa; Sampson, Margaret; Bukutu, Cecilia; Schmid, Christopher H.; Nikles, Jane; Tate, Robyn; Johnston, Bradley C.; Zucker, Deborah; Shadish, William R.; Kravitz, Richard; Guyatt, Gordon; Altman, Douglas G.; Moher, David; Vohra, Sunita		CENT Grp	CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; SINGLE-SUBJECT DESIGNS; CLINICAL-TRIAL; HERBAL INTERVENTIONS; GENERAL-PRACTICE; PATIENT; OUTCOMES; QUALITY; SERIES; BIAS	N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.	[Shamseer, Larissa; Moher, David] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON K1N 6N5, Canada; [Sampson, Margaret] Childrens Hosp Eastern Ontario, Lib Serv, Toronto, ON, Canada; [Bukutu, Cecilia] Alberta Ctr Child Family & Community Res, Child & Youth Data Lab, Edmonton, AB, Canada; [Schmid, Christopher H.] Brown Univ, Dept Biostat, Biostat, Providence, RI 02912 USA; [Schmid, Christopher H.] Brown Univ, Ctr Evidence Based Med, Biostat, Providence, RI 02912 USA; [Nikles, Jane] Univ Queensland, Brisbane, Qld 4072, Australia; [Tate, Robyn] Univ Sydney, Sydney Med Sch Northern, Rehabil Res Ctr, Sydney, NSW 2006, Australia; [Johnston, Bradley C.] Univ Toronto, Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON M5S 1A1, Canada; [Johnston, Bradley C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Zucker, Deborah] Tufts Univ, Sch Med, Medford, MA USA; [Shadish, William R.] Univ Calif, Merced, CA USA; [Kravitz, Richard] Univ Calif Davis, Dept Internal Med, Res, Davis, CA 95616 USA; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Vohra, Sunita] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2M7, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; Brown University; Brown University; University of Queensland; University of Sydney; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Tufts University; University of California System; University of California Merced; University of California System; University of California Davis; McMaster University; University of Oxford; University of Alberta	Vohra, S (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2M7, Canada.	svohra@ualberta.ca	Nikles, Jane/F-4572-2010; Kravitz, Richard/AAF-7425-2021; Bukutu, Cecilia/GWZ-4823-2022; Moher, David/I-3408-2019; Schmid, Christopher H./J-2398-2014; Vohra, Sunita/F-5755-2016; Shamseer, Larissa/E-9645-2017	Nikles, Jane/0000-0001-5356-2291; Moher, David/0000-0003-2434-4206; Schmid, Christopher H./0000-0002-0855-5313; Vohra, Sunita/0000-0002-6210-7933; Shamseer, Larissa/0000-0003-3690-3378; Bukutu, Cecilia/0000-0002-2612-4904; Marles, Robin/0000-0003-2268-838X; Clark, Jocalyn/0000-0002-8014-3989; Kravitz, Richard/0000-0001-5575-529X	Alberta Advanced Education and Technology; Alberta Innovates - Health Solutions (AHIS); Boiron; Afexa Life Sciences; Hecht Foundation; HEEL; Pfizer USA; Schwabe Pharma; Canadian Institutes for Health Research [86766]; AHIS; MRC [MR/J004871/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J004871/1] Funding Source: researchfish	Alberta Advanced Education and Technology; Alberta Innovates - Health Solutions (AHIS); Boiron; Afexa Life Sciences; Hecht Foundation; HEEL; Pfizer USA(Pfizer); Schwabe Pharma; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); AHIS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors have completed the ICMJE uniform disclosure form and declare: the development of CENT was funded by Alberta Advanced Education and Technology, Alberta Heritage Foundation for Medical Research (now Alberta Innovates - Health Solutions (AHIS)), Boiron, CV Technologies (now Afexa Life Sciences), Hecht Foundation, HEEL, Pfizer USA, Schwabe Pharma, and in part, through operational funding awarded by the Canadian Institutes for Health Research (Reference No 86766); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; representatives from industry partners were present and participated at the CENT consensus meeting and were offered the opportunity to provide input on this manuscript, which none did. SV receives salary support from AHIS as a health scholar.	ALTMAN DG, 2000, STAT CONFIDENCE CONF, P6; ALTMAN DG, 2000, STAT CONFIDENCE, P120; [Anonymous], 1997, JAMA, V277, P927; [Anonymous], 2013, NAT METHODS, V10, P367, DOI 10.1038/nmeth.2471; Arroll B, 1989, NZ FAM PHYS, V16, P14; Avins AL, 2005, CONTEMP CLIN TRIALS, V26, P397, DOI 10.1016/j.cct.2005.02.004; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Barlow D., 1984, SINGLE CASE EXPT DES; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell M., 2010, MED STAT TXB HLTH SC, V4; Cepeda MS, 2008, PAIN MED, V9, P235, DOI 10.1111/j.1526-4637.2007.00329.x; Chalmers I, 2009, OBSTET GYNECOL, V114, P1341, DOI 10.1097/AOG.0b013e3181c3020d; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chin R, 2008, PRINCIPLES AND PRACTICE OF CLINICAL TRIAL MEDICINE, P1, DOI 10.1016/B978-0-12-373695-6.00001-6; Coxeter PD, 2003, COMPLEMENT THER MED, V11, P215, DOI 10.1016/S0965-2299(03)00122-5; DALES RE, 1992, PHARMACOTHERAPY, V12, P331; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Dziegielewski S. F., 2000, J PSYCHOTHERAPY INDE, V1, P1, DOI [10.1300/J288v01n03_01, DOI 10.1300/J288V01N03_]; ESTRADA CA, 1993, J GEN INTERN MED, V8, P619, DOI 10.1007/BF02599719; Fedele D J, 1993, Spec Care Dentist, V13, P215, DOI 10.1111/j.1754-4505.1993.tb01499.x; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gage NA, 2012, J SPECIAL ED; Gage NA, 2013, J APPL SPORT PSYCHOL, V25, P46, DOI 10.1080/10413200.2012.660673; Gagne JJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6802; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Gitterman DP, 2008, PEDIATR RES, V64, P462, DOI 10.1203/PDR.0b013e31818912fd; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Gordon K, 1996, J CHILD NEUROL, V11, P41, DOI 10.1177/088307389601100110; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Guyatt G, 2008, USERS GUIDES MED LIT; Guyatt GH, 2002, USERS GUIDES MED LIT, P275; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Guyatt GH, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3863; Guyatt GH, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P665; Haas DC, 2004, HEADACHE, V44, P1029, DOI 10.1111/j.1526-4610.2004.04199.x; Hersen, 1976, SINGLE CASE EXPT DES; Heyvaert M, 2014, J SPECIAL ED; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hoffmeyer CA, 2000, THESIS U COLORADO; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Horner RH, 2012, EDUC TREAT CHILD, V35, P269, DOI 10.1353/etc.2012.0011; IRWIG L, 1995, LANCET, V345, P469, DOI 10.1016/S0140-6736(95)90578-2; JOHANNESSEN T, 1991, SCAND J GASTROENTERO, V26, P974, DOI 10.3109/00365529108996251; JOHANNESSEN T, 1992, SCAND J GASTROENTERO, V27, P189, DOI 10.3109/00365529208999947; Johnston BC, 2010, PEDIATRICS, V126, pE222, DOI 10.1542/peds.2009-3667; Johnston MV, 2010, OTJR-OCCUP PART HEAL, V30, P4, DOI 10.3928/15394492-20091214-02; Kamien M, 1998, Aust Fam Physician, V27 Suppl 2, pS103; Kazdin A., 2021, SINGLE CASE RES DESI, V3rd; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kravitz R. L, 2014, AHRQ PUBLICATION, V13(14)-EHC122-EF; Kravitz RL, 2014, DESIGN IMPLEMENTATIO, V13(14)-EHC122-EF, P33; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Louly PG, 2009, CLIN THER, V31, P1007, DOI 10.1016/j.clinthera.2009.05.015; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; Maggin DM, 2011, J SCHOOL PSYCHOL, V49, P301, DOI 10.1016/j.jsp.2011.03.004; Maggin DM, 2011, EXCEPTIONALITY, V19, P109, DOI 10.1080/09362835.2011.565725; MAHON JL, 1995, LANCET, V345, P989, DOI 10.1016/S0140-6736(95)90738-6; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; MCLEOD RS, 1986, LANCET, V1, P726; Miyar J, 2013, SCHIZOPHRENIA BULL, V39, P226, DOI 10.1093/schbul/sbr140; Moher D, 2007, CAN J ANAESTH, V54, P331, DOI 10.1007/BF03022653; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Morrow KL, 2006, J COMMUN DISORD, V39, P2, DOI 10.1016/j.jcomdis.2005.05.001; Nathan PC, 2006, SUPPORT CARE CANCER, V14, P268, DOI 10.1007/s00520-005-0875-7; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Nikles C Jane, 2005, Am J Ther, V12, P92, DOI 10.1097/00045391-200501000-00012; Nikles J, 2011, J CLIN EPIDEMIOL, V64, P471, DOI 10.1016/j.jclinepi.2010.05.009; Nonoyama ML, 2007, AM J RESP CRIT CARE, V176, P343, DOI 10.1164/rccm.200702-308OC; Oxford Centre for Evidence-Based Medicine Work Group, 2011, OXF LEV EV 2; Parker RI, 2007, J SPEC EDUC, V40, P194, DOI 10.1177/00224669070400040101; Parker RI, 2011, BEHAV MODIF, V35, P303, DOI 10.1177/0145445511399147; Paterson C, 2005, NATO SCI SER II MATH, V198, P11; Paterson C, 1996, BRIT MED J, V312, P1016; Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098; Pereira JA, 2005, ANN PHARMACOTHER, V39, P1188, DOI 10.1345/aph.1G003; Price JD, 2002, AGE AGEING, V31, P227, DOI 10.1093/ageing/31.4.227; Price JD, 2002, AGE AGEING, V31, P307, DOI 10.1093/ageing/31.4.307; Punja S, 2014, THESIS U ALBERTA; Punja S, 2014, AHRQ PUBLICATION, V13(14)-EHC122-EF, P13; Reed JF, 2005, J MOD APP STAT METH, V5, P19; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; ROCHON J, 1990, J CLIN EPIDEMIOL, V43, P499, DOI 10.1016/0895-4356(90)90139-G; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Senn S, 2002, CROSS OVER TRIALS CL; Shadish WR, 2014, CURR DIR PSYCHOL SCI, V23, P139, DOI 10.1177/0963721414524773; Sinha IP, 2012, PEDIATRICS, V129, pS146, DOI 10.1542/peds.2012-0055H; Smith B J, 2004, Chron Respir Dis, V1, P63, DOI 10.1191/1479972304cd028oa; Sung L, 2007, EUR J CANCER, V43, P1269, DOI 10.1016/j.ejca.2007.02.001; Tate R. L., 2012, BRAIN IMPAIR, V13, P135; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tison F, 2013, PARKINSONISM RELAT D, V19, P416, DOI 10.1016/j.parkreldis.2012.12.003; Trader J, 2007, ZFA, V83, P238; Turner L, 2011, 9 ANN COCHR CAN S FE; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Wegman ACM, 2005, FAM PRACT, V22, P152, DOI 10.1093/fampra/cmh726; Wegman ACM, 2003, ANN RHEUM DIS, V62, P1156, DOI 10.1136/ard.2002.002865; Woodfield R, 2005, BRIT J GEN PRACT, V55, P181; Yelland MJ, 2007, RHEUMATOLOGY, V46, P135, DOI 10.1093/rheumatology/kel195; Zarin DA, 2005, SOC PSYCH PSYCH EPID, V40, P27, DOI 10.1007/s00127-005-0838-9; Zucker DR, 2006, J RHEUMATOL, V33, P2069; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5; Zwaigenbaum L, 2006, J DEV PHYS DISABIL, V18, P45, DOI 10.1007/s10882-006-9005-9	117	70	72	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h1793	10.1136/bmj.h1793	http://dx.doi.org/10.1136/bmj.h1793			30	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CI	25976162	hybrid			2022-12-28	WOS:000354770100002
J	Snyder, A				Snyder, Alison			John Arras Obituary	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1828	1828		10.1016/S0140-6736(15)60918-7	http://dx.doi.org/10.1016/S0140-6736(15)60918-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25987147				2022-12-28	WOS:000354184500016
J	Camaschella, C				Camaschella, Clara			Iron-Deficiency Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTRAVENOUS FERRIC CARBOXYMALTOSE; CHRONIC HEART-FAILURE; ORAL IRON; HEMOGLOBIN CONCENTRATION; SYSTEMATIC ANALYSIS; PRESCHOOL-CHILDREN; MICROCYTIC ANEMIA; CAPSULE ENDOSCOPY; CONTROLLED-TRIAL; CELIAC-DISEASE		[Camaschella, Clara] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Camaschella, Clara] Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Camaschella, C (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Via Olgettina 58, I-20132 Milan, Italy.	camaschella.clara@hsr.it						Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Auerbach M, 2013, AM J HEMATOL, V88, P944, DOI 10.1002/ajh.23534; Auerbach M, 2010, HEMATOL-AM SOC HEMAT, P338, DOI 10.1182/asheducation-2010.1.338; Bach V, 2014, CLIN INTERV AGING, V9, P1187, DOI 10.2147/CIA.S61125; Bager P, 2010, J CROHNS COLITIS, V4, P427, DOI 10.1016/j.crohns.2010.01.007; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bircher AJ, 2014, IMMUNOL ALLERGY CLIN, V34, P707, DOI 10.1016/j.iac.2014.04.013; Bregman DB, 2014, THER ADV HEMATOL, V5, P48, DOI 10.1177/2040620714521127; Brugnara C, 2013, CURR OPIN HEMATOL, V20, P222, DOI 10.1097/MOH.0b013e32835f5933; Camaschella C, 2013, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2013.1.1; Camaschella C, 2013, BRIT J HAEMATOL, V160, P12, DOI 10.1111/bjh.12081; Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446; Cohen-Solal A, 2014, EUR J HEART FAIL, V16, P984, DOI 10.1002/ejhf.139; Comin-Colet J, 2013, EUR HEART J, V34, P30, DOI 10.1093/eurheartj/ehr504; De Falco L, 2013, HAEMATOLOGICA, V98, P845, DOI 10.3324/haematol.2012.075515; DeLoughery TG, 2014, NEW ENGL J MED, V371, P1324, DOI 10.1056/NEJMra1215361; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Fishbane S, 2014, NAT REV NEPHROL, V10, P488, DOI 10.1038/nrneph.2014.139; Franceschi F, 2014, NAT REV GASTRO HEPAT, V11, P234, DOI 10.1038/nrgastro.2013.243; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Goenka MK, 2014, WORLD J GASTROENTERO, V20, P10024, DOI 10.3748/wjg.v20.i29.10024; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Gupta A, 2014, INDIAN J HEMATOL BLO, V30, P120, DOI 10.1007/s12288-012-0224-1; Heeney MM, 2014, HEMATOL ONCOL CLIN N, V28, P637, DOI 10.1016/j.hoc.2014.04.009; Heidelbaugh JJ, 2013, THER ADV DRUG SAF, V4, P125, DOI 10.1177/2042098613482484; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hershko C, 2014, BLOOD, V123, P326, DOI 10.1182/blood-2013-10-512624; Jankowska EA, 2013, EUR HEART J, V34, P827, DOI 10.1093/eurheartj/ehs377; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086; Krayenbuehl PA, 2011, BLOOD, V118, P3222, DOI 10.1182/blood-2011-04-346304; Macdougall IC, 2014, NEPHROL DIAL TRANSPL, V29, P2075, DOI 10.1093/ndt/gfu201; Macdougall IC, 2011, ONCOLOGIST, V16, P25, DOI 10.1634/theoncologist.2011-S3-25; Fernandez-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8; Markovic M, 2007, INT J LAB HEMATOL, V29, P341, DOI 10.1111/j.1365-2257.2006.00875.x; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Murray JA, 2013, CLIN GASTROENTEROL H, V11, P808, DOI 10.1016/j.cgh.2013.02.009; Mustafa BF, 2013, EXPERT REV GASTROENT, V7, P323, DOI [10.1586/EGH.13.20, 10.1586/egh.13.20]; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Obinwanne KM, 2014, J AM COLL SURGEONS, V218, P246, DOI 10.1016/j.jamcollsurg.2013.10.023; Onken JE, 2014, TRANSFUSION, V54, P306, DOI 10.1111/trf.12289; Pasricha SR, 2014, J NUTR, V144, P906, DOI 10.3945/jn.113.189589; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x; Ponikowski P, 2015, EUR HEART J, V36, P657, DOI 10.1093/eurheartj/ehu385; Powers JM, 2014, HEMATOL ONCOL CLIN N, V28, P729, DOI 10.1016/j.hoc.2014.04.007; Rampton D, 2014, HAEMATOLOGICA, V99, P1671, DOI 10.3324/haematol.2014.111492; Reinisch W, 2013, ALIMENT PHARM THER, V38, P1109, DOI 10.1111/apt.12493; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schrier SL, 2014, CAUSES DIAGNOSIS IRO; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Stein J, 2014, ALIMENT PHARM THER, V40, P582, DOI 10.1111/apt.12872; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Vadhan-Raj S, 2014, AM J HEMATOL, V89, P7, DOI 10.1002/ajh.23582; van Santen S, 2014, HAEMATOLOGICA, V99, pE171, DOI 10.3324/haematol.2014.106799; van Veldhuisen DJ, 2011, NAT REV CARDIOL, V8, P485, DOI 10.1038/nrcardio.2011.77; Warsch Sean, 2013, World J Gastrointest Pharmacol Ther, V4, P49, DOI 10.4292/wjgpt.v4.i3.49; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292	76	703	737	19	242	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1832	1843		10.1056/NEJMra1401038	http://dx.doi.org/10.1056/NEJMra1401038			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25946282				2022-12-28	WOS:000353974700008
J	Rysavy, MA; Li, L; Bell, EF; Das, A; Hintz, SR; Stoll, BJ; Vohr, BR; Carlo, WA; Shankaran, S; Walsh, MC; Tyson, JE; Cotten, CM; Smith, PB; Murray, JC; Colaizy, TT; Brumbaugh, JE; Higgins, RD				Rysavy, Matthew A.; Li, Lei; Bell, Edward F.; Das, Abhik; Hintz, Susan R.; Stoll, Barbara J.; Vohr, Betty R.; Carlo, Waldemar A.; Shankaran, Seetha; Walsh, Michele C.; Tyson, Jon E.; Cotten, C. Michael; Smith, P. Brian; Murray, Jeffrey C.; Colaizy, Tarah T.; Brumbaugh, Jane E.; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst	Between-Hospital Variation in Treatment and Outcomes in Extremely Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; NEONATAL RESEARCH NETWORK; GESTATIONAL-AGE; NEURODEVELOPMENTAL OUTCOMES; INTENSIVE-CARE; COGNITIVE FUNCTION; VIABILITY; BORN; MORTALITY; PREGNANCY	BACKGROUND Between-hospital variation in outcomes among extremely preterm infants is largely unexplained and may reflect differences in hospital practices regarding the initiation of active lifesaving treatment as compared with comfort care after birth. METHODS We studied infants born between April 2006 and March 2011 at 24 hospitals included in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Data were collected for 4987 infants born before 27 weeks of gestation without congenital anomalies. Active treatment was defined as any potentially lifesaving intervention administered after birth. Survival and neurodevelopmental impairment at 18 to 22 months of corrected age were assessed in 4704 children (94.3%). RESULTS Overall rates of active treatment ranged from 22.1% (interquartile range [IQR], 7.7 to 100) among infants born at 22 weeks of gestation to 99.8% (IQR, 100 to 100) among those born at 26 weeks of gestation. Overall rates of survival and survival without severe impairment ranged from 5.1% (IQR, 0 to 10.6) and 3.4% (IQR, 0 to 6.9), respectively, among children born at 22 weeks of gestation to 81.4% (IQR, 78.2 to 84.0) and 75.6% (IQR, 69.5 to 80.0), respectively, among those born at 26 weeks of gestation. Hospital rates of active treatment accounted for 78% and 75% of the between-hospital variation in survival and survival without severe impairment, respectively, among children born at 22 or 23 weeks of gestation, and accounted for 22% and 16%, respectively, among those born at 24 weeks of gestation, but the rates did not account for any of the variation in outcomes among those born at 25 or 26 weeks of gestation. CONCLUSIONS Differences in hospital practices regarding the initiation of active treatment in infants born at 22, 23, or 24 weeks of gestation explain some of the between-hospital variation in survival and survival without impairment among such patients. (Funded by the National Institutes of Health.)	[Rysavy, Matthew A.; Bell, Edward F.; Murray, Jeffrey C.; Colaizy, Tarah T.; Brumbaugh, Jane E.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA; [Rysavy, Matthew A.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Li, Lei] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Hintz, Susan R.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Vohr, Betty R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Shankaran, Seetha] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Walsh, Michele C.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Tyson, Jon E.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX USA; [Cotten, C. Michael; Smith, P. Brian] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	University of Iowa; University of Iowa; Research Triangle Institute; Research Triangle Institute; Stanford University; Emory University; Children's Healthcare of Atlanta (CHOA); Brown University; Women & Infants Hospital Rhode Island; University of Alabama System; University of Alabama Birmingham; Wayne State University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Texas System; University of Texas Health Science Center Houston; Duke University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bell, EF (corresponding author), Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	edward-bell@uiowa.edu	Das, Abhik/AAF-1883-2020	Das, Abhik/0000-0003-2722-0479; Rysavy, Matthew/0000-0002-1209-6607; Colaizy, Tarah/0000-0003-2582-1633; Bell, Edward/0000-0002-5568-0889; li, lei/0000-0002-3993-2193; Hintz, Susan/0000-0001-7023-4433	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD053109, UG1HD021385, U10HD027853, U10HD021373, U10HD053089, U10HD053119, UG1HD087229, U10HD036790, U10HD034216, UG1HD027880, U10HD027856, UG1HD034216, U10HD021385, U10HD040689, U10HD027904, U10HD027880, U10HD040492, U10HD027871, U10HD027851, U10HD021364, U10HD053124, U10HD053109, UG1HD021364, UG1HD053089] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD036790] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Institutes of Health.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Alleman BW, 2013, PEDIATRICS, V132, pE175, DOI 10.1542/peds.2012-3707; American Academy of Pediatrics American College of Obstetricians and Gynecologists, 2012, GUID PER CAR; American College of Obstetricians and Gynecologists, 2002, OBSTET GYNECOL, V100, P617; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Batton D, 2013, CAN MED ASSOC J, V185, P1559, DOI 10.1503/cmaj.130268; Batton DG, 2009, PEDIATRICS, V124, P422, DOI 10.1542/peds.2009-1060; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Chervenak FA, 2007, J OBSTET GYNAECOL, V27, P3, DOI 10.1080/01443610601133605; Gallagher K, 2014, ARCH DIS CHILD-FETAL, V99, pF245, DOI 10.1136/archdischild-2013-305191; Gjessing HK, 1999, AM J PUBLIC HEALTH, V89, P213, DOI 10.2105/AJPH.89.2.213; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P443; Kaempf JW, 2006, PEDIATRICS, V117, P22, DOI 10.1542/peds.2004-2547; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Lantos JD, 2009, PEDIATRICS, V123, P1588, DOI 10.1542/peds.2009-0030; Mahgoub L, 2014, PEDIATRICS, V134, pE1405, DOI 10.1542/peds.2014-0904; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Morse SB, 2000, PEDIATRICS, V105, P1046, DOI 10.1542/peds.105.5.1046; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Raghuveer TS, 2011, AM FAM PHYSICIAN, V83, P911; Raju TNK, 2014, OBSTET GYNECOL, V123, P1083, DOI 10.1097/AOG.0000000000000243; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; Snijders T., 1999, MULTILEVEL MODELING; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Stark AR, 2007, PEDIATRICS, V119, P401, DOI 10.1542/peds.2006-3180; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tyson JE, 1996, JAMA-J AM MED ASSOC, V276, P1645, DOI 10.1001/jama.276.20.1645; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Verhagen AAE, 2013, JAMA PEDIATR, V167, P987, DOI 10.1001/jamapediatrics.2013.3065; Vohr BR, 2014, CLIN PERINATOL, V41, P241, DOI 10.1016/j.clp.2013.09.003; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Vohr BR, 2004, PEDIATRICS, V113, P781, DOI 10.1542/peds.113.4.781; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; WILCOSKY TC, 1985, J CHRON DIS, V38, P849, DOI 10.1016/0021-9681(85)90109-2	39	405	411	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1801	1811		10.1056/NEJMoa1410689	http://dx.doi.org/10.1056/NEJMoa1410689			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25946279	Green Accepted			2022-12-28	WOS:000353974700005
J	Barraclough, K; Gale, CP; Hall, R				Barraclough, Kevin; Gale, Chris P.; Hall, Roger			UNCERTAINTIES Assessment of chest pain in a low risk patient: is the exercise tolerance test obsolete?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; DIAGNOSIS; PROBABILITY; ANGIOGRAPHY; TOMOGRAPHY; GUIDELINES; MANAGEMENT		[Barraclough, Kevin] Hoyland House, Painswick GL6 6TY, Glos, England; [Gale, Chris P.] Univ Leeds, Ctr Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England; [Hall, Roger] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Leeds; University of East Anglia	Barraclough, K (corresponding author), Hoyland House, Painswick GL6 6TY, Glos, England.	k.barraclough@btinternet.com		Gale, Chris/0000-0003-4732-382X	Medical Research Council [MR/L01629X/1] Funding Source: researchfish; MRC [MR/L01629X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam EA, 2014, JAMA INTERN MED, V174, P553, DOI 10.1001/jamainternmed.2013.13415; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2014, AM HEART J, V167, P796, DOI 10.1016/j.ahj.2014.03.003; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hulten E, 2013, J AM COLL CARDIOL, V61, P880, DOI 10.1016/j.jacc.2012.11.061; Jelinek M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4117; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; McKavanagh P, 2015, EUR HEART J-CARD IMG, V16, P441, DOI 10.1093/ehjci/jeu284; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; National Institute for Health and Care Excellence, 2011, MAN STABL ANG; National Institute for Health and Care Excellence, 2010, CHEST PAIN REC ONS A; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; Office for National Statistics, 2014, DEATH REG SUMM TABL; Safavi KC, 2014, JAMA INTERN MED, V74, P553; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Sekhri N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2240; SOX HC, 1990, AM J MED, V89, P7, DOI 10.1016/0002-9343(90)90090-Z	23	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h1905	10.1136/bmj.h1905	http://dx.doi.org/10.1136/bmj.h1905			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25948490				2022-12-28	WOS:000354414000002
J	Morse, RJ; DuBeau, CE				Morse, Randall J.; DuBeau, Catherine E.			Update in Geriatric Medicine: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OLDER-ADULTS; DISEASE; COHORT; TRIAL; RISK		[Morse, Randall J.; DuBeau, Catherine E.] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	DuBeau, CE (corresponding author), Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Div Geriatr Med, 365 Plantat St,Biotech One,Suite 100, Worcester, MA 01605 USA.	catherine.dubeau@umassmemorial.org						Hwang YJ, 2014, ANN INTERN MED, V161, P242, DOI 10.7326/M13-2796; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Makam AN, 2014, J AM GERIATR SOC, V62, P1039, DOI 10.1111/jgs.12839; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Tannenbaum C, 2014, JAMA INTERN MED, V174, P890, DOI 10.1001/jamainternmed.2014.949; Tjia J, 2014, JAMA INTERN MED, V174, P1763, DOI 10.1001/jamainternmed.2014.4103	6	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W102	W105		10.7326/M15-0298	http://dx.doi.org/10.7326/M15-0298			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927564				2022-12-28	WOS:000379893300005
J	Agenor, M; Peitzmeier, S; Gordon, AR; Haneuse, S; Potter, JE; Austin, SB				Agenor, Madina; Peitzmeier, Sarah; Gordon, Allegra R.; Haneuse, Sebastien; Potter, Jennifer E.; Austin, S. Bryn			Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among US Women and Girls A National Survey	ANNALS OF INTERNAL MEDICINE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; LESBIAN HEALTH; SAME-SEX; TRANSMITTED INFECTIONS; HPV VACCINATION; CANCER; RISK; ADOLESCENT; BEHAVIORS; INSURANCE	Background: Lesbians and bisexual women are at risk for human papillomavirus (HPV) infection from female and male sexual partners. Objective: To examine the association between sexual orientation identity and HPV vaccination among U.S. women and girls. Design: Cross-sectional, using 2006-2010 National Survey of Family Growth data. Setting: U.S.civilian noninstitutionalized population. Participants: The 2006-2010 National Survey of Family Growth used stratified cluster sampling to establish a national probability sample of 12 279 U.S. women and girls aged 15 to 44 years. Analyses were restricted to 3253 women and girls aged 15 to 25 years who were asked about HPV vaccination. Measurements: Multivariable logistic regression was used to obtain prevalence estimates of HPV vaccine awareness and initiation adjusted for sociodemographic and health care factors for each sexual orientation identity group. Results: Among U.S. women and girls aged 15 to 25 years, 84.4% reported having heard of the HPV vaccine; of these, 28.5% had initiated HPV vaccination. The adjusted prevalence of vaccine awareness was similar among heterosexual, bisexual, and lesbian respondents. After adjustment for covariates, 8.5% (P = 0.007) of lesbians and 33.2% (P = 0.33) of bisexual women and girls who had heard of the vaccine had initiated vaccination compared with 28.4% of their heterosexual counterparts. Limitation: Self-reported, cross-sectional data, and findings may not be generalizable to periods after 2006 to 2010 or all U. S. lesbians aged 15 to 25 years (because of the small sample size for this group). Conclusion: Adolescent and young adult lesbians may be less likely to initiate HPV vaccination than their heterosexual counterparts. Programs should facilitate access to HPV vaccination services among young lesbians.	Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Fenway Hlth,Beth Israel Deaconess Med Ctr,Med Sch, Boston, MA 02115 USA; Boston Childrens Hosp, Boston, MA USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Agenor, M (corresponding author), Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Kresge Bldg,7th Floor,677 Huntington Ave, Boston, MA 02115 USA.	magenor@mail.harvard.edu		Peitzmeier, Sarah/0000-0003-4552-1099	National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA075308, R25CA057711] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	Aaron DJ, 2001, AM J PUBLIC HEALTH, V91, P972, DOI 10.2105/AJPH.91.6.972; Agenor M, 2014, AM J PUBLIC HEALTH, V104, pE68, DOI 10.2105/AJPH.2013.301548; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Bauer GR, 2001, AM J PUBLIC HEALTH, V91, P1282, DOI 10.2105/AJPH.91.8.1282; Bednarczyk RA, 2011, VACCINE, V29, P3138, DOI 10.1016/j.vaccine.2011.02.045; Ben-Natan M, 2014, INT J STD AIDS, V25, P800, DOI 10.1177/0956462414521167; Boehmer U, 2007, AM J PUBLIC HEALTH, V97, P1134, DOI 10.2105/AJPH.2006.088419; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Buchmueller T, 2010, AM J PUBLIC HEALTH, V100, P489, DOI 10.2105/AJPH.2009.160804; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carroll N, 1997, J GAY LESBIAN MED AS, V1, P15, DOI DOI 10.1023/B:JOLA.0000007008.17392.2D; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Charlton BM, 2011, J ADOLESCENT HEALTH, V49, P505, DOI 10.1016/j.jadohealth.2011.03.013; Clark MA, 2003, WOMEN HEALTH, V38, P19, DOI 10.1300/J013v38n02_02; Cochran SD, 2001, AM J PUBLIC HEALTH, V91, P591, DOI 10.2105/AJPH.91.4.591; Cochran SD, 2013, AM J PUBLIC HEALTH, V103, P1837, DOI 10.2105/AJPH.2013.301423; Committee on Infectious Diseases, 2012, Pediatrics, V129, P602, DOI 10.1542/peds.2011-3865; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Diamant AL, 1999, ARCH INTERN MED, V159, P2730, DOI 10.1001/archinte.159.22.2730; Diamant AL, 2000, ARCH FAM MED, V9, P1043, DOI 10.1001/archfami.9.10.1043; Eliason MJ., 2001, J GAY LESBIAN MED AS, V5, P125, DOI [DOI 10.1023/A:1014257910462, 10.1023/A:1014257910462]; Everett BG, 2013, ARCH SEX BEHAV, V42, P225, DOI 10.1007/s10508-012-9902-1; Ferris DG, 1996, J FAM PRACTICE, V43, P581; Fish J., 2009, CERVICAL SCREENING L, P51; Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Goodenow C, 2008, AM J PUBLIC HEALTH, V98, P1051, DOI 10.2105/AJPH.2005.080531; Gorgos LM, 2011, CLIN INFECT DIS, V53, pS84, DOI 10.1093/cid/cir697; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Korn EL., 1999, ANAL HLTH SURVEYS; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N., 2014, CURR EPIDEMIOL REP, V1, P45, DOI [DOI 10.1007/S40471-013-0001-1, 10.1007/s40471-013-0001-1]; Krieger N., 2011, ECOSOCIAL THEORY EMB, DOI [DOI 10.1007/s10803-010-0982-2, 10.1093/acprof:oso/9780195383874.001.0001]; Lepkowski James M, 2006, Vital Health Stat 2, P1; Lepkowski James M, 2010, Vital Health Stat 2, P1; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; Marrazzo JM, 2005, SEX TRANSM DIS, V32, P570, DOI 10.1097/01.olq.0000175368.82940.61; Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947; Marrazzo JM, 2000, AM J OBSTET GYNECOL, V183, P770, DOI 10.1067/mob.2000.106681; Matthews AK, 2004, PREV MED, V38, P105, DOI 10.1016/j.ypmed.2003.09.034; McNair R, 2003, WOMEN HEALTH, V37, P89, DOI 10.1300/J013v37n04_07; McNair RP, 2003, MED J AUSTRALIA, V178, P643, DOI 10.5694/j.1326-5377.2003.tb05394.x; McNair R, 2009, AUST NZ J PUBL HEAL, V33, P87, DOI 10.1111/j.1753-6405.2009.00345.x; McNair Ruth, 2005, Sex Health, V2, P209, DOI 10.1071/SH04046; McNair RP, 2010, ANN FAM MED, V8, P533, DOI 10.1370/afm.1173; Mcree AL, 2014, VACCINE, V32, P4736, DOI 10.1016/j.vaccine.2014.07.001; Miller MK, 2014, J COMMUN HEALTH, V39, P835, DOI 10.1007/s10900-014-9858-2; OHanlan KA, 1996, OBSTET GYNECOL, V88, P702, DOI 10.1016/0029-7844(96)00206-2; Polek Carolee, 2010, Oncol Nurs Forum, V37, pE191, DOI 10.1188/10.ONF.E191-E197; Polonijo AN, 2013, SOC SCI MED, V82, P115, DOI 10.1016/j.socscimed.2012.12.020; Ponce NA, 2010, HEALTH AFFAIR, V29, P1539, DOI 10.1377/hlthaff.2009.0583; Power J, 2009, CULT HEALTH SEX, V11, P67, DOI 10.1080/13691050802541674; Price JH, 1996, J COMMUN HEALTH, V21, P89, DOI 10.1007/BF01682301; Roberts ME, 2010, PEDIATRICS, V125, P982, DOI 10.1542/peds.2009-2888; Roberts SJ, 2004, WOMEN HEALTH, V39, P41, DOI 10.1300/J013v39n04_03; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; RUST PC, 1992, SOC PROBL, V39, P366, DOI 10.1525/sp.1992.39.4.03x0044r; Ryan JM., 2011, DESIGN DEV TESTING N; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Singh D., 2009, OPEN INFECT DIS J, V3, P128, DOI DOI 10.2174/187427930; Valanis BG, 2000, ARCH FAM MED, V9, P843, DOI 10.1001/archfami.9.9.843; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Williams WW, 2014, MMWR-MORBID MORTAL W, V63, P95; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18	66	45	44	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					99	+		10.7326/M14-2108	http://dx.doi.org/10.7326/M14-2108			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN4NS	25961737	Green Accepted			2022-12-28	WOS:000358407500017
J	Elwert, F				Elwert, Felix			Public health: real-world network targeting of interventions	LANCET			English	Editorial Material									[Elwert, Felix] Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA; [Elwert, Felix] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Elwert, F (corresponding author), Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA.	elwert@wisc.edu						Aral S., 2013, NETW SCI, V1, P125, DOI [10.1017/nws.2013.6, DOI 10.1017/NWS.2013.6]; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Kim D. A, 2015, LANCET; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	6	1	1	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					112	113		10.1016/S0140-6736(15)60503-7	http://dx.doi.org/10.1016/S0140-6736(15)60503-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	25952355				2022-12-28	WOS:000357742200008
J	Park, SY; Yang, JS; Schmider, AB; Soberman, RJ; Hsu, VW				Park, Seung-Yeol; Yang, Jia-Shu; Schmider, Angela B.; Soberman, Roy J.; Hsu, Victor W.			Coordinated regulation of bidirectional COPI transport at the Golgi by CDC42	NATURE			English	Article							CISTERNAL MATURATION; MEMBRANE CURVATURE; VESICLE FORMATION; ARFGAP1 PROMOTES; APPARATUS; COMPLEX; YEAST	The Golgi complex has a central role in the intracellular sorting of secretory proteins(1,2). Anterograde transport through the Golgi has been explained by the movement of Golgi cisternae, known as cisternal maturation(3-5). Because this explanation is now appreciated to be incomplete(6), interest has developed in understanding tubules that connect the Golgi cisternae(7-9). Here we show that the coat protein (COPI) complex sorts anterograde cargoes into these tubules in human cells. Moreover, the small GTPase CDC42 regulates bidirectional Golgi transport by targeting the dual functions of COPI in cargo sorting and carrier formation. CDC42 also directly imparts membrane curvature to promote COPI tubule formation. Our findings further reveal that COPI tubular transport complements cisternal maturation in explaining how anterograde Golgi transport is achieved, and that bidirectional COPI transport is modulated by environmental cues through CDC42.	[Park, Seung-Yeol; Yang, Jia-Shu; Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Park, Seung-Yeol; Yang, Jia-Shu; Schmider, Angela B.; Soberman, Roy J.; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Schmider, Angela B.; Soberman, Roy J.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Schmider, Angela B.; Soberman, Roy J.] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Soberman, Roy J.] Massachusetts Gen Hosp, Mol Imaging Core, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hsu, VW (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	vhsu@research.bwh.harvard.edu		Park, Seung-Yeol/0000-0001-5061-4535	National Institutes of Health [R01GM058615, R01AI068871, R01AR065538, 1S10RR027931-01, K01DK089145]; National Research Foundation of Korea [2014R1A6A3A03056673]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Li, M. Bai, X. Michelet and C. Alves for discussions, and M. Ericsson for electron microscopy technical advice. This work was funded by grants from the National Institutes of Health to V.W.H. (R01GM058615), R.J.S. (R01AI068871, R01AR065538 and 1S10RR027931-01), A.B.S. (K01DK089145), and also by the Basic Science Research Program of the National Research Foundation of Korea to S.-Y.P. (2014R1A6A3A03056673).	Azcutia V, 2013, MOL BIOL CELL, V24, P3358, DOI 10.1091/mbc.E13-01-0063; Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Nakano A, 2010, CURR OPIN CELL BIOL, V22, P471, DOI 10.1016/j.ceb.2010.05.003; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	24	60	62	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					529	U257		10.1038/nature14457	http://dx.doi.org/10.1038/nature14457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25945738	Green Accepted, Green Submitted			2022-12-28	WOS:000355286600045
J	Duff, MO; Olson, S; Wei, XT; Garrett, SC; Osman, A; Bolisetty, M; Plocik, A; Celniker, SE; Graveley, BR				Duff, Michael O.; Olson, Sara; Wei, Xintao; Garrett, Sandra C.; Osman, Ahmad; Bolisetty, Mohan; Plocik, Alex; Celniker, Susan E.; Graveley, Brenton R.			Genome-wide identification of zero nucleotide recursive splicing in Drosophila	NATURE			English	Article							IN-VIVO; GENERATION; JUNCTIONS; INTRONS	Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points-5' splice sites recreated after splicing(1). Recursive splicing was first identified in the Drosophila Ultrabithorax (Ubx) gene(1) and only three additional Drosophila genes have since been experimentally shown to undergo recursive splicing(2,3). Here we identify 197 zero nucleotide exon ratchet points in 130 introns of 115 Drosophila genes from total RNA sequencing data generated from developmental time points, dissected tissues and cultured cells. The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points. We also show that recursive splicing is a constitutive process, that depletion of U2AF inhibits recursive splicing, and that the sequence and function of ratchet points are evolutionarily conserved in Drosophila. Finally, we identify four recursively spliced human genes, one of which is also recursively spliced in Drosophila. Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed.	[Duff, Michael O.; Olson, Sara; Wei, Xintao; Garrett, Sandra C.; Osman, Ahmad; Bolisetty, Mohan; Plocik, Alex; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA; [Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA	University of Connecticut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Genome Sci, Farmington, CT 06030 USA.	graveley@uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	NHGRI [U54HG006994, R01GM095296]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095296] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHGRI grant U54HG006994 to S.E.C. (PI) and B.R.G. (co-PI), and R01GM095296 to B.R.G.	Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bieberstein NI, 2012, CELL REP, V2, P62, DOI 10.1016/j.celrep.2012.05.019; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Conklin JF, 2005, METHODS, V37, P368, DOI 10.1016/j.ymeth.2005.08.002; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Hollins C, 2005, RNA, V11, P248, DOI 10.1261/rna.7221605; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Sibley CR, 2015, NATURE, V521, P371, DOI 10.1038/nature14466; Taggart AJ, 2012, NAT STRUCT MOL BIOL, V19, P719, DOI 10.1038/nsmb.2327; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	18	105	108	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					376	+		10.1038/nature14475	http://dx.doi.org/10.1038/nature14475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25970244	Green Submitted, Green Accepted			2022-12-28	WOS:000354816500061
J	Smith, R				Smith, Richard			Antimicrobial resistance is a social problem requiring a social solution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Syst Econ, London, England; [Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Smith, R (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Syst Econ, London, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				[Anonymous], 2015, TACKL GLOB HLTH CRIS; Doshi P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1453; Economic and Social Research Council, 2014, ANT RES SETT SOC SCI; Hatch O, 2015, PROMISE ANTIBIOTICS; Medical Research Council, 2014, TACKL AMR THEM 2 ACC; O'Neill, 2015, REV ANTIMICROBIAL RE; ONeill J, 2014, REV AMR ANTIMICROBIA; Outterson K, 2014, NEW BUSINESS MODELS; Smith RD, 2013, BMJ-BRIT MED J, V346, P20; Wise J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2635	10	20	20	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2015	350								h2682	10.1136/bmj.h2682	http://dx.doi.org/10.1136/bmj.h2682			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YU	25990475	Green Accepted			2022-12-28	WOS:000355128000018
J	Wegner, NC; Snodgrass, OE; Dewar, H; Hyde, JR				Wegner, Nicholas C.; Snodgrass, Owyn E.; Dewar, Heidi; Hyde, John R.			Whole-body endothermy in a mesopelagic fish, the opah, Lampris guttatus	SCIENCE			English	Article							LAMNID SHARKS; TUNA HEARTS; EVOLUTION; PERFORMANCE; PHYSIOLOGY; HEATER; BRAIN	Endothermy (the metabolic production and retention of heat to warm body temperature above ambient) enhances physiological function, and whole-body endothermy generally sets mammals and birds apart from other animals. Here, we describe a whole-body form of endothermy in a fish, the opah (Lampris guttatus), that produces heat through the constant "flapping" of wing-like pectoral fins and minimizes heat loss through a series of counter-current heat exchangers within its gills. Unlike other fish, opah distribute warmed blood throughout the body, including to the heart, enhancing physiological performance and buffering internal organ function while foraging in the cold, nutrient-rich waters below the ocean thermocline.	[Wegner, Nicholas C.; Dewar, Heidi; Hyde, John R.] NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, NMFS, La Jolla, CA 92037 USA; [Snodgrass, Owyn E.] NOAA, Ocean Associates, Southwest Fisheries Sci Ctr, NMFS, La Jolla, CA 92037 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Wegner, NC (corresponding author), NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, NMFS, La Jolla, CA 92037 USA.	nick.wegner@noaa.gov		Wegner, Nicholas/0000-0002-8447-1488				BENNETT AF, 1984, AM J PHYSIOL, V247, pR217, DOI 10.1152/ajpregu.1984.247.2.R217; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; BLOCK BA, 1986, J MORPHOL, V190, P169, DOI 10.1002/jmor.1051900203; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Brill RW, 1996, COMP BIOCHEM PHYS A, V113, P3, DOI 10.1016/0300-9629(95)02064-0; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1982, SCIENCE, V216, P1327, DOI 10.1126/science.7079766; Castilho PC, 2007, COMP BIOCHEM PHYS A, V148, P124, DOI 10.1016/j.cbpa.2007.03.033; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; Dickson KA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P998, DOI 10.1086/423743; Donley JM, 2004, NATURE, V429, P61, DOI 10.1038/nature02435; Graham J. B., 2001, TUNA PHYSL ECOLOGY E, V19, P121; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Hyde JR, 2014, MOL ECOL RESOUR, V14, P1239, DOI 10.1111/1755-0998.12268; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Olney J. E., 1999, SPECIES IDENTIFICA 1, P155; Polovina JJ, 2008, MAR BIOL, V153, P257, DOI 10.1007/s00227-007-0801-2; ROSENBLATT RH, 1976, COPEIA, P367; RUBEN J, 1995, ANNU REV PHYSIOL, V57, P69, DOI 10.1146/annurev.ph.57.030195.000441; Runcie RM, 2009, J EXP BIOL, V212, P461, DOI 10.1242/jeb.022814; Shiels HA, 2011, P ROY SOC B-BIOL SCI, V278, P18, DOI 10.1098/rspb.2010.1274; Stevens ED, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1119; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616	26	78	81	11	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					786	789		10.1126/science.aaa8902	http://dx.doi.org/10.1126/science.aaa8902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977549				2022-12-28	WOS:000354428700040
J	Champ, CE; Smith, RP				Champ, Colin E.; Smith, Ryan P.			Radiation Recall and Woody Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Champ, Colin E.; Smith, Ryan P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Champ, CE (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.	champce@upmc.edu	Champ, Colin/AAA-6842-2019	Champ, Colin/0000-0002-1879-7463					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20							e26	10.1056/NEJMicm1409470	http://dx.doi.org/10.1056/NEJMicm1409470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970071				2022-12-28	WOS:000354493300011
J	Kociak, M				Kociak, Mathieu			Quantum control of free electrons	NATURE			English	Editorial Material							MICROSCOPY	Optical pulses have previously been used to place the electrons in the beam of an electron microscope into well-defined energy states. These electrons can now be put in a quantum superposition of those states. SEE LETTER P.200	Univ Paris 11, CNRS, Phys Solides Lab, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Kociak, M (corresponding author), Univ Paris 11, CNRS, Phys Solides Lab, Bat 425, F-91400 Orsay, France.	mathieu.kociak@u-psud.fr	kociak, mathieu/T-3110-2018	kociak, mathieu/0000-0001-8858-0449				Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; Feist A, 2015, NATURE, V521, P200, DOI 10.1038/nature14463; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s	4	4	4	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					166	167		10.1038/521166a	http://dx.doi.org/10.1038/521166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25971506				2022-12-28	WOS:000354377800045
J	Malhotra, A; Maughan, D; Ansell, J; Lehman, R; Henderson, A; Gray, M; Stephenson, T; Bailey, S				Malhotra, A.; Maughan, D.; Ansell, J.; Lehman, R.; Henderson, A.; Gray, M.; Stephenson, T.; Bailey, S.			Choosing Wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHARED DECISION-MAKING; CARE; INTERVENTIONS; BENEFITS		[Malhotra, A.; Henderson, A.; Stephenson, T.; Bailey, S.] Acad Med Royal Coll, London, England; [Maughan, D.] Ctr Sustainable Healthcare, Oxford, England; [Ansell, J.] Cardiff Medictr, Welsh Inst Minimal Access Therapy, Cardiff, S Glam, Wales; [Lehman, R.] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Gray, M.] Better Value Healthcare, Oxford, England; [Stephenson, T.] Inst Child Hlth, London, England	Cardiff University; University of Oxford; University of London; University College London	Malhotra, A (corresponding author), Acad Med Royal Coll, London, England.	Aseem_malhotra@hotmail.com		Stephenson, Terence/0000-0001-8871-7847				Academy of Royal Medical Colleges, 2014, PROTECTING RESOURCES; [Anonymous], 2014, UNNECESSARY TESTS AN; [Anonymous], 2010, NHS ATLAS OF VARIATI; Clement F, 2015, JAMA INT MED; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Garner S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4519; Gigerenzer G, 2011, ENVISIONING HEALTHCA; Gigerenzer G, 2009, B WORLD HEALTH ORGAN, V87, P567, DOI 10.2471/BLT.09.069872; Glover J A, 1938, Proc R Soc Med, V31, P1219; Hoffman A, 2009, HEALTH AFFAIR, V28, pW710, DOI 10.1377/hlthaff.28.4.w710; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4289; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h904; Levinson W, 2015, BMJ QUAL SAF, V24, P167, DOI 10.1136/bmjqs-2014-003821; Macdonald H, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1163; Malhotra A, 2014, JAMA INTERN MED, V174, P1367, DOI 10.1001/jamainternmed.2013.9190; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Morgan DJ, 2015, JAMA INTERN MED, V175, P120, DOI 10.1001/jamainternmed.2014.5444; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Rothberg MB, 2014, JAMA INTERN MED, V174, P1623, DOI 10.1001/jamainternmed.2014.3331; Walsh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g188; Welch HG., 2012, OVERDIAGNOSED MAKING, V1st; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102	24	98	99	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2015	350								h2308	10.1136/bmj.h2308	http://dx.doi.org/10.1136/bmj.h2308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BX	25985331	Green Published, hybrid			2022-12-28	WOS:000354769000004
J	Nasca, TJ				Nasca, Thomas J.			Professionalism and its Implications for Governance and Accountability of Graduate Medical Education in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nasca, Thomas J.] ACGME Int, Accreditat Council Grad Med Educ, Chicago, IL 60654 USA; [Nasca, Thomas J.] Thomas Jefferson Univ, Med & Mol Physiol & Biophys, Sidney Kimmel Coll Med, Chicago, IL USA		Nasca, TJ (corresponding author), ACGME Int, Accreditat Council Grad Med Educ, 515 N State St,Ste 2000, Chicago, IL 60654 USA.	tnasca@acgme.org						Association of American Medical Colleges, 2014, 2014 PHYS SPEC DAT B, P21; Eden J., 2014, GRADUATE MED ED MEET; Emanuel EJ, 1996, ANN INTERN MED, V124, P229, DOI 10.7326/0003-4819-124-2-199601150-00007; Nasca Thomas J, 2011, Virtual Mentor, V13, P769, DOI 10.1001/virtualmentor.2011.13.11.medu1-1111; Nasca TJ, 2012, RESPONSE ACCREDITATI; UK General Medical Counsel, POSTGR ED TRAIN; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112	7	8	8	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1801	1802		10.1001/jama.2015.3738	http://dx.doi.org/10.1001/jama.2015.3738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965215				2022-12-28	WOS:000354391000010
J	Ardlie, KG; DeLuca, DS; Segre, AV; Sullivan, TJ; Young, TR; Gelfand, ET; Trowbridge, CA; Maller, JB; Tukiainen, T; Lek, M; Ward, LD; Kheradpour, P; Iriarte, B; Meng, Y; Palmer, CD; Esko, T; Winckler, W; Hirschhorn, JN; Kellis, M; MacArthur, DG; Getz, G; Shabalin, AA; Li, G; Zhou, YH; Nobel, AB; Rusyn, I; Wright, FA; Lappalainen, T; Ferreira, PG; Ongen, H; Rivas, MA; Battle, A; Mostafavi, S; Monlong, J; Sammeth, M; Mele, M; Reverter, F; Goldmann, JM; Koller, D; Guigo, R; McCarthy, MI; Dermitzakis, ET; Gamazon, ER; Im, HK; Konkashbaev, A; Nicolae, DL; Cox, NJ; Flutre, T; Wen, XQ; Stephens, M; Pritchard, JK; Tu, ZD; Zhang, B; Huang, T; Long, Q; Lin, L; Yang, JL; Zhu, J; Liu, J; Brown, A; Mestichelli, B; Tidwell, D; Lo, E; Salvatore, M; Shad, S; Thomas, JA; Lonsdale, JT; Moser, MT; Gillard, BM; Karasik, E; Ramsey, K; Choi, C; Foster, BA; Syron, J; Fleming, J; Magazine, H; Hasz, R; Walters, GD; Bridge, JP; Miklos, M; Sullivan, S; Barker, LK; Traino, HM; Mosavel, M; Siminoff, LA; Valley, DR; Rohrer, DC; Jewell, SD; Branton, PA; Sobin, LH; Barcus, M; Qi, LQ; McLean, J; Hariharan, P; Um, KS; Wu, SP; Tabor, D; Shive, C; Smith, AM; Buia, SA; Undale, AH; Robinson, KL; Roche, N; Valentino, KM; Britton, A; Burges, R; Bradbury, D; Hambright, KW; Seleski, J; Korzeniewski, GE; Erickson, K; Marcus, Y; Tejada, J; Taherian, M; Lu, CR; Basile, M; Mash, DC; Volpi, S; Struewing, JP; Temple, GF; Boyer, J; Colantuoni, D; Little, R; Koester, S; Carithers, LJ; Moore, HM; Guan, P; Compton, C; Sawyer, SJ; Demchok, JP; Vaught, JB; Rabiner, CA; Lockhart, NC; Ardlie, KG; Getz, G; Wright, FA; Kellis, M; Volpi, S; Dermitzakis, ET				Ardlie, Kristin G.; DeLuca, David S.; Segre, Ayellet V.; Sullivan, Timothy J.; Young, Taylor R.; Gelfand, Ellen T.; Trowbridge, Casandra A.; Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; Ward, Lucas D.; Kheradpour, Pouya; Iriarte, Benjamin; Meng, Yan; Palmer, Cameron D.; Esko, Tonu; Winckler, Wendy; Hirschhorn, Joel N.; Kellis, Manolis; MacArthur, Daniel G.; Getz, Gad; Shabalin, Andrey A.; Li, Gen; Zhou, Yi-Hui; Nobel, Andrew B.; Rusyn, Ivan; Wright, Fred A.; Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit; Rivas, Manuel A.; Battle, Alexis; Mostafavi, Sara; Monlong, Jean; Sammeth, Michael; Mele, Marta; Reverter, Ferran; Goldmann, Jakob M.; Koller, Daphne; Guigo, Roderic; McCarthy, Mark I.; Dermitzakis, Emmanouil T.; Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.; Flutre, Timothee; Wen, Xiaoquan; Stephens, Matthew; Pritchard, Jonathan K.; Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun; Liu, Jun; Brown, Amanda; Mestichelli, Bernadette; Tidwell, Denee; Lo, Edmund; Salvatore, Michael; Shad, Saboor; Thomas, Jeffrey A.; Lonsdale, John T.; Moser, Michael T.; Gillard, Bryan M.; Karasik, Ellen; Ramsey, Kimberly; Choi, Christopher; Foster, Barbara A.; Syron, John; Fleming, Johnell; Magazine, Harold; Hasz, Rick; Walters, Gary D.; Bridge, Jason P.; Miklos, Mark; Sullivan, Susan; Barker, Laura K.; Traino, Heather M.; Mosavel, Maghboeba; Siminoff, Laura A.; Valley, Dana R.; Rohrer, Daniel C.; Jewell, Scott D.; Branton, Philip A.; Sobin, Leslie H.; Barcus, Mary; Qi, Liqun; McLean, Jeffrey; Hariharan, Pushpa; Um, Ki Sung; Wu, Shenpei; Tabor, David; Shive, Charles; Smith, Anna M.; Buia, Stephen A.; Undale, Anita H.; Robinson, Karna L.; Roche, Nancy; Valentino, Kimberly M.; Britton, Angela; Burges, Robin; Bradbury, Debra; Hambright, Kenneth W.; Seleski, John; Korzeniewski, Greg E.; Erickson, Kenyon; Marcus, Yvonne; Tejada, Jorge; Taherian, Mehran; Lu, Chunrong; Basile, Margaret; Mash, Deborah C.; Volpi, Simona; Struewing, Jeffery P.; Temple, Gary F.; Boyer, Joy; Colantuoni, Deborah; Little, Roger; Koester, Susan; Carithers, Latarsha J.; Moore, Helen M.; Guan, Ping; Compton, Carolyn; Sawyer, Sherilyn J.; Demchok, Joanne P.; Vaught, Jimmie B.; Rabiner, Chana A.; Lockhart, Nicole C.; Ardlie, Kristin G.; Getz, Gad; Wright, Fred A.; Kellis, Manolis; Volpi, Simona; Dermitzakis, Emmanouil T.		GTEx Consortium	The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; IDENTIFICATION; TRANSCRIPTOME; LOCI; ARCHITECTURE; RESOURCE; SYSTEMS	Understanding the functional consequences of genetic variation, and how it affects complex human disease and quantitative traits, remains a critical challenge for biomedicine. We present an analysis of RNA sequencing data from 1641 samples across 43 tissues from 175 individuals, generated as part of the pilot phase of the Genotype-Tissue Expression (GTEx) project. We describe the landscape of gene expression across tissues, catalog thousands of tissue-specific and shared regulatory expression quantitative trait loci (eQTL) variants, describe complex network relationships, and identify signals from genome-wide association studies explained by eQTLs. These findings provide a systematic understanding of the cellular and biological consequences of human genetic variation and of the heterogeneity of such effects among a diverse set of human tissues.	[DeLuca, David S.; Segre, Ayellet V.; Sullivan, Timothy J.; Young, Taylor R.; Gelfand, Ellen T.; Trowbridge, Casandra A.; Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; Ward, Lucas D.; Kheradpour, Pouya; Meng, Yan; Palmer, Cameron D.; Esko, Tonu; Winckler, Wendy; Hirschhorn, Joel N.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ward, Lucas D.; Kheradpour, Pouya; Iriarte, Benjamin] MIT, MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Palmer, Cameron D.; Esko, Tonu; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Palmer, Cameron D.; Esko, Tonu; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shabalin, Andrey A.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA; [Li, Gen; Nobel, Andrew B.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Li, Gen; Nobel, Andrew B.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Zhou, Yi-Hui] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Zhou, Yi-Hui] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Zhou, Yi-Hui] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Univ Geneva, Inst Genet & Genom Geneva iG3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10011 USA; [Lappalainen, Tuuli] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Rivas, Manuel A.; McCarthy, Mark I.] Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet Res, Oxford OX3 7BN, England; [Battle, Alexis; Mostafavi, Sara; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Monlong, Jean; Sammeth, Michael; Mele, Marta; Reverter, Ferran; Goldmann, Jakob M.; Guigo, Roderic] CRG, Barcelona 08003, Catalonia, Spain; [Monlong, Jean; Sammeth, Michael; Mele, Marta; Guigo, Roderic] Univ Pompeu Fabra, Barcelona 08003, Catalonia, Spain; [Monlong, Jean] McGill Univ, Human Genet Dept, Montreal, PQ H3A 0G1, Canada; [Sammeth, Michael] Natl Inst Sci Comp, BR-25651075 Rio De Janeiro, Brazil; [Mele, Marta] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Reverter, Ferran] Univ Barcelona, E-08028 Barcelona, Spain; [Goldmann, Jakob M.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Guigo, Roderic] Inst Hosp Mar Invest Med IMIM, Barcelona 08003, Spain; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gamazon, Eric R.; Konkashbaev, Anuar; Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Genet Med, Nashville, TN 37232 USA; [Flutre, Timothee; Stephens, Matthew; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Flutre, Timothee] INRA, Dept Plant Biol & Breeding, UMR 1334, AGAP, F-34060 Montpellier, France; [Wen, Xiaoquan] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Genet & Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Liu, Jun] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Brown, Amanda; Mestichelli, Bernadette; Tidwell, Denee; Lo, Edmund; Salvatore, Michael; Shad, Saboor; Thomas, Jeffrey A.; Lonsdale, John T.] Natl Dis Res Interchange, Philadelphia, PA 19103 USA; [Moser, Michael T.; Gillard, Bryan M.; Karasik, Ellen; Ramsey, Kimberly; Choi, Christopher; Foster, Barbara A.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Syron, John; Fleming, Johnell; Magazine, Harold] Sci Care Inc, Phoenix, AZ USA; [Hasz, Rick] Gift Life Donor Program, Philadelphia, PA 19103 USA; [Walters, Gary D.] LifeNet Hlth, Virginia Beach, VA 23453 USA; [Bridge, Jason P.; Miklos, Mark; Sullivan, Susan] UNYTS, Buffalo, NY 14203 USA; [Barker, Laura K.; Traino, Heather M.; Mosavel, Maghboeba; Siminoff, Laura A.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Traino, Heather M.; Siminoff, Laura A.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Valley, Dana R.; Rohrer, Daniel C.; Jewell, Scott D.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Branton, Philip A.; Carithers, Latarsha J.; Moore, Helen M.; Guan, Ping; Compton, Carolyn; Sawyer, Sherilyn J.; Vaught, Jimmie B.; Rabiner, Chana A.; Lockhart, Nicole C.] NCI, Biorepositories & Biospecimen Res Branch, Bethesda, MD 20892 USA; [Sobin, Leslie H.; Barcus, Mary; Qi, Liqun; McLean, Jeffrey; Hariharan, Pushpa; Um, Ki Sung; Wu, Shenpei; Tabor, David; Shive, Charles; Smith, Anna M.; Buia, Stephen A.; Undale, Anita H.; Robinson, Karna L.; Roche, Nancy; Valentino, Kimberly M.; Britton, Angela; Burges, Robin; Bradbury, Debra; Hambright, Kenneth W.; Korzeniewski, Greg E.] Leidos Biomed Res Inc, Clin Res Directorate, Biospecimen Res Grp, Rockville, MD 20852 USA; [Seleski, John] iDoxSolutions Inc, Bethesda, MD 20814 USA; [Erickson, Kenyon] Sapient Govt Serv, Arlington, VA 22201 USA; [Marcus, Yvonne; Tejada, Jorge; Taherian, Mehran; Lu, Chunrong; Basile, Margaret; Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol, Brain Endowment Bank, Miami, FL 33136 USA; [Struewing, Jeffery P.; Temple, Gary F.; Colantuoni, Deborah] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Boyer, Joy; Lockhart, Nicole C.] NHGRI, Div Genom & Soc, Bethesda, MD 20892 USA; [Little, Roger] NIMH, Off Sci Policy Planning & Commun, Bethesda, MD 20892 USA; [Koester, Susan] NIMH, Div Neurosci & Basic Behav Sci, Bethesda, MD 20892 USA; [Demchok, Joanne P.] NCI, Canc Diag Program, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Tartu; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Stanford University; Columbia University; University of Oxford; Wellcome Centre for Human Genetics; Stanford University; Johns Hopkins University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; McGill University; Harvard University; University of Barcelona; Radboud University Nijmegen; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Oxford; University of Oxford; University of Chicago; University of Chicago; Vanderbilt University; University of Chicago; INRAE; Universite de Montpellier; University of Michigan System; University of Michigan; University of Chicago; Stanford University; Howard Hughes Medical Institute; University of Chicago; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Roswell Park Cancer Institute; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ardlie, KG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	kardlie@broadinstitute.org; emmanouil.dermitzakis@unige.ch	Qi, LI/AAF-3389-2019; Ferreira, Pedro/HDO-1346-2022; Kellis, Manolis/ABE-7385-2020; Monlong, Jean/AAZ-8589-2020; Guigo, Roderic/D-1303-2010; Lappalainen, Tuuli/AAE-6532-2020; Rusyn, Ivan/S-2426-2016; Rivas, Manuel/ABE-8173-2020; Sammeth, Michael/C-1157-2014; reverter, ferran/I-1547-2015; Gamazon, Eric/I-6873-2018; Ferreira, Pedro G/J-6379-2013; Goldmann, Jakob M/K-5948-2013; McCarthy, Mark/M-3763-2015	Kellis, Manolis/0000-0001-7113-9630; Monlong, Jean/0000-0002-9737-5516; Guigo, Roderic/0000-0002-5738-4477; Lappalainen, Tuuli/0000-0002-7746-8109; Rivas, Manuel/0000-0003-1457-9925; Sammeth, Michael/0000-0002-6528-9883; reverter, ferran/0000-0002-9489-3350; Gamazon, Eric/0000-0003-4204-8734; Ferreira, Pedro G/0000-0003-3838-8664; Goldmann, Jakob M/0000-0002-8514-573X; Flutre, Timothee/0000-0003-4489-4782; Esko, Tonu/0000-0003-1982-6569; Rusyn, Ivan/0000-0001-9340-7384; Ongen, Halit/0000-0002-4197-5790; Wen, Xiaoquan/0000-0001-8990-2737; mele, marta/0000-0001-8874-6453; MacArthur, Daniel/0000-0002-5771-2290; Tukiainen, Taru/0000-0002-5404-8398; Nicolae, Dan/0000-0002-0918-4630; McCarthy, Mark/0000-0002-4393-0510; Ward, Lucas/0000-0002-8017-809X; Shabalin, Andrey/0000-0003-0309-6821	Common Fund of the Office of the Director, U.S. National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NIA; NIAID; NINDS through NIH [HHSN261200800001E, 10XS170, 10XS171, 12ST1039, 10ST1035, HHSN268201000029C]; European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation; Wellcome Trust [098381]; Clarendon Scholarship; NDM Studentship; Univ. of Oxford Green Templeton College Award; NIH [R01 DA006227-17, R01 MH090941, R01 MH090951, R01 MH090937, R01 MH090936, R01 MH090948, R01 GM104371, R01AG046170, R01CA163772, U01AI111598-01]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K12CA139160, P30CA016056, R01CA163772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI111598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090936, R01MH090951, R01MH090941, R01MH101819, R01MH090937, R01MH101820, R01MH090948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	Common Fund of the Office of the Director, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS through NIH; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Clarendon Scholarship; NDM Studentship; Univ. of Oxford Green Templeton College Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the donors and their families for their generous gifts of organ donation for transplantation and tissue donations for the GTEx research study; the Genomics Platform at the Broad Institute for data generation; J. Nedzel, K. Huang, and K. Hadley for work on the GTEx Portal; L. Gaffney for help with figures; and members of the Analysis Working Group for scientific editing and feedback. The primary and processed data used to generate the analyses presented here are available in the following locations: all primary sequence and clinical data files, and any other protected data, are deposited in and available from dbGaP (www.ncbi.nlm.nih.gov/gap) (phs000424.v3.p1, except for whole-exome sequencing data, which are part of phs000424.v5.p1); derived analysis files are available on the GTEx Portal (www.gtexportal.org). Biospecimens remaining from the study may be requested for research studies. The sample request form, biospecimen access policy, and material transfer agreement (MTA) are available on the GTEx Portal (www.gtexportal.org/home/samplesPage). Supported by the Common Fund of the Office of the Director, U.S. National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, NIA, NIAID, and NINDS through NIH contracts HHSN261200800001E (Leidos Prime contract with NCI), 10XS170 (NDRI), 10XS171 (Roswell Park Cancer Institute), 10X172 (Science Care Inc.), 12ST1039 (IDOX), 10ST1035 (Van Andel Institute), and HHSN268201000029C (Broad Institute) and through NIH grants R01 DA006227-17 (Univ. of Miami Brain Bank), R01 MH090941 (Univ. of Geneva), R01 MH090951 and R01 MH090937 (Univ. of Chicago), R01 MH090936 (Univ. of North Carolina-Chapel Hill), R01 MH090948 (Harvard Univ.), R01 GM104371 (Massachusetts General Hospital), and R01AG046170, R01CA163772, and U01AI111598-01 (Icahn School of Medicine, Mount Sinai). Additional support: European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation (E.T.D.); Wellcome Trust grant 098381 (M.I.M.); Clarendon Scholarship, a NDM Studentship, and a Univ. of Oxford Green Templeton College Award (M.A.R.). J.K.P. is compensated for his work on the scientific advisory board for 23andMe and computational advisory board for DNANexus; W.W. is an employee and shareholder of Novartis Inc.; A. Battle is a shareholder of Google, Inc.; J. Fleming is executive director of the American Medical and Research Association; and J.B.V. and R. Little serve on the board of NDRI. Author contributions: The GTEx Consortium contributed collectively to this study. Biospecimens were provided by the Biospecimen source sites and the brain bank operations, and processed by the LDACC and comprehensive biospecimen resource. Pathological review of specimens was conducted by the pathology resource center, and all donor data entry and review by the comprehensive data resource. Data generation was undertaken by the Laboratory, Data Analysis and Coordinating Center (LDACC), and analyses were performed by all members of the Analysis Working Group. Project activities were coordinated by caHUB operations and overseen by the NHGRI, NIMH, and NCI project teams. We acknowledge the following investigators of the Analysis Working Group who contributed substantially to analyses presented here. Transcriptome variation: D.S.D., P.G.F. Single-tissue eQTL analysis: A.A.S., D.S.D., A.V.S. Multitissue eQTL analysis: T.F., X.W., A.A.S., G.L. Allele-specific expression: T.L. Splice QTLs: J.M., H.O. Functional annotation: L.D.W., P.K. Network Analyses: A. Battle, S.M., Z.T., T.H., B.I. Protein-truncating analyses: M.A.R., M.; L. GWAS analysis: E.R.G., A.V.S., L.D.W.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Monlong J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5698; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen XQ, 2014, BIOMETRICS, V70, P73, DOI 10.1111/biom.12112; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	45	3027	3058	15	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					648	660		10.1126/science.1262110	http://dx.doi.org/10.1126/science.1262110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954001	Green Published, Green Accepted			2022-12-28	WOS:000354045700036
J	Greer, EL; Blanco, MA; Gu, L; Sendinc, E; Liu, JZ; Aristizabal-Corrales, D; Hsu, CH; Aravind, L; He, C; Shi, Y				Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Liu, Jianzhao; Aristizabal-Corrales, David; Hsu, Chih-Hung; Aravind, L.; He, Chuan; Shi, Yang			DNA Methylation on N-6-Adenine in C-elegans	CELL			English	Article							EPIGENETIC INHERITANCE; CAENORHABDITIS-ELEGANS; HISTONE METHYLATION; MOUSE; RNA; MECHANISMS; MEMORY; INACTIVATION; GENERATIONS; DEMETHYLASE	In mammalian cells, DNA methylation on the fifth position of cytosine (5mC) plays an important role as an epigenetic mark. However, DNA methylation was considered to be absent in C. elegans because of the lack of detectable 5mC, as well as homologs of the cytosine DNA methyltransferases. Here, using multiple approaches, we demonstrate the presence of adenine N-6-methylation (6mA) in C. elegans DNA. We further demonstrate that this modification increases trans-generationally in a paradigm of epigenetic inheritance. Importantly, we identify a DNA demethylase, NMAD-1, and a potential DNA methyltransferase, DAMT-1, which regulate 6mA levels and crosstalk between methylations of histone H3K4 and adenines and control the epigenetic inheritance of phenotypes associated with the loss of the H3K4me2 demethylase spr-5. Together, these data identify a DNA modification in C. elegans and raise the exciting possibility that 6mA may be a carrier of heritable epigenetic information in eukaryotes.	[Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Aristizabal-Corrales, David; Hsu, Chih-Hung; Shi, Yang] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Aristizabal-Corrales, David; Hsu, Chih-Hung; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Aravind, L.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Greer, EL (corresponding author), Childrens Hosp, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.	eric.greer@childrens.harvard.edu; yshi@hms.harvard.edu	Gu, Lei/GWQ-6785-2022; Hsu, Chih-Hung/AEM-8298-2022; Liu, Jianzhao/E-9165-2011; Liu, Jianzhao/AAO-2359-2020	Hsu, Chih-Hung/0000-0001-8071-0122; Liu, Jianzhao/0000-0001-9465-6075; Liu, Jianzhao/0000-0001-9465-6075; Blanco, M. Andres/0000-0003-4404-2301; Greer, Eric/0000-0002-7501-7371; Aravind, L/0000-0003-0771-253X	NIH Office of Research Infrastructure Programs [P40OD010440]; Tufts University Core Facility Genomics Core; University of Massachusetts Medical School Deep Sequencing Core; Helen Hay Whitney postdoctoral fellowship; National Institute on Aging of the NIH [K99AG043550]; NIH NRSA postdoctoral fellowship [1F32CA180450-01]; Leukemia & Lymphoma Society [3353-15]; National Library of Health, NIH; U.S. department of Health and Human Services; NIH [K99AG043550, GM058012, CA118487, MH096066]; Ellison Foundation; Samual Waxman Cancer Research Foundation [SWCRF-1856]; NATIONAL CANCER INSTITUTE [R01CA118487, F32CA180450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG043550, K99AG043550] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University Core Facility Genomics Core; University of Massachusetts Medical School Deep Sequencing Core; Helen Hay Whitney postdoctoral fellowship; National Institute on Aging of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Library of Health, NIH; U.S. department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); Samual Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Shi lab for helpful discussions, Elizabeth Pollina for feedback on the manuscript, and Madeline Schuck and LaVondea Elow for technical and administrative support. We thank the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40OD010440) for C. elegans strains, and the Tufts University Core Facility Genomics Core and the University of Massachusetts Medical School Deep Sequencing Core for MeDIP-seq and SMRT sequencing, respectively. E.L.G. was supported by a Helen Hay Whitney postdoctoral fellowship and a National Institute on Aging of the NIH grant (K99AG043550). M.A.B. was supported by an NIH NRSA postdoctoral fellowship (1F32CA180450-01) and is currently supported by a Special Fellow award from the Leukemia & Lymphoma Society (3353-15). L.A. was supported by funds of the Intramural Research Program of the National Library of Health, NIH, and U.S. department of Health and Human Services. C.H. is a Howard Hughes Medical Institute investigator. This work was supported by NIH grants to Y.S. (GM058012, CA118487, and MH096066) and E.L.G. (K99AG043550), by an Ellison Foundation Senior Scholar Award to Y.S, and by a Samual Waxman Cancer Research Foundation grant to Y.S. (SWCRF-1856). Y.S. is an American Cancer Society Research Professor. Y.S. is also a cofounder of Constellation Pharmaceuticals Inc. and is a member of its scientific advisory board.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r100; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Greer EL, 2014, CELL REP, V7, P113, DOI 10.1016/j.celrep.2014.02.044; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gutierrez Juan C., 2000, International Microbiology, V3, P139; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Iyer LM, 2014, P NATL ACAD SCI USA, V111, P1676, DOI 10.1073/pnas.1321818111; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kerr SC, 2014, P NATL ACAD SCI USA, V111, P9509, DOI 10.1073/pnas.1321843111; Koh KP, 2013, CURR OPIN CELL BIOL, V25, P152, DOI 10.1016/j.ceb.2013.02.014; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nottke AC, 2011, P NATL ACAD SCI USA, V108, P12805, DOI 10.1073/pnas.1102298108; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wenzel D, 2011, GENESIS, V49, P647, DOI 10.1002/dvg.20762; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Yi CQ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012575; Zemach A, 2010, CURR BIOL, V20, pR780, DOI 10.1016/j.cub.2010.07.007; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	46	401	425	11	166	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					868	878		10.1016/j.cell.2015.04.005	http://dx.doi.org/10.1016/j.cell.2015.04.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936839	Green Accepted, Bronze			2022-12-28	WOS:000354175200019
J	Ma, DKG; Stolte, C; Krycer, JR; James, DE; O'Donoghue, SI				Ma, David K.G.; Stolte, Christian; Krycer, James R.; James, David E.; O'Donoghue, Sean I.			SnapShot: Insulin/IGF1 Signaling	CELL			English	Editorial Material							PHOSPHODIESTERASE 3B; PHOSPHORYLATION; ACTIVATION; PROTEIN; AKT		[Ma, David K.G.; O'Donoghue, Sean I.] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Ma, David K.G.] UNSW, Sch Comp Sci & Engn, Sydney, NSW 2052, Australia; [Stolte, Christian; O'Donoghue, Sean I.] CSIRO, N Ryde, NSW 1670, Australia; [Krycer, James R.; James, David E.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; University of Sydney	Ma, DKG (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia.		; O'Donoghue, Sean/A-9522-2012	Stolte, Christian/0000-0002-8228-4195; O'Donoghue, Sean/0000-0001-9520-6623; James, David/0000-0001-5946-5257; Krycer, James/0000-0003-1536-7270				Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Ma DKG, 2013, AIP CONF PROC, V1559, P185, DOI 10.1063/1.4825010; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	10	14	14	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4							948.e1	10.1016/j.cell.2015.04.041	http://dx.doi.org/10.1016/j.cell.2015.04.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957692	Bronze			2022-12-28	WOS:000354175200026
J	Wang, JH; Cao, JL; Dickson, AL; Poss, KD				Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.			Epicardial regeneration is guided by cardiac outflow tract and Hedgehog signalling	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; IN-VIVO; TRANSCRIPTION FACTORS; FLOOR PLATE; CELLS; INJURY; CARDIOMYOCYTES; NOTOCHORD	In response to cardiac damage, a mesothelial tissue layer enveloping the heart called the epicardium is activated to proliferate and accumulate at the injury site. Recent studies have implicated the epicardium in multiple aspects of cardiac repair: as a source of paracrine signals for cardiomyocyte survival or proliferation; a supply of perivascular cells and possibly other cell types such as cardiomyocytes; and as a mediator of inflammation1-9. However, the biology and dynamism of the adult epicardium is poorly understood. To investigate this, we created a transgenic line to ablate the epicardial cell population in adult zebrafish. Here we find that genetic depletion of the epicardium after myocardial loss inhibits cardiomyocyte proliferation and delays muscle regeneration. The epicardium vigorously regenerates after its ablation, through proliferation and migration of spared epicardial cells as a sheet to cover the exposed ventricular surface in a wave from the chamber base towards its apex. By reconstituting epicardial regeneration ex vivo, we show that extirpation of the bulbous arteriosus-a distinct, smooth-muscle-rich tissue structure that distributes outflow from the ventricle-prevents epicardial regeneration. Conversely, experimental repositioning of the bulbous arteriosus by tissue recombination initiates epicardial regeneration and can govern its direction. Hedgehog (Hh) ligand is expressed in the bulbous arteriosus, and treatment with a Hh signalling antagonist arrests epicardial regeneration and blunts the epicardial response to muscle injury. Transplantation of Sonic hedgehog (Shh)-soaked beads at the ventricular base stimulates epicardial regeneration after bulbous arteriosus removal, indicating that Hh signalling can substitute for the influence of the outflow tract. Thus, the ventricular epicardium has pronounced regenerative capacity, regulated by the neighbouring cardiac outflow tract and Hh signalling. These findings extend our understanding of tissue interactions during regeneration and have implications for mobilizing epicardial cells for therapeutic heart repair.	[Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Cao, Jingli/0000-0001-5938-6604; Wang, Jinhu/0000-0001-9477-0310; Poss, Kenneth/0000-0002-6743-5709	American Heart Association; National Institutes of Health [HL081674]; American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Burris, N. Lee, A. Dunlap and S. Davies for fish care, and M. Bagnat, B. Hogan, J. Kang and R. Karra for comments on the manuscript. This work was funded by postdoctoral fellowships from the American Heart Association to J.W. and J.C., and grants from the National Institutes of Health (HL081674) and American Federation for Aging Research to K.D.P.	Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Guerrero I, 2014, SEMIN CELL DEV BIOL, V33, P52, DOI 10.1016/j.semcdb.2014.06.016; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kim J, 2012, NAT PROTOC, V7, P247, DOI 10.1038/nprot.2011.440; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Singh SP, 2012, DEV CELL, V22, P879, DOI 10.1016/j.devcel.2012.03.006; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Zhou B, 2012, METHODS MOL BIOL, V843, P155, DOI 10.1007/978-1-61779-523-7_15; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	29	131	134	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					226	+		10.1038/nature14325	http://dx.doi.org/10.1038/nature14325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25938716	Green Accepted			2022-12-28	WOS:000356016700041
J	Cook-Andersen, H; Wilkinson, MF				Cook-Andersen, Heidi; Wilkinson, Miles F.			MOLECULAR BIOLOGY Splicing does the two-step	NATURE			English	Editorial Material							LARGE INTRON; EXON; TDP-43; DECAY	An intricate recursive RNA splicing mechanism that removes especially long introns (non-coding sequences) from genes has been found to be evolutionarily conserved and more prevalent than previously thought. SEE LETTERS P.371 & P.376	[Cook-Andersen, Heidi; Wilkinson, Miles F.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cook-Andersen, H (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	mfwilkinson@ucsd.edu		Cook-Andersen, Heidi/0000-0003-3916-5120	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111838] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007203, K12 HD001259] Funding Source: Medline; NIGMS NIH HHS [R01 GM111838] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Sibley CR, 2015, NATURE, V521, P371, DOI 10.1038/nature14466	11	7	7	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					300	301		10.1038/nature14524	http://dx.doi.org/10.1038/nature14524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25970243	Green Accepted, Bronze			2022-12-28	WOS:000354816500045
J	Wu, J; Okamura, D; Li, M; Suzuki, K; Luo, CY; Ma, L; He, YP; Li, ZW; Benner, C; Tamura, I; Krause, MN; Nery, JR; Du, TT; Zhang, ZZ; Hishida, T; Takahashi, Y; Aizawa, E; Kim, NY; Lajara, J; Guillen, P; Campistol, JM; Esteban, CR; Ross, PJ; Saghatelian, A; Ren, B; Ecker, JR; Belmonte, JCI				Wu, Jun; Okamura, Daiji; Li, Mo; Suzuki, Keiichiro; Luo, Chongyuan; Ma, Li; He, Yupeng; Li, Zhongwei; Benner, Chris; Tamura, Isao; Krause, Marie N.; Nery, Joseph R.; Du, Tingting; Zhang, Zhuzhu; Hishida, Tomoaki; Takahashi, Yuta; Aizawa, Emi; Kim, Na Young; Lajara, Jeronimo; Guillen, Pedro; Campistol, Josep M.; Esteban, Concepcion Rodriguez; Ross, Pablo J.; Saghatelian, Alan; Ren, Bing; Ecker, Joseph R.; Belmonte, Juan Carlos Izpisua			An alternative pluripotent state confers interspecies chimaeric competency	NATURE			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE STREAK; MOUSE EMBRYOS; HOMOLOGOUS RECOMBINATION; REGULATORY REGIONS; SELF-RENEWAL; CULTURE; EMBRYOGENESIS; SPECIFICATION; TRANSCRIPTION	Pluripotency, the ability to generate any cell type of the body, is an evanescent attribute of embryonic cells. Transitory pluripotent cells can be captured at different time points during embryogenesis and maintained as embryonic stem cells or epiblast stem cells in culture. Since ontogenesis is a dynamic process in both space and time, it seems counterintuitive that these two temporal states represent the full spectrum of organismal pluripotency. Here we show that by modulating culture parameters, a stem-cell type with unique spatial characteristics and distinct molecular and functional features, designated as region-selective pluripotent stem cells (rsPSCs), can be efficiently obtained from mouse embryos and primate pluripotent stem cells, including humans. The ease of culturing and editing the genome of human rsPSCs offers advantages for regenerative medicine applications. The unique ability of human rsPSCs to generate post-implantation interspecies chimaeric embryos may facilitate our understanding of early human development and evolution.	[Wu, Jun; Okamura, Daiji; Li, Mo; Suzuki, Keiichiro; Ma, Li; Li, Zhongwei; Tamura, Isao; Krause, Marie N.; Hishida, Tomoaki; Takahashi, Yuta; Aizawa, Emi; Kim, Na Young; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Luo, Chongyuan; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Luo, Chongyuan; He, Yupeng; Nery, Joseph R.; Zhang, Zhuzhu; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Benner, Chris] Salk Inst Biol Studies, Integrated Genom, La Jolla, CA 92037 USA; [Du, Tingting; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hishida, Tomoaki] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Lajara, Jeronimo; Guillen, Pedro] Univ Catolica, Med, Guadalupe 30107, Spain; [Guillen, Pedro] Fdn Pedro Guillen, Clin Cemtro, Madrid 28035, Spain; [Campistol, Josep M.] Hosp Clin Barcelona, E-08036 Barcelona, Spain; [Ross, Pablo J.] Univ Calif Davis, Davis, CA 95616 USA; [Saghatelian, Alan] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Tsukuba; Universidad Catolica de Valencia San Vicente Martir; University of Barcelona; Hospital Clinic de Barcelona; University of California System; University of California Davis; Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Li, Mo/AAM-8266-2021; Wu, Jun/AAF-1830-2019; Ecker, Joseph R/B-9144-2008; Nery, Joseph/AAE-8422-2019	Li, Mo/0000-0003-0827-8907; Wu, Jun/0000-0001-9863-1668; Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Suzuki, Keiichiro/0000-0001-5603-9105; Benner, Christopher/0000-0002-4618-0719; Lajara Blesa, Jeronimo/0000-0003-1859-8998; Josep M, Campistol/0000-0001-6244-0253	California Institute for Regenerative Medicine Training Grant; UCAM; Fundacion Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation	California Institute for Regenerative Medicine Training Grant; UCAM; Fundacion Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation	We would like to thank S. Mitalipov and J. Thomson for providing rhesus ESCs and iPSCs, respectively, F. Gage for providing chimpanzee iPSCs, K. Zhang for assistance with cell line derivation, M. Ku of the H. A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core for performing RNA-seq and mouse ChIP-seq experiments, M. Chang of the Integrative Genomic and Bioinformatics Core for bioinformatics analysis, W. T. Berggren and the staff of the Salk STEM Core for preparation of custom-mTeSR1 base medium and supply of validated stem culture materials, G. Pao and K. Hasegawa for discussions, Y. Dayn from transgenic core facility and J. Luo for blastocyst injections, Y. Tsunekawa for providing the mutante GFP human ESCs reporter line, E. O'Connor and K. Marquez of Human Embryonic Stem Cell Core Facility of Sanford Consortium for Regenerative Medicine for FACS sorting, R. H. Benitez, A. Goebl, R. D. Soligalia for assistance with genome editing, M. F. Pera for critical reading of the manuscript, and M. Schwarz, and P. Schwarz for administrative help. M. L. and K. S. are supported by a California Institute for Regenerative Medicine Training Grant. We thank J. L. Mendoza for his support on this project. This work was funded in part by UCAM (mouse studies). J. R. E. is an Investigator of the Howard Hughes Medical Institute. P. G. was supported by Fundacion Pedro Guillen. Work in the laboratory of J.C.I.B. was supported by G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and The Moxie Foundation.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Berge D., 2011, NATURE CELL BIOL, V13, P1; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fooksman DR, 2014, J IMMUNOL, V192, P1004, DOI 10.4049/jimmunol.1300977; Fossat N, 2007, DEV CELL, V13, P761, DOI 10.1016/j.devcel.2007.11.011; Glanville-Jones HC, 2013, INT J DEV BIOL, V57, P61, DOI 10.1387/ijdb.120098ra; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hayashi K, 2013, NAT PROTOC, V8, P1513, DOI 10.1038/nprot.2013.090; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamura D, 2005, MOL REPROD DEV, V70, P20, DOI 10.1002/mrd.20136; Okamura D, 2003, DEVELOPMENT, V130, P6423, DOI 10.1242/dev.00870; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pera MF, 2014, CELL STEM CELL, V15, P543, DOI 10.1016/j.stem.2014.10.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	57	163	170	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					316	+		10.1038/nature14413	http://dx.doi.org/10.1038/nature14413			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25945737	Green Accepted			2022-12-28	WOS:000354816500048
J	Wyllie, E; Rincon, SP; Pierce, VM				Wyllie, Elaine; Rincon, Sandra P.; Pierce, Virginia M.			Case 16-2015: A 9-Year-Old Girl with Loss of Consciousness and Seizures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAT-SCRATCH DISEASE; BARTONELLA-HENSELAE DNA; STATUS EPILEPTICUS; ACUTE ENCEPHALOPATHY; ENCEPHALITIS; CHILDREN; DIAGNOSIS; EPIDEMIOLOGY; SPECTRUM; VIRUS		[Wyllie, Elaine] Cleveland Clin, Epilepsy Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Wyllie, Elaine] Cleveland Clin, Inst Pediat, Cleveland, OH USA; [Wyllie, Elaine] Case Western Reserve Univ, Cleveland Clin Lerner, Coll Med, Cleveland, OH 44106 USA; [Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Rincon, Sandra P.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Pierce, Virginia M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pierce, Virginia M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wyllie, E (corresponding author), Cleveland Clin, Epilepsy Ctr, Neurol Inst, Cleveland, OH 44106 USA.			Pierce, Virginia/0000-0002-3723-1326				Adenot M, 2014, J CHILD NEUROL, V29, P1508, DOI 10.1177/0883073813513330; Anand G, 2013, EUR J PAEDIATR NEURO, V17, P429, DOI 10.1016/j.ejpn.2013.03.005; Armengol CE, 1999, J PEDIATR-US, V134, P635, DOI 10.1016/S0022-3476(99)70252-0; Arvand M, 2006, J CLIN MICROBIOL, V44, P2288, DOI 10.1128/JCM.00239-06; ASHKENASI A, 1993, CLIN PEDIATR, V32, P701; Bergmans Anneke M C, 2013, Methods Mol Biol, V943, P217, DOI 10.1007/978-1-60327-353-4_14; CARITHERS HA, 1991, AM J DIS CHILD, V145, P98, DOI 10.1001/archpedi.1991.02160010104026; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; Cherinet Y, 2008, EMERG MED J, V25, P703, DOI 10.1136/emj.2008.060616; Chondrogiannis K, 2012, BRAZ J INFECT DIS, V16, P96, DOI 10.1590/S1413-86702012000100019; Dale RC, 2005, ARCH DIS CHILD, V90, P636, DOI 10.1136/adc.2004.062935; Dohle C, 2012, J NEUROL SCI, V318, P168, DOI 10.1016/j.jns.2012.04.005; Easley RB, 1999, SOUTHERN MED J, V92, P73, DOI 10.1097/00007611-199901000-00015; Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897; García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004; Gemmete JJ, 2013, NEUROIMAG CLIN N AM, V23, P781, DOI 10.1016/j.nic.2013.03.019; Goncalves LF, 2014, PEDIATR RADIOL, V44, P234, DOI 10.1007/s00247-013-2786-y; GUERINA NG, 1992, NEW ENGL J MED, V326, P1480; Gulati D, 2014, STROKE, V45, pE16, DOI 10.1161/STROKEAHA.113.003964; HADLEY S, 1995, NEUROLOGY, V45, P196, DOI 10.1212/WNL.45.1.196; HAHN JS, 1994, PEDIATR NEUROL, V10, P255, DOI 10.1016/0887-8994(94)90035-3; Hansmann Y, 2005, J CLIN MICROBIOL, V43, P3800, DOI 10.1128/JCM.43.8.3800-3806.2005; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Kieslich M, 2001, DEV MED CHILD NEUROL, V43, P555, DOI 10.1017/S0012162201001001; Laothamatas J, 2011, ADV VIRUS RES, V79, P309, DOI 10.1016/B978-0-12-387040-7.00014-7; Liem MSL, 1997, SURGERY, V122, P114, DOI 10.1016/S0039-6060(97)90273-7; Lin WC, 2014, J MICROBIOL IMMUNOL; Lonnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045; Metzkor-Cotter E, 2003, CLIN INFECT DIS, V37, P1149, DOI 10.1086/378738; Muttalib F, 2014, J CLIN MICROBIOL, V52, P1022, DOI 10.1128/JCM.03262-13; NOAH DL, 1995, PEDIATR INFECT DIS J, V14, P866, DOI 10.1097/00006454-199510000-00009; Ogura K, 2004, EUR NEUROL, V51, P109, DOI 10.1159/000076789; Phillips BC, 2013, CLIN NEUROL NEUROSUR, V115, P1102, DOI 10.1016/j.clineuro.2012.08.015; Riviello JJ, 1998, NEW ENGL J MED, V338, P112, DOI 10.1056/NEJM199801083380208; Rohr A, 2012, PEDIATR RADIOL, V42, P1380, DOI 10.1007/s00247-012-2451-x; Sahai S, 2013, PEDIATR REV, V34, P216, DOI 10.1542/pir.34-5-216; Sander A, 2001, EUR J CLIN MICROBIOL, V20, P392, DOI 10.1007/PL00011280; Shin OR, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-62; Singh TD, 2015, NEUROLOGY, V84, P359, DOI 10.1212/WNL.0000000000001190; Stidd DA, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.10.040; To TM, 2014, PEDIATR INFECT DIS J, V33, P1287, DOI 10.1097/INF.0000000000000422; TSAO CY, 1992, CLIN ELECTROENCEPHAL, V23, P65, DOI 10.1177/155005949202300204; Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067; Wilmshurst JM, 2006, J CHILD NEUROL, V21, P788, DOI 10.1177/08830738060210091901; Windsor JJ, 2001, BRIT J BIOMED SCI, V58, P101; YAGUPSKY P, 1990, Pediatric Emergency Care, V6, P43, DOI 10.1097/00006565-199003000-00014; Yasar KK, 2011, J NEUROSCI RURAL PRA, V2, P77, DOI 10.4103/0976-3147.80114	47	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2050	2058		10.1056/NEJMcpc1501149	http://dx.doi.org/10.1056/NEJMcpc1501149			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25992750				2022-12-28	WOS:000354809300013
J	Alperovitch, A; Kurth, T; Bertrand, M; Ancelin, ML; Helmer, C; Debette, S; Tzourio, C				Alperovitch, Annick; Kurth, Tobias; Bertrand, Marion; Ancelin, Marie-Laure; Helmer, Catherine; Debette, Stephanie; Tzourio, Christophe			Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; HEMORRHAGIC STROKE; CHOLESTEROL LEVELS; ISCHEMIC-STROKE; THERAPY; PRAVASTATIN; 3-CITY; METAANALYSIS; INDIVIDUALS	OBJECTIVE To determine the association between use of lipid lowering drugs (statin or fibrate) in older people with no known history of vascular events and long term risk of coronary heart disease and stroke. DESIGN Ongoing prospective population based cohort study recruited in 1999-2000, with five face-to-face examinations. SETTING Random sample of community dwelling population aged 65 years and over, living in three French cities (Bordeaux, Dijon, Montpellier). PARTICIPANTS 7484 men and women (63%) with mean age 73.9 years and no known history of vascular events at entry. Mean follow-up was 9.1 years. MAIN OUTCOME MEASURES Adjusted hazard ratios of coronary heart disease and stroke in baseline lipid lowering drug users compared with non-users, calculated using multivariable Cox proportional hazard models adjusted for numerous potential confounding factors. Hazard ratios were estimated for use of any lipid lowering drug and for statin and fibrate separately. RESULTS Lipid lowering drug users were at decreased risk of stroke compared with non-users (hazard ratio 0.66, 95% confidence interval 0.49 to 0.90); hazard ratios for stroke were similar for statin (0.68, 0.45 to1.01) and fibrate (0.66, 0.44 to 0.98). No association was found between lipid lowering drug use and coronary heart disease (hazard ratio 1.12, 0.90 to 1.40). Analyses stratified by age, sex, body mass index, hypertension, systolic blood pressure, triglyceride concentrations, and propensity score did not show any effect modification by these variables, either for stroke or for coronary heart disease. CONCLUSION In a population based cohort of older people with no history of vascular events, use of statins or fibrates was associated with a 30% decrease in the incidence of stroke.	[Alperovitch, Annick; Kurth, Tobias; Bertrand, Marion; Helmer, Catherine; Debette, Stephanie; Tzourio, Christophe] INSERM, Epidemiol & Biostat U897, Bordeaux, France; [Alperovitch, Annick; Kurth, Tobias; Bertrand, Marion; Helmer, Catherine; Debette, Stephanie; Tzourio, Christophe] Univ Bordeaux, F-33076 Bordeaux, France; [Ancelin, Marie-Laure] INSERM, U1061, Montpellier, France; [Ancelin, Marie-Laure] Univ Montpellier I, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Tzourio, C (corresponding author), Univ Bordeaux, INSERM, U897, 146 Rue Leo Saignat Case 11, F-33076 Bordeaux, France.	christophe.tzourio@u-bordeaux.fr	Debette, Stephanie/T-4946-2019; Ancelin, Marie-Laure/L-1198-2019; Ancelin, Marie-Laure/F-3079-2013; HELMER, Catherine/I-6581-2015; Kurth, Tobias/A-9243-2012; HELMER, Catherine/AAG-5126-2021; Tzourio, christophe/B-4015-2009; Tzourio, christophe/L-6344-2019	Debette, Stephanie/0000-0001-8675-7968; Ancelin, Marie-Laure/0000-0002-1149-4320; Ancelin, Marie-Laure/0000-0002-1149-4320; HELMER, Catherine/0000-0002-5169-7421; Kurth, Tobias/0000-0001-7169-2620; Tzourio, christophe/0000-0002-6517-2984; Tzourio, christophe/0000-0002-6517-2984	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseil Regionaux of Aquitaine; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Fondation Plan Alzheimer; Conseil Regionaux of Bourgogne	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseil Regionaux of Aquitaine(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Fondation Plan Alzheimer; Conseil Regionaux of Bourgogne(Region Bourgogne-Franche-Comte)	The Three-City (3C) Study was conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen- Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques," the Fondation Plan Alzheimer. The funding organisations played no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Berger JS, 2012, STROKE, V43, P958, DOI 10.1161/STROKEAHA.111.641324; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Bonaventure A, 2010, ATHEROSCLEROSIS, V210, P243, DOI 10.1016/j.atherosclerosis.2009.10.043; Canoui-Poitrine F, 2010, CEREBROVASC DIS, V30, P252, DOI 10.1159/000319067; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Elisaf M, 2002, CURR MED RES OPIN, V18, P269, DOI 10.1185/030079902125000516; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Fleg JL, 2011, NAT REV CARDIOL, V8, P13, DOI 10.1038/nrcardio.2010.162; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Heart Protection Study Collaborative Group, 2011, Lancet, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Noize P, 2009, PHARMACOEPIDEM DR S, V18, P310, DOI 10.1002/pds.1717; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Remick J, 2008, CARDIOL REV, V16, P129, DOI 10.1097/CRD.0b013e31816b43d3; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, JAMA-J AM MED ASSOC, V310, P1123, DOI 10.1001/jama.2013.276529; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sorensen HT, 2006, HEPATOLOGY, V44, P1075, DOI 10.1002/hep.21404; Steffens Sabine, 2004, Semin Vasc Med, V4, P417, DOI 10.1055/s-2004-869599; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Tziomalos K, 2009, CURR MED CHEM, V16, P676, DOI 10.2174/092986709787458416; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Wieberdink RG, 2011, ARTERIOSCL THROM VAS, V31, P2982, DOI 10.1161/ATVBAHA.111.234948; World Health Organization Collaborating Centre for Drug Statistics Methodology, 1996, GUID ACT CLASS DDD A	39	35	36	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2015	350								h2335	10.1136/bmj.h2335	http://dx.doi.org/10.1136/bmj.h2335			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YU	25989805	Green Published, hybrid			2022-12-28	WOS:000355128000001
J	Nicholson, E				Nicholson, Emily			Accounting for career breaks	SCIENCE			English	Editorial Material									[Nicholson, Emily] Deakin Univ, Ctr Integrat Ecol, Melbourne Burwood, Australia	Deakin University	Nicholson, E (corresponding author), Deakin Univ, Ctr Integrat Ecol, Melbourne Burwood, Australia.		Nicholson, Emily/H-9001-2013	Nicholson, Emily/0000-0003-2199-3446					0	4	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					830	830		10.1126/science.348.6236.830	http://dx.doi.org/10.1126/science.348.6236.830			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977555				2022-12-28	WOS:000354428700049
J	Cosentino, C; Alberio, L; Gazzarrini, S; Aquila, M; Romano, E; Cermenati, S; Zuccolini, P; Petersen, J; Beltrame, M; Van Etten, JL; Christie, JM; Thiel, G; Moroni, A				Cosentino, Cristian; Alberio, Laura; Gazzarrini, Sabrina; Aquila, Marco; Romano, Edoardo; Cermenati, Solei; Zuccolini, Paolo; Petersen, Jan; Beltrame, Monica; Van Etten, James L.; Christie, John M.; Thiel, Gerhard; Moroni, Anna			Engineering of a light-gated potassium channel	SCIENCE			English	Article							CHLORIDE CHANNEL; ION CHANNELS; K+ CHANNEL; CHANNELRHODOPSIN; DOMAIN; LOV	The present palette of opsin-based optogenetic tools lacks a light-gated potassium (K+) channel desirable for silencing of excitable cells. Here, we describe the construction of a blue-light-induced K+ channel 1 (BLINK1) engineered by fusing the plant LOV2-J alpha photosensory module to the small viral K+ channel Kcv. BLINK1 exhibits biophysical features of Kcv, including K+ selectivity and high single-channel conductance, but reversibly photoactivates in blue light. Opening of BLINK1 channels hyperpolarizes the cell to the K+ equilibrium potential. Ectopic expression of BLINK1 reversibly inhibits the escape response in light-exposed zebrafish larvae. BLINK1 therefore provides a single-component optogenetic tool that can establish prolonged, physiological hyperpolarization of cells at low light intensities.	[Cosentino, Cristian; Alberio, Laura; Gazzarrini, Sabrina; Aquila, Marco; Romano, Edoardo; Cermenati, Solei; Zuccolini, Paolo; Beltrame, Monica; Moroni, Anna] Univ Milan, Dept Biosci, I-20122 Milan, Italy; [Petersen, Jan; Christie, John M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Van Etten, James L.] Univ Nebraska Lincoln, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska Lincoln, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Thiel, Gerhard] Tech Univ Darmstadt, Membrane Biophys, Darmstadt, Germany	University of Milan; University of Glasgow; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Technical University of Darmstadt	Moroni, A (corresponding author), Univ Milan, Dept Biosci, I-20122 Milan, Italy.	anna.moroni@unimi.it	; moroni, anna/H-2097-2014	Alberio, Laura Silvia/0000-0002-2887-3343; Thiel, Gerhard/0000-0002-2335-1351; Cosentino, Cristian/0000-0002-2784-0048; Christie, John/0000-0002-9976-0055; gazzarrini, sabrina/0000-0003-3062-7536; Petersen, Jan/0000-0002-8469-6679; Beltrame, Monica/0000-0001-5094-3494; moroni, anna/0000-0002-1860-406X	Fondazione Cariplo grant [2009-3519]; PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale) [2010CSJX4F]; MAE (Ministero Affari Esteri) [01467532013-06-27]; UK Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128]; Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control; BBSRC [BB/J016047/1, BB/M002128/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1] Funding Source: researchfish	Fondazione Cariplo grant(Fondazione Cariplo); PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MAE (Ministero Affari Esteri); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. Romani for providing the antibody to Kcv; D. Minor for the Saccharomyces cerevisiae SGY1528 strain; U. P. Hansen, I. Schroeder, and A. Bertl for helpful discussion; and M. Ascagni for technical help with confocal microscopy. This work was supported by Fondazione Cariplo grant 2009-3519, PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale) 2010CSJX4F, and MAE (Ministero Affari Esteri) 01467532013-06-27 to A. M.; by the UK Biotechnology and Biological Sciences Research Council (BB/J016047/1 and BB/M002128) to J.M.C.; and by the Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control to G.T.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Arrigoni C, 2013, J GEN PHYSIOL, V141, P389, DOI 10.1085/jgp.201210940; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hertel B, 2010, EUR BIOPHYS J BIOPHY, V39, P1057, DOI 10.1007/s00249-009-0451-z; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Kang JY, 2013, NEURON, V80, P358, DOI 10.1016/j.neuron.2013.08.016; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Schmidt D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4019; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	23	90	93	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					707	710		10.1126/science.aaa2787	http://dx.doi.org/10.1126/science.aaa2787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954011	Green Submitted			2022-12-28	WOS:000354045700049
J	Xing, L; Li, XY; Snider, WD				Xing, Lei; Li, Xiaoyan; Snider, William D.			"RASopathic" astrocytes constrain neural plasticity	SCIENCE			English	Editorial Material									[Xing, Lei; Li, Xiaoyan; Snider, William D.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Xing, L (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu	xing, lei/K-5104-2015	Xing, Lei/0000-0003-2325-0806	NIH [RO1 NS031768]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	W.D.S. is supported by NIH grant RO1 NS031768.	Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Gripp K.W., 2006, GENEREVIEWS; Krencik R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5645; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Lin AL, 2013, NAT REV CLIN ONCOL, V10, P616, DOI 10.1038/nrclinonc.2013.144; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wang Y, 2012, CELL, V150, P816, DOI 10.1016/j.cell.2012.06.034; Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929	15	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					636	637		10.1126/science.aab3738	http://dx.doi.org/10.1126/science.aab3738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953994				2022-12-28	WOS:000354045700028
J	Ait-Ali, N; Fridlich, R; Millet-Puel, G; Clerin, E; Delalande, F; Jaillard, C; Blond, F; Perrocheau, L; Reichman, S; Byrne, LC; Olivier-Bandini, A; Bellalou, J; Moyse, E; Bouillaud, F; Nicol, X; Dalkara, D; van Dorsselaer, A; Sahel, JA; Leveillard, T				Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Delalande, Francois; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Byrne, Leah C.; Olivier-Bandini, Anne; Bellalou, Jacques; Moyse, Emmanuel; Bouillaud, Frederic; Nicol, Xavier; Dalkara, Deniz; van Dorsselaer, Alain; Sahel, Jose-Alain; Leveillard, Thierry			Rod-Derived Cone Viability Factor Promotes Cone Survival by Stimulating Aerobic Glycolysis	CELL			English	Article							THIOREDOXIN-LIKE PROTEIN; PYRUVATE-KINASE; RDCVF; EXPRESSION; CD147; PHOTORECEPTORS; DYSFUNCTION; SECRETION; RESCUE; MODEL	Rod-derived cone viability factor (RdCVF) is an inactive thioredoxin secreted by rod photoreceptors that protects cones from degeneration. Because the secondary loss of cones in retinitis pigmentosa (RP) leads to blindness, the administration of RdCVF is a promising therapy for this untreatable neurodegenerative disease. Here, we investigated the mechanism underlying the protective role of RdCVF in RP. We show that RdCVF acts through binding to Basigin-1 (BSG1), a transmembrane protein expressed specifically by photoreceptors. BSG1 binds to the glucose transporter GLUT1, resulting in increased glucose entry into cones. Increased glucose promotes cone survival by stimulation of aerobic glycolysis. Moreover, a missense mutation of RdCVF results in its inability to bind to BSG1, stimulate glucose uptake, and prevent secondary cone death in a model of RP. Our data uncover an entirely novel mechanism of neuroprotection through the stimulation of glucose metabolism.	[Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, F-75012 Paris, France; [Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, Sorbonne Univ, UMR S 968, Inst Vis, F-75012 Paris, France; [Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, F-75012 Paris, France; [Delalande, Francois; van Dorsselaer, Alain] Univ Strasbourg, IPHC, BioOrgan Mass Spectrometry Lab LSMBO, F-67087 Strasbourg, France; [Delalande, Francois; van Dorsselaer, Alain] CNRS, IPHC, UMR7178, F-67087 Strasbourg, France; [Byrne, Leah C.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Olivier-Bandini, Anne] Sanofi R&D, F-91385 Chilly Mazarin, France; [Bellalou, Jacques] Inst Pasteur, Platform Prod Recombinant Prot & Antibodies 5, F-75724 Paris 15, France; [Moyse, Emmanuel] Univ Francois Rabelais Tours, Ctr INRA Tours, Unite Physiol Reprod & Comportements PRC, UMR INRA 85, F-37380 Nouzilly, France; [Bouillaud, Frederic] INSERM, U1016, Inst Cochin, F-75014 Paris, France; [Bouillaud, Frederic] CNRS, UMR8104, F-75014 Paris, France; [Bouillaud, Frederic] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Berkeley; Sanofi-Aventis; Sanofi France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Leveillard, T (corresponding author), INSERM, U968, F-75012 Paris, France.	thierry.leveillard@inserm.fr	Nicol, Xavier/D-6087-2012; MOYSE, Emmanuel/ABE-1819-2021; Aït-Ali, Najate/B-7988-2016; Reichman, Sacha/R-7581-2017; Dalkara, Deniz/D-5057-2017; Bouillaud, Frédéric R/L-3238-2017; Sahel, Jose-Alain/F-3172-2017; Léveillard, Thierry/AAR-1804-2020	Nicol, Xavier/0000-0002-0310-8047; Aït-Ali, Najate/0000-0003-1323-4087; Reichman, Sacha/0000-0003-1776-6339; Dalkara, Deniz/0000-0003-4112-9321; Bouillaud, Frédéric R/0000-0002-7518-9237; Sahel, Jose-Alain/0000-0002-4831-1153; Léveillard, Thierry/0000-0001-5692-8770; Byrne, Leah/0000-0002-3229-4993; Delalande, Francois/0000-0003-3590-9874; Clerin, Emmanuelle/0000-0003-1451-6051; Puel, Geraldine/0000-0003-2387-538X; Blond, Frederic/0000-0002-2314-0570; MOYSE, Emmanuel/0000-0002-9590-1367; Najate, AIT-ALI/0000-0002-7626-8746	Sanofi; UPMC; Inserm; CNRS; EC; FFB; ANR	Sanofi; UPMC; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EC(European CommissionEuropean Commission Joint Research Centre); FFB; ANR(French National Research Agency (ANR))	We thank C. Petit, J. Kaplan, J. Ochrietor, D.J. Zack, M. Canto-Soler, A. Chedotal, D. Hicks, R. Goument, N. Berdugo, V. Ferracane, Y. Zagar, M.L. Niepon, G. Lucchi, V. and M. Fradot, M. Desrosiers, G. Tarlet, S. Fouquet, NDRI, cornea bank of Beverwijk, and MIRCEN for scientific advice and/or biological materials. This work was supported by Sanofi, UPMC, Inserm, CNRS, EC, FFB, and ANR. J-A.S., and T.L. are patent holders on the use of RdCVF to treat inherited retinal degenerations. A.v.D, J-A.S., and T.L. are patent holders on the use of BSG1 RdCVF to treat inherited retinal degenerations.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Casson RJ, 2013, CLIN EXP OPHTHALMOL, V41, P517, DOI 10.1111/ceo.12050; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5; Clerin E, 2014, JOVE-J VIS EXP, DOI 10.3791/51954; Clerin E, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-38; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Delyfer MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028791; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Elachouri G, 2015, FREE RADICAL BIO MED, V81, P22, DOI 10.1016/j.freeradbiomed.2015.01.003; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Hanein S, 2006, ADV EXP MED BIOL, V572, P9; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Jaillard C, 2012, HUM MOL GENET, V21, P2298, DOI 10.1093/hmg/dds050; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Matsuo Y, 2013, CYTOKINE GROWTH F R, V24, P345, DOI 10.1016/j.cytogfr.2013.01.001; Mitamura Y, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/518170; Ochrietor JD, 2003, INVEST OPHTH VIS SCI, V44, P4086, DOI 10.1167/iovs.02-0995; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Redzic JS, 2011, J MOL BIOL, V411, P68, DOI 10.1016/j.jmb.2011.04.060; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Sahaf B, 2000, ANTIOXID REDOX SIGN, V2, P717, DOI 10.1089/ars.2000.2.4-717; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	44	229	236	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					817	832		10.1016/j.cell.2015.03.023	http://dx.doi.org/10.1016/j.cell.2015.03.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957687	Bronze			2022-12-28	WOS:000354175200015
J	Gerding, DN; Meyer, T; Lee, C; Cohen, SH; Murthy, UK; Poirier, A; Van Schooneveld, TC; Pardi, DS; Ramos, A; Barron, MA; Chen, HZ; Villano, S				Gerding, Dale N.; Meyer, Thomas; Lee, Christine; Cohen, Stuart H.; Murthy, Uma K.; Poirier, Andre; Van Schooneveld, Trevor C.; Pardi, Darrell S.; Ramos, Antonio; Barron, Michelle A.; Chen, Hongzi; Villano, Stephen			Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIARRHEA; DISEASE; METRONIDAZOLE; COLONIZATION; VANCOMYCIN; HAMSTERS	IMPORTANCE Clostridium difficile is the most common cause of health care-associated infection in US hospitals. Recurrence occurs in 25% to 30% of patients. OBJECTIVE To determine the safety, fecal colonization, recurrence rate, and optimal dosing schedule of nontoxigenic C difficile strain M3 (VP20621; NTCD-M3) for prevention of recurrent C difficile infection (CDI). DESIGN, SETTING, AND PARTICIPANTS Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study conducted from June 2011 to June 2013 among 173 patients aged 18 years or older who were diagnosed as having CDI (first episode or first recurrence) and had successfully completed treatment with metronidazole, oral vancomycin, or both at 44 study centers in the United States, Canada, and Europe. INTERVENTIONS Patients were randomly assigned to receive 1 of 4 treatments: oral liquid formulation of NTCD-M3, 104 spores/d for 7 days (n = 43), 107 spores/d for 7 days (n = 44), or 107 spores/d for 14 days (n = 42), or placebo for 14 days (n = 44). MAIN OUTCOMES AND MEASURES The primary outcomewas safety and tolerability of NTCD-M3 within 7 days of treatment. Exploratory secondary outcomes included fecal colonization with NTCD-M3 from end of study drug through week 6 and CDI recurrence from day 1 through week 6. RESULTS Among 168 patients who started treatment, 157 completed treatment. One or more treatment-emergent adverse events were reported in 78% of patients receiving NTCD-M3 and 86% of patients receiving placebo. Diarrhea and abdominal pain were reported in 46% and 17% of patients receiving NTCD-M3 and 60% and 33% of placebo patients, respectively. Serious treatment-emergent adverse events were reported in 7% of patients receiving placebo and 3% of all patients who received NTCD-M3. Headache was reported in 10% of patients receiving NTCD-M3 and 2% of placebo patients. Fecal colonization occurred in 69% of NTCD-M3 patients: 71% with 10(7) spores/d and 63% with 10(4) spores/d. Recurrence of CDI occurred in 13 (30%) of 43 placebo patients and 14 (11%) of 125 NTCD-M3 patients (odds ratio [OR], 0.28; 95% CI, 0.11-0.69; P = .006); the lowest recurrence was in 2 (5%) of 43 patients receiving 10(7) spores/d for 7 days (OR, 0.1; 95% CI, 0.0-0.6; P = .01 vs placebo]). Recurrence occurred in 2 (2%) of 86 patients who were colonized vs 12 (31%) of 39 patients who received NTCD-M3 and were not colonized (OR, 0.01; 95% CI, 0.00-0.05; P < .001). CONCLUSIONS AND RELEVANCE Among patients with CDI who clinically recovered following treatment with metronidazole or vancomycin, oral administration of spores of NTCD-M3 was well tolerated and appeared to be safe. Nontoxigenic C difficile strain M3 colonized the gastrointestinal tract and significantly reduced CDI recurrence. Copyright 2015 American Medical Association. All rights reserved.	[Gerding, Dale N.] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Gerding, Dale N.] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Meyer, Thomas] Indiana Univ, Hlth Arnett Hosp, Lafayette, IN USA; [Lee, Christine] McMaster Univ, St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Cohen, Stuart H.] Univ Calif Davis, Med Ctr, Div Infect Dis, Sacramento, CA 95817 USA; [Murthy, Uma K.] VA Med Ctr, Syracuse, NY USA; [Murthy, Uma K.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Poirier, Andre] Ctr Sante & Serv Sociaux Trois Rivieres, Trois Rivieres, PQ, Canada; [Van Schooneveld, Trevor C.] Univ Nebraska Med Ctr, Div Infect Dis, Omaha, NE USA; [Pardi, Darrell S.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Ramos, Antonio] Hosp Univ Puerta Hierro, Madrid, Spain; [Barron, Michelle A.] Univ Colorado Denver, Internal Med & Infect Dis, Aurora, CO USA; [Chen, Hongzi; Villano, Stephen] Shire, Wayne, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Indiana University System; McMaster University; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Nebraska System; University of Nebraska Medical Center; Mayo Clinic; Hospital Puerta de Hierro-Majadahonda; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Shire Pharmaceuticals Limited	Gerding, DN (corresponding author), US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Res & Dev, Fifth Ave & Roosevelt Rd,Bldg 1,Room B347, Hines, IL 60141 USA.	dale.gerding2@va.gov	Ramos-Martinez, Antonio/A-7456-2018	Ramos-Martinez, Antonio/0000-0002-4840-9425; Van Schooneveld, Trevor/0000-0002-9928-4546	ViroPharma Incorporated, which is now part of the Shire group of companies	ViroPharma Incorporated, which is now part of the Shire group of companies	This study was sponsored by ViroPharma Incorporated, which is now part of the Shire group of companies.	Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; BORRIELLO SP, 1985, J MED MICROBIOL, V19, P339, DOI 10.1099/00222615-19-3-339; Brouwer MSM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3601; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Gerding DN, 2012, DISCOV MED, V13, P75; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Merrigan MM, 2003, J INFECT DIS, V188, P1922, DOI 10.1086/379836; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; SEAL D, 1987, EUR J CLIN MICROBIOL, V6, P51, DOI 10.1007/BF02097191; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Villano SA, 2012, ANTIMICROB AGENTS CH, V56, P5224, DOI 10.1128/AAC.00913-12; WILSON KH, 1983, J INFECT DIS, V147, P733, DOI 10.1093/infdis/147.4.733; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	20	198	207	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1719	1727		10.1001/jama.2015.3725	http://dx.doi.org/10.1001/jama.2015.3725			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942722	Bronze			2022-12-28	WOS:000353921000017
J	Carter, R				Carter, Rowena			MEDICINE AND THE MEDIA How to stop making a crisis out of a drama: towards better portrayal of mental ill health in television and film	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									South London & Maudsley NHS Fdn Trust, Psychiat, London SE5 8AZ, England	South London & Maudsley NHS Trust	Carter, R (corresponding author), South London & Maudsley NHS Fdn Trust, Psychiat, London SE5 8AZ, England.	rowena.carter@slam.nhs.uk						[Anonymous], 2014, TIME CHANGE MAKING D	1	0	0	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2015	350								h2307	10.1136/bmj.h2307	http://dx.doi.org/10.1136/bmj.h2307			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH3UX	25934685				2022-12-28	WOS:000353957100003
J	Lambertucci, SA; Shepard, ELC; Wilson, RP				Lambertucci, Sergio A.; Shepard, Emily L. C.; Wilson, Rory P.			Human-wildlife conflicts in a crowded airspace	SCIENCE			English	Editorial Material							COLLISIONS; ECOLOGY; BIRDS		[Lambertucci, Sergio A.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Shepard, Emily L. C.; Wilson, Rory P.] Swansea Univ, Swansea Lab Anim Movement, Biosci, Swansea, W Glam, Wales	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Swansea University	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar		LAMBERTUCCI, SERGIO/0000-0002-2624-2185; Shepard, Emily/0000-0001-7325-6398	PIP [0095]; CONICET; Swansea University;  [PICT1156/2010]	PIP; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Swansea University; 	The authors thank PICT1156/2010, PIP 0095, CONICET, and Swansea University for funding; reviewers for comments; and F. Ballejo for help with the figure.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Dai KS, 2015, RENEW ENERG, V75, P911, DOI 10.1016/j.renene.2014.10.074; Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015; Dolbeer R., 2014, WILDLIFE STRIKES CIV; Dolbeer RA, 2006, J WILDLIFE MANAGE, V70, P1345, DOI 10.2193/0022-541X(2006)70[1345:HDOBRB]2.0.CO;2; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Polymenakou PN, 2012, ATMOSPHERE-BASEL, V3, P87, DOI 10.3390/atmos3010087; Satheesan S. M., 2000, SERIOUS VULTURE HITS; Vas E, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0754	14	45	47	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					502	504		10.1126/science.aaa6743	http://dx.doi.org/10.1126/science.aaa6743			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931541				2022-12-28	WOS:000353778100022
J	Malnick, S; Abdul-Hai, A; Abdullah, A; Gharaba, Y; Brand, A; Basevitz, A; Alin, P; Binder, Y; Raz, O; Melzer, E; Ziv-Sokolowski, N; Somin, M				Malnick, Stephen; Abdul-Hai, Ali; Abdullah, Ali; Gharaba, Yazid; Brand, Avital; Basevitz, Alon; Alin, Pavel; Binder, Yuval; Raz, Ofer; Melzer, Ehud; Ziv-Sokolowski, Nadia; Somin, Marina			Bloody diarrhoea in a hunger striker: starvation colitis	LANCET			English	Editorial Material									[Malnick, Stephen; Abdul-Hai, Ali; Abdullah, Ali; Gharaba, Yazid; Brand, Avital; Basevitz, Alon; Alin, Pavel; Binder, Yuval; Somin, Marina] Kaplan Med Ctr, Dept Internal Med, Rehovot, Israel; [Binder, Yuval; Raz, Ofer; Melzer, Ehud] Kaplan Med Ctr, Inst Gastroenterol & Liver Dis, Rehovot, Israel; [Ziv-Sokolowski, Nadia] Kaplan Med Ctr, Inst Pathol, Rehovot, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center	Malnick, S (corresponding author), Hebrew Univ Jerusalem, Kaplan Med Ctr, IL-76100 Rehovot, Israel.	stephen@malnick.net						Altun G, 2004, FORENSIC SCI INT, V146, P35, DOI 10.1016/j.forsciint.2004.03.022; GORE DC, 1993, ANN SURG, V218, P679, DOI 10.1097/00000658-199321850-00015; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; ROEDIGER WEW, 1990, DIS COLON RECTUM, V33, P858, DOI 10.1007/BF02051922; WATFORD M, 1979, BIOCHEM J, V178, P589, DOI 10.1042/bj1780589	5	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1696	1696		10.1016/S0140-6736(15)60309-9	http://dx.doi.org/10.1016/S0140-6736(15)60309-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25943822				2022-12-28	WOS:000353418000042
J	Webb, BA; Forouhar, F; Szu, FE; Seetharaman, J; Tong, L; Barber, DL				Webb, Bradley A.; Forouhar, Farhad; Szu, Fu-En; Seetharaman, Jayaraman; Tong, Liang; Barber, Diane L.			Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations	NATURE			English	Article							SKELETAL-MUSCLE 6-PHOSPHOFRUCTO-1-KINASE; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; PLATELET ISOFORM; GLYCOLYSIS; ENZYME; SYSTEM; SITES; CELLS; ATP	Phosphofructokinase-1 (PFK1), the 'gatekeeper' of glycolysis, catalyses the committed step of the glycolytic pathway by converting fructose-6-phosphate to fructose-1,6-bisphosphate. Allosteric activation and inhibition of PFK1 by over ten metabolites and in response to hormonal signalling fine-tune glycolytic flux to meet energy requirements(1). Mutations inhibiting PFK1 activity cause glycogen storage disease type VII, also known as Tarui disease(2), and mice deficient in muscle PFK1 have decreased fat stores(3). Additionally, PFK1 is proposed to have important roles in metabolic reprogramming in cancer(4,5). Despite its critical role in glucose flux, the biologically relevant crystal structure of the mammalian PFK1 tetramer has not been determined. Here we report the first structures of the mammalian PFK1 tetramer, for the human platelet isoform (PFKP), in complex with ATP-Mg2+ and ADP at 3.1 and 3.4 angstrom, respectively. The structures reveal substantial conformational changes in the enzyme upon nucleotide hydrolysis as well as a unique tetramer interface. Mutations of residues in this interface can affect tetramer formation, enzyme catalysis and regulation, indicating the functional importance of the tetramer. With altered glycolytic flux being a hallmark of cancers(6), these new structures allow a molecular understanding of the functional consequences of somatic PFK1 mutations identified in human cancers. We characterize three of these mutations and show they have distinct effects on allosteric regulation of PFKP activity and lactate production. The PFKP structural blueprint for somatic mutations as well as the catalytic site can guide therapeutic targeting of PFK1 activity to control dysregulated glycolysis in disease.	[Webb, Bradley A.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Forouhar, Farhad; Szu, Fu-En; Seetharaman, Jayaraman; Tong, Liang] Columbia Univ, Dept Biol Sci, Northeast Struct Genom Consortium, New York, NY 10027 USA	University of California System; University of California San Francisco; Columbia University	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	ltong@columbia.edu; diane.barber@ucsf.edu	Webb, Bradley/F-6946-2013; Webb, Bradley/HDO-7820-2022	Webb, Bradley/0000-0002-5299-2852; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [R01 GM047413]; Canadian Institutes of Health Research; University of California, San Francisco, Liver Center [P30 DK026743]; Protein Structure Initiative of the National Institutes of Health [U54-GM094597]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047413, U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of California, San Francisco, Liver Center(University of California System); Protein Structure Initiative of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Oakes for access to FPLC instrumentation, R. Fletterick and K. White for discussions, and A. Lauricella and G. DeTitta for the crystallization screening. This work was supported by National Institutes of Health R01 GM047413 to D.L.B., a Canadian Institutes of Health Research postdoctoral fellowship and a Pilot/Feasibility grant from the University of California, San Francisco, Liver Center (P30 DK026743) to B.A.W., and a grant from the Protein Structure Initiative of the National Institutes of Health U54-GM094597 to L.T.	Abrantes JL, 2012, BBA-MOL BASIS DIS, V1822, P1198, DOI 10.1016/j.bbadis.2012.04.011; AKKERMAN JW, 1974, BIOCHIM BIOPHYS ACTA, V370, P102, DOI 10.1016/0005-2744(74)90036-9; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Bruser A, 2012, J BIOL CHEM, V287, P17546, DOI 10.1074/jbc.M112.347153; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Getty-Kaushik L, 2010, OBESITY, V18, P434, DOI 10.1038/oby.2009.295; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HESTERBERG LK, 1982, BIOCHEMISTRY-US, V21, P216, DOI 10.1021/bi00531a003; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; LUNDHOLM L, 1963, ACTA PHYSIOL SCAND, V58, P243, DOI 10.1111/j.1748-1716.1963.tb02645.x; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moon JS, 2011, J BIOL CHEM, V286, P23808, DOI 10.1074/jbc.M111.236737; Moreno-Sanchez R, 2012, J CELL BIOCHEM, V113, P1692, DOI 10.1002/jcb.24039; Mosser R, 2013, BIOCHEMISTRY-US, V52, P5421, DOI 10.1021/bi4002503; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paricharttanakul NM, 2005, BIOCHEMISTRY-US, V44, P15280, DOI 10.1021/bi051283g; Park YY, 2013, HEPATOLOGY, V58, P182, DOI 10.1002/hep.26310; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; RIZZO SC, 1966, AM J PHYSIOL, V211, P429, DOI 10.1152/ajplegacy.1966.211.2.429; RYPNIEWSKI WR, 1989, J MOL BIOL, V207, P805, DOI 10.1016/0022-2836(89)90246-5; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schoneberg T, 2013, BIOL CHEM, V394, P977, DOI 10.1515/hsz-2013-0130; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Strater N, 2011, FASEB J, V25, P89, DOI 10.1096/fj.10-163865; TARUI S, 1965, BIOCHEM BIOPH RES CO, V19, P517, DOI 10.1016/0006-291X(65)90156-7; TELFORD JN, 1975, P NATL ACAD SCI USA, V72, P3054, DOI 10.1073/pnas.72.8.3054; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zancan P, 2008, IUBMB LIFE, V60, P526, DOI 10.1002/iub.58	40	67	70	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					111	+		10.1038/nature14405	http://dx.doi.org/10.1038/nature14405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25985179	Green Submitted, Green Accepted			2022-12-28	WOS:000357169500042
J	Brown, LS; Lankford, WF				Brown, Laura S.; Lankford, William F.			Clean cooking empowers women	NATURE			English	Editorial Material									[Brown, Laura S.; Lankford, William F.] Cent Amer Solar Energy Project CASEP, Charlottesville, VA 22902 USA		Brown, LS (corresponding author), Cent Amer Solar Energy Project CASEP, Charlottesville, VA 22902 USA.	casep12@gmail.com						KAMMEN DM, 1990, NATURE, V348, P385, DOI 10.1038/348385a0; Subramanian M, 2014, NATURE, V509, P548, DOI 10.1038/509548a; Vega N. M., 2001, SOL VIDA RED SOLAR, P5	3	6	6	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					284	285		10.1038/521284a	http://dx.doi.org/10.1038/521284a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI5RM	25993943	Bronze			2022-12-28	WOS:000354816500030
J	Oye, K; Bubela, T; Lawson, JCH				Oye, Kenneth; Bubela, Tania; Lawson, J. Chappell H.			Regulate 'home-brew' opiates	NATURE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE		[Oye, Kenneth; Lawson, J. Chappell H.] MIT, Dept Polit Sci, Cambridge, MA 02139 USA; [Bubela, Tania] Univ Alberta, Sch Publ Hlth, Res, Edmonton, AB, Canada	Massachusetts Institute of Technology (MIT); University of Alberta	Oye, K (corresponding author), MIT, Dept Polit Sci, Cambridge, MA 02139 USA.	oye@mit.edu	Bubela, Tania/F-4860-2014	Bubela, Tania/0000-0002-0807-2899				Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Beaudoin GAW., 2015, CHARACTERIZATION OXI, DOI [10.11575/PRISM/25284, DOI 10.11575/PRISM/25284]; Bubela T, 2012, TRENDS BIOTECHNOL, V30, P132, DOI 10.1016/j.tibtech.2011.10.003; DeLoache W. C, 2015, NATURE CHEM BIOL; Fossati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124459; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; International Narcotics Control Board, 2011, REP INT NAR CONTR BO; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]	10	18	19	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					281	283		10.1038/521281a	http://dx.doi.org/10.1038/521281a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI5RM	25993942	Bronze			2022-12-28	WOS:000354816500029
J	Parsons, H; Stearns, V				Parsons, Heather; Stearns, Vered			Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHEMOPREVENTION; RALOXIFENE		[Parsons, Heather; Stearns, Vered] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Parsons, H (corresponding author), Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA.			Parsons, Heather/0000-0001-8178-6612				Freedman AN, 2011, J CLIN ONCOL, V29, P2327, DOI 10.1200/JCO.2010.33.0258; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC11	10.7326/ACPJC-2015-162-10-011	http://dx.doi.org/10.7326/ACPJC-2015-162-10-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984872				2022-12-28	WOS:000355015200013
J	Brody, H				Brody, Herb			Colorectal cancer	NATURE			English	Editorial Material																			0	326	342	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S1	S1		10.1038/521S1a	http://dx.doi.org/10.1038/521S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25970450	Bronze			2022-12-28	WOS:000354377800001
J	O'Maille, P				O'Maille, Paul			Fungus against the wall	NATURE			English	Editorial Material							CELL-WALL; OF-ACTION; YEAST	A compound derived from plant cell-wall material that is a waste product of biofuel manufacture has been found to have fungicidal properties: it interacts with a carbohydrate called beta 1,3 glucan, thus compromising the integrity of fungal cells.	[O'Maille, Paul] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [O'Maille, Paul] Inst Food Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	O'Maille, P (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	paul.o'maille@jic.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0644] Funding Source: Medline; BBSRC [BBS/E/J/000C0644] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004; Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Kiraz N, 2010, ANTIMICROB AGENTS CH, V54, P2244, DOI 10.1128/AAC.01527-09; Kurtz MB, 1997, J MED VET MYCOL, V35, P79; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Okada H, 2014, MOL BIOL CELL, V25, P222, DOI 10.1091/mbc.E13-07-0396; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Piotrowski JS, 2015, P NATL ACAD SCI USA, V112, pE1490, DOI 10.1073/pnas.1410400112; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7	10	5	5	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					168	169		10.1038/521168a	http://dx.doi.org/10.1038/521168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25971507				2022-12-28	WOS:000354377800046
J	Ussher, M; Lewis, S; Aveyard, P; Manyonda, I; West, R; Lewis, B; Marcus, B; Riaz, M; Taylor, A; Daley, A; Coleman, T				Ussher, Michael; Lewis, Sarah; Aveyard, Paul; Manyonda, Isaac; West, Robert; Lewis, Beth; Marcus, Bess; Riaz, Muhammad; Taylor, Adrian; Daley, Amanda; Coleman, Tim			Physical activity for smoking cessation in pregnancy: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; EXERCISE; WOMEN; AID; PREVALENCE; DEPRESSION; EFFICACY; TOBACCO	OBJECTIVE To determine the effectiveness of a physical activity intervention for smoking cessation during pregnancy. DESIGN Parallel group, randomised controlled, multicentre trial. SETTING 13 hospitals in England, April 2009 to January 2014. PARTICIPANTS 789 pregnant smokers, aged 16-50 years and at 10-24 weeks' gestation, who smoked at least one cigarette daily and were prepared to quit smoking one week after enrollment were randomised (1:1); 785 were included in the intention to treat analyses, with 392 assigned to the physical activity group. INTERVENTIONS Interventions began one week before a target quit date. Participants were randomised to six weekly sessions of behavioural support for smoking cessation (control) or to this support plus 14 sessions combining supervised treadmill exercise and physical activity consultations. MAINOUTCOME MEASURES The primary outcome was continuous smoking abstinence from the target quit date until end of pregnancy, validated by exhaled carbon monoxide or salivary cotinine levels. To assess adherence, levels of moderate-vigorous intensity physical activity were self reported and in a 11.5% (n=90) random subsample of participants, physical activity was objectively measured by an accelerometer. RESULTS No significant difference was found in rates of smoking abstinence at end of pregnancy between the physical activity and control groups (8% v 6%; odds ratio 1.21, 95% confidence interval 0.70 to 2.10). For the physical activity group compared with the control group, there was a 40% (95% confidence interval 13% to 73%), 34% (6% to 69%), and 46% (12% to 91%) greater increase in self reported minutes carrying out physical activity per week from baseline to one week, four weeks, and six weeks post-quit day, respectively. According to the accelerometer data there was no significant difference in physical activity levels between the groups. Participants attended a median of four treatment sessions in the intervention group and three in the control group. Adverse events and birth outcomes were similar between the two groups, except for significantly more caesarean births in the control group than in the physical activity group (29% v 21%, P=0.023). CONCLUSION Adding a physical activity intervention to behavioural smoking cessation support for pregnant women did not increase cessation rates at end of pregnancy. During pregnancy, physical activity is not recommended for smoking cessation but remains indicated for general health benefits.	[Ussher, Michael; Riaz, Muhammad] St Georges Univ London, Populat Hlth Res Inst, London SW17 ORE, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Lewis, Sarah; Coleman, Tim] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England; [Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Manyonda, Isaac] St Georges Univ London, Dept Obstet & Gynaecol, London SW17 ORE, England; [Manyonda, Isaac] St Georges NHS Trust, London, England; [West, Robert] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London, England; [Lewis, Beth] Univ Minnesota, Sch Kinesiol, Minneapolis, MN USA; [Marcus, Bess] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Taylor, Adrian] Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL4 8AA, Devon, England; [Daley, Amanda] Univ Birmingham, Primary Care Clin Sci, Birmingham, W Midlands, England; [Coleman, Tim] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England	St Georges University London; University of Nottingham; University of Nottingham; University of Oxford; St Georges University London; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of Plymouth; University of Birmingham; University of Nottingham	Ussher, M (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London SW17 ORE, England.	mussher@sgul.ac.uk	Taylor, Adrian/GME-5077-2022; Riaz, Muhammad/AAA-5500-2021; West, Robert/B-5414-2009	Taylor, Adrian/0000-0003-2701-9468; Riaz, Muhammad/0000-0002-5512-1745; West, Robert/0000-0001-6398-0921; Coleman, Tim/0000-0002-7303-4805; Aveyard, Paul/0000-0002-1802-4217; Ussher, Michael/0000-0002-0995-7955	NIHR health technology assessment programme [07.01.14]; Cancer Research UK [14135] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [07/01/14] Funding Source: researchfish	NIHR health technology assessment programme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the NIHR health technology assessment programme (grant 07.01.14). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Affonso DD, 2000, J PSYCHOSOM RES, V49, P207, DOI 10.1016/S0022-3999(00)00176-8; Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; Babor T.F., 1992, AUDIT ALCOHOL USE DI; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; Coleman T, 2012, NEW ENGL J MED, V366, P808, DOI 10.1056/NEJMoa1109582; Domenjoz I, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.030; FERGUSSON D, 2002, BMJ-BRIT MED J, V325, P652, DOI DOI 10.1136/BMJ.325.7365.652; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Haasova M, 2013, ADDICTION, V108, P26, DOI 10.1111/j.1360-0443.2012.04034.x; Hajek P, 2001, ADDICTION, V96, P485, DOI 10.1046/j.1360-0443.2001.96348511.x; Harrison CL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-19; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hedeker D, 2007, ADDICTION, V102, P1564, DOI 10.1111/j.1360-0443.2007.01946.x; Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Matthey S, 2004, J AFFECT DISORDERS, V78, P269, DOI 10.1016/S0165-0327(02)00313-0; Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; NHS Information Centre, 2011, INF FEED SURV 2010 E; Richmond R, 2003, ADDICTION, V98, P553, DOI 10.1046/j.1360-0443.2003.00342.x; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Ussher M, 2013, PSYCHOPHARMACOLOGY, V226, P83, DOI 10.1007/s00213-012-2886-7; Ussher M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-186; Ussher M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-328; Ussher M, 2007, J SMOK CESS, V2, P12, DOI 10.1375/jsc.2.1.12; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 1998, PSYCHOPHARMACOLOGY, V136, P201, DOI 10.1007/s002130050557; WEST RJ, 1985, PSYCHOPHARMACOLOGY, V87, P334, DOI 10.1007/BF00432717	38	37	38	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h2145	10.1136/bmj.h2145	http://dx.doi.org/10.1136/bmj.h2145			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5CI	25976288	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000354770100004
J	Zhao, JH; Benlekbir, S; Rubinstein, JL				Zhao, Jianhua; Benlekbir, Samir; Rubinstein, John L.			Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase	NATURE			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; CENTRAL STALK; ROTARY MOTOR; SUBUNIT-C; CRYO-EM; RESOLUTION; SYNTHASE; REVEALS; ROTOR	Eukaryotic vacuolar H+-ATPases (V-ATPases) are rotary enzymes that use energy from hydrolysis of ATP to ADP to pump protons across membranes and control the pH of many intracellular compartments. ATP hydrolysis in the soluble catalytic region of the enzyme is coupled to proton translocation through the membrane-bound region by rotation of a central rotor subcomplex, with peripheral stalks preventing the entire membrane-bound region from turning with the rotor. The eukaryotic V-ATPase is the most complex rotary ATPase: it has three peripheral stalks, a hetero-oligomeric proton-conducting proteolipid ring, several subunits not found in other rotary ATPases, and is regulated by reversible dissociation of its catalytic and proton-conducting regions(1,2). Studies of ATP synthases, V-ATPases, and bacterial/archaeal V/A-ATPases have suggested that flexibility is necessary for the catalytic mechanism of rotary ATPases(3-5), but the structures of different rotational states have never been observed experimentally. Here we use electron cryomicroscopy to obtain structures for three rotational states of the V-ATPase from the yeast Saccharomyces cerevisiae. The resulting series of structures shows ten proteolipid subunits in the c-ring, setting the ATP: H+ ratio for proton pumping by the V-ATPase at 3: 10, and reveals long and highly tilted transmembrane alpha-helices in the a-subunit that interact with the c-ring. The three different maps reveal the conformational changes that occur to couple rotation in the symmetry-mismatched soluble catalytic region to the membrane-bound proton-translocating region. Almost all of the subunits of the enzyme undergo conformational changes during the transitions between these three rotational states. The structures of these states provide direct evidence that deformation during rotation enables the smooth transmission of power through rotary ATPases.	[Zhao, Jianhua; Benlekbir, Samir; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Zhao, Jianhua; Rubinstein, John L.] Univ Toronto, Dept Med Biophys, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rubinstein, JL (corresponding author), Hosp Sick Children, Res Inst, Mol Struct & Funct Program, 686 Bay St, Toronto, ON M5G 0A4, Canada.	john.rubinstein@utoronto.ca	Zhao, Jianhua/AAU-6301-2021	Rubinstein, John/0000-0003-0566-2209; Zhao, Jianhua/0000-0002-4997-766X	Natural Sciences and Engineering Research Council of Canada; Mary Gertrude l'Anson Scholarship; Canadian Institutes of Health Research [MOP 81294]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mary Gertrude l'Anson Scholarship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank P. Rosenthal, R. Henderson, V. Kanelis, and L. Kay for comments on the manuscript. J.Z. was supported by a Doctoral Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and a Mary Gertrude l'Anson Scholarship. J.L.R. is the Canada Research Chair in Electron Cryomicroscopy. This work was supported by operating grant MOP 81294 from the Canadian Institutes of Health Research.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Bueler SA, 2015, BIOCHEMISTRY-US, V54, P853, DOI 10.1021/bi5013172; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; Marr CR, 2014, J STRUCT BIOL, V185, P42, DOI 10.1016/j.jsb.2013.11.002; Matthies D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6286; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nicholls D. G, 2002, BIOENERGETICS; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; Nishi T, 2001, J BIOL CHEM, V276, P34122, DOI 10.1074/jbc.M104682200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Rubinstein J. L, 2014, ARXIV, P1; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Zhao J, 2015, ARXIV, P1; Zhao JH, 2013, J STRUCT BIOL, V181, P234, DOI 10.1016/j.jsb.2012.12.010; Zhou M, 2014, NAT CHEM, V6, P208, DOI [10.1038/nchem.1868, 10.1038/NCHEM.1868]	51	188	194	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					241	+		10.1038/nature14365	http://dx.doi.org/10.1038/nature14365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971514				2022-12-28	WOS:000354377800063
J	Fisichella, PM				Fisichella, P. Marco			Hoarseness and Laryngopharyngeal Reflux	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTROESOPHAGEAL-REFLUX	IMPORTANCE Current approaches to the diagnosis and subsequent management of specific voice disorders vary widely among primary care physicians (PCPs). In addition, sparse literature describes current primary care practice patterns concerning empirical treatment for vocal disorders. OBJECTIVE To examine how PCPs manage patients with dysphonia, especially with regard to laryngopharyngeal reflux. DESIGN, SETTING, AND PARTICIPANTS Prospective, questionnaire-based study by an academic laryngology practice among academic PCPs from all major US geographic regions. MAIN OUTCOMES AND MEASURES A 16-question web-based survey, distributed via e-mail, concerning management and possible empirical treatment options for patients with dysphonia. RESULTS Of 2441 physicians who received the e-mail broadcast, 314 (12.9%) completed the survey. Among those who completed the survey, 46.3% were family practitioners, 46.5% were trained in internal medicine, and 7.2% identified as specialists. Among all respondents, 64.0% preferred to treat rather than immediately refer a patient with chronic hoarseness (symptoms persisting for > 6 weeks) of unclear origin. Reflux medication (85.8%) and antihistamines (54.2%) were the most commonly selected choices for empirical treatment. Most physician respondents (79.2%) reported that they would treat chronic hoarseness with reflux medication in a patient without evidence of gastroesophageal reflux disease. CONCLUSIONS AND RELEVANCE Most PCPs who responded to our survey report empirically treating patients with chronic hoarseness of unknown origin. Many physician respondents were willing to empirically prescribe reflux medication as primary therapy, even when symptoms of gastroesophageal reflux disease were not present. These data suggest that PCPs strongly consider reflux a common cause of dysphonia and may empirically treat patients having dysphonia with reflux medication before referral.	[Fisichella, P. Marco] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston VA Healthcare Syst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Fisichella, PM (corresponding author), Harvard Univ, Sch Med, Boston VA Healthcare Syst, 1400 VFW Pkwy, West Roxbury, MA 02132 USA.	piero.fisichella@va.gov						Ford CN, 2005, JAMA-J AM MED ASSOC, V294, P1534, DOI 10.1001/jama.294.12.1534; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Ruiz R, 2014, JAMA OTOLARYNGOL, V140, P192, DOI 10.1001/jamaoto.2013.6533; Schwartz SR, 2009, OTOLARYNG HEAD NECK, V141, pS1, DOI 10.1016/j.otohns.2009.06.744; Vaezi MF, 2006, LARYNGOSCOPE, V116, P254, DOI 10.1097/01.mlg.0000192173.00498.ba; Vaezi MF, 2003, CLIN GASTROENTEROL H, V1, P333, DOI 10.1053/S1542-3565(03)00177-0; Vavricka SR, 2007, AM J GASTROENTEROL, V102, P716, DOI 10.1111/j.1572-0241.2007.01145.x	8	3	4	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1853	1854		10.1001/jama.2014.17969	http://dx.doi.org/10.1001/jama.2014.17969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965234				2022-12-28	WOS:000354391000029
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Daily drug shortages place avoidable pressure on primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				All-Party Pharmacy Group, 2012, REP APPG INQ MED SHO; All-Party Pharmacy Group, 2015, ACT NEW GOV 1 100 DA; [Anonymous], 2015, Drug Ther Bull, V53, P33, DOI 10.1136/dtb.2015.3.0316; Gu A, 2011, INOV PHARM, V2; Koba M, 2015, FORBES MAGAZINE; Torjesen I., 2015, PHARM J	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2015	350								h2514	10.1136/bmj.h2514	http://dx.doi.org/10.1136/bmj.h2514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BT	25964678	Bronze			2022-12-28	WOS:000354768600013
J	Gillingwater, TH; Findlater, GS				Gillingwater, Thomas H.; Findlater, Gordon S.			Anatomy: back in the public spotlight	LANCET			English	Editorial Material									[Gillingwater, Thomas H.; Findlater, Gordon S.] Univ Edinburgh, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Gillingwater, TH (corresponding author), Univ Edinburgh, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland.	t.gillingwater@ed.ac.uk		Gillingwater, Thomas/0000-0002-0306-5577					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1825	1825		10.1016/S0140-6736(15)60916-3	http://dx.doi.org/10.1016/S0140-6736(15)60916-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25987145				2022-12-28	WOS:000354184500014
J	Yamashita, Y; Yakiwara, H; Asano, Y; Shimizu, H; Uchida, K; Hirano, S; Umakoshi, K; Miyamachi, H; Nakamoto, M; Fukui, M; Kamizono, M; Kanehara, H; Yamada, T; Shinohara, M; Obara, K				Yamashita, Y.; Yakiwara, H.; Asano, Y.; Shimizu, H.; Uchida, K.; Hirano, S.; Umakoshi, K.; Miyamachi, H.; Nakamoto, M.; Fukui, M.; Kamizono, M.; Kanehara, H.; Yamada, T.; Shinohara, M.; Obara, K.			Migrating tremor off southern Kyushu as evidence for slow slip of a shallow subduction interface	SCIENCE			English	Article							LOW FREQUENCY EARTHQUAKES; SOUTHWEST JAPAN; ZONE; COLLISION; PENINSULA; EVENTS; RIDGE; OKI	Detection of shallow slow earthquakes offers insight into the near-trench part of the subduction interface, an important region in the development of great earthquake ruptures and tsunami generation. Ocean-bottom monitoring of offshore seismicity off southern Kyushu, Japan, recorded a complete episode of low-frequency tremor, lasting for 1 month, that was associated with very-low-frequency earthquake (VLFE) activity in the shallow plate interface. The shallow tremor episode exhibited two migration modes reminiscent of deep tremor down-dip of the seismogenic zone in some other subduction zones: a large-scale slower propagation mode and a rapid reversal mode. These similarities in migration properties and the association with VLFEs strongly suggest that both the shallow and deep tremor and VLFE may be triggered by the migration of episodic slow slip events.	[Yamashita, Y.; Shimizu, H.; Uchida, K.; Nakamoto, M.; Fukui, M.; Kamizono, M.] Kyushu Univ, Fac Sci, Inst Seismol & Volcanol SEVO, Shimabara 8550843, Japan; [Yakiwara, H.; Hirano, S.; Miyamachi, H.] Kagoshima Univ, Grad Sch Sci & Engn, Nansei Toko Observ Earthquakes & Volcanoes, Kagoshima 8920871, Japan; [Asano, Y.] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Umakoshi, K.] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Kanehara, H.] Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan; [Yamada, T.; Shinohara, M.; Obara, K.] Univ Tokyo, ERI, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan	Kyushu University; Kagoshima University; National Research Institute for Earth Science & Disaster Resilience; Nagasaki University; Nagasaki University; University of Tokyo	Yamashita, Y (corresponding author), Univ Tokyo, ERI, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	yamac@eri.u-tokyo.ac.jp		Yamashita, Yusuke/0000-0002-5347-5216	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions; Japan Society for the Promotion of Science [24-3726]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the crew of the T/S Nagasaki-maru (Faculty of Fisheries, Nagasaki University) for their skillful work and K. Creager, H. Houston, M. Vallee, K. Goto, Y. Yamanaka, K. Mochizuki, the members of SEVO of Kyushu University, and the ERI of The University of Tokyo for valuable discussions and comments. We also thank the anonymous reviewers for providing suggestions and comments that improved the manuscript. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions. Y. Y. received support as a Japan Society for the Promotion of Science research fellow (grant 24-3726). Shallow tremor catalog data are available in the supplementary materials.	Ando R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043056; Asano Y, 2008, EARTH PLANETS SPACE, V60, P871, DOI 10.1186/BF03352839; Bartlow NM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048714; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Dragert H, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008609; Ghosh A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003305; Houston H, 2011, NAT GEOSCI, V4, P404, DOI [10.1038/ngeo1157, 10.1038/NGEO1157]; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Matsuzawa T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007566; Miyazaki S, 2001, J GEOPHYS RES-SOL EA, V106, P4305, DOI 10.1029/2000JB900312; Nishimura T, 2014, PROG EARTH PLANET SC, V1, DOI 10.1186/s40645-014-0022-5; Obana K, 2009, EARTH PLANET SC LETT, V287, P168, DOI 10.1016/j.epsl.2009.08.005; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2005, EARTH PLANETS SPACE, V57, P321, DOI 10.1186/BF03352570; Obara K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047110; Obara K, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006048; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Scholz CH, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009003; Sugioka H, 2012, NAT GEOSCI, V5, P414, DOI [10.1038/NGEO1466, 10.1038/ngeo1466]; Wallace LM, 2009, GEOLOGY, V37, P143, DOI 10.1130/G25221A.1; Walter JI, 2013, GEOPHYS RES LETT, V40, P1517, DOI 10.1002/grl.50213; Wang KL, 2011, GEOLOGY, V39, P819, DOI 10.1130/G31856.1; Yagi Y, 1999, GEOPHYS RES LETT, V26, P3161, DOI 10.1029/1999GL005340; Yagi Y., 1998, J SEISMOL SOC JPN, V2, P139; Yamamoto Y, 2013, TECTONOPHYSICS, V589, P90, DOI 10.1016/j.tecto.2012.12.028; Yamashita Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051476	29	74	74	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					676	679		10.1126/science.aaa4242	http://dx.doi.org/10.1126/science.aaa4242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954006				2022-12-28	WOS:000354045700041
J	Albores, J; Wang, TS				Albores, Jeffrey; Wang, Tisha			Trapped Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Albores, Jeffrey; Wang, Tisha] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Albores, J (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	jeffalbores@yahoo.com							0	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19							e25	10.1056/NEJMicm1404964	http://dx.doi.org/10.1056/NEJMicm1404964			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25946304				2022-12-28	WOS:000353974700010
J	Alford, MH; Peacock, T; MacKinnon, JA; Nash, JD; Buijsman, MC; Centuroni, LR; Chao, SY; Chang, MH; Farmer, DM; Fringer, OB; Fu, KH; Gallacher, PC; Graber, HC; Helfrich, KR; Jachec, SM; Jackson, CR; Klymak, JM; Ko, DS; Jan, S; Johnston, TMS; Legg, S; Lee, IH; Lien, RC; Mercier, MJ; Moum, JN; Musgrave, R; Park, JH; Pickering, AI; Pinkel, R; Rainville, L; Ramp, SR; Rudnick, DL; Sarkar, S; Scotti, A; Simmons, HL; St Laurent, LC; Venayagamoorthy, SK; Wang, YH; Wang, J; Yang, YJ; Paluszkiewicz, T; Tang, TY				Alford, Matthew H.; Peacock, Thomas; MacKinnon, Jennifer A.; Nash, Jonathan D.; Buijsman, Maarten C.; Centuroni, Luca R.; Chao, Shenn-Yu; Chang, Ming-Huei; Farmer, David M.; Fringer, Oliver B.; Fu, Ke-Hsien; Gallacher, Patrick C.; Graber, Hans C.; Helfrich, Karl R.; Jachec, Steven M.; Jackson, Christopher R.; Klymak, Jody M.; Ko, Dong S.; Jan, Sen; Johnston, T. M. Shaun; Legg, Sonya; Lee, I-Huan; Lien, Ren-Chieh; Mercier, Matthieu J.; Moum, James N.; Musgrave, Ruth; Park, Jae-Hun; Pickering, Andrew I.; Pinkel, Robert; Rainville, Luc; Ramp, Steven R.; Rudnick, Daniel L.; Sarkar, Sutanu; Scotti, Alberto; Simmons, Harper L.; St Laurent, Louis C.; Venayagamoorthy, Subhas K.; Wang, Yu-Huai; Wang, Joe; Yang, Yiing J.; Paluszkiewicz, Theresa; Tang, Tswen-Yung (David)			The formation and fate of internal waves in the South China Sea	NATURE			English	Article							BAROCLINIC TIDES; SOLITARY WAVES; LEE WAVES; OCEAN; PROPAGATION; MODEL; CIRCULATION; GENERATION; PREDICTION; RIDGE	Internal gravity waves, the subsurface analogue of the familiar surface gravity waves that break on beaches, are ubiquitous in the ocean. Because of their strong vertical and horizontal currents, and the turbulent mixing caused by their breaking, they affect a panoply of ocean processes, such as the supply of nutrients for photosynthesis(1), sediment and pollutant transport(2) and acoustic transmission(3); they also pose hazards for man-made structures in the ocean(4). Generated primarily by the wind and the tides, internal waves can travel thousands of kilometres from their sources before breaking(5), making it challenging to observe them and to include them in numerical climate models, which are sensitive to their effects(6,7). For over a decade, studies(8-11) have targeted the South China Sea, where the oceans' most powerful known internal waves are generated in the Luzon Strait and steepen dramatically as they propagate west. Confusion has persisted regarding their mechanism of generation, variability and energy budget, however, owing to the lack of in situ data from the Luzon Strait, where extreme flow conditions make measurements difficult. Here we use new observations and numerical models to (1) show that the waves begin as sinusoidal disturbances rather than arising from sharp hydraulic phenomena, (2) reveal the existence of >200-metre-high breaking internal waves in the region of generation that give rise to turbulence levels >10,000 times that in the open ocean, (3) determine that the Kuroshio western boundary current noticeably refracts the internal wave field emanating from the Luzon Strait, and (4) demonstrate a factor-of-two agreement between modelled and observed energy fluxes, which allows us to produce an observationally supported energy budget of the region. Together, these findings give a cradle-to-grave picture of internal waves on a basin scale, which will support further improvements of their representation in numerical climate predictions.	[Alford, Matthew H.; MacKinnon, Jennifer A.; Centuroni, Luca R.; Johnston, T. M. Shaun; Musgrave, Ruth; Pinkel, Robert; Rudnick, Daniel L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Alford, Matthew H.; Lien, Ren-Chieh; Pickering, Andrew I.; Rainville, Luc] Univ Washington, Seattle, WA 98105 USA; [Peacock, Thomas; Pickering, Andrew I.] MIT, Cambridge, MA 02139 USA; [Nash, Jonathan D.; Moum, James N.] Oregon State Univ, Corvallis, OR 97370 USA; [Buijsman, Maarten C.] Univ So Mississippi, Stennis Space Ctr, MS 39529 USA; [Chao, Shenn-Yu] Univ Maryland, Cambridge, MD 21613 USA; [Chang, Ming-Huei; Jan, Sen; Wang, Joe; Yang, Yiing J.; Tang, Tswen-Yung (David)] Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan; [Farmer, David M.] Univ Rhode Isl, Narragansett, RI 02882 USA; [Fringer, Oliver B.] Stanford Univ, Stanford, CA 94305 USA; [Fu, Ke-Hsien; Lee, I-Huan; Wang, Yu-Huai] Natl Sun Yat Sen Univ, Kaohsiung 80424, Taiwan; [Gallacher, Patrick C.; Ko, Dong S.] NRL, Stennis Space Ctr, MS 39529 USA; [Graber, Hans C.] Univ Miami, Miami, FL 33149 USA; [Helfrich, Karl R.; St Laurent, Louis C.] Woods Hole Oceanog Inst, Falmouth, MA 02543 USA; [Jachec, Steven M.] Florida Inst Technol, Melbourne, FL 32901 USA; [Jackson, Christopher R.] Global Ocean Associates, Alexandria, VA 22310 USA; [Klymak, Jody M.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Legg, Sonya] Princeton Univ, Princeton, NJ 08542 USA; [Mercier, Matthieu J.] Inst Mecan Fluides Toulouse, F-31400 Toulouse, France; [Park, Jae-Hun] Korea Inst Ocean Sci & Technol, Ansan 426744, South Korea; [Ramp, Steven R.] Soliton Ocean Serv, Carmel, CA 93924 USA; [Sarkar, Sutanu] Univ Calif San Diego, La Jolla, CA 92037 USA; [Scotti, Alberto] Univ N Carolina, Chapel Hill, NC 27599 USA; [Simmons, Harper L.] Univ Alaska Fairbanks, Fairbanks, AK 99775 USA; [Venayagamoorthy, Subhas K.] Colorado State Univ, Ft Collins, CO 80523 USA; [Paluszkiewicz, Theresa] Off Naval Res, Arlington, VA 22217 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Oregon State University; University of Southern Mississippi; National Taiwan University; University of Rhode Island; Stanford University; National Sun Yat Sen University; United States Department of Defense; United States Navy; Naval Research Laboratory; University of Miami; Woods Hole Oceanographic Institution; Florida Institute of Technology; University of Victoria; Princeton University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Korea Institute of Ocean Science & Technology (KIOST); University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of Alaska System; University of Alaska Fairbanks; Colorado State University; United States Department of Defense; United States Navy	Alford, MH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA.	malford@ucsd.edu	Moum, James N/N-1187-2019; Rudnick, Daniel L/J-8948-2016; Fringer, Oliver/GZL-2507-2022; Mercier, Matthieu/H-4278-2012; Klymak, Jody M/A-3041-2008; Nash, Jonathan/K-8101-2019; Legg, Sonya/E-5995-2010; Klymak, Jody M./AAD-7557-2021; Scotti, Alberto/H-6015-2019	Rudnick, Daniel L/0000-0002-2624-7074; Fringer, Oliver/0000-0003-3176-6925; Mercier, Matthieu/0000-0001-9965-3316; Klymak, Jody M/0000-0003-4612-8600; Klymak, Jody M./0000-0003-4612-8600; Scotti, Alberto/0000-0001-8283-3070; Buijsman, Maarten/0000-0001-8478-5957; Wang, Joe/0000-0002-3298-2956; Johnston, T. M. Shaun/0000-0002-8760-3749; CHANG, MING-HUEI/0000-0002-6409-7652; Jan, Sen/0000-0002-4128-9715; Park, Jae-Hun/0000-0003-0442-695X; Yang, Yiing-Jang/0000-0002-6637-9311; Nash, Jonathan/0000-0003-4005-9368	US Office of Naval Research; Taiwan National Science Council	US Office of Naval Research(Office of Naval Research); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This article is dedicated to the memory of author T.-Y. Tang. Our work was supported by the US Office of Naval Research and the Taiwan National Science Council. We are indebted to the captains and crew of all of the research vessels that supported this work, as well as to the technical staff of the seagoing institutions. Without the skill and hard work of all of these people, these observations would not have been possible.	Alford MH, 2006, J PHYS OCEANOGR, V36, P997, DOI 10.1175/JPO2877.1; Alford MH, 2014, GEOPHYS RES LETT, V41, P906, DOI 10.1002/2013GL059070; Alford MH, 2011, J PHYS OCEANOGR, V41, P2211, DOI 10.1175/JPO-D-11-073.1; Alford MH, 2010, J PHYS OCEANOGR, V40, P1338, DOI 10.1175/2010JPO4388.1; Alford MH, 2003, NATURE, V423, P159, DOI 10.1038/nature01628; Althaus AM, 2003, J PHYS OCEANOGR, V33, P1510, DOI 10.1175/1520-0485(2003)033<1510:ITRFME>2.0.CO;2; Bogucki D, 1997, J PHYS OCEANOGR, V27, P1181, DOI 10.1175/1520-0485(1997)027<1181:SRAMBR>2.0.CO;2; Buijsman MC, 2014, J PHYS OCEANOGR, V44, P850, DOI 10.1175/JPO-D-13-024.1; Cai SQ, 2012, SURV GEOPHYS, V33, P927, DOI 10.1007/s10712-012-9176-0; Chang MH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025196; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Chen YJ, 2013, J GEOPHYS RES-OCEANS, V118, P6578, DOI 10.1002/2013JC009319; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; Doherty KW, 1999, J ATMOS OCEAN TECH, V16, P1816, DOI 10.1175/1520-0426(1999)016<1816:AMPI>2.0.CO;2; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Farmer D, 2009, ATMOS OCEAN, V47, P267, DOI 10.3137/OC313.2009; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Ferron B, 1998, J PHYS OCEANOGR, V28, P1929, DOI 10.1175/1520-0485(1998)028<1929:MITRFZ>2.0.CO;2; Gregg MC, 1998, COAST ESTUAR STUD, V54, P305; Guo C, 2014, PROG OCEANOGR, V121, P7, DOI 10.1016/j.pocean.2013.04.002; Hallberg R, 1996, J PHYS OCEANOGR, V26, P913, DOI 10.1175/1520-0485(1996)026<0913:BDCIAO>2.0.CO;2; Helfrich KR, 2008, J PHYS OCEANOGR, V38, P686, DOI 10.1175/2007JPO3826.1; Jan S, 2008, J OCEANOGR, V64, P789, DOI 10.1007/s10872-008-0066-5; Johnston T. M. S., 2013, J GEOPHYS RES, V118, P1; Kelly SM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045598; Klymak JM, 2006, J PHYS OCEANOGR, V36, P1148, DOI 10.1175/JPO2885.1; Klymak JM, 2011, J PHYS OCEANOGR, V41, P926, DOI 10.1175/2010JPO4500.1; Klymak JM, 2010, OCEAN MODEL, V33, P224, DOI 10.1016/j.ocemod.2010.02.005; Ko DS, 2008, J MARINE SYST, V69, P17, DOI 10.1016/j.jmarsys.2007.02.022; Li Q, 2011, J PHYS OCEANOGR, V41, P1345, DOI 10.1175/2011JPO4587.1; Li Q, 2009, J ATMOS OCEAN TECH, V26, P2228, DOI 10.1175/2009JTECHO652.1; Lien RC, 2014, J PHYS OCEANOGR, V44, P1095, DOI 10.1175/JPO-D-13-088.1; Ma BB, 2013, J OCEANOGR, V69, P619, DOI 10.1007/s10872-013-0198-0; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Mater BD, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4813809; Melet A, 2013, J PHYS OCEANOGR, V43, P602, DOI 10.1175/JPO-D-12-055.1; Mercier MJ, 2013, GEOPHYS RES LETT, V40, P5704, DOI 10.1002/2013GL058064; Moore SE, 2007, MAR MAMMAL SCI, V23, P193, DOI 10.1111/j.1748-7692.2006.00086.x; Moum JN, 2007, J PHYS OCEANOGR, V37, P1968, DOI 10.1175/JPO3094.1; Nash JD, 2005, J ATMOS OCEAN TECH, V22, P1551, DOI 10.1175/JTECH1784.1; OSBORNE AR, 1978, J PETROL TECHNOL, V30, P1497, DOI 10.2118/6913-PA; Park JH, 2013, J GEOPHYS RES-OCEANS, V118, P7081, DOI 10.1002/2013JC008983; Pickering A. I., J PHYS OCEA IN PRESS; Pinkel R, 2012, OCEANOGRAPHY, V25, P160, DOI 10.5670/oceanog.2012.51; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; Ramp SR, 2010, NONLINEAR PROC GEOPH, V17, P481, DOI 10.5194/npg-17-481-2010; Ramp SR, 2004, IEEE J OCEANIC ENG, V29, P1157, DOI 10.1109/JOE.2004.840839; Ray RD, 1996, GEOPHYS RES LETT, V23, P2101, DOI 10.1029/96GL02050; Rudnick DL, 2003, SCIENCE, V301, P355, DOI 10.1126/science.1085837; Sherman J, 2001, IEEE J OCEANIC ENG, V26, P437, DOI 10.1109/48.972076; Simmons H, 2011, OCEANOGRAPHY, V24, P88, DOI 10.5670/oceanog.2011.97; Simmons HL, 2004, OCEAN MODEL, V6, P245, DOI 10.1016/S1463-5003(03)00011-8; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; St Laurent L, 2011, OCEANOGRAPHY, V24, P78, DOI 10.5670/oceanog.2011.96; TEAGUE WJ, 1990, J GEOPHYS RES-OCEANS, V95, P7167, DOI 10.1029/JC095iC05p07167; Vitousek S, 2011, OCEAN MODEL, V40, P72, DOI 10.1016/j.ocemod.2011.07.002; Wang YH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030658; Williams KL, 2001, IEEE J OCEANIC ENG, V26, P102, DOI 10.1109/48.917939	58	345	371	17	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					65	U381		10.1038/nature14399	http://dx.doi.org/10.1038/nature14399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951285	Green Submitted			2022-12-28	WOS:000354040900033
J	Ritter, C; Gobel, CH; Liebig, T; Kaminksy, E; Fink, GR; Lehmann, HC				Ritter, Christian; Goebel, Carl H.; Liebig, Thomas; Kaminksy, Elke; Fink, Gereon R.; Lehmann, Helmar C.			An epigenetic cause of seizures and brain calcification: pseudohypoparathyroidism	LANCET			English	Editorial Material									[Ritter, Christian; Goebel, Carl H.; Fink, Gereon R.; Lehmann, Helmar C.] Univ Hosp Cologne, Dept Neurol, D-50937 Cologne, Germany; [Liebig, Thomas] Univ Hosp Cologne, Dept Radiol & Neuroradiol, D-50937 Cologne, Germany; [Kaminksy, Elke] Univ Hamburg, Inst Human Genet, Hamburg, Germany; [Fink, Gereon R.] Forschungszentrum Julich, Inst Neurosci & Med INM 3, D-52425 Julich, Germany	University of Cologne; University of Cologne; University of Hamburg; Helmholtz Association; Research Center Julich	Lehmann, HC (corresponding author), Univ Hosp Cologne, Dept Neurol, Kerpener Str 62, D-50937 Cologne, Germany.	helmar.lehmann@uk-koeln.de	Göbel, Hartmut/AAE-4719-2020; Fink, Gereon R./AFW-9377-2022; Lehmann, Helmar C/G-4998-2016; Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Lehmann, Helmar C/0000-0001-6205-2293; Fink, Gereon R./0000-0002-8230-1856				Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Izzi B, 2012, CURR MOL MED, V12, P566, DOI 10.2174/156652412800619969; Levine MA, 2012, CURR OPIN ENDOCRINOL, V19, P443, DOI 10.1097/MED.0b013e32835a255c; Mantovani G, 2011, J CLIN ENDOCR METAB, V96, P3020, DOI 10.1210/jc.2011-1048	4	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1802	1802		10.1016/S0140-6736(15)60451-2	http://dx.doi.org/10.1016/S0140-6736(15)60451-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943944				2022-12-28	WOS:000353726000037
J	Sampson, GS; Sanchirico, JN; Roheim, CA; Bush, SR; Taylor, JE; Allison, EH; Anderson, JL; Ban, NC; Fujita, R; Jupiter, S; Wilson, JR				Sampson, Gabriel S.; Sanchirico, James N.; Roheim, Cathy A.; Bush, Simon R.; Taylor, J. Edward; Allison, Edward H.; Anderson, James L.; Ban, Natalie C.; Fujita, Rod; Jupiter, Stacy; Wilson, Jono R.			Secure sustainable seafood from developing countries	SCIENCE			English	Editorial Material							MSC CERTIFICATION; STEWARDSHIP		[Sampson, Gabriel S.; Sanchirico, James N.; Taylor, J. Edward] Univ Calif Davis, Davis, CA 95616 USA; [Sanchirico, James N.] Resources Future Inc, Washington, DC 20036 USA; [Roheim, Cathy A.] Univ Idaho, Moscow, ID 83844 USA; [Bush, Simon R.] Wageningen Univ, NL-6708 LX Wageningen, Netherlands; [Allison, Edward H.] Univ Washington, Seattle, WA 98105 USA; [Anderson, James L.] Univ Florida, Gainesville, FL 32611 USA; [Ban, Natalie C.] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Fujita, Rod] Environm Def Fund, San Francisco, CA 94105 USA; [Jupiter, Stacy] Wildlife Conservat Soc, Suva, Fiji; [Wilson, Jono R.] Nature Conservancy, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; Resources for the Future; Idaho; University of Idaho; Wageningen University & Research; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; University of Victoria; Environmental Defense Fund; Nature Conservancy	Sampson, GS (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	jsanchirico@ucdavis.edu	Allison, Edward Hugh/B-8615-2009	Allison, Edward/0000-0003-4663-1396; Bush, Simon/0000-0002-6689-2246; Jupiter, Stacy/0000-0001-9742-1677	David and Lucile Packard Foundation [9072]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research is an output of a workshop hosted by the University of California Davis Coastal and Marine Science Institute (J. N. S.) and funded by the David and Lucile Packard Foundation in June of 2014 (grant no. 9072). We thank K. Lee, W. Reid, R. Cudney, J. Claussen, S. Hogan, H. Ludemann, M. Weber, and M. Levine for comments.	[Anonymous], 2013, COMM FISH IMPR PROJ; Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Borit M, 2012, MAR POLICY, V36, P96, DOI 10.1016/j.marpol.2011.03.012; Bush SR, 2015, SUSTAINABILITY-BASEL, V7, P1861, DOI 10.3390/su7021861; Bush SR, 2013, MAR POLICY, V37, P288, DOI 10.1016/j.marpol.2012.05.011; Christian C, 2013, BIOL CONSERV, V161, P10, DOI 10.1016/j.biocon.2013.01.002; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Deighan LK, 2015, MAR POLICY, V51, P476, DOI 10.1016/j.marpol.2014.10.009; Goyert W, 2010, MAR POLICY, V34, P1103, DOI 10.1016/j.marpol.2010.03.010; Helyar SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098691; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Micheli F, 2014, FRONT ECOL ENVIRON, V12, P297, DOI 10.1890/110257; Mills M, 2013, CONSERV LETT, V6, P418, DOI 10.1111/conl.12025; MSC, 2013, GLOB IMP REP 2013 MO; MSC, 2014, ANN REP 2013 2014 MS; Perez-Ramirez M, 2012, OCEAN COAST MANAGE, V63, P24, DOI 10.1016/j.ocecoaman.2012.03.009; Perez-Ramirez M, 2012, MAR POLICY, V36, P297, DOI 10.1016/j.marpol.2011.06.013; Ruddle Kenneth, 2008, Environment Development and Sustainability, V10, P565, DOI 10.1007/s10668-008-9152-5; Trumble R. J., 2013, EC MAH MAH FIP REV M	19	77	77	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					504	506		10.1126/science.aaa4639	http://dx.doi.org/10.1126/science.aaa4639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931542				2022-12-28	WOS:000353778100023
J	Drummond, MB				Drummond, M. Bradley			Electronic Cigarettes: Perhaps the Devil Unknown Is Better Than the Devil Known	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SMOKING; ADULTS		[Drummond, M. Bradley] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Drummond, MB (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle,JHAAC 4B-70, Baltimore, MD 21224 USA.	mdrummo3@jhmi.edu		Drummond, Michael/0000-0002-6968-4610				Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Drummond M Bradley, 2014, Ann Am Thorac Soc, V11, P236, DOI 10.1513/AnnalsATS.201311-391FR; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health, 2014, REPORT SURG GEN	10	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					61	62		10.7326/M15-0361	http://dx.doi.org/10.7326/M15-0361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25961965				2022-12-28	WOS:000357442000008
J	Keen, DA; Goodwin, AL				Keen, David A.; Goodwin, Andrew L.			The crystallography of correlated disorder	NATURE			English	Review							PAIR DISTRIBUTION FUNCTION; DIFFUSE-SCATTERING; X-RAY; MONTE-CARLO; PHASE-TRANSITIONS; CRYSTALS; DYNAMICS; ICE; NANOREGIONS; SIMULATION	Classical crystallography can determine structures as complicated as multi-component ribosomal assemblies with atomic resolution, but is inadequate for disordered systems-even those as simple as water ice-that occupy the complex middle ground between liquid-like randomness and crystalline periodic order. Correlated disorder nevertheless has clear crystallographic signatures that map to the type of disorder, irrespective of the underlying physical or chemical interactions and material involved. This mapping hints at a common language for disordered states that will help us to understand, control and exploit the disorder responsible for many interesting physical properties.	[Keen, David A.] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Goodwin, Andrew L.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford OX1 3QR, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford	Keen, DA (corresponding author), Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England.	david.keen@stfc.ac.uk; andrew.goodwin@chem.ox.ac.uk	Goodwin, Andrew/A-5256-2016	Goodwin, Andrew/0000-0001-9231-3749	ERC [279705]	ERC(European Research Council (ERC)European Commission)	We are grateful for discussions with J. A. M. Paddison, M. J. Cliffe and A. B. Cairns. A.L.G. acknowledges financial support from the ERC (grant number 279705).	Algara-Siller G, 2015, NATURE, V519, P443, DOI 10.1038/nature14295; Bennemann K.-H., 2008, SUPERCONDUCTIVITY CO, V1; Bennett TD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.115503; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; BERNAL JD, 1969, SOV PHYS CRYSTALLOGR, V13, P811; BERRET JF, 1992, PHYS REV B, V46, P13747, DOI 10.1103/PhysRevB.46.13747; Billinge SJL, 2000, PHYS REV B, V62, P1203, DOI 10.1103/PhysRevB.62.1203; Bowron DT, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3331655; Bozin ES, 2010, SCIENCE, V330, P1660, DOI 10.1126/science.1192759; Bramwell ST, 2009, NATURE, V461, P956, DOI 10.1038/nature08500; Bramwell ST, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047205; BUTLER BD, 1992, J APPL CRYSTALLOGR, V25, P391, DOI 10.1107/S0021889891014322; Cartwright JHE, 2012, PHILOS T R SOC A, V370, P2807, DOI 10.1098/rsta.2012.0106; Chan EJ, 2009, ACTA CRYSTALLOGR B, V65, P382, DOI 10.1107/S0108768109015857; Chang LJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1989; Christensen M, 2008, NAT MATER, V7, P811, DOI 10.1038/nmat2273; Chupas PJ, 2003, J APPL CRYSTALLOGR, V36, P1342, DOI 10.1107/S0021889803017564; Cliffe MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5176; COMES R, 1970, ACTA CRYSTALL A-CRYS, VA 26, P244, DOI 10.1107/S056773947000061X; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Danilkin SA, 2009, SOLID STATE IONICS, V180, P483, DOI 10.1016/j.ssi.2008.06.012; DAVID WIF, 1992, EUROPHYS LETT, V18, P219, DOI 10.1209/0295-5075/18/3/006; Eggeman AS, 2013, NAT MATER, V12, P1044, DOI [10.1038/NMAT3710, 10.1038/nmat3710]; Fairbank VE, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.104113; Farrow CL, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/33/335219; Fennell T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.017203; Goossens DJ, 2011, METALL MATER TRANS A, V42A, P23, DOI 10.1007/s11661-010-0199-1; Goossens DJ, 2014, METALL MATER TRANS A, V45A, P152, DOI 10.1007/s11661-013-1812-x; Gutmann MJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/31/315402; Hull S, 2009, DALTON T, P8737, DOI 10.1039/b910484b; Keeble DS, 2013, ADV FUNCT MATER, V23, P185, DOI 10.1002/adfm.201201564; Keen DA, 2001, J APPL CRYSTALLOGR, V34, P172, DOI 10.1107/S0021889800019993; Keen DA, 2006, J APPL CRYSTALLOGR, V39, P714, DOI 10.1107/S0021889806025921; Krayzman V, 2012, J APPL CRYSTALLOGR, V45, P106, DOI 10.1107/S0021889812000398; KUHS WF, 1986, WATER SCI REV, V2, P1; KWEI GH, 1993, J PHYS CHEM-US, V97, P2368, DOI 10.1021/j100112a043; Lacroix C, 2011, INTRO FRUSTRATED MAG; Levin I, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024106; LIEB EH, 1967, PHYS REV, V162, P162, DOI 10.1103/PhysRev.162.162; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Lonsdale K, 1942, P PHYS SOC, V54, P314, DOI 10.1088/0959-5309/54/4/302; Lonsdale K, 1941, PROC R SOC LON SER-A, V179, P0008, DOI 10.1098/rspa.1941.0075; Lynn JW, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014437; MADDEN PA, 1992, PHYS REV B, V45, P10206, DOI 10.1103/PhysRevB.45.10206; Maisel SB, 2013, J APPL CRYSTALLOGR, V46, P1211, DOI 10.1107/S0021889813016270; McGreevy RL, 2001, J PHYS-CONDENS MAT, V13, pR877, DOI 10.1088/0953-8984/13/46/201; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nakatsuji S, 2012, SCIENCE, V336, P559, DOI 10.1126/science.1212154; Neder R. B., 2008, DIFFUSE SCATTERING D; Ogitsu T, 2013, CHEM REV, V113, P3425, DOI 10.1021/cr300356t; Paddison JAM, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014411; Paddison JAM, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/45/454220; Paddison JAM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267207; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Rademacher N, 2012, J APPL CRYSTALLOGR, V45, P482, DOI 10.1107/S0021889812016159; Rasche B, 2013, NAT MATER, V12, P422, DOI [10.1038/NMAT3570, 10.1038/nmat3570]; Shintani H, 2006, NAT PHYS, V2, P200, DOI 10.1038/nphys235; Skinner LB, 2012, NUCL INSTRUM METH A, V662, P61, DOI 10.1016/j.nima.2011.09.031; Soper AK, 2011, J APPL CRYSTALLOGR, V44, P714, DOI 10.1107/S0021889811021455; Tucker MG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/33/335218; Tucker MG, 2001, J PHYS-CONDENS MAT, V13, P403, DOI 10.1088/0953-8984/13/3/304; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Weber T, 2012, Z KRIST-CRYST MATER, V227, P238, DOI 10.1524/zkri.2012.1504; Wehinger B, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/26/265401; Welberry TR, 2011, ACTA CRYSTALLOGR B, V67, P516, DOI 10.1107/S0108768111037542; Welberry TR, 2011, METALL MATER TRANS A, V42A, P6, DOI 10.1007/s11661-010-0243-1; Welberry TR, 2010, PHASE TRANSIT, V83, P80, DOI 10.1080/01411590903491752; Welberry TR, 2003, J APPL CRYSTALLOGR, V36, P1440, DOI 10.1107/S002188980302209X; Withers RL, 2005, Z KRISTALLOGR, V220, P1027, DOI 10.1524/zkri.2005.220.12_2005.1027; Wood BC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.166401; Xu GY, 2008, NAT MATER, V7, P562, DOI 10.1038/nmat2196; Xu RQ, 2005, Z KRISTALLOGR, V220, P1009, DOI 10.1524/zkri.2005.220.12_2005.1009; Zhang W, 2010, ANGEW CHEM INT EDIT, V49, P6608, DOI 10.1002/anie.201001208	73	202	204	12	338	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					303	309		10.1038/nature14453	http://dx.doi.org/10.1038/nature14453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993960				2022-12-28	WOS:000354816500046
J	Means, RT				Means, Robert T., Jr.			Review: IV iron does not increase serious adverse events compared with other forms of iron	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									E Tennessee State Univ, James H Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Means, RT (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Johnson City, TN 37614 USA.		Means, Robert T/A-4454-2008	Means, Robert/0000-0002-0947-2624				Auerbach M, 2008, AM J HEMATOL, V83, P580, DOI 10.1002/ajh.21154	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC8	10.7326/ACPJC-2015-162-10-008	http://dx.doi.org/10.7326/ACPJC-2015-162-10-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984881				2022-12-28	WOS:000355015200010
J	Delamarre, L; Mellman, I; Yadav, M				Delamarre, Lelia; Mellman, Ira; Yadav, Mahesh			Neo approaches to cancer vaccines	SCIENCE			English	Editorial Material							IMMUNOTHERAPY; BLOCKADE; ANTIGENS; MELANOMA; CELLS		[Delamarre, Lelia; Mellman, Ira; Yadav, Mahesh] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Delamarre, L (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	12	36	37	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					760	761		10.1126/science.aab3465	http://dx.doi.org/10.1126/science.aab3465			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977539				2022-12-28	WOS:000354428700023
J	Bauchner, H; Fontanarosa, PB; Thompson, AE				Bauchner, Howard; Fontanarosa, Phil B.; Thompson, Amy E.			Professionalism, Governance, and Self-regulation of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bauchner, Howard; Fontanarosa, Phil B.; Thompson, Amy E.] JAMA, Chicago, IL 60611 USA		Bauchner, H (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	howard.bauchner@jamanetwork.org						ACCME at a Glance. Accreditation Council for Continuing Medical Education, ACCME AT A GLANC; American Medical Association, 2018, COD MED ETH AM MED A; Baron RJ, 2015, JAMA-J AM MED ASSOC, V313, P1807, DOI 10.1001/jama.2015.4060; Baron RJ., ABIM ANNOUNCES IMMED; Berwick DM, 2015, JAMA-J AM MED ASSOC, V313, P1803, DOI 10.1001/jama.2015.4048; Chassin MR, 2015, JAMA-J AM MED ASSOC, V313, P1795, DOI 10.1001/jama.2015.3818; Chaudhry HJ, 2015, JAMA-J AM MED ASSOC, V313, P1791, DOI 10.1001/jama.2015.4017; Cohen JJ, 2015, JAMA-J AM MED ASSOC, V313, P1839, DOI 10.1001/jama.2015.3736; Crosson FJ, 2015, JAMA-J AM MED ASSOC, V313, P1817, DOI 10.1001/jama.2015.3742; DeAngelis CD, 2015, JAMA-J AM MED ASSOC, V313, P1837, DOI 10.1001/jama.2015.3597; Emanuel EJ, 2015, JAMA-J AM MED ASSOC, V313, P1799, DOI 10.1001/jama.2015.4336; Fontanarosa PB, 2015, JAMA-J AM MED ASSOC, V313, P145, DOI 10.1001/jama.2014.17937; Fuchs VR, 2015, JAMA-J AM MED ASSOC, V313, P1821, DOI 10.1001/jama.2015.2915; Gimpel JR, COMMUNICATION; Golub RM, 2012, JAMA-J AM MED ASSOC, V308, P2254, DOI 10.1001/jama.2012.74128; Huckman RS, 2015, JAMA-J AM MED ASSOC, V313, P1811, DOI 10.1001/jama.2015.4619; Kirch DG, 2015, JAMA-J AM MED ASSOC, V313, P1797, DOI 10.1001/jama.2015.4019; Lee TH, 2014, JAMA-J AM MED ASSOC, V312, P2340, DOI 10.1001/jama.2014.13566; Lee VS, 2015, JAMA-J AM MED ASSOC, V313, P1815, DOI 10.1001/jama.2015.4062; Levey NN, 2015, JAMA-J AM MED ASSOC, V313, P1827, DOI 10.1001/jama.2015.4172; Madara JL, 2015, JAMA-J AM MED ASSOC, V313, P1793, DOI 10.1001/jama.2015.4045; Marcovitch H, 2015, JAMA-J AM MED ASSOC, V313, P1823, DOI 10.1001/jama.2015.3187; Margolis JD, 2015, JAMA-J AM MED ASSOC, V313, P1819, DOI 10.1001/jama.2015.4398; Nasca TJ, 2015, JAMA-J AM MED ASSOC, V313, P1801, DOI 10.1001/jama.2015.3738; Naylor CD, 2015, JAMA-J AM MED ASSOC, V313, P1825, DOI 10.1001/jama.2015.3705; Nissen SE, 2015, JAMA-J AM MED ASSOC, V313, P1813, DOI 10.1001/jama.2015.4138; Nora LM, 2015, JAMA-J AM MED ASSOC, V313, P1805, DOI 10.1001/jama.2015.4025; Reinhardt UE, 2013, JAMA-J AM MED ASSOC, V310, P1927, DOI 10.1001/jama.2013.281854; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V312, P695, DOI 10.1001/jama.2014.9809; Teirstein PS, 2015, JAMA-J AM MED ASSOC, V313, P1809, DOI 10.1001/jama.2015.3576	30	21	22	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1831	1836		10.1001/jama.2015.4569	http://dx.doi.org/10.1001/jama.2015.4569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965230	Bronze			2022-12-28	WOS:000354391000025
J	Horton, R; Das, P				Horton, Richard; Das, Pamela			Global health security now	LANCET			English	Editorial Material									[Horton, Richard; Das, Pamela] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Commission on Human Security, 2003, HUM SEC NOW; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3; The African CDC and WHO AFRO, 2015, LANCET, V385, P1592	5	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1805	1806		10.1016/S0140-6736(15)60909-6	http://dx.doi.org/10.1016/S0140-6736(15)60909-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25987140				2022-12-28	WOS:000354184500004
J	Gerlach, C; Loughhead, SM; von Andrian, UH				Gerlach, Carmen; Loughhead, Scott M.; von Andrian, Ulrich H.			Figuring Fact from Fiction: Unbiased Polling of Memory T Cells	CELL			English	Editorial Material							TISSUE; SUBSETS	Immunization generates several memory T cell subsets that differ in their migratory properties, anatomic distribution, and, hence, accessibility to investigation. In this issue, Steinert et al. demonstrate that what was believed to be a minor memory cell subset in peripheral tissues has been dramatically underestimated. Thus, current models of protective immunity require revision.	[Gerlach, Carmen; Loughhead, Scott M.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	uva@hms.harvard.edu		Gerlach, Carmen/0000-0001-7889-2393				Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; MACKAY CR, 1988, J EXP MED, V167, P1755, DOI 10.1084/jem.167.6.1755; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SQUIRE P, 1988, PUBLIC OPIN QUART, V52, P125, DOI 10.1086/269085	8	4	4	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					702	704		10.1016/j.cell.2015.04.038	http://dx.doi.org/10.1016/j.cell.2015.04.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957676	Bronze			2022-12-28	WOS:000354175200002
J	Zheng, SM; Vuong, BQ; Vaidyanathan, B; Lin, JY; Huang, FT; Chaudhuri, J				Zheng, Simin; Vuong, Bao Q.; Vaidyanathan, Bharat; Lin, Jia-Yu; Huang, Feng-Ting; Chaudhuri, Jayanta			Non-coding RNA Generated following Lariat Debranching Mediates Targeting of AID to DNA	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; TETRAMOLECULAR QUADRUPLEX G4-DNA; GENOME-REARRANGEMENT; RESOLVING ACTIVITY; SUPER-ENHANCERS; MAJOR SOURCE; RECRUIT AID; TRANSCRIPTION; GENE	Transcription through immunoglobulin switch (S) regions is essential for class switch recombination (CSR), but no molecular function of the transcripts has been described. Likewise, recruitment of activation-induced cytidine deaminase (AID) to S regions is critical for CSR; however, the underlying mechanism has not been fully elucidated. Here, we demonstrate that intronic switch RNA acts in trans to target AID to S region DNA. AID binds directly to switch RNA through G-quadruplexes formed by the RNA molecules. Disruption of this interaction by mutation of a key residue in the putative RNA-binding domain of AID impairs recruitment of AID to S region DNA, thereby abolishing CSR. Additionally, inhibition of RNA lariat processing leads to loss of AID localization to S regions and compromises CSR; both defects can be rescued by exogenous expression of switch transcripts in a sequence-specific manner. These studies uncover an RNA-mediated mechanism of targeting AID to DNA.	[Zheng, Simin; Vuong, Bao Q.; Vaidyanathan, Bharat; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Zheng, Simin; Vaidyanathan, Bharat; Chaudhuri, Jayanta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Vuong, Bao Q.] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Lin, Jia-Yu; Huang, Feng-Ting] Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 106, Taiwan	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; City University of New York (CUNY) System; City College of New York (CUNY); National Taiwan University	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	chaudhuj@mskcc.org	Hsiao, Wei-Hung/B-9931-2013	Zheng, Simin/0000-0002-3442-1255; Vuong, Bao/0000-0001-5416-9635	NIH [1RO1AI072194]; Starr Cancer Foundation [I4-A447, I7-A767]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors wish to thank T. Honjo for AID<SUP>-/-</SUP> mice and CH12 cells, S. Kabir (Rockefeller University) for telomere-specific probes, and S. Vasudevan (Harvard University) and T. Agarwal for their helpful technical advice. We thank members of J.C.'s laboratory for their comments and discussion. This work was supported by grants from the NIH (1RO1AI072194) and the Starr Cancer Foundation (I4-A447 and I7-A767) to J.C.	ARENAS J, 1987, J BIOL CHEM, V262, P4274; Azzalin CM, 2007, NATURE, V448, P1001, DOI 10.1038/4481001a; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Kao YP, 2013, MOL IMMUNOL, V54, P208, DOI 10.1016/j.molimm.2012.11.009; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Li HL, 2013, BIOSENS BIOELECTRON, V41, P563, DOI 10.1016/j.bios.2012.09.024; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Mahdaviani SA, 2012, EXPERT REV CLIN IMMU, V8, P539, DOI 10.1586/ECI.12.46; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muller JR, 1998, J IMMUNOL, V161, P1354; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Xu Yan, 2008, Nucleic Acids Symp Ser (Oxf), P175, DOI 10.1093/nass/nrn089; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	53	121	122	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					762	773		10.1016/j.cell.2015.03.020	http://dx.doi.org/10.1016/j.cell.2015.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957684	Green Accepted, Bronze			2022-12-28	WOS:000354175200011
J	Gould, CV				Gould, Carolyn V.			In Pursuit of Appropriate Urinary Catheter Indications: Details Matter	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFECTION		[Gould, Carolyn V.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Gould, CV (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop A-31, Atlanta, GA 30333 USA.	CGould@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Fakih MG, 2012, AM J INFECT CONTROL, V40, P359, DOI 10.1016/j.ajic.2011.05.012; Fakih MG, 2010, ACAD EMERG MED, V17, P337, DOI 10.1111/j.1553-2712.2009.00677.x; Gould CV., 2009, GUIDELINE PREVENTION; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; Hollingsworth JM, 2013, ANN INTERN MED, V159, P401, DOI 10.7326/0003-4819-159-6-201309170-00006; Kaler W., 2014, CDC SAFE HEALTH 0902; Meddings J, 2015, ANN INTERN MED, V162, pS1, DOI 10.7326/M14-1304; Meddings J, 2014, BMJ QUAL SAF, V23, P277, DOI 10.1136/bmjqs-2012-001774; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9; Weinstein JW, 1999, INFECT CONT HOSP EP, V20, P543, DOI 10.1086/501675; Werner NL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-187	12	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9		S			S35	S36		10.7326/M14-1610	http://dx.doi.org/10.7326/M14-1610			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IA	25938929	Green Accepted			2022-12-28	WOS:000355014300002
J	Carson-Stevens, A; Edwards, A; Panesar, S; Parry, G; Rees, P; Sheikh, A; Donaldson, L				Carson-Stevens, Andrew; Edwards, Adrian; Panesar, Sukhmeet; Parry, Gareth; Rees, Philippa; Sheikh, Aziz; Donaldson, Liam			Reducing the burden of iatrogenic harm in children	LANCET			English	Editorial Material									[Carson-Stevens, Andrew; Edwards, Adrian; Rees, Philippa] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales; [Carson-Stevens, Andrew] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Carson-Stevens, Andrew; Panesar, Sukhmeet; Sheikh, Aziz] Univ Edinburgh, Med Informat Ctr, Edinburgh, Midlothian, Scotland; [Parry, Gareth] Inst Healthcare Improvement, Cambridge, MA USA; [Parry, Gareth; Sheikh, Aziz] Harvard Univ, Sch Med, Boston, MA USA; [Sheikh, Aziz] Brigham & Womens Hosp, Boston, MA 02115 USA; [Donaldson, Liam] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Cardiff University; University of British Columbia; University of Edinburgh; Institute for Healthcare Improvement; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Imperial College London	Carson-Stevens, A (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales.	carson-stevensap@cardiff.ac.uk	Parry, Gareth/CAF-6975-2022	Sheikh, Aziz/0000-0001-7022-3056; Rees, Philippa/0000-0002-1074-5837; Carson-Stevens, Andrew/0000-0002-7580-7699	Department of Health [12/64/118] Funding Source: Medline; National Institute for Health Research [12/64/118] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Department for Education, 2013, CHILD DEATH REV YEAR; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Modi N, 2013, LANCET, V381, P73, DOI 10.1016/S0140-6736(12)61818-2; Parry G, 2012, JAMA-J AM MED ASSOC, V307, P2155, DOI 10.1001/jama.2012.3649; Pearson G., 2008, WHY CHILDREN DIE PIL; Walsh KE, 2014, JAMA-J AM MED ASSOC, V311, P1731, DOI 10.1001/jama.2014.2038; Wang H, 2014, LANCET; WHO, REP PAT SAF INC; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6	9	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1593	1594		10.1016/S0140-6736(14)61739-6	http://dx.doi.org/10.1016/S0140-6736(14)61739-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25943799				2022-12-28	WOS:000353418000007
J	Jones, DS; Podolsky, SH				Jones, David S.; Podolsky, Scott H.			The history and fate of the gold standard	LANCET			English	Editorial Material									[Jones, David S.; Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	scott_podolsky@hms.harvard.edu						BONCHEK LI, 1979, NEW ENGL J MED, V301, P44, DOI 10.1056/NEJM197907053010110; Chalmers I, 2014, LANCET, V383, P1713, DOI 10.1016/S0140-6736(14)60821-7; Daly J., 2005, EVIDENCE BASED MED S; DUGGAN PF, 1992, BRIT MED J, V304, P1568, DOI 10.1136/bmj.304.6841.1568-b; Favaloro RG, 1998, J AM COLL CARDIOL, V31, p1B, DOI 10.1016/S0735-1097(97)00559-7; FEINSTEIN AR, 1982, NEW ENGL J MED, V307, P1611, DOI 10.1056/NEJM198212233072604; Kleinman A., 1995, WRITING MARGIN DISCO, P21; Timmermans S, 2003, GOLD STANDARD CHALLE	8	71	75	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1502	1503		10.1016/S0140-6736(15)60742-5	http://dx.doi.org/10.1016/S0140-6736(15)60742-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25933270	Bronze, Green Submitted			2022-12-28	WOS:000353220000017
J	Leong, DP; Teo, KK; Rangarajan, S; Lopez-Jaramillo, P; Avezum, A; Orlandini, A; Seron, P; Ahmed, SH; Rosengren, A; Kelishadi, R; Rahman, O; Swaminathan, S; Iqbal, R; Gupta, R; Lear, SA; Oguz, A; Yusoff, K; Zatonska, K; Chifamba, J; Igumbor, E; Mohan, V; Anjana, RM; Gu, HQ; Li, W; Yusuf, S				Leong, Darryl P.; Teo, Koon K.; Rangarajan, Sumathy; Lopez-Jaramillo, Patricio; Avezum, Alvaro, Jr.; Orlandini, Andres; Seron, Pamela; Ahmed, Suad H.; Rosengren, Annika; Kelishadi, Roya; Rahman, Omar; Swaminathan, Sumathi; Iqbal, Romaina; Gupta, Rajeev; Lear, Scott A.; Oguz, Aytekin; Yusoff, Khalid; Zatonska, Katarzyna; Chifamba, Jephat; Igumbor, Ehimario; Mohan, Viswanathan; Anjana, Ranjit Mohan; Gu, Hongqiu; Li, Wei; Yusuf, Salim		Prospective Urban Rural Epidemiolo	Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study	LANCET			English	Article							ALL-CAUSE MORTALITY; HANDGRIP STRENGTH; MUSCLE STRENGTH; CARDIORESPIRATORY FITNESS; MUSCULAR STRENGTH; BODY-COMPOSITION; QUESTIONNAIRE; ASSOCIATION; RELIABILITY; RESISTANCE	Background Reduced muscular strength, as measured by grip strength, has been associated with an increased risk of all-cause and cardiovascular mortality. Grip strength is appealing as a simple, quick, and inexpensive means of stratifying an individual's risk of cardiovascular death. However, the prognostic value of grip strength with respect to the number and range of populations and confounders is unknown. The aim of this study was to assess the independent prognostic importance of grip strength measurement in socioculturally and economically diverse countries. Methods The Prospective Urban-Rural Epidemiology (PURE) study is a large, longitudinal population study done in 17 countries of varying incomes and sociocultural settings. We enrolled an unbiased sample of households, which were eligible if at least one household member was aged 35-70 years and if household members intended to stay at that address for another 4 years. Participants were assessed for grip strength, measured using a Jamar dynamometer. During a median follow-up of 4.0 years (IQR 2.9-5.1), we assessed all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, myocardial infarction, stroke, diabetes, cancer, pneumonia, hospital admission for pneumonia or chronic obstructive pulmonary disease (COPD), hospital admission for any respiratory disease (including COPD, asthma, tuberculosis, and pneumonia), injury due to fall, and fracture. Study outcomes were adjudicated using source documents by a local investigator, and a subset were adjudicated centrally. Findings Between January, 2003, and December, 2009, a total of 142 861 participants were enrolled in the PURE study, of whom 139 691 with known vital status were included in the analysis. During a median follow-up of 4.0 years (IQR 2.9-5.1), 3379 (2%) of 139 691 participants died. After adjustment, the association between grip strength and each outcome, with the exceptions of cancer and hospital admission due to respiratory illness, was similar across country-income strata. Grip strength was inversely associated with all-cause mortality (hazard ratio per 5 kg reduction in grip strength 1.16, 95% CI 1.13-1.20; p<0.0001), cardiovascular mortality (1.17, 1.11-1.24; p<0.0001), non-cardiovascular mortality (1.17, 1.12-1.21; p<0.0001), myocardial infarction (1.07, 1.02-1.11; p=0.002), and stroke (1.09, 1.05-1.15; p<0.0001). Grip strength was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure. We found no significant association between grip strength and incident diabetes, risk of hospital admission for pneumonia or COPD, injury from fall, or fracture. In high-income countries, the risk of cancer and grip strength were positively associated (0.916, 0.880-0.953; p<0.0001), but this association was not found in middle-income and low-income countries. Interpretation This study suggests that measurement of grip strength is a simple, inexpensive risk-stratifying method for all-cause death, cardiovascular death, and cardiovascular disease. Further research is needed to identify determinants of muscular strength and to test whether improvement in strength reduces mortality and cardiovascular disease.	[Leong, Darryl P.; Teo, Koon K.; Rangarajan, Sumathy; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Leong, Darryl P.; Teo, Koon K.; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmolog Santander, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Sch Med, Bucaramanga, Colombia; [Avezum, Alvaro, Jr.] Univ Sao Paulo, Dante Pazzanese Inst Cardiol, BR-05508 Sao Paulo, Brazil; [Orlandini, Andres] ECLA Fdn, Inst Cardiovasc Rosario, Rosario, Argentina; [Seron, Pamela] Univ La Frontera, Temuco, Chile; [Ahmed, Suad H.] Dubai Hlth Author, Dubai, U Arab Emirates; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Swaminathan, Sumathi] St Johns Med Coll, St Johns Res Inst, Bangalore, Karnataka, India; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Lear, Scott A.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Oguz, Aytekin] Istanbul Medeniyet Univ, Dept Internal Med, Istanbul, Turkey; [Yusoff, Khalid] Univ Teknol MARA, Sungai Buloh, Selangor, Malaysia; [Yusoff, Khalid] UCSI Univ, Kuala Lumpur, Malaysia; [Zatonska, Katarzyna] Med Univ Wroclaw, Dept Social Med, Wroclaw, Poland; [Chifamba, Jephat] Univ Zimbabwe, Harare, Zimbabwe; [Igumbor, Ehimario] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Mohan, Viswanathan; Anjana, Ranjit Mohan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Gu, Hongqiu; Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Gu, Hongqiu; Li, Wei] Peking Union Med Coll, Beijing 100021, Peoples R China	McMaster University; Population Health Research Institute; McMaster University; Universidad Industrial de Santander; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidad de La Frontera; University of Gothenburg; Isfahan University Medical Science; Independent University Bangladesh (IUB); St. John's National Academy of Health Sciences; St. John's Medical College; St. John's Research Institute; Aga Khan University; Fortis Escorts Hospital; Simon Fraser University; Istanbul Medeniyet University; Universiti Teknologi MARA; UCSI University; Wroclaw Medical University; University of Zimbabwe; University of the Western Cape; Madras Diabetes Research Foundation; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Leong, DP (corresponding author), Hamilton Gen Hosp, DBCVSRI, C3-16, Hamilton, ON L8L 2X2, Canada.	leongd@phri.ca	Seron, Pamela/AAN-3304-2021; Igumbor, Ehimario U/B-2652-2012; Kelishadi, Roya/E-6154-2012; Oguz, Aytekin/AAJ-2732-2021; Rahman, Omar/E-1329-2019; Zatońska, Katarzyna/ABD-4236-2021; Swaminathan, Sumathi/AGI-7678-2022; Chifamba, Jephat/AHE-4535-2022; Yusoff, Khalid/I-7029-2019; Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020; Qorbani, Mostafa/M-8171-2017; Gomez-Arbelaez, Diego/K-1883-2013	Seron, Pamela/0000-0003-0190-8988; Igumbor, Ehimario U/0000-0002-6313-6031; Kelishadi, Roya/0000-0001-7455-1495; Oguz, Aytekin/0000-0002-2595-5167; Rahman, Omar/0000-0002-0606-2507; Chifamba, Jephat/0000-0001-8166-1182; Yusoff, Khalid/0000-0001-5669-5188; Avezum, Alvaro AA/0000-0002-3073-6890; Levitt, Naomi/0000-0001-6480-8066; Teo, Koon/0000-0002-3731-0956; Zatonska, Katarzyna/0000-0002-3772-5588; Camacho, Paul Anthony/0000-0002-6233-9582; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Gulec, Sadi/0000-0002-2685-2522; Rosengren, Annika/0000-0002-5409-6605; Iqbal, Romaina/0000-0002-5364-4366; Yusuf, Salim/0000-0003-4776-5601; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Jerling, Johann/0000-0003-2600-3536; Lanas, Fernando/0000-0003-3595-9759	EJ Moran Campbell Award, McMaster University, Canada; Marion Burke Chair of the Heart and Stroke Foundation of Canada; Population Health Research Institute, Canada; Canadian Institutes of Health Research, Canada; Heart and Stroke Foundation of Ontario, Canada; AstraZeneca (Sweden); Sanofi-Aventis (France); AstraZeneca (Canada); AstraZeneca (Turkey); Sanofi-Aventis (Canada); Sanofi-Aventis (Turkey); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Bangladesh Independent University, Bangladesh; Mitra and Associates, Bangladesh; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canada; Universidad de la Frontera, Chile; National Center for Cardiovascular Diseases, China; Colciencias, Colombia [6566-04-18062]; Indian Council of Medical Research, India; Ministry of Science, Technology and Innovation, Malaysia [07-05-IFN-MEB010]; Ministry of Higher Education, Malaysia [600-RMI/LRGS/5/3]; Universiti Kebangsaan Malaysia, Malaysia [UKM-Hejim-Komuniti-15-2010]; Ministry of Science and Higher Education, Poland [290/W-PURE/2008/0]; Wroclaw Medical University, Poland; North-West University, South Africa; South Africa Netherlands Research Programme on Alternatives in Development (SANPAD); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association (SASA), South Africa; Faculty of Community and Health Sciences (UWC), South Africa; Council for Working Life and Social Research, Sweden; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden; Swedish Heart and Lung Foundation, Sweden; Swedish Research Council; Swedish State under LUA (LakarUtbildningsAvtalet); Vastra Gotaland Region (FOUU), Sweden; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, the United Arab Emirates	EJ Moran Campbell Award, McMaster University, Canada; Marion Burke Chair of the Heart and Stroke Foundation of Canada; Population Health Research Institute, Canada; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); AstraZeneca (Sweden)(AstraZeneca); Sanofi-Aventis (France)(Sanofi-Aventis); AstraZeneca (Canada)(AstraZeneca); AstraZeneca (Turkey)(AstraZeneca); Sanofi-Aventis (Canada)(Sanofi-Aventis); Sanofi-Aventis (Turkey)(Sanofi-Aventis); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Bangladesh Independent University, Bangladesh; Mitra and Associates, Bangladesh; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canada; Universidad de la Frontera, Chile; National Center for Cardiovascular Diseases, China; Colciencias, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Universiti Kebangsaan Malaysia, Malaysia; Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Wroclaw Medical University, Poland; North-West University, South Africa; South Africa Netherlands Research Programme on Alternatives in Development (SANPAD); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association (SASA), South Africa; Faculty of Community and Health Sciences (UWC), South Africa; Council for Working Life and Social Research, Sweden; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden; Swedish Heart and Lung Foundation, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LUA (LakarUtbildningsAvtalet); Vastra Gotaland Region (FOUU), Sweden; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, the United Arab Emirates	DPL is supported by the EJ Moran Campbell Award, McMaster University, Canada. SY is funded by the Marion Burke Chair of the Heart and Stroke Foundation of Canada. The main PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Ontario, Canada; by unrestricted grants from AstraZeneca (Sweden, Canada, Turkey), Sanofi-Aventis (France, Canada, Turkey), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma; by the Bangladesh Independent University and Mitra and Associates, Bangladesh, Unilever Health Institute, Brazil, Public Health Agency of Canada, Champlain Cardiovascular Disease Prevention Network, Canada, Universidad de la Frontera, Chile, National Center for Cardiovascular Diseases, China, Colciencias, Colombia (grant number 6566-04-18062), Indian Council of Medical Research, India, Ministry of Science, Technology and Innovation (grant number 07-05-IFN-MEB010), Malaysia, Ministry of Higher Education (grant number 600-RMI/LRGS/5/3), Malaysia, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), Malaysia, Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0), Poland, Wroclaw Medical University, Poland, The North-West University, South Africa, South Africa Netherlands Research Programme on Alternatives in Development (SANPAD), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association (SASA), South Africa, Faculty of Community and Health Sciences (UWC), South Africa, Council for Working Life and Social Research, Sweden, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden, Swedish Heart and Lung Foundation, Sweden, Swedish Research Council, grant from the Swedish State under LUA (LakarUtbildningsAvtalet) agreement, and grant from the Vastra Gotaland Region (FOUU), Sweden, Metabolic Syndrome Society, and the Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, the United Arab Emirates.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Charakida M, 2010, EUR HEART J, V31, P2854, DOI 10.1093/eurheartj/ehq340; Chen CN, 2008, PHYS THER, V88, P1355, DOI 10.2522/ptj.20080064; Clarkson P, 1999, J AM COLL CARDIOL, V33, P1379, DOI 10.1016/S0735-1097(99)00036-4; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037958; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Iqbal R, 2009, PUBLIC HEALTH NUTR, V12, P12, DOI 10.1017/S1368980008001845; Jenkins NDM, 2014, EXP GERONTOL, V58, P47, DOI 10.1016/j.exger.2014.07.007; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lopez-Jaramillo P, 2014, INT J CARDIOL, V174, P458, DOI 10.1016/j.ijcard.2014.04.013; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Orr R, 2008, SPORTS MED, V38, P317, DOI 10.2165/00007256-200838040-00004; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Taylor AC, 2003, MED SCI SPORT EXER, V35, P251, DOI 10.1249/01.MSS.0000048725.15026.B5; Vaz M, 1996, BRIT J NUTR, V76, P9, DOI 10.1079/BJN19960005; Yamamoto K, 2009, AM J PHYSIOL-HEART C, V297, pH1314, DOI 10.1152/ajpheart.00061.2009; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	30	937	970	11	214	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					266	273		10.1016/S0140-6736(14)62000-6	http://dx.doi.org/10.1016/S0140-6736(14)62000-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25982160				2022-12-28	WOS:000358213700031
J	Yates, R				Yates, Robert			Universal health coverage: progressive taxes are key	LANCET			English	Editorial Material									UHC Policy Forum, London SW1Y 4LE, England		Yates, R (corresponding author), UHC Policy Forum, Chatham House, London SW1Y 4LE, England.	ryates@chathamhouse.org		Yates, Robert/0000-0002-6149-7335				[Anonymous], 2014, SHARED RESPONSIBILIT; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Gilligan A., 2012, TELEGRAPH; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Kutzin J, 2009, B WORLD HEALTH ORGAN, V87, P549, DOI 10.2471/BLT.07.049544; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Maeda A, 2014, DIR DEV, P1, DOI 10.1596/978-1-4648-0297-3; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reeves A, 2015, LANCET; Savedoff WD, 2012, T HLTH FIN POL UN HL; WHO, 2010, WOR HEALT REP, P1; World Bank World Health Organization, 2014, MON PROGR UN HLTH CO	13	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					227	229		10.1016/S0140-6736(15)60868-6	http://dx.doi.org/10.1016/S0140-6736(15)60868-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN1XI	25982039	hybrid			2022-12-28	WOS:000358213700009
J	Lee, HY; Gao, XF; Barrasa, MI; Li, H; Elmes, RR; Peters, LL; Lodish, HF				Lee, Hsiang-Ying; Gao, Xiaofei; Barrasa, M. Inmaculada; Li, Hu; Elmes, Russell R.; Peters, Luanne L.; Lodish, Harvey F.			PPAR-alpha and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal	NATURE			English	Article							DIAMOND-BLACKFAN ANEMIA; TRANSCRIPTION FACTORS; ERYTHROPOIESIS; IDENTIFICATION; SUPERFAMILY; DEFICIENCY; REGISTRY; THERAPY; GENES; CELLS	Many acute and chronic anaemias, including haemolysis, sepsis and genetic bone marrow failure diseases such as Diamond-Blackfan anaemia, are not treatable with erythropoietin (Epo), because the colony-forming unit erythroid progenitors (CFU-Es) that respond to Epo are either too few in number or are not sensitive enough to Epo to maintain sufficient red blood cell production(1-9). Treatment of these anaemias requires a drug that acts at an earlier stage of red cell formation and enhances the formation of Epo-sensitive CFU-E progenitors. Recently, we showed that glucocorticoids specifically stimulate self-renewal of an early erythroid progenitor, burst-forming unit erythroid (BFU-E), and increase the production of terminally differentiated erythroid cells(10,11). Here we show that activation of the peroxisome proliferator-activated receptor alpha (PPAR-alpha) by the PPAR-alpha agonists GW7647 and fenofibrate synergizes with the glucocorticoid receptor (GR) to promote BFU-E self-renewal. Over time these agonists greatly increase production of mature red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34(+) peripheral blood progenitors, with a new and effective culture system being used for the human cells that generates normal enucleated reticulocytes. Although Ppara(-/-) mice show no haematological difference from wild-typemice in both normal and phenylhydrazine (PHZ)-induced stress erythropoiesis, PPAR-alpha agonists facilitate recovery of wild-type but not Ppara(-/-) mice from PHZ-induced acute haemolytic anaemia. We also show that PPAR-alpha alleviates anaemia in a mouse model of chronic anaemia. Finally, both in control and corticosteroid- treated BFU-E cells, PPAR-alpha co-occupies many chromatin sites with GR; when activated by PPAR-alpha agonists, additional PPAR-alpha is recruited to GR-adjacent sites and presumably facilitates GR-dependent BFU-E self-renewal. Our discovery of the role of PPAR-alpha agonists in stimulating self-renewal of early erythroid progenitor cells suggests that the clinically tested PPAR-alpha agonists we used may improve the efficacy of corticosteroids in treating Epo-resistant anaemias.	[Lee, Hsiang-Ying; Gao, Xiaofei; Barrasa, M. Inmaculada; Elmes, Russell R.; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Li, Hu] Mayo Clin, Ctr Individualized Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Peters, Luanne L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lodish, Harvey F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Mayo Clinic; Jackson Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu		Lee, Hsiang-Ying/0000-0002-1503-5818; Peters, Luanne/0000-0002-0784-0534	Defense Advanced Research Projects Agency [HR0011-14-2-0005]; Department of Defense/US Army Medical Research and Materiel Command [W81WH-12-1-0449]; National institutes of Health (NIH)/National Heart, Lung, and Blood Institute [2 P01 HL032262-25]; Diamond-Blackfan Anemia Foundation; Diamond Blackfan Anemia Canada; NIH [DK100692]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100692] Funding Source: NIH RePORTER; Direct For Biological Sciences [1262049] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Defense/US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diamond-Blackfan Anemia Foundation; Diamond Blackfan Anemia Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the Whitehead Institute Flow Cytometry Facility, Genome Technology Core and Bioinformatics & Research Computing Facility, as well as the Massachusetts Institute of Technology Koch Institute Flow Cytometry Core. We thank V. Sankaran for haemoglobin HPLC and J. Flygare for the plasmid encoding the RPS19 shRNA, and are grateful to animal technicians F. Reinhardt and T. E. Chavarria for their assistance. We thank T. DiCesare for assistance with graphics. This study was supported by grants to H.F.L. (Defense Advanced Research Projects Agency HR0011-14-2-0005; Department of Defense/US Army Medical Research and Materiel Command W81WH-12-1-0449, National institutes of Health (NIH)/National Heart, Lung, and Blood Institute 2 P01 HL032262-25; as well as research support from the Diamond-Blackfan Anemia Foundation and Diamond Blackfan Anemia Canada. L.L.P. was supported by NIH grant DK100692. X.G. was supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Ebert BL, 2005, BLOOD, V105, P4620, DOI 10.1182/blood-2004-08-3313; FIORILLO A, 1991, AM J HEMATOL, V37, P65, DOI 10.1002/ajh.2830370121; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jones Kevin B, 2005, Iowa Orthop J, V25, P129; Kaushansky K, 2010, WILLIAMS HEMATOLOGY; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lipton JM, 2006, PEDIATR BLOOD CANCER, V46, P558, DOI 10.1002/pbc.20642; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; NIEMEYER CM, 1991, CONTRIB NEPHROL, V88, P276; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson Y, 2008, ACTA ANAESTH SCAND, V52, P605, DOI 10.1111/j.1399-6576.2008.01656.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vlachos A, 2010, BLOOD, V116, P3715, DOI 10.1182/blood-2010-02-251090; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Yang LPH, 2009, AM J CARDIOVASC DRUG, V9, P401, DOI 10.2165/11203920-000000000-00000; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zimmerman Janice L, 2004, Crit Care Med, V32, pS542, DOI 10.1097/01.CCM.0000145906.63859.1A	30	89	92	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					474	+		10.1038/nature14326	http://dx.doi.org/10.1038/nature14326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	25970251	Green Submitted, Green Accepted			2022-12-28	WOS:000356782900049
J	Halpern, SD; French, B; Small, DS; Saulsgiver, K; Harhay, MO; Audrain-McGovern, J; Loewenstein, G; Brennan, TA; Asch, DA; Volpp, KG				Halpern, Scott D.; French, Benjamin; Small, Dylan S.; Saulsgiver, Kathryn; Harhay, Michael O.; Audrain-McGovern, Janet; Loewenstein, George; Brennan, Troyen A.; Asch, David A.; Volpp, Kevin G.			Randomized Trial of Four Financial-Incentive Programs for Smoking Cessation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLLECTIVE DYNAMICS; ADAPTIVE DESIGNS; WEIGHT-LOSS; PAY; CONTRACTS; THERAPY	BACKGROUND Financial incentives promote many health behaviors, but effective ways to deliver health incentives remain uncertain. METHODS We randomly assigned CVS Caremark employees and their relatives and friends to one of four incentive programs or to usual care for smoking cessation. Two of the incentive programs targeted individuals, and two targeted groups of six participants. One of the individual-oriented programs and one of the group-oriented programs entailed rewards of approximately $800 for smoking cessation; the others entailed refundable deposits of $150 plus $650 in reward payments for successful participants. Usual care included informational resources and free smoking-cessation aids. RESULTS Overall, 2538 participants were enrolled. Of those assigned to reward-based programs, 90.0% accepted the assignment, as compared with 13.7% of those assigned to deposit-based programs (P<0.001). In intention-to-treat analyses, rates of sustained abstinence from smoking through 6 months were higher with each of the four incentive programs (range, 9.4 to 16.0%) than with usual care (6.0%) (P<0.05 for all comparisons); the superiority of reward-based programs was sustained through 12 months. Group-oriented and individual-oriented programs were associated with similar 6-month abstinence rates (13.7% and 12.1%, respectively; P = 0.29). Reward-based programs were associated with higher abstinence rates than deposit-based programs (15.7% vs. 10.2%, P<0.001). However, in instrumental-variable analyses that accounted for differential acceptance, the rate of abstinence at 6 months was 13.2 percentage points (95% confidence interval, 3.1 to 22.8) higher in the deposit-based programs than in the reward-based programs among the estimated 13.7% of the participants who would accept participation in either type of program. CONCLUSIONS Reward-based programs were much more commonly accepted than deposit-based programs, leading to higher rates of sustained abstinence from smoking. Group-oriented incentive programs were no more effective than individual-oriented programs. (Funded by the National Institutes of Health and CVS Caremark; ClinicalTrials.gov number, NCT01526265.)	[Halpern, Scott D.; Asch, David A.; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Halpern, Scott D.; French, Benjamin; Saulsgiver, Kathryn; Harhay, Michael O.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Halpern, Scott D.; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Audrain-McGovern, Janet] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Halpern, Scott D.; French, Benjamin; Small, Dylan S.; Saulsgiver, Kathryn; Audrain-McGovern, Janet; Loewenstein, George; Asch, David A.; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Ctr Hlth Equ Res & Promot, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Ctr Hlth Equ Res & Promot, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn Hlth Syst, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn Hlth Syst, Ctr Hlth Care Innovat, Philadelphia, PA USA; [Loewenstein, George] Carnegie Mellon Univ, Ctr Behav Decis Res, Pittsburgh, PA 15213 USA; [Brennan, Troyen A.] CVS Caremark, Woonsocket, RI USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Carnegie Mellon University	Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X; Harhay, Michael/0000-0002-0553-674X	NATIONAL CANCER INSTITUTE [R01CA159932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036592, P30AG034546] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA159932] Funding Source: Medline; NIA NIH HHS [P30 AG034546, RC2 AG036592] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Audrain-McGovern J, 2009, DRUG ALCOHOL DEPEN, V103, P99, DOI 10.1016/j.drugalcdep.2008.12.019; Berman M, 2014, TOB CONTROL, V23, P428, DOI 10.1136/tobaccocontrol-2012-050888; Brown CH, 2009, ANNU REV PUBL HEALTH, V30, P1, DOI 10.1146/annurev.publhealth.031308.100223; Cheng J, 2006, J ROY STAT SOC B, V68, P815, DOI 10.1111/j.1467-9868.2006.00568.x; Cheng J, 2009, BIOMETRIKA, V96, P19, DOI 10.1093/biomet/asn056; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Connolly T, 2006, J BEHAV DECIS MAKING, V19, P139, DOI 10.1002/bdm.510; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Dragalin V, 2006, DRUG INF J, V40, P425, DOI 10.1177/216847900604000408; French B, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0592-6; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Halpern SD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e522; HIGGINS ST, 1994, ARCH GEN PSYCHIAT, V51, P568; Hoelzl E, 2005, ORGAN BEHAV HUM DEC, V98, P15, DOI 10.1016/j.obhdp.2005.04.004; Hu FF, 2009, ANN STAT, V37, P2543, DOI 10.1214/08-AOS655; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Jacob P, 2002, CANCER EPIDEM BIOMAR, V11, P1668; JEFFERY RW, 1983, J CONSULT CLIN PSYCH, V51, P242, DOI 10.1037/0022-006X.51.2.242; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Kullgren JT, 2013, ANN INTERN MED, V158, P505, DOI 10.7326/0003-4819-158-7-201304020-00002; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Paul-Ebhohimhen V, 2009, OBESITY FACTS, V2, P17, DOI 10.1159/000186144; Petry NM, 2000, J CONSULT CLIN PSYCH, V68, P250, DOI 10.1037/0022-006X.68.2.250; Rogers T, 2014, JAMA-J AM MED ASSOC, V311, P2065, DOI 10.1001/jama.2014.3485; Rostron BL, 2014, JAMA INTERN MED, V174, P1922, DOI 10.1001/jamainternmed.2014.5219; Schnoll RA, 2010, ANN INTERN MED, V152, P144, DOI 10.7326/0003-4819-152-3-201002020-00005; SCHOTTER A, 1992, MANAGE SCI, V38, P1280, DOI 10.1287/mnsc.38.9.1280; SOMMER A, 1991, STAT MED, V10, P45, DOI 10.1002/sim.4780100110; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Strickland S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2458; Sussman JB, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2073; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Towers Watson National Business Group on Health, 2014, EMPL SURV PURCH VAL; Volpp KG, 2014, JAMA-J AM MED ASSOC, V311, P909, DOI 10.1001/jama.2014.418; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	45	239	241	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2108	2117		10.1056/NEJMoa1414293	http://dx.doi.org/10.1056/NEJMoa1414293			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0EI	25970009	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000355146800006
J	Gravitz, L				Gravitz, Lauren			ANIMAL BEHAVIOUR Nested instincts	NATURE			English	Editorial Material																		NIEH JC, 1993, BEHAV ECOL SOCIOBIOL, V33, P51, DOI 10.1007/BF00164346; Oldroyd B. P., 2013, P R SOC B, V281, DOI DOI 10.1098/RSPB.2013.2388; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112	3	0	0	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S60	S61		10.1038/521S60a	http://dx.doi.org/10.1038/521S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992675	Bronze			2022-12-28	WOS:000354816500010
J	Aguilar, M; Bhuket, T; Torres, S; Liu, B; Wong, RJ				Aguilar, Maria; Bhuket, Taft; Torres, Sharon; Liu, Benny; Wong, Robert J.			Prevalence of the Metabolic Syndrome in the United States, 2003-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							US ADULTS; MORTALITY; HEALTH		[Aguilar, Maria] Alameda Hlth Syst Highland Hosp, Dept Med, Oakland, CA USA; [Bhuket, Taft; Torres, Sharon; Liu, Benny; Wong, Robert J.] Alameda Hlth Syst Highland Hosp, Div Gastroenterol & Hepatol, Oakland, CA USA		Wong, RJ (corresponding author), Alameda Hlth Syst Highland Hosp Campus, Div Gastroenterol & Hepatol, Endoscopy Unit, 1411 E 31st St, Oakland, CA 94602 USA.	rowong@alamedahealthsystem.org						Ford ES, 2008, ANN EPIDEMIOL, V18, P165, DOI 10.1016/j.annepidem.2007.10.009; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553	6	788	815	3	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1973	1974		10.1001/jama.2015.4260	http://dx.doi.org/10.1001/jama.2015.4260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988468	Bronze			2022-12-28	WOS:000354691200020
J	O'Brien, MR; Rosenthal, MS; Dharmarajan, K; Krumholz, HM				O'Brien, Michael R.; Rosenthal, Marjorie S.; Dharmarajan, Kumar; Krumholz, Harlan M.			Balloon Animals, Guitars, and Fewer Blood Draws: Applying Strategies From Pediatrics to the Treatment of Hospitalized Adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ELDER LIFE PROGRAM		[O'Brien, Michael R.; Rosenthal, Marjorie S.; Dharmarajan, Kumar; Krumholz, Harlan M.] Yale Univ, New Haven, CT 06520 USA	Yale University	O'Brien, MR (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, 333 Cedar St,SHM IE-61,POB 208088, New Haven, CT 06520 USA.	michael.robert.obrien@yale.edu	, Harlan/AAI-2875-2020					Bao YJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/170396; Brown C, 2014, PEDIATRICS, V133, pE1471, DOI 10.1542/peds.2014-0556; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2169, DOI 10.1001/jama.2014.3695; Duff AJA, 2012, ARCH DIS CHILD, V97, P1, DOI 10.1136/archdischild-2011-300762; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Mittal V, 2014, PEDIATR CLIN N AM, V61, P663, DOI 10.1016/j.pcl.2014.04.003; Rapoport A, 2014, PEDIATR CLIN N AM, V61, P749, DOI 10.1016/j.pcl.2014.04.010; Rubin FH, 2011, J AM GERIATR SOC, V59, P359, DOI 10.1111/j.1532-5415.2010.03243.x	9	7	7	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					726	+		10.7326/M14-2219	http://dx.doi.org/10.7326/M14-2219			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984849				2022-12-28	WOS:000355015200023
J	Ossenkoppele, R; Jansen, WJ; Rabinovici, GD; Knol, DL; van der Flier, WM; van Berckel, BNM; Scheltens, P; Visser, PJ				Ossenkoppele, Rik; Jansen, Willemijn J.; Rabinovici, Gil D.; Knol, Dirk L.; van der Flier, Wiesje M.; van Berckel, Bart N. M.; Scheltens, Philip; Visser, Pieter Jelle		Amyloid PET Study Grp	Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NATIONAL INSTITUTE; DIAGNOSIS; PATHOLOGY; ASSOCIATION; CRITERIA; PATIENT; IMPACT; TRIALS	IMPORTANCE Amyloid-beta positron emission tomography (PET) imaging allows in vivo detection of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its diagnostic utility is still unclear because amyloid plaques also occur in patients with non-AD dementia. OBJECTIVE To use individual participant data meta-analysis to estimate the prevalence of amyloid positivity on PET in a wide variety of dementia syndromes. DATA SOURCES The MEDLINE and Web of Science databases were searched from January 2004 to April 2015 for amyloid PET studies. STUDY SELECTION Case reports and studies on neurological or psychiatric diseases other than dementia were excluded. Corresponding authors of eligible cohorts were invited to provide individual participant data. DATA EXTRACTION AND SYNTHESIS Data were provided for 1359 participants with clinically diagnosed AD and 538 participants with non-AD dementia. The reference groups were 1849 healthy control participants (based on amyloid PET) and an independent sample of 1369 AD participants (based on autopsy). MAIN OUTCOMES AND MEASURES Estimated prevalence of positive amyloid PET scans according to diagnosis, age, and apolipoprotein E (APOE) epsilon 4 status, using the generalized estimating equations method. RESULTS The likelihood of amyloid positivity was associated with age and APOE epsilon 4 status. InAD dementia, the prevalence of amyloid positivity decreased from age 50 to 90 years in APOE epsilon 4 noncarriers(86%[95% CI, 73%-94%] at 50 years to68%[95% CI, 57%-77%] at 90 years; n = 377) and to a lesser degree in APOE epsilon 4 carriers (97%[95% CI, 92%-99%] at 50 years to 90%[95% CI, 83%-94%] at 90 years; n = 593; P <.01). Similar associations of age and APOE epsilon 4 with amyloid positivity were observed in participants with AD dementia at autopsy. Inmost non-AD dementias, amyloid positivity increased with both age (from 60 to 80years) and APOE epsilon 4 carriership. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among participants with dementia, the prevalence of amyloid positivity was associated with clinical diagnosis, age, and APOE genotype. These findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE epsilon 4 status who are older than 70 years.	[Ossenkoppele, Rik; van der Flier, Wiesje M.; Scheltens, Philip; Visser, Pieter Jelle] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Ossenkoppele, Rik; van der Flier, Wiesje M.; Scheltens, Philip; Visser, Pieter Jelle] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Ossenkoppele, Rik; van Berckel, Bart N. M.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Ossenkoppele, Rik; Rabinovici, Gil D.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Ossenkoppele, Rik; Rabinovici, Gil D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jansen, Willemijn J.; Visser, Pieter Jelle] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, NL-6200 MD Maastricht, Netherlands; [Knol, Dirk L.; van der Flier, Wiesje M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Ossenkoppele, R (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands.	r.ossenkoppele@vumc.nl	Sanchez-Juan, Pascual/B-9282-2009; Visser, Pieter Jelle/S-5242-2019; Jansen, Willemijn/G-2374-2019; Chetelat, Gael/G-2316-2015; Vandenberghe, Rik/K-2145-2014; Visser, Pieter J/C-8541-2015; Ossenkoppele, Rik/J-5826-2013; Rabinovici, Gil/AAA-2495-2020; Frölich, Lutz/AAA-6940-2019; Scheltens, Philip/AAL-9631-2020	Sanchez-Juan, Pascual/0000-0002-6081-8037; Visser, Pieter Jelle/0000-0001-8008-9727; Jansen, Willemijn/0000-0001-9081-1496; Vandenberghe, Rik/0000-0001-6237-2502; Visser, Pieter J/0000-0001-8008-9727; Frölich, Lutz/0000-0003-1494-0813; Scheltens, Philip/0000-0002-1046-6408; frederiksen, Kristian Steen/0000-0001-5124-4417; van der Flier, Wiesje/0000-0001-8766-6224; Roe, Catherine/0000-0002-1405-0485; Rodrigue, Karen/0000-0002-4781-7961; Fortea, Juan/0000-0002-1340-638X; Lammertsma, Adriaan/0000-0003-1237-2891; Hellwig, Sabine/0000-0002-3074-2588; Gael, Chetelat/0000-0002-4889-7932; Drzezga, Alexander/0000-0001-6018-716X; Leyton, Cristian E./0000-0002-8236-6561; Barkhof, Frederik/0000-0003-3543-3706; Koglin, Norman/0000-0001-7583-8201; Verfaillie, Sander/0000-0003-1820-3378; Camus, Vincent/0000-0002-6845-221X; Ossenkoppele, Rik/0000-0003-1584-7477; Brooks, David/0000-0003-2602-2518; Nordberg, Agneta/0000-0001-7345-5151; Klunk, William/0000-0001-5512-0251	National Institute on Aging [U01 AG016976, P50 AG005681, P01 AD 003991, P01 AD 026276]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering [U01 AG024904]; Canadian Institutes of Health Research; Australian Commonwealth Scientific Industrial and Research Organization [CSIRO]; Edith Cowan University [ECU]; Mental Health Research Institute [MHRI]; Alzheimer's Australia [AA]; National Ageing Research Institute [NARI]; Austin Health; CogState; Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council (NHMRC); Dementia Collaborative Research Centres program (DCRC2); Science and Industry Endowment Fund (SIEF); Innovative Medicines Initiative Joint Undertaking under EMIF [115372]; European Union; German research foundation (Deutsche Forschungsgemeinschaft) [HE 4560/1-2, DR 445/3-1, DR 445/4-1]; KKF-grant for clinical research of the Technische Universitat Munchen; Health and Health Services Research Fund [06070231]; Lui Che Woo Institute of Innovative Medicine; Fred Simmons and Olga Mohan, and the Joanne Knight Alzheimer's Research Initiative of the Washington Knight Alzheimer's Disease Research Center; French Ministry of Health [PHRC-N 2008 1004]; EC-FP6-project (DiMI) [LSHB-CT-2005-512146]; Pennsylvanian Department of Health [4100037703]; NIH NCRR [UL1RR024992]; NIH NINDS [NS075321]; American Parkinson Disease Association (APDA) Advanced Research Center for Parkinson Disease at Washington University in St. Louis; Greater St Louis Chapter of the APDA; Center for Translational Molecular Medicine (CTMM), project LeARN [02N-101]; Agence Nationale de la Reserche; Programme Hospitalier de Reserche Clinique; Region Basse Normandie; Institut National de la Sante et de la Reserche Medicale (INSERM); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, U01AG024904, R01AG045611, P01AG019724, P50AG005681, R01AG032306, P30AG010124, P01AG026276, P01AG003991, U01AG016976] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian Commonwealth Scientific Industrial and Research Organization [CSIRO]; Edith Cowan University [ECU]; Mental Health Research Institute [MHRI]; Alzheimer's Australia [AA]; National Ageing Research Institute [NARI]; Austin Health; CogState(CogState Limited); Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centres program (DCRC2)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Science and Industry Endowment Fund (SIEF); Innovative Medicines Initiative Joint Undertaking under EMIF; European Union(European Commission); German research foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); KKF-grant for clinical research of the Technische Universitat Munchen; Health and Health Services Research Fund; Lui Che Woo Institute of Innovative Medicine; Fred Simmons and Olga Mohan, and the Joanne Knight Alzheimer's Research Initiative of the Washington Knight Alzheimer's Disease Research Center; French Ministry of Health; EC-FP6-project (DiMI)(European Commission); Pennsylvanian Department of Health; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association (APDA) Advanced Research Center for Parkinson Disease at Washington University in St. Louis; Greater St Louis Chapter of the APDA; Center for Translational Molecular Medicine (CTMM), project LeARN; Agence Nationale de la Reserche(French National Research Agency (ANR)); Programme Hospitalier de Reserche Clinique; Region Basse Normandie(Region Normandie); Institut National de la Sante et de la Reserche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Alzheimer's Coordinating Center (NACC) database is funded by grant U01 AG016976 from the National Institute on Aging. The Alzheimer's Disease Neuroimaging Initiative (ADNI; National Institutes of Health, grant U01 AG024904) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences; AstraZeneca; Bayer HealthCare; BioClinica; Biogen Idec; Bristol-Myers Squibb; Eisai; Elan Pharmaceuticals; Eli Lilly; F. Hoffmann-La Roche and its affiliated company Genentech; GE Healthcare; Innogenetics, NV; IXICO; Janssen Alzheimer Immunotherapy Research and Development; Johnson & Johnson Pharmaceutical Research and Development; Medpace; Merck and Company; Meso Scale Diagnostics; Novartis Pharmaceuticals; Pfizer; Servier; Synarc; and Takeda Pharmaceutical. The Canadian Institutes of Health Research provides funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study was coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuroimaging at the University of California, Los Angeles. Funding for the Australian Imaging, Biomarkers, and Lifestyle (AIBL) study was provided in part by the study partners (Australian Commonwealth Scientific Industrial and Research Organization [CSIRO], Edith Cowan University [ECU], Mental Health Research Institute [MHRI], Alzheimer's Australia [AA], National Ageing Research Institute [NARI], Austin Health, CogState, Hollywood Private Hospital, Sir Charles Gardner Hospital). The study also received support from the National Health and Medical Research Council (NHMRC) and the Dementia Collaborative Research Centres program (DCRC2), as well as ongoing funding from the Science and Industry Endowment Fund (SIEF). The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement 115372, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The florbetaben phase 2 study, from which data were derived for this multicenter evaluation, was sponsored by Bayer Healthcare/Piramal Imaging (Berlin, Germany). The assembling of the TU Munich data set was supported in part by the German research foundation (Deutsche Forschungsgemeinschaft; HE 4560/1-2, DR 445/3-1 and DR 445/4-1 to Dr Drzezga), and by a KKF-grant for clinical research of the Technische Universitat Munchen (to Drs Drzezga and Grimmer). The amyloid PET studies of The Chinese University of Hong Kong are supported by Health and Health Services Research Fund (06070231) and seeding money from Lui Che Woo Institute of Innovative Medicine. Funding for this study was provided by the National Institute on Aging (P50 AG005681, P01 AD 003991, and P01 AD 026276); Fred Simmons and Olga Mohan, and the Joanne Knight Alzheimer's Research Initiative of the Washington Knight Alzheimer's Disease Research Center. The study in Tours was financially supported by the French Ministry of Health (grant PHRC-N 2008 1004) and the EC-FP6-project (DiMI, LSHB-CT-2005-512146).; Data from the University of Pennsylvania was supported by the Pennsylvanian Department of Health (4100037703). Data from Washington University in St Louis was supported by grants NIH NCRR UL1RR024992, NINDS NS075321, the American Parkinson Disease Association (APDA) Advanced Research Center for Parkinson Disease at Washington University in St. Louis, and the Greater St Louis Chapter of the APDA. This research was performed within the framework of The Center for Translational Molecular Medicine (CTMM; http://www.ctmm.nl), project LeARN (grant 02N-101). The Caen study was funded by Agence Nationale de la Reserche, Programme Hospitalier de Reserche Clinique, Region Basse Normandie, and Institut National de la Sante et de la Reserche Medicale (INSERM).	Agdeppa ED, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0004.2001; Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Armstrong MJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0282-1; Barkhof F, 2007, NEUROLOGY, V69, P1521, DOI 10.1212/01.wnl.0000277459.83543.99; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Caso F, 2013, BEHAV NEUROL, V26, P95, DOI [10.3233/BEN-2012-120255, 10.1155/2013/793530]; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P1096; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Ducharme S, 2013, JAMA NEUROL, V70, P912, DOI 10.1001/jamaneurol.2013.420; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grundman M, 2013, ALZ DIS ASSOC DIS, V27, P4, DOI 10.1097/WAD.0b013e318279d02a; Harding AJ, 2001, ACTA NEUROPATHOL, V102, P355; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Johnson KA, 2013, J NUCL MED, V54, P1011, DOI 10.2967/jnumed.113.127068; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Landau SM, 2014, EUR J NUCL MED MOL I, V41, P1398, DOI 10.1007/s00259-014-2753-3; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Ossenkoppele R, 2015, ANN NEUROL, V77, P338, DOI 10.1002/ana.24321; Ossenkoppele R, 2013, ALZHEIMERS DEMENT, V9, P414, DOI 10.1016/j.jalz.2012.07.003; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sanchez-Juan P, 2014, NEUROLOGY, V82, P230, DOI 10.1212/WNL.0000000000000032; Serrano-Pozo A, 2014, ANN NEUROL, V75, P597, DOI 10.1002/ana.24125; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; World Health Organization and Alzheimer Disease International, 2012, DEM PUBL HLTH PRIOR; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061	49	367	368	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1939	1949		10.1001/jama.2015.4669	http://dx.doi.org/10.1001/jama.2015.4669			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988463	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000354691200015
J	Galy, V; Peucker-Ehrenbrink, B; Eglinton, T				Galy, Valier; Peucker-Ehrenbrink, Bernhard; Eglinton, Timothy			Global carbon export from the terrestrial biosphere controlled by erosion	NATURE			English	Article							PARTICULATE ORGANIC-CARBON; MOUNTAIN RIVERS; TRANSPORT; BURIAL; OCEAN; SEDIMENT; SYSTEM; CLIMATE; IMPACT; RATES	Riverine export of particulate organic carbon (POC) to the ocean affects the atmospheric carbon inventory over a broad range of timescales(1-5). On geological timescales, the balance between sequestration of POC from the terrestrial biosphere and oxidation of rock-derived (petrogenic) organic carbon sets the magnitude of the atmospheric carbon and oxygen reservoirs(6,7). Over shorter timescales, variations in the rate of exchange between carbon reservoirs, such as soils and marine sediments, also modulate atmospheric carbon dioxide levels(1). The respective fluxes of biospheric and petrogenic organic carbon are poorly constrained, however, and mechanisms controlling POC export have remained elusive, limiting our ability to predict POC fluxes quantitatively as a result of climatic or tectonic changes. Here we estimate biospheric and petrogenic POC fluxes for a suite of river systems representative of the natural variability in catchment properties. We show that export yields of both biospheric and petrogenic POC are positively related to the yield of suspended sediment, revealing that POC export is mostly controlled by physical erosion. Using a global compilation of gauged suspended sediment flux, we derive separate estimates of global biospheric and petrogenic POC fluxes of 157(-50)(+74) and 43(-25)(+61) megatonnes of carbon per year, respectively. We find that biospheric POC export is primarily controlled by the capacity of rivers to mobilize and transport POC, and is largely insensitive to the magnitude of terrestrial primary production. Globally, physical erosion rates affect the rate of biospheric POC burial in marine sediments more strongly than carbon sequestration through silicate weathering. We conclude that burial of biospheric POC in marine sediments becomes the dominant long-term atmospheric carbon dioxide sink under enhanced physical erosion.	[Galy, Valier; Peucker-Ehrenbrink, Bernhard; Eglinton, Timothy] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Eglinton, Timothy] ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland	Woods Hole Oceanographic Institution; Swiss Federal Institutes of Technology Domain; ETH Zurich	Galy, V (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	vgaly@whoi.edu	galy, valier/I-6185-2012; Galy, valier/AAD-2248-2021	galy, valier/0000-0003-0385-8443; Galy, valier/0000-0003-0385-8443; Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X; Eglinton, Timothy/0000-0001-5060-2155	US National Science Foundation (NSF) [OCE-0851015]; NSF [OCE-0928582]; Swiss National Science Foundation [200021_140850]	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Y. Godderis, J. Hemingway and G. Soulet for comments on early versions of the manuscript. G. Fiske generated the NPP data. Support for this project was provided by US National Science Foundation (NSF) grant OCE-0851015 (to B.P.-E., T.E. and V.G.), NSF grant OCE-0928582 (to V.G. and T.E.) and Swiss National Science Foundation grant 200021_140850 (to T.E.).	Alam MJ, 2007, NUCL INSTRUM METH B, V259, P513, DOI 10.1016/j.nimb.2007.01.194; BERNER RA, 1982, AM J SCI, V282, P451, DOI 10.2475/ajs.282.4.451; Bianchi TS, 2007, ESTUAR COAST SHELF S, V73, P211, DOI 10.1016/j.ecss.2007.01.004; Blair NE, 2004, MAR CHEM, V92, P141, DOI 10.1016/j.marchem.2004.06.023; Blair NE, 2003, GEOCHIM COSMOCHIM AC, V67, P63, DOI 10.1016/S0016-7037(02)01043-8; Bouchez J, 2014, GEOCHIM COSMOCHIM AC, V133, P280, DOI 10.1016/j.gca.2014.02.032; Bouchez J, 2010, GEOLOGY, V38, P255, DOI 10.1130/G30608.1; DEGENS ET, 1991, BIOGEOCHEMISTRY MAJO; Drenzek NJ, 2007, MAR CHEM, V103, P146, DOI 10.1016/j.marchem.2006.06.017; Drenzek NJ, 2009, GEOLOGY, V37, P239, DOI 10.1130/G25351A.1; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy V, 2008, SCIENCE, V322, P943, DOI 10.1126/science.1161408; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Galy V, 2011, NAT GEOSCI, V4, P843, DOI [10.1038/ngeo1293, 10.1038/NGEO1293]; Graham ST, 1999, WATER RESOUR RES, V35, P583, DOI 10.1029/1998WR900068; Hilton R. G., NATURE UNPUB; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Hilton RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004314; Hilton RG, 2011, EARTH SURF PROC LAND, V36, P1670, DOI 10.1002/esp.2191; Hilton RG, 2011, GEOLOGY, V39, P71, DOI 10.1130/G31352.1; Hilton RG, 2010, GEOCHIM COSMOCHIM AC, V74, P3164, DOI 10.1016/j.gca.2010.03.004; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kao SJ, 2014, EARTH SURF DYNAM, V2, P127, DOI 10.5194/esurf-2-127-2014; Komada T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019512; Larsen IJ, 2014, GEOLOGY, V42, P527, DOI 10.1130/G35136.1; Leithold EL, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002677; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; MEYBECK M, 1993, INTERACTIONS C N P S, P163, DOI DOI 10.1007/978-3-642-76064-8_6; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Peucker-Ehrenbrink B, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002356; Rosenheim BE, 2013, GLOBAL BIOGEOCHEM CY, V27, P154, DOI 10.1002/gbc.20018; Sarmiento J, 2006, OCEAN BIOGEOCHEMICAL, P392, DOI DOI 10.1126/SCIENCE.290.5495.1342; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Voss B. M., 2014, THESIS MIT; Wakeham SG, 2009, MAR CHEM, V115, P211, DOI 10.1016/j.marchem.2009.08.005; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020	39	295	309	35	503	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					204	+		10.1038/nature14400	http://dx.doi.org/10.1038/nature14400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971513				2022-12-28	WOS:000354377800055
J	Howard, S				Howard, Sally			TripAdvisor for fertility clinics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						HFEA, FERT TREATM 2011; Morris S., 2010, GUARDIAN	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h2599	10.1136/bmj.h2599	http://dx.doi.org/10.1136/bmj.h2599			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CI	25976236				2022-12-28	WOS:000354770100018
J	Vigod, SN; Gomes, T; Wilton, AS; Taylor, VH; Ray, JG				Vigod, Simone N.; Gomes, Tara; Wilton, Andrew S.; Taylor, Valerie H.; Ray, Joel G.			Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL DIABETES-MELLITUS; BIPOLAR DISORDER; EXPOSURE; BIRTH; RISK; OUTCOMES; WOMEN; MOOD; MEDICATIONS; PREVALENCE	OBJECTIVE To evaluate maternal medical and perinatal outcomes associated with antipsychotic drug use in pregnancy. DESIGN High dimensional propensity score (HDPS) matched cohort study. SETTING Multiple linked population health administrative databases in the entire province of Ontario, Canada. PARTICIPANTS Among women who delivered a singleton infant between 2003 and 2012, and who were eligible for provincially funded drug coverage, those with >= 2 consecutive prescriptions for an antipsychotic medication during pregnancy, at least one of which was filled in the first or second trimester, were selected. Of these antipsychotic drug users, 1021 were matched 1: 1 with 1021 non-users by means of a HDPS algorithm. MAIN OUTCOME MEASURES The main maternal medical outcomes were gestational diabetes, hypertensive disorders of pregnancy, and venous thromboembolism. The main perinatal outcomes were preterm birth (<37 weeks), and a birth weight <3rd or >97th centile. Conditional Poisson regression analysis was used to generate rate ratios and 95% confidence intervals, adjusting for additionally prescribed non-antipsychotic psychotropic medications. RESULTS Compared with non-users, women prescribed an antipsychotic medication in pregnancy did not seem to be at higher risk of gestational diabetes (rate ratio 1.10 (95% CI 0.77 to 1.57)), hypertensive disorders of pregnancy (1.12 (0.70 to 1.78)), or venous thromboembolism (0.95 (0.40 to 2.27)). The preterm birth rate, though high among antipsychotic users (14.5%) and matched non-users (14.3%), was not relatively different (rate ratio 0.99 (0.78 to 1.26)). Neither birth weight <3rd centile or >97th centile was associated with antipsychotic drug use in pregnancy (rate ratios 1.21 (0.81 to 1.82) and 1.26 (0.69 to 2.29) respectively). CONCLUSIONS Antipsychotic drug use in pregnancy had minimal evident impact on important maternal medical and short term perinatal outcomes. However, the rate of adverse outcomes is high enough to warrant careful assessment of maternal and fetal wellbeing among women prescribed an antipsychotic drug in pregnancy.	[Vigod, Simone N.; Taylor, Valerie H.] Univ Toronto, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Vigod, Simone N.; Taylor, Valerie H.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1B2, Canada; [Vigod, Simone N.; Gomes, Tara; Wilton, Andrew S.; Ray, Joel G.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Vigod, Simone N.; Taylor, Valerie H.] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynaecol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Vigod, SN (corresponding author), Univ Toronto, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada.	simone.vigod@wchospital.ca	Taylor, Valerie H/H-6242-2015	Taylor, Valerie/0000-0002-8948-638X; Vigod, Simone/0000-0002-2736-9639; Gomes, Tara/0000-0002-1468-1965	Canadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant from the Canadian Institutes of Health Research (CIHR). It was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Abel KM, 2013, BRIT J PSYCHIAT, V202, P321, DOI 10.1192/bjp.bp.112.117556; Barbui C, 2014, DRUG SAFETY, V37, P79, DOI 10.1007/s40264-013-0127-6; Bellantuono C, 2013, GEN HOSP PSYCHIAT, V35, P3, DOI 10.1016/j.genhosppsych.2012.09.003; Boden Robert, 2012, BMJ, V345, pe7085, DOI 10.1136/bmj.e7085; Boden R, 2012, ARCH GEN PSYCHIAT, V69, P715, DOI 10.1001/archgenpsychiatry.2011.1870; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borders AEB, 2007, OBSTET GYNECOL, V109, P331, DOI 10.1097/01.AOG.0000250535.97920.b5; Canadian Chronic Disease Surveillance System, 2010, HYP CAN; Canadian Perinatal Surveillance System, 2000, PER HLTH IND CAN RES; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Gomes T, 2011, J UROLOGY, V186, P1340, DOI 10.1016/j.juro.2011.05.077; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hirdes JP, 2002, J BEHAV HEALTH SER R, V29, P419, DOI 10.1007/BF02287348; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joseph KS, 2010, J OBSTET GYNAECOL CA, V32, P837, DOI 10.1016/S1701-2163(16)34655-2; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Juurlink D, 2006, CANADIAN I HLTH INFO; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; Kennedy SH, 2009, J AFFECT DISORDERS, V117, pS1, DOI 10.1016/j.jad.2009.06.043; Landon MB, 2011, OBSTET GYNECOL, V117, P218, DOI 10.1097/AOG.0b013e318203ebe0; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; National Diabetes Surveillance System, 2008, DAIB IN CAN; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Parkerson GR, 2001, MED CARE, V39, P1170, DOI 10.1097/00005650-200111000-00004; Public Health Agency of Canada, 2008, CAN PER HLTH REP; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Quispel C, 2014, MIDWIFERY, V30, P919, DOI 10.1016/j.midw.2014.03.008; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; Ray JG, 2001, QJM-INT J MED, V94, P347, DOI 10.1093/qjmed/94.7.347; Ray JG, 2012, J OBSTET GYNAECOL CA, V34, P159, DOI 10.1016/S1701-2163(16)35159-3; Ray JG, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000337; Reis M, 2008, J CLIN PSYCHOPHARM, V28, P279, DOI 10.1097/JCP.0b013e318172b8d5; Ros H, 2001, PREECLAMPSIA OTHER C; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Toh S, 2013, ARCH WOMEN MENT HLTH, V16, P149, DOI 10.1007/s00737-013-0330-6; Urbanoski KA, 2012, CAN J PSYCHIAT, V57, P687, DOI 10.1177/070674371205701106; Urquia Marcelo L, 2007, Health Rep, V18, P21; Vigod SN, 2012, SCHIZOPHR RES, V139, P169, DOI 10.1016/j.schres.2012.05.010; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025; You JJ, 2010, CAN MED ASSOC J, V182, P143, DOI 10.1503/cmaj.090979	43	95	95	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2015	350								h2298	10.1136/bmj.h2298	http://dx.doi.org/10.1136/bmj.h2298			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5CE	25972273	hybrid, Green Published			2022-12-28	WOS:000354769700002
J	Cohen, JJ				Cohen, Jordan J.			Tasking the "Self" in the Self-governance of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALISM		[Cohen, Jordan J.] Arnold P Gold Fdn, Englewood Cliffs, NJ USA; [Cohen, Jordan J.] Assoc Amer Med Coll, Washington, DC USA	Association of American Medical Colleges	Cohen, JJ (corresponding author), 360 S Ocean Blvd, Palm Beach, FL 33480 USA.	jjcohenmd@gmail.com						Beck M., MISSOURI ALLOW MED S; Cohen JJ, 2007, ACAD MED, V82, P1029, DOI 10.1097/01.ACM.0000285307.17430.74; Cruess SR, 2004, PROFESSIONALISM MED; Federation of State Medical Boards, STAT SPEC REQ IN MED; Medscape Multispecialty, STAT CME REQ; Miller FH, 2003, JAMA-J AM MED ASSOC, V289, P913, DOI 10.1001/jama.289.7.913; National Institutes of Health, NOT LEG MAND EFF FY; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	8	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1839	1840		10.1001/jama.2015.3736	http://dx.doi.org/10.1001/jama.2015.3736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965232				2022-12-28	WOS:000354391000027
J	Sedgwick, P				Sedgwick, Philip			How to read a receiver operating characteristic curve	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Ikeda M, 2002, BRIT MED J, V325, P800, DOI 10.1136/bmj.325.7368.800; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1801	2	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2015	350								h2464	10.1136/bmj.h2464	http://dx.doi.org/10.1136/bmj.h2464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GP	25956305				2022-12-28	WOS:000354415400002
J	Cui, GL; Staron, MM; Gray, SM; Ho, PC; Amezquita, RA; Wu, JX; Kaech, SM				Cui, Guoliang; Staron, Matthew M.; Gray, Simon M.; Ho, Ping-Chih; Amezquita, Robert A.; Wu, Jingxia; Kaech, Susan M.			IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8(+) T Cell Longevity	CELL			English	Article							BASAL HOMEOSTATIC PROLIFERATION; INTERLEUKIN (IL)-7; IL-7; NAIVE; GENERATION; EXPRESSION; EXPANSION; SURVIVAL; BCL-2; REQUIREMENTS	Memory T cells are critical for long-term immunity against reinfection and require interleukin-7 (IL-7), but the mechanisms by which IL-7 controls memory T cell survival, particularly metabolic fitness, remain elusive. We discover that IL-7 induces expression of the glycerol channel aquaporin 9 (AQP9) in virus-specific memory CD8+ T cells, but not naive cells, and that AQP9 is vitally required for their long-term survival. AQP9 deficiency impairs glycerol import into memory CD8+ T cells for fatty acid esterification and triglyceride (TAG) synthesis and storage. These defects can be rescued by ectopic expression of TAG synthases, which restores lipid stores and memory T cell survival. Finally, we find that TAG synthesis is a central component of IL-7-mediated survival of human and mouse memory CD8+ T cells. This study uncovers the metabolic mechanisms by which IL-7 tailors the metabolism of memory T cells to promote their longevity and fast response to rechallenge.	[Cui, Guoliang; Staron, Matthew M.; Gray, Simon M.; Ho, Ping-Chih; Amezquita, Robert A.; Kaech, Susan M.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Amezquita, Robert A.; Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wu, Jingxia] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Kaech, SM (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.	susan.kaech@yale.edu	wu, Jingxia/AFR-6587-2022	Ho, Ping-Chih/0000-0003-3078-3774; Cui, Guoliang/0000-0001-5559-7957	NIH [R37AI066232/R01AI074699, T32GM07205, U19AI089992]; Howard Hughes Medical Institute; Trudeau Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066232, U19AI089992, R01AI066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Trudeau Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Aleksandra Rojek, Soren Nielsen, and Peter Agre for providing Aqp9<SUP>-/-</SUP> mice. We thank Drs. Gerald Shulman and Rachel Perry for their discussion. We thank Barbara Siconolfi for collecting human samples. Drs. Huajin Wang and Tobias Walther provided generous help with TLC assay. This study is supported by grants from the NIH R37AI066232/R01AI074699 (S.M.K.), T32GM07205 (S.M.G.), U19AI089992 (D. Hafler, Yale University), Howard Hughes Medical Institute (S.M.K.), and a Trudeau Fellowship (G.C.).	Abrami L, 1996, PFLUG ARCH EUR J PHY, V431, P408, DOI 10.1007/BF02207279; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Liu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5244; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nanjappa SG, 2008, J CLIN INVEST, V118, P1027, DOI 10.1172/JCI32020; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pearson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033998; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Sportes C, 2010, CLIN CANCER RES, V16, P727, DOI 10.1158/1078-0432.CCR-09-1303; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297	48	199	208	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					750	761		10.1016/j.cell.2015.03.021	http://dx.doi.org/10.1016/j.cell.2015.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957683	Green Accepted, Bronze			2022-12-28	WOS:000354175200010
J	Vyas, VS; Lotsch, BV				Vyas, Vijay S.; Lotsch, Bettina V.			MATERIALS CHEMISTRY Organic polymers form fuel from water	NATURE			English	Editorial Material							VISIBLE-LIGHT		[Vyas, Vijay S.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Univ Munich LMU, Dept Chem, Munich, Germany	Max Planck Society; University of Munich	Vyas, VS (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.	b.lotsch@fkf.mpg.de	Vyas, Vijay S/A-4478-2018; Lotsch, Bettina V./E-8022-2015	Vyas, Vijay S/0000-0002-9309-0249; Lotsch, Bettina V./0000-0002-3094-303X				Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Ding SY, 2013, CHEM SOC REV, V42, P548, DOI 10.1039/c2cs35072f; Simon T, 2014, NAT MATER, V13, P1013, DOI [10.1038/NMAT4049, 10.1038/nmat4049]; Sprick RS, 2015, J AM CHEM SOC, V137, P3265, DOI 10.1021/ja511552k; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Xu YH, 2013, CHEM SOC REV, V42, P8012, DOI 10.1039/c3cs60160a	6	61	62	3	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					41	42		10.1038/521041a	http://dx.doi.org/10.1038/521041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951281				2022-12-28	WOS:000354040900027
J	Ayoola, R; Mansour, W; Gujral, J				Ayoola, Rotimi; Mansour, William; Gujral, Jaspal			Tattoo Rash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SARCOIDOSIS		[Ayoola, Rotimi; Mansour, William; Gujral, Jaspal] Georgia Regents Univ, Dept Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ayoola, R (corresponding author), Georgia Regents Univ, Dept Med, 1120 15th St,BI 5070, Augusta, GA 30912 USA.	rayoola@gru.edu		Ayoola, Rotimi/0000-0001-5951-5664				AINSLIE GM, 1985, Q J MED, V55, P253; Ali MM, 2010, J EUR ACAD DERMATOL, V24, P747, DOI 10.1111/j.1468-3083.2009.03517.x; Antonovich DD, 2005, ARCH DERMATOL, V141, P869, DOI 10.1001/archderm.141.7.869; English JC, 2001, J AM ACAD DERMATOL, V44, P725, DOI 10.1067/mjd.2001.114596; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Lodha S, 2009, CHEST, V136, P583, DOI 10.1378/chest.08-1527; O'Regan Anthony, 2012, Ann Intern Med, V156, pITC5, DOI 10.7326/0003-4819-156-9-201205010-01005; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; Torpy Janet M, 2011, JAMA, V305, P423, DOI 10.1001/jama.305.4.423	10	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1747	1748		10.1001/jama.2015.0990	http://dx.doi.org/10.1001/jama.2015.0990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942726				2022-12-28	WOS:000353921000021
J	Basaria, S				Basaria, Shehzad			Testosterone Levels for Evaluation of Androgen Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HORMONE-BINDING-GLOBULIN; SERUM TESTOSTERONE; OBESE MEN; LIFE		Harvard Univ, Brigham & Womens Hosp, Sect Mens Hlth Aging & Metab, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Basaria, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sect Mens Hlth Aging & Metab, Sch Med, Boston, MA 02115 USA.	sbasaria@partners.org		Basaria, Shehzad/0000-0003-1749-8549				Basaria S, 2014, LANCET, V383, P1250, DOI 10.1016/S0140-6736(13)61126-5; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Brambilla DJ, 2007, CLIN ENDOCRINOL, V67, P853, DOI 10.1111/j.1365-2265.2007.02976.x; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; GLASS AR, 1977, J CLIN ENDOCR METAB, V45, P1211, DOI 10.1210/jcem-45-6-1211; Hammoud A, 2009, J CLIN ENDOCR METAB, V94, P1329, DOI 10.1210/jc.2008-1598; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; PLYMATE SR, 1988, J CLIN ENDOCR METAB, V67, P460, DOI 10.1210/jcem-67-3-460; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666	10	5	5	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1749	1750		10.1001/jama.2015.4179	http://dx.doi.org/10.1001/jama.2015.4179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942727				2022-12-28	WOS:000353921000022
J	Jost, TS				Jost, Timothy Stoltzfus			An Affordable Care Act at Year 5 Key Issues for Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Sydney Lewis Hall, Lexington, VA 24450 USA.	jostt@wlu.edu						Brooks T., 2014, FAM GLITCH HLTH POL; Collins SR, 2015, RISE HLTH CARE COVER; Delire T, 2014, IMPACT INSURANCE EXP; Hall JP, 2015, WHY HIGH RISK POOLS; Hartman M, 2015, HEALTH AFFAIR, V34, P150, DOI 10.1377/hlthaff.2014.1107; KLEIN PHILLIP, 2015, OVERCOMING OBAMACARE; Organisation for Economic Co-operation and Development, OECD HLTH STAT 2014	7	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1709	1710		10.1001/jama.2015.2769	http://dx.doi.org/10.1001/jama.2015.2769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942719				2022-12-28	WOS:000353921000012
J	Lo, S; Horton, R				Lo, Selina; Horton, Richard			Everyone counts-so count everyone	LANCET			English	Editorial Material									[Lo, Selina; Horton, Richard] The Lancet, London EC2Y 5AS, England		Lo, S (corresponding author), The Lancet, London EC2Y 5AS, England.							Abouzahr C, 2015, LANCET; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Mikkelsen L, 2015, LANCET; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Phillips DE, 2015, LANCET; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Shibuya K, 2015, LANCET	7	19	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1313	1314		10.1016/S0140-6736(15)60305-1	http://dx.doi.org/10.1016/S0140-6736(15)60305-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	25971219				2022-12-28	WOS:000362316200006
J	Dixon, WG				Dixon, William G.			Rheumatoid arthritis: biological drugs and risk of infection	LANCET			English	Editorial Material							NECROSIS-FACTOR THERAPY; SERIOUS INFECTION; METHOTREXATE; METAANALYSIS; INFLIXIMAB; ANTIBODY		Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England	University of Manchester	Dixon, WG (corresponding author), Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England.	will.dixon@manchester.ac.uk	Dixon, William/L-8408-2019	Dixon, William/0000-0001-5881-4857	MRC [G0902272] Funding Source: UKRI; Medical Research Council [G0902272] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Askling J, 2008, CURR OPIN RHEUMATOL, V20, P138, DOI 10.1097/BOR.0b013e3282f4b392; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Singh JA, 2015, LANCET; Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043; Thompson AE, 2011, ARTHRITIS RHEUM-US, V63, P1479, DOI 10.1002/art.30310; Zink A, 2014, ANN RHEUM DIS, V73, P1673, DOI 10.1136/annrheumdis-2013-203341	9	7	8	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					224	225		10.1016/S0140-6736(14)61907-3	http://dx.doi.org/10.1016/S0140-6736(14)61907-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25975453				2022-12-28	WOS:000358213700007
J	Rothwell, PM				Rothwell, Peter M.			AVERT: a major milestone in stroke research	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS		John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford OX2 6HE, England	University of Oxford	Rothwell, PM (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Department of Health [12/01/16] Funding Source: Medline; National Institute for Health Research [NF-SI-0514-10168, 12/01/16] Funding Source: researchfish; Stroke Association [TSA2009/09] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association		AVERT Trial Collaboration group, 2015, LANCET; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Lynch E, 2014, INT J STROKE, V9, P468, DOI 10.1111/ijs.12262; Manning L, 2014, LANCET NEUROL, V13, P364, DOI 10.1016/S1474-4422(14)70018-3; Mishra NK, 2010, STROKE, V41, P2840, DOI 10.1161/STROKEAHA.110.586206; Rothwell PM, 2006, LANCET, V368, P262, DOI 10.1016/S0140-6736(06)69010-7; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Skarin M, 2011, INT J STROKE, V6, P10, DOI 10.1111/j.1747-4949.2010.00534.x	9	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					7	9		10.1016/S0140-6736(15)60906-0	http://dx.doi.org/10.1016/S0140-6736(15)60906-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25971220	hybrid			2022-12-28	WOS:000357519400006
J	Bartesaghi, A; Merk, A; Banerjee, S; Matthies, D; Wu, XW; Milne, JLS; Subramaniam, S				Bartesaghi, Alberto; Merk, Alan; Banerjee, Soojay; Matthies, Doreen; Wu, Xiongwu; Milne, Jacqueline L. S.; Subramaniam, Sriram			2.2 angstrom resolution cryo-EM structure of beta-galactosidase in complex with a cell-permeant inhibitor	SCIENCE			English	Article							ATOMIC MODEL; SUBUNIT; MICROSCOPY; MECHANISM; RIBOSOME; REVEALS; VIRUS	Cryo-electron microscopy (cryo-EM) is rapidly emerging as a powerful tool for protein structure determination at high resolution. Here we report the structure of a complex between Escherichia coli beta-galactosidase and the cell-permeant inhibitor phenylethyl beta-D-thiogalactopyranoside (PETG), determined by cryo-EM at an average resolution of similar to 2.2 angstroms (angstrom). Besides the PETG ligand, we identified densities in the map for similar to 800 water molecules and for magnesium and sodium ions. Although it is likely that continued advances in detector technology may further enhance resolution, our findings demonstrate that preparation of specimens of adequate quality and intrinsic protein flexibility, rather than imaging or image-processing technologies, now represent the major bottlenecks to routinely achieving resolutions close to 2 angstrom using single-particle cryo-EM.	[Bartesaghi, Alberto; Merk, Alan; Banerjee, Soojay; Matthies, Doreen; Milne, Jacqueline L. S.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wu, Xiongwu] NHLBI, Lab Computat Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ss1@nih.gov		Subramaniam, Sriram/0000-0003-4231-4115; Matthies, Doreen/0000-0001-9221-4484	NIH, Center for Cancer Research, National Cancer Institute; Intramural AIDS Targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010826, ZIABC010824, ZIABC010412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001027] Funding Source: NIH RePORTER	NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by funds from the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute, and the Intramural AIDS Targeted Antiviral Program. We thank R. Mueller and J. Cometa for technical assistance with electron microscopy, P. Mooney and F. Ulmer for advice and assistance with optimizing detector performance, K. Podolsky for assistance with data collection, J.-J. Fernandez for providing the code to run the TOMOCTFFIND program, and V. Falconieri for assistance in preparation of the figures and the supplementary movie. This study used the high-performance computational capabilities of the Biowulf Linux cluster at NIH (http://biowulf.nih.gov). The density map and refined atomic model have been deposited with the Electron Microscopy Data Bank (accession number EMD-2984) and the Protein Data Bank (entry code 5a1a), respectively.	Agard D., 2014, ADV IMAG ELECT PHYS, P113; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Campbell MG, 2015, ELIFE, V4, DOI 10.7554/eLife.06380; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Guo F, 2014, P NATL ACAD SCI USA, V111, pE4606, DOI 10.1073/pnas.1407020111; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	25	340	347	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1147	1151		10.1126/science.aab1576	http://dx.doi.org/10.1126/science.aab1576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25953817	Green Accepted			2022-12-28	WOS:000355590500051
J	Ma, DKK; Li, ZJ; Lu, AY; Sun, F; Chen, SD; Rothe, M; Menzel, R; Sun, F; Horvitz, HR				Ma, Dengke K.; Li, Zhijie; Lu, Alice Y.; Sun, Fang; Chen, Sidi; Rothe, Michael; Menzel, Ralph; Sun, Fei; Horvitz, H. Robert			Acyl-CoA Dehydrogenase Drives Heat Adaptation by Sequestering Fatty Acids	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C.-ELEGANS; ORGANISMAL PROTEOSTASIS; CRYSTAL-STRUCTURE; TEMPERATURE; THERMOTAXIS; MEMBRANES; GENETICS; HOMEOSTASIS; DESATURASE	Cells adapt to temperature shifts by adjusting levels of lipid desaturation and membrane fluidity. This fundamental process occurs in nearly all forms of life, but its mechanism in eukaryotes is unknown. We discovered that the evolutionarily conserved Caenorhabditis elegans gene acdh-11 (acyl-CoA dehydrogenase [ACDH]) facilitates heat adaptation by regulating the lipid desaturase FAT-7. Human ACDH deficiency causes the most common inherited disorders of fatty acid oxidation, with syndromes that are exacerbated by hyperthermia. Heat upregulates acdh-11 expression to decrease fat-7 expression. We solved the high-resolution crystal structure of ACDH-11 and established the molecular basis of its selective and high-affinity binding to C11/C12-chain fatty acids. ACDH-11 sequesters C11/C12-chain fatty acids and prevents these fatty acids from activating nuclear hormone receptors and driving fat-7 expression. Thus, the ACDH-11 pathway drives heat adaptation by linking temperature shifts to regulation of lipid desaturase levels and membrane fluidity via an unprecedented mode of fatty acid signaling.	[Ma, Dengke K.; Lu, Alice Y.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, McGovern Inst Brain Res, Dept Biol, Cambridge, MA 02139 USA; [Li, Zhijie; Sun, Fang; Sun, Fei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Chen, Sidi; Horvitz, H. Robert] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Rothe, Michael] Lipidomix GmbH, D-13125 Berlin, Germany; [Menzel, Ralph] Humboldt Univ, Dept Biol Freshwater & Stress Ecol, D-12437 Berlin, Germany	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Institute of Biophysics, CAS; Massachusetts Institute of Technology (MIT); Humboldt University of Berlin	Ma, DKK (corresponding author), UCSF Sch Med, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94158 USA.	dengke.ma@ucsf.edu; horvitz@mit.edu	CHEN, SIDI/D-8284-2016; Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	CHEN, SIDI/0000-0002-3819-5005; Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144	NIH [GM24663, K99HL116654]; Chinese Ministry of Science and Technology grant [2011CB910301, 2011CB910901]; German Research Foundation grant [ME2056/3-1]; Damon Runyon Fellowship [DRG-2117-12]; Helen Hay Whitney postdoctoral fellowship; Charles King Trust postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL116654, K99HL116654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663, R01GM117461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology grant; German Research Foundation grant; Damon Runyon Fellowship; Helen Hay Whitney postdoctoral fellowship; Charles King Trust postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Boyden, A. Fire, Y. Iino, and M. Pilon for reagents and the Caenorhabditis Genetics Center and the Million Mutation Project for strains, and M. Bai, N. Bhatla, S. Luo, R. Vozdek, T. Wang, and J. Ward for comments on the manuscript. H.R.H. is an Investigator of the Howard Hughes Medical Institute and the David H. Koch Professor of Biology at MIT. This work was supported by NIH grants GM24663 (H.R.H.) and K99HL116654 (D.K.M.), Chinese Ministry of Science and Technology grant 2011CB910301 and 2011CB910901 (F.S.), German Research Foundation grant ME2056/3-1 (R. M.), Damon Runyon Fellowship DRG-2117-12 (S.C.), and Helen Hay Whitney and Charles King Trust postdoctoral fellowships (D.K.M.).	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Antebi Adam, 2006, WormBook, P1; Ashrafi Kaveh, 2007, WormBook, P1; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Baird NA, 2014, SCIENCE, V346, P360, DOI 10.1126/science.1253168; Bowles T, 2008, P NATL ACAD SCI USA, V105, P15299, DOI 10.1073/pnas.0806521105; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; de Mendoza D, 2014, ANNU REV MICROBIOL, V68, P101, DOI 10.1146/annurev-micro-091313-103612; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Imbeault P, 2009, METABOLISM, V58, P552, DOI 10.1016/j.metabol.2008.11.017; Jank JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093852; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Li ZJ, 2010, ACTA CRYSTALLOGR F, V66, P426, DOI 10.1107/S1744309110005002; LYMAN GH, 1976, NATURE, V262, P360, DOI 10.1038/262360a0; Ma DKK, 2013, SCIENCE, V341, P554, DOI 10.1126/science.1235753; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shmeeda H, 2002, AM J PHYSIOL-REG I, V283, pR389, DOI 10.1152/ajpregu.00423.2001; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Srinivasan S, 2015, ANNU REV PHYSIOL, V77, P161, DOI 10.1146/annurev-physiol-021014-071704; Stephens K., 1993, GENEREVIEWS; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TRENT C, 1983, GENETICS, V104, P619; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Woldeyes RA, 2014, CURR OPIN STRUC BIOL, V28, P56, DOI 10.1016/j.sbi.2014.07.005; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534	60	80	86	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1152	1163		10.1016/j.cell.2015.04.026	http://dx.doi.org/10.1016/j.cell.2015.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25981666	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000355152600021
J	Oberlander, J; Jones, DK				Oberlander, Jonathan; Jones, David K.			The Children's Cliff - Extending CHIP	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27514 USA; [Jones, David K.] Boston Univ, Boston, MA 02215 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.							Alker J, 2015, REPUBLICANS INTRO DI; Ferris S, 2015, ADVOCATES DONT TURN; Mathematica Policy Research Urban Institute, 2014, CHIPRA MAND EV CHILD; Medicaid and CHIP Payment and Access Commission (MACPAC), 2014, C MED CHIP JUN; Rosenbaum S, 2014, HEALTH AFFAIR, V33, P2125, DOI 10.1377/hlthaff.2014.0906	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1979	1981		10.1056/NEJMp1503576	http://dx.doi.org/10.1056/NEJMp1503576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5PD	25946141				2022-12-28	WOS:000354809300002
J	Brooks, KC				Brooks, Katherine C.			A Silent Curriculum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Brooks, KC (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	katherine_brooks@brown.edu							0	38	38	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1909	1910		10.1001/jama.2015.1676	http://dx.doi.org/10.1001/jama.2015.1676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988457				2022-12-28	WOS:000354691200009
J	Wagenlehner, FM; Umeh, O; Steenbergen, J; Yuan, GJ; Darouiche, RO				Wagenlehner, Florian M.; Umeh, Obiamiwe; Steenbergen, Judith; Yuan, Guojun; Darouiche, Rabih O.			Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)	LANCET			English	Article							GRAM-NEGATIVE BACILLI; UNITED-STATES; TRIMETHOPRIM-SULFAMETHOXAZOLE; INTRAVENOUS DORIPENEM; RESISTANCE PATTERNS; ESCHERICHIA-COLI; CIPROFLOXACIN; MULTICENTER; PREVALENCE; PREVENTION	Background Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a novel antibacterial with Gram-negative activity, in the treatment of patients with complicated lower-urinary-tract infections or pyelonephritis. Methods ASPECT-cUTI was a randomised, double-blind, double-dummy, non-inferiority trial done in 209 centres in 25 countries. Between July, 2011, and September, 2013, hospital inpatients aged 18 years or older who had pyuria and a diagnosis of a complicated lower-urinary-tract infection or pyelonephritis were randomly assigned in a 1:1 ratio to receive intravenous 1.5 g ceftolozane-tazobactam every 8 h or intravenous high-dose (750 mg) levofloxacin once daily for 7 days. The randomisation schedule was computer generated in blocks of four and stratified by study site. The next allocation was obtained by the study site pharmacist via an interactive voice-response system. The primary endpoint was a composite of microbiological eradication and clinical cure 5-9 days after treatment in the microbiological modified intention-to-treat (MITT) population, with a non-inferiority margin of 10%. This study is registered with ClinicalTrials.gov, numbers NCT01345929 and NCT01345955. Findings Of 1083 patients enrolled, 800 (73.9%), of whom 656 (82.0%) had pyelonephritis, were included in the microbiological MITT population. Ceftolozane-tazobactam was non-inferior to levofloxacin for composite cure (306 [76.9%] of 398 vs 275 [68.4%] of 402, 95% CI 2.3-14.6) and, as the lower bound of the two-sided 95% CI around the treatment difference was positive and greater than zero, superiority was indicated. Adverse event profiles were similar in the two treatment groups and were mainly non-serious. Interpretation Treatment with ceftolozane-tazobactam led to better responses than high-dose levofloxacin in patients with complicated lower-urinary-tract infections or pyelonephritis.	[Wagenlehner, Florian M.] Univ Giessen, Clin Urol Paediat Urol & Androl, D-35392 Giessen, Germany; [Umeh, Obiamiwe] Cubist Pharmaceut, Lexington, MA USA; [Darouiche, Rabih O.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Darouiche, Rabih O.] Baylor Coll Med, Houston, TX 77030 USA	Justus Liebig University Giessen; Baylor College of Medicine; Baylor College of Medicine	Wagenlehner, FM (corresponding author), Univ Giessen, Clin Urol Paediat Urol & Androl, Rudolf Buchheim Str 7, D-35392 Giessen, Germany.	florian.wagenlehner@chiru.med.uni-giessen.de			Cubist Pharmaceuticals	Cubist Pharmaceuticals	Cubist Pharmaceuticals.	Bouchillon Sam, 2012, Open Microbiol J, V6, P74; Bouchillon SK, 2013, CLIN THER, V35, P872, DOI 10.1016/j.clinthera.2013.03.022; Cek M, 2014, WORLD J UROL, V32, P1587, DOI 10.1007/s00345-013-1218-9; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUSC; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086/655827; COX CE, 1989, UROLOGY, V34, P322, DOI 10.1016/0090-4295(89)90335-X; COX CE, 1995, CLIN INFECT DIS, V21, P86, DOI 10.1093/clinids/21.1.86; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Farrell DJ, 2013, ANTIMICROB AGENTS CH, V57, P6305, DOI 10.1128/AAC.01802-13; Grabe M, 2011, GUIDELINES UROLOGICA; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Itani KMF, 2006, NEW ENGL J MED, V355, P2640, DOI 10.1056/NEJMoa054408; Lee SS, 2011, J INFECTION, V62, P159, DOI 10.1016/j.jinf.2010.10.009; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mehrotra DV, 2000, STAT MED, V19, P811, DOI 10.1002/(SICI)1097-0258(20000330)19:6<811::AID-SIM390>3.0.CO;2-Z; Naber KG, 2009, ANTIMICROB AGENTS CH, V53, P3782, DOI 10.1128/AAC.00837-08; Nicolle L E, 2005, Can J Infect Dis Med Microbiol, V16, P349; NICOLLE LE, 1994, ANTIMICROB AGENTS CH, V38, P1368, DOI 10.1128/AAC.38.6.1368; Peterson J, 2008, UROLOGY, V71, P17, DOI 10.1016/j.urology.2007.09.002; Rafat C, 2013, EXPERT OPIN PHARMACO, V14, P1241, DOI 10.1517/14656566.2013.792805; Redman R, 2010, J CHEMOTHERAPY, V22, P384, DOI 10.1179/joc.2010.22.6.384; Sader HS, 2014, J INFECTION, V69, P266, DOI 10.1016/j.jinf.2014.04.004; Sandberg T, 2012, LANCET, V380, P484, DOI 10.1016/S0140-6736(12)60608-4; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Spoorenberg V, 2014, CLIN INFECT DIS, V58, P164, DOI 10.1093/cid/cit688; Tandogdu Z, 2014, WORLD J UROL, V32, P791, DOI 10.1007/s00345-013-1154-8; The European Agency for the Evaluation of Medicinal Products, 2000, POINTS CONS SWITCH S; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2012, GUID IND COMPL UR TR; US Department of Heath and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2010, GUID IND NON CLIN TR; Wagenlehner FME, 2012, WORLD J UROL, V30, P59, DOI 10.1007/s00345-011-0757-1; Wagenlehner FME, 2008, EUR J CLIN INVEST, V38, P45, DOI 10.1111/j.1365-2362.2008.02008.x; Wiens Brian L, 2003, J Biopharm Stat, V13, P103, DOI 10.1081/BIP-120017729; Yang YS, 2010, J MICROBIOL IMMUNOL, V43, P194, DOI 10.1016/S1684-1182(10)60031-X; Zhanel GG, 2014, DRUGS, V74, P31, DOI 10.1007/s40265-013-0168-2	35	249	261	2	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1949	1956		10.1016/S0140-6736(14)62220-0	http://dx.doi.org/10.1016/S0140-6736(14)62220-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	25931244				2022-12-28	WOS:000354541700028
J	Margolis, JD				Margolis, Joshua D.			Professionalism, Fiduciary Duty, and Health-Related Business Leadership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Margolis, Joshua D.] Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Margolis, JD (corresponding author), Harvard Univ, Sch Business, Dept Org Behav, 321 Morgan Hall, Boston, MA 02163 USA.	jmargolis@hbs.edu						Battilana J, 2014, ACAD MANAG ANN, V8, P397, DOI 10.1080/19416520.2014.893615; Battilana J, 2010, ACAD MANAGE J, V53, P1419, DOI 10.5465/AMJ.2010.57318391; Bazerman MH, 2011, BLIND SPOTS WHY WE F; Epley N, 2004, SOC JUSTICE RES, V17, P171, DOI [10.1023/B:SORE.0000027408.72713.45, DOI 10.1023/B:SORE.0000027408.72713.45]; Greenwood R, 2011, ACAD MANAG ANN, V5, P317, DOI 10.1080/19416520.2011.590299; Groysberg B, 2010, CHASING STARS: THE MYTH OF TALENT AND THE PORTABILITY OF PERFORMANCE, P197; Jackall R, 1988, MORAL MAZES WORLD CO; Kraatz MS., 2010, I WORK ACTORS AGENCY, P59; Paine LS, 2003, 9304064 HARV BUS SCH; Pfeffer J., 1978, EXTERNAL CONTROL ORG	10	6	6	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1819	1820		10.1001/jama.2015.4398	http://dx.doi.org/10.1001/jama.2015.4398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965224				2022-12-28	WOS:000354391000019
J	Wray, CM; Davis, AM				Wray, Charlie M.; Davis, Andrew M.			Screening for Hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES TASK-FORCE; VIRUS-INFECTION; PERSONS BORN; ADULTS		[Wray, Charlie M.; Davis, Andrew M.] Univ Chicago, Med Ctr, Sect Hosp Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Wray, CM (corresponding author), Univ Chicago, Med Ctr, Sect Hosp Med, MC 5000,5841 S Maryland Ave, Chicago, IL 60637 USA.	cwray@medicine.bsd.uchicago.edu						Chou R, 2013, TREATMENT HEPATITIS; Chou R, 2013, ANN INTERN MED, V158, P101, DOI 10.7326/0003-4819-158-2-201301150-00574; McGowan CE, 2012, LIVER INT, V32, P151, DOI 10.1111/j.1478-3231.2011.02706.x; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ward JW, 2013, CLIN LIVER DIS, V17, P1, DOI 10.1016/j.cld.2012.09.011; WHO, 2014, GUID SCREEN CAR TREA	9	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1855	1856		10.1001/jama.2015.2833	http://dx.doi.org/10.1001/jama.2015.2833			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965235				2022-12-28	WOS:000354391000030
J	Heymann, DL; Chen, L; Takemi, K; Fidler, DP; Tappero, JW; Thomas, MJ; Kenyon, TA; Frieden, TR; Yach, D; Nishtar, S; Kalache, A; Olliaro, PL; Horby, P; Torreele, E; Gostin, LRO; Ndomondo-Sigonda, M; Carpenter, D; Rushton, S; Lillywhite, L; Devkota, B; Koser, K; Yates, R; Dhillon, RS; Rannan-Eliya, RP				Heymann, David L.; Chen, Lincoln; Takemi, Keizo; Fidler, David P.; Tappero, Jordan W.; Thomas, Mathew J.; Kenyon, Thomas A.; Frieden, Thomas R.; Yach, Derek; Nishtar, Sania; Kalache, Alex; Olliaro, Piero L.; Horby, Peter; Torreele, Els; Gostin, Law Rence O.; Ndomondo-Sigonda, Margareth; Carpenter, Daniel; Rushton, Simon; Lillywhite, Louis; Devkota, Bhimsen; Koser, Khalid; Yates, Rob; Dhillon, Ranu S.; Rannan-Eliya, Ravi P.			Global health security: the wider lessons from the west African Ebola virus disease epidemic	LANCET			English	Article							OBESOGENIC ENVIRONMENTS; ARMED CONFLICT; SEPTEMBER; INTERVENTIONS; FRAMEWORK; OUTBREAK; WORLD	The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and impact. Out of this human calamity has come renewed attention to global health security-its definition, meaning, and the practical implications for programmes and policy. For example, how does a government begin to strengthen its core public health capacities, as demanded by the International Health Regulations? What counts as a global health security concern? In the context of the governance of global health, including WHO reform, it will be important to distil lessons learned from the Ebola outbreak. The Lancet invited a group of respected global health practitioners to reflect on these lessons, to explore the idea of global health security, and to off er suggestions for next steps. Their contributions describe some of the major threats to individual and collective human health, as well as the values and recommendations that should be considered to counteract such threats in the future. Many different perspectives are proposed. Their common goal is a more sustainable and resilient society for human health and wellbeing.	[Heymann, David L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Heymann, David L.; Koser, Khalid] Ctr Global Hlth Secur, London, England; [Rushton, Simon; Lillywhite, Louis; Devkota, Bhimsen; Yates, Rob] Royal Inst Int Affairs, London, England; [Chen, Lincoln] China Med Board, Cambridge, MA USA; [Takemi, Keizo] Japan House Councillors, Tokyo, Japan; [Fidler, David P.] Indiana Univ, Maurer Sch Law, Bloomington, IN USA; [Tappero, Jordan W.; Thomas, Mathew J.] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA; [Kenyon, Thomas A.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Yach, Derek] Vital Inst, New York, NY USA; [Yach, Derek] World Econ Forum Global Agenda Council Ageing, Geneva, Switzerland; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Kalache, Alex] Int Longev Ctr ILC Global Alliance, Rio De Janeiro, Brazil; [Kalache, Alex] ILC Brazil, Rio De Janeiro, Brazil; [Kalache, Alex] New York Acad Med, New York, NY USA; [Kalache, Alex] HelpAge Int, London, England; [Olliaro, Piero L.] WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland; [Olliaro, Piero L.; Horby, Peter] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Torreele, Els] Open Soc Fdn, Publ Hlth Program, New York, NY USA; [Gostin, Law Rence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Ndomondo-Sigonda, Margareth] New Partnership Africas Dev, Pretoria, South Africa; [Carpenter, Daniel] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Rushton, Simon] Univ Sheffield, Dept Polit, Sheffield, S Yorkshire, England; [Devkota, Bhimsen] Tribhuvan Univ, Kathmandu, Nepal; [Dhillon, Ranu S.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Dhillon, Ranu S.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Dhillon, Ranu S.] Columbia Univ, Earth Inst, New York, NY USA; [Rannan-Eliya, Ravi P.] Inst Hlth Policy, Colombo, Sri Lanka	University of London; London School of Hygiene & Tropical Medicine; Indiana University System; Indiana University Bloomington; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New York Academy of Medicine; The World Bank; World Health Organization; University of Oxford; Georgetown University; Harvard University; University of Sheffield; Tribhuvan University; Harvard University; Brigham & Women's Hospital; Harvard University; Columbia University	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	david.heymann@lshtm.ac.uk	Lillywhite, Louis P/A-1879-2019; Rannan-Eliya, Ravindra/AAR-2096-2021	Lillywhite, Louis P/0000-0001-5328-6805; Rannan-Eliya, Ravindra/0000-0002-5013-2816; Rushton, Simon/0000-0003-1055-9871; Frieden, Thomas/0000-0002-4759-2256; Yates, Robert/0000-0002-6149-7335; Horby, Peter/0000-0002-9822-1586	European Union [607960]	European Union(European Commission)	PLO is a WHO staff member; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy, or views of WHO. LOG, MN-S, and DC thank Daniel A Hougendobler for his contributions to this Public Policy paper. SR, LL, and BD prepared their chapter as part of a European Union's Seventh Framework grant agreement no 607960 "Evidence based policy for post crisis stabilization: bridging the gap".	Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Alzheimer's Disease International, DEM STAT; [Anonymous], 2015, Prescrire Int, V24, P107; [Anonymous], 2014, LANCET, V384, P1321, DOI 10.1016/S0140-6736(14)61697-4; [Anonymous], 2015, NY TIMES; [Anonymous], 2013, COUNT PROBL FALS SUB; [Anonymous], 2003, SUBST COUNT MED; [Anonymous], 2014, GUARDIAN; Arwady MA, 2015, EMERG INFECT DIS, V21, P578, DOI 10.3201/eid2104.141940; BBC, 2014, BBC; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2015, LANCET, V385, P1011, DOI 10.1016/S0140-6736(15)60133-7; Berle A, 1940, NEW DIRECTIONS NEW W; Bloom DE, 2011, GLOBAL EC BURDEN NON; Boltz F, 2014, ECONOMIST; Booth K, 2007, CAMB STUD INT REL, P1, DOI 10.1017/CBO9780511840210; Bornemisza O, 2010, SOC SCI MED, V70, P80, DOI 10.1016/j.socscimed.2009.09.032; Braden CR, 2013, EMERG INFECT DIS, V19, P864, DOI 10.3201/eid1906.130192; Centers for Disease Control and Prevention, GLOB HLTH SEC VIS OV; Centers for Disease Control and Prevention, UPD CDCS POL ER EFF; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P389; Chen L., 2003, GLOBAL HLTH CHALLENG; Cheng TM, 2008, HEALTH AFFAIR, V27, P1103, DOI 10.1377/hlthaff.27.4.1103; Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1; Chicago Council on Global Affairs, 2015, 2015 GLOB FOOD SEC R; Cormack L, 2014, SYDNEY MORNING HERAL; Daniels ME, 2014, EMERGING GLOBAL HLTH; Davies SE, 2008, INT AFF, V84, P295, DOI 10.1111/j.1468-2346.2008.00704.x; Department for International Development (DFID), 2011, DEF DIS RES DFID APP; Devkota B, 2010, CONFL HEALTH, V4, P1, DOI DOI 10.1186/1752-1505-4-1; Edelstein M., 2014, Forced Migration Review, P36; Elliot L, 2014, GUARDIAN; Emmers, 2010, CONT SECURITY STUDIE, P173; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Fidler DP, 2008, EMERG INFECT DIS, V14, P88, DOI 10.3201/eid1401.070700; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Fidler David P., 2003, PUBLIC HLTH NATL SEC, P416; Fink S., 2014, NY TIMES; Fischer JE, 2013, BIOSECUR BIOTERROR, V11, P153, DOI 10.1089/bsp.2013.0030; Flanigan ST, 2008, STUD CONFL TERROR, V31, P499, DOI 10.1080/10576100802065103; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Frieden TR, 2014, LANCET, V383, P764, DOI 10.1016/S0140-6736(14)60189-6; Fustukian S, 2014, EBOLA EMERGES FRAGIL; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Ghobarah HA, 2003, AM POLIT SCI REV, V97, P189; Guha-Sapir D., 2015, ANN DISASTER STAT RE; Hancock C, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-23; Harris J., 2009, KEEPING IT REAL COMB; Hayashi C., 2009, TRANSFORMING PENSION; Heller PS, 2003, FINANC DEV, P36; Hennock EP, 2007, ORIGIN OF THE WELFARE STATE IN ENGLAND AND GERMANY, 1850-1914: SOCIAL POLICIES COMPARED, P1; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Horton R, 2014, LANCET, V384, P2186, DOI 10.1016/S0140-6736(14)62387-4; Human Rights Watch, 2009, S AFR END STRAIN AS; International Committee of the Red Cross, HLTH CAR DANG; International Organization for Migration, 2013, HIGH LEV DIAL INT MI; ISDR/WHO/World Bank, 2009, HOSP SAF DIS RED RIS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jones A, 2007, TACKLING OBESITIES F; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kamradt-Scott A, 2015, LANCET, V385, P111, DOI 10.1016/S0140-6736(15)60012-5; Kennedy SB, 2015, B WORLD HEALTH ORGAN, V93, P2, DOI 10.2471/BLT.14.151068; Kieny MP, 2015, LANCET, V385, P91, DOI 10.1016/S0140-6736(14)62479-X; Klein A, 2014, WND NEW YORK    0922; Koons C, 2015, BLOOMBERG BUSINESS; Koser K, 2014, WHY TRAVEL BANS WIL; Kupferschmidt K, 2015, SCIENCE NEW YOR 0326; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877; Lopaz MA, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.1.21003; Mackenzie JS, 2014, GLOB PUBLIC HEALTH, V9, P1023, DOI 10.1080/17441692.2014.951870; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Maurice J, 2014, LANCET, V384, pE45, DOI 10.1016/S0140-6736(14)61411-2; McInnes C, 2006, REV INT STUD, V32, P5, DOI 10.1017/S0260210506006905; McInnes C, 2012, GLOBAL HLTH INT RELA; McNeill WilliamH., 1998, PLAGUES PEOPLES; McQueen D.V., 2013, GLOBAL HDB NONCOMMUN; Millen JV, 2000, DYING GROWTH GLOBAL; Millman J., 2014, WASHINGTON POST; Mirkovic K, 2014, MMWR-MORBID MORTAL W, V63, P873; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Murray CJL, 2002, BRIT MED J, V324, P346, DOI 10.1136/bmj.324.7333.346; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NATO, HIST BACKGR; Oxfam, 2011, WHOS AID IS IT ANYW; Polgreen L, 2009, NY TIMES, pA7; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; Riedel Stefan, 2004, Proc (Bayl Univ Med Cent), V17, P400; Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732; Roosevelt Franklin D., 1941, COMMUNICATION; Schuchat A, 2014, LANCET, V384, P98, DOI 10.1016/S0140-6736(14)60570-5; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Stearn E. W., 1945, EFFECT SMALLPOX DEST; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; Torreele E., 2014, AL JAZEERA 1106; UN Department of Economic and Social Affairs, 3 INT C FIN DEV; United Nations Commission on Human Security, 2003, HUM SEC NOW PROT EMP; Uppsala Conflict Data Program, GEOR EV DAT; US Department of Health and Human Services, 2014, GLOB HLTH SEC AG WOR; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, 2015 GUIN EB VIR SHO; WHO, WHAT IS UN HLTH COV; WHO, 2007, WHA6028 WHO; WHO, 2005, MARB HAEM FEV ANG UP; WHO, 2013, GUID IMPL ART 6 WHO; WHO, 2014, CUB MED TEAM HEAD SI; WHO, 1983, HLTH REG; WHO, 2002, MACR HLTH INV HLTH E; WHO, EXP PROGR IMM; WHO Director-General Margaret Chan, 2015, REP DIR GEN SEPC SEO; WHO Executive Board, 2015, EB END CURR OUTBR ST; WHO Executive Board. IHR and Ebola, 2015, EBSS 3 INF 4 EB136 I; WHO Expert Committee, 2007, World Health Organ Tech Rep Ser, P1; WHO. Implementation of the International Health Regulations, 2005, A6510 WHO; World Health Organization, 2009, PAND INFL PREP RESP; World Health Organization (WHO), 2016, INT HLTH REG 2005; Yach D, 2014, LANCET, V383, P1771, DOI 10.1016/S0140-6736(13)62155-8; Yates R, 2014, B WORLD HEALTH ORGAN, V92, P547, DOI 10.2471/BLT.14.143495	122	265	272	10	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1884	1901		10.1016/S0140-6736(15)60858-3	http://dx.doi.org/10.1016/S0140-6736(15)60858-3			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25987157	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000354184500032
J	deQuilettes, DW; Vorpahl, SM; Stranks, SD; Nagaoka, H; Eperon, GE; Ziffer, ME; Snaith, HJ; Ginger, DS				deQuilettes, Dane W.; Vorpahl, Sarah M.; Stranks, Samuel D.; Nagaoka, Hirokazu; Eperon, Giles E.; Ziffer, Mark E.; Snaith, Henry J.; Ginger, David S.			Impact of microstructure on local carrier lifetime in perovskite solar cells	SCIENCE			English	Article							SOLUTION-PROCESSED PEROVSKITE; LEAD HALIDE PEROVSKITES; SINGLE-CRYSTALS; EFFICIENT; ELECTRON; PERFORMANCE; CH3NH3PBI3; TRIHALIDE; DIFFUSION; LENGTHS	The remarkable performance of hybrid perovskite photovoltaics is attributed to their long carrier lifetimes and high photoluminescence (PL) efficiencies. High-quality films are associated with slower PL decays, and it has been claimed that grain boundaries have a negligible impact on performance. We used confocal fluorescence microscopy correlated with scanning electron microscopy to spatially resolve the PL decay dynamics from films of nonstoichiometric organic-inorganic perovskites, CH3NH3PbI3(Cl). The PL intensities and lifetimes varied between different grains in the same film, even for films that exhibited long bulk lifetimes. The grain boundaries were dimmer and exhibited faster nonradiative decay. Energy-dispersive x-ray spectroscopy showed a positive correlation between chlorine concentration and regions of brighter PL, whereas PL imaging revealed that chemical treatment with pyridine could activate previously dark grains.	[deQuilettes, Dane W.; Vorpahl, Sarah M.; Nagaoka, Hirokazu; Ziffer, Mark E.; Ginger, David S.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Stranks, Samuel D.; Eperon, Giles E.; Snaith, Henry J.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England	University of Washington; University of Washington Seattle; University of Oxford	Ginger, DS (corresponding author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.	ginger@chem.washington.edu	Stranks, Samuel D/M-7837-2015; Eperon, Giles/J-2316-2015; Snaith, Henry J/A-7367-2016; Ginger, David S/C-4866-2011	Stranks, Samuel D/0000-0002-8303-7292; Eperon, Giles/0000-0001-9600-4847; Snaith, Henry J/0000-0001-8511-790X; Ginger, David S/0000-0002-9759-5447; Ziffer, Mark/0000-0003-2324-3876; Africa, Josephine/0000-0002-8117-9211	State of Washington through the University of Washington Clean Energy Institute; NSF Graduate Research Fellowship [DGE-1256082]; National Defense Science and Engineering Graduate Fellowship; European Union [604032]; Engineering and Physical Sciences Research Council; Oxford Photovoltaics through a Nanotechnology Knowledge Transfer Network Collaborative Award in Science and Engineering; National Institute for Biomedical Imaging and Bioengineering (NIH) [EB-002027]; Engineering and Physical Sciences Research Council [1511477] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002027] Funding Source: NIH RePORTER	State of Washington through the University of Washington Clean Energy Institute; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford Photovoltaics through a Nanotechnology Knowledge Transfer Network Collaborative Award in Science and Engineering; National Institute for Biomedical Imaging and Bioengineering (NIH); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This material is based in part on work supported by the State of Washington through the University of Washington Clean Energy Institute. D.W.D. acknowledges support from an NSF Graduate Research Fellowship (DGE-1256082). S.M.V. acknowledges support from a National Defense Science and Engineering Graduate Fellowship. The research leading to these results has received funding from the European Union Seventh Framework Program (FP7/2007-2013) under Grant Agreement No. 604032 of the MESO project. G.E.E. is supported by the Engineering and Physical Sciences Research Council and Oxford Photovoltaics through a Nanotechnology Knowledge Transfer Network Collaborative Award in Science and Engineering. The authors gratefully acknowledge funding from the National Institute for Biomedical Imaging and Bioengineering (NIH grant EB-002027) supporting the National ESCA and Surface Analysis Center for Biomedical Problems and ToF-SIMS instrumentation. D.W.D. thanks I. Braly, S. Braswell, D. Moerman, and B. Miller for valuable assistance. S. M. V. gratefully acknowledges D. Graham for assistance with ToF-SIMS. Additional data, including materials, methods, and key controls, are available online as supplementary materials (19).	Abate A, 2014, NANO LETT, V14, P3247, DOI 10.1021/nl500627x; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; De Wolf S, 2014, J PHYS CHEM LETT, V5, P1035, DOI 10.1021/jz500279b; Deschler F, 2014, J PHYS CHEM LETT, V5, P1421, DOI 10.1021/jz5005285; Dong QF, 2015, SCIENCE, V347, P967, DOI 10.1126/science.aaa5760; Edri E, 2014, NANO LETT, V14, P1000, DOI 10.1021/nl404454h; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Gao P, 2014, ENERG ENVIRON SCI, V7, P2448, DOI 10.1039/c4ee00942h; Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Grancini G, 2014, J PHYS CHEM LETT, V5, P3836, DOI 10.1021/jz501877h; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231; Manser JS, 2014, NAT PHOTONICS, V8, P737, DOI [10.1038/nphoton.2014.171, 10.1038/NPHOTON.2014.171]; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Munechika K, 2011, NANO LETT, V11, P2725, DOI 10.1021/nl2010127; National Center for Photovoltaics at the National Renewable Energy Laboratory, RES CELL EFF REC; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Noel NK, 2014, ACS NANO, V8, P9815, DOI 10.1021/nn5036476; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Saba M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6049; SEAGER CH, 1985, ANNU REV MATER SCI, V15, P271; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Stranks SD, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034007; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Sum TC, 2014, ENERG ENVIRON SCI, V7, P2518, DOI 10.1039/c4ee00673a; Tidhar Y, 2014, J AM CHEM SOC, V136, P13249, DOI 10.1021/ja505556s; Tvingstedt K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06071; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Wehrenfennig C, 2014, ENERG ENVIRON SCI, V7, P2269, DOI 10.1039/c4ee01358a; Wen XM, 2014, J PHYS CHEM LETT, V5, P3849, DOI 10.1021/jz502014r; Williams ST, 2014, ACS NANO, V8, P10640, DOI 10.1021/nn5041922; Xing GC, 2014, NAT MATER, V13, P476, DOI [10.1038/NMAT3911, 10.1038/nmat3911]; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Yin WJ, 2014, ADV MATER, V26, P4653, DOI 10.1002/adma.201306281; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Yun JS, 2015, J PHYS CHEM LETT, V6, P875, DOI 10.1021/acs.jpclett.5b00182; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050	40	1572	1585	74	1498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					683	686		10.1126/science.aaa5333	http://dx.doi.org/10.1126/science.aaa5333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25931446				2022-12-28	WOS:000354045700043
J	Liechti, KM				Liechti, Kenneth M.			Understanding friction in layered materials	SCIENCE			English	Editorial Material							ORDERED ORGANIC MONOLAYERS; WEARLESS FRICTION; ATOMIC-SCALE; NANOTRIBOLOGY		Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Ctr Mech Solids Struct & Mat, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Liechti, KM (corresponding author), Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Ctr Mech Solids Struct & Mat, Austin, TX 78712 USA.	kml@mail.utexas.edu		Liechti, Kenneth/0000-0001-5064-0354	National Science Foundation; Basic Energy Sciences program of the U.S. Department of Energy	National Science Foundation(National Science Foundation (NSF)); Basic Energy Sciences program of the U.S. Department of Energy(United States Department of Energy (DOE))	Supported by the National Science Foundation and the Basic Energy Sciences program of the U.S. Department of Energy.	BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; Carpick RW, 1996, LANGMUIR, V12, P3334, DOI 10.1021/la9509007; CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209; Koren E, 2015, SCIENCE, V348, P679, DOI 10.1126/science.aaa4157; KRIM J, 1991, PHYS REV LETT, V66, P181, DOI 10.1103/PhysRevLett.66.181; Ohzono T, 1999, JPN J APPL PHYS 2, V38, pL675, DOI 10.1143/JJAP.38.L675; Ohzono T, 1998, JPN J APPL PHYS 1, V37, P6535, DOI 10.1143/JJAP.37.6535; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001	8	12	12	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					632	633		10.1126/science.aab0930	http://dx.doi.org/10.1126/science.aab0930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953991				2022-12-28	WOS:000354045700025
J	Goodarzi, H; Liu, XH; Nguyen, HCB; Zhang, S; Fish, L; Tavazoie, SF				Goodarzi, Hani; Liu, Xuhang; Nguyen, Hoang C. B.; Zhang, Steven; Fish, Lisa; Tavazoie, Sohail F.			Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement	CELL			English	Article							TARGETING HYPOXIA; YB-1; METASTASIS; BIOGENESIS; SURVIVAL; THERAPY; CLIP	Upon exposure to stress, tRNAs are enzymatically cleaved, yielding distinct classes of tRNA-derived fragments (tRFs), yielding distinct classes of tRFs. We identify a novel class of tRFs derived from tRNA(Glu), tRNA(Asp), tRNA(Gly), and tRNA(Tyr) that, upon induction, suppress the stability of multiple oncogenic transcripts in breast cancer cells by displacing their 30 untranslated regions (UTRs) from the RNA-binding protein YBX1. This mode of post-transcriptional silencing is sequence specific, as these fragments all share a common motif that matches the YBX1 recognition sequence. Loss-of-function and gain-of-function studies, using anti-sense locked-nucleic acids (LNAs) and synthetic RNA mimetics, respectively, revealed that these fragments suppress growth under serum-starvation, cancer cell invasion, and metastasis by breast cancer cells. Highly metastatic cells evade this tumor-suppressive pathway by attenuating the induction of these tRFs. Our findings reveal a tumor-suppressive role for specific tRNA-derived fragments and describe a molecular mechanism for their action. This transcript displacement-based mechanism may generalize to other tRNA, ribosomal-RNA, and sno-RNA fragments.	[Goodarzi, Hani; Liu, Xuhang; Nguyen, Hoang C. B.; Zhang, Steven; Fish, Lisa; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu		Bui Nguyen, Hoang/0000-0001-6975-3084; Goodarzi, Hani/0000-0002-9648-8949; Fish, Lisa/0000-0001-9184-0512	Ruth L. Kirschstein National Research Service Award from the NIH [T32CA009673-36A1]; Department of Defense; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Saeed Tavazoie, Claudio Alarcon, and Alexander Nguyen for their thoughtful comments on this manuscript. We thank Nora Pencheva for insightful discussions on YBX1. We thank C. Zhao, W. Zhang, C. Lai, and S. Dewell of the Rockefeller Genomics Resource Center for assistance with next-generation RNA sequencing and microarray profiling. We also thank H. Molina at Rockefeller Proteomics Resource Center. H.G. was previously supported by an Anderson Cancer Center Fellowship and is currently the recipient of a Ruth L. Kirschstein National Research Service Award from the NIH (T32CA009673-36A1). S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient.	BOREK E, 1977, CANCER RES, V37, P3362; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moyer MW, 2012, NAT MED, V18, P636, DOI 10.1038/nm0512-636b; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; SPEER J, 1979, CANCER, V44, P2120, DOI 10.1002/1097-0142(197912)44:6<2120::AID-CNCR2820440623>3.0.CO;2-6; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	27	442	471	9	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					790	802		10.1016/j.cell.2015.02.053	http://dx.doi.org/10.1016/j.cell.2015.02.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957686	Green Accepted, Bronze			2022-12-28	WOS:000354175200013
J	Pefanis, E; Wang, JG; Rothschild, G; Lim, J; Kazadi, D; Sun, JB; Federation, A; Chao, J; Elliott, O; Liu, ZP; Economides, AN; Bradner, JE; Rabadan, R; Basu, U				Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Kazadi, David; Sun, Jianbo; Federation, Alexander; Chao, Jaime; Elliott, Oliver; Liu, Zhi-Ping; Economides, Aris N.; Bradner, James E.; Rabadan, Raul; Basu, Uttiya			RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity	CELL			English	Article							POLYMERASE-II; DIVERGENT TRANSCRIPTION; SEQUENCING REVEALS; CELL IDENTITY; TARGETS AID; TERMINATION; CHROMATIN; ACCUMULATION; GENERATION; INITIATION	We have ablated the cellular RNA degradation machinery in differentiated B cells and pluripotent embryonic stem cells (ESCs) by conditional mutagenesis of core (Exosc3) and nuclear RNase (Exosc10) components of RNA exosome and identified a vast number of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) with emergent functionality. Unexpectedly, eRNA-expressing regions accumulate R-loop structures upon RNA exosome ablation, thus demonstrating the role of RNA exosome in resolving deleterious DNA/RNA hybrids arising from active enhancers. We have uncovered a distal divergent eRNA-expressing element (lncRNA-CSR) engaged in long-range DNA interactions and regulating IgH 30 regulatory region super-enhancer function. CRISPR-Cas9-mediated ablation of lncRNA-CSR transcription decreases its chromosomal looping-mediated association with the IgH 30 regulatory region super-enhancer and leads to decreased class switch recombination efficiency. We propose that the RNA exosome protects divergently transcribed lncRNA expressing enhancers by resolving deleterious transcription-coupled secondary DNA structures, while also regulating long-range super-enhancer chromosomal interactions important for cellular function.	[Pefanis, Evangelos; Rothschild, Gerson; Lim, Junghyun; Kazadi, David; Sun, Jianbo; Chao, Jaime; Basu, Uttiya] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Wang, Jiguang; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [Wang, Jiguang; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Liu, Zhi-Ping] Shandong Univ, Sch Control Sci & Engn, Dept Biomed Engn, Jinan 250061, Shandong, Peoples R China; [Pefanis, Evangelos; Economides, Aris N.] Regeneron Pharmaceut & Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Federation, Alexander; Bradner, James E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Federation, Alexander; Bradner, James E.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Columbia University; Columbia University; Columbia University; Shandong University; Regeneron; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Rabadan, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA.	rr2579@cumc.columbia.edu; ub2121@cumc.columbia.edu	Lim, Junghyun/AAX-3678-2021; Liu, Zhi-Ping/C-9846-2010; Sun, Jianbo/ACQ-1702-2022; Rabadan, Raul/AAZ-7367-2020; Sun, Jianbo/E-2316-2013; Wang, Jiguang/B-2717-2012	Lim, Junghyun/0000-0002-5292-7487; Liu, Zhi-Ping/0000-0001-7742-9161; Sun, Jianbo/0000-0001-8153-1847; Sun, Jianbo/0000-0001-8153-1847; Rabadan, Raul/0000-0001-7946-9255; Federation, Alexander/0000-0002-7771-1148; Wang, Jiguang/0000-0002-6923-4097; Economides, Aris/0000-0002-6508-8942; Kazadi, David/0000-0001-5117-2900	NIH [1DP2OD008651-01, 1R01CA185486-01, 1R01CA179044-01A1, 1U54CA121852-05, F31AI098411-01A1]; NIAID [1R01AI099195-01A1]; NATIONAL CANCER INSTITUTE [R01CA179044, U54CA121852, R01CA185486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI098411, R01AI099195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Christopher Lima (MSKCC, New York), Frederic Chedin (University of California, Davis), Saul Silverstein, Stephen Goff, Sankar Ghosh, Lorraine Symington, and members of the Basu lab for critical input and reagents. We thank Olivier Courrone of Columbia University genome center for RNA sequencing and Victor Lin of Herbert Irving Cancer Center Transgenic facility for targeting and generation of Exosc3<SUP>COIN</SUP> and Exosc10<SUP>COIN</SUP> allele ESCs and mouse models. This work was supported by grants from NIH (1DP2OD008651-01) and NIAID (1R01AI099195-01A1) to U.B.; NIH (1R01CA185486-01; 1R01CA179044-01A1; 1U54CA121852-05) to R.R.; and F31AI098411-01A1 to D.K. U.B. is a scholar of the Irma Hirschl Charitable Trust and the Leukemia and Lymphoma Society.	Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Birshtein BK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00163; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Colin J, 2014, MOL CELL, V56, P667, DOI 10.1016/j.molcel.2014.10.026; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Januszyk K, 2010, ADV EXP MED BIOL, V702, P9, DOI 10.1007/978-1-4419-7841-7_2; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Manfrini N, 2015, EMBO REP, V16, P221, DOI 10.15252/embr.201439458; Marin-Vicente C, 2015, J CELL SCI, V128, P1097, DOI 10.1242/jcs.158733; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schaeffer D, 2011, P NATL ACAD SCI USA, V108, P2366, DOI 10.1073/pnas.1013180108; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Sun JB, 2013, TRANSCR-AUSTIN, V4, P127, DOI 10.4161/trns.24556; Sun JB, 2013, GENE DEV, V27, P1821, DOI 10.1101/gad.210211.112; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006	58	284	297	5	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					774	789		10.1016/j.cell.2015.04.034	http://dx.doi.org/10.1016/j.cell.2015.04.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957685	Bronze, Green Accepted			2022-12-28	WOS:000354175200012
J	Chen, S; Itoh, Y; Masuda, T; Shimizu, S; Zhao, J; Ma, J; Nakamura, S; Okuro, K; Noguchi, H; Uosaki, K; Aida, T				Chen, Shuo; Itoh, Yoshimitsu; Masuda, Takuya; Shimizu, Seishi; Zhao, Jun; Ma, Jing; Nakamura, Shugo; Okuro, Kou; Noguchi, Hidenori; Uosaki, Kohei; Aida, Takuzo			Subnanoscale hydrophobic modulation of salt bridges in aqueous media	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; AIR/WATER INTERFACE; WATER; SURFACE; FLUORESCENCE; VOLTAGE; ENERGY; FORCE; PH	Polar interactions such as electrostatic forces and hydrogen bonds play an essential role in biological molecular recognition. On a protein surface, polar interactions occur mostly in a hydrophobic environment because nonpolar amino acid residues cover similar to 75% of the protein surface. We report that ionic interactions on a hydrophobic surface are modulated by their subnanoscale distance to the surface. We developed a series of ionic head groups-appended self-assembled monolayers with C2, C6, C8, and C12 space-filling alkyl chains, which capture a dendritic guest via the formation of multiple salt bridges. The guest release upon protonolysis is progressively suppressed when its distance from the background hydrophobe changes from 1.2 (C2) to 0.2 (C12) nanometers, with an increase in salt bridge strength of similar to 3.9 kilocalories per mole.	[Chen, Shuo; Itoh, Yoshimitsu; Okuro, Kou; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Masuda, Takuya; Noguchi, Hidenori; Uosaki, Kohei] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Shimizu, Seishi] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zhao, Jun; Ma, Jing] Nanjing Univ, Sch Chem & Chem Engn, Collaborat Innovat Ctr Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Nakamura, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Noguchi, Hidenori; Uosaki, Kohei] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Noguchi, Hidenori; Uosaki, Kohei] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan; [Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	University of Tokyo; National Institute for Materials Science; University of York - UK; Nanjing University; University of Tokyo; National Institute for Materials Science; Hokkaido University; RIKEN	Itoh, Y (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	itoh@macro.t.u-tokyo.ac.jp; aida@macro.t.u-tokyo.ac.jp	Itoh, Yoshimitsu/G-8162-2012; Ma, Jing/K-3359-2013; Zhao, Jun/J-9087-2015; Masuda, Takuya/H-2540-2011; Aida, Takuzo/I-9117-2012; Uosaki, Kohei/A-8217-2008; NOGUCHI, Hidenori/H-2534-2011	Itoh, Yoshimitsu/0000-0002-8356-7605; Ma, Jing/0000-0001-5848-9775; Zhao, Jun/0000-0001-7118-4992; Uosaki, Kohei/0000-0001-8886-3270; NOGUCHI, Hidenori/0000-0001-9643-1689; Chen, Shuo/0000-0003-3581-0997; Okuro, Kou/0000-0003-0445-6358; Shimizu, Seishi/0000-0002-7853-1683	Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; National Natural Science Foundation of China [21273102]	Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank N. Matubayashi from Division of Chemical Engineering, Graduate School of Engineering Science, Osaka University for valuable discussion. We also thank E. Silver for generous discussion. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). Y. I. acknowledges the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grant-in-Aid for Young Scientists B. S.N. is partly supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan. K.U. and H.N. thank the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics from MEXT, Japan. J.M. is supported by the National Natural Science Foundation of China (no. 21273102).	ALIVISATOS AP, 1987, J CHEM PHYS, V86, P6540, DOI 10.1063/1.452396; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Bard A. J., 2001, ELECTROCHEMICAL METH; Ben-Naim AY., 1992, STAT THERMODYNAMICS, V1st ed.; Burgess I, 2006, LANGMUIR, V22, P4420, DOI 10.1021/la052767g; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chorny I, 2005, J PHYS CHEM B, V109, P24056, DOI 10.1021/jp055043m; DIEHL H, 1985, TALANTA, V32, P159, DOI 10.1016/0039-9140(85)80049-7; DIETRICH B, 1979, HELV CHIM ACTA, V62, P2763, DOI 10.1002/hlca.19790620827; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Han Y, 2011, LANGMUIR, V27, P11951, DOI 10.1021/la2020995; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Luo MX, 2012, J PHYS CHEM C, V116, P13964, DOI 10.1021/jp3020996; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; MARTIN MM, 1975, J LUMIN, V10, P381, DOI 10.1016/0022-2313(75)90003-4; McArthur EA, 2004, J AM CHEM SOC, V126, P2260, DOI 10.1021/ja038062n; Morrow R, 2012, P ROY SOC A-MATH PHY, V468, P18, DOI 10.1098/rspa.2011.0323; Ng CCA, 2012, ANGEW CHEM INT EDIT, V51, P7706, DOI 10.1002/anie.201202118; Nihonyanagi S, 2011, J AM CHEM SOC, V133, P16875, DOI 10.1021/ja2053754; Onclin S, 2005, ANGEW CHEM INT EDIT, V44, P6282, DOI 10.1002/anie.200500633; Presiado I, 2011, J PHYS CHEM C, V115, P10245, DOI 10.1021/jp2008094; Rant U, 2007, P NATL ACAD SCI USA, V104, P17364, DOI 10.1073/pnas.0703974104; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; SCHELLMAN JA, 1953, J PHYS CHEM-US, V57, P472, DOI 10.1021/j150505a020; Shen YR, 2006, CHEM REV, V106, P1140, DOI 10.1021/cr040377d; Snyder PW, 2014, EUR PHYS J-SPEC TOP, V223, P853, DOI 10.1140/epjst/e2013-01818-y; Teschke O, 2003, APPL PHYS LETT, V82, P1126, DOI 10.1063/1.1542945; Valtiner M, 2012, J AM CHEM SOC, V134, P1746, DOI 10.1021/ja209653n; Venkateshwaran V, 2014, P NATL ACAD SCI USA, V111, P8729, DOI 10.1073/pnas.1403294111; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Yeung CL, 2010, ADV FUNCT MATER, V20, P2657, DOI 10.1002/adfm.201000411	33	41	41	4	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					555	559		10.1126/science.aaa7532	http://dx.doi.org/10.1126/science.aaa7532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931555				2022-12-28	WOS:000353778100037
J	Tanaka, A; Sakaguchi, S				Tanaka, Atsushi; Sakaguchi, Shimon			Early life Aire	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; SELF-TOLERANCE		[Tanaka, Atsushi; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Osaka 5650871, Japan	Osaka University	Tanaka, A (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Osaka 5650871, Japan.	shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Tanaka, Atsushi/U-6761-2019	Tanaka, Atsushi/0000-0003-1660-9892				Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Darrasse-Jeze G, 2005, BLOOD, V105, P4715, DOI 10.1182/blood-2004-10-4051; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Husebye ES, 2010, IMMUNITY, V32, P479, DOI 10.1016/j.immuni.2010.03.016; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Romagnoli P, 2012, J IMMUNOL, V189, P3831, DOI 10.4049/jimmunol.1201564; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	12	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					506	507		10.1126/science.aab2998	http://dx.doi.org/10.1126/science.aab2998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931543				2022-12-28	WOS:000353778100024
J	Berman, D; Deshmukh, SA; Sankaranarayanan, SKRS; Erdemir, A; Sumant, AV				Berman, Diana; Deshmukh, Sanket A.; Sankaranarayanan, Subramanian K. R. S.; Erdemir, Ali; Sumant, Anirudha V.			Macroscale superlubricity enabled by graphene nanoscroll formation	SCIENCE			English	Article							LOW-FRICTION; WEAR; FILMS	Friction and wear remain as the primary modes of mechanical energy dissipation in moving mechanical assemblies; thus, it is desirable to minimize friction in a number of applications. We demonstrate that superlubricity can be realized at engineering scale when graphene is used in combination with nanodiamond particles and diamondlike carbon (DLC). Macroscopic superlubricity originates because graphene patches at a sliding interface wrap around nanodiamonds to form nanoscrolls with reduced contact area that slide against the DLC surface, achieving an incommensurate contact and substantially reduced coefficient of friction (similar to 0.004). Atomistic simulations elucidate the overall mechanism and mesoscopic link bridging the nanoscale mechanics and macroscopic experimental observations.	[Berman, Diana; Deshmukh, Sanket A.; Sankaranarayanan, Subramanian K. R. S.; Sumant, Anirudha V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Erdemir, Ali] Argonne Natl Lab, Energy Syst Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Sumant, AV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA.	sumant@anl.gov	Erdemir, Ali/P-7643-2018; Erdemir, Ali/AAF-9422-2019	Erdemir, Ali/0000-0002-6489-9620; Erdemir, Ali/0000-0002-6489-9620	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Office of Science of the U.S. Department of Energy [DE-AC02-06CH11357, DE-AC02-05CH11231]; Vehicle Technologies Program of the Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy [DE-AC02-06CH11357]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Vehicle Technologies Program of the Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy(United States Department of Energy (DOE))	The help in the TEM data collection by Y. Liu is greatly appreciated. Use of the Center for Nanoscale Materials was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. This research used tribological test facilities of the Energy Systems Division supported by the Vehicle Technologies Program of the Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy under contract DE-AC02-06CH11357. An award of computer time was provided by the Innovative and Novel Computational Impact on Theory and Experiment (INCITE) program. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-06CH11357. Experimental data and simulations are archived on servers at Argonne National Laboratory. Part of the experimental results are covered by a patent (US20140023864A1). Both D.B. and S.D. contributed equally in this work. D.B. performed the experiments and analyzed the data. S.D. and S.K.R.S. devised and performed the molecular dynamics simulations and performed all the related data analysis. A.V.S. conceived the idea, helped in the data analysis of experimental results, and directed the project. A.E. codirected the project and helped in the data analysis of tribological tests. S.K.R.S. guided the simulation effort. D.B., S.D., S.K.R.S., A.E., and A.V.S equally contributed to discussing the results and composing the manuscript.	Berman D, 2013, CARBON, V59, P167, DOI 10.1016/j.carbon.2013.03.006; Berman D, 2013, CARBON, V54, P454, DOI 10.1016/j.carbon.2012.11.061; Chhowalla M, 2000, NATURE, V407, P164, DOI 10.1038/35025020; Cumings J, 2000, SCIENCE, V289, P602, DOI 10.1126/science.289.5479.602; Deng Z, 2012, NAT MATER, V11, P1032, DOI [10.1038/NMAT3452, 10.1038/nmat3452]; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Dienwiebel M, 2005, SURF SCI, V576, P197, DOI 10.1016/j.susc.2004.12.011; Erdemir A., 2001, MODERN TRIBOLOGY HDB, V2, P787; Erdemir A, 2006, J PHYS D APPL PHYS, V39, pR311, DOI 10.1088/0022-3727/39/18/R01; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Guo YF, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155429; Heimberg JA, 2001, APPL PHYS LETT, V78, P2449, DOI 10.1063/1.1366649; HIRANO M, 1990, PHYS REV B, V41, P11837, DOI 10.1103/PhysRevB.41.11837; Hirano M, 1997, PHYS REV LETT, V78, P1448, DOI 10.1103/PhysRevLett.78.1448; Kandanur SS, 2012, CARBON, V50, P3178, DOI 10.1016/j.carbon.2011.10.038; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Liu Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205503; MARTIN JM, 1993, PHYS REV B, V48, P10583, DOI 10.1103/PhysRevB.48.10583; Mo YF, 2009, NATURE, V457, P1116, DOI 10.1038/nature07748; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Szeri A. Z., 1980, TRIBOLOGY FRICTION L; Turner S, 2009, ADV FUNCT MATER, V19, P2116, DOI 10.1002/adfm.200801872; Wang CB, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/22/225709; Xu L, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285708; Zhang RF, 2013, NAT NANOTECHNOL, V8, P912, DOI [10.1038/nnano.2013.217, 10.1038/NNANO.2013.217]	25	508	528	63	787	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1118	1122		10.1126/science.1262024	http://dx.doi.org/10.1126/science.1262024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25977372	Bronze			2022-12-28	WOS:000355590500043
J	Eisenstein, M				Eisenstein, Michael			PESTICIDES Seeking answers amid a toxic debate	NATURE			English	Editorial Material							FIELD											Carreck NL, 2014, J APICULT RES, V53, P607, DOI 10.3896/IBRA.1.53.5.08; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Garbuzov M, 2015, AGR ECOSYST ENVIRON, V203, P62, DOI 10.1016/j.agee.2014.12.009; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	11	26	26	4	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S52	S55		10.1038/521S52a	http://dx.doi.org/10.1038/521S52a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992672	Bronze			2022-12-28	WOS:000354816500001
J	Lo, HY; Kienzler, D; de Clercq, L; Marinelli, M; Negnevitsky, V; Keitch, BC; Home, JP				Lo, Hsiang-Yu; Kienzler, Daniel; de Clercq, Ludwig; Marinelli, Matteo; Negnevitsky, Vlad; Keitch, Ben C.; Home, Jonathan P.			Spin-motion entanglement and state diagnosis with squeezed oscillator wavepackets	NATURE			English	Article							QUANTUM; SUPERPOSITION	Mesoscopic superpositions of distinguishable coherent states provide an analogue of the 'Schrodinger's cat' thought experiment(1,2). For mechanical oscillators these have primarily been realized using coherent wavepackets, for which the distinguishability arises as a result of the spatial separation of the superposed states(3-5). Here we demonstrate superpositions composed of squeezed wavepackets, which we generate by applying an internal-state-dependent force to a single trapped ion initialized in a squeezed vacuum state with nine decibel reduction in the quadrature variance. This allows us to characterize the initial squeezed wavepacket by monitoring the onset of spin-motion entanglement, and to verify the evolution of the number states of the oscillator as a function of the duration of the force. In both cases we observe clear differences between displacements aligned with the squeezed and anti-squeezed axes. We observe coherent revivals when inverting the state-dependent force after separating the wavepackets by more than 19 times the ground-state root mean squared extent, which corresponds to 56 times the root mean squared extent of the squeezed wavepacket along the displacement direction. Aside from their fundamental nature, these states may be useful for quantum metrology(6) or quantum information processing with continuous variables(7-9).	[Lo, Hsiang-Yu; Kienzler, Daniel; de Clercq, Ludwig; Marinelli, Matteo; Negnevitsky, Vlad; Keitch, Ben C.; Home, Jonathan P.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lo, HY (corresponding author), ETH, Inst Quantum Elect, Otto Stern Weg 1, CH-8093 Zurich, Switzerland.	hylo@phys.ethz.ch; jhome@phys.ethz.ch		Home, Jonathan/0000-0002-4093-1550; Keitch, Ben/0000-0001-7030-1966; Kienzler, Daniel/0000-0002-2557-6589	Swiss National Science Foundation [200021 134776]; National Centre of Competence in Research for Quantum Science and Technology (QSIT)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research for Quantum Science and Technology (QSIT)	We thank J. Alonso and F. Leupold for comments on the manuscript, and F. Leupold, F. Lindenfelser, J. Alonso, M. Sepiol, K. Fisher and C. Fluhmann for contributions to the experimental apparatus. We acknowledge support from the Swiss National Science Foundation under grant number 200021 134776, and through the National Centre of Competence in Research for Quantum Science and Technology (QSIT).	Abadie J, 2011, NAT PHYS, V7, P962, DOI [10.1038/NPHYS2083, 10.1038/nphys2083]; Bartlett SD, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052316; Breitenbach G, 1997, NATURE, V387, P471, DOI 10.1038/387471a0; Casanova J, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2012-30016-6; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Di Fidio C, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.031802; Gerritsma R, 2010, NATURE, V463, P68, DOI 10.1038/nature08688; Haljan PC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153602; Haroche S., 2006, EXPLORING QUANTUM; Haroche S, 2013, REV MOD PHYS, V85, P1083, DOI 10.1103/RevModPhys.85.1083; Hempel C, 2013, NAT PHOTONICS, V7, P630, DOI [10.1038/nphoton.2013.172, 10.1038/NPHOTON.2013.172]; Kienzler D, 2015, SCIENCE, V347, P53, DOI 10.1126/science.1261033; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; MANDEL L, 1979, OPT LETT, V4, P205, DOI 10.1364/OL.4.000205; McDonnell MJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.063603; Meekhof DM, 1996, PHYS REV LETT, V77, P2346, DOI 10.1103/PhysRevLett.77.2346; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Munro WJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023819; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103; YUEN HP, 1976, PHYS REV A, V13, P2226, DOI 10.1103/PhysRevA.13.2226; Zeng HS, 2005, CHINESE PHYS LETT, V22, P798, DOI 10.1088/0256-307X/22/4/005	29	49	49	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					336	+		10.1038/nature14458	http://dx.doi.org/10.1038/nature14458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993964	Green Submitted			2022-12-28	WOS:000354816500052
J	Rosenbaum, L				Rosenbaum, Lisa			Beyond Moral Outrage - Weighing the Trade-Offs of COI Regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		American Medical Student Association, AMSA SCOR; Bai M, 2014, NY TIMES MAGAZINE; BARON J, 1993, J RISK UNCERTAINTY, V7, P17, DOI 10.1007/BF01065312; Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h231; Haidt J., 2012, RIGHTEOUS MIND WHY G; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; Scientific Advisory Committee on Nutrition, 2014, CARB HLTH R IN PRESS; Singer N., 2009, NY TIMES; Sunstein CR, 2003, 180 U CHIC I LAW EC; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; Walker J., 2014, WALL STREET J	12	67	67	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2064	2068		10.1056/NEJMms1502498	http://dx.doi.org/10.1056/NEJMms1502498			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5PD	25992752				2022-12-28	WOS:000354809300016
J	Gill, TM; Gahbauer, EA; Han, L; Allore, HG				Gill, Thomas M.; Gahbauer, Evelyne A.; Han, Ling; Allore, Heather G.			The role of intervening hospital admissions on trajectories of disability in the last year of life: prospective cohort study of older people	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESTRICTED ACTIVITY; SAS PROCEDURE; RISK-FACTORS; CARE; REHABILITATION; PRECIPITANTS; TRANSITIONS; MORTALITY; DISCHARGE; SUBTYPES	OBJECTIVE To evaluate the role of intervening hospital admissions on trajectories of disability in the last year of life. DESIGN Prospective cohort study. SETTING Greater New Haven, Connecticut, United States, from March 1998 to June 2013. PARTICIPANTS 552 decedents from a cohort of 754 community living people, aged 70 years or older, who were initially non-disabled in four essential activities of daily living: bathing, dressing, walking, and transferring. MAIN OUTCOME MEASURE Occurrence of admissions to hospital and severity of disability (range 0-4), ascertained during monthly interviews for more than 15 years. RESULTS In the last year of life, six distinct trajectories of disability were identified, from least disabled to most disabled: 95 participants (17.2%) had no disability, 61 (11.1%) had catastrophic disability, 53 (9.6%) had accelerated disability, 61 (11.1%) had progressively mild disability, 127 (23.0%) had progressively severe disability, and 155 (28.1%) had persistently severe disability. 392 (71.0%) participants had at least one hospital admission and 248 (44.9%) had multiple hospital admissions. For each trajectory the course of disability closely tracked the monthly prevalence of hospital admission. In a set of multivariable models that included several potential confounders, hospital admission in a given month had a strong independent effect on the severity of disability, in both relative and absolute terms. The largest absolute effect was observed for catastrophic disability, with a mean increase in disability score of 1.9 (95% confidence interval 1.5 to 2.4) in the setting of a hospital admission, corresponding to a rate ratio (or relative effect) of 2.0 (95% confidence interval 1.5 to 2.7). CONCLUSIONS In the last year of life, acute hospital admissions play an important role in the disabling process. Knowledge about the course of disability before these intervening events may facilitate clinical decision making at the end of life. For older patients admitted to hospital with progressive or persistent levels of severe disability, representing more than half of the decedents, clinicians might consider a palliative care approach to facilitate discussions about advance care planning and to better deal with personal care needs.	[Gill, Thomas M.; Gahbauer, Evelyne A.; Han, Ling; Allore, Heather G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Gill, Thomas M.] Adler Geriatr Ctr, New Haven, CT 06510 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	thomas.gill@yale.edu	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, R01AG022993, K07AG043587]; NATIONAL INSTITUTE ON AGING [R37AG017560, K07AG043587, P30AG021342, R01AG022993, P50AG047270] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Aging (R37AG17560, R01AG022993). The study was conducted at the Yale Claude D Pepper Older Americans Independence Center (P30AG21342). TMG is the recipient of an academic leadership award (K07AG043587) from the National Institute on Aging. The funders had no role in the conduct of the research.	Alpert JS, 2007, AM J MED, V120, P469, DOI 10.1016/j.amjmed.2007.03.006; Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2169, DOI 10.1001/jama.2014.3695; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Effron B, 1993, INTRO BOOTSTRAP; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Ferrucci L, 1996, J GERONTOL A-BIOL, V51, pM123, DOI 10.1093/gerona/51A.3.M123; Flood KL, 2013, JAMA INTERN MED, V173, P981, DOI 10.1001/jamainternmed.2013.524; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2014, GERONTOLOGIST, V54, P533, DOI 10.1093/geront/gnu067; Gill TM, 2012, ANN INTERN MED, V156, P131, DOI 10.7326/0003-4819-156-2-201201170-00009; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Gill TM, 2010, J AM GERIATR SOC, V58, pS308, DOI 10.1111/j.1532-5415.2010.02914.x; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gill TM, 2004, AM J MED, V117, P484, DOI 10.1016/j.amjmed.2004.05.018; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Harrold Joan, 2005, J Palliat Med, V8, P503, DOI 10.1089/jpm.2005.8.503; Hoenig H, 1997, J AM GERIATR SOC, V45, P1371, DOI 10.1111/j.1532-5415.1997.tb02939.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Lee AH, 2006, STAT METHODS MED RES, V15, P47, DOI 10.1191/0962280206sm429oa; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; Nagin D. S, 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; National Hospice and Palliative Care Organization facts and figures, 2013, HOSP CAR AM; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; US Census Bureau, 2013, AM FACTFINDER	48	74	75	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2361	10.1136/bmj.h2361	http://dx.doi.org/10.1136/bmj.h2361			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI9YZ	25995357	hybrid, Green Published			2022-12-28	WOS:000355128700002
J	Harris, RP; Wilt, TJ; Qaseem, A				Harris, Russell P.; Wilt, Timothy J.; Qaseem, Amir		Amer Coll Phys	A Value Framework for Cancer Screening: Advice for High-Value Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; COST-CONSCIOUS CARE; COLORECTAL-CANCER; UNITED-STATES; HARMS; BENEFITS; TESTS; MAMMOGRAPHY; CONSEQUENCES; STRATEGIES	Experts, professional societies, and consumer groups often recommend different strategies for cancer screening. These strategies vary in the intensity of their search for asymptomatic lesions and in their value. This article outlines a framework for thinking about the value of varying intensities of cancer screening. The authors conclude that increasing intensity beyond an optimal level leads to low-value screening and speculate about pressures that encourage overly intensive, low-value screening.	Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Res Ctr Excellence Clin Prevent Serv, Chapel Hill, NC USA; Minneapolis Vet Affairs High Value Care Initiat, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Baker DW, 2013, ANN INTERN MED, V158, P55, DOI 10.7326/0003-4819-158-1-201301010-00560; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Caverly TJ, 2014, JAMA INTERN MED, V174, P8, DOI 10.1001/jamainternmed.2013.9967; Colla CH, 2014, NEW ENGL J MED, V371, P1280, DOI 10.1056/NEJMp1404503; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Garber AM, 2008, ANN INTERN MED, V148, P964, DOI 10.7326/0003-4819-148-12-200806170-00223; Gawande A, 2014, NEW ENGL J MED, V370, DOI 10.1056/NEJMp1401245; Harris R, 2011, EPIDEMIOL REV, V33, P1, DOI 10.1093/epirev/mxr006; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Herndon MB, 2008, J GEN INTERN MED, V23, P1547, DOI 10.1007/s11606-008-0626-9; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Kulasingam SL, 2011, AHRQ PUBLICATION; LeFevre ML, 2013, JAMA INTERN MED, V173, P856, DOI 10.1001/jamainternmed.2013.535; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Morioka-Douglas N, 2013, JAMA INTERN MED, V173, P855, DOI 10.1001/jamainternmed.2013.316; Moyer VA, 2012, ANN INTERN MED, V156, P392, DOI 10.7326/0003-4819-156-5-201203060-00015; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Ransohoff DF, 2002, AM J MED, V113, P663, DOI 10.1016/S0002-9343(02)01235-4; Robertson DJ, 2009, ANN INTERN MED, V151, P103, DOI 10.7326/0003-4819-151-2-200907210-00007; Rychetnik L, 2013, JNCI-J NATL CANCER I, V105, P380, DOI 10.1093/jnci/djs649; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wilt TJ, 2015, ANN INTERN MED, V162, P718, DOI 10.7326/M14-2326; Woolf SH, 2012, JAMA-J AM MED ASSOC, V307, P565, DOI 10.1001/jama.2012.100; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	40	65	66	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					712	+		10.7326/M14-2327	http://dx.doi.org/10.7326/M14-2327			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984846				2022-12-28	WOS:000355015200021
J	Chakradhar, S				Chakradhar, Shraddha			Colorectal cancer: 5 big questions	NATURE			English	Editorial Material																			0	22	25	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S16	S16		10.1038/521S16a	http://dx.doi.org/10.1038/521S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25970454	Bronze			2022-12-28	WOS:000354377800067
J	Clandinin, TR; Giocomo, LM				Clandinin, Thomas R.; Giocomo, Lisa M.			Internal compass puts flies in their place	NATURE			English	Editorial Material							HEAD-DIRECTION CELLS; FREELY MOVING RATS; REPRESENTATION; POSTSUBICULUM	An analysis reveals that fruit-fly neurons orient flies relative to cues in the insects' environment, providing evidence that the fly's brain contains a key component for drawing a cognitive map of the insect's surroundings. SEE ARTICLE P.186	[Clandinin, Thomas R.; Giocomo, Lisa M.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trclandinin@gmail.com; giocomo@gmail.com		Giocomo, Lisa/0000-0003-0416-2528				Bjerknes TL, 2014, NEURON, V82, P71, DOI 10.1016/j.neuron.2014.02.014; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Zhang K, 1996, J NEUROSCI, V16, P2112	12	3	4	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					165	166		10.1038/521165a	http://dx.doi.org/10.1038/521165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25971505				2022-12-28	WOS:000354377800044
J	Chaudhry, HJ; Gifford, JD; Hengerer, AS				Chaudhry, Humayun J.; Gifford, J. Daniel; Hengerer, Arthur S.			Ensuring Competency and Professionalism Through State Medical Licensing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chaudhry, Humayun J.; Gifford, J. Daniel; Hengerer, Arthur S.] Federat State Med Boards, Euless, TX 76039 USA		Chaudhry, HJ (corresponding author), Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA.	hchaudhry@fsmb.org						Farnan JM, 2013, ANN INTERN MED, V158, P620, DOI 10.7326/0003-4819-158-8-201304160-00100; Federation of State Medical Boards, PHYS DAT CTR RAW DAT; Flexner A, 1910, MED ED US CANADA CAM, P67; Johnson David A., 2012, MED LICENSING DISCIP, P156; Pincoffs EL, 1985, VIRTUE MED EXPLORATI, P130; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V312, P695, DOI 10.1001/jama.2014.9809; SUNSTEIN CASS R., 2014, VALUING LIFE HUMANIZ, P1	7	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1791	1792		10.1001/jama.2015.4017	http://dx.doi.org/10.1001/jama.2015.4017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965210				2022-12-28	WOS:000354391000005
J	Gostin, LO; Friedman, EA				Gostin, Lawrence O.; Friedman, Eric A.			A retrospective and prospective analysis of the west African Ebola virus disease epidemic: robust national health systems at the foundation and an empowered WHO at the apex	LANCET			English	Article							FUTURE	The Ebola virus disease outbreak in west Africa is pivotal for the worldwide health system. Just as the depth of the crisis ultimately spurred an unprecedented response, the failures of leadership suggest the need for innovative reforms. Such reforms would transform the existing worldwide health system architecture into a purposeful, organised system with an empowered, highly capable WHO at its apex and enduring, equitable national health systems at its foundation. It would be designed not only to provide security against epidemic threats, but also to meet everyday health needs, thus realising the right to health. This retrospective and prospective analysis offers a template for these reforms, responding to the profound harms posed by fragile national health systems, delays in the international response, deficient resource mobilisation, ill defined responsibilities, and insufficient coordination. The scope of the reforms should address failures in the Ebola response, and entrenched weaknesses that enabled the epidemic to reach its heights.	[Gostin, Lawrence O.; Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], BBC NEWS; [Anonymous], 2014, ECONOMIST, P13; [Anonymous], WHO CONST; [Anonymous], 2014, NIG IS NOW FREE EB V; [Anonymous], NY TIMES; [Anonymous], 2015, ECONOMIST, P34; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; BBC, 2014, BBC; Boseley S, 2014, GUARDIAN; Boseley S., GUARDIAN; Center for Strategic and International Studies, AUD CREAT UNM DISC A; Center for Strategic and International Studies, 2015, ROAD REC REB LIB HLT; Cheng M, 2015, ASS PRESS; Clift Charles, 2015, DEVIL DETAIL WHOS EB; Dennis B., WASHINGTON POST; Dieleman JL, JAMA IN PRESS; Ellison C, 2015, DAVOS EBOLA PANEL AD; Fernandez M., 2014, NY TIMES; Fink S., 2014, NY TIMES; Global Health Workforce Alliance and World Health Organization, UN TRUTH NO HLTH WOR; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P27, DOI 10.1001/jama.2014.16572; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P2497, DOI 10.1001/jama.2014.15041; Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; Gostin Lawrence O, 2013, Yale J Health Policy Law Ethics, V13, P1; Hook BH, 2014, WALL STREET J; Integrated Regional Information Networks, OV EB STIGM TAK TIM; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Marchione M., 2014, ASS PRESS       1018; Medecins Sans Frontieres, EB CREAT AW POP YOU; Medecins Sans Frontieres, RUS LIM YEAR LARG EV; Medecins Sans Frontieres, MIX WELC HOM EB SURV; Medecins Sans Frontieres, EB W AFR EP REQ MASS; Medicins Sans Frontiers, 2015, EB CRIS UPD; Mullan Z, 2015, LANCET GLOB HEALTH, V3, pE113, DOI 10.1016/S2214-109X(15)70083-5; Nebehay S, 2011, WHO SLASHES BUDGET J; Nebehay S., EBOLA STILL SPREADIN; Nishi N, 2014, NY TIMES; O'Neill Institute for National and Global Health Law, ON I REFL FRONTL EB; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Rivers B., 2004, RECOMMENDED COUNTRY; Sack K., 2014, NEW YORK TIMES; South African Government News Agency, W AFR EB 2 GROUP HLT; The Lancet, 2014, LANCET, V384, P1321; Thompson D, 2015, NATL GEOGRAPHIC; UN, EB VIR DIS OUTBR OV; UN, NIMBL FLEX APPR NEED; UN Development Group-Western and Central Africa, CALL NAT REG CONT RE; UN Office for the Coordination of Humanitarian Affairs, 2014, EB VIR OUTBR W AFR; UNMEER, EB OUTBR UPD OV NEED; UNMEER, FUND EB RESP; US Department of Health and Human Services, 2014, GLOB HLTH SEC AG WHT; WHO, KEY ISS DEV POL ENG; WHO, FRAM ENG NONST ACT R; WHO, WHO REF OV REF IMPL; WHO, 2015, WB SIT REP; WHO, STREAML WORK GOV BOD; WHO, REV HUM RES STRAT; WHO, WHO EX BOARD SPEC SE; WHO. Governments of Guinea Liberia and Sierra Leone, EVD OUTBR RESP PLAN; WHO Regional Office for Africa, UG HLTH WORK SUPP W; World Bank, SUMM EB REC SIERR LE; World Bank, SUMM EB REC PLAN LIB; World Bank, SUMM EB REC PLAN GUN; World Bank, PAND EM FAC FREQ ASS; World Bank, WORLD BANK GROUP PRE; World Health Organization, M INT HLTH REG EM CO; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization (WHO), PROP PROGR BUDG 2014	69	134	138	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1902	1909		10.1016/S0140-6736(15)60644-4	http://dx.doi.org/10.1016/S0140-6736(15)60644-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25987158	Green Published			2022-12-28	WOS:000354184500033
J	Davies, K				Davies, Kay			Keep the directive that protects research animals	NATURE			English	Editorial Material									Univ Oxford, MRC Funct Genom Unit, Oxford OX1 2JD, England	University of Oxford	Davies, K (corresponding author), Univ Oxford, MRC Funct Genom Unit, Oxford OX1 2JD, England.	kay.davies@dpag.ox.ac.uk							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					7	7		10.1038/521007a	http://dx.doi.org/10.1038/521007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH4YS	25951248	Bronze			2022-12-28	WOS:000354040900004
J	Kardon, JR; Yien, YY; Huston, NC; Branco, DS; Hildick-Smith, GJ; Rhee, KY; Paw, BH; Baker, TA				Kardon, Julia R.; Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Hildick-Smith, Gordon J.; Rhee, Kyu Y.; Paw, Barry H.; Baker, Tania A.			Mitochondrial ClpX Activates a Key Enzyme for Heme Biosynthesis and Erythropoiesis	CELL			English	Article							5-AMINOLEVULINATE SYNTHASE; PYRIDOXAL KINASE; PORE LOOPS; PROTEIN; DEGRADATION; GENE; ORGANIZATION; RECOGNITION; HYDROLYSIS; DIAGNOSIS	The mitochondrion maintains and regulates its proteome with chaperones primarily inherited from its bacterial endosymbiont ancestor. Among these chaperones is the AAA+ unfoldase ClpX, an important regulator of prokaryotic physiology with poorly defined function in the eukaryotic mitochondrion. We observed phenotypic similarity in S. cerevisiae genetic interaction data between mitochondrial ClpX (mtClpX) and genes contributing to heme biosynthesis, an essential mitochondrial function. Metabolomic analysis revealed that 5-aminolevulinic acid (ALA), the first heme precursor, is 5-fold reduced in yeast lacking mtClpX activity and that total heme is reduced by half. mtClpX directly stimulates ALA synthase in vitro by catalyzing incorporation of its cofactor, pyridoxal phosphate. This activity is conserved in mammalian homologs; additionally, mtClpX depletion impairs vertebrate erythropoiesis, which requires massive upregulation of heme biosynthesis to supply hemoglobin. mtClpX, therefore, is a widely conserved stimulator of an essential biosynthetic pathway and uses a previously unrecognized mechanism for AAA+ unfoldases.	[Kardon, Julia R.; Baker, Tania A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Hildick-Smith, Gordon J.; Paw, Barry H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; [Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY 10065 USA; [Paw, Barry H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol,Dept Med, Boston, MA 02115 USA; [Paw, Barry H.] Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA; [Kardon, Julia R.; Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu		Paw, Barry/0000-0002-0492-1419; Kardon, Julia/0000-0002-6621-4461	NIH [RO1 GM049224, F32DK095726, T32HL007574, F32DK098866, R01DK070838, P01HL032262]; March of Dimes Foundation [6-FY09-289]; Brazilian CAPES Foundation; Brazilian FAPESP Foundation; Burroughs Wellcome Career Award in the Biomedical Sciences; William Randolph Hearst Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007574, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095726, F32DK098866, R01DK070838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Brazilian CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian FAPESP Foundation; Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); William Randolph Hearst Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bell, J. Weissman, R. Vale, J. Nunnari, and N. Bradshaw for critical reading of the manuscript; L. Zon for the Tg(globin-LCR:eGFP) transgenic line; K. Hoffmeister for fluorescence-activated cell sorting (FACS) machine use; and C. Lawrence and his team for zebrafish husbandry. This work was supported by grants from the NIH (RO1 GM049224 to T.A.B., F32DK095726 to J. R. K., T32HL007574 and F32DK098866 to Y.Y.Y., and R01DK070838 and P01HL032262 to B.H.P.), the March of Dimes Foundation (6-FY09-289 to B.H.P.), and the Brazilian CAPES and FAPESP Foundations (to D.S.B.). K.Y.R. is the recipient of a Burroughs Wellcome Career Award in the Biomedical Sciences and of support from the William Randolph Hearst Foundation. T.A.B. is an employee of the Howard Hughes Medical Institute.	Al-Furoukh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103141; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; ARESE M, 1983, CURR GENET, V7, P175, DOI 10.1007/BF00434887; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Cheung PY, 2003, J BIOCHEM, V134, P731, DOI 10.1093/jb/mvg201; Cooney JD, 2013, DEV BIOL, V373, P431, DOI 10.1016/j.ydbio.2012.08.015; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HAMFELT A, 1967, CLIN CHIM ACTA, V16, P19, DOI 10.1016/0009-8981(67)90264-1; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kasashima K, 2012, EXP CELL RES, V318, P2335, DOI 10.1016/j.yexcr.2012.07.012; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; KIM YT, 1988, J BIOL CHEM, V263, P13712; Konieczny I, 1997, P NATL ACAD SCI USA, V94, P14378, DOI 10.1073/pnas.94.26.14378; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Lawrence JM, 2003, COMP BIOCHEM PHYS A, V134, P71; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Russell R, 2014, CELL, V158, P479, DOI 10.1016/j.cell.2014.07.009; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; van Dyck L, 1998, FEBS LETT, V438, P250, DOI 10.1016/S0014-5793(98)01310-6; Vass RH, 2013, P NATL ACAD SCI USA, V110, P18138, DOI 10.1073/pnas.1311302110; VOLLAND C, 1984, EUR J BIOCHEM, V142, P551, DOI 10.1111/j.1432-1033.1984.tb08321.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WANG ZY, 1992, PLANT PHYSIOL, V99, P1348, DOI 10.1104/pp.99.4.1348; Wintrobe MM, 2004, WINTROBES CLIN HEMAT, V11th; Wu TH, 2003, BBA-PROTEINS PROTEOM, V1647, P315, DOI 10.1016/S1570-9639(03)00081-5	57	72	77	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					858	867		10.1016/j.cell.2015.04.017	http://dx.doi.org/10.1016/j.cell.2015.04.017			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957689	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000354175200018
J	Ma, AD				Ma, Alice D.			Update in Hematology: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS; TRANSFUSION; LEUKEMIA		[Ma, Alice D.] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Ma, AD (corresponding author), Univ N Carolina, Div Hematol Oncol, 170 Manning Dr,CB 7305, Chapel Hill, NC 27599 USA.	alice_ma@med.unc.edu						Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Hicks LK, 2014, BLOOD, V124, P3524, DOI 10.1182/blood-2014-09-599399; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P1330, DOI 10.1001/jamainternmed.2014.2368	8	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W106	W110		10.7326/M15-0271	http://dx.doi.org/10.7326/M15-0271			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927631				2022-12-28	WOS:000379893300006
J	Kirby, T				Kirby, Tony			Alan Lopez: making everyone count	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1331	1331		10.1016/S0140-6736(15)60506-2	http://dx.doi.org/10.1016/S0140-6736(15)60506-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	25971223				2022-12-28	WOS:000362316200015
J	Buitrago-Delgado, E; Nordin, K; Rao, A; Geary, L; LaBonne, C				Buitrago-Delgado, Elsy; Nordin, Kara; Rao, Anjali; Geary, Lauren; LaBonne, Carole			Shared regulatory programs suggest retention of blastula-stage potential in neural crest cells	SCIENCE			English	Article							SELF-RENEWAL; STEM-CELLS; ES CELLS; XENOPUS; PLURIPOTENCY; INDUCTION; EXPRESSION; PAX3; MYC; DIFFERENTIATION	Neural crest cells, which are specific to vertebrates, arise in the ectoderm but can generate cell types that are typically categorized as mesodermal. This broad developmental potential persists past the time when most ectoderm-derived cells become lineage-restricted. The ability of neural crest to contribute mesodermal derivatives to the bauplan has raised questions about how this apparent gain in potential is achieved. Here, we describe shared molecular underpinnings of potency in neural crest and blastula cells. We show that in Xenopus, key neural crest regulatory factors are also expressed in blastula animal pole cells and promote pluripotency in both cell types. We suggest that neural crest cells may have evolved as a consequence of a subset of blastula cells retaining activity of the regulatory network underlying pluripotency.	[Buitrago-Delgado, Elsy; Nordin, Kara; Rao, Anjali; Geary, Lauren; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [LaBonne, Carole] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	LaBonne, C (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	clabonne@northwestern.edu	Rao, Anjali/AGQ-5949-2022; Rao, Anjali/AAT-8123-2020	Rao, Anjali/0000-0001-8815-9865	 [F31DE021922];  [T32CA009560-24];  [T32GM008061];  [R01GM114058]; NATIONAL CANCER INSTITUTE [T32CA009560, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R01GM077288] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010997] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Nguyen for technical assistance, S. Sokol for providing activin, and R. Carthew and X. Wang for helpful discussions. K.N. was supported by grants F31DE021922 and T32CA009560-24. L.G was supported by grant T32GM008061. This work was supported by grant R01GM114058 to C.L. The supplementary materials contain additional data.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; ANDERSON DJ, 1989, TRENDS GENET, V5, P174, DOI 10.1016/0168-9525(89)90072-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; Furue M., 2004, HDB STEM CELLS, V1; GRAINGER RM, 1989, P NATL ACAD SCI USA, V86, P1900, DOI 10.1073/pnas.86.6.1900; Hall BK, 1999, NEURAL CREST DEV EVO; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; JONES EA, 1987, DEVELOPMENT, V101, P557; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; Light W, 2005, DEVELOPMENT, V132, P1831, DOI 10.1242/dev.01734; Lin YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4070; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIEUWKOOP PD, 1969, ROUX ARCH DEV BIOL, V163, P298; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordin K, 2014, DEV CELL, V31, P374, DOI 10.1016/j.devcel.2014.10.003; Rogers CD, 2008, DEV BIOL, V313, P307, DOI 10.1016/j.ydbio.2007.10.023; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Scerbo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036855; Taylor KM, 2007, CURR OPIN GENET DEV, V17, P326, DOI 10.1016/j.gde.2007.05.012; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	33	94	96	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1332	1335		10.1126/science.aaa3655	http://dx.doi.org/10.1126/science.aaa3655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	25931449	Green Accepted			2022-12-28	WOS:000356449500043
J	Liu, Y; Holmstrom, E; Zhang, JW; Yu, P; Wang, JB; Dyba, MA; Chen, D; Ying, JF; Lockett, S; Nesbitt, DJ; Ferre-D'Amare, AR; Sousa, R; Stagno, JR; Wang, YX				Liu, Yu; Holmstrom, Erik; Zhang, Jinwei; Yu, Ping; Wang, Jinbu; Dyba, Marzena A.; Chen, De; Ying, Jinfa; Lockett, Stephen; Nesbitt, David J.; Ferre-D'Amare, Adrian R.; Sousa, Rui; Stagno, Jason R.; Wang, Yun-Xing			Synthesis and applications of RNAs with position-selective labelling and mosaic composition	NATURE			English	Article							SINGLE-MOLECULE; TRANSCRIPTION INITIATION; MESSENGER-RNAS; DNA TEMPLATES; POLYMERASE; RIBOSWITCH; STABILITY; LIGAND; DISSOCIATION; SPECIFICITY	Knowledge of the structure and dynamics of RNA molecules is critical to understanding their many biological functions. Furthermore, synthetic RNAs have applications as therapeutics and molecular sensors. Both research and technological applications of RNA would be dramatically enhanced by methods that enable incorporation of modified or labelled nucleotides into specifically designated positions or regions of RNA. However, the synthesis of tens of milligrams of such RNAs using existing methods has been impossible. Here we develop a hybrid solid-liquid phase transcription method and automated robotic platform for the synthesis of RNAs with position-selective labelling. We demonstrate its use by successfully preparing various isotope- or fluorescently labelled versions of the 71-nucleotide aptamer domain of an adenine riboswitch(1) for nuclear magnetic resonance spectroscopy or single-molecule Forster resonance energy transfer, respectively. Those RNAs includemolecules that were selectively isotope-labelled in specific loops, linkers, a helix, several discrete positions, or a single internal position, as well as RNA molecules that were fluorescently labelled in and near kissing loops. These selectively labelled RNAs have the same fold as those transcribed using conventional methods, but they greatly simplify the interpretation of NMR spectra. The single-position isotope-and fluorescently labelled RNA samples reveal multiple conformational states of the adenine riboswitch. Lastly, we describe a robotic platform- and the operation that automates this technology. Our selective labelling method may be useful for studying RNA structure and dynamics and for making RNA sensors for a variety of applications including cell-biological studies, substance detection(2), and disease diagnostics(3,4).	[Liu, Yu; Wang, Jinbu; Stagno, Jason R.; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Holmstrom, Erik; Nesbitt, David J.] Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Holmstrom, Erik; Nesbitt, David J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Zhang, Jinwei; Ferre-D'Amare, Adrian R.] NHLBI, Biochem & Biophys Ctr, Bethesda, MD 20892 USA; [Yu, Ping; Dyba, Marzena A.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Basic Sci Program, Struct Biophys Lab, Frederick, MD 21702 USA; [Chen, De; Lockett, Stephen] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Opt Microscopy & Anal Lab, Frederick, MD 21702 USA; [Ying, Jinfa] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA; [Sousa, Rui] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Health San Antonio	Wang, YX (corresponding author), NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA.	wangyunx@mail.nih.gov	Zhang, Jinwei/AAU-9195-2020; Stagno, Jason/AAP-2159-2020	Zhang, Jinwei/0000-0002-2114-173X; Stagno, Jason/0000-0002-6464-7829; Sousa, Rui/0000-0003-4314-121X	National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health; National Institutes of Health; National Cancer Institute [HHSN261200800001E]; National Science Foundation [CHE1266416, PHYS1125844]; National Institutes of Health Molecular Biophysics Training Program [T32 GM-065103]; W. M. Keck Foundation; National Institute of Standards and Technology; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052522, T32GM065103] Funding Source: NIH RePORTER	National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Molecular Biophysics Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. E. Draper, A. Bax, A. Byrd, M. Summers, A. Rein, and J. Strathern for discussions. This work was supported in part by the Intramural Research Programs of the National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; by the Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health; by the 2013 Director's Challenge Innovation Award of the National Institutes of Health; by the fund from the National Cancer Institute under contract number HHSN261200800001E; by the National Science Foundation (CHE1266416, PHYS1125844); by the National Institutes of Health Molecular Biophysics Training Program (T32 GM-065103); and by the W. M. Keck Foundation, and the National Institute of Standards and Technology. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dalgarno PA, 2013, NUCLEIC ACIDS RES, V41, P4253, DOI 10.1093/nar/gkt128; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare A. R., 1996, NUCLEIC ACIDS RES, V24, P977; Fiore JL, 2008, BIOPHYS J, V95, P3892, DOI 10.1529/biophysj.108.134346; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Holmstrom ED, 2014, J PHYS CHEM B, V118, P3853, DOI 10.1021/jp501893c; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Leipply D, 2011, BIOCHEMISTRY-US, V50, P2790, DOI 10.1021/bi101948k; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lu K, 2010, J BIOMOL NMR, V46, P113, DOI 10.1007/s10858-009-9375-2; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; Makarova OV, 1995, P NATL ACAD SCI USA, V92, P12250, DOI 10.1073/pnas.92.26.12250; MARBLE HA, 1995, BIOTECHNOL PROGR, V11, P393, DOI 10.1021/bp00034a005; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Pavlov MY, 1997, BIOCHIMIE, V79, P415, DOI 10.1016/S0300-9084(97)86151-2; Pinheiro VB, 2014, TRENDS BIOTECHNOL, V32, P321, DOI 10.1016/j.tibtech.2014.03.010; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Steinberg G, 2004, BIOPOLYMERS, V73, P597, DOI 10.1002/bip.20006; USMAN N, 1987, J AM CHEM SOC, V109, P7845, DOI 10.1021/ja00259a037; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001; Ying JF, 2011, J BIOMOL NMR, V51, P89, DOI 10.1007/s10858-011-9544-y; Zhang JW, 2014, STRUCTURE, V22, P1363, DOI 10.1016/j.str.2014.07.011; Zuo XB, 2010, P NATL ACAD SCI USA, V107, P1385, DOI 10.1073/pnas.0908140107	45	72	74	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					368	+		10.1038/nature14352	http://dx.doi.org/10.1038/nature14352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25938715	Green Accepted			2022-12-28	WOS:000356425400059
J	Stephan, F; Barrucand, B; Petit, P; Rezaiguia-Delclaux, S; Medard, A; Delannoy, B; Cosserant, B; Flicoteaux, G; Imbert, A; Pilorge, C; Berard, L				Stephan, Francois; Barrucand, Benoit; Petit, Pascal; Rezaiguia-Delclaux, Saida; Medard, Anne; Delannoy, Bertrand; Cosserant, Bernard; Flicoteaux, Guillaume; Imbert, Audrey; Pilorge, Catherine; Berard, Laurence		BiPOP Study Grp	High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; CARDIAC SURGICAL-PATIENTS; LUNG RESECTION; FACE MASK; VENTILATION; EXTUBATION; THERAPY; RISK; CANNULAE; EFFICACY	IMPORTANCE Noninvasive ventilation delivered as bilevel positive airway pressure (BiPAP) is often used to avoid reintubation and improve outcomes of patients with hypoxemia after cardiothoracic surgery. High-flow nasal oxygen therapy is increasingly used to improve oxygenation because of its ease of implementation, tolerance, and clinical effectiveness. OBJECTIVE To determine whether high-flow nasal oxygen therapy was not inferior to BiPAP for preventing or resolving acute respiratory failure after cardiothoracic surgery. DESIGN AND SETTING Multicenter, randomized, noninferiority trial (BiPOP Study) conducted between June 15, 2011, and January 15, 2014, at 6 French intensive care units. PARTICIPANTS A total of 830 patients who had undergone cardiothoracic surgery, of which coronary artery bypass, valvular repair, and pulmonary thromboendarterectomy were the most common, were included when they developed acute respiratory failure (failure of a spontaneous breathing trial or successful breathing trial but failed extubation) or were deemed at risk for respiratory failure after extubation due to preexisting risk factors. INTERVENTIONS Patients were randomly assigned to receive high-flow nasal oxygen therapy delivered continuously through a nasal cannula (flow, 50 L/min; fraction of inspired oxygen [FIO2], 50%) (n = 414) or BiPAP delivered with a full-face mask for at least 4 hours per day (pressure support level, 8 cm H2O; positive end-expiratory pressure, 4 cm H2O; FIO2, 50%) (n = 416). MAIN OUTCOMES AND MEASURES The primary outcome was treatment failure, defined as reintubation, switch to the other study treatment, or premature treatment discontinuation (patient request or adverse effects, including gastric distention). Noninferiority of high-flow nasal oxygen therapy would be demonstrated if the lower boundary of the 95% CI were less than 9%. Secondary outcomes included mortality during intensive care unit stay, changes in respiratory variables, and respiratory complications. RESULTS High-flow nasal oxygen therapy was not inferior to BiPAP: the treatment failed in 87 of 414 patients with high-flow nasal oxygen therapy (21.0%) and 91 of 416 patients with BiPAP (21.9%) (absolute difference, 0.9%; 95% CI, -4.9% to 6.6%; P =.003). No significant differences were found for intensive care unit mortality (23 patients with BiPAP [5.5%] and 28 with high-flow nasal oxygen therapy [6.8%]; P = .66) (absolute difference, 1.2%[95% CI, -2.3% to 4.8%]. Skin breakdown was significantly more common with BiPAP after 24 hours (10% vs 3%; 95% CI, 7.3%-13.4% vs 1.8%-5.6%; P < .001). CONCLUSIONS AND RELEVANCE Among cardiothoracic surgery patients with or at risk for respiratory failure, the use of high-flow nasal oxygen therapy compared with intermittent BiPAP did not result in a worse rate of treatment failure. The findings support the use of high-flow nasal oxygen therapy in similar patients.	[Stephan, Francois; Rezaiguia-Delclaux, Saida; Imbert, Audrey; Pilorge, Catherine] Ctr Chirurg Marie Lannelongue, Serv Reanimat Adulte, F-92350 Le Plessis Robinson, France; [Barrucand, Benoit; Petit, Pascal; Flicoteaux, Guillaume] CHU Besancon, Dept Anesthesie Reanimat, F-25030 Besancon, France; [Medard, Anne; Cosserant, Bernard] Ctr Hosp Univ, Dept Anesthesie Reanimat, Clermont Ferrand, France; [Delannoy, Bertrand] Ctr Hosp Univ, Dept Anesthesie Reanimat, Lyon, France; [Berard, Laurence] Hop St Antoine, Plateforme Rech Clin Est Parisien, F-75571 Paris, France	Hopital Marie Lannelongue; Universite de Franche-Comte; CHU Besancon; CHU Clermont Ferrand; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Stephan, F (corresponding author), Ctr Chirurg Marie Lannelongue, Reanimat Adulte, 133 Ave Resistance, F-92350 Le Plessis Robinson, France.	f.stephan@ccml.fr		Ouattara, Alexandre/0000-0002-7346-7539				Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Boeken U, 2010, THORAC CARDIOV SURG, V58, P398, DOI 10.1055/s-0030-1249940; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; Crimi C, 2010, EUR RESPIR J, V36, P362, DOI 10.1183/09031936.00123509; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; El Solh AA, 2006, EUR RESPIR J, V28, P588, DOI 10.1183/09031936.06.00150705; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Guarracino Fabio, 2013, J Cardiothorac Vasc Anesth, V27, pe63, DOI 10.1053/j.jvca.2013.04.005; Jaber S, 2014, INTENS CARE MED, V40, P280, DOI 10.1007/s00134-014-3213-z; Jaber S, 2010, ANESTHESIOLOGY, V112, P453, DOI 10.1097/ALN.0b013e3181c5e5f2; Jiang YD, 2008, J APPL PHYSIOL, V105, P854, DOI 10.1152/japplphysiol.90599.2008; Lee JH, 2013, INTENS CARE MED, V39, P247, DOI 10.1007/s00134-012-2743-5; Lefebvre A, 2009, INTENS CARE MED, V35, P663, DOI 10.1007/s00134-008-1317-z; Lorut C, 2014, INTENS CARE MED, V40, P220, DOI 10.1007/s00134-013-3150-2; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Matte P, 2000, ACTA ANAESTH SCAND, V44, P75, DOI 10.1034/j.1399-6576.2000.440114.x; Michelet P, 2009, BRIT J SURG, V96, P54, DOI 10.1002/bjs.6307; Mundel T, 2013, J APPL PHYSIOL, V114, P1058, DOI 10.1152/japplphysiol.01308.2012; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7; Nicolet J, 2011, ANN FR ANESTH, V30, P331, DOI 10.1016/j.annfar.2011.01.017; Parke R, 2013, BRIT J ANAESTH, V111, P925, DOI 10.1093/bja/aet262; Parke R, 2009, BRIT J ANAESTH, V103, P886, DOI 10.1093/bja/aep280; Ranucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093992; Riviere S, 2011, EUR J CARDIO-THORAC, V39, P769, DOI 10.1016/j.ejcts.2010.08.016; Schwabbauer N, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-66; Servera E, 2003, CHEST, V123, P1773, DOI 10.1378/chest.123.5.1773; Spoletini G, CHEST, DOI 101378/chest14-2871; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; Truwit JD, 2004, NEW ENGL J MED, V350, P2512, DOI 10.1056/NEJMe048049; Ugurlu AO, 2014, CHEST, V145, P964, DOI 10.1378/chest.13-1707; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Ward JJ, 2013, RESP CARE, V58, P98, DOI 10.4187/respcare.01941; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791; Xue FS, 1999, ANESTH ANALG, V88, P213, DOI 10.1097/00000539-199901000-00040; Yu HP, 2014, HEART LUNG, V43, P99, DOI 10.1016/j.hrtlng.2014.01.002; Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602; Zhu GF, 2013, CHINESE MED J-PEKING, V126, P4463, DOI 10.3760/cma.j.issn.0366-6999.20131704	42	290	316	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2331	2339		10.1001/jama.2015.5213	http://dx.doi.org/10.1001/jama.2015.5213			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	25980660	Bronze			2022-12-28	WOS:000356300200018
J	Elsasser, SJ; Noh, KM; Diaz, N; Allis, CD; Banaszynski, LA				Elsasser, Simon J.; Noh, Kyung-Min; Diaz, Nichole; Allis, C. David; Banaszynski, Laura A.			Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells	NATURE			English	Article							DNA; RETROTRANSPOSONS; CHROMATIN; DISTINCT; CHAPERONE; GENOME; GENES; DAXX; TRANSCRIPTION; REPRESSION	Transposable elements comprise roughly 40% of mammalian genomes(1). They have an active role in genetic variation, adaptation and evolution through the duplication or deletion of genes or their regulatory elements(2-4), and transposable elements themselves can act as alternative promoters for nearby genes, resulting in noncanonical regulation of transcription(5,6). However, transposable element activity can lead to detrimental genome instability(7), and hosts have evolved mechanisms to silence transposable element mobility appropriately(8,9). Recent studies have demonstrated that a subset of transposable elements, endogenous retroviral elements (ERVs) containing long terminal repeats (LTRs), are silenced through trimethylation of histone H3 on lysine 9 (H3K9me3) by ESET (also known as SETDB1 or KMT1E)(10) and a co-repressor complex containing KRAB-associated protein 1 (KAP1; also known as TRIM28)(11) in mouse embryonic stem cells. Here we show that the replacement histone variant H3.3 is enriched at class I and class II ERVs, notably those of the early transposon (ETn)/MusD family and intracisternal A-type particles (IAPs). Deposition at a subset of these elements is dependent upon the H3.3 chaperone complex containing alpha-thalassaemia/mental retardation syndrome X-linked (ATRX) 12 and death-domain-associated protein (DAXX)(12-14). We demonstrate that recruitment of DAXX, H3.3 and KAP1 to ERVs is co-dependent and occurs upstream of ESET, linking H3.3 to ERV-associated H3K9me3. Importantly, H3K9me3 is reduced at ERVs upon H3.3 deletion, resulting in derepression and dysregulation of adjacent, endogenous genes, along with increased retrotransposition of IAPs. Our study identifies a unique heterochromatin state marked by the presence of both H3.3 and H3K9me3, and establishes an important role for H3.3 in control of ERV retrotransposition in embryonic stem cells.	[Elsasser, Simon J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Elsasser, Simon J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden; [Noh, Kyung-Min; Diaz, Nichole; Allis, C. David; Banaszynski, Laura A.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Banaszynski, Laura A.] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Banaszynski, Laura A.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA	MRC Laboratory Molecular Biology; Karolinska Institutet; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Elsasser, SJ (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	simon.elsasser@scilifelab.se; alliscd@rockefeller.edu; laura.banaszynski@utsouthwestern.edu	Elsässer, Simon/AAM-3986-2020	Elsässer, Simon/0000-0001-8724-4849; Noh, Kyung-Min/0000-0002-0708-787X	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; EMBO ALTF [1232-2011]; Cambridge University Herchel Smith Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; EMBO ALTF; Cambridge University Herchel Smith Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Rockefeller University Fund and the Tri-Institutional Stem Cell Initiative. S.J.E. acknowledges funding from EMBO ALTF 1232-2011 and the Cambridge University Herchel Smith Fund. We thank D. Pickett, D. Trono and D. Shinkai for cell lines. We thank A. Goldberg and C. Li for technical assistance and members of the Allis laboratory for helpful discussions.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; DeNizio JE, 2014, NUCLEIC ACIDS RES, V42, P4318, DOI 10.1093/nar/gku090; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P117, DOI 10.1159/000084943; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Longo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-334; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Robberecht C, 2013, GENOME RES, V23, P411, DOI 10.1101/gr.145631.112; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Yildirim O, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004515; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	40	218	225	6	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					240	U323		10.1038/nature14345	http://dx.doi.org/10.1038/nature14345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25938714	Green Accepted			2022-12-28	WOS:000356016700044
J	Wong, YL; Anzola, JV; Davis, RL; Yoon, M; Motamedi, A; Kroll, A; Seo, CP; Hsia, JE; Kim, SK; Mitchell, JW; Mitchell, BJ; Desai, A; Gahman, TC; Shiau, AK; Oegema, K				Wong, Yao Liang; Anzola, John V.; Davis, Robert L.; Yoon, Michelle; Motamedi, Amir; Kroll, Ashley; Seo, Chanmee P.; Hsia, Judy E.; Kim, Sun K.; Mitchell, Jennifer W.; Mitchell, Brian J.; Desai, Arshad; Gahman, Timothy C.; Shiau, Andrew K.; Oegema, Karen			Reversible centriole depletion with an inhibitor of Polo-like kinase 4	SCIENCE			English	Article							CENTROSOME DUPLICATION; CYCLE; P53; CYTOKINESIS; CFI-400945; PATHWAY	Centrioles are ancient organelles that build centrosomes, the major microtubule-organizing centers of animal cells. Extra centrosomes are a common feature of cancer cells. To investigate the importance of centrosomes in the proliferation of normal and cancer cells, we developed centrinone, a reversible inhibitor of Polo-like kinase 4 (Plk4), a serine-threonine protein kinase that initiates centriole assembly. Centrinone treatment caused centrosome depletion in human and other vertebrate cells. Centrosome loss irreversibly arrested normal cells in a senescence-like G(1) state by a p53-dependent mechanism that was independent of DNA damage, stress, Hippo signaling, extended mitotic duration, or segregation errors. In contrast, cancer cell lines with normal or amplified centrosome numbers could proliferate indefinitely after centrosome loss. Upon centrinone washout, each cancer cell line returned to an intrinsic centrosome number "set point." Thus, cells with cancer-associated mutations fundamentally differ from normal cells in their response to centrosome loss.	[Wong, Yao Liang; Kroll, Ashley; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Anzola, John V.; Davis, Robert L.; Yoon, Michelle; Motamedi, Amir; Seo, Chanmee P.; Hsia, Judy E.; Gahman, Timothy C.; Shiau, Andrew K.] Ludwig Inst Canc Res, Small Mol Discovery Program, La Jolla, CA 92093 USA; [Kim, Sun K.; Mitchell, Jennifer W.; Mitchell, Brian J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Northwestern University; Feinberg School of Medicine	Oegema, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ashiau@ucsd.edu; koegema@ucsd.edu		Kim, Sun/0000-0002-6033-6142; Mitchell, Brian/0000-0001-6281-1536; Wong, Yao Liang/0000-0003-0298-8510	NIH [GM103403, GM074207, GM089970]; Hilton Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207, P41GM103403, R01GM089970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hilton Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Li for leading the Sundia Meditech chemistry team, Advanced Photon Source NE-CAT (supported by NIH GM103403) for assistance with x-ray data collection, Q. Zhu and I. Verma for the p53 and Glu4 shRNA lentiviruses, A. Holland and D. Cleveland for the Plk4-YFP DLD-1 cell line, R. Gassmann for help with initial cell-based assays, M. Kaulich for technical advice on CRISPR/Cas9, and A. Dammermann for generation of the Sas6 and Cep192 antibodies. J.V.A, R.L.D., M.Y., A.M., C.P.S., J.E.H., A.D., T.C.G., A.K.S., and K.O. receive salary and other support from the Ludwig Institute for Cancer Research. This work was supported by NIH grants to K.O. (GM074207) and B.J.M. (GM089970), and with funds from the Hilton Ludwig Cancer Prevention Initiative to A.K.S. and T.C.G. The data described here are tabulated in the main paper and Supplementary Materials. The structure of the centrinone-bound Plk4 kinase domain complex has been deposited in the Protein Data Bank (4YUR). The Ludwig Institute for Cancer Research has filed a patent application (62/149,292) related to the structures, syntheses, and uses of centrinone, centrinone B, and chemically related Plk4 inhibitors. Requests for the centrinones should be directed to A.K.S. (ashiau@ucsd.edu).	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rios RM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0462; Sampson PB, 2015, J MED CHEM, V58, P147, DOI 10.1021/jm5005336; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Sumigray Kaelyn D, 2011, Bioarchitecture, V1, P221; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018	35	258	261	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1155	1160		10.1126/science.aaa5111	http://dx.doi.org/10.1126/science.aaa5111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25931445	Green Accepted, Green Submitted			2022-12-28	WOS:000355590500053
J	Cao, Y; Kulkarni, SR; Howell, DA; Gal-Yam, A; Kasliwal, MM; Valenti, S; Johansson, J; Amanullah, R; Goobar, A; Sollerman, J; Taddia, F; Horesh, A; Sagiv, I; Cenko, SB; Nugent, PE; Arcavi, I; Surace, J; Wozniak, PR; Moody, DI; Rebbapragada, UD; Bue, BD; Gehrels, N				Cao, Yi; Kulkarni, S. R.; Howell, D. Andrew; Gal-Yam, Avishay; Kasliwal, Mansi M.; Valenti, Stefano; Johansson, J.; Amanullah, R.; Goobar, A.; Sollerman, J.; Taddia, F.; Horesh, Assaf; Sagiv, Ilan; Cenko, S. Bradley; Nugent, Peter E.; Arcavi, Iair; Surace, Jason; Wozniak, P. R.; Moody, Daniela I.; Rebbapragada, Umaa D.; Bue, Brian D.; Gehrels, Neil			A strong ultraviolet pulse from a newborn type Ia supernova	NATURE			English	Article							TIME OPTICAL-SPECTRA; SN 2011FE; LOW-RESOLUTION; PROGENITOR; SWIFT; SPECTROGRAPH; CONSTRAINTS; COMPANIONS; GALAXIES; SINGLE	Type Ia supernovae(1) are destructive explosions of carbon-oxygen white dwarfs(2,3). Although they are used empirically to measure cosmological distances(4-6), the nature of their progenitors remains mysterious(3). One of the leading progenitor models, called the single degenerate channel, hypothesizes that a white dwarf accretes matter from a companion star and the resulting increase in its central pressure and temperature ignites thermonuclear explosion(3,7,8). Here we report observations with the Swift Space Telescope of strong but declining ultraviolet emission from a type Ia supernova within four days of its explosion. This emission is consistent with theoretical expectations of collision between material ejected by the supernova and a companion star(9), and therefore provides evidence that some type Ia supernovae arise from the single degenerate channel.	[Cao, Yi; Kulkarni, S. R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Kulkarni, S. R.] CALTECH, Caltech Opt Observ, Pasadena, CA 91125 USA; [Howell, D. Andrew; Valenti, Stefano; Arcavi, Iair] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Howell, D. Andrew; Valenti, Stefano] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Gal-Yam, Avishay; Horesh, Assaf; Sagiv, Ilan] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Kasliwal, Mansi M.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Johansson, J.; Amanullah, R.; Goobar, A.] Stockholm Univ, Dept Phys, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Sollerman, J.; Taddia, F.] Stockholm Univ, Dept Astron, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Cenko, S. Bradley; Gehrels, Neil] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Nugent, Peter E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Nugent, Peter E.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Arcavi, Iair] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Surace, Jason] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Wozniak, P. R.; Moody, Daniela I.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Rebbapragada, Umaa D.; Bue, Brian D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California Santa Barbara; Weizmann Institute of Science; Carnegie Institution for Science; Oskar Klein Centre; Stockholm University; Oskar Klein Centre; Stockholm University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; California Institute of Technology; United States Department of Energy (DOE); Los Alamos National Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Cao, Y (corresponding author), CALTECH, Dept Astron, Pasadena, CA 91125 USA.	ycao@astro.caltech.edu	Howell, Andy/ABE-6446-2020; Valenti, Stefano/M-5924-2017; Horesh, Assaf/O-9873-2016; Nugent, Peter Edward/AGG-8472-2022	Valenti, Stefano/0000-0001-8818-0795; Horesh, Assaf/0000-0002-5936-1156; Wozniak, Przemyslaw/0000-0002-9919-3310; Taddia, Francesco/0000-0002-2387-6801; Kasliwal, Tamay/0000-0001-5634-7167; Sollerman, Jesper/0000-0003-1546-6615; Johansson, Joel/0000-0001-5975-290X; Nugent, Peter/0000-0002-3389-0586	W. M. Keck Foundation; National Science Foundation; EU/FP7 via an ERC grant; "Quantum Universe" I-Core programme; ISF; Minerva and Weizmann-UK grants; Kimmel Award; Carnegie-Princeton fellowship; Swedish Research Council; Knut and Alice Wallenberg Foundation; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US Department of Energy as part of the Laboratory Directed Research and Development programme; National Aeronautics and Space Administration; Direct For Mathematical & Physical Scien [1009987] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1313484] Funding Source: National Science Foundation	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); EU/FP7 via an ERC grant; "Quantum Universe" I-Core programme; ISF(Israel Science Foundation); Minerva and Weizmann-UK grants; Kimmel Award; Carnegie-Princeton fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US Department of Energy as part of the Laboratory Directed Research and Development programme(United States Department of Energy (DOE)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. L. Piro, M. Kromer and J. Cohen for discussions. We also thank A. Waszczak, A. Rubin, O. Yaron, A. De Cia, D. A. Perley, G. E. Duggan, O. Smirnova, S. Papadogiannakis, A. Nyholm, Y. F. Martinez and the staff at the Nordic Optical Telescope and Gemini for observation and data reduction. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The observatory was made possible by the generous financial support of the W. M. Keck Foundation. Some data were obtained with the Nordic Optical Telescope, which is operated by the Nordic Optical Telescope Scientific Association at the Observatorio del Roque de los Muchachos, La Palma, Spain. This work also makes use of observations from the Las Cumbres Observatory Global Telescope (LCOGT) network. Research at California Institute of Technology is supported by the National Science Foundation. D.A.H. acknowledges support from the National Science Foundation. A.G.-Y. acknowledges support from the EU/FP7 via an ERC grant, the "Quantum Universe" I-Core programme, the ISF, Minerva and Weizmann-UK grants, and the Kimmel Award. M.M.K. acknowledges generous support from the Carnegie-Princeton fellowship. Supernova research at the Oskar Klein Centre is supported by the Swedish Research Council and by the Knut and Alice Wallenberg Foundation. The National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231, provided staff, computational resources, and data storage for this project. The participation of the Los Alamos National Laboratory (LANL) in iPTF is supported by the US Department of Energy as part of the Laboratory Directed Research and Development programme. A portion of this work was carried out at the Jet Propulsion Laboratory under a Research and Technology Development Grant, under contract with the National Aeronautics and Space Administration.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Bianco FB, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/20; Bolton AS, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/144; Brink H, 2013, MON NOT R ASTRON SOC, V435, P1047, DOI 10.1093/mnras/stt1306; Brown PJ, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/22; Brown PJ, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/18; Bue B. D., 2014, P 2014 C BIG DAT SPA, P206; Burrows DN, 2004, PROC SPIE, V5165, P201, DOI 10.1117/12.504868; Cartier R, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/89; Faber SM, 2003, P SOC PHOTO-OPT INS, V4841, P1657, DOI 10.1117/12.460346; FILIPPENKO AV, 1992, ASTRON J, V104, P1543, DOI 10.1086/116339; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Foley RJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/29; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Foley RJ, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/38; Foley RJ, 2010, ASTROPHYS J LETT, V708, pL61, DOI 10.1088/2041-8205/708/1/L61; Gal-Yam A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/159; Gamezo VN, 2003, SCIENCE, V299, P77, DOI 10.1126/science.1078129; Ganeshalingam M, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/142; Hernandez JIG, 2012, NATURE, V489, P533, DOI 10.1038/nature11447; Hayden BT, 2010, ASTROPHYS J, V722, P1691, DOI 10.1088/0004-637X/722/2/1691; Holoien T. W.-S., 2014, ASTRON TELEGR, V6168, P1; Hook IM, 2004, PUBL ASTRON SOC PAC, V116, P425, DOI 10.1086/383624; Huchra JP, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/26; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Kromer M, 2010, ASTROPHYS J, V719, P1067, DOI 10.1088/0004-637X/719/2/1067; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395, DOI 10.1086/648598; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Maoz D, 2014, ANNU REV ASTRON ASTR, V52, P107, DOI 10.1146/annurev-astro-082812-141031; McCully C, 2014, NATURE, V512, P54, DOI 10.1038/nature13615; Milne PA, 2010, ASTROPHYS J, V721, P1627, DOI 10.1088/0004-637X/721/2/1627; Nugent P, 1997, ASTROPHYS J, V485, P812, DOI 10.1086/304459; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Ofek EO, 2012, PUBL ASTRON SOC PAC, V124, P62, DOI 10.1086/664065; OKE JB, 1982, PUBL ASTRON SOC PAC, V94, P586, DOI 10.1086/131027; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Pan KC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/151; Parrent JT, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/30; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Roming PWA, 2004, P SOC PHOTO-OPT INS, V5165, P262, DOI 10.1063/1.1810927; Sagiv I, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/4/79; Scodeggio M, 1998, ASTRON J, V116, P2728, DOI 10.1086/300639; Silverman JM, 2012, MON NOT R ASTRON SOC, V425, P1917, DOI 10.1111/j.1365-2966.2012.21276.x; Sullivan M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/102; Thomas RC, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/27; Vinko J, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201220043; Wagner R. M., 2014, ASTRON TELEGR, V6203, P1; Wang B, 2012, NEW ASTRON REV, V56, P122, DOI 10.1016/j.newar.2012.04.001; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; White CJ, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/52; Wozniak P. R., 2013, AM ASTR SOC M, V221; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656; Yasuda N, 2010, ASTRON J, V139, P39, DOI 10.1088/0004-6256/139/1/39	62	125	125	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					328	+		10.1038/nature14440	http://dx.doi.org/10.1038/nature14440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993962	Green Submitted			2022-12-28	WOS:000354816500050
J	Lipton, JO; Yuan, ED; Boyle, LM; Ebrahimi-Fakhari, D; Kwiatkowski, E; Nathan, A; Guttler, T; Davis, F; Asara, JM; Sahin, M				Lipton, Jonathan O.; Yuan, Elizabeth D.; Boyle, Lara M.; Ebrahimi-Fakhari, Darius; Kwiatkowski, Erica; Nathan, Ashwin; Guettler, Thomas; Davis, Fred; Asara, John M.; Sahin, Mustafa			The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation	CELL			English	Article							CLOCK; MTOR; RHYTHMS; INITIATION; TRANSCRIPTION; DEGRADATION; METABOLISM; MECHANISMS; KINASE; CANCER	The circadian timing system synchronizes cellular function by coordinating rhythmic transcription via a transcription-translational feedback loop. How the circadian system regulates gene expression at the translational level remains a mystery. Here, we show that the key circadian transcription factor BMAL1 associates with the translational machinery in the cytosol and promotes protein synthesis. The mTOR-effector kinase, ribosomal S6 protein kinase 1 (S6K1), an important regulator of translation, rhythmically phosphorylates BMAL1 at an evolutionarily conserved site. S6K1-mediated phosphorylation is critical for BMAL1 to both associate with the translational machinery and stimulate protein synthesis. Protein synthesis rates demonstrate circadian oscillations dependent on BMAL1. Thus, in addition to its critical role in circadian transcription, BMAL1 is a translation factor that links circadian timing and the mTOR signaling pathway. More broadly, these results expand the role of the circadian clock to the regulation of protein synthesis.	[Lipton, Jonathan O.; Yuan, Elizabeth D.; Boyle, Lara M.; Ebrahimi-Fakhari, Darius; Kwiatkowski, Erica; Nathan, Ashwin; Sahin, Mustafa] Childrens Hosp, Dept Neurol, Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Lipton, Jonathan O.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Guettler, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Davis, Fred] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center	Sahin, M (corresponding author), Childrens Hosp, Dept Neurol, Kirby Neurobiol Ctr, Boston, MA 02115 USA.	mustafa.sahin@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019; Güttler, Thomas/O-4851-2016	SAHIN, MUSTAFA/0000-0001-7044-2953; Güttler, Thomas/0000-0002-1456-7310; Ebrahimi-Fakhari, Darius/0000-0002-0026-4714; Kwiatkowski, Erica/0000-0003-1349-4858	AAN Clinical Research Training Program; Tuberous Sclerosis Alliance; William Randolph Hearst Foundation; American Sleep Medicine Foundation Physician Scientist Training Award; National Institute of Child, Health and Human Development (NICHD) [K08 HD071026, P30 HD018655]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS058956]; John Merck Fund; Nancy Lurie Marks Family Foundation; Children's Hospital Boston Translational Research Program; Heidelberg University Young Investigator Award; Daimler and Benz Foundation; Reinhard Frank Foundation; NIH [P01CA120964, S10RR032861]; European Molecular Biology Organization (EMBO) [ALTF 1054-2010]; Human Frontier Science Program (HFSP) [LT001215/2011-L]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD071026, P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956] Funding Source: NIH RePORTER	AAN Clinical Research Training Program; Tuberous Sclerosis Alliance; William Randolph Hearst Foundation; American Sleep Medicine Foundation Physician Scientist Training Award; National Institute of Child, Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John Merck Fund; Nancy Lurie Marks Family Foundation; Children's Hospital Boston Translational Research Program; Heidelberg University Young Investigator Award; Daimler and Benz Foundation; Reinhard Frank Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to Drs. T. Scammell, S.L. Pomeroy, E. Henske, D.J. Kwiatkowski, P.T. Tsai, G. Lipton, and members of the M.S. lab for critical reading of the manuscript. We thank W. Lewis for technical assistance and Dr. Susanne Breitkopf and Min Yuan for help with MS experiments. We thank D. Kwiatkowski and W. Harper (Harvard), S. Kozma (University of Cincinnati), J. Hogenesch (UPENN), T. Pappagiannakopoulos (MIT), and R. Rozenfeld (Cell Signaling) for providing critical reagents. This work was supported by AAN Clinical Research Training Program, Tuberous Sclerosis Alliance, William Randolph Hearst Foundation, American Sleep Medicine Foundation Physician Scientist Training Award, the National Institute of Child, Health and Human Development (NICHD) (K08 HD071026 to J.O.L. and P30 HD018655 to M.S.), the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS058956), John Merck Fund, Nancy Lurie Marks Family Foundation, the Children's Hospital Boston Translational Research Program (to M.S.), Heidelberg University Young Investigator Award, the Daimler and Benz Foundation, the Reinhard Frank Foundation (to D.E.-F.), NIH (P01CA120964 and S10RR032861 to J.M.A.), European Molecular Biology Organization (EMBO) (ALTF 1054-2010), and the Human Frontier Science Program (HFSP) (LT001215/2011-L to T.G). J.O.L. dedicates this paper to the memory of Dr. Amiram Lipton.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Couch FJ, 1999, CANCER RES, V59, P1408; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001703; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; SCAMMELL TE, 1989, BRAIN RES, V494, P155, DOI 10.1016/0006-8993(89)90155-8; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; SHIBATA S, 1992, BRAIN RES, V584, P251, DOI 10.1016/0006-8993(92)90902-L; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	203	205	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1138	1151		10.1016/j.cell.2015.04.002	http://dx.doi.org/10.1016/j.cell.2015.04.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25981667	Green Accepted, Bronze			2022-12-28	WOS:000355152600020
J	Draper, JW				Draper, John W.			The Humors: Some Psychological Aspects of Shakespeare's Tragedies (Reprinted from JAMA, vol 188, pg 259-262, 1964)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint											Draper, JW (corresponding author), 100 McLane Ave, Morgantown, WV USA.							Draper J. W., 1945, HUMORS SHAKESPEARES; 1964, JAMA, V188, P259	2	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1980	1980		10.1001/jama.2014.11758	http://dx.doi.org/10.1001/jama.2014.11758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988476				2022-12-28	WOS:000354691200027
J	Jacquin, G; Oczkowski, W				Jacquin, Gregory; Oczkowski, Wieslaw			In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LARGE VESSEL OCCLUSIONS; TRIAL		[Jacquin, Gregory; Oczkowski, Wieslaw] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University	Jacquin, G (corresponding author), McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada.							Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Hansen CK, 2015, INT J STROKE, V10, P336, DOI 10.1111/ijs.12383; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC2	10.7326/ACPJC-2015-162-10-002	http://dx.doi.org/10.7326/ACPJC-2015-162-10-002			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984875				2022-12-28	WOS:000355015200004
J	Jansen, WJ; Ossenkoppele, R; Knol, DL; Tijms, BM; Scheltens, P; Verhey, FRJ; Visser, PJ				Jansen, Willemijn J.; Ossenkoppele, Rik; Knol, Dirk L.; Tijms, Betty M.; Scheltens, Philip; Verhey, Frans R. J.; Visser, Pieter Jelle		Amyloid Biomarker Study Grp	Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; ALZHEIMER-DISEASE; DIAGNOSTIC-CRITERIA; BETA-AMYLOIDOSIS; PIB PET; ASSOCIATION; POPULATION; APOE; AGE	IMPORTANCE Cerebral amyloid-beta aggregation is an early pathological event in Alzheimer disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid pathology in persons without dementia are needed to understand the development of AD and to design prevention studies. OBJECTIVE To use individual participant data meta-analysis to estimate the prevalence of amyloid pathology as measured with biomarkers in participants with normal cognition, subjective cognitive impairment (SCI), or mild cognitive impairment (MCI). DATA SOURCES Relevant biomarker studies identified by searching studies published before April 2015 using the MEDLINE and Web of Science databases and through personal communication with investigators. STUDY SELECTION Studies were included if they provided individual participant data for participants without dementia and used an a priori defined cutoff for amyloid positivity. DATA EXTRACTION AND SYNTHESIS Individual records were provided for 2914 participants with normal cognition, 697 with SCI, and 3972 with MCI aged 18 to 100 years from 55 studies. MAIN OUTCOMES AND MEASURES Prevalence of amyloid pathology on positron emission tomography or in cerebrospinal fluid according to AD risk factors (age, apolipoprotein E [APOE] genotype, sex, and education) estimated by generalized estimating equations. RESULTS The prevalence of amyloid pathology increased from age 50 to 90 years from 10% (95% CI, 8%-13%) to 44%(95% CI, 37%-51%) among participants with normal cognition; from 12%(95% CI, 8%-18%) to 43%(95% CI, 32%-55%) among patients with SCI; and from 27%(95% CI, 23%-32%) to 71%(95% CI, 66%-76%) among patients with MCI. APOE-epsilon 4 carriers had 2 to 3 times higher prevalence estimates than noncarriers. The age at which 15% of the participants with normal cognition were amyloid positive was approximately 40 years for APOE epsilon 4 epsilon 4 carriers, 50 years for epsilon 2 epsilon 4 carriers, 55 years for epsilon 3 epsilon 4 carriers, 65 years for epsilon 3 epsilon 3 carriers, and 95 years for epsilon 2 epsilon 3 carriers. Amyloid positivity was more common in highly educated participants but not associated with sex or biomarker modality. CONCLUSIONS AND RELEVANCE Among persons without dementia, the prevalence of cerebral amyloid pathology as determined by positron emission tomography or cerebrospinal fluid findings was associated with age, APOE genotype, and presence of cognitive impairment. These findings suggest a 20-to 30-year interval between first development of amyloid positivity and onset of dementia.	[Jansen, Willemijn J.; Verhey, Frans R. J.; Visser, Pieter Jelle] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, NL-6200 MD Maastricht, Netherlands; [Ossenkoppele, Rik; Tijms, Betty M.; Scheltens, Philip; Visser, Pieter Jelle] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Ossenkoppele, Rik; Tijms, Betty M.; Scheltens, Philip; Visser, Pieter Jelle] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Ossenkoppele, Rik] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Ossenkoppele, Rik] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Ossenkoppele, Rik] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knol, Dirk L.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Jansen, WJ (corresponding author), Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, POB 616, NL-6200 MD Maastricht, Netherlands.	willemijn.jansen@maastrichtuniversity.nl; pj.visser@maastrichtuniversity.nl	Parnetti, Lucilla/K-8258-2016; Verbeek, Marcel M/D-1971-2010; Meulenbroek, Olga/A-2790-2016; Chetelat, Gael/G-2316-2015; Jansen, Willemijn/G-2374-2019; Rodriguez-Rodriguez, Eloy/G-5826-2013; Scheltens, Philip/AAL-9631-2020; Ossenkoppele, Rik/J-5826-2013; Frisoni, Giovanni B./K-1360-2016; Visser, Pieter Jelle/S-5242-2019; Sanchez-Juan, Pascual/B-9282-2009; Kandimalla, Ramesh/O-4047-2017; Vandenberghe, Rik/K-2145-2014; Tijms, Betty M./I-2218-2019; Frölich, Lutz/AAA-6940-2019; Visser, Pieter J/C-8541-2015; van Waalwijk van Doorn, Linda/I-7487-2013; , Enrica/K-2652-2016; Frisoni, Giovanni/K-1360-2016; Johannsen, Peter/G-1079-2011; MROCZKO, BARBARA/R-5955-2018	Parnetti, Lucilla/0000-0001-5722-3967; Verbeek, Marcel M/0000-0003-4635-7876; Jansen, Willemijn/0000-0001-9081-1496; Scheltens, Philip/0000-0002-1046-6408; Frisoni, Giovanni B./0000-0002-6419-1753; Visser, Pieter Jelle/0000-0001-8008-9727; Sanchez-Juan, Pascual/0000-0002-6081-8037; Kandimalla, Ramesh/0000-0002-3313-4393; Vandenberghe, Rik/0000-0001-6237-2502; Tijms, Betty M./0000-0002-2612-1797; Frölich, Lutz/0000-0003-1494-0813; Visser, Pieter J/0000-0001-8008-9727; van Waalwijk van Doorn, Linda/0000-0002-4114-4663; van der Flier, Wiesje/0000-0001-8766-6224; Freund-Levi, Yvonne/0000-0001-6863-6679; Roe, Catherine/0000-0002-1405-0485; Alcolea, Daniel/0000-0002-3819-3245; Rodriguez-Rodriguez, Eloy/0000-0001-7742-677X; Nordberg, Agneta/0000-0001-7345-5151; Hampel, Harald/0000-0003-0894-8982; de Mendonca, Alexandre/0000-0002-0488-1453; , Enrica/0000-0003-2306-0164; Baldeiras, Ines/0000-0002-8106-7308; Perera, Gayan/0000-0002-3414-303X; Tsolaki, Magda/0000-0002-2072-8010; Wiltfang, Jens/0000-0003-1492-5330; Oliveira, Catarina/0000-0001-6942-4328; Santana, Isabel/0000-0002-8114-9434; frederiksen, Kristian Steen/0000-0001-5124-4417; Fladby, Tormod/0000-0002-9984-9797; Frisoni, Giovanni/0000-0001-7075-7082; Fortea, Juan/0000-0002-1340-638X; Alexander, Myriam/0000-0002-6848-9370; Johannsen, Peter/0000-0002-0528-1070; Aarsland, Dag/0000-0001-6314-216X; Rodrigue, Karen/0000-0002-4781-7961; Hellwig, Sabine/0000-0002-3074-2588; Camus, Vincent/0000-0002-6845-221X; Koglin, Norman/0000-0001-7583-8201; Ossenkoppele, Rik/0000-0003-1584-7477; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; , enrica/0000-0003-2127-816X; Almdahl, Ina S./0000-0001-6070-4921; Peters, Oliver/0000-0003-0568-2998; Popp, Julius/0000-0002-0068-0312; Klunk, William/0000-0001-5512-0251; Drzezga, Alexander/0000-0001-6018-716X; MROCZKO, BARBARA/0000-0002-4075-8479	GE Healthcare; Piramal; Merck; EU/EFPIA Innovative Medicines Initiative Joint Undertaking; EU Joint Programme-Neurodegenerative Disease Research (JPND); ZonMw; Bristol-Myers Squibb; Astra-Zeneca; H. Lundbeck; Novartis Pharmaceuticals; GE Health; Siemens Healthcare; Roche Diagnostics; IBL International; Novartis; Eli Lilly; French Ministry of Health; National Institutes of Health (NIH); AVID/Lilly; NIH; Fred Simmons; Olga Mohan, and Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Knight Alzheimer's Disease Research Center; Roche; AbbVie; NIA; Avid Radiopharmaceutical; Boehringer Ingelheim; Piramal Imaging; Bayer; GE; Lilly; Lundbeck; Elan; AstraZeneca; Pfizer; Taurx; Wyeth; Baxter; Avid; Alzheimer's Association; Indian Council of Medical Research, New Delhi, India; Boehringer Ingelheim Pharmaceuticals; Boehringer-Ingelheim; Eisai; sanofi-aventis; Roche Pharmaceuticals and Diagnostics; GlaxoSmithKline Biologicals; Jung-Diagnostics; Cytox; Medical Faculty, University of Freiburg; Banner Alzheimer Institute/Genentech; Synarc/Bioclinica; Indian Council of Medical Research, India; European Union (European Regional Development Fund [ERDF]); Greek national funds through the Operational Program "Competitiveness and Entrepreneurship"; University of Pittsburgh; Bayer Healthcare/Piramal Imaging (Berlin, Germany); University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); Research Foundation Flanders (FWO); Agency for Innovation by Science and Technology (IWT); Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government-initiated Methusalem excellence grant; NATIONAL INSTITUTE ON AGING [RF1AG025516, P01AG003991, P01AG025204, P50AG005133, R37AG025516, U01AG024904, P30AG010124, R01AG013616, U19AG010483, R01AG012101, P30AG008051, U19AG032438, P01AG026276, P50AG005681, R01AG022374] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [POCTI/MAT/37670/2001, SFRH/BD/98266/2013] Funding Source: FCT	GE Healthcare(General ElectricGE Healthcare); Piramal; Merck(Merck & Company); EU/EFPIA Innovative Medicines Initiative Joint Undertaking; EU Joint Programme-Neurodegenerative Disease Research (JPND); ZonMw(Netherlands Organization for Health Research and Development); Bristol-Myers Squibb(Bristol-Myers Squibb); Astra-Zeneca(AstraZeneca); H. Lundbeck(Lundbeck Corporation); Novartis Pharmaceuticals(Novartis); GE Health(General ElectricGE Healthcare); Siemens Healthcare(Siemens AG); Roche Diagnostics; IBL International; Novartis(Novartis); Eli Lilly(Eli Lilly); French Ministry of Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AVID/Lilly; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Simmons; Olga Mohan, and Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Knight Alzheimer's Disease Research Center; Roche(Roche Holding); AbbVie(AbbVie); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Avid Radiopharmaceutical; Boehringer Ingelheim(Boehringer Ingelheim); Piramal Imaging; Bayer(Bayer AG); GE; Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Elan; AstraZeneca(AstraZeneca); Pfizer(Pfizer); Taurx; Wyeth(Wyeth); Baxter; Avid; Alzheimer's Association(Alzheimer's Association); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Boehringer-Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); sanofi-aventis(Sanofi-Aventis); Roche Pharmaceuticals and Diagnostics; GlaxoSmithKline Biologicals(GlaxoSmithKline); Jung-Diagnostics; Cytox; Medical Faculty, University of Freiburg; Banner Alzheimer Institute/Genentech; Synarc/Bioclinica; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); European Union (European Regional Development Fund [ERDF]); Greek national funds through the Operational Program "Competitiveness and Entrepreneurship"; University of Pittsburgh(University of Pittsburgh); Bayer Healthcare/Piramal Imaging (Berlin, Germany); University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); Research Foundation Flanders (FWO)(FWO); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government-initiated Methusalem excellence grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fundação para a Ciência e a Tecnologia	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Scheltens reported having received grants from GE Healthcare, Piramal, and Merck, paid to his institution. Dr Verhey reported having received compensation as a speaker and consultant for Nutricia Advanced Medical Food. Dr Visser reported having received grants from EU/EFPIA Innovative Medicines Initiative Joint Undertaking, EU Joint Programme-Neurodegenerative Disease Research (JPND), ZonMw, and Bristol-Myers Squibb; having served as member of the advisory board of Roche Diagnostics; and having received nonfinancial support from GE Healthcare. Dr Aarsland reported having received research support or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals, and GE Health. Dr Alexander reported being an employee of Roche Products. Dr Barthel reported having received speaker and consultant honoraria as well as travel expenses from Piramal Imaging (Berlin) and personal fees from Siemens Healthcare. Dr Bibeau reported being a share-holding employee of GlaxoSmithKline. Dr Blennow reported having received personal fees (advisory board) from Roche Diagnostics, IBL International, Novartis, and Eli Lilly. Dr Brooks reported having served as consultant for GE Healthcare. Dr Camus reported having received grants from the French Ministry of Health. Dr Chen reported having received grants from the National Institutes of Health (NIH). Dr Drzezga reported having received speaker honoraria and consulting fees from GE Healthcare, AVID/Lilly, and Piramal. Dr Fagan reported having received grants from NIH, Fred Simmons and Olga Mohan, and Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Knight Alzheimer's Disease Research Center; having received personal fees from IBL International, Roche, and AbbVie; and having a patent, 6,465,195 B2, "Predictive diagnostic for Alzheimer's disease," issued and a patent, PCT/US09/050255, " A risk factor and new therapeutic target for Alzheimer's disease," pending. Dr Fladby reported having a patent " Methods and compositions for monitoring phagocytic activity," PCT/US2011/062233, pending. Dr Fleisher reported having been a full-time employee of the Banner Alzheimer's Institute; being a full-time employee of Eli Lilly; maintaining a voluntary faculty appointment at the University of California, San Diego; having been a member of data and safety monitoring boards for Merck, Pfizer, and the National Institute of Aging (NIA); having received grant funding from NIA and Avid Radiopharmaceutical; and having been a consultant for Eli Lilly, Grifols, Avid Radiopharmaceuticals, and Siemens Imaging. Dr van der Flier reported having received grants from Boehringer Ingelheim, Piramal Imaging, and Roche. Dr Forster reported having received personal fees (consultancy) from Piramal, Bayer, and GE. Dr Foskett reported being a full-time employee of Roche Prod and holding Roche shares and share options. Dr Frisoni reported having received grants and/or personal fees from Lilly, Bristol-Myers Squibb, Bayer, Lundbeck, Elan, AstraZeneca, Pfizer, Taurx, Wyeth, GE, Baxter, Avid, Roche, Piramal, and the Alzheimer's Association. Dr Gill reported having received grants from the Indian Council of Medical Research, New Delhi, India. Dr Gordon reported being a salaried employee of Boehringer Ingelheim Pharmaceuticals. Dr Grimmer reported having received personal fees from Eli Lilly.; Dr Hampel reported having received grants, personal fees, and/or nonfinancial support from Boehringer-Ingelheim, Bristol-Myers Squibb, Elan, Novartis, Eisai, Pfizer, sanofi-aventis, Roche Pharmaceuticals and Diagnostics, GE Healthcare, Avid, Eli Lilly, GlaxoSmithKline Biologicals, Jung-Diagnostics, and Cytox and having a patent, "Method for predicting whether subjects with mild cognitive impairment (MCI) will develop Alzheimer's disease," pending; a patent, "3-Hydroxykynurenin im Serum als diagnotischer Marker fur die Demenz vomAlzheimer-Typ," pending; a patent, "Neurodegenerative markers for psychiatric conditions," pending; a patent, " Ratio Ass42/40 im Plasma in der Fruh- und Differentialdiagnose der Alzheimer Krankheit," pending; a patent "Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz Erkrankungen und neuroinflammatorischen Erkrankungen," pending; and a patent, " In vitro Verfahren zur Diagnose von neurodegenerativen Erkrankungen," pending. Dr Hellwig reported having received grants from GE Healthcare and Medical Faculty, University of Freiburg. Dr Ishihara reported being an employee and shareholder of GlaxoSmithKline. Dr Jagust reported having received personal fees from Banner Alzheimer Institute/Genentech, Synarc/Bioclinica, and Novartis. Dr Kandimalla reported having received grants from the Indian Council of Medical Research, India. Dr Kapaki reported having received grants from the European Union (European Regional Development Fund [ERDF]) and Greek national funds through the Operational Program "Competitiveness and Entrepreneurship" of the National Strategic Reference Framework (NSRF) Research Funding Program: Joint Programming Neurodegenerative Disease, "Biomarkers for Alzheimer's disease and Parkinson's disease." Dr Klunk reported being a co-inventor of the amyloid imaging tracer PiB and, as such, having a financial interest in the license agreement. (PiB intellectual property is owned by the University of Pittsburgh, and GE Healthcare holds a license agreement with the University of Pittsburgh based on the PiB technology described in this article. Dr Klunk receives " inventors share" payments from the University of Pittsburgh based on income from that license.) Dr Koglin reported having received personal fees from employment at Piramal Imaging, who is marketing Neuraceq were derived for this multicenter evaluation was sponsored by Bayer Healthcare/Piramal Imaging (Berlin, Germany). This work was supported by the University of Antwerp Research Fund; the Alzheimer Research Foundation (SAO-FRA); the Research Foundation Flanders (FWO); the Agency for Innovation by Science and Technology (IWT); the Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; and the Flemish Government-initiated Methusalem excellence grant.	Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; [Anonymous], DEM PUBL HLTH PRIOR; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bennett D. A., 2005, Neurology, V64, P834; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Brodaty H, 2014, ANN EPIDEMIOL, V24, P63, DOI 10.1016/j.annepidem.2013.10.005; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jack CR, 2015, JAMA NEUROL, V72, P511, DOI 10.1001/jamaneurol.2014.4821; Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; Landau SM, 2013, ANN NEUROL, V74, P826, DOI 10.1002/ana.23908; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Lin YT, 2009, J ALZHEIMERS DIS, V18, P907, DOI 10.3233/JAD-2009-1214; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x; Palmqvist S, 2014, JAMA NEUROL, V71, P1282, DOI 10.1001/jamaneurol.2014.1358; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Randall C, 2013, FRONT BIOSCI-LANDMRK, V18, P1150, DOI 10.2741/4170; Roe CM, 2010, NEUROLOGY, V75, P42, DOI 10.1212/WNL.0b013e3181e620f4; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scholl M, 2012, NEUROLOGY, V79, P229, DOI 10.1212/WNL.0b013e31825fdf18; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P1182, DOI 10.1097/NEN.0000000000000016; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Thomas D, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-79; van Harten AC, 2013, ALZHEIMERS DEMENT, V9, P481, DOI 10.1016/j.jalz.2012.08.004; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zwan M, 2014, J ALZHEIMERS DIS, V41, P801, DOI 10.3233/JAD-132561	49	841	854	1	113	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1924	1938		10.1001/jama.2015.4668	http://dx.doi.org/10.1001/jama.2015.4668			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988462	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000354691200014
J	Lipska, KJ; Montori, VM				Lipska, Kasia J.; Montori, Victor M.			In type 1 diabetes, intensive insulin therapy for 6.5 y reduced mortality at 27 y compared with usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lipska, Kasia J.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Montori, Victor M.] Mayo Clin, Rochester, MN USA	Yale University; Mayo Clinic	Lipska, KJ (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.			Montori, Victor/0000-0003-0595-2898				Cooper MN, 2014, DIABETIC MED, V31, P1550, DOI 10.1111/dme.12522; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401	3	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC12	10.7326/ACPJC-2015-162-10-012	http://dx.doi.org/10.7326/ACPJC-2015-162-10-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984873				2022-12-28	WOS:000355015200014
J	Rymer, JA; Newby, LK				Rymer, Jennifer A.; Newby, L. Kristin			Review: In patients having PCI, high-dose clopidogrel reduces major cardiac events vs standard-dose clopidogrel	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TICAGRELOR		[Rymer, Jennifer A.; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Rymer, JA (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.			Rymer, Jennifer/0000-0001-9841-2393				Bonaca MP, 2015, N ENGL J MED; Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC13	10.7326/ACPJC-2015-162-10-013	http://dx.doi.org/10.7326/ACPJC-2015-162-10-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984874				2022-12-28	WOS:000355015200015
J	Jacobson, SG; Cideciyan, AV; Roman, AJ; Sumaroka, A; Schwartz, SB; Heon, E; Hauswirth, WW				Jacobson, Samuel G.; Cideciyan, Artur V.; Roman, Alejandro J.; Sumaroka, Alexander; Schwartz, Sharon B.; Heon, Elise; Hauswirth, William W.			Improvement and Decline in Vision with Gene Therapy in Childhood Blindness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEBER CONGENITAL AMAUROSIS; RPE65 MUTATIONS; ADENOASSOCIATED VIRUS; DISEASE; SAFETY; ROD	Retinal gene therapy for Leber's congenital amaurosis, an autosomal recessive childhood blindness, has been widely considered to be safe and efficacious. Three years after therapy, improvement in vision was maintained, but the rate of loss of photoreceptors in the treated retina was the same as that in the untreated retina. Here we describe long-term follow-up data from three treated patients. Topographic maps of visual sensitivity in treated regions, nearly 6 years after therapy for two of the patients and 4.5 years after therapy for the third patient, indicate progressive diminution of the areas of improved vision.	[Jacobson, Samuel G.; Cideciyan, Artur V.; Roman, Alejandro J.; Sumaroka, Alexander; Schwartz, Sharon B.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Sch Med, Philadelphia, PA 19104 USA; [Heon, Elise] Univ Toronto, Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; [Heon, Elise] Univ Toronto, Hosp Sick Children, Dept Vis Sci, Toronto, ON M5G 1X8, Canada; [Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University System of Florida; University of Florida	Jacobson, SG (corresponding author), Scheie Eye Inst, 51 N 39th St, Philadelphia, PA 19104 USA.	jacobsos@mail.med.upenn.edu; cideciya@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X; hauswirth, william/0000-0002-3244-4947	National Eye Institute; NATIONAL EYE INSTITUTE [P30EY021721, P30EY001583, U10EY013729, U10EY017280] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by the National Eye Institute; ClinicalTrials.gov number, NCT00481546.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Banin E, 2010, HUM GENE THER, V21, P1749, DOI 10.1089/hum.2010.047; Bruewer AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060218; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Farrar GJ, 2014, VISUAL NEUROSCI, V31, P289, DOI 10.1017/S0952523814000133; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Pal Sumanta Kumar, 2013, Clin Adv Hematol Oncol, V11, P146; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001	21	259	268	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1920	1926		10.1056/NEJMoa1412965	http://dx.doi.org/10.1056/NEJMoa1412965			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25936984	Green Accepted			2022-12-28	WOS:000354493300007
J	Zanella, A; Daddi, E; Le Floc'h, E; Bournaud, F; Gobat, R; Valentino, F; Strazzullo, V; Cibinel, A; Onodera, M; Perret, V; Renaud, F; Vignali, C				Zanella, A.; Daddi, E.; Le Floc'h, E.; Bournaud, F.; Gobat, R.; Valentino, F.; Strazzullo, V.; Cibinel, A.; Onodera, M.; Perret, V.; Renaud, F.; Vignali, C.			An extremely young massive clump forming by gravitational collapse in a primordial galaxy	NATURE			English	Article							STAR-FORMATION RATES; SINS/ZC-SINF SURVEY; ULTRA DEEP FIELD; HIGH-REDSHIFT; EMISSION-LINE; GIANT CLUMPS; STELLAR FEEDBACK; RAPID FORMATION; GAS FRACTIONS; COLD STREAMS	When cosmic star formation history reaches a peak (at about redshift z approximate to 2), galaxies vigorously fed by cosmic reservoirs(1,2) are dominated by gas(3,4) and contain massive star-forming clumps(5,6), which are thought to form by violent gravitational instabilities in highly turbulent gas-rich disks(7,8). However, a clump formation event has not yet been observed, and it is debated whether clumps can survive energetic feedback from young stars, and afterwards migrate inwards to form galaxy bulges(9-12). Here we report the spatially resolved spectroscopy of a bright off-nuclear emission line region in a galaxy at z = 1.987. Although this region dominates star formation in the galaxy disk, its stellar continuum remains undetected in deep imaging, revealing an extremely young (less than ten million years old) massive clump, forming through the gravitational collapse of more than one billion solarmasses of gas. Gas consumption in this young clump is more than tenfold faster than in the host galaxy, displaying high star-formation efficiency during this phase, in agreement with our hydrodynamic simulations. The frequency of older clumps with similar masses(13), coupled with our initial estimate of their formation rate (about 2.5 per billion years), supports long lifetimes (about 500 million years), favouring models in which clumps survive feedback and grow the bulges of present-day galaxies.	[Zanella, A.; Daddi, E.; Le Floc'h, E.; Bournaud, F.; Gobat, R.; Valentino, F.; Strazzullo, V.; Cibinel, A.; Renaud, F.] CEA DSM CNRS Univ Paris Diderot, Lab AIM Paris Saclay, Irfu Serv Astrophys, CEA Saclay, F-91191 Gif Sur Yvette, France; [Gobat, R.] Korea Inst Adv Study, Sch Phys, Seoul 130722, South Korea; [Strazzullo, V.] Univ Munich, Dept Phys, D-81679 Munich, Germany; [Cibinel, A.] Univ Sussex, Dept Phys & Astron, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Onodera, M.] Swiss Fed Inst Technol, Inst Astron, CH-8093 Zurich, Switzerland; [Perret, V.] Aix Marseille Univ, CNRS, LAM, F-13388 Marseille, France; [Renaud, F.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Vignali, C.] Univ Bologna, Dipartimento Fis & Astron, I-40127 Bologna, Italy; [Vignali, C.] INAF Osservatorio Astron Bologna, I-40127 Bologna, Italy	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Korea Institute for Advanced Study (KIAS); University of Munich; University of Sussex; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Surrey; University of Bologna; Istituto Nazionale Astrofisica (INAF)	Zanella, A (corresponding author), CEA DSM CNRS Univ Paris Diderot, Lab AIM Paris Saclay, Irfu Serv Astrophys, CEA Saclay, F-91191 Gif Sur Yvette, France.	anita.zanella@cea.fr	Daddi, Emanuele/D-1649-2012; Vignali, Cristian/J-4974-2012; Valentino, Francesco/AHC-7409-2022	Daddi, Emanuele/0000-0002-3331-9590; Vignali, Cristian/0000-0002-8853-9611; Valentino, Francesco/0000-0001-6477-4011; Onodera, Masato/0000-0003-3228-7264; Zanella, Anita/0000-0001-8600-7008; Cibinel, Anna/0000-0003-4578-514X; Renaud, Florent/0000-0001-5073-2267; Strazzullo, Veronica/0000-0001-7975-2894	Agence Nationale de la Recherche [ANR-12-JS05-0008-01]; European Commission through European Research Council [StG-257720, StG-240039]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission through European Research Council	We thank S. Juneau for discussions, and M. Cappellari for sharing his Multi-Gaussian Expansion fit software publicly. The simulations were performed at the Tres Grand Centre de Calcul of the CEA (Commissariat a l'Energie Atomique et aux energies alternatives) under GENCI (Grand Equipement National de Calcul Intensif) allocation 2014-GEN2192. We acknowledge financial support from Agence Nationale de la Recherche (contract ANR-12-JS05-0008-01) and the European Commission through European Research Council grants StG-257720 and StG-240039.	BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; BINETTE L, 1985, ASTROPHYS J, V297, P476, DOI 10.1086/163544; Bournaud F, 2007, ASTROPHYS J, V670, P237, DOI 10.1086/522077; Bournaud F, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/57; Bournaud F, 2009, ASTROPHYS J LETT, V694, pL158, DOI 10.1088/0004-637X/694/2/L158; Caccianiga A, 2011, MON NOT R ASTRON SOC, V415, P1928, DOI 10.1111/j.1365-2966.2011.18838.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Cappellari M, 2002, MON NOT R ASTRON SOC, V333, P400, DOI 10.1046/j.1365-8711.2002.05412.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Cibinel A., ASTROPHYS J IN PRESS; Conselice CJ, 2003, ASTROPHYS J SUPPL S, V147, P1, DOI 10.1086/375001; Contini T., 2012, ASTRON ASTROPHYS, V593, P91; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dekel A, 2009, ASTROPHYS J, V703, P785, DOI 10.1088/0004-637X/703/1/785; Elmegreen BG, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/86; Elmegreen BG, 2010, ASTROPHYS J, V712, P294, DOI 10.1088/0004-637X/712/1/294; Elmegreen BG, 2009, ASTROPHYS J, V692, P12, DOI 10.1088/0004-637X/692/1/12; Elmegreen DM, 2007, ASTROPHYS J, V658, P763, DOI 10.1086/511667; Elmegreen DM, 2004, ASTROPHYS J, V604, pL21, DOI 10.1086/383312; Genel S, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/11; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Genzel R, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/7; Genzel R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/101; Genzel R, 2010, MON NOT R ASTRON SOC, V407, P2091, DOI 10.1111/j.1365-2966.2010.16969.x; Gobat R, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/9; Guo YC, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/120; Hong S, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/63; Hopkins PF, 2012, MON NOT R ASTRON SOC, V427, P968, DOI 10.1111/j.1365-2966.2012.21981.x; Kashino D, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/1/L8; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Kewley LJ, 2004, ASTRON J, V127, P2002, DOI 10.1086/382723; Kroupa P, 2002, MON NOT R ASTRON SOC, V336, P1188, DOI 10.1046/j.1365-8711.2002.05848.x; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Kummel M, 2009, PUBL ASTRON SOC PAC, V121, P59, DOI 10.1086/596715; Lada CJ, 2010, ASTROPHYS J, V724, P687, DOI 10.1088/0004-637X/724/1/687; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Lotz JM, 2004, ASTRON J, V128, P163, DOI 10.1086/421849; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Mandelker N, 2014, MON NOT R ASTRON SOC, V443, P3675, DOI 10.1093/mnras/stu1340; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; Panessa F, 2006, ASTRON ASTROPHYS, V455, P173, DOI 10.1051/0004-6361:20064894; Peng CY, 2010, ASTRON J, V139, P2097, DOI 10.1088/0004-6256/139/6/2097; Perret V, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322395; Persic M, 2004, ASTRON ASTROPHYS, V419, P849, DOI 10.1051/0004-6361:20034500; Renaud F, 2013, MON NOT R ASTRON SOC, V436, P1836, DOI 10.1093/mnras/stt1698; Rodighiero G, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L40; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Sargent MT, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/19; Scalo J. M., 1986, Fundamentals of Cosmic Physics, V11, P1; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Schreiber NMF, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/45; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Sersic J. L., 1963, B ASOC ARGENTINA AST, V6, P41; Shapiro KL, 2010, MON NOT R ASTRON SOC, V403, pL36, DOI 10.1111/j.1745-3933.2010.00810.x; Soto KT, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/3; Steidel CC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/165; Stern J, 2013, MON NOT R ASTRON SOC, V431, P836, DOI 10.1093/mnras/stt211; Strazzullo V, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/118; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; Valentino F, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/132; van Dokkum PG, 2001, PUBL ASTRON SOC PAC, V113, P1420, DOI 10.1086/323894; Wuyts S, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/135; Wuyts S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/114; Zahid HJ, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/130	71	43	43	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					54	U362		10.1038/nature14409	http://dx.doi.org/10.1038/nature14409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951282	Green Submitted			2022-12-28	WOS:000354040900030
J	[Anonymous]				[Anonymous]			Towards better management of COPD	LANCET			English	Editorial Material																			0	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1697	1697						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943917				2022-12-28	WOS:000353726000001
J	Zhou, XX; Halladin, DK; Rojas, ER; Koslover, EF; Lee, TK; Huang, KC; Theriot, JA				Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Lee, Timothy K.; Huang, Kerwyn Casey; Theriot, Julie A.			Mechanical crack propagation drives millisecond daughter cell separation in Staphylococcus aureus	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY; DIVISION; GROWTH; PEPTIDOGLYCAN; RING; AUTOLYSIN; BACTERIA; GEOMETRY; ENZYMES; WALLS	When Staphylococcus aureus undergoes cytokinesis, it builds a septum, generating two hemispherical daughters whose cell walls are only connected via a narrow peripheral ring. We found that resolution of this ring occurred within milliseconds ("popping"), without detectable changes in cell volume. The likelihood of popping depended on cell-wall stress, and the separating cells split open asymmetrically, leaving the daughters connected by a hinge. An elastostatic model of the wall indicated high circumferential stress in the peripheral ring before popping. Last, we observed small perforations in the peripheral ring that are likely initial points of mechanical failure. Thus, the ultrafast daughter cell separation in S. aureus appears to be driven by accumulation of stress in the peripheral ring and exhibits hallmarks of mechanical crack propagation.	[Zhou, Xiaoxue] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Theriot, Julie A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Theriot, Julie A.] Stanford Univ, Howard Hughes Med Inst HHMI, Sch Med, Stanford, CA 94305 USA; [Rojas, Enrique R.; Huang, Kerwyn Casey; Theriot, Julie A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Rojas, Enrique R.; Lee, Timothy K.; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Theriot, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	theriot@stanford.edu	Koslover, Elena/K-4548-2017; Theriot, Julie/HHN-2034-2022	Koslover, Elena/0000-0003-4139-9209; Zhou, Xiaoxue/0000-0002-4551-0608; Theriot, Julie/0000-0002-2334-2535	National Center for Research Resources [1S10OD01227601]; Stanford Interdisciplinary Graduate Fellowship; Stanford Cell and Molecular Biology Training Grant [T32-GM007276]; NIH Center for Biomedical Computation [U54-GM072970]; James S. McDonnell Foundation; Siebel Scholars Graduate Fellowship; NIH Biotechnology Training Grant; NIH Director's New Innovator Award [DP2OD006466]; HHMI; National Institute of Allergy and Infectious Diseases [R01-AI36929]; Stanford Center for Systems Biology [P50-GM107615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036929, R01AI067712, R37AI036929, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970, T32GM007276, P50GM107615] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Stanford Interdisciplinary Graduate Fellowship; Stanford Cell and Molecular Biology Training Grant; NIH Center for Biomedical Computation; James S. McDonnell Foundation; Siebel Scholars Graduate Fellowship; NIH Biotechnology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Center for Systems Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. A. Levin for strain Newman; A. Cheung for RN6390 Delta spa; W. M. Nauseef for plasmid pCM29; J. Bose and K. W. Bayles for UAMS-1 and UAMS-1 Delta atl; J. Mulholland and L. Joubert in the Cell Sciences Imaging Facility at Stanford for technical assistance with 3D SIM (funded by National Center for Research Resources award number 1S10OD01227601) and SEM; S. Lou and L. Harris for help with the blind SEM analysis; M. Pinho, F. Chang, and L. Cegelski for discussions; and J. Shaevitz, D. Fisher, L. Harris, and the anonymous reviewers for helpful comments on the manuscript. X.Z. was supported by a Stanford Interdisciplinary Graduate Fellowship; D.K.H. was supported by the Stanford Cell and Molecular Biology Training Grant (T32-GM007276); E.R.R. was supported by a Distinguished Postdoctoral Fellowship from the Simbios NIH Center for Biomedical Computation (U54-GM072970); E.F.K. was supported by the James S. McDonnell Foundation Postdoctoral Fellowship Award in Studying Complex Systems; T.K.L. was supported by a Siebel Scholars Graduate Fellowship and an NIH Biotechnology Training Grant; K.C.H. was funded by a NIH Director's New Innovator Award (DP2OD006466); and J.A.T. was funded by HHMI, the National Institute of Allergy and Infectious Diseases (R01-AI36929) and the Stanford Center for Systems Biology (P50-GM107615).	AMAKO K, 1977, J ULTRA MOL STRUCT R, V58, P34, DOI 10.1016/S0022-5320(77)80005-1; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baumberger T, 2006, NAT MATER, V5, P552, DOI 10.1038/nmat1666; Baumberger T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078267; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Dill E. H., 2007, CONTINUUM MECH ELAST, P239; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/NMETH.1452, 10.1038/nmeth.1452]; Griffith A, 1921, PHILOS T R SOC LON A, V221, P163, DOI [10.1098/rsta.1921.0006, DOI 10.1098/RSTA.1921.0006]; KOYAMA T, 1977, J BACTERIOL, V129, P1518, DOI 10.1128/JB.129.3.1518-1523.1977; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; PREVIC EP, 1970, J THEOR BIOL, V27, P471, DOI 10.1016/S0022-5193(70)80010-8; Rojas E, 2014, P NATL ACAD SCI USA, V111, P7807, DOI 10.1073/pnas.1402591111; Schijve J., 2009, FATIGUE STRUCTURES M, DOI [DOI 10.1007/978-1-4020-6808-9, 10.1007/978-1-4020-6808-9_17]; SELIGMAN SJ, 1987, J THEOR BIOL, V124, P275, DOI 10.1016/S0022-5193(87)80116-9; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; WAGNER M, 1979, Z IMMUNITATSFORSCH, V156, P57; WALSH JM, 1984, J APPL PHYS, V56, P1997, DOI 10.1063/1.334234; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Zhou F, 2006, INT J IMPACT ENG, V33, P880, DOI 10.1016/j.ijimpeng.2006.09.070	31	63	63	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					574	578		10.1126/science.aaa1511	http://dx.doi.org/10.1126/science.aaa1511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931560	Green Accepted			2022-12-28	WOS:000353778100042
J	AbouZahr, C; De Savigny, D; Mikkelsen, L; Setel, PW; Lozano, R; Nichols, E; Notzon, F; Lopez, AD				AbouZahr, Carla; De Savigny, Don; Mikkelsen, Lene; Setel, Philip W.; Lozano, Rafael; Nichols, Erin; Notzon, Francis; Lopez, Alan D.			Civil registration and vital statistics: progress in the data revolution for counting and accountability	LANCET			English	Article							MATERNAL MORTALITY; DEATH; SYSTEM; BIRTHS; RISK	New momentum for civil registration and vital statistics (CRVS) is building, driven by the confluence of growing demands for accountability and results in health, improved equity, and rights-based approaches to development challenges, and by the immense potential of innovation and new technologies to accelerate CRVS improvement. Examples of country successes in strengthening of hitherto weak systems are emerging. The key to success has been to build collaborative partnerships involving local ownership by several sectors that span registration, justice, health, statistics, and civil society. Regional partners can be important to raise awareness, set regional goals and targets, foster country-to-country exchange and mutual learning, and build high-level political commitment. These regional partners continue to provide a platform through which country stakeholders, development partners, and technical experts can share experiences, develop and document good practices, and propose innovative approaches to tackle CRVS challenges. This country and regional momentum would benefit from global leadership, commitment, and support.	[AbouZahr, Carla] CAZ Consulting, CH-1218 Geneva, Switzerland; [De Savigny, Don] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mikkelsen, Lene] LM Consulting, Brisbane, Qld, Australia; [Setel, Philip W.] Union North Amer, New York, NY USA; [Lozano, Rafael] Natl Inst Publ Hlth, Mexico City, DF, Mexico; [Nichols, Erin; Notzon, Francis] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Basel; Swiss Tropical & Public Health Institute; Instituto Nacional de Salud Publica; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of Melbourne	AbouZahr, C (corresponding author), CAZ Consulting, CH-1218 Geneva, Switzerland.	abouzahr.carla@gmail.com	Setel, Philip/ABD-6362-2020; Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Lopez, Alan/AAA-2734-2022	Setel, Philip/0000-0002-9042-5699; Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; 	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Abouzahr C., 2014, Asia-Pacific Population Journal, V29, P39; Abouzahr C., 2010, MORTALITY STAT TOOL; Abouzahr C, 2015, LANCET; AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Afele M, 2011, B WORLD HEALTH ORGAN, V89, P322, DOI 10.2471/BLT.11.020511; Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; [Anonymous], 2014, CRVS TECHN IN PRESS; [Anonymous], 2012, 2 C AFR MIN RESP CIV; [Anonymous], 2012, HLTH METR NETW MOVE; [Anonymous], 2010, AFR STAT J, V11, P127; Aung E., 2009, ASSESSING PRODUCTION; Australian Bureau of Statistics, 2010, 15 U QUEENSL SCH POP; Bah Sulaiman, 2009, World Health Popul, V11, P50; Bradshaw D, 1995, VITAL REGISTRATION S; Breckenridge K, 2001, REGISTRATION RECOGNI; Cambridge Economic Policy Associates, 2014, COUNTR CRVS INV PLAN; Chan M, 2007, COMMUNICATION; Commission on information and accountability for women's and children's health, 2011, KEEP PROM MEAS RES; Dababneh F, B WHO IN PRESS; Donati S, 2011, BJOG-INT J OBSTET GY, V118, P872, DOI 10.1111/j.1471-0528.2011.02916.x; Economic and Social Commission for Asia and the Pacific, 2012, COMM STAT 3 SESS BAN; Gelb A, 2013, 315 CGD; Glassman A, YOU SAY YOU WANT DAT; Government of Korea African Development Bank Asian Development Bank Inter-American Development Bank International Civil Aviation Authority, 2014, INT ID MAN C SEOUL S; Harbitz M, 2011, INTERAMERICAN DEV BA, VIBD-TN-196; Harbitz M.E., 2009, SIGNIFICANCE LEGAL I; Health Metrics Network, 2008, FRAM STAND COUNTR HL; Health Metrics Network, 2012, CAS INV CIV REG VIT; Health Metrics Network, 2011, CORP PLAN; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; IEAG, 2014, WORLD COUNTS MOB DAT; Kabadi G, 2013, 31 U QUEENSL HLTH IN; Kharas H., 2013, DATA REVOLUTION POST; KYVIK KO, 1995, INT J EPIDEMIOL, V24, P589, DOI 10.1093/ije/24.3.589; Lee J. W., 2003, COMMUNICATION; Lehohla PJ, 2010, COMMUNICATION; Lopez A, 2013, LANCET, V381, P1275, DOI 10.1016/S0140-6736(13)60838-7; Lopez AD, 2007, LANCET, V370, P1744, DOI 10.1016/S0140-6736(07)61419-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mikkelsen L, 2010, 10 U QUEENSL SCH POP; Mikkelsen L, 2012, WORKING PAPER SERIES, V24; Mikkelsen L, 2015, LANCET; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-18; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Muzzi M., 2010, WORKING PAPER; Naidu S, 2013, 35 U QUEENSL HLTH IN; Navaratne KV, 2009, IMPROVING VITAL STAT; Ngoma C, 2011, E INFRASTUCTURES E S; Nojilana B, 2009, SAMJ S AFR MED J, V99, P648; Office of the Registrar General India, 2013, VIT STAT IND BAS CIV; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Pallin DJ, 2002, AM J PUBLIC HEALTH, V92, P1319, DOI 10.2105/AJPH.92.8.1319; Pan American Health Organization, 2008, 60 SESS REG COMM WHO; PARIS21, 2013, ENG DEV DAT REV UN G; Pavillon G, 2007, WHO FAM INT CLASS NE; Pedersen CB, 2006, DAN MED BULL, V53, P441; Phillips DE, 2015, LANCET; Rampatige R, 2013, ASSESSING RELIABILIT; Rampatige R, 2012, HDB DOCTORS CAUSE OF; Rampatige R, 2013, HEALTH INF MANAG J, V42, P20, DOI 10.1177/183335831304200302; Roodman D., 2014, INTERPRETING DATA 1; Scott JamesC., 1998, SEEING STATE; Secretariat of the Pacific Community University of Queensland Health Information Systems Knowledge Hub, 2011, 9 M MIN HLTH PAC ISL; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Skiri H, 2012, MODERNISE CIVIL REGI; Statistics Norway Department of Social Statistics Albanian Ministry of Local Government and Decentralisation, 2012, SEL DOC MOD CIV REG; Statistics South Africa, 2012, REC LIV BIRTHS 2011; Szreter S, 2007, WORLD DEV, V35, P67, DOI 10.1016/j.worlddev.2006.09.004; Szwarcwald CL, 2013, LANCET, V381, P140; Szwarcwald CL, 2008, INT J EPIDEMIOL, V37, P738, DOI 10.1093/ije/dyn130; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; The Brisbane Accord Group, 2014, MIN C CIV REG VIT ST; The Brisbane Accord Group and the Pacific Vital Statistics Action Plan, 2011, OUTL DOC; The Society of Obstetricians and Gynaecologists of Canada, SAV EV WOM EV CHILD; The World Bank, 2014, GLOB CIV REG VIT STA; Tyler TomR., 2003, TRUST GOVERNANCE, P269; U.N. General Assembly, 2010, PREV CONTR NONC DIS; UN ECA African Centre for Statistics, AFR CIV REG VIT STAT; UN Economic and Social Commission for Western Asia, 2009, TECHN REP STAT CIV R; UN ESCAP, EESCAPMCCRVSL3; UN ESCAP, 2013, RES IMPL OUTC HIGH L; UN Statistics Division, 1998, HDB CIV REG VIT STAT, V1998 98.XVII.10; UNECA, 2009, INT EXP MEET IMPR CI; UNESCAP, 2014, CLINT BLOOMB ANN UN; UNHCR, 2014, GLOB PLAN ACT END ST; UNICEF, 2013, PASSP PROT GUID BIRT; UNICEF. United Nations Children's Fund, 2013, EV CHILDS BIRTH RIGH; United Nations, 2013, NEW GLOB PARTN ER PO; United Nations Department of Economic and Social Affairs, 2014, UN PRINC REC VIT STA; University of Oslo HISP India Health Metrics Network, SYST REV ECRVS MCRVS; WHO, 2014, CRVS TECHN IN PRESS; [WHO Department of Health Statistics and Information Systems], 2011, AN MORT LEV CAUS DEA; WHO, 2014, WHOHISHSI20146; WHO, 2014, 2012 WORLD HLTH STAT; WHO, 2010, CAUS DEATH DEATH CER; WHO, 2007, HLTH METR NETW HMN M; WHO, 2014, SUMM REP CIV REG VIT; WHO, 2014, CRVS INV PLANN TECHN; WHO, 2010, INT STAT CLASS DIS R; WHO, 2014, CODEDIT VERS 1 0 UG; WHO Regional Committee for the Eastern Mediterranean, 2013, REG STRAT IMPR CIV R; WHO University of Queensland School of Population Health, 2010, RAP ASS NAT CIV REG; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322; World Health Organization, 2010, IMPR QUAL US BIRTH D; World Health Organization, 2014, IMPR MORT STAT CIV R; World Health Organization, 2012, VERB AUT STAND ASC A; World Health Organization, 2013, MOVE IT REP MON VIT; World Health Organization, 2013, STRENGTH CIV REG VIT; Zelazny Frances, 2012, 008 CGD	112	102	103	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1373	1385		10.1016/S0140-6736(15)60173-8	http://dx.doi.org/10.1016/S0140-6736(15)60173-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	25971224	Green Accepted			2022-12-28	WOS:000362316200031
J	Shibuya, K; Gilmour, S				Shibuya, Kenji; Gilmour, Stuart			Civil registration as a means to promote human security	LANCET			English	Editorial Material									[Shibuya, Kenji; Gilmour, Stuart] Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Tokyo 1130033, Japan	University of Tokyo	Shibuya, K (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530				Abouzahr C, 2015, LANCET; Anand S, 2012, LANCET, V379, P9, DOI 10.1016/S0140-6736(11)61148-3; [Anonymous], 2015, LANCET, V385, P1152, DOI 10.1016/S0140-6736(15)60619-5; Commission on Human Security, 2003, HUMAN SECURITY NOW P; Horton R, 2015, LANCET, V385, P1156, DOI 10.1016/S0140-6736(14)61742-6; Horton R, 2014, LANCET, V383, P2196, DOI 10.1016/S0140-6736(14)61046-1; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Mikkelsen L, 2015, LANCET; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Phillips DE, 2015, LANCET; Rosling H, 2013, BBC NEWS MAGAZINE; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5	12	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					E14	E15		10.1016/S0140-6736(15)60765-6	http://dx.doi.org/10.1016/S0140-6736(15)60765-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	25971221				2022-12-28	WOS:000362316200001
J	Singh, JA; Cameron, C; Noorbaloochi, S; Cullis, T; Tucker, M; Christensen, R; Ghogomu, ET; Coyle, D; Clifford, T; Tugwell, P; Wells, GA				Singh, Jasvinder A.; Cameron, Chris; Noorbaloochi, Shahrzad; Cullis, Tyler; Tucker, Matthew; Christensen, Robin; Ghogomu, Elizabeth Tanjong; Coyle, Doug; Clifford, Tammy; Tugwell, Peter; Wells, George A.			Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; ANTITUMOR-NECROSIS-FACTOR; ISPOR TASK-FORCE; EULAR RECOMMENDATIONS; NETWORK METAANALYSIS; THERAPY; HOSPITALIZATION; INHIBITION; MANAGEMENT; UPDATE	Background Serious infections are a major concern for patients considering treatments for rheumatoid arthritis. Evidence is inconsistent as to whether biological drugs are associated with an increased risk of serious infection compared with traditional disease-modifying antirheumatic drugs (DMARDs). We did a systematic review and meta-analysis of serious infections in patients treated with biological drugs compared with those treated with traditional DMARDs. Methods We did a systematic literature search with Medline, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from their inception to Feb 11, 2014. Search terms included "biologics", "rheumatoid arthritis" and their synonyms. Trials were eligible for inclusion if they included any of the approved biological drugs and reported serious infections. We assessed the risk of bias with the Cochrane Risk of Bias Tool. We did a Bayesian network meta-analysis of published trials using a binomial likelihood model to assess the risk of serious infections in patients with rheumatoid arthritis who were treated with biological drugs, compared with those treated with traditional DMARDs. The odds ratio (OR) of serious infection was the primary measure of treatment effect and calculated 95% credible intervals using Markov Chain Monte Carlo methods. Findings The systematic review identified 106 trials that reported serious infections and included patients with rheumatoid arthritis who received biological drugs. Compared with traditional DMARDs, standard-dose biological drugs (OR 1.31, 95% credible interval [CrI] 1.09-1.58) and high-dose biological drugs (1.90, 1.50-2.39) were associated with an increased risk of serious infections, although low-dose biological drugs (0.93, 0.65-1.33) were not. The risk was lower in patients who were methotrexate naive compared with traditional DMARD-experienced or anti-tumour necrosis factor biological drug-experienced patients. The absolute increase in the number of serious infections per 1000 patients treated each year ranged from six for standard-dose biological drugs to 55 for combination biological therapy, compared with traditional DMARDs. Interpretation Standard-dose and high-dose biological drugs (with or without traditional DMARDs) are associated with an increase in serious infections in rheumatoid arthritis compared with traditional DMARDs, although low-dose biological drugs are not. Clinicians should discuss the balance between benefit and harm with the individual patient before starting biological treatment for rheumatoid arthritis.	[Singh, Jasvinder A.] Birmingham Vet Aff airs Med Ctr, Birmingham, AL USA; [Singh, Jasvinder A.; Tucker, Matthew] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA; [Cameron, Chris; Ghogomu, Elizabeth Tanjong; Coyle, Doug; Clifford, Tammy; Tugwell, Peter; Wells, George A.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada; [Noorbaloochi, Shahrzad] Amer Univ, Washington, DC 20016 USA; [Christensen, Robin] Copenhagen Univ Hosp, Dept Rheumatol, Musculoskeletal Stat Unit, Parker Inst, Bispebjerg, Denmark; [Christensen, Robin] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Musculoskeletal Stat Unit, Frederiksberg, Denmark	University of Alabama System; University of Alabama Birmingham; Mayo Clinic; University of Ottawa; American University; University of Copenhagen; University of Copenhagen	Singh, JA (corresponding author), Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	jasvinder.md@gmail.com	Tugwell, Peter/AFD-8076-2022; Singh, Jasvinder/R-6172-2019	Tugwell, Peter/0000-0001-5062-0556; Singh, Jasvinder/0000-0003-3485-0006; Christensen, Robin/0000-0002-6600-0631; Coyle, Doug/0000-0003-3492-2268; Tucker, Matthew/0000-0002-8193-8986	Rheumatology Division at the University of Alabama at Birmingham; Agency for Health Quality and Research Center for Education and Research on Therapeutics [U19 HS021110]; National Institute of Arthritis, Musculoskeletal and Skin Diseases [P50 AR060772, U34 AR062891]; National Institute of Aging [U01 AG018947]; National Cancer Institute [U10 CA149950]; Patient Centered Outcomes Research Institute [CE-1304-6631]; Canadian Institute of Health Research (CIHR) Canada Vanier Graduate Scholarship [CGV 121171]; Canadian Network and Centre for Trials Internationally; CIHR Drug Safety and Effectiveness Network [116573]; Oak Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U10CA149950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060772, U34AR062891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018947] Funding Source: NIH RePORTER	Rheumatology Division at the University of Alabama at Birmingham; Agency for Health Quality and Research Center for Education and Research on Therapeutics; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Canadian Institute of Health Research (CIHR) Canada Vanier Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally; CIHR Drug Safety and Effectiveness Network(Canadian Institutes of Health Research (CIHR)); Oak Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Rheumatology Division at the University of Alabama at Birmingham.; This study was funded by the Rheumatology Division at the University of Alabama at Birmingham. JAS is supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics (U19 HS021110), National Institute of Arthritis, Musculoskeletal and Skin Diseases (P50 AR060772 and U34 AR062891), National Institute of Aging (U01 AG018947), National Cancer Institute (U10 CA149950), and the Patient Centered Outcomes Research Institute (research contract CE-1304-6631). JAS is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, AL, USA. CC receives funding from the Canadian Institute of Health Research (CIHR) Canada Vanier Graduate Scholarship (CGV 121171). CC also receives support from the Canadian Network and Centre for Trials Internationally and is a trainee on a team grant through the CIHR Drug Safety and Effectiveness Network (116573). The Musculoskeletal Statistics Unit at the Parker Institute (RC) is supported by grants from the Oak Foundation. We thank Tamara Rader for doing the literature searches.	Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bernatsky S, 2010, J RHEUMATOL, V37, P928, DOI 10.3899/jrheum.091107; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Gaujoux-Viala C, 2014, ANN RHEUM DIS, V73, P510, DOI 10.1136/annrheumdis-2013-204588; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Ioannidis JPA, 2013, NAT REV RHEUMATOL, V9, P665, DOI 10.1038/nrrheum.2013.134; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Katchamart W, 2010, COCHRANE DB SYST REV, V4; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Novosad SA, 2014, CLIN INFECT DIS, V58, P1587, DOI 10.1093/cid/ciu104; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schneeweiss S, 2007, ARTHRITIS RHEUM-US, V56, P1754, DOI 10.1002/art.22600; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Singh JA, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD008794.PUB2; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043; Thompson AE, 2011, ARTHRITIS RHEUM-US, V63, P1479, DOI 10.1002/art.30310; Tugwell P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4027; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Wolfe F, 2006, ARTHRITIS RHEUM-US, V54, P628, DOI 10.1002/art.21568	31	366	383	1	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					258	265		10.1016/S0140-6736(14)61704-9	http://dx.doi.org/10.1016/S0140-6736(14)61704-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25975452	Green Accepted			2022-12-28	WOS:000358213700030
J	Lori, C; Ozaki, S; Steiner, S; Bohm, R; Abel, S; Dubey, BN; Schirmer, T; Hiller, S; Jenal, U				Lori, C.; Ozaki, S.; Steiner, S.; Boehm, R.; Abel, S.; Dubey, B. N.; Schirmer, T.; Hiller, S.; Jenal, U.			Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication	NATURE			English	Article							BACTERIAL-DNA REPLICATION; CAULOBACTER-CRESCENTUS; DEPENDENT KINASES; DIGUANYLATE CYCLASE; RESPONSE REGULATOR; POLAR LOCALIZATION; HISTIDINE KINASES; PROTEIN; PHOSPHORYLATION; PROGRESSION	Fundamental to all living organisms is the capacity to coordinate cell division and cell differentiation to generate appropriate numbers of specialized cells. Whereas eukaryotes use cyclins and cyclin-dependent kinases to balance division with cell fate decisions(1), equivalent regulatory systems have not been described in bacteria. Moreover, the mechanisms used by bacteria to tune division in line with developmental programs are poorly understood. Here we show that Caulobacter crescentus, a bacterium with an asymmetric division cycle, uses oscillating levels of the second messenger cyclic diguanylate (c-di-GMP) to drive its cell cycle. We demonstrate that c-diGMP directly binds to the essential cell cycle kinase CckA to inhibit kinase activity and stimulate phosphatase activity. An upshift of c-di-GMP during the G1-S transition switches CckA from the kinase to the phosphatase mode, thereby allowing replication initiation and cell cycle progression. Finally, we show that during division, c-di-GMP imposes spatial control on CckA to install the replication asymmetry of future daughter cells. These studies reveal c-di-GMP to be a cyclin-like molecule in bacteria that coordinates chromosome replication with cell morphogenesis in Caulobacter. The observation that c-di-GMP-mediated control is conserved in the plant pathogen Agrobacterium tumefaciens suggests a general mechanism through which this global regulator of bacterial virulence and persistence coordinates behaviour and cell proliferation.	[Lori, C.; Ozaki, S.; Steiner, S.; Abel, S.; Jenal, U.] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Boehm, R.; Dubey, B. N.; Schirmer, T.; Hiller, S.] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Jenal, U (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch	Hiller, Sebastian/B-3573-2008	Hiller, Sebastian/0000-0002-6709-4684; Dubey, Badri Nath/0000-0002-8626-8918; Ozaki, Shogo/0000-0002-4384-1366; Abel, Soren/0000-0002-4041-6989	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships; Swiss National Science Foundation [310030B_147090]; ERC Advanced Research Grant	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC Advanced Research Grant	We thank T. Sharp for help with protein analysis and F. Hamburger for plasmid constructions. S.O. is a recipient of a Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for research abroad. This work was supported by Swiss National Science Foundation grant 310030B_147090 to U.J. and an ERC Advanced Research Grant to U.J.	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; Angelastro PS, 2010, J BACTERIOL, V192, P539, DOI 10.1128/JB.00985-09; Arellano BH, 2010, APPL ENVIRON MICROB, V76, P3004, DOI 10.1128/AEM.02085-09; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Childers WS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001979; Choi YJ, 2014, ONCOGENE, V33, P1890, DOI 10.1038/onc.2013.137; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; ELY B, 1991, METHOD ENZYMOL, V204, P372; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Ishidate T, 2014, CELL CYCLE, V13, P1384, DOI 10.4161/cc.28656; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; KIM J, 2013, NATL GEOGR, V224, P8; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Taylor JA, 2011, MOL MICROBIOL, V82, P312, DOI 10.1111/j.1365-2958.2011.07785.x; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	46	120	123	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					236	U278		10.1038/nature14473	http://dx.doi.org/10.1038/nature14473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	25945741	Green Accepted			2022-12-28	WOS:000357695900040
J	Harmand, S; Lewis, JE; Feibel, CS; Lepre, CJ; Prat, S; Lenoble, A; Boes, X; Quinn, RL; Brenet, M; Arroyo, A; Taylor, N; Clement, S; Daver, G; Brugal, JP; Leakey, L; Mortlock, RA; Wright, JD; Lokorodi, S; Kirwa, C; Kent, DV; Roche, H				Harmand, Sonia; Lewis, Jason E.; Feibel, Craig S.; Lepre, Christopher J.; Prat, Sandrine; Lenoble, Arnaud; Boes, Xavier; Quinn, Rhonda L.; Brenet, Michel; Arroyo, Adrian; Taylor, Nicholas; Clement, Sophie; Daver, Guillaume; Brugal, Jean-Philip; Leakey, Louise; Mortlock, Richard A.; Wright, James D.; Lokorodi, Sammy; Kirwa, Christopher; Kent, Dennis V.; Roche, Helene			3.3-million-year-old stone tools from Lomekwi 3, West Turkana, Kenya	NATURE			English	Article							RAW-MATERIAL SELECTIVITY; OMO GROUP; ENVIRONMENTAL-CHANGE; PALEOSOL CARBONATES; ISOTOPIC EVIDENCE; HUMAN-EVOLUTION; HADAR FORMATION; BED-I; HOMININ; GONA	Human evolutionary scholars have long supposed that the earliest stone tools were made by the genus Homo and that this technological development was directly linked to climate change and the spread of savannah grasslands. New fieldwork in West Turkana, Kenya, has identified evidence of much earlier hominin technological behaviour. We report the discovery of Lomekwi 3, a 3.3-million-year-old archaeological site where in situ stone artefacts occur in spatio-temporal association with Pliocene hominin fossils in a wooded palaeoenvironment. The Lomekwi 3 knappers, with a developing understanding of stone's fracture properties, combined core reduction with battering activities. Given the implications of the Lomekwi 3 assemblage for models aiming to converge environmental change, hominin evolution and technological origins, we propose for it the name 'Lomekwian', which predates the Oldowan by 700,000 years and marks a new beginning to the known archaeological record.	[Harmand, Sonia; Lewis, Jason E.; Leakey, Louise] SUNY Stony Brook, Turkana Basin Inst, Stony Brook, NY 11794 USA; [Harmand, Sonia; Arroyo, Adrian; Taylor, Nicholas; Roche, Helene] Univ Paris Ouest Nanterre Def, CNRS, UMR Prehist & Technol 7055, F-92023 Nanterre, France; [Harmand, Sonia; Lewis, Jason E.; Feibel, Craig S.; Lepre, Christopher J.; Prat, Sandrine; Lenoble, Arnaud; Boes, Xavier; Quinn, Rhonda L.; Taylor, Nicholas; Clement, Sophie; Brugal, Jean-Philip; Lokorodi, Sammy; Kirwa, Christopher; Roche, Helene] West Turkana Archaeol Project, Nairobi, Kenya; [Lewis, Jason E.; Feibel, Craig S.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Lewis, Jason E.; Feibel, Craig S.] Rutgers State Univ, Ctr Human Evolutionary Studies, New Brunswick, NJ 08901 USA; [Feibel, Craig S.; Lepre, Christopher J.; Quinn, Rhonda L.; Mortlock, Richard A.; Wright, James D.; Kent, Dennis V.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Lepre, Christopher J.; Kent, Dennis V.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Prat, Sandrine; Boes, Xavier] CNRS, UPR 2147, Dynam Evolut Humaine, F-75014 Paris, France; [Lenoble, Arnaud; Brenet, Michel] Univ Bordeaux, CNRS, UMR PACEA 5199, F-33615 Pessac, France; [Quinn, Rhonda L.] Seton Hall Univ, Dept Sociol Anthropol & Social Work, S Orange, NJ 07079 USA; [Brenet, Michel] Ctr Mixte Rech Archeol, Inrap, F-24620 Campagne, France; [Clement, Sophie] Inrap, F-93120 La Courneuve, France; [Daver, Guillaume] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, CNRS, UMR 7262, F-86073 Poitiers 9, France; [Brugal, Jean-Philip] Aix Marseille Univ, CNRS, MCC, UMR 7269,LAMPEA, F-13094 Aix En Provence 2, France; [Kirwa, Christopher] Natl Museums Kenya, Dept Earth Sci, Archaeol Sect, Nairobi, Kenya	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris Nanterre; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Seton Hall University; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Harmand, S (corresponding author), SUNY Stony Brook, Turkana Basin Inst, Stony Brook, NY 11794 USA.	sonia.harmand@stonybrook.edu; jason.lewis@stonybrook.edu	Arroyo, Adrian/I-1522-2019; Harmand, Sonia/AAG-3874-2021; Wright, James/AAF-7180-2019	Arroyo, Adrian/0000-0002-5850-0847; Harmand, Sonia/0000-0003-1765-6180; Lepre, Christopher/0000-0001-9930-9339; Quinn, Rhonda/0000-0003-2580-864X; Wright, James/0000-0001-5212-9146; Mortlock, Richard/0000-0002-6019-5941; Brugal, Jean-Philip/0000-0002-5138-3545; Kent, Dennis/0000-0002-7677-2993; Leakey, Louise/0000-0003-3420-6341; Lewis, Jason/0000-0001-8325-1128; Lenoble, Arnaud/0000-0001-9023-9741	French Ministry of Foreign Affairs [681/DGM/ATT/RECH, 986/DGM/DPR/PRG]; French National Research Agency [ANR-12-CULT-0006]; Fondation Fyssen; National Geographic Society (Expeditions Council) [EC0569-12]; Rutgers University Research Council; Center for Human Evolutionary Studies; INTM Indigo Group France	French Ministry of Foreign Affairs; French National Research Agency(French National Research Agency (ANR)); Fondation Fyssen; National Geographic Society (Expeditions Council)(National Geographic Society); Rutgers University Research Council; Center for Human Evolutionary Studies; INTM Indigo Group France	We thank the office of the President of Kenya, the Ministry of Education, Science and Technology, the National Council for Science and Technology (NCST/RCD/12B/012/25) and the National Museums of Kenya for permission to conduct research. Funding was provided by the French Ministry of Foreign Affairs (No681/DGM/ATT/RECH, No986/DGM/DPR/PRG), the French National Research Agency (ANR-12-CULT-0006), the Fondation Fyssen, the National Geographic Society (Expeditions Council #EC0569-12), the Rutgers University Research Council and Center for Human Evolutionary Studies, and INTM Indigo Group France. We thank the Turkana Basin Institute and Total Kenya Limited for logistical support and the GeoEye Foundation for satellite imagery; the Turkana communities from Nariokotome, Kokiselei and Katiko for field assistance, and the 2011-12 WTAP team, S. Kahinju, P. Egolan, L. P. Martin, D. Massika, B. K. Mulwa S. M. Musyoka, A. Mutisiya, J. Mwambua, F. M. Wambua, M. Terrade, A. Weiss, R. Benitez, S. Feibel. M. Leakey and F. Spoor supplied information on hominin fossils, and I. de la Torre and E. Hovers provided lithic assemblage data. We are very grateful to A. Brooks, I. de la Torre, J. Shea, R. Klein and M. Leakey for comments on earlier drafts. We also thank the Zoller & Frohlich GmbH company, Ch. Frohlich and M. Reinkoster, Autodesk and Faro (T. O'Mahoney, K. Almeida Warren and T. Gichunge) for technical support with scanning and J. P. Chirey for photographic assistance.	Alimen M.-H., 1963, B SOC PREHIST FR, V60, P43, DOI DOI 10.3406/BSPF.1963.3879; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Aronson JL, 2008, J HUM EVOL, V55, P532, DOI 10.1016/j.jhevol.2008.04.004; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Campisano CJ, 2012, J HUM EVOL, V62, P338, DOI 10.1016/j.jhevol.2011.05.002; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; CERLING TE, 1988, PALAEOGEOGR PALAEOCL, V63, P335, DOI 10.1016/0031-0182(88)90104-6; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Crabtree D. E., 1972, OCCASIONAL PAPERS ID, V28; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I., 2005, ERAUL, P112; de la Torre I., 2010, PALEO REV DARCHEOLOG, P13; de la Torre I, 2011, PHILOS T R SOC B, V366, P1028, DOI 10.1098/rstb.2010.0350; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Diez-Martin F, 2010, QUATERNARY RES, V74, P376, DOI 10.1016/j.yqres.2010.07.019; Diez-Martin F, 2009, J ANTHROPOL ARCHAEOL, V28, P274, DOI 10.1016/j.jaa.2009.03.001; Elisabetta V, 2013, J ARCHAEOL SCI, V40, P3222, DOI 10.1016/j.jas.2013.03.021; Fox DL, 2004, PALAEOGEOGR PALAEOCL, V207, P305, DOI 10.1016/j.palaeo.2003.09.030; Goldman-Neuman T, 2012, J HUM EVOL, V62, P353, DOI 10.1016/j.jhevol.2011.05.006; Harmand S, 2009, VERTEBR PALEOBIOL PA, P85, DOI 10.1007/978-1-4020-9060-8_8; Harris J.M., 1988, CONTRIBUTIONS SCI, V399, P1; Harris J.W.K., 1983, AFR ARCHAEOL REV, V1, P3, DOI DOI 10.1007/BF01116770; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hovers E., 2009, CUTTING EDGE NEW APP, P137; Hovers E, 2012, DEV QUATER SCI, V16, P51, DOI 10.1016/B978-0-444-53821-5.00005-1; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kingston J.D., 1992, THESIS HARVARD U THESIS HARVARD U; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY LSB, 1934, ESSAYS PRESENTED CG, P143; Leakey M.D., 1971, OLDUVAI GORGE; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Levin N.E., 2013, INTEGRATED EARTH DAT; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Marchant LF., 2005, STONE KNAPPING NECES, P341; Matsuzawa Tetsuro, 1996, P196, DOI 10.1017/CBO9780511752414.017; McDougall I, 2008, J GEOL SOC LONDON, V165, P549, DOI 10.1144/0016-76492006-170; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; Mourre V., 2010, PALEO, P49; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Piperno M., 1989, P189; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quinn RL, 2013, J HUM EVOL, V65, P65, DOI 10.1016/j.jhevol.2013.04.002; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; ROCHE H, 1977, CR ACAD SCI D NAT, V284, P1871; Roche Helene, 2009, P135, DOI 10.1007/978-1-4020-9980-9_12; SAKURA O, 1991, ETHOLOGY, V87, P237; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Semaw S., 2009, CUTTING EDGE NEW APP, P211; Shea JJ, 2013, J ARCHAEOL METHOD TH, V20, P151, DOI 10.1007/s10816-012-9128-5; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Toth N., 2006, OLDOWAN CASE STUDIES, P155; White F., 1983, NAT RESOUR RES, V20, P1, DOI DOI 10.2307/2260340; Wood B, 2011, EVOL ANTHROPOL, V20, P264, DOI 10.1002/evan.20335; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Wynn JG, 2006, NATURE, V443, P332, DOI 10.1038/nature05048	64	448	466	2	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					310	+		10.1038/nature14464	http://dx.doi.org/10.1038/nature14464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993961	Green Published			2022-12-28	WOS:000354816500047
J	Northup, T				Northup, Tracy			QUANTUM PHYSICS Squeezed ions in two places at once	NATURE			English	Editorial Material							TRAPPED IONS; STATES; ATOM	Experiments on a trapped calcium ion have again exposed the strange nature of quantum phenomena, and could pave the way for sensitive techniques to explore the boundary between the quantum and classical worlds. SEE LETTER P.336	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Northup, T (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	tracy.northup@uibk.ac.at	Northup, Tracy E./N-1439-2017	Northup, Tracy E./0000-0002-1071-2218	Austrian Science Fund (FWF) [V 252] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Kienzler D, 2015, SCIENCE, V347, P53, DOI 10.1126/science.1261033; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Lo HY, 2015, NATURE, V521, P336, DOI 10.1038/nature14458; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Poyatos JF, 1996, PHYS REV A, V54, P1532, DOI 10.1103/PhysRevA.54.1532	7	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					295	296		10.1038/521295a	http://dx.doi.org/10.1038/521295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993955				2022-12-28	WOS:000354816500041
J	Sawyer, RG; Claridge, JA; Nathens, AB; Rotstein, OD; Duane, TM; Evans, HL; Cook, CH; O'Neill, PJ; Mazuski, JE; Askari, R; Wilson, MA; Napolitano, LM; Namias, N; Miller, PR; Dellinger, EP; Watson, CM; Coimbra, R; Dent, DL; Lowry, SF; Cocanour, CS; West, MA; Banton, KL; Cheadle, WG; Lipsett, PA; Guidry, CA; Popovsky, K				Sawyer, R. G.; Claridge, J. A.; Nathens, A. B.; Rotstein, O. D.; Duane, T. M.; Evans, H. L.; Cook, C. H.; O'Neill, P. J.; Mazuski, J. E.; Askari, R.; Wilson, M. A.; Napolitano, L. M.; Namias, N.; Miller, P. R.; Dellinger, E. P.; Watson, C. M.; Coimbra, R.; Dent, D. L.; Lowry, S. F.; Cocanour, C. S.; West, M. A.; Banton, K. L.; Cheadle, W. G.; Lipsett, P. A.; Guidry, C. A.; Popovsky, K.			Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBIOTIC-THERAPY; CHILDREN GUIDELINES; DISEASES SOCIETY; MANAGEMENT; MORTALITY; ADULTS; DIAGNOSIS; BACTERIAL; INJURY; SEPSIS	BACKGROUND The successful treatment of intraabdominal infection requires a combination of anatomical source control and antibiotics. The appropriate duration of antimicrobial therapy remains unclear. METHODS We randomly assigned 518 patients with complicated intraabdominal infection and adequate source control to receive antibiotics until 2 days after the resolution of fever, leukocytosis, and ileus, with a maximum of 10 days of therapy (control group), or to receive a fixed course of antibiotics (experimental group) for 4 +/- 1 calendar days. The primary outcome was a composite of surgical-site infection, recurrent intraabdominal infection, or death within 30 days after the index source-control procedure, according to treatment group. Secondary outcomes included the duration of therapy and rates of subsequent infections. RESULTS Surgical-site infection, recurrent intraabdominal infection, or death occurred in 56 of 257 patients in the experimental group (21.8%), as compared with 58 of 260 patients in the control group (22.3%) (absolute difference, -0.5 percentage point; 95% confidence interval [CI], -7.0 to 8.0; P = 0.92). The median duration of antibiotic therapy was 4.0 days (interquartile range, 4.0 to 5.0) in the experimental group, as compared with 8.0 days (interquartile range, 5.0 to 10.0) in the control group (absolute difference, -4.0 days; 95% CI, -4.7 to -3.3; P<0.001). No significant between-group differences were found in the individual rates of the components of the primary outcome or in other secondary outcomes. CONCLUSIONS In patients with intraabdominal infections who had undergone an adequate source-control procedure, the outcomes after fixed-duration antibiotic therapy (approximately 4 days) were similar to those after a longer course of antibiotics (approximately 8 days) that extended until after the resolution of physiological abnormalities.	[Sawyer, R. G.; Guidry, C. A.; Popovsky, K.] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA; [Duane, T. M.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA; [Claridge, J. A.] Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA; [Nathens, A. B.; Rotstein, O. D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Evans, H. L.; Dellinger, E. P.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Cook, C. H.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Askari, R.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [O'Neill, P. J.] Maricopa Integrated Hlth Syst, Dept Surg, Phoenix, AZ USA; [Mazuski, J. E.] Washington Univ, Dept Surg, St Louis, MO USA; [Wilson, M. A.] VA Pittsburgh Healthcare Syst, Dept Surg, Pittsburgh, PA USA; [Napolitano, L. M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Namias, N.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Miller, P. R.] Wake Forest Sch Med, Dept Surg, Winston Salem, NC USA; [Watson, C. M.] Univ S Carolina, Dept Surg, Columbia, SC 29208 USA; [Coimbra, R.] Univ Calif San Diego, San Diego, CA 92103 USA; [Cocanour, C. S.] Univ Calif Davis, Med Ctr, Dept Surg, Sacramento, CA 95817 USA; [West, M. A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Dent, D. L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Lowry, S. F.] Univ Med & Dent New Jersey, Dept Surg, Newark, NJ 07103 USA; [Banton, K. L.] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA; [Cheadle, W. G.] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Lipsett, P. A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	University of Virginia; Virginia Commonwealth University; Case Western Reserve University; University of Toronto; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Maricopa County General Hospital; Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Michigan System; University of Michigan; University of Miami; Wake Forest University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Louisville; Johns Hopkins University	Sawyer, RG (corresponding author), Univ Virginia Hlth Syst, Dept Surg, Box 800709, Charlottesville, VA 22908 USA.	rws2k@virginia.edu	Evans, Heather/F-9113-2014; Cook, Charles/AAE-3222-2020; Coimbra, Raul/AAP-3019-2020; Napolitano, Lena/AAZ-8651-2021; Guidry, Christopher/GRS-5109-2022	Evans, Heather/0000-0002-3661-0666; Coimbra, Raul/0000-0002-3759-6851; Namias, Nicholas/0000-0001-7021-2250; West, Michaela A/0000-0002-6598-4114; Sawyer, Robert/0000-0002-8155-2661	National Institutes of Health [R01GM081510, T32 AI078875]; 3M; Pfizer; Bayer; Merck; AstraZeneca; Baxter; Ortho-McNeil; Targanta Therapeutics; Schering-Plough; Astellas; CareFusion; Durata Therapeutics; Rib-X Pharmaceuticals; Affinium Pharmaceuticals; Tetraphase Pharmaceuticals; R-Pharm; Applied Medical; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 3M(3M); Pfizer(Pfizer); Bayer(Bayer AG); Merck(Merck & Company); AstraZeneca(AstraZeneca); Baxter; Ortho-McNeil; Targanta Therapeutics; Schering-Plough(Merck & CompanySchering Plough Corporation); Astellas(Astellas Pharmaceuticals); CareFusion; Durata Therapeutics; Rib-X Pharmaceuticals; Affinium Pharmaceuticals; Tetraphase Pharmaceuticals; R-Pharm; Applied Medical; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (R01GM081510 and T32 AI078875) from the National Institutes of Health.; Dr. Sawyer reports receiving consulting fees from 3M and Pfizer; Dr. Duane, lecture fees from Pfizer; Dr. O'Neill, fees for serving on a surgical review panel for Cubist; Dr. Mazuski, fees for serving on advisory boards from AstraZeneca, Cubist, Merck, and Pfizer, consulting fees from Bayer, lecture fees from Merck, and grant support from AstraZeneca, Bayer, Merck, and Pfizer; and Dr. Dellinger, fees for serving on advisory boards from Merck, Baxter, Ortho-McNeil, Targanta Therapeutics, Schering-Plough, Astellas, CareFusion, Durata Therapeutics, Pfizer, Rib-X Pharmaceuticals, Affinium Pharmaceuticals, Tetraphase Pharmaceuticals, and R-Pharm, and lecture fees from Applied Medical. No other potential conflict of interest relevant to this article was reported.	Basoli A, 2008, J GASTROINTEST SURG, V12, P592, DOI 10.1007/s11605-007-0277-x; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; CHRISTOU NV, 1993, ARCH SURG-CHICAGO, V128, P193; DeFrances Carol J, 2007, Vital Health Stat 13, P1; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dupont H, 2011, J ANTIMICROB CHEMOTH, V66, P2379, DOI 10.1093/jac/dkr308; Guirao X, 2013, J ANTIMICROB CHEMOTH, V68, pii37, DOI 10.1093/jac/dkt143; Inui T, 2009, SURGERY, V146, P654, DOI 10.1016/j.surg.2009.06.051; Marshall John C, 2004, Crit Care Med, V32, pS513, DOI 10.1097/01.CCM.0000143119.41916.5D; Riccio LM, 2014, SURG INFECT, V15, P417, DOI 10.1089/sur.2012.077; Samuelsson A, 2012, SCAND J INFECT DIS, V44, P820, DOI 10.3109/00365548.2012.695455; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-37; SCHEIN M, 1994, BRIT J SURG, V81, P989, DOI 10.1002/bjs.1800810720; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Sursal T, 2013, SHOCK, V39, P55, DOI 10.1097/SHK.0b013e318276f4ca; Turnbull IR, 2004, SHOCK, V21, P121, DOI 10.1097/01.shk.0000108399.56565.e7; Wong YY, 2013, PERITON DIALYSIS INT, V33, P507, DOI 10.3747/pdi.2012.00281	18	381	397	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1996	2005		10.1056/NEJMoa1411162	http://dx.doi.org/10.1056/NEJMoa1411162			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25992746	Green Accepted, Green Published			2022-12-28	WOS:000354809300006
J	Wilt, TJ; Harris, RP; Qaseem, A				Wilt, Timothy J.; Harris, Russell P.; Qaseem, Amir		Amer Coll Phys	Screening for Cancer: Advice for High-Value Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL GUIDELINES COMMITTEE; SOCIETY-TASK-FORCE; COLORECTAL-CANCER; PROSTATE-CANCER; UNITED-STATES; GUIDANCE STATEMENT; PELVIC EXAMINATION; COST-EFFECTIVENESS; SERVICES; WOMEN	Background: Cancer screening is one approach to reducing cancer-related morbidity and mortality rates. Screening strategies vary in intensity. Higher-intensity strategies are not necessarily higher value. High-value strategies provide a degree of benefits that clearly justifies the harms and costs incurred; low-value screening provides limited or no benefits to justify the harms and costs. When cancer screening leads to benefits, an optimal intensity of screening maximizes value. Some aspects of screening practices, especially overuse and underuse, are low value. Methods: Screening strategies for asymptomatic, average-risk adults for 5 common types of cancer were evaluated by reviewing clinical guidelines and evidence syntheses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, American Cancer Society, American Congress of Obstetricians and Gynecologists, American Gastroenterological Association, and American Urological Association. "High value" was defined as the lowest screening intensity threshold at which organizations agree about screening recommendations for each type of cancer and "low value" as agreement about not recommending overly intensive screening strategies. This information is supplemented with additional findings from randomized, controlled trials; modeling studies; and studies of costs or resource use, including information found in the National Cancer Institute's Physician Data Query and UpToDate. The ACP provides high-value care screening advice for 5 common types of cancer; the specifics are outlined in this article. The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening.	Minneapolis Vet Affairs High Value Care Initiat, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Res Ctr Excellence Clin Prevent Serv, Chapel Hill, NC USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	American Academy of Family Physicians, 2015, SUMM REC CLIN PREV S; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; Baker DW, 2013, ANN INTERN MED, V158, P55, DOI 10.7326/0003-4819-158-1-201301010-00560; Baldwin LM, 2012, ANN INTERN MED, V156, P182, DOI 10.7326/0003-4819-156-3-201202070-00006; Bellizzi KM, 2011, ARCH INTERN MED, V171, P2031, DOI 10.1001/archinternmed.2011.570; Berkowitz Z, 2013, JAMA INTERN MED, V173, P922, DOI 10.1001/jamainternmed.2013.368; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Carter HB, EARLY DETECTION PROS; Curry S, 2003, FULFILLING POTENTIAL; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Gross CP, 2013, JAMA INTERN MED, V173, P220, DOI 10.1001/jamainternmed.2013.1397; Harris RP, 2015, ANN INTERN MED, V162, P712, DOI 10.7326/M14-2327; Howard DH, 2009, HEALTH AFFAIR, V28, P1838, DOI 10.1377/hlthaff.28.6.1838; Kapp JM, 2010, BREAST CANCER RES TR, V119, P485, DOI 10.1007/s10549-008-0305-x; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Ma XM, 2014, CANCER-AM CANCER SOC, V120, P96, DOI 10.1002/cncr.28373; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; National Cancer Institute, 2014, BREAST CANC SCREEN P; O'Donoghue C, 2014, ANN INTERN MED, V160, P145, DOI 10.7326/M13-1217; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Partin MR, 2012, J GEN INTERN MED, V27, P1618, DOI 10.1007/s11606-012-2163-9; Pataky R, 2014, INT J CANCER, V135, P939, DOI 10.1002/ijc.28732; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Qaseem A, 2014, ANN INTERN MED, V161, P67, DOI 10.7326/M14-0701; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Sawaya GF, 2015, ANN INTERN MED, V162, P851, DOI 10.7326/M14-2426; Schwartz LM, 2011, ARCH INTERN MED, V171, P489, DOI 10.1001/archinternmed.2011.73; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sheffield KM, 2013, JAMA INTERN MED, V173, P542, DOI 10.1001/jamainternmed.2013.2912; Shteynshlyuger A, 2011, J UROLOGY, V185, P828, DOI 10.1016/j.juro.2010.10.079; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Smith RA, 2015, CA-CANCER J CLIN, V65, P30, DOI 10.3322/caac.21261; Stormo AR, 2011, ARCH INTERN MED, V171, P2053, DOI 10.1001/archinternmed.2011.575; Stout NK, 2014, JAMA INTERN MED, V174, P114, DOI 10.1001/jamainternmed.2013.11958; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; Walter LC, 2014, JAMA-J AM MED ASSOC, V311, P1336, DOI 10.1001/jama.2014.2834; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012	52	129	135	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					718	+		10.7326/M14-2326	http://dx.doi.org/10.7326/M14-2326			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984847				2022-12-28	WOS:000355015200022
J	Dyble, M; Salali, GD; Chaudhary, N; Page, A; Smith, D; Thompson, J; Vinicius, L; Mace, R; Migliano, AB				Dyble, M.; Salali, G. D.; Chaudhary, N.; Page, A.; Smith, D.; Thompson, J.; Vinicius, L.; Mace, R.; Migliano, A. B.			Sex equality can explain the unique social structure of hunter-gatherer bands	SCIENCE			English	Article							COOPERATION; RESIDENCE; EVOLUTION	The social organization of mobile hunter-gatherers has several derived features, including low within-camp relatedness and fluid meta-groups. Although these features have been proposed to have provided the selective context for the evolution of human hypercooperation and cumulative culture, how such a distinctive social system may have emerged remains unclear. We present an agent-based model suggesting that, even if all individuals in a community seek to live with as many kin as possible, within-camp relatedness is reduced if men and women have equal influence in selecting camp members. Our model closely approximates observed patterns of co-residence among Agta and Mbendjele BaYaka hunter-gatherers. Our results suggest that pair-bonding and increased sex egalitarianism in human evolutionary history may have had a transformative effect on human social organization.	[Dyble, M.; Salali, G. D.; Chaudhary, N.; Page, A.; Smith, D.; Thompson, J.; Vinicius, L.; Mace, R.; Migliano, A. B.] Univ Coll London UCL Anthropol, London WC1H 0BW, England	University of London; University College London	Dyble, M (corresponding author), Univ Coll London UCL Anthropol, 14 Taviton St, London WC1H 0BW, England.	mark.dyble.12@ucl.ac.uk	Page, Abigail E./AAF-4436-2021	Chaudhary, Nikhil/0000-0001-7528-8529; Salali, Gul Deniz/0000-0001-9538-3064; Page, Abigail/0000-0002-0973-1569; Migliano, Andrea/0000-0003-4364-2735; Mace, Ruth/0000-0002-6137-7739; Smith, Daniel/0000-0001-6467-2023	Leverhulme Trust [RP2011-R-045]; European Research Council [AdG 249347]	Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	This project was funded by the Leverhulme Trust grant RP2011-R-045 to A.B.M. R.M. also received funding from European Research Council Advanced Grant AdG 249347. A.B.M. conceived the project; M.D. created the model; M.D., A.P., G.D.S., N.C., A.B.M., D.S., and J.T. collected the data; and M.D. and G.D.S. wrote scripts and analyzed the data. M.D., A.B.M, L.V., and R.M. wrote the paper. We thank P. Gerbault, J. Stevenson, J. Lewis, and R. Schlaepfer for help in the field and the Human Evolutionary Ecology Group at UCL, as well as three anonymous reviewers for valuable comments on the manuscript. Last, we thank our assistants in both Congo and the Philippines, as well as the Agta, Paranan, and Mbendjele communities.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Burkart JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5747; Chapais B., 2009, PRIMEVAL KINSHIP PAI; Fry DP, 2013, SCIENCE, V341, P270, DOI 10.1126/science.1235675; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hill KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102806; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Ivey PK, 2000, CURR ANTHROPOL, V41, P856, DOI 10.1086/317414; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan HS, 2003, OFFSPRING, P170; KELLY RL, 1983, J ANTHROPOL RES, V39, P277, DOI 10.1086/jar.39.3.3629672; Kempe M, 2014, EVOL HUM BEHAV, V35, P285, DOI 10.1016/j.evolhumbehav.2014.02.009; Lee RB., 1979, THE KUNG SAN; Lewis HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6789; Lewis J, 2017, HUNTER-GATHERERS OF THE CONGO BASIN: CULTURES, HISTORIES, AND BIOLOGY OF AFRICAN PYGMIES, P219; Mace R, 2013, EVOL ANTHROPOL, V22, P251, DOI 10.1002/evan.21374; Marlowe FW, 2004, CURR ANTHROPOL, V45, P277, DOI 10.1086/382256; Martin MK, 1975, FEMALE SPECIES; Meehan CL, 2013, AM J HUM BIOL, V25, P42, DOI 10.1002/ajhb.22336; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; SICOTTE P, 1993, AM J PRIMATOL, V30, P21, DOI 10.1002/ajp.1350300103; Tonkinson R., 1978, THE MARDU ABORIGINES; Vinicius L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112236; Walker RS, 2014, EVOL HUM BEHAV, V35, P384, DOI 10.1016/j.evolhumbehav.2014.05.003; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Wrangham Richard, 1996, DEMONIC MALES APES O	31	104	106	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					796	798		10.1126/science.aaa5139	http://dx.doi.org/10.1126/science.aaa5139			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977551				2022-12-28	WOS:000354428700043
J	Woodruff, JB; Wueseke, O; Viscardi, V; Mahamid, J; Ochoa, SD; Bunkenborg, J; Widlund, PO; Pozniakovsky, A; Zanin, E; Bahmanyar, S; Zinke, A; Hong, SH; Decker, M; Baumeister, W; Andersen, JS; Oegema, K; Hyman, AA				Woodruff, Jeffrey B.; Wueseke, Oliver; Viscardi, Valeria; Mahamid, Julia; Ochoa, Stacy D.; Bunkenborg, Jakob; Widlund, Per O.; Pozniakovsky, Andrei; Zanin, Esther; Bahmanyar, Shirin; Zinke, Andrea; Hong, Sun Hae; Decker, Marcus; Baumeister, Wolfgang; Andersen, Jens S.; Oegema, Karen; Hyman, Anthony A.			Regulated assembly of a supramolecular centrosome scaffold in vitro	SCIENCE			English	Article							GAMMA-TUBULIN COMPLEXES; DROSOPHILA SPD-2; ELEGANS REQUIRE; PROTEIN; PERICENTRIN; MATURATION; PCM; RECRUITMENT; CENTRIOLES; PLK1	The centrosome organizes microtubule arrays within animal cells and comprises two centrioles surrounded by an amorphous protein mass called the pericentriolar material (PCM). Despite the importance of centrosomes as microtubule-organizing centers, the mechanism and regulation of PCM assembly are not well understood. In Caenorhabditis elegans, PCM assembly requires the coiled-coil protein SPD-5. We found that recombinant SPD-5 could polymerize to form micrometer-sized porous networks in vitro. Network assembly was accelerated by two conserved regulators that control PCM assembly in vivo, Polo-like kinase-1 and SPD-2/Cep192. Only the assembled SPD-5 networks, and not unassembled SPD-5 protein, functioned as a scaffold for other PCM proteins. Thus, PCM size and binding capacity emerge from the regulated polymerization of one coiled-coil protein to form a porous network.	[Woodruff, Jeffrey B.; Wueseke, Oliver; Widlund, Per O.; Pozniakovsky, Andrei; Zinke, Andrea; Decker, Marcus; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Viscardi, Valeria; Ochoa, Stacy D.; Zanin, Esther; Bahmanyar, Shirin; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Mahamid, Julia; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Bunkenborg, Jakob] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark; [Bunkenborg, Jakob; Andersen, Jens S.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Hong, Sun Hae] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Max Planck Society; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Max Planck Society; University of Copenhagen; University of Southern Denmark; University of California System; University of California Berkeley	Oegema, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	koegema@ucsd.edu; hyman@mpi-cbg.de	Widlund, Per/J-1238-2019; Zanin, Esther/L-6457-2017; Wueseke, Oliver/A-5660-2016; Hyman, Tony/F-1923-2011; Andersen, Jens S/L-2100-2015; Hyman, Anthony A/B-3917-2017	Widlund, Per/0000-0002-3645-0009; Zanin, Esther/0000-0003-1450-8684; Wueseke, Oliver/0000-0002-0519-492X; Andersen, Jens S/0000-0002-6091-140X; Hyman, Anthony A/0000-0003-3664-154X; Bunkenborg, Jakob/0000-0002-2908-9323	Max Planck Society; European Commission [FP7-HEALTH-2009-241548/MitoSys]; NIH [R01-GM074207]; Ludwig Institute for Cancer Research; EU FP7 PROSPECTS network grant [HEALTH-F4-2008-201648]; Alexander von Humboldt fellowship; European Molecular Biology Organization (EMBO) fellowship; EMBO; Human Frontier Science Program fellowship; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207, R25GM079300] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0006527] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; EU FP7 PROSPECTS network grant; Alexander von Humboldt fellowship(Alexander von Humboldt Foundation); European Molecular Biology Organization (EMBO) fellowship(European Molecular Biology Organization (EMBO)); EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowship(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank the Protein Expression and Purification (Dresden and Martinsried) and Light Microscopy (Dresden) facilities, M. Braun, H. Petzold, B. Ferreira Gomes, M. Podolski, and A. Hibbel for experimental help, and L. Pelletier for helpful comments. This project was funded by the Max Planck Society and the European Commission's 7th Framework Programme grant (FP7-HEALTH-2009-241548/MitoSys) to A. H. and an NIH grant (R01-GM074207) to K.O. K.O. received salary and additional support from the Ludwig Institute for Cancer Research. J.S.A. and J.B. were funded in part by the EU FP7 PROSPECTS network grant (HEALTH-F4-2008-201648). J.B.W. was supported by Alexander von Humboldt and European Molecular Biology Organization (EMBO) fellowships. J. M. was supported by EMBO and Human Frontier Science Program fellowships. E.Z. was supported by a Deutsche Forschungsgemeinschaft fellowship. The supplemental materials contain additional data.	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Conduit PT, 2014, ELIFE, V3, DOI 10.7554/eLife.03399; Conduit PT, 2014, DEV CELL, V28, P659, DOI 10.1016/j.devcel.2014.02.013; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu ZX, 2013, BRIEF BIOINFORM, V14, P344, DOI 10.1093/bib/bbs041; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Woodruff J. B., 2014, PHIL T R SOC B, V369, P1; Wueseke O, 2014, MOL BIOL CELL, V25, P2984, DOI 10.1091/mbc.E13-09-0514; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	33	117	118	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					808	812		10.1126/science.aaa3923	http://dx.doi.org/10.1126/science.aaa3923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977552	Green Accepted			2022-12-28	WOS:000354428700046
J	Bainbridge, JWB; Mehat, MS; Sundaram, V; Robbie, SJ; Barker, SE; Ripamonti, C; Georgiadis, A; Mowat, FM; Beattie, SG; Gardner, PJ; Feathers, KL; Luong, VA; Yzer, S; Balaggan, K; Viswanathan, A; de Ravel, TJL; Casteels, I; Holder, GE; Tyler, N; Fitzke, FW; Weleber, RG; Nardini, M; Moore, AT; Thompson, DA; Petersen-Jones, SM; Michaelides, M; van den Born, LI; Stockman, A; Smith, AJ; Rubin, G; Ali, RR				Bainbridge, J. W. B.; Mehat, M. S.; Sundaram, V.; Robbie, S. J.; Barker, S. E.; Ripamonti, C.; Georgiadis, A.; Mowat, F. M.; Beattie, S. G.; Gardner, P. J.; Feathers, K. L.; Luong, V. A.; Yzer, S.; Balaggan, K.; Viswanathan, A.; de Ravel, T. J. L.; Casteels, I.; Holder, G. E.; Tyler, N.; Fitzke, F. W.; Weleber, R. G.; Nardini, M.; Moore, A. T.; Thompson, D. A.; Petersen-Jones, S. M.; Michaelides, M.; van den Born, L. I.; Stockman, A.; Smith, A. J.; Rubin, G.; Ali, R. R.			Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENOASSOCIATED VIRUS; SUBRETINAL INJECTION; RETINAL-DETACHMENT; RPE65 MUTATIONS; VISION; MULLER; DEGENERATION; EXPRESSION; ISOMERASE; PROTEINS	BACKGROUND Mutations in RPE65 cause Leber's congenital amaurosis, a progressive retinal degenerative disease that severely impairs sight in children. Gene therapy can result in modest improvements in night vision, but knowledge of its efficacy in humans is limited. METHODS We performed a phase 1-2 open-label trial involving 12 participants to evaluate the safety and efficacy of gene therapy with a recombinant adeno-associated virus 2/2 (rAAV2/2) vector carrying the RPE65 complementary DNA, and measured visual function over the course of 3 years. Four participants were administered a lower dose of the vector, and 8 were administered a higher dose. In a parallel study in dogs, we investigated the relationship among vector dose, visual function, and electroretinography (ERG) findings. RESULTS Improvements in retinal sensitivity were evident, to varying extents, in six participants for up to 3 years, peaking at 6 to 12 months after treatment and then declining. No associated improvement in retinal function was detected by means of ERG. Three participants had intraocular inflammation, and two had clinically significant deterioration of visual acuity. The reduction in central retinal thickness varied among participants. In dogs, RPE65 gene therapy with the same vector at lower doses improved vision-guided behavior, but only higher doses resulted in improvements in retinal function that were detectable with the use of ERG. CONCLUSIONS Gene therapy with rAAV2/2 RPE65 vector improved retinal sensitivity, albeit modestly and temporarily. Comparison with the results obtained in the dog model indicates that there is a species difference in the amount of RPE65 required to drive the visual cycle and that the demand for RPE65 in affected persons was not met to the extent required for a durable, robust effect.	[Bainbridge, J. W. B.; Mehat, M. S.; Sundaram, V.; Robbie, S. J.; Barker, S. E.; Ripamonti, C.; Georgiadis, A.; Mowat, F. M.; Beattie, S. G.; Gardner, P. J.; Luong, V. A.; Balaggan, K.; Viswanathan, A.; Holder, G. E.; Fitzke, F. W.; Nardini, M.; Moore, A. T.; Michaelides, M.; Stockman, A.; Smith, A. J.; Rubin, G.; Ali, R. R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Tyler, N.] UCL, Dept Civil Environm & Geomat Engn, London EC1V 9EL, England; [Bainbridge, J. W. B.; Mehat, M. S.; Sundaram, V.; Robbie, S. J.; Georgiadis, A.; Balaggan, K.; Holder, G. E.; Moore, A. T.; Michaelides, M.] Moorfields Eye Hosp, London, England; [Nardini, M.] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Mowat, F. M.; Petersen-Jones, S. M.] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Feathers, K. L.; Thompson, D. A.; Ali, R. R.] Univ Michigan, Kellogg Eye Ctr, Sch Med, Ann Arbor, MI 48109 USA; [de Ravel, T. J. L.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Casteels, I.] UZ Leuven, Dept Ophthalmol, Leuven, Belgium; [Yzer, S.; van den Born, L. I.] Rotterdam Eye Hosp, Rotterdam, Netherlands; [Weleber, R. G.] Oregon Hlth & Sci Univ, Casey Eye Inst, Oregon Retinal Degenerat Ctr, Ophthalm Genet Serv, Portland, OR 97201 USA	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Durham University; Michigan State University; University of Michigan System; University of Michigan; KU Leuven; KU Leuven; University Hospital Leuven; Rotterdam Eye Hospital; Oregon Health & Science University	Bainbridge, JWB (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	j.bainbridge@ucl.ac.uk; r.ali@ucl.ac.uk	Beattie, Stuart Gavin/AFK-4415-2022; Petersen-Jones, Simon/B-3822-2018; MOWAT, FREYA/AAD-5102-2021; Nardini, Marko/C-1905-2008; Beattie, Stuart Gavin/AAG-3146-2022; Georgiadis, Anastasios/G-8777-2012	Beattie, Stuart Gavin/0000-0002-5735-3881; Petersen-Jones, Simon/0000-0002-7410-2304; Nardini, Marko/0000-0001-6614-7775; Beattie, Stuart Gavin/0000-0002-5735-3881; Thompson, Debra/0000-0003-3485-0794; Bainbridge, James/0000-0003-1318-8201; de Ravel, Thomy/0000-0002-3361-3781; Gardner, Pete/0000-0002-4940-2639; Ali, Robin/0000-0003-3126-6517; Glassen, Ronald/0000-0003-3195-5718; Georgiadis, Anastasios/0000-0001-5079-3588; Tyler, Nick/0000-0001-7079-1301; Mowat, Freya/0000-0002-8726-8768	National Institute for Health Research; BBSRC [BB/M00211X/1] Funding Source: UKRI; EPSRC [EP/J005193/1, EP/J017698/1] Funding Source: UKRI; MRC [MR/M015815/1, MR/J005215/1, MR/K024000/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M00211X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J017698/1, EP/J005193/1] Funding Source: researchfish; Medical Research Council [MR/J005215/1, MR/K024000/1, MR/M015815/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10074, NF-SI-0507-10204, NIHR-RP-011-003] Funding Source: researchfish; Fight for Sight [1353/54] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	Funded by the National Institute for Health Research and others; ClinicalTrials.gov number, NCT00643747.)	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Annear MJ, 2013, HUM GENE THER, V24, P883, DOI 10.1089/hum.2013.146; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Banin E, 2010, HUM GENE THER, V21, P1749, DOI 10.1089/hum.2010.047; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; Bland JM, 1996, BRIT MED J, V313, P744; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Geller SF, 2001, INVEST OPHTH VIS SCI, V42, P1363; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Li SH, 2014, J BIOL CHEM, V289, P18943, DOI 10.1074/jbc.M114.552117; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mowat FM, 2013, GENE THER, V20, P545, DOI 10.1038/gt.2012.63; Philpa AR, 2009, HUM MUTAT, V30, P1183, DOI 10.1002/humu.21033; Poehner WJ, 2000, MOL VIS, V6, P192; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Schocket LS, 2006, OPHTHALMOLOGY, V113, P666, DOI 10.1016/j.ophtha.2006.01.003; Takahashi Y, 2011, FEBS J, V278, P2913, DOI 10.1111/j.1742-4658.2011.08216.x; Tang PH, 2011, J NEUROSCI, V31, P10403, DOI 10.1523/JNEUROSCI.0182-11.2011; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048	29	476	497	1	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1887	1897		10.1056/NEJMoa1414221	http://dx.doi.org/10.1056/NEJMoa1414221			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25938638	Green Accepted, Green Published			2022-12-28	WOS:000354493300004
J	Chassin, MR; Baker, DW				Chassin, Mark R.; Baker, David W.			Aiming Higher to Enhance Professionalism Beyond Accreditation and Certification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chassin, Mark R.; Baker, David W.] Int Joint Commiss, Oak Brook Terrace, IL 60181 USA		Chassin, MR (corresponding author), Int Joint Commiss, One Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	mchassin@jointcommission.org						ABIM Foundation, PHYS CHART PRINC CHA; ABIM Foundation, CHOOS WIS IN ABIM FD; American Medical Association, HIST AMA ETH; Chassin MR, 2015, JT COMM J QUAL PATIE, V41, P4, DOI 10.1016/S1553-7250(15)41002-5; Chassin MR, 2015, JT COMM J QUAL PATIE, V41, P13, DOI 10.1016/S1553-7250(15)41003-7; Chassin MR, 2013, MILBANK Q, V91, P459, DOI 10.1111/1468-0009.12023; Joint Commission, 2008, ISS 40 BEH UND CULT	7	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1795	1796		10.1001/jama.2015.3818	http://dx.doi.org/10.1001/jama.2015.3818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965212				2022-12-28	WOS:000354391000007
J	Nissen, SE				Nissen, Steven E.			Reforming the Continuing Medical Education System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,J2-230, Cleveland, OH 44195 USA.	nissens@ccf.org						[Anonymous], 2008, ACCME RESP MAC FDN R; Committee on Planning a Continuing Health Professional Education Institute Institute of Medicine, RED CONT ED HLTH PRO; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Hager M, C P J MACY FDN; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; Rutschmann OT, 2004, RESP MED, V98, P932, DOI 10.1016/j.rmed.2004.03.018	7	38	39	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1813	1814		10.1001/jama.2015.4138	http://dx.doi.org/10.1001/jama.2015.4138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965221				2022-12-28	WOS:000354391000016
J	Mele, M; Ferreira, PG; Reverter, F; DeLuca, DS; Monlong, J; Sammeth, M; Young, TR; Goldmann, JM; Pervouchine, DD; Sullivan, TJ; Johnson, R; Segre, AV; Djebali, S; Niarchou, A; Wright, FA; Lappalainen, T; Calvo, M; Getz, G; Dermitzakis, ET; Ardlie, KG; Guigo, R				Mele, Marta; Ferreira, Pedro G.; Reverter, Ferran; DeLuca, David S.; Monlong, Jean; Sammeth, Michael; Young, Taylor R.; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Sullivan, Timothy J.; Johnson, Rory; Segre, Ayellet V.; Djebali, Sarah; Niarchou, Anastasia; Wright, Fred A.; Lappalainen, Tuuli; Calvo, Miquel; Getz, Gad; Dermitzakis, Emmanouil T.; Ardlie, Kristin G.; Guigo, Roderic		GTEx Consortium	The human transcriptome across tissues and individuals	SCIENCE			English	Article							REVEALS; DISCOVERY	Transcriptional regulation and posttranscriptional processing underlie many cellular and organismal phenotypes. We used RNA sequence data generated by Genotype-Tissue Expression (GTEx) project to investigate the patterns of transcriptome variation across individuals and tissues. Tissues exhibit characteristic transcriptional signatures that show stability in postmortem samples. These signatures are dominated by a relatively small number of genes-which is most clearly seen in blood-though few are exclusive to a particular tissue and vary more across tissues than individuals. Genes exhibiting high interindividual expression variation include disease candidates associated with sex, ethnicity, and age. Primary transcription is the major driver of cellular specificity, with splicing playing mostly a complementary role; except for the brain, which exhibits a more divergent splicing program. Variation in splicing, despite its stochasticity, may play in contrast a comparatively greater role in defining individual phenotypes.	[Mele, Marta; Ferreira, Pedro G.; Reverter, Ferran; Monlong, Jean; Sammeth, Michael; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Johnson, Rory; Djebali, Sarah; Guigo, Roderic] CRG, Barcelona, Catalonia, Spain; [Mele, Marta] Harvard Univ, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Genom Geneva iGE3, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Geneva, Switzerland; [Reverter, Ferran; Calvo, Miquel] UB, Fac Biol, Barcelona, Catalonia, Spain; [Reverter, Ferran; Monlong, Jean; Sammeth, Michael; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Johnson, Rory; Djebali, Sarah; Guigo, Roderic] UPF, Barcelona, Catalonia, Spain; [DeLuca, David S.; Young, Taylor R.; Sullivan, Timothy J.; Segre, Ayellet V.; Getz, Gad; Ardlie, Kristin G.] Broad Inst & Harvard, Cambridge, MA USA; [Monlong, Jean] McGill Univ, Montreal, PQ, Canada; [Sammeth, Michael] Natl Inst Sci Comp LNCC, Rio De Janeiro, Brazil; [Goldmann, Jakob M.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Pervouchine, Dmitri D.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119992, Russia; [Wright, Fred A.] N Carolina State Univ, Raleigh, NC 27695 USA; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY USA; [Getz, Gad] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guigo, Roderic] Inst Hosp Mar Invest Med IMIM, Barcelona, Catalonia, Spain; [Guigo, Roderic] IRB, Joint CRG Barcelona Super Comp Ctr BSC, Program Computat Biol, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Barcelona; Pompeu Fabra University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Laboratorio Nacional de Computacao Cientifica (LNCC); Radboud University Nijmegen; Lomonosov Moscow State University; University of North Carolina; North Carolina State University; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Ardlie, KG (corresponding author), CRG, Barcelona, Catalonia, Spain.	kardlie@broadinstitute.org; roderic.guigo@crg.cat	Ferreira, Pedro G/J-6379-2013; Pervouchine, Dmitri/H-5252-2015; Sammeth, Michael/C-1157-2014; Pervouchine, Dmitri/AAU-5399-2021; Johnson, Rory/ABE-2503-2021; Guigo, Roderic/D-1303-2010; Lappalainen, Tuuli/AAE-6532-2020; Goldmann, Jakob M/K-5948-2013; Monlong, Jean/AAZ-8589-2020; reverter, ferran/I-1547-2015; Ferreira, Pedro/HDO-1346-2022; Djebali, Sarah/O-9817-2014; Pervouchine, Dmitri/AAE-2178-2020; Little, Roger/O-6191-2014	Ferreira, Pedro G/0000-0003-3838-8664; Pervouchine, Dmitri/0000-0003-0543-9760; Sammeth, Michael/0000-0002-6528-9883; Pervouchine, Dmitri/0000-0003-0543-9760; Johnson, Rory/0000-0003-4607-2782; Guigo, Roderic/0000-0002-5738-4477; Lappalainen, Tuuli/0000-0002-7746-8109; Goldmann, Jakob M/0000-0002-8514-573X; Monlong, Jean/0000-0002-9737-5516; reverter, ferran/0000-0002-9489-3350; Djebali, Sarah/0000-0002-0599-1267; Little, Roger/0000-0001-6831-0177; Calvo LLorca, Miguel/0000-0002-4016-3336; mele, marta/0000-0001-8874-6453	Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute (NCI); National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; United States National Institutes of Health [HHSN261200800001E, 10XS170, 10XS171, 10X172, 12ST1039, 10ST1035, HHSN268201000029C, R01 DA006227-17, R01 MH090941]; European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation [R01 MH090936]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2011-26205]; Generalitat de Catalunya [2014 SGR 464, 2014 SGR 1319]; European Research Council-European Commission [294653]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101819, R01MH090936, R01MH090941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Research Council-European Commission(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge and thank the donors and their families for their generous gifts of organ donation for transplantation and tissue donations for the GTEx research study. We thank the Genomics Platform at the Broad Institute for data generation; L. Gaffney for help with figures; E. Gelfand and C. Trowbridge for project support and members of the Analysis Working Group for feedback; and D. MacArthur, J. Maller, and B. Neale for critical reading of the manuscript. The primary and processed data used to generate the analyses presented here are available in the following locations: All primary sequence files are deposited in and available from dbGaP (phs000424.v3.p1); gene and transcript quantifications are available on the GTEx Portal (www.gtexportal.org). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health (http://commonfund.nih.gov/GTEx). Additional funds were provided by the National Cancer Institute (NCI); National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; and National Institute of Neurological Disorders and Stroke. This work was supported by the following grants and contracts from the United States National Institutes of Health: contract HHSN261200800001E (Leidos Prime contract with NCI); contracts 10XS170 [National Disease Research Interchange (NDRI)], 10XS171 (Roswell Park Cancer Institute), 10X172 (Science Care Inc.), and 12ST1039 (IDOX); contract 10ST1035 (Van Andel Institute); contract HHSN268201000029C (Broad Institute); R01 DA006227-17 (University of Miami Brain Bank); R01 MH090941 (University of Geneva), European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation to E.T.D.; R01 MH090936 (University of North Carolina-Chapel Hill); and grants BIO2011-26205 from the Spanish Ministerio de Ciencia e Innovacion (MICINN), 2014 SGR 464 and 2014 SGR 1319 from the Generalitat de Catalunya, and 294653 from the European Research Council-European Commission.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Regitz-Zagrosek V, 2011, WIEN MED WOCHENSCHR, V161, P109, DOI 10.1007/s10354-011-0892-8; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	22	733	744	8	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					660	665		10.1126/science.aaa0355	http://dx.doi.org/10.1126/science.aaa0355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954002	Green Accepted			2022-12-28	WOS:000354045700037
J	Spitale, JN; Hurford, TA; Rhoden, AR; Berkson, EE; Platts, SS				Spitale, Joseph N.; Hurford, Terry A.; Rhoden, Alyssa R.; Berkson, Emily E.; Platts, Symeon S.			Curtain eruptions from Enceladus' south-polar terrain	NATURE			English	Article							JETS	Observations of the south pole of the Saturnian moon Enceladus revealed large rifts in the south-polar terrain, informally called 'tiger stripes', named Alexandria, Baghdad, Cairo and Damascus Sulci. These fractures have been shown to be the sources of the observed jets of water vapour and icy particles(1-4) and to exhibit higher temperatures than the surrounding terrain(5,6). Subsequent observations have focused on obtaining close-up imaging of this region to better characterize these emissions. Recent work(7) examined those newer data sets and used triangulation of discrete jets3 to produce maps of jetting activity at various times. Here we show that much of the eruptive activity can be explained by broad, curtain-like eruptions. Optical illusions in the curtain eruptions resulting from a combination of viewing direction and local fracture geometry produce image features that were probably misinterpreted previously as discrete jets. We present maps of the total emission along the fractures, rather than just the jet-like component, for five times during an approximately one-year period in 2009 and 2010. An accurate picture of the style, timing and spatial distribution of the south-polar eruptions is crucial to evaluating theories for the mec(h)anism controlling the eruptions.	[Spitale, Joseph N.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Hurford, Terry A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Rhoden, Alyssa R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Berkson, Emily E.] Rochester Inst Technol, Rochester, NY 14623 USA; [Platts, Symeon S.] Univ Arizona, Film & Televis Dept, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Rochester Institute of Technology; University of Arizona	Spitale, JN (corresponding author), Planetary Sci Inst, 1700 East Ft Lowell Rd,Suite 106, Tucson, AZ 85719 USA.	jnspitale@psi.edu	Hurford, Terry/F-2625-2012		Cassini Data Analysis and Participating Scientists Program [NNX13AG45G]	Cassini Data Analysis and Participating Scientists Program	This work was funded by grant number NNX13AG45G of the Cassini Data Analysis and Participating Scientists Program. We thank M. Hedman, P. Thomas and C. Howett for conversations on this topic.	Hansen CJ, 2008, NATURE, V456, P477, DOI 10.1038/nature07542; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Howett CJA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003718; Porco C, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/3/45; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217	7	40	40	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					57	U368		10.1038/nature14368	http://dx.doi.org/10.1038/nature14368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951283				2022-12-28	WOS:000354040900031
J	Sprunck, S; Dresselhaus, T				Sprunck, Stefanie; Dresselhaus, Thomas			Three Cell Fusions during Double Fertilization	CELL			English	Editorial Material							TUBE GROWTH; ARABIDOPSIS; GUIDANCE	Fertilization of both egg and central cell is a major distinguishing feature of flowering plants. Now, Maruyama et al. report a third cell fusion event between the persistent synergid and the fertilized central cell shortly after double fertilization in Arabidopsis. This causes rapid dilution of pollen tube attractant(s), preventing polytubey.	[Sprunck, Stefanie; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, D-93053 Regensburg, Germany	University of Regensburg	Dresselhaus, T (corresponding author), Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, D-93053 Regensburg, Germany.	thomas.dresselhaus@ur.de						Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Dresselhaus T, 2013, MOL PLANT, V6, P1018, DOI 10.1093/mp/sst061; Friedman WE, 2009, AM J BOT, V96, P129, DOI 10.3732/ajb.0800311; Guignard M.L., 1899, REV G N BOT, V11, P129; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; Navashin S. G., 1898, B ACAD SCI ST PETERS, V9, P377; Schulz S.R., 1968, AM J BOT, V55, P541; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449	9	4	4	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					708	709		10.1016/j.cell.2015.04.032	http://dx.doi.org/10.1016/j.cell.2015.04.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957679	Bronze			2022-12-28	WOS:000354175200005
J	Verma, A; Jiang, CY; Betts, TR; Chen, J; Deisenhofer, I; Mantovan, R; Macle, L; Morillo, CA; Haverkamp, W; Weerasooriya, R; Albenque, JP; Nardi, S; Menardi, E; Novak, P; Sanders, P				Verma, Atul; Jiang, Chen-Yang; Betts, Timothy R.; Chen, Jian; Deisenhofer, Isabel; Mantovan, Roberto; Macle, Laurent; Morillo, Carlos A.; Haverkamp, Wilhelm; Weerasooriya, Rukshen; Albenque, Jean-Paul; Nardi, Stefano; Menardi, Endrj; Novak, Paul; Sanders, Prashanthan		STAR AF II Investigators	Approaches to Catheter Ablation for Persistent Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the European-Society-of-Cardiology (ESC)	AUG 30-SEP 03, 2014	Barcelona, SPAIN	European Soc Cardiol			PULMONARY VEIN ISOLATION; TRIGGER ABLATION; LINEAR ABLATION; MULTICENTER; ELECTROGRAMS; VALIDATION; SUBSTRATE; AF	BACKGROUND Catheter ablation is less successful for persistent atrial fibrillation than for paroxysmal atrial fibrillation. Guidelines suggest that adjuvant substrate modification in addition to pulmonary-vein isolation is required in persistent atrial fibrillation. METHODS We randomly assigned 589 patients with persistent atrial fibrillation in a 1: 4: 4 ratio to ablation with pulmonary-vein isolation alone (67 patients), pulmonary-vein isolation plus ablation of electrograms showing complex fractionated activity (263 patients), or pulmonary-vein isolation plus additional linear ablation across the left atrial roof and mitral valve isthmus (259 patients). The duration of follow-up was 18 months. The primary end point was freedom from any documented recurrence of atrial fibrillation lasting longer than 30 seconds after a single ablation procedure. RESULTS Procedure time was significantly shorter for pulmonary-vein isolation alone than for the other two procedures (P < 0.001). After 18 months, 59% of patients assigned to pulmonary-vein isolation alone were free from recurrent atrial fibrillation, as compared with 49% of patients assigned to pulmonary-vein isolation plus complex electrogram ablation and 46% of patients assigned to pulmonary-vein isolation plus linear ablation (P = 0.15). There were also no significant differences among the three groups for the secondary end points, including freedom from atrial fibrillation after two ablation procedures and freedom from any atrial arrhythmia. Complications included tamponade (three patients), stroke or transient ischemic attack (three patients), and atrioesophageal fistula (one patient). CONCLUSIONS Among patients with persistent atrial fibrillation, we found no reduction in the rate of recurrent atrial fibrillation when either linear ablation or ablation of complex fractionated electrograms was performed in addition to pulmonary-vein isolation. (Funded by St. Jude Medical; ClinicalTrials.gov number, NCT01203748.)	[Verma, Atul] Southlake Reg Hlth Ctr, Newmarket, ON L3Y 2P6, Canada; [Macle, Laurent] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Morillo, Carlos A.] McMaster Univ, Hamilton, ON, Canada; [Novak, Paul] Royal Jubilee Hosp, Victoria, BC, Canada; [Jiang, Chen-Yang] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Betts, Timothy R.] John Radcliffe Hosp, Oxford OX3 9DU, England; [Chen, Jian] Haukeland Hosp, N-5021 Bergen, Norway; [Deisenhofer, Isabel] German Heart Ctr, Munich, Germany; [Haverkamp, Wilhelm] Charite Campus Virchow Klinikum, Berlin, Germany; [Mantovan, Roberto] Osped Gen Provinciale M Bufalini, Cesena, Italy; [Nardi, Stefano] Presidio Osped Pineta Grande, Castel Volturno, Italy; [Menardi, Endrj] Osped Santa Croce & Carle, Cuneo, Italy; [Weerasooriya, Rukshen] Hollywood Private Hosp, Perth, WA, Australia; [Sanders, Prashanthan] Univ Adelaide, Adelaide, SA, Australia; [Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA, Australia; [Albenque, Jean-Paul] Clin Pasteur Toulouse, Toulouse, France	Southlake Regional Health Centre; Universite de Montreal; McMaster University; Zhejiang University; University of Oxford; German Heart Centre Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Western Australia; University of Adelaide; Royal Adelaide Hospital	Verma, A (corresponding author), Southlake Reg Hlth Ctr, 602-581 Davis Dr, Newmarket, ON L3Y 2P6, Canada.	atul.verma@utoronto.ca	Sanders, Prashanthan/D-7641-2013; Nardi, Stefano/AAW-4829-2021; Macle, laurent/AAA-4675-2021	Sanders, Prashanthan/0000-0003-3803-8429; Nardi, Stefano/0000-0001-6906-1766; Macle, laurent/0000-0002-3328-5239; Morillo, Carlos/0000-0002-8739-2099; Deisenhofer, Isabel/0000-0001-5826-6846; Betts, Timothy/0000-0001-9063-9905; Essebag, Vidal/0000-0003-0107-5197				Arbelo E, 2014, EUR HEART J, V35, P1466, DOI 10.1093/eurheartj/ehu001; Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017; Calkins H, 2009, HEART RHYTHM, V6, P148, DOI 10.1016/j.hrthm.2008.12.008; Calkins H, 2012, J INTERV CARD ELECTR, V33, P171, DOI 10.1007/s10840-012-9672-7; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Dixit S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P287, DOI 10.1161/CIRCEP.111.966226; Dorian P, 2009, CIRC-ARRHYTHMIA ELEC, V2, P218, DOI 10.1161/CIRCEP.108.812347; Elayi CS, 2008, HEART RHYTHM, V5, P1658, DOI 10.1016/j.hrthm.2008.09.016; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2014, J AM COLL CARDIOL, V63, P1761, DOI 10.1016/j.jacc.2014.02.543; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Oral H, 2009, J AM COLL CARDIOL, V53, P782, DOI 10.1016/j.jacc.2008.10.054; Parkash R, 2010, CURR OPIN CARDIOL, V25, P1, DOI 10.1097/HCO.0b013e3283336d52; Sawhney N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P243, DOI 10.1161/CIRCEP.109.924878; Shah AJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P957, DOI 10.1161/CIRCEP.112.971259; Shah AJ, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/950763; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Verma A, 2012, AM HEART J, V164, P1, DOI 10.1016/j.ahj.2012.04.002; Verma A, 2011, CAN J CARDIOL, V27, P60, DOI 10.1016/j.cjca.2010.11.011; Verma A, 2011, CURR OPIN CARDIOL, V26, P17, DOI 10.1097/HCO.0b013e3283413925; Verma A, 2010, EUR HEART J, V31, P1344, DOI 10.1093/eurheartj/ehq041; Verma A, 2008, HEART RHYTHM, V5, P198, DOI 10.1016/j.hrthm.2007.09.027; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; Wyse DG, 2013, CAN J CARDIOL, V29, P1150, DOI 10.1016/j.cjca.2013.03.001	31	1231	1260	4	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1812	1822		10.1056/NEJMoa1408288	http://dx.doi.org/10.1056/NEJMoa1408288			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CH4BB	25946280				2022-12-28	WOS:000353974700006
J	Gregg, J				Gregg, Jessica			A Startling Injustice: Pain, Opioids, and Addiction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICATION-ASSISTED TREATMENT; GUIDELINES		Hooper Detoxificat & Stabilizat Ctr, Portland, OR 97232 USA		Gregg, J (corresponding author), Hooper Detoxificat & Stabilizat Ctr, 1535 North Williams Ave, Portland, OR 97232 USA.	Jessica.Gregg@centralcityconcern.org						Centers for Disease Control and Prevention, 2010, HOM REC SAF PRESCR D; Centers for Disease Control and Prevention (CDC), 2011, VIT SIGNS PRESCR PAI; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Krupitsky EM, 2010, CURR OPIN PSYCHIATR, V23, P210, DOI 10.1097/YCO.0b013e3283386578; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; National Center on Addiction and Substance Abuse at Columbia University, 2012, ADD MED CLOS GAP SCI; Thomas CP, 2014, PSYCHIAT SERV, V65, P158, DOI 10.1176/appi.ps.201300256	10	4	4	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					651	U247		10.7326/M14-1396	http://dx.doi.org/10.7326/M14-1396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938994				2022-12-28	WOS:000354119100010
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Bad language	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2015	350								h2342	10.1136/bmj.h2342	http://dx.doi.org/10.1136/bmj.h2342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0FV	25944547	Bronze			2022-12-28	WOS:000354413100004
J	Watts, G				Watts, Geoff			Wayne Riley: energetic new President for century-old ACP	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1719	1719		10.1016/S0140-6736(15)60880-7	http://dx.doi.org/10.1016/S0140-6736(15)60880-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943927				2022-12-28	WOS:000353726000014
J	Koenderink, AF; Alu, A; Polman, A				Koenderink, A. Femius; Alu, Andrea; Polman, Albert			Nanophotonics: Shrinking light-based technology	SCIENCE			English	Review							SINGLE-MOLECULE; SOLAR-CELLS; PLASMONICS; EMISSION; PLATFORM	The study of light at the nanoscale has become a vibrant field of research, as researchers now master the flow of light at length scales far below the optical wavelength, largely surpassing the classical limits imposed by diffraction. Using metallic and dielectric nanostructures precisely sculpted into two-dimensional (2D) and 3D nanoarchitectures, light can be scattered, refracted, confined, filtered, and processed in fascinating new ways that are impossible to achieve with natural materials and in conventional geometries. This control over light at the nanoscale has not only unveiled a plethora of new phenomena but has also led to a variety of relevant applications, including new venues for integrated circuitry, optical computing, solar, and medical technologies, setting high expectations for many novel discoveries in the years to come.	[Koenderink, A. Femius; Alu, Andrea; Polman, Albert] FOM Inst AMOLF, Ctr Nanophoton, NL-1098 XG Amsterdam, Netherlands; [Alu, Andrea] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA	AMOLF; University of Texas System; University of Texas Austin	Polman, A (corresponding author), FOM Inst AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	polman@amolf.nl	Polman, Albert/D-1490-2011; Alu, Andrea/A-1328-2007; Koenderink, A. Femius/A-3955-2008	Polman, Albert/0000-0002-0685-3886; Alu, Andrea/0000-0002-4297-5274; Koenderink, A. Femius/0000-0003-1617-5748	European Research Council; NanoNextNL, a research and technology program of the Dutch Ministry of Economic Affairs; Royal Netherlands Academy of Arts and Sciences Visiting Professorship program; U.S. Office of Naval Research; Multidisciplinary University Research Initiative [N00014-10-1-0942]	European Research Council(European Research Council (ERC)European Commission); NanoNextNL, a research and technology program of the Dutch Ministry of Economic Affairs; Royal Netherlands Academy of Arts and Sciences Visiting Professorship program; U.S. Office of Naval Research(Office of Naval Research); Multidisciplinary University Research Initiative(MURI)	This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO). It is also supported by the European Research Council and NanoNextNL, a research and technology program of the Dutch Ministry of Economic Affairs. A. A. was supported by the Royal Netherlands Academy of Arts and Sciences Visiting Professorship program and by the U.S. Office of Naval Research with Multidisciplinary University Research Initiative grant N00014-10-1-0942. A.P. is cofounder and co-owner of a Delmic BV, a startup company that commercializes a cathodoluminescence microscopy instrument. We gratefully acknowledge discussions with A. Lagendijk, K. Kuipers, J. Gomez Rivas, E. Garnett, E. Verhagen, B. Ehrler, the students and postdocs of AMOLF's Center for Nanophotonics, and many nanophotonics colleagues all over the world.	Akselrod GM, 2014, NAT PHOTONICS, V8, P835, DOI [10.1038/nphoton.2014.228, 10.1038/NPHOTON.2014.228]; Atre AC, 2015, NAT NANOTECHNOL, V10, P429, DOI [10.1038/nnano.2015.39, 10.1038/NNANO.2015.39]; Bardhan R, 2011, ACCOUNTS CHEM RES, V44, P936, DOI 10.1021/ar200023x; Burgos SP, 2013, ACS NANO, V7, P10038, DOI 10.1021/nn403991d; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Chen XW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.233001; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Englund D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.093604; Fakonas JS, 2014, NAT PHOTONICS, V8, P317, DOI [10.1038/NPHOTON.2014.40, 10.1038/nphoton.2014.40]; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Frimmer M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.123602; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Garnett EC, 2012, NAT MATER, V11, P241, DOI [10.1038/NMAT3238, 10.1038/nmat3238]; Hausmann BJM, 2012, NANO LETT, V12, P1578, DOI 10.1021/nl204449n; Hirose K, 2014, NAT PHOTONICS, V8, P406, DOI 10.1038/nphoton.2014.75; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Krogstrup P, 2013, NAT PHOTONICS, V7, P306, DOI [10.1038/NPHOTON.2013.32, 10.1038/nphoton.2013.32]; Kuramochi E, 2014, NAT PHOTONICS, V8, P474, DOI 10.1038/nphoton.2014.93; Lapine M, 2014, REV MOD PHYS, V86, P1093, DOI 10.1103/RevModPhys.86.1093; le Feber B, 2014, NAT PHOTONICS, V8, P43, DOI [10.1038/nphoton.2013.323, 10.1038/NPHOTON.2013.323]; Lee J, 2014, NATURE, V511, P65, DOI 10.1038/nature13455; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Lozano G, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.22; McNally B, 2010, NANO LETT, V10, P2237, DOI 10.1021/nl1012147; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Nicoletti O, 2013, NATURE, V502, P80, DOI 10.1038/nature12469; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Pendry JB, 2015, SCIENCE, V348, P521, DOI 10.1126/science.1261244; Plum E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113902; Punj D, 2013, NAT NANOTECHNOL, V8, P512, DOI [10.1038/NNANO.2013.98, 10.1038/nnano.2013.98]; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Sapienza R, 2012, NAT MATER, V11, P781, DOI [10.1038/NMAT3402, 10.1038/nmat3402]; Sauvan C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.237401; Savage KJ, 2012, NATURE, V491, P574, DOI 10.1038/nature11653; Schaferling M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031010; Schwartz T, 2011, PHYS REV LETT, V106, DOI [10.1109/CLEOE.2011.5943715, 10.1103/PhysRevLett.106.196405]; Sersic I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.223903; Sheldon MT, 2014, SCIENCE, V346, P828, DOI 10.1126/science.1258405; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]; Sounas DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3407; Spinelli P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1691; Tzuang LD, 2014, NAT PHOTONICS, V8, P701, DOI [10.1038/NPHOTON.2014.177, 10.1038/nphoton.2014.177]; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wallentin J, 2013, SCIENCE, V339, P1057, DOI 10.1126/science.1230969; Xu T, 2013, NATURE, V497, P470, DOI 10.1038/nature12158; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151	53	380	396	15	552	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					516	521		10.1126/science.1261243	http://dx.doi.org/10.1126/science.1261243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931548				2022-12-28	WOS:000353778100028
J	Ray, MW; Ruokokoski, E; Tiurev, K; Mottonen, M; Hall, DS				Ray, M. W.; Ruokokoski, E.; Tiurev, K.; Mottonen, M.; Hall, D. S.			Observation of isolated monopoles in a quantum field	SCIENCE			English	Article							MAGNETIC MONOPOLES	Topological defects play important roles throughout nature, appearing in contexts as diverse as cosmology, particle physics, superfluidity, liquid crystals, and metallurgy. Point defects can arise naturally as magnetic monopoles resulting from symmetry breaking in grand unified theories. We devised an experiment to create and detect quantum mechanical analogs of such monopoles in a spin-1 Bose-Einstein condensate. The defects, which were stable on the time scale of our experiments, were identified from spin-resolved images of the condensate density profile that exhibit a characteristic dependence on the choice of quantization axis. Our observations lay the foundation for experimental studies of the dynamics and stability of topological point defects in quantum systems.	[Ray, M. W.; Hall, D. S.] Amherst Coll, Dept Phys & Astron, Amherst, MA 01002 USA; [Ruokokoski, E.; Tiurev, K.; Mottonen, M.] Aalto Univ, QCD Labs, COMP Ctr Excellence, Dept Appl Phys, FI-00076 Aalto, Finland; [Mottonen, M.] Aalto Univ, Low Temp Lab OVLL, FI-00076 Aalto, Finland	Amherst College; Aalto University; Aalto University	Mottonen, M (corresponding author), Aalto Univ, QCD Labs, COMP Ctr Excellence, Dept Appl Phys, FI-00076 Aalto, Finland.	mikko.mottonen@aalto.fi	Möttönen, Mikko/A-6929-2012; Ray, Michael W/A-2217-2014; Möttönen, Mikko/AAW-6120-2021	Möttönen, Mikko/0000-0001-5084-2298; Möttönen, Mikko/0000-0001-5084-2298; Ray, Michael/0000-0002-8829-1257; Hall, David/0000-0002-2839-7623; Tiurev, Konstantin/0000-0002-9216-3696	NSF [PHY-1205822]; Academy of Finland through its Centres of Excellence Program [251748]; Finnish Doctoral Programme in Computational Sciences; Magnus Ehrnrooth Foundation; CSC-IT Center for Science Ltd. [ay2090];  [135794];  [272806]; Division Of Physics [1205822] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Academy of Finland through its Centres of Excellence Program; Finnish Doctoral Programme in Computational Sciences; Magnus Ehrnrooth Foundation; CSC-IT Center for Science Ltd.; ; ; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by NSF grant PHY-1205822, the Academy of Finland through its Centres of Excellence Program (grant 251748) and grants 135794 and 272806, the Finnish Doctoral Programme in Computational Sciences, and the Magnus Ehrnrooth Foundation. We thank CSC-IT Center for Science Ltd. (project no. ay2090) and Aalto Science-IT project for computational resources, M. Nakahara and M. Krusius for discussions concerning this work, and N. H. Thomas and S. J. Vickery for experimental assistance. All data used to support the conclusions of this work are presented in this manuscript and the supplementary materials. M.W.R. and D.S.H. developed and conducted the experiments and analyzed the data. E.R. and K.T. performed the numerical simulations under the guidance of M. M., who provided the initial ideas and suggestions for the experiment. All authors discussed both experimental and theoretical results and commented on the manuscript.	Ashcroft N.W., 1976, SOLID STATE PHYS; Blaauwgeers R, 2000, NATURE, V404, P471, DOI 10.1038/35006583; Blaauwgeers R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.155301; Borgh MO, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.015302; Bramwell ST, 2009, NATURE, V461, P956, DOI 10.1038/nature08500; Choi JY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.245301; Choi JY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035301; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Donnelly R. J., 1991, QUANTIZED VORTICES H, V2; Fetter AL, 2009, REV MOD PHYS, V81, P647, DOI 10.1103/RevModPhys.81.647; Kawaguchi Y, 2012, PHYS REP, V520, P253, DOI 10.1016/j.physrep.2012.07.005; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Milde P, 2013, SCIENCE, V340, P1076, DOI 10.1126/science.1234657; Nakahara M., 2003, GEOMETRY TOPOLOGY PH; Pietila V, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.030401; Pietila V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.080403; POLYAKOV AM, 1974, JETP LETT+, V20, P194; Preskill J, 1984, ANNU REV NUCL PART S, V34, P461, DOI 10.1146/annurev.ns.34.120184.002333; Ray MW, 2014, NATURE, V505, P657, DOI 10.1038/nature12954; Ruostekoski J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.190402; Ruseckas J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010404; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Senyuk B, 2013, NATURE, V493, P200, DOI 10.1038/nature11710; Stoof HTC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120407; THOOFT G, 1974, NUCL PHYS B, VB 79, P276; TOULOUSE G, 1976, J PHYS LETT-PARIS, V37, pL149, DOI 10.1051/jphyslet:01976003706014900; Zhang WX, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.180403; Zhou F, 2003, INT J MOD PHYS B, V17, P2643, DOI 10.1142/S0217979203018399	29	79	79	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					544	547		10.1126/science.1258289	http://dx.doi.org/10.1126/science.1258289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931553				2022-12-28	WOS:000353778100034
J	Reeves, A; Gourtsoyannis, Y; Basu, S; McCoy, D; McKee, M; Stuckler, D				Reeves, Aaron; Gourtsoyannis, Yannis; Basu, Sanjay; McCoy, David; McKee, Martin; Stuckler, David			Financing universal health coverage-effects of alternative tax structures on public health systems: cross-national modelling in 89 low-income and middle-income countries	LANCET			English	Article							SOUTH-AFRICA; CARE; EQUITY; TAXATION	Background How to finance progress towards universal health coverage in low-income and middle-income countries is a subject of intense debate. We investigated how alternative tax systems affect the breadth, depth, and height of health system coverage. Methods We used cross-national longitudinal fixed effects models to assess the relationships between total and different types of tax revenue, health system coverage, and associated child and maternal health outcomes in 89 low-income and middle-income countries from 1995-2011. Findings Tax revenue was a major statistical determinant of progress towards universal health coverage. Each US$100 per capita per year of additional tax revenues corresponded to a yearly increase in government health spending of $9.86 (95% CI 3.92-15.8), adjusted for GDP per capita. This association was strong for taxes on capital gains, profits, and income ($16.7, 9.16 to 24.3), but not for consumption taxes on goods and services (-$4.37, -12.9 to 4.11). In countries with low tax revenues (<$1000 per capita per year), an additional $100 tax revenue per year substantially increased the proportion of births with a skilled attendant present by 6.74 percentage points (95% CI 0.87-12.6) and the extent of financial coverage by 11.4 percentage points (5.51-17.2). Consumption taxes, a more regressive form of taxation that might reduce the ability of the poor to afford essential goods, were associated with increased rates of post-neonatal mortality, infant mortality, and under-5 mortality rates. We did not detect these adverse associations with taxes on capital gains, profits, and income, which tend to be more progressive. Interpretation Increasing domestic tax revenues is integral to achieving universal health coverage, particularly in countries with low tax bases. Pro-poor taxes on profits and capital gains seem to support expanding health coverage without the adverse associations with health outcomes observed for higher consumption taxes. Progressive tax policies within a pro-poor framework might accelerate progress toward achieving major international health goals. Copyright (C) Reeves et al. Open Access article distributed under the terms of CC BY.	[Reeves, Aaron; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England; [Gourtsoyannis, Yannis; Basu, Sanjay; McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Basu, Sanjay] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [McCoy, David] Queen Mary Univ London, Dept Primary Care & Publ Hlth, London, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Stanford University; University of London; Queen Mary University London	Reeves, A (corresponding author), Dept Sociol, Manor Rd Bldg,Manor Rd, Oxford OX1 3UQ, England.	aaron.reeves@sociology.ox.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401; Reeves, Aaron/0000-0001-9114-965X	Commission of the European Communities (FP7-DEMETRIQ); European Union's HRES grants; Wellcome Trust; Commission of the European Communities [278511]; EU-HRES [313590]; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Commission of the European Communities (FP7-DEMETRIQ); European Union's HRES grants; Wellcome Trust(Wellcome TrustEuropean Commission); Commission of the European Communities(European Commission); EU-HRES; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Commission of the European Communities (FP7-DEMETRIQ), the European Union's HRES grants, and the Wellcome Trust.; This study was carried out with financial support from the Commission of the European Communities, Grant Agreement no. 278511. The study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. DS is funded by a Wellcome Trust Investigator Award, and by EU-HRES, Grant Agreement no. 313590.	Auriol E, 2005, J PUBLIC ECON, V89, P625, DOI 10.1016/j.jpubeco.2004.04.008; Chan M., 2012, COMMUNICATION; Dieckmann Sarah, 2011, NOT SHARING LOOT INV; Feigl AB, 2013, HEALTH POLICY, V113, P50, DOI 10.1016/j.healthpol.2013.06.009; Fiscal Affairs Department, 2011, REV MOB DEV COUNTR; ILO, 2010, WORLD SOC SEC REP 20; International Monetary Fund (IMF), 2001, GOV FIN STAT MAN 200; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Laffer A, 2004, LAFFER CURVE PRESENT; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Lusardi A, 2015, SOC SCI QUART, V96, P202, DOI 10.1111/ssqu.12076; Martin IW, 2014, ANNU REV SOCIOL, V40, P331, DOI 10.1146/annurev-soc-071913-043229; McIntyre, 2014, FISCAL SPACE DOMESTI; McIntyre D, 2012, HEALTH POLICY PLANN, V27, pi101, DOI 10.1093/heapol/czs003; McKee M, 2013, VALUE HEALTH, V16, pS39, DOI 10.1016/j.jval.2012.10.001; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Moore M, 2004, INT POLIT SCI REV, V25, P297, DOI 10.1177/0192512104043018; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Morrissey O, 2013, TAX INCIDENCE LOW IN; Navarro V, 2006, LANCET, V368, P1033, DOI 10.1016/S0140-6736(06)69341-0; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Prasad M, 2009, SOCIO-ECON REV, V7, P431, DOI 10.1093/ser/mwp005; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Rego SO, 2003, CONTEMP ACCOUNT RES, V20, P805, DOI 10.1506/VANN-B7UB-GMFA-9E6W; Stuckler D, 2010, 1 GLOB S HLTH SYST R; Stuckler D, 2011, INT J HEALTH SERV, V41, P67, DOI 10.2190/HS.41.1.e; Treasury H, 2013, UK GOVT ASSIST TANZA; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2014, GLOB HLTH OBS GHO; WHO World Health Organization, 2006, CONST WHO; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Health Organization, 2012, 65 WORLD HLTH ASS; World Health Organization, 2021, COVID 19 SOCIAL DETE; Yu CP, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-15	36	87	88	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					274	280		10.1016/S0140-6736(15)60574-8	http://dx.doi.org/10.1016/S0140-6736(15)60574-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN1XI	25982041	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000358213700032
J	Winter, GE; Buckley, DL; Paulk, J; Roberts, JM; Souza, A; Dhe-Paganon, S; Bradner, JE				Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.			Phthalimide conjugation as a strategy for in vivo target protein degradation	SCIENCE			English	Article							BET BROMODOMAINS; SELECTIVE-INHIBITION; THALIDOMIDE; MOLECULES; COMPLEX; UBIQUITINATION; ACTIVATION; LEUKEMIA; CANCER; CELLS	The development of effective pharmacological inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem. In part, this is because many small-molecule antagonists disrupt the activity of only one domain in the target protein. We devised a chemical strategy that promotes ligand-dependent target protein degradation using as an example the transcriptional coactivator BRD4, a protein critical for cancer cell growth and survival. We appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex. The resultant compound, dBET1, induced highly selective cereblon-dependent BET protein degradation in vitro and in vivo and delayed leukemia progression in mice. A second series of probes resulted in selective degradation of the cytosolic protein FKBP12. This chemical strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.	[Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Bradner, JE (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	james_bradner@dfci.harvard.edu	高, 雨莉/HGU-8187-2022	Roberts, Justin/0000-0001-6112-7476; Winter, Georg/0000-0001-6606-1437	EMBO long-term fellowship; NATIONAL CANCER INSTITUTE [R01CA176745, P01CA066996] Funding Source: NIH RePORTER	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Kaelin, S. Orkin, and R. Mazitschek for engaging discussions and W. Kaelin for cellular reagents; S.-H. Seo and S. Deangelo for assistance in the purification of BRD4; C. Ott for help with in vivo model studies; and N. Thoma for CRBN expression reagents. This research was supported by generous philanthropic gifts from Marc Cohen and Alain Cohen, the William Lawrence and Blanche Hughes Foundation, and the NIH (R01-CA176745 and P01-CA066996 to J.E.B.). G.E.W. is supported by an EMBO long-term fellowship. D.L.B. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2196-14). Atomic coordinates and structure factors have been deposited in the Protein Data Bank (accession code 4ZC9). Quantitative proteomics studies were performed by R. Kunz of the Thermo Fisher Scientific Center for Multiplexed Proteomics at Harvard Medical School. Dana-Farber Cancer Institute has filed patent applications (62/096,318; 62/128,457; 62/149,170) that include the dBET and dFKBP compositions described in this manuscript. J.E.B. is a Founder of Tensha Therapeutics, a biotechnology company that develops druglike derivatives of JQ1 as investigational cancer therapies.	Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Hines J, 2013, P NATL ACAD SCI USA, V110, P8942, DOI 10.1073/pnas.1217206110; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Itoh Y, 2010, J AM CHEM SOC, V132, P5820, DOI 10.1021/ja100691p; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sufan RI, 2006, NEOPLASIA, V8, P956, DOI 10.1593/neo.06520; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	870	957	28	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1376	1381		10.1126/science.aab1433	http://dx.doi.org/10.1126/science.aab1433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	25999370	Green Accepted			2022-12-28	WOS:000356449500055
J	Varkey, JB; Shantha, JG; Crozier, I; Kraft, CS; Lyon, GM; Mehta, AK; Kumar, G; Smith, JR; Kainulainen, MH; Whitmer, S; Stroher, U; Uyeki, TM; Ribner, BS; Yeh, S				Varkey, Jay B.; Shantha, Jessica G.; Crozier, Ian; Kraft, Colleen S.; Lyon, G. Marshall; Mehta, Aneesh K.; Kumar, Gokul; Smith, Justine R.; Kainulainen, Markus H.; Whitmer, Shannon; Stroeher, Ute; Uyeki, Timothy M.; Ribner, Bruce S.; Yeh, Steven			Persistence of Ebola Virus in Ocular Fluid during Convalescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; DISEASE; KIKWIT; CONGO	Among the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown. We describe a patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence. Viable Zaire ebolavirus (EBOV) was detected in aqueous humor 14 weeks after the onset of EVD and 9 weeks after the clearance of viremia.	[Varkey, Jay B.; Kraft, Colleen S.; Lyon, G. Marshall; Mehta, Aneesh K.; Ribner, Bruce S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Shantha, Jessica G.; Kumar, Gokul; Yeh, Steven] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Kraft, Colleen S.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kainulainen, Markus H.; Whitmer, Shannon; Stroeher, Ute; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Crozier, Ian] Mulago Hosp Complex, Infect Dis Inst, Kampala, Uganda; [Smith, Justine R.] Flinders Univ S Australia, Adelaide, SA 5001, Australia	Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Mulago National Referral Hospital; Flinders University South Australia	Yeh, S (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, 1365B Clifton Rd NE, Atlanta, GA 30322 USA.	steven.yeh@emory.edu	Smith, Justine/Y-9044-2019; Kraft, Colleen S/M-2347-2013; Mehta, Aneesh/B-8054-2012	Smith, Justine/0000-0002-4756-5493; Kraft, Colleen S/0000-0003-1757-8477; Mehta, Aneesh/0000-0002-6552-9162	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Research to Prevent Blindness; National Eye Institute [P30-EY06360]; Australian Research Council [FT130101648]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY006360] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Australian Research Council(Australian Research Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by a grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454, to the Atlanta Clinical and Translational Science Institute), an unrestricted grant from Research to Prevent Blindness and a grant from the National Eye Institute (P30-EY06360, to the Department of Ophthalmology, Emory University School of Medicine), and a fellowship grant from the Australian Research Council (FT130101648, to Dr. Smith). Favipiravir was provided by the Department of Defense Joint Project Manager Medical Countermeasure Systems.	Amano S, 1999, AM J OPHTHALMOL, V127, P721, DOI 10.1016/S0002-9394(99)00018-5; [Anonymous], 2015, EB EB VIR DIS EB ASS; [Anonymous], 2015, EB EB VIR DIS Q AS T; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hill CE, 2014, LABMEDICINE, V45, pE109, DOI 10.1309/LMTMW3VVN20HIFS; Kibadi K, 1999, J INFECT DIS, V179, pS13, DOI 10.1086/514288; Kraft CS, 2015, CLIN INFECT DIS; KUMING BS, 1977, BRIT J OPHTHALMOL, V61, P265, DOI 10.1136/bjo.61.4.265; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Trenchard T., 2014, AL JAZEERA; WHO, 2014, SIERR LEON HELP EB S; WHO, 2014, GLOB AL RESP EB VIR; World Health Organization, 2015, EB SIT REP 29 APR 20	17	300	304	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2423	2427		10.1056/NEJMoa1500306	http://dx.doi.org/10.1056/NEJMoa1500306			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	25950269	Green Accepted			2022-12-28	WOS:000356354600008
J	Zhang, WQ; Li, JY; Suzuki, K; Qu, J; Wang, P; Zhou, JZ; Liu, XM; Ren, RT; Xu, XL; Ocampo, A; Yuan, TT; Yang, JP; Li, Y; Shi, L; Guan, D; Pan, HZ; Duan, SL; Ding, ZC; Li, M; Yi, F; Bai, RJ; Wang, YY; Chen, C; Yang, FQ; Li, XY; Wang, ZM; Aizawa, E; Goebl, A; Soligalla, RD; Reddy, P; Esteban, CR; Tang, FC; Liu, GH; Belmonte, JCI				Zhang, Weiqi; Li, Jingyi; Suzuki, Keiichiro; Qu, Jing; Wang, Ping; Zhou, Junzhi; Liu, Xiaomeng; Ren, Ruotong; Xu, Xiuling; Ocampo, Alejandro; Yuan, Tingting; Yang, Jiping; Li, Ying; Shi, Liang; Guan, Dee; Pan, Huize; Duan, Shunlei; Ding, Zhichao; Li, Mo; Yi, Fei; Bai, Ruijun; Wang, Yayu; Chen, Chang; Yang, Fuquan; Li, Xiaoyu; Wang, Zimei; Aizawa, Emi; Goebl, April; Soligalla, Rupa Devi; Reddy, Pradeep; Esteban, Concepcion Rodriguez; Tang, Fuchou; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua			A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging	SCIENCE			English	Article							GENE; DEFECTS; DISEASE; WRN	Werner syndrome (WS) is a premature aging disorder caused by WRN protein deficiency. Here, we report on the generation of a human WS model in human embryonic stem cells (ESCs). Differentiation of WRN-null ESCs to mesenchymal stem cells (MSCs) recapitulates features of premature cellular aging, a global loss of H3K9me3, and changes in heterochromatin architecture. We show that WRN associates with heterochromatin proteins SUV39H1 and HP1 alpha and nuclear lamina-heterochromatin anchoring protein LAP2 beta. Targeted knock-in of catalytically inactive SUV39H1 in wild-type MSCs recapitulates accelerated cellular senescence, resembling WRN-deficient MSCs. Moreover, decrease in WRN and heterochromatin marks are detected in MSCs from older individuals. Our observations uncover a role for WRN in maintaining heterochromatin stability and highlight heterochromatin disorganization as a potential determinant of human aging.	[Zhang, Weiqi; Wang, Ping; Zhou, Junzhi; Ren, Ruotong; Xu, Xiuling; Yuan, Tingting; Yang, Jiping; Li, Ying; Guan, Dee; Pan, Huize; Duan, Shunlei; Ding, Zhichao; Chen, Chang; Yang, Fuquan; Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Li, Jingyi; Liu, Xiaomeng; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Suzuki, Keiichiro; Ocampo, Alejandro; Li, Mo; Aizawa, Emi; Goebl, April; Soligalla, Rupa Devi; Reddy, Pradeep; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Qu, Jing; Bai, Ruijun] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Shi, Liang; Wang, Yayu] PLA, Hosp 306, Diagnosis & Treatment Ctr Oral Dis, Beijing, Peoples R China; [Yi, Fei] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Li, Xiaoyu] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Zimei; Liu, Guang-Hui] Shenzhen Univ, Ctr Antiaging & Regenerat Med, Shenzhen 518060, Peoples R China; [Goebl, April] Univ Catolica San Antonio Murcia, Murcia 30107, Spain; [Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Tang, Fuchou; Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China; [Tang, Fuchou] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University; Salk Institute; Chinese Academy of Sciences; Institute of Zoology, CAS; Stanford University; Peking University; Shenzhen University; Universidad Catolica de Murcia; Peking University	Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	tangfuchou@pku.edu.cn; ghliu@ibp.ac.cn; belmonte@salk.edu	Ren, Ruotong/AAF-4046-2020; Qu, Jing/ABB-9088-2020; Liu, Xiaomeng/GNM-9778-2022; Li, Mo/AAM-8266-2021; Pan, Huize/ACM-3473-2022; Reddy, Pradeep/G-1770-2014	Liu, Xiaomeng/0000-0002-3288-212X; Li, Mo/0000-0003-0827-8907; Pan, Huize/0000-0002-3478-6799; Reddy, Pradeep/0000-0002-9173-3845; Zhang, Weiqi/0000-0002-8885-5104; Duan, Shunlei/0000-0003-0548-5150; Ocampo, Alejandro/0000-0002-3731-3647; chen, chang/0000-0003-1008-1062; qu, jing/0000-0002-3988-5067; Suzuki, Keiichiro/0000-0001-5603-9105; Tas, Sadik Taskin/0000-0002-4732-4761	National Natural Science Foundation of China [NSFC: 81330008]; National Basic Research Program of China (973 Program) [2015CB964800, 2014CB910500, 2014CB964600, 2012CB966704]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; NSFC [31222039, 31201111, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, 81401159, 31322037, 81471407]; National High Technology Research and Development Program of China (863 program) [2015AA020307]; Beijing Natural Science Foundation [7141005, 5142016]; Chinese Academy of Sciences [KJZDEW-TZ-L05]; Thousand Young Talents program of China; National Laboratory of Biomacromolecules [012kf02, 2013kf05, 2013kf11, 2014kf02, 2015kf10]; State Key Laboratory of Drug Research [SIMM1302KF-17]; China Postdoctoral Science Foundation [2013M530751]; California Institute for Regenerative Medicine Training Grant; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; UCAM; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL INSTITUTE ON AGING [F32AG047770] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; State Key Laboratory of Drug Research; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); California Institute for Regenerative Medicine Training Grant; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCAM; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to W. G. Zhu, L. Comai, K. Mitani, P. Ng, and A. Lieber for sharing experimental materials; L. Sun, W. Ding, G. Yuan, and X. Zhu from Center for Biological Imaging for technical assistance; and M. Schwarz and L. Zhao for administrative help. This work was supported by National Natural Science Foundation of China (NSFC: 81330008), National Basic Research Program of China (973 Program, 2015CB964800; 2014CB910500; 2014CB964600; 2012CB966704), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), NSFC (31222039; 31201111; 81371342; 81300261; 81300677; 81271266; 81471414; 81422017; 81401159; 31322037; 81471407), National High Technology Research and Development Program of China (863 program: 2015AA020307), Beijing Natural Science Foundation (7141005; 5142016), Key Research Program of the Chinese Academy of Sciences (KJZDEW-TZ-L05), the Thousand Young Talents program of China, National Laboratory of Biomacromolecules (012kf02;2013kf05;2013kf11;2014kf02;2015kf10) and State Key Laboratory of Drug Research (SIMM1302KF-17), and China Postdoctoral Science Foundation Grant (2013M530751). K. Sand M. L. are supported by a California Institute for Regenerative Medicine Training Grant. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. The physiological human cell aging studies were supported by UCAM. The J.C.I.B. laboratory was supported by The Glenn Foundation, The G. Harold and Leila Y. Mathers Charitable Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002). All materials are available from the G.-H.L., F.T., and J.C.I.B. laboratories under a material transfer agreement with Institute of Biophysics (CAS), Peking University, or The Salk Institute for Biological Studies. Myc-HP1 alpha plasmid can be obtained from W. G. Zhu under a material transfer agreement with Peking University.	Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Liu GH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5330; Liu GH, 2012, CURR OPIN CELL BIOL, V24, P765, DOI 10.1016/j.ceb.2012.08.014; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Zhang WQ, 2013, TRENDS CELL BIOL, V23, P587, DOI 10.1016/j.tcb.2013.07.001	20	307	321	9	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1160	1168		10.1126/science.aaa1356	http://dx.doi.org/10.1126/science.aaa1356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25931448	Green Accepted			2022-12-28	WOS:000355590500054
J	Hogan, BM; Black, BL				Hogan, Benjamin M.; Black, Brian L.			DEVELOPMENTAL BIOLOGY Diversity in the lymphatic vasculature	NATURE			English	Editorial Material							HEARTS	Two studies of the cells that give rise to lymphatic vessels reveal that precursors arise from unexpected sources, demonstrating that the origins of this vasculature are more diverse than anticipated. See Articles p.56 & p.62	[Hogan, Benjamin M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of Queensland; University of California System; University of California San Francisco	Hogan, BM (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.hogan@imb.uq.edu.au; brian.black@ucsf.edu	Hogan, Benjamin M/J-1807-2014; Hogan, Benjamin/AAD-7410-2022	Hogan, Benjamin M/0000-0002-0651-7065; Hogan, Benjamin/0000-0002-0651-7065; Black, Brian/0000-0002-6664-8913				Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Flaht A, 2012, DEV DYNAM, V241, P1473, DOI 10.1002/dvdy.23827; Huntington GS, 1910, AM J ANAT, V10, P177, DOI 10.1002/aja.1000100108; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Koltowska K, 2013, DEVELOPMENT, V140, P1857, DOI 10.1242/dev.089565; Kutkut I, 2015, EUR J CLIN INVEST, V45, P100, DOI 10.1111/eci.12372; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677	8	6	7	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					37	38		10.1038/nature14523	http://dx.doi.org/10.1038/nature14523			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25992543				2022-12-28	WOS:000355543400021
J	Laursen, L				Laursen, Lucas			WILD BEES Lone rangers	NATURE			English	Editorial Material																			0	2	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S62	S63		10.1038/521S62a	http://dx.doi.org/10.1038/521S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992676	Bronze			2022-12-28	WOS:000354816500011
J	Deweerdt, S				Deweerdt, Sarah			MICROBIOME Microbial mystery	NATURE			English	Editorial Material							COLORECTAL-CANCER; GUT MICROBIOME											Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129	5	13	13	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S10	S11		10.1038/521S10a	http://dx.doi.org/10.1038/521S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25970451	Bronze			2022-12-28	WOS:000354377800005
J	Holmes, D				Holmes, David			A disease of growth	NATURE			English	Editorial Material							COLORECTAL-CANCER											Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Robbins AS, 2012, J CLIN ONCOL, V30, P401, DOI 10.1200/JCO.2011.37.5527; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; *US NAT CANC I SUR, EP END RES PROGR	9	16	18	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S2	S4		10.1038/521S2a	http://dx.doi.org/10.1038/521S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25970455				2022-12-28	WOS:000354377800066
J	Melief, CJM				Melief, Cornelis J. M.			Mutation-Specific T Cells for Immunotherapy of Gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MELANOMA; BLOCKADE		[Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Melief, Cornelis J. M.] ISA Pharmaceut, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Melief, CJM (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.							Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; KAST WM, 1986, J EXP MED, V164, P723, DOI 10.1084/jem.164.3.723; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498	5	12	12	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1956	1958		10.1056/NEJMcibr1501818	http://dx.doi.org/10.1056/NEJMcibr1501818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970054				2022-12-28	WOS:000354493300014
J	Patel, V				Patel, Vikram			Rethinking personalised medicine	LANCET			English	Editorial Material									[Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Patel, Vikram] Publ Hlth Fdn India, Inst Area, Ctr Control Chron Condit, Delhi 22002, India; [Patel, Vikram] Sangath, Porvorim, Goa, India	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Patel, V (corresponding author), London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England.	vikram.patel@lshtm.ac.uk			Wellcome Trust [084674, 091834] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	11	11	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1826	1827		10.1016/S0140-6736(15)60917-5	http://dx.doi.org/10.1016/S0140-6736(15)60917-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25987146				2022-12-28	WOS:000354184500015
J	Poordad, F; Sievert, W; Mollison, L; Bennett, M; Tse, E; Brau, N; Levin, J; Sepe, T; Lee, SS; Angus, P; Conway, B; Pol, S; Boyer, N; Bronowicki, JP; Jacobson, I; Muir, AJ; Reddy, KR; Tam, E; Ortiz-Lasanta, G; de Ledinghen, V; Sulkowski, M; Boparai, N; McPhee, F; Hughes, E; Swenson, ES; Yin, PD				Poordad, Fred; Sievert, William; Mollison, Lindsay; Bennett, Michael; Tse, Edmund; Braeu, Norbert; Levin, James; Sepe, Thomas; Lee, Samuel S.; Angus, Peter; Conway, Brian; Pol, Stanislas; Boyer, Nathalie; Bronowicki, Jean-Pierre; Jacobson, Ira; Muir, Andrew J.; Reddy, K. Rajender; Tam, Edward; Ortiz-Lasanta, Grisell; de Ledinghen, Victor; Sulkowski, Mark; Boparai, Navdeep; McPhee, Fiona; Hughes, Eric; Swenson, E. Scott; Yin, Philip D.		UNITY-1 Study Grp	Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATITIS-C VIRUS; TREATMENT-NAIVE PATIENTS; PLUS ASUNAPREVIR; RIBAVIRIN; ABT-450/R-OMBITASVIR; SOFOSBUVIR; LEDIPASVIR; DASABUVIR; BMS-791325	IMPORTANCE The antiviral activity of all-oral, ribavirin-free, direct-acting antiviral regimens requires evaluation in patients with chronic hepatitis C virus (HCV) infection. OBJECTIVE To determine the rates of sustained virologic response (SVR) in patients receiving the 3-drug combination of daclatasvir (a pan-genotypic NS5A inhibitor), asunaprevir (an NS3 protease inhibitor), and beclabuvir (a nonnucleoside NS5B inhibitor). DESIGN, SETTING, AND PARTICIPANTS Thiswas an open-label, single-group, uncontrolled international study (UNITY-1) conducted at 66 sites in the United States, Canada, France, and Australia between December 2013 and August 2014. Patients without cirrhosis who were either treatment-naive (n = 312) or treatment-experienced (n = 103) and had chronic HCV genotype 1 infection were included. INTERVENTIONS Patients received a twice-daily fixed-dose combination of daclatasvir, 30mg; asunaprevir, 200mg; and beclabuvir, 75 mg. MAIN OUTCOMES AND MEASURES The primary study outcome was SVR12 (HCV-RNA <25 IU/mL at posttreatment week 12) in patients naive to treatment. A key secondary outcome was SVR12 in the treatment-experienced cohort. RESULTS Baseline characteristics were comparable between the treatment-naive and treatment-experienced cohorts. Patients were 58% male, 26% had IL28B (rs12979860) CC genotype, 73% were infected with genotype 1a, and 27% were infected with genotype 1b. Overall, SVR12 was observed in 379 of 415 patients (91.3%; 95% CI, 88.6%-94.0%): 287 of 312 treatment-naive patients (92.0%; 95% CI, 89.0%-95.0%) and 92 of 103 treatment-experienced patients (89.3%; 95% CI, 83.4%-95.3%). Virologic failure occurred in 34 patients (8%) overall. One patient died at posttreatment week 3; this was not considered related to study medication. There were 7 serious adverse events, all considered unrelated to study treatment, and 3 adverse events (<1%) leading to treatment discontinuation, including 2 grade 4 alanine aminotransferase elevations. The most common adverse events (in >= 10% of patients) were headache, fatigue, diarrhea, and nausea. CONCLUSIONS AND RELEVANCE In this open-label, nonrandomized, uncontrolled study, a high rate of SVR12 was achieved in treatment-naive and treatment-experienced noncirrhotic patients with chronic HCV genotype 1 infection who received 12 weeks of treatment with the oral fixed-dose regimen of daclatasvir, asunaprevir, and beclabuvir. Copyright 2015 American Medical Association. All rights reserved.	[Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78215 USA; [Sievert, William] Monash Hlth, Melbourne, Vic, Australia; [Sievert, William] Monash Univ, Melbourne, Vic 3004, Australia; [Mollison, Lindsay] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hepatitis Serv, Fremantle, WA, Australia; [Bennett, Michael] Med Associates Res Grp, San Diego, CA USA; [Tse, Edmund] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Braeu, Norbert] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Braeu, Norbert] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Levin, James] Dean Fdn, Madison, WI USA; [Sepe, Thomas] Univ Gastroenterol, Providence, RI USA; [Lee, Samuel S.] Univ Calgary, Calgary, AB, Canada; [Angus, Peter] Austin Hosp, Heidelberg, Vic, Australia; [Conway, Brian] Vancouver Infect Dis Ctr, Vancouver, BC, Canada; [Pol, Stanislas] Univ Paris 05, Hop Cochin, AP HP, Unite Hepatol,INSERM,UMS 20,Inst Pasteur, Paris, France; [Boyer, Nathalie] Hop Beaujon, Serv Hepatol, Clichy, France; [Bronowicki, Jean-Pierre] Univ Lorraine, Ctr Hosp Univ Nancy, INSERM, U954, Vandoeuvre Les Nancy, France; [Jacobson, Ira] Weill Cornell Med Coll, New York, NY USA; [Muir, Andrew J.] Duke Univ, Med Ctr, Durham, NC USA; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Tam, Edward] LAIR Ctr, Vancouver, BC, Canada; [Ortiz-Lasanta, Grisell] Fdn Invest, San Juan, PR USA; [de Ledinghen, Victor] Hop Du Haut Leveque, Pessac, France; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Boparai, Navdeep; Hughes, Eric] Bristol Myers Squibb Co, Princeton, NJ USA; [McPhee, Fiona; Swenson, E. Scott; Yin, Philip D.] Bristol Myers Squibb Co, Wallingford, CT 06492 USA	University of Texas System; University of Texas Health San Antonio; Monash University; University of Western Australia; Royal Adelaide Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of Calgary; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Cornell University; Duke University; University of Pennsylvania; CHU Bordeaux; Johns Hopkins University; Bristol-Myers Squibb; Bristol-Myers Squibb	Poordad, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, 607 Camden St,Ste 101, San Antonio, TX 78215 USA.	poordad@uthscsa.edu		Tse, Edmund/0000-0003-0643-3926; TAM, EDWARD/0000-0002-8306-3968	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb. Editorial support was provided by Andrew Street, PhD, of Articulate Science and was funded by Bristol-Myers Squibb.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Bronowicki JP, 2013, ANTIVIR THER, V18, P885, DOI 10.3851/IMP2660; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Everson GT, 2013, HEPATOLOGY, V58, p1377A; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hassanein T, 2015, J HEPATOL, V62, P1204, DOI 10.1016/j.jhep.2014.12.025; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Li CH, 2013, J GEN VIROL, V94, P1780, DOI 10.1099/vir.0.048835-0; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Muir AJ, 2015, JAMA-J AM MED ASSOC, V313, P1736, DOI 10.1001/jama.2015.3868; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	20	81	85	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1728	1735		10.1001/jama.2015.3860	http://dx.doi.org/10.1001/jama.2015.3860			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942723	Bronze			2022-12-28	WOS:000353921000018
J	KIM, JS; REES, DC				KIM, JS; REES, DC			CRYSTALLOGRAPHIC STRUCTURE AND FUNCTIONAL IMPLICATIONS OF THE NITROGENASE MOLYBDENUM IRON PROTEIN FROM AZOTOBACTER-VINELANDII	NATURE			English	Article							ALPHA-SUBUNIT; MOFE PROTEIN; COFACTOR; NIFD; DINITROGENASE; RESOLUTION; REFINEMENT; EVOLUTION; MECHANISM; FIXATION	The crystal structure of the nitrogenase molybdenum-iron protein from Azotobacter vinelandii has been determined at 2.7 angstrom resolution. The alpha- and beta-subunits in this alpha2beta2 tetramer have similar polypeptide folds. The FeMo-cofactor is completely encompassed by the alpha-subunit, whereas the P-cluster pair occurs at the interface between alpha- and beta-subunits. Structural similarities are apparent between nitrogenase and other electron transfer systems, including hydrogenases and the photosynthetic reaction centre.	CALTECH, DIV CHEM & CHEM ENGN 14775CH, PASADENA, CA 91125 USA	California Institute of Technology								ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; Bishop P. E., 1988, Nitrogen fixation: Hundred years after. Proceedings of the 7th International Congress on Nitrogen Fixation, Koln (Cologne), FRG, March 13-20, 1988., P71; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BRIGLE KE, 1985, GENE, V37, P37, DOI 10.1016/0378-1119(85)90255-0; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; Burgess B. K., 1984, Advances in nitrogen fixation research, P103; BURGESS BK, 1990, CHEM REV, V90, P1377, DOI 10.1021/cr00106a002; BURRIS RH, 1991, J BIOL CHEM, V266, P9339; CARSON M, 1986, J MOL GRAPHICS, V4, P121, DOI 10.1016/0263-7855(86)80010-8; CASE DA, 1979, J MOL BIOL, V132, P343, DOI 10.1016/0022-2836(79)90265-1; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; EADY RR, 1991, ADV INORG CHEM RAD, V36, P77; FEHER G, 1989, NATURE, V339, P111, DOI 10.1038/339111a0; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GOVEZENSKY D, 1989, J BACTERIOL, V171, P5729, DOI 10.1128/jb.171.10.5729-5735.1989; HADFIELD KL, 1969, BIOCHEMISTRY-US, V8, P5103, DOI 10.1021/bi00840a064; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; Holm R. H., 1985, MOLYBDENUM ENZYMES; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; LAMMERS PJ, 1983, P NATL ACAD SCI-BIOL, V80, P4723, DOI 10.1073/pnas.80.15.4723; LOWE DJ, 1984, BIOCHEM J, V224, P895, DOI 10.1042/bj2240895; MURRELL SA, 1988, BIOCHEM J, V251, P609, DOI 10.1042/bj2510609; ORMEJOHNSON WH, 1985, ANNU REV BIOPHYS BIO, V14, P419, DOI 10.1146/annurev.biophys.14.1.419; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; Rossmann M. G., 1972, MOL REPLACEMENT METH; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SIMPSON FB, 1984, SCIENCE, V224, P1095, DOI 10.1126/science.6585956; SMITH BE, 1992, EUR J BIOCHEM, V205, P1, DOI 10.1111/j.1432-1033.1992.tb16746.x; STIEFEL EI, 1988, METAL CLUSTERS PROTE, P372; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; THOMANN H, 1991, P NATL ACAD SCI USA, V88, P6620, DOI 10.1073/pnas.88.15.6620; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; THORNELEY RNF, 1990, NITROGEN FIXATION : ACHIEVEMENTS AND OBJECTIVES, P103; THORNELEY RNF, IN PRESS MOLYBDENUM; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WANG SZ, 1988, BIOCHEMISTRY-US, V27, P2800, DOI 10.1021/bi00408a021; WILLING A, 1990, J BIOL CHEM, V265, P6596; WUTTKE DS, 1992, SCIENCE, V256, P1007, DOI 10.1126/science.256.5059.1007; YAMANE T, 1982, J BIOL CHEM, V257, P1221	44	590	600	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	1992	360	6404					553	560						8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KB959	25989647				2022-12-28	WOS:A1992KB95900074
J	Phillips, DE; AbouZahr, C; Lopez, AD; Mikkelsen, L; de Savigny, D; Lozano, R; Wilmoth, J; Setel, PW				Phillips, David E.; AbouZahr, Carla; Lopez, Alan D.; Mikkelsen, Lene; de Savigny, Don; Lozano, Rafael; Wilmoth, John; Setel, Philip W.			Are well functioning civil registration and vital statistics systems associated with better health outcomes?	LANCET			English	Article							GLOBAL BURDEN; CHILD-MORTALITY; 187 COUNTRIES; TIME-SERIES; DISEASE; DEATH; INFANT	In this Series paper, we examine whether well functioning civil registration and vital statistics (CRVS) systems are associated with improved population health outcomes. We present a conceptual model connecting CRVS to wellbeing, and describe an ecological association between CRVS and health outcomes. The conceptual model posits that the legal identity that civil registration provides to individuals is key to access entitlements and services. Vital statistics produced by CRVS systems provide essential information for public health policy and prevention. These outcomes benefit individuals and societies, including improved health. We use marginal linear models and lag-lead analysis to measure ecological associations between a composite metric of CRVS performance and three health outcomes. Results are consistent with the conceptual model: improved CRVS performance coincides with improved health outcomes worldwide in a temporally consistent manner. Investment to strengthen CRVS systems is not only an important goal for individuals and societies, but also a development imperative that is good for health.	[Phillips, David E.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [AbouZahr, Carla] CAZ Consulting, Geneva, Switzerland; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Mikkelsen, Lene] LM Consulting, Brisbane, Qld, Australia; [de Savigny, Don] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Lozano, Rafael] Natl Publ Hlth Inst, Mexico City, DF, Mexico; [Wilmoth, John] UN, Populat Div, New York, NY 10017 USA; [Setel, Philip W.] Union North Amer, New York, NY USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute	Phillips, DE (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	davidp6@uw.edu	Lopez, Alan D/F-1487-2010; Setel, Philip/ABD-6362-2020; Lozano, Rafael/T-5352-2018; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Setel, Philip/0000-0002-9042-5699; Lozano, Rafael/0000-0002-7356-8823; 				Ahmed S, 2002, DEMOGRAPHY, V39, P75, DOI 10.1353/dem.2002.0001; Al Riyami Asya, 2004, Reprod Health Matters, V12, P144, DOI 10.1016/S0968-8080(04)23113-5; Boekle-Giuffrida B, 2009, WORKING PAPER; Caplan J., 2001, DOCUMENTING INDIVIDU; Cooper E, 2011, CHALLENGES OPPORTUNI; Corbacho A, 2013, DOES BIRTH REGISTRAT; DaVanzo J, 2008, POP STUD-J DEMOG, V62, P131, DOI 10.1080/00324720802022089; DAVIS DL, 1990, ANN NY ACAD SCI, V609, P5; De Silva N, 2010, PROTECTING RIGHTS TS; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Harbitz M.E., 2009, SIGNIFICANCE LEGAL I; HARVEY AC, 1986, J ROY STAT SOC A STA, V149, P187, DOI 10.2307/2981553; Innocenti Research Centre, 2007, BIRTH REG ARM CONFL; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Jimenez-Soto E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106234; Linder FE, 1984, IMPROVING CIVIL REGI; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Mumtaz Z, 2005, SOC SCI MED, V60, P1751, DOI 10.1016/j.socscimed.2004.08.019; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nakahara S, 2004, J EPIDEMIOL COMMUN H, V58, P976, DOI 10.1136/jech.2003.018804; O'Connell T, 2014, LANCET, V383, P277, DOI 10.1016/S0140-6736(13)60955-1; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pais M. S., 2002, UNICEF INNOCENTI DIG, V9, P1; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Rommelmann V, 2005, B WORLD HEALTH ORGAN, V83, P569; Rose LL, 2006, CHILDRENS PROPERTY I; Ruzicka L, 1989, DIFFERENTIAL MORTALI; Saleem Shabana, 2005, Reprod Health, V2, P8, DOI 10.1186/1742-4755-2-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Sumner C., 2011, INT J COURT ADMIN, V4, P3, DOI [DOI 10.18352/IJCA.66, 10.18352/ijca.66]; Szreter S, 2007, WORLD DEV, V35, P67, DOI 10.1016/j.worlddev.2006.09.004; The World Bank, 2014, GLOB CIV REG VIT STA; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Todres Jonathan, 2003, HUMAN RIGHTS BRIEF, V10, p[32, 32]; TRUSSELL J, 1984, STUD FAMILY PLANN, V15, P267, DOI 10.2307/1966071; UNDP, 2013, HUMAN DEV REPORT; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; Unity Dow, 1998, PROGR NATIONS, P5; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; World Health Organization, 2001, MACR HLTH INV HLTH E	45	74	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1386	1394		10.1016/S0140-6736(15)60172-6	http://dx.doi.org/10.1016/S0140-6736(15)60172-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	25971222				2022-12-28	WOS:000362316200032
J	Johnson, CL; Phillips, RJ; Purucker, ME; Anderson, BJ; Byrne, PK; Denevi, BW; Feinberg, JM; Hauck, SA; Head, JW; Korth, H; James, PB; Mazarico, E; Neumann, GA; Philpott, LC; Siegler, MA; Tsyganenko, NA; Solomon, SC				Johnson, Catherine L.; Phillips, Roger J.; Purucker, Michael E.; Anderson, Brian J.; Byrne, Paul K.; Denevi, Brett W.; Feinberg, Joshua M.; Hauck, Steven A., II; Head, James W., III; Korth, Haje; James, Peter B.; Mazarico, Erwan; Neumann, Gregory A.; Philpott, Lydia C.; Siegler, Matthew A.; Tsyganenko, Nikolai A.; Solomon, Sean C.			Low-altitude magnetic field measurements by MESSENGER reveal Mercury's ancient crustal field	SCIENCE			English	Article							THERMOCHEMICAL EVOLUTION; GLOBAL CONTRACTION; ORIGIN; SURFACE; PLAINS; ORBIT	Magnetized rocks can record the history of the magnetic field of a planet, a key constraint for understanding its evolution. From orbital vector magnetic field measurements of Mercury taken by the MErcury Surface, Space ENvironment, GEochemistry, and Ranging (MESSENGER) spacecraft at altitudes below 150 kilometers, we have detected remanent magnetization in Mercury's crust. We infer a lower bound on the average age of magnetization of 3.7 to 3.9 billion years. Our findings indicate that a global magnetic field driven by dynamo processes in the fluid outer core operated early in Mercury's history. Ancient field strengths that range from those similar to Mercury's present dipole field to Earth-like values are consistent with the magnetic field observations and with the low iron content of Mercury's crust inferred from MESSENGER elemental composition data.	[Johnson, Catherine L.; Philpott, Lydia C.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Johnson, Catherine L.; Siegler, Matthew A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Phillips, Roger J.] Southwest Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Purucker, Michael E.; Mazarico, Erwan; Neumann, Gregory A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Anderson, Brian J.; Denevi, Brett W.; Korth, Haje] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Byrne, Paul K.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Feinberg, Joshua M.] Univ Minnesota, Inst Rock Magnetism, Dept Earth Sci, Minneapolis, MN 55455 USA; [Hauck, Steven A., II] Case Western Reserve Univ, Dept Earth Environm & Planetary Sci, Cleveland, OH 44106 USA; [Head, James W., III] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [James, Peter B.; Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Siegler, Matthew A.] So Methodist Univ, Dept Earth Sci, Dallas, TX 75205 USA; [Tsyganenko, Nikolai A.] St Petersburg State Univ, Inst & Fac Phys, St Petersburg 199034, Russia; [Byrne, Paul K.; Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University of British Columbia; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; Brown University; Columbia University; Southern Methodist University; Saint Petersburg State University; Carnegie Institution for Science	Johnson, CL (corresponding author), Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada.	cjohnson@eos.ubc.ca	Tsyganenko, Nikolai A/J-7377-2012; Korth, Haje/C-3182-2016; Johnson, Catherine L./AAZ-7295-2020; Neumann, Gregory A/I-5591-2013; Denevi, Brett W./I-6502-2012; Byrne, Paul k/N-8606-2017; Mazarico, Erwan/N-6034-2014; Hauck, Steven A/A-7865-2008	Tsyganenko, Nikolai A/0000-0002-5938-1579; Korth, Haje/0000-0001-7394-7439; Neumann, Gregory A/0000-0003-0644-9944; Denevi, Brett W./0000-0001-7837-6663; Byrne, Paul k/0000-0002-5644-7069; Mazarico, Erwan/0000-0003-3456-427X; Hauck, Steven A/0000-0001-8245-146X; Philpott, Lydia/0000-0002-5286-8528; Feinberg, Joshua/0000-0002-5845-9848	NASA Discovery Program; MESSENGER Participating Scientist Program; Natural Sciences and Engineering Research Council of Canada; Division Of Earth Sciences [1339505] Funding Source: National Science Foundation	NASA Discovery Program(National Aeronautics & Space Administration (NASA)); MESSENGER Participating Scientist Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the MESSENGER operations and engineering teams for enabling the low-altitude observations reported here. We are also grateful for the contributions of our friend and colleague M. H. Acuna whose expertise was critical to the Magnetometer development. The MESSENGER mission is supported by the NASA Discovery Program and the MESSENGER Participating Scientist Program. C.L.J. and L.C.P. also acknowledge support from the Natural Sciences and Engineering Research Council of Canada. Data from the MESSENGER mission are archived with the NASA Planetary Data System. We thank three reviewers for thoughtful comments that improved the manuscript.	Anderson BJ, 2008, SCIENCE, V321, P82, DOI 10.1126/science.1159081; Anderson BJ, 2014, GEOPHYS RES LETT, V41, P7444, DOI 10.1002/2014GL061677; Anderson BJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P3875, DOI 10.1002/ggge.20242; Anderson BJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004159; Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Byrne PK, 2014, NAT GEOSCI, V7, P301, DOI 10.1038/ngeo2097; Cao H, 2014, GEOPHYS RES LETT, V41, P4127, DOI 10.1002/2014GL060196; Correia ACM, 2009, ICARUS, V201, P1, DOI 10.1016/j.icarus.2008.12.034; Denevi BW, 2013, J GEOPHYS RES-PLANET, V118, P891, DOI 10.1002/jgre.20075; Evans LG, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004178; Grott M, 2011, EARTH PLANET SC LETT, V307, P135, DOI 10.1016/j.epsl.2011.04.040; James PB, 2015, J GEOPHYS RES-PLANET, V120, P287, DOI 10.1002/2014JE004713; Johnson CL, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004217; Korth H., 2015, JGR SPACE PHYS, DOI [10.1002/2015JA021022, DOI 10.1002/2015JA021022]; Marchi S, 2013, NATURE, V499, P59, DOI 10.1038/nature12280; Mazarico E, 2014, J GEOPHYS RES-PLANET, V119, P2417, DOI 10.1002/2014JE004675; McCubbin FM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051711; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Padovan S, 2015, GEOPHYS RES LETT, V42, P1029, DOI 10.1002/2014GL062487; Philpott LC, 2014, GEOPHYS RES LETT, V41, P6627, DOI 10.1002/2014GL061401; Purucker ME, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003650; Stanley S, 2010, SPACE SCI REV, V152, P617, DOI 10.1007/s11214-009-9573-y; Tosi N, 2013, J GEOPHYS RES-PLANET, V118, P2474, DOI 10.1002/jgre.20168; Vander Kaaden KE, 2015, J GEOPHYS RES-PLANET, V120, P195, DOI 10.1002/2014JE004733; Weider SZ, 2014, ICARUS, V235, P170, DOI 10.1016/j.icarus.2014.03.002; Whitten JL, 2014, ICARUS, V241, P97, DOI 10.1016/j.icarus.2014.06.013; Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773; Williams JP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031164	29	62	62	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					892	895		10.1126/science.aaa8720	http://dx.doi.org/10.1126/science.aaa8720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25953822				2022-12-28	WOS:000354877900039
J	Capps, J; Flight, W				Capps, Jennifer; Flight, William			CASE REVIEW A woman with upper and lower airway symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Capps, Jennifer] Royal Bolton Hosp, Bolton BL4 0JR, England; [Flight, William] Salford Royal Hosp NHS Fdn Trust, Salford, Lancs, England; [Flight, William] Oxford Univ Hosp NHS Trust, Oxford, England	Royal Bolton Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Oxford University Hospitals NHS Foundation Trust	Capps, J (corresponding author), Royal Bolton Hosp, Bolton BL4 0JR, England.	Jennifer.capps@doctors.org.uk		Chrysochou, Constantina/0000-0003-1966-5558				de Groot Kirsten, 2012, Cleve Clin J Med, V79 Suppl 3, pS22, DOI 10.3949/ccjm.79.s3.05; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kamesh L, 2002, J AM SOC NEPHROL, V13, P1953, DOI 10.1097/01.ASN.0000016442.33680.3E; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Ntatsaki E, 2014, RHEUMATOLOGY, V53, P2306, DOI 10.1093/rheumatology/ket445	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2015	350								h2708	10.1136/bmj.h2708	http://dx.doi.org/10.1136/bmj.h2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZD	25997852				2022-12-28	WOS:000355129300003
J	Krug, N; Hohlfeld, JM; Kirsten, AM; Kornmann, O; Beeh, KM; Kappeler, D; Korn, S; Ignatenko, S; Timmer, W; Rogon, C; Zeitvogel, J; Zhang, N; Bille, J; Homburg, U; Turowska, A; Bachert, C; Werfel, T; Buhl, R; Renz, J; Garn, H; Renz, H				Krug, Norbert; Hohlfeld, Jens M.; Kirsten, Anne-Marie; Kornmann, Oliver; Beeh, Kai M.; Kappeler, Dominik; Korn, Stephanie; Ignatenko, Stanislav; Timmer, Wolfgang; Rogon, Cordelia; Zeitvogel, Jana; Zhang, Nan; Bille, Joachim; Homburg, Ursula; Turowska, Agnieszka; Bachert, Claus; Werfel, Thomas; Buhl, Roland; Renz, Jonas; Garn, Holger; Renz, Harald			Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED AIRWAY INFLAMMATION; EOSINOPHILIC ASTHMA; INHALED ALLERGEN; INHALATION; PHENOTYPES; CELL; MEPOLIZUMAB; CHALLENGE; INNATE; RESPONSIVENESS	BACKGROUND The most prevalent phenotype of asthma is characterized by eosinophil-dominated inflammation that is driven by a type 2 helper T cell (Th2). Therapeutic targeting of GATA3, an important transcription factor of the Th2 pathway, may be beneficial. We evaluated the safety and efficacy of SB010, a novel DNA enzyme (DNAzyme) that is able to cleave and inactivate GATA3 messenger RNA (mRNA). METHODS We conducted a randomized, double-blind, placebo-controlled, multicenter clinical trial of SB010 involving patients who had allergic asthma with sputum eosinophilia and who also had biphasic early and late asthmatic responses after laboratory-based allergen provocation. A total of 40 patients could be evaluated; 21 were assigned to receive 10 mg of SB010, and 19 were assigned to receive placebo, with each study drug administered by means of inhalation once daily for 28 days. An allergen challenge was performed before and after the 28-day period. The primary end point was the late asthmatic response as quantified by the change in the area under the curve (AUC) for forced expiratory volume in 1 second (FEV1). RESULTS After 28 days, SB010 attenuated the mean late asthmatic response by 34%, as compared with the baseline response, according to the AUC for FEV1, whereas placebo was associated with a 1% increase in the AUC for FEV1 (P = 0.02). The early asthmatic response with SB010 was attenuated by 11% as measured by the AUC for FEV1, whereas the early response with placebo was increased by 10% (P = 0.03). Inhibition of the late asthmatic response by SB010 was associated with attenuation of allergen-induced sputum eosinophilia and with lower levels of tryptase in sputum and lower plasma levels of interleukin-5. Allergen-induced levels of fractional exhaled nitric oxide and airway hyperresponsiveness to methacholine were not affected by either SB010 or placebo. CONCLUSIONS Treatment with SB010 significantly attenuated both late and early asthmatic responses after allergen provocation in patients with allergic asthma. Biomarker analysis showed an attenuation of Th2-regulated inflammatory responses.	[Krug, Norbert; Hohlfeld, Jens M.] Hannover Med Sch, Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Zeitvogel, Jana; Werfel, Thomas] Hannover Med Sch, Dept Dermatol & Allergy, Hannover, Germany; [Kirsten, Anne-Marie] Lung Clin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany; [Kornmann, Oliver] Clin Res Ctr Resp Med, Inst Klin Forsch Pneumol, Frankfurt, Germany; [Beeh, Kai M.] Insaf Resp Res Inst, Wiesbaden, Germany; [Kappeler, Dominik; Timmer, Wolfgang] Inamed, Gauting, Germany; [Korn, Stephanie; Buhl, Roland] Univ Hosp Mainz, Med Clin, Dept Pulm, Mainz, Germany; [Ignatenko, Stanislav] Charite Res Org, Berlin, Germany; [Rogon, Cordelia] FGK Clin Res, Munich, Germany; [Bille, Joachim; Homburg, Ursula; Turowska, Agnieszka; Renz, Jonas] Univ Marburg, Sterna Biol, D-35043 Marburg, Germany; [Garn, Holger; Renz, Harald] Univ Marburg, Inst Lab Med, D-35043 Marburg, Germany; [Garn, Holger; Renz, Harald] Marburg Lung Ctr, Marburg, Germany; [Zhang, Nan; Bachert, Claus] Univ Hosp Ghent, Upper Airways Res Lab, Ghent, Belgium; [Zhang, Nan; Bachert, Claus] Karolinska Inst, Div Ear Nose & Throat Dis Clintec, Stockholm, Sweden	Fraunhofer Gesellschaft; Hannover Medical School; Hannover Medical School; University Hospital Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Philipps University Marburg; Ghent University; Ghent University Hospital; Karolinska Institutet	Renz, H (corresponding author), Univ Marburg, Inst Lab Med, Baldinger Str, D-35043 Marburg, Germany.	harald.renz@uk-gm.de	Bachert, Claus/J-8825-2012; Werfel, Thomas/B-6921-2012	Garn, Holger/0000-0002-5178-4023; Hohlfeld, Jens/0000-0003-2646-6186	Sterna Biologicals; German Federal Ministry of Education and Research [031A188]	Sterna Biologicals; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by Sterna Biologicals and by a grant (031A188) from the German Federal Ministry of Education and Research.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Asthma G., 2020, GLOB STRAT ASTHM MAN; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bergqvist A, 2013, AM J RESP CRIT CARE, V188, P1475, DOI 10.1164/rccm.201308-1444LE; Bhakta NR, 2011, IMMUNOL REV, V242, P220, DOI 10.1111/j.1600-065X.2011.01032.x; Brand P, 2003, EUR RESPIR J, V22, P263, DOI 10.1183/09031936.03.00096802; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Cho EA, 2013, LANCET, V381, P1835, DOI 10.1016/S0140-6736(12)62166-7; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Diamant Z, 2013, J ALLERGY CLIN IMMUN, V132, P1045, DOI 10.1016/j.jaci.2013.08.023; Dicke T, 2012, NUCLEIC ACID THER, V22, P117, DOI 10.1089/nat.2011.0294; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Fernando FS, 2001, J MOL MED-JMM, V79, P695, DOI 10.1007/s001090100272; Fuhst R, 2013, PULM PHARMACOL THER, V26, P281, DOI 10.1016/j.pupt.2012.12.005; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Gauvreau GM, 2005, J ALLERGY CLIN IMMUN, V116, P285, DOI 10.1016/j.jaci.2005.05.021; Gauvreau GM, 1999, J ALLERGY CLIN IMMUN, V104, P66, DOI 10.1016/S0091-6749(99)70115-6; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Holgate ST, 2012, TRENDS IMMUNOL, V33, P238, DOI 10.1016/j.it.2012.02.003; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Homburg U, 2015, J ALLERGY CLIN IMMUN; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Janssen O, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-19; Kent SE, 2013, CLIN EXP ALLERGY, V43, P177, DOI 10.1111/cea.12002; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; O'Byrne PM, 2009, ALLERGY ASTHMA IMMUN, V1, P3, DOI 10.4168/aair.2009.1.1.3; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Petsky HL, 2012, THORAX, V67, P199, DOI 10.1136/thx.2010.135574; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Sadat MA, 1998, FEBS LETT, V436, P390; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Turowska A, 2013, TOXICOL APPL PHARM, V272, P365, DOI 10.1016/j.taap.2013.06.020; Vijverberg SJH, 2013, BIOL-TARGETS THER, V7, P199, DOI 10.2147/BTT.S29976; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Winandy S, 2007, NAT IMMUNOL, V8, P796, DOI 10.1038/ni0807-796; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	45	215	227	5	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1987	1995		10.1056/NEJMoa1411776	http://dx.doi.org/10.1056/NEJMoa1411776			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25981191	Green Published, Bronze			2022-12-28	WOS:000354809300005
J	Goldberg, H; Firtch, W; Tyburski, M; Pressman, A; Ackerson, L; Hamilton, L; Smith, W; Carver, R; Maratukulam, A; Won, LA; Carragee, E; Avins, AL				Goldberg, Harley; Firtch, William; Tyburski, Mark; Pressman, Alice; Ackerson, Lynn; Hamilton, Luisa; Smith, Wayne; Carver, Ryan; Maratukulam, Annu; Won, Lawrence A.; Carragee, Eugene; Avins, Andrew L.			Oral Steroids for Acute Radiculopathy Due to a Herniated Lumbar Disk A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; OSWESTRY DISABILITY INDEX; PLACEBO-CONTROLLED TRIAL; NERVE ROOT; ACUTE SCIATICA; DOUBLE-BLIND; QUESTIONNAIRE; DEXAMETHASONE; METAANALYSIS; MANAGEMENT	IMPORTANCE Oral steroids are commonly used to treat acute sciatica due to a herniated disk but have not been evaluated in an appropriately powered clinical trial. OBJECTIVE To determine if oral prednisone is more effective than placebo in improving function and pain among patients with acute sciatica. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled clinical trial conducted from 2008 to 2013 in a large integrated health care delivery system in Northern California. Adults (n=269) with radicular pain for 3 months or less, an Oswestry Disability Index (ODI) score of 30 or higher (range, 0-100; higher scores indicate greater dysfunction), and a herniated disk confirmed by magnetic resonance imaging were eligible. INTERVENTIONS Participants were randomly assigned in a 2:1 ratio to receive a tapering 15-day course of oral prednisone (5 days each of 60 mg, 40mg, and 20 mg; total cumulative dose = 600 mg; n = 181) or matching placebo (n = 88). MAIN OUTCOMES AND MEASURES The primary outcome was ODI change at 3 weeks; secondary outcomes were ODI change at 1 year, change in lower extremity pain (measured on a 0-10 scale; higher scores indicate more pain), spine surgery, and Short Form 36 Health Survey (SF-36) Physical Component Summary (PCS) and Mental Component Summary (MCS) scores (0-100 scale; higher scores better). RESULTS Observed baseline and 3-week mean ODI scores were 51.2 and 32.2 for the prednisone group and 51.1 and 37.5 for the placebo group, respectively. The prednisone-treated group showed an adjusted mean 6.4-point (95% CI, 1.9-10.9; P =.006) greater improvement in ODI scores at 3 weeks than the placebo group and a mean 7.4-point (95% CI, 2.2-12.5; P = .005) greater improvement at 52 weeks. Compared with the placebo group, the prednisone group showed an adjusted mean 0.3-point (95% CI, -0.4 to 1.0; P = .34) greater reduction in pain at 3 weeks and a mean 0.6-point (95% CI, -0.2 to 1.3; P = .15) greater reduction at 52 weeks. The prednisone group showed an adjusted mean 3.3-point (95% CI, 1.3-5.2; P = .001) greater improvement in the SF-36 PCS score at 3 weeks, no difference in the SF-36 PCS score at 52 weeks (mean, 2.5; 95% CI, -0.3 to 5.4; P = .08), no change in the SF-36 MCS score at 3 weeks (mean, 2.2; 95% CI, -0.4 to 4.8; P = .10), and an adjusted 3.6-point (95% CI, 0.6-6.7; P = .02) greater improvement in the SF-36 MCS score at 52 weeks. There were no differences in surgery rates at 52-week follow-up. Having 1 or more adverse events at 3-week follow-up was more common in the prednisone group than in the placebo group (49.2% vs 23.9%; P < .001). CONCLUSIONS AND RELEVANCE Among patients with acute radiculopathy due to a herniated lumbar disk, a short course of oral steroids, compared with placebo, resulted in modestly improved function and no improvement in pain.	[Goldberg, Harley; Smith, Wayne; Won, Lawrence A.] Kaiser Permanente No Calif, Spine Care Program, San Jose, CA 95119 USA; [Goldberg, Harley; Pressman, Alice; Ackerson, Lynn; Hamilton, Luisa; Avins, Andrew L.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Firtch, William; Maratukulam, Annu] Kaiser Permanente No Calif, Spine Care Program, Redwood City, CA USA; [Tyburski, Mark; Carver, Ryan] Kaiser Permanente No Calif, Spine Care Program, Roseville, CA USA; [Pressman, Alice] Sutter Hlth Res Dev & Disseminat, Walnut Creek, CA USA; [Carragee, Eugene] Stanford Univ, Dept Orthoped, Orthoped Spine Surg Div, Palo Alto, CA 94304 USA; [Avins, Andrew L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Avins, Andrew L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Goldberg, H (corresponding author), Kaiser Permanente No Calif, Dept Phys Med, 275 Hosp Pkwy,Ste 702, San Jose, CA 95119 USA.	harley.goldberg@kp.org			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the US National Institutes of Health [R01 AR053960]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053960] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grant R01 AR053960 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the US National Institutes of Health to Drs Goldberg and Avins.	[Anonymous], 2006, ART BULL, V88, P7, DOI DOI 10.1175/JHM474.1; Center for Drug Evaluation and Research, 2014, FDA DRUG SAF COMM FD; Childs MJD, 2005, EUR SPINE J, V14, P1008, DOI 10.1007/s00586-005-0900-z; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Cleland JA, 2012, SPINE J, V12, P921, DOI 10.1016/j.spinee.2012.05.004; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Fairbank JCT, 2014, J NEUROSURG-SPINE, V20, P83, DOI 10.3171/2013.9.SPINE13344; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; Friedman BW, 2008, SPINE, V33, pE624, DOI 10.1097/BRS.0b013e3181822711; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; HAIMOVIC IC, 1986, NEUROLOGY, V36, P1593, DOI 10.1212/WNL.36.12.1593; HEDEBOE J, 1982, ACTA NEUROL SCAND, V65, P6, DOI 10.1111/j.1600-0404.1982.tb03055.x; Holve RL, 2008, J AM BOARD FAM MED, V21, P469, DOI 10.3122/jabfm.2008.05.070220; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Kobayashi S, 2005, SPINE, V30, P1699, DOI 10.1097/01.brs.0000171910.97937.0e; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Levin K, 2014, ACUTE LUMBOSACRAL RA; Luke A, 2015, CURRENT MED DIAGNOSI; Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE451; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OLMARKER K, 1994, SPINE, V19, P1803, DOI 10.1097/00007632-199408150-00003; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; PORSMAN O, 1979, SCAND J RHEUMATOL, V8, P142, DOI 10.3109/03009747909114446; Roncoroni C, 2011, RHEUMATOLOGY, V50, P1603, DOI 10.1093/rheumatology/ker151; Stata Corp, 2013, STAT REL 13 STAT SOF; Valat JP, 2010, BEST PRACT RES CL RH, V24, P241, DOI 10.1016/j.berh.2009.11.005; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wong DA, 2002, ORAL STEROIDS N AM S, P41; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	62	68	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1915	1923		10.1001/jama.2015.4468	http://dx.doi.org/10.1001/jama.2015.4468			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988461	Green Accepted, Bronze			2022-12-28	WOS:000354691200013
J	Tanner, M				Tanner, Michael			Review: In patients with mild hypertension and no CV disease, BP-lowering drugs reduce stroke and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10016 USA	New York University	Tanner, M (corresponding author), NYU, Sch Med, New York, NY 10016 USA.			Tanner, Michael/0000-0002-3012-8641				Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC5	10.7326/ACPJC-2015-162-10-005	http://dx.doi.org/10.7326/ACPJC-2015-162-10-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984878				2022-12-28	WOS:000355015200007
J	Siomi, H; Siomi, MC				Siomi, Haruhiko; Siomi, Mikiko C.			Phased piRNAs tackle transposons	SCIENCE			English	Editorial Material							BIOGENESIS; DROSOPHILA; COMPLEX		[Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Siomi, Mikiko C.] Univ Tokyo, Grad Sch Sci, Tokyo 1130032, Japan	Keio University; University of Tokyo	Siomi, H (corresponding author), Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan.	awa403@keio.jp; siomim@bs.s.u-tokyo.ac.jp	Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822				Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030	11	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					756	757		10.1126/science.aab3004	http://dx.doi.org/10.1126/science.aab3004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977536				2022-12-28	WOS:000354428700020
J	Avorn, J				Avorn, Jerry			The $2.6 Billion Pill - Methodologic and Policy Considerations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.							Biotechnology Industry Organization, 2015, BIO RESP AL BURR REP; Kaiser J., 2015, SCI INSIDER; Kesselheim AS, 2015, HEALTH AFFAIR, V34, P286, DOI 10.1377/hlthaff.2014.1038; Phillips R., 2014, OFFSHORE SHELL GAMES; Tufts Center for the Study of Drug Development, 2014, TUFTS CTR STUD DRUG	5	183	187	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1877	1879		10.1056/NEJMp1500848	http://dx.doi.org/10.1056/NEJMp1500848			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25970049				2022-12-28	WOS:000354493300001
J	Emanuel, EJ				Emanuel, Ezekiel J.			Enhancing Professionalism Through Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Med Eth & Hlth Policy, Perelman Sch Med, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						DeNavas-Walt C, INCOME POVERTY US 20; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Emanuel EJ, 1992, ENDS HUMAN LIFE; Kane L., 2014, MEDSCAPE PHYS COMPEN; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; Weinfield W, 1951, INCOME PHYS 1929 194, P9	6	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1799	1800		10.1001/jama.2015.4336	http://dx.doi.org/10.1001/jama.2015.4336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965214				2022-12-28	WOS:000354391000009
J	Madara, JL; Burkhart, J				Madara, James L.; Burkhart, Jon			Professionalism, Self-regulation, and Motivation How Did Health Care Get This So Wrong?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Madara, James L.] Amer Med Assoc, Chicago, IL 60611 USA; [Madara, James L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Burkhart, Jon] Amer Med Assoc, Execut Off, Chicago, IL 60611 USA	American Medical Association; Northwestern University; Feinberg School of Medicine; American Medical Association	Madara, JL (corresponding author), Amer Med Assoc, 330 N Wabash Ave,Ste 39300, Chicago, IL 60611 USA.	james.madara@ama-assn.org						Benabou R, INTRINSIC EXTRINSIC; Bertkau Anne, 2005, Virtual Mentor, V7, DOI 10.1001/virtualmentor.2005.7.4.fred1-0504; Friedberg MW., EFFECTS HLTH CARE PA; Friedberg MW, FACTORS AFFECTING PH; Kolstad JT, INFORM QUALITY MOTIV; Reinhardt UE, 2014, PATIENT CARE PROFESS	6	23	23	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1793	1794		10.1001/jama.2015.4045	http://dx.doi.org/10.1001/jama.2015.4045			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965211				2022-12-28	WOS:000354391000006
J	Peabody, FW				Peabody, Francis W.			The Care of the Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001	1	18	18	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1868	1868		10.1001/jama.2014.11744	http://dx.doi.org/10.1001/jama.2014.11744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965245				2022-12-28	WOS:000354391000039
J	Cole, TB				Cole, Thomas B.			Bay Bridge Anchorage Construction George Booth Post	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1696	1697		10.1001/jama.2014.11723	http://dx.doi.org/10.1001/jama.2014.11723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942708				2022-12-28	WOS:000353921000035
J	Radetsky, M				Radetsky, Michael			The Hero in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Radetsky, Michael] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Radetsky, Michael] Presbyterian Hlth Syst, Albuquerque, NM USA	University of New Mexico	Radetsky, M (corresponding author), Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA.	msradetsky@sprintmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1715	1715		10.1001/jama.2015.3390	http://dx.doi.org/10.1001/jama.2015.3390			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942720				2022-12-28	WOS:000353921000015
J	Watts, G				Watts, Geoff			Sheila Kitzinger Obituary	LANCET			English	Biographical-Item																		KITZINGER S, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1722	1722		10.1016/S0140-6736(15)60882-0	http://dx.doi.org/10.1016/S0140-6736(15)60882-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943929	Bronze			2022-12-28	WOS:000353726000016
J	Heath, I				Heath, Iona			ESSAY Role of fear in overdiagnosis and overtreatment-an essay by Iona Heath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						Bakewell Sarah, 2010, LIVE LIFE MONTAIGNE, P123; BARNARD D, 1988, J MED PHILOS, V13, P393, DOI 10.1093/jmp/13.4.393; Bauman Z, 1994, ALONE AGAIN ETHICS U; Larkin Philip, 1988, COLLECTED POEMS, p[208, 208]; McCormick J, 1975, J R Coll Gen Pract, V25, P9; Nussbaum M., 2001, FRAGILITY GOODNESS L; Skrabanek P., 1991, HLTH LIFESTYLE ENV, P47; Sontag S., 1978, ILLNESS METAPHOR; Toulmin Stephen, 1990, COSMOPOLIS HIDDEN AG	9	37	38	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6123	10.1136/bmj.g6123	http://dx.doi.org/10.1136/bmj.g6123			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25954986				2022-12-28	WOS:000343768700003
J	van Rooy, MJ; Pretorius, E				van Rooy, Mia-Jeanne; Pretorius, Etheresia			Platelet interaction with erythrocytes and propensity to aggregation in essential thrombocythaemia	LANCET			English	Editorial Material									[van Rooy, Mia-Jeanne; Pretorius, Etheresia] Univ Pretoria, Dept Physiol, ZA-0007 Arcadia, South Africa	University of Pretoria	Pretorius, E (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Physiol, Private Bag x323, ZA-0007 Arcadia, South Africa.	resia.pretorius@up.ac.za	Pretorius, Etheresia/ACH-6368-2022; Pretorius, Etheresia/P-2978-2016	Pretorius, Etheresia/0000-0002-9108-2384; Pretorius, Etheresia/0000-0002-9108-2384; van Rooy, Mia-Jeanne/0000-0003-1224-5147					0	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1210	1210		10.1016/S0140-6736(14)62293-5	http://dx.doi.org/10.1016/S0140-6736(14)62293-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	25982040	Bronze			2022-12-28	WOS:000372412000032
J	AbouZahr, C; de Savigny, D; Mikkelsen, L; Setel, PW; Lozano, R; Lopez, AD				AbouZahr, Carla; de Savigny, Don; Mikkelsen, Lene; Setel, Philip W.; Lozano, Rafael; Lopez, Alan D.			Towards universal civil registration and vital statistics systems: the time is now	LANCET			English	Article							LIFE EXPECTANCY; VERBAL AUTOPSY; GLOBAL BURDEN; HEALTH; DEATH; GOVERNANCE; MORTALITY; DISEASE	The health and development challenges of the coming decades cannot be tackled effectively without reliable data for births, deaths, and causes of death, which only a comprehensive civil registration and vital statistics (CRVS) system can deliver. Alternative methods such as surveys, censuses, or surveillance are not adequate substitutes from a statistical perspective, and do not provide individuals with the legal documentation they need to benefit from services and participate fully in a modern society. Research is needed to generate and disseminate evidence about which CRVS strategies work best in which contexts and to ensure that the potential benefits of innovation are successfully scaled up, and that possible pitfalls are avoided. Research findings need to be compiled and made readily accessible to users for policy making, programming, and practice. Modernisation of CRVS systems necessitates new, broad-based national and international coalitions. The global architecture for CRVS, so far dominated by UN agencies, should extend to include bilateral donors, funds, foundations, non-governmental organisations, the private sector, academic institutions, and civil society. This change is essential to ensure that further development of CRVS systems is inclusive, participatory, multisectoral, and has a strong evidence base.	[AbouZahr, Carla] CAZ Consulting, CH-1218 Geneva, Switzerland; [de Savigny, Don] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mikkelsen, Lene] LM Consulting, Brisbane, Qld, Australia; [Setel, Philip W.] Union North Amer, New York, NY USA; [Lozano, Rafael] Natl Inst Publ Hlth, Mexico City, DF, Mexico; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Basel; Swiss Tropical & Public Health Institute; Instituto Nacional de Salud Publica; University of Melbourne	AbouZahr, C (corresponding author), CAZ Consulting, CH-1218 Geneva, Switzerland.	abouzahr.carla@gmail.com	Lopez, Alan/AAA-2734-2022; Setel, Philip/ABD-6362-2020; Lozano, Rafael/T-5352-2018; Lopez, Alan D/F-1487-2010	Setel, Philip/0000-0002-9042-5699; Lozano, Rafael/0000-0002-7356-8823; Lopez, Alan D/0000-0001-5818-6512				Abdellatif M., 2003, GLOB FOR 3 FIGHT COR; Abouzahr C., 2014, Asia-Pacific Population Journal, V29, P99; Abouzahr C, 2015, LANCET; AbouZahr C, 2010, LANCET, V375, P619, DOI 10.1016/S0140-6736(09)60004-0; [Anonymous], 2013, ECONOMIST, P8858; [Anonymous], 2015, 10 M AFR FOR STAT DE; [Anonymous], 2 C AFR MIN RESP CIV; [Anonymous], 2013, EV WOM EV CHILD STRE; Barendrecht JM, 2008, STATE ACCESS SUCCESS; Becker R, 2006, B WORLD HEALTH ORGAN, V84, P297; Boekle-Giuffrida B, 2009, WORKING PAPER; Breckenridge Keith, 2012, REGISTRATION RECOGNI; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Chan M, 2012, LANCET, V380, P2054, DOI 10.1016/S0140-6736(12)62135-7; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Economic and Social Council UN Statistical Commission, 1993, ECN3199312 UN STAT D; Fleck F, 2013, B WORLD HEALTH ORGAN, V91, P904, DOI 10.2471/BLT.13.031213; Franca E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-39; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Gelb A., 315 CGD; Global Fund to fight AIDS TB and Malaria, 2012, GFSIIC0505 GLOB FUND; Global Fund to Fight Aids TB and Malaria, 2011, MON EV TOOLKIT; Harbitz M.E., 2009, SIGNIFICANCE LEGAL I; Health Metrics Network, 2011, CORP PLAN; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill M, 2006, POLICY POLIT, V34, P557, DOI 10.1332/030557306777695280; HMN, TECHN NOT COSTS ALT; Horton R, 2015, LANCET, V385, P1156, DOI 10.1016/S0140-6736(14)61742-6; Hunter W, 2011, APSA 2011 ANN M PAP; Institute for Health Metrics and Evaluation, 2011, FIN GLOB HLTH 2011 C; Institute for Health Metrics and Evaluation Human Development Network The World Bank, 2013, GLOB BURD DIS GEN EV, VRegional; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kabadi G, 2013, 31 U QUEENSL HLTH IN; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lamy P, 2013, OXFORD MARTIN COMMIS; Lao C, 2007, LEGAL IDENTITY INCLU; Linder FE, 1980, IMPR CIV REG; Lopez AD, 2011, VERBAL AUTOPSY INNOV; Magbity EB, 2012, PROPOSAL NATL BIRTH; Mathers CD, 2003, HLTH SYSTEMS PERFORM; Moriyama IM, 2011, HIST STAT CLASS DIS; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Ngoma C, 2011, E INFRASTUCTURES E S, P79; Nguyen K, 2015, PLOS ONE, V9; Nichols EK, 2013, GLOBAL PROGRAM CIV R; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Organisation for Economic Cooperation and Development, 2011, BUS PARTN EFF DEV CO; Ostrom E., 2007, THEORIES POLICY PROC, P21, DOI [10.1081/E-EPAP2-120041405, DOI 10.1081/E-EPAP2-120041405]; Padmanabha P, 1993, REV EVALUATION UNFPA; PARIS21, 2011, STAT TRANSP ACC RES; Partnership In Statistics For Development in the 21st Century PARIS21, 2012, PARTN REP SUPP STAT; Phillips DE, 2015, LANCET; Rampatige R, 2014, B WORLD HEALTH ORGAN, V92, P3, DOI 10.2471/BLT.13.134106; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; The Commonwealth Fund, VAR AM MOR TRENDS 16; The World Bank, 2014, CONC NOT GLOB FIN FA; The World Bank, 2014, GLOB CIV REG VIT STA; Thomas P, 2005, ENDING CHILD POVERTY; Toivanen H, 2011, MOB BIRTH REG LIB; UN, 2010, PREVENTION CONTROL N; UN DESA, 2014, UN PRINC REC VIT STA; UN ECA, 2014, SOC IMP EB VIR DIS A; UN Office of the High Commissioner for Human Rights, 2012, HUM RIGHTS IND GUID; UN Statistics Division, IMPR CIV REG VIT STA; UN Statistics Division, 1983, MAN 10 IND TECHN DEM; UNDESA; UNFPA, 2012, POPULATION DYNAMICS; UNESCAP Committee on Statistics, 2010, DEV REG PROGR IMPR V; UNFPA, 2012, FUT UNFPA WANTS ALL; UNICEF, 2002, INNOCENTI DIGEST, V9; UNICEF, 2013, PASSP PROT GUID BIRT; UNICEF UNHCR ESCAP Plan International WHO, 2014, AS PAC CIV REG M UNI; United Nations, 2014, A68970 UN; United Nations Statistics Division, 2014, COV BIRTH DEATH REG; United Nations Statistics Division, 2014, GLOB CIV REG VIT STA; University of Oslo HISP India Health Metrics Network, SYST REV ECRVS MCRVS; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; WHO, 2011, KEEP PROM MEAS RES C; WHO, WHOHISHSI20143; WHO, 2014, WHO APPL ICD 10 IN L; WHO, 2013, TECHN M SPONS WORLD; WHO, 2010, INT STAT CLASS DIS R; WHO UNICEF UNFPA World Bank, 2012, TRENSS MAT MORT 1990; World Health Organization, 2016, ANTIMICROBIAL RESIST; Zelazny Frances, 2012, 008 CGD	87	71	74	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1407	1418		10.1016/S0140-6736(15)60170-2	http://dx.doi.org/10.1016/S0140-6736(15)60170-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	25971217				2022-12-28	WOS:000362316200034
J	Kim, DA; Hwong, AR; Stafford, D; Hughes, DA; O'Malley, AJ; Fowler, JH; Christakis, NA				Kim, David A.; Hwong, Alison R.; Stafford, Derek; Hughes, D. Alex; O'Malley, A. James; Fowler, James H.; Christakis, Nicholas A.			Social network targeting to maximise population behaviour change: a cluster randomised controlled trial	LANCET			English	Article							IMMUNIZATION; COOPERATION; DIFFUSION; COMMUNITY; SMOKING; OBESITY; SPREAD	Background Information and behaviour can spread through interpersonal ties. By targeting influential individuals, health interventions that harness the distributive properties of social networks could be made more effective and efficient than those that do not. Our aim was to assess which targeting methods produce the greatest cascades or spillover effects and hence maximise population-level behaviour change. Methods In this cluster randomised trial, participants were recruited from villages of the Department of Lempira, Honduras. We blocked villages on the basis of network size, socioeconomic status, and baseline rates of water purification, for delivery of two public health interventions: chlorine for water purification and multivitamins for micronutrient deficiencies. We then randomised villages, separately for each intervention, to one of three targeting methods, introducing the interventions to 5% samples composed of either: randomly selected villagers (n=9 villages for each intervention); villagers with the most social ties (n=9); or nominated friends of random villagers (n=9; the last strategy exploiting the so-called friendship paradox of social networks). Participants and data collectors were not aware of the targeting methods. Primary endpoints were the proportions of available products redeemed by the entire population under each targeting method. This trial is registered with ClinicalTrials.gov, number NCT01672580. Findings Between Aug 4, and Aug 14, 2012, 32 villages in rural Honduras (25-541 participants each; total study population of 5773) received public health interventions. For each intervention, nine villages (each with 1-20 initial target individuals) were randomised, using a blocked design, to each of the three targeting methods. In nomination-targeted villages, 951 (74.3%) of 1280 available multivitamin tickets were redeemed compared with 940 (66.2%) of 1420 in randomly targeted villages and 744 (61.0%) of 1220 in indegree-targeted villages. All pairwise differences in redemption rates were significant (p<0.01) after correction for multiple comparisons. Targeting nominated friends increased adoption of the nutritional intervention by 12.2% compared with random targeting (95% CI 6.9-17.9). Targeting the most highly connected individuals, by contrast, produced no greater adoption of either intervention, compared with random targeting. Interpretation Introduction of a health intervention to the nominated friends of random individuals can enhance that intervention's diffusion by exploiting intrinsic properties of human social networks. This method has the additional advantage of scalability because it can be implemented without mapping the network. Deployment of certain types of health interventions via network targeting, without increasing the number of individuals targeted or the resources used, could enhance the adoption and efficiency of those interventions, thereby improving population health.	[Kim, David A.; Hwong, Alison R.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Stafford, Derek] Yale Univ, Yale Inst Network Sci, New Haven, CT USA; [Hughes, D. Alex; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [O'Malley, A. James] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Fowler, James H.] Univ Calif San Diego, Dept Med Genet, La Jolla, CA 92093 USA; [Christakis, Nicholas A.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA	Harvard University; Yale University; University of California System; University of California San Diego; Dartmouth College; University of California System; University of California San Diego; Yale University; Yale University; Yale University; Yale University	Christakis, NA (corresponding author), Yale Inst Network Sci, POB 208263, New Haven, CT 06520 USA.	nicholas.christakis@yale.edu		Kim, David/0000-0003-0151-5121	National Institutes of Health; Bill & Melinda Gates Foundation; Star Family Foundation; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [F30AG046978, P30AG034420, P01AG031093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Star Family Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health, The Bill & Melinda Gates Foundation, Star Family Foundation, and the Canadian Institutes of Health Research.	Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2013, NETWORK SCI, V1, P1; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Cascio EU, 2012, WORKING PAPER SERIES, V18038; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cho Y, 2012, TECHNOL FORECAST SOC, V79, P97, DOI 10.1016/j.techfore.2011.06.003; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P1282, DOI 10.2105/AJPH.2009.165449; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; GART JJ, 1988, BIOMETRICS, V44, P323, DOI 10.2307/2531848; Hasler M, 2008, STAT MED, V27, P490, DOI 10.1002/sim.3052; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; Newman MEJ, 2002, PHYS REV LETT, V89; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Giron JOS, 2006, REV PANAM SALUD PUBL, V20, P377; Valente TW, 2007, ADDICTION, V102, P1804, DOI 10.1111/j.1360-0443.2007.01992.x; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; World Health Organization, 2013, COUNTR PROF ENV BURD	32	172	175	0	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					145	153		10.1016/S0140-6736(15)60095-2	http://dx.doi.org/10.1016/S0140-6736(15)60095-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	25952354	Green Accepted			2022-12-28	WOS:000357742200031
J	Potter, BJ; Le Lorier, J				Potter, Brian J.; Le Lorier, Jacques			Taking the pulse of atrial fibrillation	LANCET			English	Editorial Material							PROJECTIONS		[Potter, Brian J.] Univ Montreal Hosp Ctr, Cardiovasc Ctr, Montreal, PQ, Canada; [Potter, Brian J.; Le Lorier, Jacques] Univ Montreal, Dept Med, Montreal, PQ H2X 0A9, Canada	Universite de Montreal; Universite de Montreal	Le Lorier, J (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H2X 0A9, Canada.	jacques.le.lorier@sympatico.ca	Potter, Brian/GYE-3596-2022; Potter, Brian/A-5083-2015	Potter, Brian/0000-0002-0316-9026				Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cooke G, 2006, J FAM PRACTICE, V55, P130; Ghasemzadeh N, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/164832; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Madoc-Sutton H., 2009, PRACTICE NURSING, V20, P310; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Moran PS, 2013, COCHRANE DB SYST REV, V4; Poulin F, 2013, CAN J CARDIOL, V29, P1256, DOI 10.1016/j.cjca.2013.03.005; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8	9	14	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					113	115		10.1016/S0140-6736(14)61991-7	http://dx.doi.org/10.1016/S0140-6736(14)61991-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	25960109				2022-12-28	WOS:000357742200009
J	Rockall, TA				Rockall, Timothy A.			Transfusion after acute upper gastrointestinal haemorrhage	LANCET			English	Editorial Material							BLOOD-TRANSFUSION		Royal Surrey Cty Hosp NHS Trust, Guildford GU2 7XX, Surrey, England	Royal Surrey County Hospital	Rockall, TA (corresponding author), Royal Surrey Cty Hosp NHS Trust, Guildford GU2 7XX, Surrey, England.	tim.rockall@btinternet.com						Al-Jaghbeer M, 2013, CRIT CARE, V17, DOI 10.1186/cc13020; [Anonymous], 2015, LANCET; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Jairath V, 2010, COCHRANE DB SYST REV, V9; Jairath V, 2011, TRANSFUSION, V51, P1940, DOI 10.1111/j.1537-2995.2011.03119.x; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Pape A, 2009, BLOOD TRANSFUS-ITALY, V7, P250, DOI 10.2450/2008.0072-08; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801	12	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					110	112		10.1016/S0140-6736(14)62351-5	http://dx.doi.org/10.1016/S0140-6736(14)62351-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	25956717				2022-12-28	WOS:000357742200007
J	Bergstrom, CT; Kerr, B				Bergstrom, Carl T.; Kerr, Benjamin			MICROBIOLOGY Taking the bad with the good	NATURE			English	Editorial Material							ROCK-PAPER-SCISSORS; COMMUNITIES; COMPETITION; DIVERSITY; DYNAMICS; GAME		[Bergstrom, Carl T.; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bergstrom, CT (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	cbergst@uw.edu; kerrb@uw.edu	Bergstrom, Carl T./H-2299-2011	Bergstrom, Carl T./0000-0002-2070-385X				Cameron DD, 2009, J ECOL, V97, P1311, DOI 10.1111/j.1365-2745.2009.01568.x; Frean M, 2001, P ROY SOC B-BIOL SCI, V268, P1323, DOI 10.1098/rspb.2001.1670; GILPIN ME, 1975, AM NAT, V109, P51, DOI 10.1086/282973; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Yurtsev EA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.39	11	6	6	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					431	432		10.1038/nature14525	http://dx.doi.org/10.1038/nature14525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25992542				2022-12-28	WOS:000355286600028
J	Dzau, VJ; Ginsburg, GS; Van Nuys, K; Agus, D; Goldman, D				Dzau, Victor J.; Ginsburg, Geoffrey S.; Van Nuys, Karen; Agus, David; Goldman, Dana			Aligning incentives to fulfil the promise of personalised medicine	LANCET			English	Editorial Material									[Dzau, Victor J.] Inst Med, Washington, DC 20001 USA; [Ginsburg, Geoffrey S.] Duke Ctr Appl Genom & Precis Med, Durham, NC USA; [Van Nuys, Karen] Precis Hlth Econ, Los Angeles, CA USA; [Agus, David] Univ So Calif, Keck Sch Med, Beverly Hills, CA USA; [Agus, David] Univ So Calif, Viterbi Sch Engn, Beverly Hills, CA USA; [Goldman, Dana] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Dzau, VJ (corresponding author), Inst Med, Washington, DC 20001 USA.	vdzau@nas.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Agus, David B./0000-0002-7499-7822	NIA NIH HHS [P30 AG024968] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Goldman Dana P, 2013, Forum Health Econ Policy, V16, pS87, DOI 10.1515/fhep-2013-0023; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Michaud PC, 2011, SOC SCI MED, V73, P254, DOI 10.1016/j.socscimed.2011.05.027	4	54	55	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2118	2119		10.1016/S0140-6736(15)60722-X	http://dx.doi.org/10.1016/S0140-6736(15)60722-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	25957453	Green Accepted			2022-12-28	WOS:000354979100031
J	Grayson, M				Grayson, Michelle			Bees	NATURE			English	Editorial Material																			0	2	2	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S47	S47		10.1038/521S47a	http://dx.doi.org/10.1038/521S47a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992669	Bronze			2022-12-28	WOS:000354816500065
J	Olling, RP; Mushotzky, R; Shaya, EJ; Rest, A; Garnavich, PM; Tucker, BE; Kasen, D; Margheim, S; Filippenko, AV				Olling, Rob P.; Mushotzky, Richard; Shaya, Edward J.; Rest, Armin; Garnavich, Peter M.; Tucker, Brad E.; Kasen, Daniel; Margheim, Steve; Filippenko, Alexei V.			No signature of ejecta interaction with a stellar companion in three type Ia supernovae	NATURE			English	Article							SN 2011FE; LEGACY SURVEY; LIGHT CURVES; RISE-TIME; STAR; CATALOG; PROGENITORS; DISCOVERY; SPECTRA; 2012CG	Type Ia supernovae are thought to be the result of a thermonuclear runaway in carbon/oxygen white dwarfs, but it is uncertain whether the explosion is triggered by accretion from a non-degenerate companion star or by a merger with another white dwarf. Observations of a supernova immediately following the explosion provide unique information on the distribution of ejected material(1) and the progenitor system. Models predict(2) that the interaction of supernova ejecta with a companion star or circumstellar debris lead to a sudden brightening lasting from hours to days. Here we present data for three supernovae that are likely to be type Ia observed during the Kepler mission(3) with a time resolution of 30 minutes. We find no signatures of the supernova ejecta interacting with nearby companions. The lack of observable interaction signatures is consistent with the idea that these three supernovae resulted from the merger of binary white dwarfs or other compact stars such as helium stars.	[Olling, Rob P.; Mushotzky, Richard; Shaya, Edward J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Rest, Armin] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Garnavich, Peter M.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Tucker, Brad E.] Australian Natl Univ, Mt Stromlo Observ, Weston, ACT 2611, Australia; [Tucker, Brad E.; Kasen, Daniel; Filippenko, Alexei V.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kasen, Daniel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Margheim, Steve] AURA, Southern Operat Ctr, Gemini Observ, La Serena, Chile	University System of Maryland; University of Maryland College Park; Space Telescope Science Institute; University of Notre Dame; Australian National University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Olling, RP (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	olling@astro.umd.edu	Rest, Armin/ABE-6469-2020; Mushotzky, Richard/AAW-9465-2021; Kasen, Daniel/I-3443-2015	Shaya, Edward/0000-0002-3234-8699; Mushotzky, Richard/0000-0002-7962-5446; Tucker, Brad/0000-0002-4283-5159; Kasen, Daniel/0000-0002-5981-1022	Kepler GO3; GO4 [NNX12AC95G, NNX13AC27G]; Kepler grants [NNX12AC89G, NNX11AG95G]; NSF [AST-1211916, GN-2013A-Q-4, GS-2013A-Q-115]; TABASGO Foundation; Christopher R. Redlich Fund; NASA [NAS5-26555]; NASA Office of Space Science [NNX13AC07G]; NASA Science Mission directorate; National Science Foundation (United States); National Research Council (Canada); CONICYT (Chile); Australian Research Council (Australia); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); W. M. Keck Foundation; Direct For Mathematical & Physical Scien [1211916] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1109896] Funding Source: National Science Foundation	Kepler GO3; GO4; Kepler grants; NSF(National Science Foundation (NSF)); TABASGO Foundation; Christopher R. Redlich Fund; NASA(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); NASA Science Mission directorate(National Aeronautics & Space Administration (NASA)); National Science Foundation (United States)(National Science Foundation (NSF)); National Research Council (Canada); CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Australian Research Council (Australia)(Australian Research Council); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); W. M. Keck Foundation(W.M. Keck Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Still, M. Fanelli, and S. Gezari for useful conversations, M. Graham, P. Kelly, K. Clubb, and O. Fox for assistance with the observations and reductions of the host-galaxy spectra, D. Scolnic for help with PSNID, and F. Bianco for sending us time series of the companion shock models integrated over the Kepler bandpass. D. Thilker kindly provided the SDSS magnitudes for the supernova host galaxies. R.P.O. and E.J.S. were, in a small part, supported by Kepler GO3 and GO4 grants NNX12AC95G and NNX13AC27G. P.M.G. was partly supported by Kepler grants NNX12AC89G and NNX11AG95G. A.V.F. and B.E.T. were supported by NSF grant AST-1211916, the TABASGO Foundation, and the Christopher R. Redlich Fund. Some of the data presented herein were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts. This paper includes data collected by the Kepler mission. Funding for the Kepler mission is provided by the NASA Science Mission directorate. This work is based in part on observations obtained at the Gemini Observatory (program IDs GN-2013A-Q-4 and GS-2013A-Q-115) which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (United States), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), Ministerio da Ciencia, Tecnologia e Inovacao (Brazil) and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina). Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; the Observatory was made possible by the generous financial support of the W. M. Keck Foundation.	ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Bianco FB, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/20; Bloom JS, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/2/L17; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Conley A, 2006, ASTRON J, V132, P1707, DOI 10.1086/507788; Foley RJ, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/38; Gallagher JS, 2008, ASTROPHYS J, V685, P752, DOI 10.1086/590659; Ganeshalingam M, 2011, MON NOT R ASTRON SOC, V416, P2607, DOI 10.1111/j.1365-2966.2011.19213.x; Haas MR, 2010, ASTROPHYS J LETT, V713, pL115, DOI 10.1088/2041-8205/713/2/L115; Hachinger S, 2013, MON NOT R ASTRON SOC, V429, P2228, DOI 10.1093/mnras/sts492; Hayden BT, 2010, ASTROPHYS J, V722, P1691, DOI 10.1088/0004-637X/722/2/1691; Hayden BT, 2010, ASTROPHYS J, V712, P350, DOI 10.1088/0004-637X/712/1/350; Jarrett TH, 2000, ASTRON J, V119, P2498, DOI 10.1086/301330; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL120, DOI 10.1088/2041-8205/713/2/L120; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; Kessler R, 2009, ASTROPHYS J SUPPL S, V185, P32, DOI 10.1088/0067-0049/185/1/32; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Monet DG, 2003, ASTRON J, V125, P984, DOI 10.1086/345888; Munari U, 2013, NEW ASTRON, V20, P30, DOI 10.1016/j.newast.2012.09.003; Nugent P. E., 2011, ATEL, V3581, P1; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Piro AL, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/67; Sako M, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/162; Silverman JM, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/1/L7; TODY D, 1993, ASTR SOC P, V52, P173; Tucker BE, 2011, ASTROPHYS SPACE SCI, V335, P223, DOI 10.1007/s10509-011-0615-z; Zheng WK, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L24; Zheng WK, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L15	31	96	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					332	+		10.1038/nature14455	http://dx.doi.org/10.1038/nature14455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993963				2022-12-28	WOS:000354816500051
J	Wang, KH; Penmatsa, A; Gouaux, E				Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric			Neurotransmitter and psychostimulant recognition by the dopamine transporter	NATURE			English	Article							BIOGENIC-AMINE TRANSPORTERS; RAT-BRAIN SYNAPTOSOMES; COCAINE BINDING; CONFORMATIONAL DYNAMICS; SEROTONIN TRANSPORTER; SUBSTRATE TRANSPORT; ALTERNATING-ACCESS; TRANSMITTER UPTAKE; BACTERIAL HOMOLOG; MAMMALIAN-CELLS	Na+/Cl--coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates. Here we determine X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analogue 3,4-dichlorophenethylamine, the psychostimulants D-amphetamine and methamphetamine, or to cocaine and cocaine analogues. All ligands bind to the central binding site, located approximately halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions. The central binding site recognizes three chemically distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating molecular principles that distinguish substrates from inhibitors in biogenic amine transporters.	[Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Penmatsa, Aravind/AAQ-2688-2020	Gouaux, Eric/0000-0002-8549-2360; Penmatsa, Aravind/0000-0001-9519-5055	NIMH Ruth Kirschstein postdoctoral fellowship; Brain and Behavior Research Foundation Young Investigator research award; American Heart Association; NIH; Methamphetamine Abuse Research Center of OHSU [P50DA018165]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039, F32MH093120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165] Funding Source: NIH RePORTER	NIMH Ruth Kirschstein postdoctoral fellowship; Brain and Behavior Research Foundation Young Investigator research award; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Methamphetamine Abuse Research Center of OHSU; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Coleman, C.-H. Lee, S. Mansoor and other Gouaux laboratory members for helpful discussions, L. Vaskalis for assistance with figures and H. Owen for help with manuscript preparation. We acknowledge the staff of the Berkeley Center for Structural Biology at the Advanced Light Source and the Northeastern Collaborative Access Team at the Advanced Photon Source for assistance with data collection. This work was supported by an NIMH Ruth Kirschstein postdoctoral fellowship and Brain and Behavior Research Foundation Young Investigator research award (K. H. W.), a postdoctoral fellowship from the American Heart Association (A. P.) and by the NIH (E. G) and the Methamphetamine Abuse Research Center of OHSU (P50DA018165 to E. G). E. G. is an investigator with the Howard Hughes Medical Institute.	Abdul-Hussein S, 2013, J MOL BIOL, V425, P2198, DOI 10.1016/j.jmb.2013.03.025; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; BONISCH H, 1984, N-S ARCH PHARMACOL, V327, P267, DOI 10.1007/BF00506235; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dahal RA, 2014, J BIOL CHEM, V289, P29712, DOI 10.1074/jbc.M114.571521; Dehnes Y, 2014, NEUROCHEM INT, V73, P4, DOI 10.1016/j.neuint.2014.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Eshleman AJ, 1997, J NEUROCHEM, V69, P1459; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; GU H, 1994, J BIOL CHEM, V269, P7124; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; IVERSEN LL, 1966, MOL PHARMACOL, V2, P360; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lee SH, 2000, MOL PHARMACOL, V57, P883; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mergy MA, 2014, P NATL ACAD SCI USA, V111, pE4779, DOI 10.1073/pnas.1417294111; Newman AH, 2001, BIOORG MED CHEM LETT, V11, P1659, DOI 10.1016/S0960-894X(01)00271-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; RICHELSON E, 1984, EUR J PHARMACOL, V104, P277, DOI 10.1016/0014-2999(84)90403-5; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorensen G, 2012, PSYCHOPHARMACOLOGY, V222, P565, DOI 10.1007/s00213-012-2651-y; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; TWAROG BM, 1953, AM J PHYSIOL, V175, P157, DOI 10.1152/ajplegacy.1953.175.1.157; VON EULER U S, 1946, J Physiol, V105, P26; WALL SC, 1995, MOL PHARMACOL, V47, P544; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZACZEK R, 1991, J PHARMACOL EXP THER, V257, P820; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971	60	270	272	7	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					322	+		10.1038/nature14431	http://dx.doi.org/10.1038/nature14431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25970245	Green Accepted			2022-12-28	WOS:000354816500049
J	Brown, DL				Brown, David L.			Review: Perioperative beta-blockade reduces nonfatal MI but increases mortality in noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSOCIATION		Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Brown, DL (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.							Andersson C, 2014, JAMA INTERN MED, V174, P336, DOI 10.1001/jamainternmed.2013.11349; Chopra V, 2012, AM J MED, V125, P953, DOI 10.1016/j.amjmed.2012.03.014; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC10	10.7326/ACPJC-2015-162-10-010	http://dx.doi.org/10.7326/ACPJC-2015-162-10-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984871				2022-12-28	WOS:000355015200012
J	Ginzberg, MB; Kafri, R; Kirschner, M				Ginzberg, Miriam B.; Kafri, Ran; Kirschner, Marc			On being the right (cell) size	SCIENCE			English	Review							PROTEIN S6 PHOSPHORYLATION; HUMAN ADIPOSE-TISSUE; CYCLIN-E; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; ADIPOCYTE FUNCTIONS; SIGNALING PATHWAY; MOUSE FIBROBLASTS; POSITIVE FEEDBACK; FISSION YEAST	Different animal cell types have distinctive and characteristic sizes. How a particular cell size is specified by differentiation programs and physiology remains one of the fundamental unknowns in cell biology. In this Review, we explore the evidence that individual cells autonomously sense and specify their own size. We discuss possible mechanisms by which size-sensing and size-specification may take place. Last, we explore the physiological implications of size control: Why is it important that particular cell types maintain a particular size? We develop these questions through examination of the current literature and pose the questions that we anticipate will guide this field in the upcoming years.	[Ginzberg, Miriam B.; Kirschner, Marc] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA; [Kafri, Ran] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kirschner, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA.	marc@hms.harvard.edu		Ginzberg, Miriam/0000-0001-8431-3714	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas A. K., 2012, CELLULAR AND MOLECUL, px; ANDERSON EC, 1969, BIOPHYS J, V9, P246, DOI 10.1016/S0006-3495(69)86383-6; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; CASPERSSON T, 1963, EXP CELL RES, V32, P553, DOI 10.1016/0014-4827(63)90193-9; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; COLLINS JF, 1962, J GEN MICROBIOL, V28, P15, DOI 10.1099/00221287-28-1-15; Conlon I, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-36; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Daga RR, 1999, J CELL SCI, V112, P3137; Dhawan S, 2007, CURR OPIN CELL BIOL, V19, P634, DOI 10.1016/j.ceb.2007.09.015; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Echave P, 2007, CELL CYCLE, V6, P218, DOI 10.4161/cc.6.2.3744; FABIAN MC, 1993, TRANSPLANTATION, V56, P1137, DOI 10.1097/00007890-199311000-00017; FANKHAUSER G, 1945, J EXP ZOOL, V100, P445, DOI 10.1002/jez.1401000310; Farnier C, 2002, ANN NY ACAD SCI, V973, P594, DOI 10.1111/j.1749-6632.2002.tb04706.x; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Gregory TR, 2002, EVOLUTION, V56, P121; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haldane J. B. S., 1927, POSSIBLE WORLDS AND, pviii; Hall M. N., 2004, CELL GROWTH CONTROL, pxii; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; KUBITSCHEK HE, 1986, EXP CELL RES, V165, P243, DOI 10.1016/0014-4827(86)90548-3; Kufe D. W., 2003, CANCER MEDICINE 6 RE, px; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Maciak S, 2014, J EVOLUTION BIOL, V27, P478, DOI 10.1111/jeb.12306; Majno G., 2004, CELLS TISSUES DIS PR, pxxviii; Martin SG, 2009, CELL CYCLE, V8, P3643, DOI 10.4161/cc.8.22.9891; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mlettinen TP, 2014, CURR BIOL, V24, P598, DOI 10.1016/j.cub.2014.01.071; Moinfar F., 2007, ESSENTIALS OF DIAGNO; MONNICKENDAM MA, 1972, J CELL SCI, V11, P799; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mullany LK, 2007, J BIOL CHEM, V282, P21244, DOI 10.1074/jbc.M702110200; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Nelsen CJ, 2001, CANCER RES, V61, P8564; Nelsen CJ, 2001, ONCOGENE, V20, P1825, DOI 10.1038/sj.onc.1204248; NESTEL PJ, 1969, J LIPID RES, V10, P383; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; ROTH G, 1994, P NATL ACAD SCI USA, V91, P4796, DOI 10.1073/pnas.91.11.4796; Rubin E., 2014, ESSENTIALS OF RUBINS, pxii; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; SMITH U, 1971, J LIPID RES, V12, P65; SMITH U, 1973, ANAT RECORD, V176, P181, DOI 10.1002/ar.1091760206; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000189; Wilson E. B., 1925, pxxxvii; Wood E, 2013, CELL CYCLE, V12, P3228, DOI 10.4161/cc.26462; ZETTERBERG A, 1984, CYTOMETRY, V5, P368, DOI 10.1002/cyto.990050413; ZETTERBERG A, 1991, COLD SH Q B, V56, P137; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	77	207	209	6	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236							1245075	10.1126/science.1245075	http://dx.doi.org/10.1126/science.1245075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977557	Green Accepted			2022-12-28	WOS:000354428700034
J	Van Mooy, BAS; Krupke, A; Dyhrman, ST; Fredricks, HF; Frischkorn, KR; Ossolinski, JE; Repeta, DJ; Rouco, M; Seewald, JD; Sylva, SP				Van Mooy, B. A. S.; Krupke, A.; Dyhrman, S. T.; Fredricks, H. F.; Frischkorn, K. R.; Ossolinski, J. E.; Repeta, D. J.; Rouco, M.; Seewald, J. D.; Sylva, S. P.			Major role of planktonic phosphate reduction in the marine phosphorus redox cycle	SCIENCE			English	Article							PACIFIC SUBTROPICAL GYRE; ATLANTIC-OCEAN; TRICHODESMIUM IMS101; ION CHROMATOGRAPHY; AEROBIC PRODUCTION; NITROGEN-FIXATION; NORTH-ATLANTIC; METHANE; BACTERIA; PROCHLOROCOCCUS	Phosphorus in the +5 oxidation state (i.e., phosphate) is the most abundant form of phosphorus in the global ocean. An enigmatic pool of dissolved phosphonate molecules, with phosphorus in the +3 oxidation state, is also ubiquitous; however, cycling of phosphorus between oxidation states has remained poorly constrained. Using simple incubation and chromatography approaches, we measured the rate of the chemical reduction of phosphate to P(III) compounds in the western tropical North Atlantic Ocean. Colonial nitrogen-fixing cyanobacteria in surface waters played a critical role in phosphate reduction, but other classes of plankton, including potentially deep-water archaea, were also involved. These data are consistent with marine geochemical evidence and microbial genomic information, which together suggest the existence of a vast oceanic phosphorus redox cycle.	[Van Mooy, B. A. S.; Krupke, A.; Fredricks, H. F.; Ossolinski, J. E.; Repeta, D. J.; Seewald, J. D.; Sylva, S. P.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Dyhrman, S. T.; Frischkorn, K. R.; Rouco, M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Dyhrman, S. T.; Frischkorn, K. R.; Rouco, M.] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10027 USA	Woods Hole Oceanographic Institution; Columbia University; Columbia University	Van Mooy, BAS (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	bvanmooy@whoi.edu	Sylva, Sean/D-4400-2014	Sylva, Sean/0000-0002-4727-440X	NSF [OCE-13-32898, OCE-13-32912]; Simons Foundation; Division Of Ocean Sciences [1332898] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Simons Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful for the assistance of the officers and crew of the R/V Atlantic Explorer and the support of D. Polyviou (University of Southampton), J. Tagliaferre (Woods Hole Oceanographic Institution), and the entire PABST Cruise scientific party. We also thank T. Bibby, A. Hitchock, and C. M. Moore, (University of Southampton) as well as A. Santoro (University of Maryland), for insightful discussions and R. Johnson (Bermuda Institute of Ocean Sciences) for input on the execution of the IC methods at sea. Major support for this study was provided by grants from the NSF to B.A.S.V.M. and S.T.D. (OCE-13-32898 and OCE-13-32912). This work was also supported in part by grants from the Simons Foundation to B.A.S.V.M, S.T.D., and D. J. R. and is a contribution of the Simons Collaboration on Ocean Processes and Ecology. The data presented in all figures, as well as additional environmental data, are provided in tables S2 and S3.	Beversdorf LJ, 2010, LIMNOL OCEANOGR, V55, P1768, DOI 10.4319/lo.2010.55.4.1768; Bjorkman K, 2000, AQUAT MICROB ECOL, V22, P185, DOI 10.3354/ame022185; Carini P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5346; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; del Valle DA, 2014, AQUAT MICROB ECOL, V73, P93, DOI 10.3354/ame01714; DeVries T, 2014, BIOGEOSCIENCES, V11, P5381, DOI 10.5194/bg-11-5381-2014; Dyhrman ST, 2009, NAT GEOSCI, V2, P696, DOI 10.1038/NGEO639; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Feingersch R, 2012, ISME J, V6, P827, DOI 10.1038/ismej.2011.149; Hmelo LR, 2012, AQUAT MICROB ECOL, V67, P1, DOI 10.3354/ame01571; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Karl DM, 2014, ANNU REV MAR SCI, V6, P279, DOI 10.1146/annurev-marine-010213-135046; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Martinez A, 2012, ENVIRON MICROBIOL, V14, P1363, DOI 10.1111/j.1462-2920.2011.02612.x; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; McDowell MM, 2004, J CHROMATOGR A, V1039, P105, DOI 10.1016/j.chroma.2003.11.056; Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Pasek MA, 2014, P NATL ACAD SCI USA, V111, P15468, DOI 10.1073/pnas.1408134111; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Pech H, 2011, J CHROMATOGR SCI, V49, P573, DOI 10.1093/chrsci/49.8.573; Rouco M, 2014, LIMNOL OCEANOGR, V59, P1899, DOI 10.4319/lo.2014.59.6.1899; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Van Mooy BAS, 2012, ISME J, V6, P422, DOI 10.1038/ismej.2011.115; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; White AE, 2010, LIMNOL OCEANOGR, V55, P1755, DOI 10.4319/lo.2010.55.4.1755; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Young CL, 2010, AQUAT GEOCHEM, V16, P563, DOI 10.1007/s10498-009-9087-y; Zhang NJ, 2001, J ORG CHEM, V66, P327, DOI 10.1021/jo0013608	30	68	68	16	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					783	785		10.1126/science.aaa8181	http://dx.doi.org/10.1126/science.aaa8181			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977548				2022-12-28	WOS:000354428700039
J	van de Wetering, M; Francies, HE; Francis, JM; Bounova, G; Iorio, F; Pronk, A; van Houdt, W; van Gorp, J; Taylor-Weiner, A; Kester, L; McLaren-Douglas, A; Blokker, J; Jaksani, S; Bartfeld, S; Volckman, R; van Sluis, P; Li, VSW; Seepo, S; Pedamallu, CS; Cibulskis, K; Carter, SL; McKenna, A; Lawrence, MS; Lichtenstein, L; Stewart, C; Koster, J; Versteeg, R; van Oudenaarden, A; Saez-Rodriguez, J; Vries, RGJ; Getz, G; Wessels, L; Stratton, MR; McDermott, U; Meyerson, M; Garnett, MJ; Clevers, H				van de Wetering, Marc; Francies, Hayley E.; Francis, Joshua M.; Bounova, Gergana; Iorio, Francesco; Pronk, Apollo; van Houdt, Winan; van Gorp, Joost; Taylor-Weiner, Amaro; Kester, Lennart; McLaren-Douglas, Anne; Blokker, Joyce; Jaksani, Sridevi; Bartfeld, Sina; Volckman, Richard; van Sluis, Peter; Li, Vivian S. W.; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Stewart, Chip; Koster, Jan; Versteeg, Rogier; van Oudenaarden, Alexander; Saez-Rodriguez, Julio; Vries, Robert G. J.; Getz, Gad; Wessels, Lodewyk; Stratton, Michael R.; McDermott, Ultan; Meyerson, Matthew; Garnett, Mathew J.; Clevers, Hans			Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients	CELL			English	Article							SMALL-INTESTINE; DRUG-SENSITIVITY; WNT RECEPTORS; COLON-CANCER; STEM-CELLS; GENE; LGR5; EPITHELIUM; MUTATIONS; GENOME	In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank'' agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design.	[van de Wetering, Marc; Kester, Lennart; Blokker, Joyce; Jaksani, Sridevi; Bartfeld, Sina; van Oudenaarden, Alexander; Vries, Robert G. J.; Clevers, Hans] Canc Genom & Univ Med Ctr, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van de Wetering, Marc; Blokker, Joyce; Jaksani, Sridevi; Vries, Robert G. J.; Clevers, Hans] Fdn Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands; [Francies, Hayley E.; McLaren-Douglas, Anne; Stratton, Michael R.; McDermott, Ultan; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Francis, Joshua M.; Taylor-Weiner, Amaro; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Getz, Gad; Meyerson, Matthew] MIT, Broad Inst, Cambridge, MA 02142 USA; [Francis, Joshua M.; Taylor-Weiner, Amaro; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Stewart, Chip; Getz, Gad; Meyerson, Matthew] Harvard Univ, Cambridge, MA 02142 USA; [Francis, Joshua M.; Pedamallu, Chandra Sekhar; Carter, Scott L.; Getz, Gad; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bounova, Gergana; Wessels, Lodewyk] Netherlands Canc Inst, Computat Canc Biol, NL-1066 CX Amsterdam, Netherlands; [Iorio, Francesco; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol, Cambridge CB10 1SA, England; [Pronk, Apollo; van Houdt, Winan] Diakonessen Hosp, Dept Surg, NL-3582 KE Utrecht, Netherlands; [van Gorp, Joost] Diakonessen Hosp, Dept Pathol, NL-3582 KE Utrecht, Netherlands; [Volckman, Richard; van Sluis, Peter; Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [Li, Vivian S. W.] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Netherlands Cancer Institute; European Molecular Biology Laboratory (EMBL); Diakonessenhuis; Diakonessenhuis; University of Amsterdam; Academic Medical Center Amsterdam; MRC National Institute for Medical Research	Garnett, MJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mg12@sanger.ac.uk; h.clevers@hubrecht.eu	Lawrence, Michael/AAC-8202-2020; Koster, Jan/C-5934-2008; Pedamallu, Chandra Sekhar/AAV-6745-2020; van Oudenaarden, Alexander/AAA-1705-2019; van Houdt, Winan/AAH-6108-2019; Versteeg, Rogier/AAQ-1765-2020; Cibulskis, Kristian/AAC-7380-2019; Saez-Rodriguez, Julio/H-7114-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Iorio, Francesco/H-3282-2019; Iorio, Francesco/H-3284-2019	Koster, Jan/0000-0002-0890-7585; van Houdt, Winan/0000-0002-2303-3468; Saez-Rodriguez, Julio/0000-0002-8552-8976; Iorio, Francesco/0000-0001-7063-8913; Bartfeld, Sina/0000-0003-2493-8282; McDermott, Ultan/0000-0001-9032-4700; Meyerson, Matthew/0000-0002-9133-8108; Li, Vivian/0000-0003-2041-0085; Versteeg, Rogier/0000-0001-7172-0388; Cibulskis, Kristian/0000-0003-1343-1582; Kester, Lennart/0000-0002-8259-9971	Stichting Virtutis Opus; Alpe dHuzes/KWF; Dutch Cancer Society [H1/2014-6919]; Stichting Vrienden van het Hubrecht; The Francis Crick Institute [10105] Funding Source: researchfish	Stichting Virtutis Opus; Alpe dHuzes/KWF; Dutch Cancer Society(KWF Kankerbestrijding); Stichting Vrienden van het Hubrecht; The Francis Crick Institute	Thanks to the Broad Institute Genomics Platform for processing and generating the sequence data, the cell line screening, and analysis team at the Sanger Institute, Liliane Wijnaendts and Joost Oudejans for help with tumor dissections, Harry Begthel and Jeroen Korving for histology, Sepideh Darakhshan for help with organoids, and the members of the M.M., M.J.G., and H.C. laboratories for support. M.v.d.W. is supported by Stichting Virtutis Opus and Stichting Vrienden van het Hubrecht. R.G.J.V., S.J., and J.B. are supported by a Grant from Alpe dHuzes/KWF. This work was supported with a grant from the Dutch Cancer Society to M.S. (H1/2014-6919). The organoids are available for academic research upon evaluation of a research proposal by the Medical Ethical Comity. M.M. received a commercial research grant from Bayer and has ownership interest (including patents) in and is a consultant/advisory board member for Foundation Medicine.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Takahashi M, 2002, CANCER RES, V62, P5651; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vecchione L, 2014, CURR COLORECT CANC R, V10, P263, DOI 10.1007/s11888-014-0232-7; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	54	1238	1255	33	293	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					933	945		10.1016/j.cell.2015.03.053	http://dx.doi.org/10.1016/j.cell.2015.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957691	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000354175200024
J	Gillam, S				Gillam, Stephen			IF I RULED THE NHS Don't mention the P word	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sjg67@medschl.cam.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h2345	10.1136/bmj.h2345	http://dx.doi.org/10.1136/bmj.h2345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25947560				2022-12-28	WOS:000354414000006
J	Pearson, A				Pearson, Alison			WHAT YOUR PATIENT IS THINKING Never say never about our child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h1246	10.1136/bmj.h1246	http://dx.doi.org/10.1136/bmj.h1246			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25947174	Bronze			2022-12-28	WOS:000354414000001
J	Hellmann, DB; Imboden, JB				Hellmann, David B.; Imboden, John B.			Update in Rheumatology: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANCA-ASSOCIATED VASCULITIS; ARTHRITIS; VASCULOPATHY; INJECTIONS; RITUXIMAB; ONSET		[Hellmann, David B.; Imboden, John B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University	Hellmann, DB (corresponding author), Johns Hopkins Bayview Med Ctr, Mason F Lord Bldg,Ctr Tower,Room 322, Baltimore, MD 21224 USA.	hellmann@jhmi.edu						Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Emery P, 2014, NEW ENGL J MED, V371, P1781, DOI 10.1056/NEJMoa1316133; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE349; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Melles RB, 2014, JAMA OPHTHALMOL, V132, P1453, DOI 10.1001/jamaophthalmol.2014.3459; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	13	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W122	W126		10.7326/M15-0273	http://dx.doi.org/10.7326/M15-0273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927977				2022-12-28	WOS:000379893300009
J	Marmot, M				Marmot, Michael			The art of medicine What kind of society do we want: getting the balance right	LANCET			English	Editorial Material									UCL, UCL Dept Epidemiol & Publ Hlth, UCL Inst Hlth Equ, London WC1E 7HB, England	University of London; University College London	Marmot, M (corresponding author), UCL, UCL Dept Epidemiol & Publ Hlth, UCL Inst Hlth Equ, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0601647, G0902037, G0701830, G1000616] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0902037, G0701830, G0100222, G8802774, G19/35, G1000616, G0601647] Funding Source: Medline; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1614	1615		10.1016/S0140-6736(15)60784-X	http://dx.doi.org/10.1016/S0140-6736(15)60784-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CG6NG	25943808				2022-12-28	WOS:000353418000021
J	Spranger, S; Bao, RY; Gajewski, TF				Spranger, Stefani; Bao, Riyue; Gajewski, Thomas F.			Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity	NATURE			English	Article							DENDRITIC CELLS; MOUSE MODEL; EXPRESSION; REVEALS; IMMUNOTHERAPY; ACTIVATION; THERAPY; TUMORS; SUBSET; GENE	Melanoma treatment is being revolutionized by the development of effective immunotherapeutic approaches(1,2). These strategies include blockade of immune-inhibitory receptors on activated T cells; for example, using monoclonal antibodies against CTLA-4, PD-1, and PD-L1 (refs 3-5). However, only a subset of patients responds to these treatments, and data suggest that therapeutic benefit is preferentially achieved in patients with a pre-existing T-cell response against their tumour, as evidenced by a baseline CD8(+) T-cell infiltration within the tumour microenvironment(6,7). Understanding the molecular mechanisms that underlie the presence or absence of a spontaneous anti-tumour T-cell response in subsets of cases, therefore, should enable the development of therapeutic solutions for patients lacking a T-cell infiltrate. Here we identify a melanoma-cell-intrinsic oncogenic pathway that contributes to a lack of T-cell infiltration in melanoma. Molecular analysis of human metastatic melanoma samples revealed a correlation between activation of the WNT/beta-catenin signalling pathway and absence of a T-cell gene expression signature. Using autochthonous mouse melanoma models(8,9) we identified the mechanism by which tumour-intrinsic active beta-catenin signalling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy. Specific oncogenic signals, therefore, can mediate cancer immune evasion and resistance to immunotherapies, pointing to new candidate targets for immune potentiation.	[Spranger, Stefani; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bao, Riyue] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu			Team Science Award from the Melanoma Research Alliance; Translational Research Grant from the Cancer Research Institute; German Research Foundation	Team Science Award from the Melanoma Research Alliance; Translational Research Grant from the Cancer Research Institute; German Research Foundation(German Research Foundation (DFG))	The authors would like to thank A. Sailer and J. Turner for their assistance on mouse tissue immunofluorescent staining, M. Leung and Y. Zha for technical support, and the Special Services Animal Resources Center for assistance with mouse husbandry. We also acknowledge the Fitch Monoclonal Antibody Facility, the Human Tissue Research Core and the Integrated Microscopy core of The University of Chicago Comprehensive Cancer Center. We would like to thank A. O. Emmanuel and F. Gounari for assistance with the ChIP assay as well as for conditional beta-catenin knock-in mice; C. Slingluff, D. Deacon, J. Schaefer, G. Erdag and the University of Virginia Biorepository and Tissue Research Facility for melanoma biopsy specimens, and P. Savage for critical comments. Funding for this study was provided by a Team Science Award from the Melanoma Research Alliance and a Translational Research Grant from the Cancer Research Institute. S.S. was supported by the German Research Foundation and is currently a fellow of the Cancer Research Institute.	Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Cheung AF, 2008, CANCER RES, V68, P9459, DOI 10.1158/0008-5472.CAN-08-2634; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Driessens G, 2011, J IMMUNOL, V186, P784, DOI 10.4049/jimmunol.1001562; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Manning TC, 1997, J IMMUNOL, V159, P4665; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mollah SA, 2014, J INVEST DERMATOL, V134, P1265, DOI 10.1038/jid.2013.515; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Yaguchi T, 2012, J IMMUNOL, V189, P2110, DOI 10.4049/jimmunol.1102282	43	1585	1645	11	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					231	U261		10.1038/nature14404	http://dx.doi.org/10.1038/nature14404			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	25970248				2022-12-28	WOS:000357695900039
J	Lumley, AJ; Michalczyk, L; Kitson, JJN; Spurgin, LG; Morrison, CA; Godwin, JL; Dickinson, ME; Martin, OY; Emerson, BC; Chapman, T; Gage, MJG				Lumley, Alyson J.; Michalczyk, Lukasz; Kitson, James J. N.; Spurgin, Lewis G.; Morrison, Catriona A.; Godwin, Joanne L.; Dickinson, Matthew E.; Martin, Oliver Y.; Emerson, Brent C.; Chapman, Tracey; Gage, Matthew J. G.			Sexual selection protects against extinction	NATURE			English	Article							MUTATION LOAD; EXPERIMENTAL REMOVAL; DELETERIOUS ALLELES; FEMALE; MAINTENANCE; POPULATIONS; EVOLUTION; GENETICS; MODEL	Reproduction through sex carries substantial costs, mainly because only half of sexual adults produce offspring(1). It has been theorized that these costs could be countered if sex allows sexual selection to clear the universal fitness constraint of mutation load(2-4). Under sexual selection, competition between (usually) males and mate choice by (usually) females create important intraspecific filters for reproductive success, so that only a subset of males gains paternity. If reproductive success under sexual selection is dependent on individual condition, which is contingent to mutation load, then sexually selected filtering through 'genic capture'(5) could offset the costs of sex because it provides genetic benefits to populations. Here we test this theory experimentally by comparing whether populations with histories of strong versus weak sexual selection purge mutation load and resist extinction differently. After evolving replicate populations of the flour beetle Tribolium castaneum for 6 to 7 years under conditions that differed solely in the strengths of sexual selection, we revealed mutation load using inbreeding. Lineages from populations that had previously experienced strong sexual selection were resilient to extinction and maintained fitness under inbreeding, with some families continuing to survive after 20 generations of sib 3 sib mating. By contrast, lineages derived from populations that experienced weak or nonexistent sexual selection showed rapid fitness declines under inbreeding, and all were extinct after generation 10. Multiple mutations across the genome with individually small effects can be difficult to clear, yet sum to a significant fitness load; our findings reveal that sexual selection reduces this load, improving population viability in the face of genetic stress.	[Lumley, Alyson J.; Kitson, James J. N.; Spurgin, Lewis G.; Morrison, Catriona A.; Godwin, Joanne L.; Dickinson, Matthew E.; Chapman, Tracey; Gage, Matthew J. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Michalczyk, Lukasz] Jagiellonian Univ, Inst Zool, Dept Entomol, PL-30387 Krakow, Poland; [Martin, Oliver Y.] ETH, Inst Integrat Biol, D USYS, CH-8092 Zurich, Switzerland; [Emerson, Brent C.] Inst Prod Nat & Agrobiol IPNA CSIC, Isl Ecol & Evolut Res Grp, Santa Cruz De Tenerife 38206, Canary Islands, Spain	University of East Anglia; Jagiellonian University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Gage, MJG (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	m.gage@uea.ac.uk	MARTIN, OLIVER Y/A-4534-2009; Dickinson, Matthew/N-4924-2018; Dickinson, Matthew Edward/O-8672-2019; Chapman, Tracey/E-5100-2011; Kitson, James/H-5991-2019; Michalczyk, Łukasz/D-1362-2009	MARTIN, OLIVER Y/0000-0002-8601-7131; Dickinson, Matthew/0000-0001-5023-4233; Dickinson, Matthew Edward/0000-0001-5023-4233; Kitson, James/0000-0003-2405-1198; Michalczyk, Łukasz/0000-0002-2912-4870; Godwin, Joanne/0000-0002-8053-1383; Spurgin, Lewis/0000-0002-0874-9281; Morrison, Catriona/0000-0002-4293-2717; Emerson, Brent/0000-0003-4067-9858	Natural Environment Research Council; Leverhulme Trust; Natural Environment Research Council [NE/J012416/1, NE/C004639/1, NE/K004697/1, NE/G006881/1] Funding Source: researchfish; NERC [NE/K004697/1, NE/G006881/1, NE/J012416/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council and the Leverhulme Trust for financial support, D. Edward for statistical advice and colleagues at the 2013 Biology of Sperm meeting for comments that improved analytical design and interpretation.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257; Almbro M, 2014, EVOLUTION, V68, P295, DOI 10.1111/evo.12238; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson Malte, 1994; Arbuthnott D, 2012, EVOLUTION, V66, P2127, DOI 10.1111/j.1558-5646.2012.01584.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; Darwin C., 1959, ORIGIN SPECIES MEANS; Demont M, 2014, EVOL BIOL, V41, P62, DOI 10.1007/s11692-013-9246-3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gilpin M.E., 1986, P19; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hollis B, 2011, J EVOLUTION BIOL, V24, P1918, DOI 10.1111/j.1420-9101.2011.02323.x; Hollis B., 2014, NATURE COMMUN, V5; Hollis B, 2009, EVOLUTION, V63, P324, DOI 10.1111/j.1558-5646.2008.00551.x; Holman L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0053; Keightley PD, 2003, EVOLUTION, V57, P683, DOI 10.1111/j.0014-3820.2003.tb01561.x; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Long TAF, 2012, CURR BIOL, V22, P204, DOI 10.1016/j.cub.2011.12.020; MAYNARD SMITH J., 1978, EVOLUTION SEX; Michalczyk L, 2011, SCIENCE, V333, P1739, DOI 10.1126/science.1207314; Michalczyk L, 2011, EVOLUTION, V65, P713, DOI 10.1111/j.1558-5646.2010.01174.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Radwan J, 2004, ECOL LETT, V7, P1149, DOI 10.1111/j.1461-0248.2004.00681.x; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sharp NP, 2008, EVOLUTION, V62, P857, DOI 10.1111/j.1558-5646.2008.00333.x; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wigby S, 2004, EVOLUTION, V58, P1028	38	119	119	1	224	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					470	+		10.1038/nature14419	http://dx.doi.org/10.1038/nature14419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	25985178	Green Submitted, Green Accepted			2022-12-28	WOS:000356782900048
J	Bakshy, E; Messing, S; Adamic, LA				Bakshy, Eytan; Messing, Solomon; Adamic, Lada A.			Exposure to ideologically diverse news and opinion on Facebook	SCIENCE			English	Article							SELECTIVE EXPOSURE; MEDIA; CONSEQUENCES; SEGREGATION; INFORMATION	Exposure to news, opinion, and civic information increasingly occurs through social media. How do these online networks influence exposure to perspectives that cut across ideological lines? Using deidentified data, we examined how 10.1 million U.S. Facebook users interact with socially shared news. We directly measured ideological homophily in friend networks and examined the extent to which heterogeneous friends could potentially expose individuals to cross-cutting content. We then quantified the extent to which individuals encounter comparatively more or less diverse content while interacting via Facebook's algorithmically ranked News Feed and further studied users' choices to click through to ideologically discordant content. Compared with algorithmic ranking, individuals' choices played a stronger role in limiting exposure to cross-cutting content.	[Bakshy, Eytan; Messing, Solomon; Adamic, Lada A.] Facebook, Menlo Pk, CA 94025 USA; [Adamic, Lada A.] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	Facebook Inc; University of Michigan System; University of Michigan	Bakshy, E (corresponding author), Facebook, Menlo Pk, CA 94025 USA.	ebakshy@fb.com			Facebook	Facebook(Facebook Inc)	We thank J. Bailenson, D. Eckles, A. Franco, K. Garrett, J. Grimmer, S. Iyengar, B. Karrer, C. Nass, A. Peysakhovich, S. Taylor, R. Weiss, S. Westwood, J. M. White, and anonymous reviewers for their valuable feedback. The following code and data are archived in the Harvard Dataverse Network, http://dx.doi.org/10.7910/DVN/LDJ7MS: "Replication Data for: Exposure to Ideologically Diverse News and Opinion on Facebook"; R analysis code and aggregate data for deriving the main results (tables S5 and S6); Python code and dictionaries for training and testing the hard-soft news classifier; aggregate summary statistics of the distribution of ideological homophily in networks; and aggregate summary statistics of the distribution of ideological alignment for hard content shared by the top 500 most shared websites. The authors of this work are employed and funded by Facebook. Facebook did not place any restrictions on the design and publication of this observational study, beyond the requirement that this work was to be done in compliance with Facebook's Data Policy and research ethics review process (www.facebook.com/policy.php).	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Bakshy E., 2012, P 21 INT C WORLD WID; Bennett WL, 2008, J COMMUN, V58, P707, DOI 10.1111/j.1460-2466.2008.00410.x; Bishop Bill, 2008, BIG SORT WHY CLUSTER; Bond R, 2015, AM POLIT SCI REV, V109, P62, DOI 10.1017/S0003055414000525; Conover M. D., 2011, 5 INT AAAI C WEBLOGS; Duggan M SA, 2013, SOCIAL MEDIA UPDATE; Flaxman S., 2013, 2363701 SSRN; Gentzkow M, 2011, Q J ECON, V126, P1799, DOI 10.1093/qje/qjr044; Goel S, 2010, J PERS SOC PSYCHOL, V99, P611, DOI 10.1037/a0020697; Groeling T, 2013, ANNU REV POLIT SCI, V16, P129, DOI 10.1146/annurev-polisci-040811-115123; Huckfeldt R, 2004, POLIT PSYCHOL, V25, P65, DOI 10.1111/j.1467-9221.2004.00357.x; Iyengar S, 2009, J COMMUN, V59, P19, DOI 10.1111/j.1460-2466.2008.01402.x; Kull S, 2003, POLIT SCI QUART, V118, P569, DOI 10.1002/j.1538-165X.2003.tb00406.x; LaCour M. J., 2013, 2303138 SSRN; Lawrence E, 2010, PERSPECT POLIT, V8, P141, DOI 10.1017/S1537592709992714; Mendelberg Tali., 2002, RES MICROPOLITICS, V6, P151; Messing S., 2012, COMMUN RES, V41, P1042, DOI DOI 10.1177/0093650212466406; Mutz DC, 2006, J POLIT, V68, P140, DOI 10.1111/j.1468-2508.2006.00376.x; Mutz DC, 2002, AM J POLIT SCI, V46, P838, DOI 10.2307/3088437; Mutz DC, 2001, AM POLIT SCI REV, V95, P97, DOI 10.1017/S0003055401000223; Olmstead K., 2011, NAVIGATING NEWS ONLI; Pariser E., 2011, FILTER BUBBLE WHAT I; SEARS DO, 1967, PUBLIC OPIN QUART, V31, P194, DOI 10.1086/267513; Stroud NJ, 2008, POLIT BEHAV, V30, P341, DOI 10.1007/s11109-007-9050-9; Sunstein Cass R., 2007, REPUBLIC COM 2 0; Valentino NA, 2009, POLIT PSYCHOL, V30, P591, DOI 10.1111/j.1467-9221.2009.00716.x	27	1103	1125	29	436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1130	1132		10.1126/science.aaa1160	http://dx.doi.org/10.1126/science.aaa1160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ6FY	25953820				2022-12-28	WOS:000355590500046
J	Zieminska, D				Zieminska, Daria			HIGH-ENERGY PHYSICS Proton smasher spots rare particle decays	NATURE			English	Editorial Material								The extremely rare decays of particles known as neutral B mesons have been observed at CERN's Large Hadron Collider. The result may be a glimpse of physics beyond that of the standard model of particle physics. See Letter p.68	Indiana Univ, Dept Phys, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Zieminska, D (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	daria@indiana.edu						Aaij R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101805; Chatrchyan S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101804; Khachatryan V, 2015, NATURE, V522, P68, DOI 10.1038/nature14474	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					42	43		10.1038/nature14520	http://dx.doi.org/10.1038/nature14520			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25970249				2022-12-28	WOS:000355543400025
J	Samai, P; Pyenson, N; Jiang, WY; Goldberg, GW; Hatoum-Aslan, A; Marraffini, LA				Samai, Poulami; Pyenson, Nora; Jiang, Wenyan; Goldberg, Gregory W.; Hatoum-Aslan, Asma; Marraffini, Luciano A.			Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity	CELL			English	Article							STREPTOCOCCUS-THERMOPHILUS; NUCLEOTIDE-SEQUENCE; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; FUNCTIONAL MAP; SYSTEM; PROKARYOTES; RESISTANCE; COMPLEX; INTERFERENCE	Immune systems must recognize and destroy different pathogens that threaten the host. CRISPR-Cas immune systems protect prokaryotes from viral and plasmid infection utilizing small CRISPR RNAs that are complementary to the invader's genome and specify the targets of RNA-guided Cas nucleases. Type III CRISPR-Cas immunity requires target transcription, and whereas genetic studies demonstrated DNA targeting, in vitro data have shown crRNA-guided RNA cleavage. The molecular mechanism behind these disparate activities is not known. Here, we show that transcription across the targets of the Staphylococcus epidermidis type III-A CRISPR-Cas system results in the cleavage of the target DNA and its transcripts, mediated by independent active sites within the Cas10-Csm ribonucleoprotein effector complex. Immunity against plasmids and DNA viruses requires DNA, but not RNA, cleavage activity. Our studies reveal a highly versatile mechanism of CRISPR immunity that can defend microorganisms against diverse DNA and RNA invaders.	[Samai, Poulami; Pyenson, Nora; Jiang, Wenyan; Goldberg, Gregory W.; Hatoum-Aslan, Asma; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu		Goldberg, Gregory/0000-0002-5022-9976	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Seth Darst, Arkady Mustaev, and Brian Bae for providing CBR703 and help with transcription inhibition assays. We also like to thank Andrew Varble for critical reading of the manuscript. P.S. is supported by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University. L.A.M. is supported by the Searle Scholars Program, Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-43; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Heitman J, 1999, MOL MICROBIOL, V33, P1141, DOI 10.1046/j.1365-2958.1999.01556.x; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; HORINOUCHI S, 1982, J BACTERIOL, V150, P804, DOI 10.1128/JB.150.2.804-814.1982; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	35	248	272	7	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1164	1174		10.1016/j.cell.2015.04.027	http://dx.doi.org/10.1016/j.cell.2015.04.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959775	Green Accepted, Bronze			2022-12-28	WOS:000355152600022
J	Jacquin, G				Jacquin, Gregory			In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University	Jacquin, G (corresponding author), McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC4	10.7326/ACPJC-2015-162-10-004	http://dx.doi.org/10.7326/ACPJC-2015-162-10-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984877				2022-12-28	WOS:000355015200006
J	Cattaneo, A				Cattaneo, Andrea			The slow death of red galaxies	NATURE			English	Editorial Material							BLACK-HOLES; PROGENITORS	For most galaxies, the shutdown of star formation was a slow process that took 4 billion years. An analysis of some 27,000 galaxies suggests that 'strangulation' by their environment was the most likely cause. SEE LETTER P.192	Observ Paris, GEPI, F-75014 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite	Cattaneo, A (corresponding author), Observ Paris, GEPI, F-75014 Paris, France.	andrea.cattaneo@obspm.fr						Baldry IK, 2004, ASTROPHYS J, V600, P681, DOI 10.1086/380092; Barro G, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/104; Bell EF, 2003, ASTROPHYS J SUPPL S, V149, P289, DOI 10.1086/378847; Cattaneo A, 2013, MON NOT R ASTRON SOC, V430, P686, DOI 10.1093/mnras/sts668; Cattaneo A, 2009, NATURE, V460, P213, DOI 10.1038/nature08135; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Peng Y, 2015, NATURE, V521, P192, DOI 10.1038/nature14439; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932	8	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					164	165		10.1038/521164a	http://dx.doi.org/10.1038/521164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25971504	Green Submitted			2022-12-28	WOS:000354377800043
J	Ghosh, A; Ganesan, K				Ghosh, Arunabha; Ganesan, Karthik			Rethink India's energy strategy	NATURE			English	Editorial Material									[Ghosh, Arunabha; Ganesan, Karthik] Council Energy Environm & Water, New Delhi, India		Ghosh, A (corresponding author), Council Energy Environm & Water, New Delhi, India.	arunabha.ghosh@ceew.in						[Anonymous], 2013, REN EL; Ganesan K., 2014, ENERGY ACCESS INDIA; Harish S. M., 2014, DO RURAL RESIDENTIAL; Indian Network for Climate Change Assessment, 2010, IND GREENH GAS EM 20; Jain A., 2014, RATIONALISING SUBSID; Kammen DM, 2015, AIP CONF PROC, V1652, P14, DOI 10.1063/1.4916165; Power Finance Corporation, 2013, PERF STAT POW UT YEA; Steven D., 2014, NEW POLITICS STRATEG, P40	8	12	13	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					156	157		10.1038/521156a	http://dx.doi.org/10.1038/521156a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971495	Bronze			2022-12-28	WOS:000354377800034
J	Gupta, R; Vavvas, D; Asaad, WF				Gupta, Rajiv; Vavvas, Demetrios; Asaad, Wael F.			Case 15-2015: A 27-Year-Old Man with a Nail in the Eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUAL-ENERGY CT; PENETRATING CRANIOCEREBRAL INJURIES; INTERNAL CAROTID-ARTERY; PRINCIPLES; MANAGEMENT; ANEURYSMS; SYSTEM		[Gupta, Rajiv] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Asaad, Wael F.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Vavvas, Demetrios] Massachusetts Eye & Ear Inst, Dept Ophthalmol, Boston, MA USA; [Gupta, Rajiv] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Vavvas, Demetrios] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Asaad, Wael F.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gupta, R (corresponding author), Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA.		; Asaad, Wael/I-8485-2012	Vavvas, Demetrios/0000-0002-8622-6478; Asaad, Wael/0000-0003-4406-9096				Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; Agarwalla PK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1038; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA, V51, pS16; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Berlin R., 1873, KLIN MONATSBL AUGENH, V1, P42; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P7220, DOI 10.1167/iovs.12-9887; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P2913, DOI 10.1167/iovs.11-8564; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; Joo JY, 2005, J TRAUMA, V58, P1159, DOI 10.1097/01.TA.0000171550.01402.ED; Kansagra AP, 2014, J NEUROINTERV SURG, V6, P47, DOI 10.1136/neurintsurg-2012-010605; KOBAYASHI S, 1989, J NEUROSURG, V70, P216, DOI 10.3171/jns.1989.70.2.0216; Lee YH, 2012, EUR RADIOL, V22, P1331, DOI 10.1007/s00330-011-2370-5; Maiden N, 2009, FORENSIC SCI MED PAT, V5, P204, DOI 10.1007/s12024-009-9096-6; MING L, 1988, J TRAUMA, V28, pS104, DOI 10.1097/00005373-198801001-00023; Ogilvy CS, 1997, NEUROSURGERY, V40, P1312, DOI 10.1097/00006123-199706000-00041; Petersilka M, 2008, EUR J RADIOL, V68, P362, DOI 10.1016/j.ejrad.2008.08.013; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Souza-Santos F, 2012, RETINA-J RET VIT DIS, V32, P711, DOI 10.1097/IAE.0b013e318227fd01; WOLF AW, 1978, J TRAUMA, V18, P63, DOI 10.1097/00005373-197801000-00012; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Yu LF, 2011, MED PHYS, V38, P6371, DOI 10.1118/1.3658568; Zhou CS, 2011, ACAD RADIOL, V18, P1252, DOI 10.1016/j.acra.2011.05.009	27	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1945	1955		10.1056/NEJMcpc1310007	http://dx.doi.org/10.1056/NEJMcpc1310007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970053				2022-12-28	WOS:000354493300012
J	Baron, RJ				Baron, Richard J.			Professional Self-regulation in a Changing World Old Problems Need New Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Board Internal Med, Philadelphia, PA 19106 USA	American Board of Internal Medicine	Baron, RJ (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	rbaron@abim.org						American Board of Internal Medicine, ABIM ANN IMM CHANG M; Baron RJ, 2014, ANN INTERN MED, V161, P221, DOI 10.7326/M13-2478; Bell WJ, 1987, COLL PHYS PHILADELPH, P3; Cruess RL, 2009, TEACHING MEDICAL PROFESSIONALISM, P1; FITZ R, 1950, NEW ENGL J MED, V242, P569, DOI 10.1056/NEJM195004132421501; Goodwin DK, 1994, NO ORDINARY TIME FRA, P569	6	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1807	1808		10.1001/jama.2015.4060	http://dx.doi.org/10.1001/jama.2015.4060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965218				2022-12-28	WOS:000354391000013
J	Gotzsche, PC; Young, AH; Crace, J				Gotzsche, Peter C.; Young, Allan H.; Crace, John			Does long term use of psychiatric drugs cause more harm than good?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-UP; MOOD DISORDERS; MORTALITY; LITHIUM; SCHIZOPHRENIA; EFFICACY; CHILDREN; PEOPLE; RISK		[Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Young, Allan H.] Kings Coll London, Mood Disorders, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Crace, John] Guardian, London, England	Rigshospitalet; University of Copenhagen; University of London; King's College London	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk; allan.young@kcl.ac.uk		Young, Allan/0000-0003-2291-6952				Aiff H, 2014, J PSYCHOPHARMACOL, V28, P151, DOI 10.1177/0269881113516202; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; BLACKWELL B, 1968, LANCET, V1, P968; Bola J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006374.pub2; Breggin P, 2013, PSYCHIAT DRUG WITHDR; Breggin PR, 2014, CHILD SOC, V28, P231, DOI 10.1111/chso.12049; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Clinical Practice Research Datalink, MHRA MAIN ACT; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062; De Hert M, 2010, SCHIZOPHR RES, V117, P68, DOI 10.1016/j.schres.2009.12.029; Fok MLY, 2012, J PSYCHOSOM RES, V73, P104, DOI 10.1016/j.jpsychores.2012.05.001; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gotzsche PC, DEADLY PSYC IN PRESS; Gotzsche PC, 2014, LANCET PSYCHIAT, V1, P104, DOI 10.1016/S2215-0366(14)70280-9; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Khin NA, 2012, J CLIN PSYCHIAT, V73, P856, DOI 10.4088/JCP.11r07539; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P2318, DOI 10.1038/sj.npp.1301147; Leucht S, 2013, J AFFECT DISORDERS, V148, P243, DOI 10.1016/j.jad.2012.12.001; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Marco EM, 2011, NEUROSCI BIOBEHAV R, V35, P1722, DOI 10.1016/j.neubiorev.2011.02.011; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Moncrieff J, 2004, Cochrane Database Syst Rev, pCD003012; Nielsen M, 2012, ADDICTION, V107, P900, DOI 10.1111/j.1360-0443.2011.03686.x; Petersen M, 2008, OUR DAILY MEDS; Rawlins MD, 2013, CLIN THER, V35, P1634, DOI 10.1016/j.clinthera.2013.08.010; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Severus E, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0015-8; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Whitaker R., 2010, ANATOMY EPIDEMIC; Whitaker R, 2002, MAD IN AM	36	61	64	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2015	350								h2435	10.1136/bmj.h2435	http://dx.doi.org/10.1136/bmj.h2435			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BX	25985333	Green Published			2022-12-28	WOS:000354769000006
J	Rivas, MA; Pirinen, M; Conrad, DF; Lek, M; Tsang, EK; Karczewski, KJ; Maller, JB; Kukurba, KR; DeLuca, DS; Fromer, M; Ferreira, PG; Smith, KS; Zhang, R; Zhao, FM; Banks, E; Poplin, R; Ruderfer, DM; Purcell, SM; Tukiainen, T; Minikel, EV; Stenson, PD; Cooper, DN; Huang, KH; Sullivan, TJ; Nedzel, J; Bustamante, CD; Li, JB; Daly, MJ; Guigo, R; Donnelly, P; Ardlie, K; Sammeth, M; Dermitzakis, ET; McCarthy, MI; Montgomery, SB; Lappalainen, T; MacArthur, DG				Rivas, Manuel A.; Pirinen, Matti; Conrad, Donald F.; Lek, Monkol; Tsang, Emily K.; Karczewski, Konrad J.; Maller, Julian B.; Kukurba, Kimberly R.; DeLuca, David S.; Fromer, Menachem; Ferreira, Pedro G.; Smith, Kevin S.; Zhang, Rui; Zhao, Fengmei; Banks, Eric; Poplin, Ryan; Ruderfer, Douglas M.; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Stenson, Peter D.; Cooper, David N.; Huang, Katharine H.; Sullivan, Timothy J.; Nedzel, Jared; Bustamante, Carlos D.; Li, Jin Billy; Daly, Mark J.; Guigo, Roderic; Donnelly, Peter; Ardlie, Kristin; Sammeth, Michael; Dermitzakis, Emmanouil T.; McCarthy, Mark I.; Montgomery, Stephen B.; Lappalainen, Tuuli; MacArthur, Daniel G.		GTEx Consortium; Geuvadis Consortium	Effect of predicted protein-truncating genetic variants on the human transcriptome	SCIENCE			English	Article							EXPRESSION; DOSAGE	Accurate prediction of the functional effect of genetic variation is critical for clinical genome interpretation. We systematically characterized the transcriptome effects of protein-truncating variants, a class of variants expected to have profound effects on gene function, using data from the Genotype-Tissue Expression (GTEx) and Geuvadis projects. We quantitated tissue-specific and positional effects on nonsense-mediated transcript decay and present an improved predictive model for this decay. We directly measured the effect of variants both proximal and distal to splice junctions. Furthermore, we found that robustness to heterozygous gene inactivation is not due to dosage compensation. Our results illustrate the value of transcriptome data in the functional interpretation of genetic variants.	[Rivas, Manuel A.; Donnelly, Peter; McCarthy, Mark I.] Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Pirinen, Matti] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Conrad, Donald F.] Washington Univ, St Louis, MO USA; [Lek, Monkol; Karczewski, Konrad J.; Maller, Julian B.; DeLuca, David S.; Fromer, Menachem; Zhao, Fengmei; Banks, Eric; Poplin, Ryan; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Huang, Katharine H.; Sullivan, Timothy J.; Nedzel, Jared; Daly, Mark J.; Ardlie, Kristin; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lek, Monkol; Karczewski, Konrad J.; Maller, Julian B.; Fromer, Menachem; Zhao, Fengmei; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Tsang, Emily K.; Kukurba, Kimberly R.; Smith, Kevin S.; Zhang, Rui; Bustamante, Carlos D.; Li, Jin Billy; Montgomery, Stephen B.; Lappalainen, Tuuli] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Tsang, Emily K.; Kukurba, Kimberly R.; Smith, Kevin S.; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Tsang, Emily K.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.] Mt Sinai Hosp, Dept Psychiat, New York, NY USA; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Swiss Inst Bioinformat, Geneva, Switzerland; [Ruderfer, Douglas M.; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Stenson, Peter D.; Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales; [Guigo, Roderic; Sammeth, Michael] UPF, CRG, Barcelona, Catalonia, Spain; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Sammeth, Michael] Natl Inst Sci Comp LNCC, Rio De Janeiro, Brazil; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY USA; [MacArthur, Daniel G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Stanford University; Icahn School of Medicine at Mount Sinai; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Icahn School of Medicine at Mount Sinai; Cardiff University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Oxford; Laboratorio Nacional de Computacao Cientifica (LNCC); University of Oxford; Columbia University; Harvard University; Harvard Medical School	Rivas, MA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford, England.	rivas@well.ox.ac.uk; tlappalainen@nygenome.org; macarthur@atgu.mgh.harvard.edu	Antonarakis, Stylianos E/N-8866-2014; Ruderfer, Douglas M/M-5795-2016; Guigo, Roderic/D-1303-2010; Beltran, Sergi/I-3408-2015; Daly, Mark J/B-2453-2017; Meitinger, Thomas/O-1318-2015; Rivas, Manuel/ABE-8173-2020; Stegle, Oliver/AAU-9177-2020; Ferreira, Pedro/HDO-1346-2022; Gamazon, Eric/I-6873-2018; Kellis, Manolis/ABE-7385-2020; Cooper, David N/H-4384-2011; Häsler, Robert/A-4908-2009; Lappalainen, Tuuli/AAE-6532-2020; Esser, Daniela/ABB-9383-2020; Ferreira, Pedro G/J-6379-2013; Sammeth, Michael/C-1157-2014; Little, Roger/O-6191-2014; McCarthy, Mark/M-3763-2015; Karczewski, Jakub/L-7326-2018; Estivill, Xavier/A-3125-2013	Antonarakis, Stylianos E/0000-0001-8907-5823; Ruderfer, Douglas M/0000-0002-2365-386X; Guigo, Roderic/0000-0002-5738-4477; Beltran, Sergi/0000-0002-2810-3445; Daly, Mark J/0000-0002-0949-8752; Rivas, Manuel/0000-0003-1457-9925; Stegle, Oliver/0000-0002-8818-7193; Gamazon, Eric/0000-0003-4204-8734; Kellis, Manolis/0000-0001-7113-9630; Cooper, David N/0000-0002-8943-8484; Häsler, Robert/0000-0003-4174-8229; Lappalainen, Tuuli/0000-0002-7746-8109; Ferreira, Pedro G/0000-0003-3838-8664; Sammeth, Michael/0000-0002-6528-9883; Little, Roger/0000-0001-6831-0177; Friedlander, Marc/0000-0001-6577-4363; Esko, Tonu/0000-0003-1982-6569; Minikel, Eric Vallabh/0000-0003-2206-1608; Zhou, Yi-Hui/0000-0002-4092-7463; Meitinger, Thomas/0000-0002-8838-8403; mele, marta/0000-0001-8874-6453; Carracedo, Angel/0000-0003-1085-8986; Montgomery, Stephen/0000-0002-5200-3903; Brazma, Alvis/0000-0001-5988-7409; Tukiainen, Taru/0000-0002-5404-8398; McCarthy, Mark/0000-0002-4393-0510; Zhang, Rui/0000-0001-9000-5021; Bustamante, Carlos D./0000-0002-4187-7920; Karczewski, Jakub/0000-0001-9322-7842; Pirinen, Matti/0000-0002-1664-1350; Kilpinen, Helena/0000-0001-6692-6154; Estivill, Xavier/0000-0002-0723-2256; Ongen, Halit/0000-0002-4197-5790; MacArthur, Daniel/0000-0002-5771-2290; Karczewski, Konrad/0000-0003-2878-4671	National Institutes of Health [NIGMS R01GM104371, NIMH R01MH101814, R01MH090941, U01HG007593, R01MH101810]; Academy of Finland [257654]; Hewlett-Packard Stanford Graduate Fellowship; Natural Science and Engineering Research Council of Canada; National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD); European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation; Wellcome Trust [095552/Z/11/Z, 090532/Z/09/Z, 098381]; University of Oxford; Common Fund of the Office of the Director of NIH; NCI/SAIC-Frederick, Inc. (SAIC-F) [X10S172]; University of Geneva [MH090941]; University of Chicago [MH090951, MH090937]; University of North Carolina-Chapel Hill [MH090936]; Harvard University [MH090948];  [HHSN268201000029C];  [10ST1035];  [DA006227]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371, T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820, R01MH101810, R01MH101814, R01MH090941, R01MH090948, R01MH090936, R01MH101819, R01MH090937, R01MH090951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001942] Funding Source: researchfish; BBSRC [BBS/E/I/00001942] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Hewlett-Packard Stanford Graduate Fellowship; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Wellcome Trust(Wellcome Trust); University of Oxford; Common Fund of the Office of the Director of NIH; NCI/SAIC-Frederick, Inc. (SAIC-F); University of Geneva; University of Chicago(University of Chicago); University of North Carolina-Chapel Hill; Harvard University; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all the members of the GTEx and Geuvadis consortia and L. Solomon for assistance with the figures. This work was supported by the National Institutes of Health (NIGMS R01GM104371 to D.G.M.; NIMH R01MH101814 to E.T.D, C.D.B., S.B.M., R.G., T.L., and M.I.M.; R01MH090941 to E.T.D. and M.I.M.; U01HG007593 to J.B.L. and S.B.M.; and R01MH101810 to D.F.C.); Academy of Finland (257654 to M.P.); a Hewlett-Packard Stanford Graduate Fellowship and a doctoral fellowship from the Natural Science and Engineering Research Council of Canada to E.K.T.; a National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD) to K.R.K.; European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation to E.T.D.; Wellcome Trust (095552/Z/11/Z and 090532/Z/09/Z to P.D. and 098381 to M.I.M.); and a Clarendon Scholarship, NDM Studentship, and Green Templeton College Award from University of Oxford to M.A.R. The Genotype-Tissue Expression (GTEx) project was supported by the Common Fund of the Office of the Director of NIH. Additional funds were enrolled at Biospecimen Source sites funded by NCI/SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care, Inc. (X10S172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to the Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplement to University of Miami grant DA006227. Statistical methods development grants were made to the University of Geneva (MH090941), the University of Chicago (MH090951 and MH090937), the University of North Carolina-Chapel Hill (MH090936), and Harvard University (MH090948). The primary and processed data used to generate the analyses presented here are available in the following locations: All primary sequence and clinical data files, and any other protected data, are deposited in and available from the database of Genotypes and Phenotypes (www.ncbi.nlm.nih.gov/gap) (phs000424.v3.p1, except for whole-exome sequencing data in phs000424.v5.p1 and mmPCR-seq data and processed ASE data in phs000424.v6.p1); derived analysis files are available on the GTEx Portal (www.gtexportal.org). Biospecimens remaining from the study may be requested for research studies. The sample request form, biospecimen access policy, and material transfer agreement are available on the GTEx Portal (www.gtexportal.org/home/samplesPage). The Geuvadis data are available in ArrayExpress accession E-GEUV-1. Further details and links to data and software are available in www.well.ox.ac.uk/similar to rivas/ptv2015. C.D.B. is a paid member of the Scientific Advisory Boards of Personalis, InVitae, and Ancestry.com; he is founder and chair of the SAB of Identify Genomics, LLC; he also owns stock options in Personalis, Invitae, and Identify Genomics, LLC.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Burge CB, 1999, RNA WORLD, P525; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; KACSER H, 1981, GENETICS, V97, P639; Kukurba KR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004304; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McAnally AA, 2010, GENOME BIOL EVOL, V2, P44, DOI 10.1093/gbe/evp054; McCarthy DJ, 2014, GENOME MED, V6, DOI 10.1186/gm543; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pirinen M., 2015, BIOINFORMATICS; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	27	148	153	6	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					666	669		10.1126/science.1261877	http://dx.doi.org/10.1126/science.1261877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954003	Green Accepted			2022-12-28	WOS:000354045700038
J	Prezioso, M; Merrikh-Bayat, F; Hoskins, BD; Adam, GC; Likharev, KK; Strukov, DB				Prezioso, M.; Merrikh-Bayat, F.; Hoskins, B. D.; Adam, G. C.; Likharev, K. K.; Strukov, D. B.			Training andoperation of an integrated neuromorphic network based on metal-oxide memristors	NATURE			English	Article							CIRCUITS; DEVICE; MEMORY	Despite much progress in semiconductor integrated circuit technology, the extreme complexity of the human cerebral cortex(1), with its approximately 10(14) synapses, makes the hardware implementation of neuromorphic networks with a comparable number of devices exceptionally challenging. To provide comparable complexity while operating much faster and with manageable power dissipation, networks(2) based on circuits(3,4) combining complementary metaloxide-semiconductors (CMOSs) and adjustable two-terminal resistive devices (memristors) have been developed. In such circuits, the usual CMOS stack is augmented with one(3) or several(4) crossbar layers, with memristors at each crosspoint. There have recently been notable improvements in the fabrication of such memristive crossbars and their integration with CMOS circuits(5-12), including first demonstrations(5,6,12) of their vertical integration. Separately, discrete memristors have been used as artificial synapses in neuromorphic networks(13-18). Very recently, such experiments have been extended(19) to crossbar arrays of phase-change memristive devices. The adjustment of such devices, however, requires an additional transistor at each crosspoint, and hence these devices are much harder to scale than metal-oxide memristors(11,20,21), whose nonlinear current-voltage curves enable transistor-free operation. Here we report the experimental implementation of transistor-free metal-oxide memristor crossbars, with device variability sufficiently low to allow operation of integrated neural networks, in a simple network: a single-layer perceptron (an algorithm for linear classification). The network can be taught in situ using a coarse-grain variety of the delta rule algorithm(22) to perform the perfect classification of 3 3 3-pixel black/white images into three classes (representing letters). This demonstration is an important step towards much larger and more complex memristive neuromorphic networks.	[Prezioso, M.; Merrikh-Bayat, F.; Hoskins, B. D.; Adam, G. C.; Strukov, D. B.] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [Likharev, K. K.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	University of California System; University of California Santa Barbara; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Prezioso, M (corresponding author), Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA.	mprezioso@ece.ucsb.edu; strukov@ece.ucsb.edu	Prezioso, Mirko/D-7518-2011	Prezioso, Mirko/0000-0002-3318-9132; Adam, Gina/0000-0003-0027-1145; , Dmitri/0000-0002-4526-4347; Hoskins, Brian/0000-0002-9418-9291	AFOSR under the MURI [FA9550-12-1-0038]; DARPA via BAE Systems [HR0011-13-C-0051UPSIDE]; DENSO Corporation, Japan	AFOSR under the MURI; DARPA via BAE Systems; DENSO Corporation, Japan	We acknowledge useful discussions with F. Alibart, I. Kataeva, W. Lu, L. Sengupta, S. Stemmer, and E. Zamanidoost. This work was supported by the AFOSR under the MURI grant FA9550-12-1-0038, by DARPA under contract number HR0011-13-C-0051UPSIDE via BAE Systems, and by the DENSO Corporation, Japan.	Alibart F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3072; Chanthbouala A, 2012, NAT MATER, V11, P860, DOI [10.1038/NMAT3415, 10.1038/nmat3415]; Chevallier C. J., 2010, INT SOLID STATE CIRC, V10, P260; Eryilmaz SB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00205; Govoreanu B., 2013, ELECT DEVICES M IEDM, V13, P256, DOI DOI 10.1109/IEDM.2013.6724599; Hasler J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00118; Hertz JA, 2018, INTRO THEORY NEURAL; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Kawahara A., 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), P432, DOI 10.1109/ISSCC.2012.6177078; Kim GH, 2013, ADV FUNCT MATER, V23, P1440, DOI 10.1002/adfm.201202170; Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 2012, LECT NOTES COMPUT SC, V7700, P9, DOI DOI 10.1007/3-540-49430-8_; Likharev KK, 2011, SCI ADV MATER, V3, P322, DOI 10.1166/sam.2011.1177; Likharev KK, 2008, J NANOELECTRON OPTOE, V3, P203, DOI 10.1166/jno.2008.301; Liu TY, 2013, ISSCC DIG TECH PAP I, V56, P210, DOI 10.1109/ISSCC.2013.6487703; Miyamura M., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P228, DOI 10.1109/ISSCC.2011.5746296; Mountcastle V. B., 1998, CEREBRAL CORTEX; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Pershin YV, 2010, NEURAL NETWORKS, V23, P881, DOI 10.1016/j.neunet.2010.05.001; Pi S, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4827021; Schiffmann W, 1994, TECHNICAL REPORT; Seo K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254023; Strukov DB, 2009, P NATL ACAD SCI USA, V106, P20155, DOI 10.1073/pnas.0906949106; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]; Ziegler M, 2012, ADV FUNCT MATER, V22, P2744, DOI 10.1002/adfm.201200244	30	1680	1704	115	1247	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					61	64		10.1038/nature14441	http://dx.doi.org/10.1038/nature14441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951284	Green Submitted			2022-12-28	WOS:000354040900032
J	Mauck, KF; Sundsted, KK				Mauck, Karen F.; Sundsted, Karna K.			Update in Perioperative Medicine: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NONCARDIAC SURGERY; CARDIAC RISK; COMPLICATIONS; COHORT; PREDICTION; OUTCOMES; INDEX		Mayo Clin, Rochester, MN USA; Mayo Clin Coll Med, Rochester, MN USA; [Mauck, Karen F.; Sundsted, Karna K.] Mayo Clin, Dept Med, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mauck, KF (corresponding author), Mayo Clin, Dept Med, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	mauck.karen@mayo.edu						Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Blessberger H, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004476.pub2, 10.1002/14651858.CD004476.pub3]; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Ford MK, 2010, ANN INTERN MED, V152, P26, DOI 10.7326/0003-4819-152-1-201001050-00007; Foucrier A, 2014, ANESTH ANALG, V119, P1053, DOI 10.1213/ANE.0000000000000302; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Mutter TC, 2014, ANESTHESIOLOGY, V121, P707, DOI 10.1097/ALN.0000000000000407; Twersky RS, 2014, ANESTH ANALG, V118, P938, DOI 10.1213/ANE.0000000000000076; Valkenet K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-144; Zareba P, 2014, BRIT J SURG, V101, P1053, DOI 10.1002/bjs.9527	17	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W111	W116		10.7326/M15-0206	http://dx.doi.org/10.7326/M15-0206			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927736				2022-12-28	WOS:000379893300007
J	Spandorfer, J; Galanis, T				Spandorfer, John; Galanis, Taki			Deep Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; VEIN THROMBOSIS; RISK-FACTORS; THROMBOEMBOLISM PROPHYLAXIS; PULMONARY-EMBOLISM; ORAL ANTICOAGULANTS; MEDICAL PATIENTS; TOTAL HIP; METAANALYSIS; DIAGNOSIS											Adam SS, 2013, ANN INTERN MED, V159, P275, DOI 10.7326/0003-4819-159-4-201308200-00008; Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Alikhan R, 2014, COCHRANE DB SYST REV, V5; American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2013, Obstet Gynecol, V122, P706, DOI 10.1097/01.AOG.0000433981.36184.4e; Anderson DR, 2013, ANN INTERN MED, V158, P800, DOI 10.7326/0003-4819-158-11-201306040-00004; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Bain E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001689.pub3; Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; Bates SM, 2012, CHEST, V141; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Bruinstroop E, 2009, J THROMB HAEMOST, V7, P611, DOI 10.1111/j.1538-7836.2009.03293.x; Carrier M, 2011, J THROMB HAEMOST, V9, P1119, DOI 10.1111/j.1538-7836.2011.04254.x; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Cohn DM, 2012, COCHRANE DB SYST REV, V12; Cohoon KP, 2014, CIRCULATION, V129, P254, DOI 10.1161/CIRCULATIONAHA.113.001943; Decousus H, 2011, CHEST, V139, P69, DOI 10.1378/chest.09-3081; Dennis M, 2013, LANCET, V382, P516, DOI 10.1016/S0140-6736(13)61050-8; Dermody M, 2011, J VASC SURG, V53, P1309, DOI 10.1016/j.jvs.2010.10.115; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Fancher TL, 2004, BMJ-BRIT MED J, V329, P821, DOI 10.1136/bmj.38226.719803.EB; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2008, THROMB RES, V122, P763, DOI 10.1016/j.thromres.2007.10.011; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kanungo J, 2011, OBSTET GYNECOL, V118, P872, DOI [10.1097/AOG.0b013e31822add60, 10.1097/AOG.0b013e3182310c4c]; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kearon C, 2008, BLOOD, V112, P4432, DOI 10.1182/blood-2008-06-163279; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kuipers S, 2014, BRIT J HAEMATOL, V165, P412, DOI 10.1111/bjh.12724; Lijfering WM, 2010, BRIT J HAEMATOL, V149, P824, DOI 10.1111/j.1365-2141.2010.08206.x; Lozano F, 2014, J VASC SURG, V59, P1362, DOI 10.1016/j.jvs.2013.11.091; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pannucci CJ, 2014, CHEST, V145, P567, DOI 10.1378/chest.13-1553; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prasad V, 2013, JAMA INTERN MED, V173, P493, DOI 10.1001/jamainternmed.2013.2725; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-21; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Romualdi E, 2013, J THROMB HAEMOST, V11, P270, DOI 10.1111/jth.12085; Sampson FC, 2007, EUR RADIOL, V17, P175, DOI 10.1007/s00330-006-0178-5; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Squizzato A, 2009, EUR RESPIR J, V33, P1148, DOI 10.1183/09031936.00133608; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P1330, DOI 10.1001/jamainternmed.2014.2368; Streiff MB, 2013, J NATL COMPR CANC NE, V11, P1402, DOI 10.6004/jnccn.2013.0163; Thomas SM, 2008, CLIN RADIOL, V63, P299, DOI 10.1016/j.crad.2007.09.010; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; Watson L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002783.pub3; Wattanakit K, 2012, THROMB HAEMOSTASIS, V108, P508, DOI 10.1160/TH11-10-0726; Young T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006212.pub3	66	7	8	2	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9								10.7326/AITC201505050	http://dx.doi.org/10.7326/AITC201505050			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0DH	25939012				2022-12-28	WOS:000364659100001
J	Raschle, M; Smeenk, G; Hansen, RK; Temu, T; Oka, Y; Hein, MY; Nagaraj, N; Long, DT; Walter, JC; Hofmann, K; Storchova, Z; Cox, J; Bekker-Jensen, S; Mailand, N; Mann, M				Raeschle, Markus; Smeenk, Godelieve; Hansen, Rebecca K.; Temu, Tikira; Oka, Yasuyoshi; Hein, Marco Y.; Nagaraj, Nagarjuna; Long, David T.; Walter, Johannes C.; Hofmann, Kay; Storchova, Zuzana; Cox, Juergen; Bekker-Jensen, Simon; Mailand, Niels; Mann, Matthias			Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links	SCIENCE			English	Article							STRAND-BREAK REPAIR; REPLICATION STRESS; SMC5/6; DAMAGE; IDENTIFICATION; KIAA1018/FAN1; RECRUITMENT; DEFICIENCY; MECHANISM; CELLS	DNA interstrand cross-links (ICLs) block replication fork progression by inhibiting DNA strand separation. Repair of ICLs requires sequential incisions, translesion DNA synthesis, and homologous recombination, but the full set of factors involved in these transactions remains unknown. We devised a technique called chromatin mass spectrometry (CHROMASS) to study protein recruitment dynamics during perturbed DNA replication in Xenopus egg extracts. Using CHROMASS, we systematically monitored protein assembly and disassembly on ICL-containing chromatin. Among numerous prospective DNA repair factors, we identified SLF1 and SLF2, which form a complex with RAD18 and together define a pathway that suppresses genome instability by recruiting the SMC5/6 cohesion complex to DNA lesions. Our study provides a global analysis of an entire DNA repair pathway and reveals the mechanism of SMC5/6 relocalization to damaged DNA in vertebrate cells. Copyright 2015, American Association for the Advancement of Science.	[Raeschle, Markus; Temu, Tikira; Hein, Marco Y.; Nagaraj, Nagarjuna; Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Smeenk, Godelieve; Hansen, Rebecca K.; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Ubiquitin Signaling Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Storchova, Zuzana] Max Planck Inst Biochem, Maintenance Genome Stabil Grp, D-82152 Martinsried, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Mann, Matthias] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prote Program, DK-2200 Copenhagen, Denmark	Max Planck Society; University of Copenhagen; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; University of Cologne; University of Copenhagen	Bekker-Jensen, S (corresponding author), Univ Copenhagen, Ubiquitin Signaling Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark.	simon.bekker-jensen@cpr.ku.dk; niels.mailand@cpr.ku.dk; mmann@biochem.mpg.de	Cox, Jurgen/B-9481-2008; Hein, Marco/C-2994-2014	Cox, Jurgen/0000-0001-8597-205X; Hein, Marco/0000-0002-9490-2261; Walter, Johannes/0000-0002-4186-7570; Long, David/0000-0001-9232-0316; Storchova, Zuzana/0000-0003-2376-7047	Center for Integrated Protein Research Munich (CIPSM); Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeck Foundation; Bundesministerium fur Bildung und Forschung [FKZ01GS0861]; European Committees Marie Sklodowska-Curie actions [PIEF-GA-2012-330675]; 7th Framework Program PROSPECTS [HEALTH-F4-2008-201648]; NIH [HL098316]; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM102325] Funding Source: NIH RePORTER	Center for Integrated Protein Research Munich (CIPSM); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Committees Marie Sklodowska-Curie actions; 7th Framework Program PROSPECTS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation Center for Protein Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hyman and I. Poser for providing BAC cell lines; I. Hickson for providing BLM-deficient and -corrected cells; J. Huang for reagents; J. Cox, F. Gnad, M. Oroshi, R. Scheltema, and C. Schaab for bioinformatics support; S. Schmalbrock, A. Sewo Pires de Campos, C. Kuffer, and A. Kutznetsova for help with microscopy; K. Mayr, I. Paron, G. Sowa, S. Kroiss, B. Splettstosser, and people from the Max Planck animal facility for support; and S. Gruber, B. Pfander, M. Steger, M. Wierer, and F. Coscia for discussion and reading the manuscript. Supported by the Center for Integrated Protein Research Munich (CIPSM), the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Cancer Society, the Lundbeck Foundation, the Bundesministerium fur Bildung und Forschung (grant FKZ01GS0861, DiGtoP consortium) and the European Committees Marie Sklodowska-Curie actions (grant PIEF-GA-2012-330675) and 7th Framework Program PROSPECTS (HEALTH-F4-2008-201648). J.C.W. was supported by NIH grant HL098316. J.C.W. is an investigator of the Howard Hughes Medical Institute. The mass spectrometry data have been deposited at Proteome Exchange: http://proteomecentral.proteomexchange.org.	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Helchowski CM, 2013, CELL CYCLE, V12, P3749, DOI 10.4161/cc.26640; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; Leung GP, 2011, J BIOL CHEM, V286, P26250, DOI 10.1074/jbc.M111.235200; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Liu T, 2012, DNA REPAIR, V11, P131, DOI 10.1016/j.dnarep.2011.10.012; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sale JE, 2012, J CELL SCI, V125, P1633, DOI 10.1242/jcs.094748; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	38	121	122	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234							1253671	10.1126/science.1253671	http://dx.doi.org/10.1126/science.1253671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931565	Green Accepted			2022-12-28	WOS:000353778100032
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Women's health team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2015	350								h2030	10.1136/bmj.h2030	http://dx.doi.org/10.1136/bmj.h2030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UU	25930063				2022-12-28	WOS:000353956800002
J	Das, P				Das, Pamela			Profile Pedro L Alonso: mapping out the future of malaria control	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1613	1613		10.1016/S0140-6736(15)60783-8	http://dx.doi.org/10.1016/S0140-6736(15)60783-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25943807				2022-12-28	WOS:000353418000020
J	Bellemain-Appaix, A; Kerneis, M; O'Connor, SA; Silvain, J; Cucherat, M; Beygui, F; Barthelemy, O; Collet, JP; Jacq, L; Bernasconi, F; Montalescot, G				Bellemain-Appaix, Anne; Kerneis, Mathieu; O'Connor, Stephen A.; Silvain, Johanne; Cucherat, Michel; Beygui, Farzin; Barthelemy, Olivier; Collet, Jean-Philippe; Jacq, Laurent; Bernasconi, Francois; Montalescot, Gilles		ACTION Study Grp	Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-BYPASS SURGERY; GLYCOPROTEIN IIB/IIIA INHIBITORS; ACUITY ACUTE CATHETERIZATION; CHRONIC CLOPIDOGREL THERAPY; TRIAGE STRATEGY TRIAL; SEGMENT ELEVATION; ANTIPLATELET THERAPY; PLATELET REACTIVITY; 600 MG	Objective To investigate the effect of pretreatment with P2Y12 receptor inhibitors compared with no pretreatment on efficacy and safety of treatment of non-ST elevation acute coronary syndrome (ACS). Data sources Two reviewers independently searched Medline, Embase, Cochrane Controlled Trials, and BioMed Central databases for randomized placebo controlled trials and observational studies from August 2001 to March 2014. Study eligibility Studies must have reported both all-cause mortality (primary efficacy endpoint) and major bleeding (safety endpoint) outcomes. Data extraction Data on sample size, characteristics, drug dose and delay of administration, and outcomes were independently extracted and analyzed. Data synthesis A random-effect model was applied. The analysis was performed (i) in all patients independently of the management strategy and (ii) only in patients undergoing percutaneous coronary intervention. Results Of the 393 titles identified, seven (four randomized controlled trials, one observational analysis from a randomized controlled trial, and three observational studies) met the inclusion criteria. No study was identified for ticagrelor or cangrelor, and analyses were thus limited to thienopyridines. A total of 32 383 non-ST elevation ACS patients were included, 18 711 coming from randomized controlled trials. Of these, 55% underwent percutaneous coronary intervention (PCI). Pretreatment was not associated with a significant lower risk of mortality in all patients (odds ratio 0.90 (95% confidence interval 0.75 to 1.07), P=0.24), in particular when considering only the randomized controlled trials (odds ratio 0.90 (0.71 to 1.14), P=0.39). Similar results were observed in the cohort of patients undergoing PCI. A significant 30-45% excess of major bleeding was consistently observed in all patients (odds ratio 1.32 (1.16 to 1.49), P<0.0001) and in those undergoing PCI, as well as in the subset analyses of randomized controlled trials of these two cohorts of patients. There was a reduction in major adverse cardiovascular events in the analysis of all patients (odds ratio 0.84 (0.72 to 0.98), P=0.02), driven by the old clopidogrel studies (CURE and CREDO), but the difference was not significant for the cohort of patients undergoing PCI. Stent thrombosis, stroke, and urgent revascularization did not differ between groups (pretreatment v no pretreatment). The results were consistent for both thienopyridines and confirmed in sensitivity analyses. Limitations Analysis was not performed on individual patient's data. Conclusion In patients presenting with non-ST elevation ACS, pretreatment with thienopyridines is associated with no significant reduction of mortality but with a significant excess of major bleeding no matter the strategy adopted, invasive or not. Our results do not support a strategy of routine pretreatment in patients with non-ST elevation ACS.	[Bellemain-Appaix, Anne; Jacq, Laurent; Bernasconi, Francois] La Fontonne Hosp, Serv Cardiol, Antibes, France; [Kerneis, Mathieu; O'Connor, Stephen A.; Silvain, Johanne; Beygui, Farzin; Barthelemy, Olivier; Collet, Jean-Philippe; Montalescot, Gilles] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Inst Cardiol,INSERM,UMRS1166, F-75252 Paris 05, France; [Bellemain-Appaix, Anne; Kerneis, Mathieu; O'Connor, Stephen A.; Silvain, Johanne; Beygui, Farzin; Barthelemy, Olivier; Collet, Jean-Philippe; Montalescot, Gilles] ACT Study Grp, Paris, France; [Cucherat, Michel] Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Montalescot, G (corresponding author), Hop La Pitie Salpetriere, Bur 2 236, Inst Cardiol, ACT Study Grp, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Cucherat, Michel/B-2343-2008; SILVAIN, Johanne/C-7521-2016	Cucherat, Michel/0000-0003-2150-5932; Kerneis, Mathieu/0000-0002-7141-5209; O'Connor, Stephen/0000-0002-6539-0375; SILVAIN, Johanne/0000-0002-1901-2808	Bayer; Boehringer-Ingelheim; CFR; Europa; GLG; Iroko Cardio International; Lead-Up; LLC; Luminex; Mc Kinsey; Remedica; Servier; TIMI Group; WebMD; Wolters; Bristol-Myers Squibb; AstraZeneca; Biotronik; Eli Lilly; Medicines Company; Medtronic; Menarini; Sanofi-Aventis; Pfizer; Accumetrics; Abbott Vascular; Daiichi-Sankyo; Nanospheres; Stentys; Guerbet Medical; Boston Scientific; Cordis; Stago; Centocor; Fondation de France; INSERM; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Brahms; A Menarini; European Society of Cardiology; Haute Autorite de Sante	Bayer(Bayer AG); Boehringer-Ingelheim(Boehringer Ingelheim); CFR; Europa; GLG; Iroko Cardio International; Lead-Up; LLC; Luminex; Mc Kinsey; Remedica; Servier(Servier); TIMI Group; WebMD; Wolters; Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Biotronik; Eli Lilly(Eli Lilly); Medicines Company; Medtronic(Medtronic); Menarini(Menarini Group); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Accumetrics; Abbott Vascular(Abbott Laboratories); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Nanospheres; Stentys; Guerbet Medical; Boston Scientific(Boston Scientific); Cordis; Stago; Centocor; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Brahms; A Menarini(Menarini Group); European Society of Cardiology; Haute Autorite de Sante	GM has received consulting fees from Bayer, Boehringer-Ingelheim, CFR, Europa, GLG, Iroko Cardio International, Lead-Up, LLC, Luminex, Mc Kinsey, Remedica, Servier, TIMI Group, WebMD, and Wolters; consulting fees and grant support from Bristol-Myers Squibb, AstraZeneca, Biotronik, Eli Lilly, The Medicines Company, Medtronic, Menarini, Sanofi-Aventis, Pfizer, and Accumetrics; and grant support from Abbott Vascular, Daiichi-Sankyo, Nanospheres, and Stentys. JPC has received research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Centocor, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from Sanofi-Aventis, Eli Lilly, and Bristol-Myers Squibb; and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly. ABA has received research grants from Daiichi-Sankyo, Eli Lilly, Federation Francaise de Cardiologie and Societe Francaise de Cardiologie and lecture fees from AstraZeneca, Servier, and Daiichi-Sankyo. JS reports receiving research grants from Sanofi-Aventis, Daiichi-Sankyo, Eli Lilly, Brahms, INSERM, Federation Francaise de Cardiologie and Societe Francaise de Cardiologie; consulting fees from Daiichi-Sankyo, Eli Lilly and speaker honoraria from AstraZeneca, Daiichi Sankyo, Eli Lilly, Iroko Cardio and Servier. SAO'C has received grants from A Menarini and the European Society of Cardiology. MC has received research grants from Bristol-Myers Squibb, AstraZeneca, Bayer, Haute Autorite de Sante; consulting fees from Bayer, Bristol-Myers Squibb; and speaker honoraria from Bristol-Myers Squibb.	Amin AP, 2011, AM J CARDIOL, V107, P1751, DOI 10.1016/j.amjcard.2011.02.331; Assali AR, 2001, AM J CARDIOL, V88, P884, DOI 10.1016/S0002-9149(01)01897-5; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Bellemain-Appaix A, 2010, J AM COLL CARDIOL, V56, P1542, DOI 10.1016/j.jacc.2010.07.012; Bellemain-Appaix A, 2010, J AM COLL CARDIOL, V55, P815, DOI 10.1016/j.jacc.2009.08.082; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Biancari F, 2012, J THORAC CARDIOV SUR, V143, P665, DOI 10.1016/j.jtcvs.2011.01.069; Bonello L, 2008, AM J CARDIOL, V102, P1318, DOI 10.1016/j.amjcard.2008.07.007; Chan AW, 2003, J AM COLL CARDIOL, V42, P1188, DOI 10.1016/S0735-1097(03)00944-6; Cuisset T, 2006, J THROMB HAEMOST, V4, P542, DOI 10.1111/j.1538-7836.2005.01751.x; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Davlouros PA, 2009, AM HEART J, V158, P585, DOI 10.1016/j.ahj.2009.07.029; Dery JP, 2007, CATHETER CARDIO INTE, V70, P43, DOI 10.1002/ccd.21059; Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067; Dorler J, 2011, EUR HEART J, V32, P2954, DOI 10.1093/eurheartj/ehr360; Ebrahimi R, 2009, J AM COLL CARDIOL, V53, P1965, DOI 10.1016/j.jacc.2009.03.006; Fefer P, 2009, AM J CARDIOL, V104, P514, DOI 10.1016/j.amjcard.2009.04.013; Feldman DN, 2010, AM J CARDIOL, V105, P323, DOI 10.1016/j.amjcard.2009.09.034; Fox KAA, 2010, HEART, V96, P1095, DOI 10.1136/hrt.2009.190827; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Jung JH, 2009, CORONARY ARTERY DIS, V20, P150, DOI 10.1097/MCA.0b013e3283262de2; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; Koul S, 2011, EUR HEART J, V32, P2990, DOI 10.1093/eurheartj/ehr202; Lin GM, 2011, AM HEART J, V162, pE17, DOI 10.1016/j.ahj.2011.04.023; Mahmoudi M, 2011, AM J CARDIOL, V107, P1779, DOI 10.1016/j.amjcard.2011.02.327; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Mangiacapra F, 2012, INT J CARDIOL, V160, P213, DOI 10.1016/j.ijcard.2012.06.015; Mangiacapra F, 2010, AM J CARDIOL, V106, P1208, DOI 10.1016/j.amjcard.2010.06.044; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mehta RH, 2006, J AM COLL CARDIOL, V48, P281, DOI 10.1016/j.jacc.2006.04.029; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Navarese EP, 2013, ANN INTERN MED, V158, P261, DOI 10.7326/0003-4819-158-4-201302190-00006; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Patti G, 2013, AM J CARDIOL, V112, P162, DOI 10.1016/j.amjcard.2013.03.008; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707; Saw J, 2004, J AM COLL CARDIOL, V44, P1194, DOI 10.1016/j.jacc.2004.06.049; Song PS, 2012, YONSEI MED J, V53, P906, DOI 10.3349/ymj.2012.53.5.906; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2006, J AM COLL CARDIOL, V47, P939, DOI 10.1016/j.jacc.2005.10.047; Steinhubl SR, 2001, CIRCULATION, V103, P1403, DOI 10.1161/01.CIR.103.10.1403; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Szuk T, 2007, AM HEART J, V153, P289, DOI 10.1016/j.ahj.2006.10.030; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang TY, 2011, CIRCULATION, V123, P722, DOI 10.1161/CIRCULATIONAHA.110.958041; White HD, 2008, J AM COLL CARDIOL, V52, P807, DOI 10.1016/j.jacc.2008.05.036; Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yong G, 2009, AM HEART J, V157, P60, DOI 10.1016/j.ahj.2008.09.024; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zeymer U, 2007, CARDIOLOGY, V108, P265, DOI 10.1159/000096988	63	67	70	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6269	10.1136/bmj.g6269	http://dx.doi.org/10.1136/bmj.g6269			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25954988	hybrid, Green Published			2022-12-28	WOS:000343768700005
J	Lazer, D				Lazer, David			The rise of the social algorithm	SCIENCE			English	Editorial Material									[Lazer, David] Northeastern Univ, Dept Polit Sci, Cambridge, MA 02115 USA; [Lazer, David] Northeastern Univ, Coll Comp & Informat Sci, Cambridge, MA USA; [Lazer, David] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Northeastern University; Northeastern University; Harvard University	Lazer, D (corresponding author), Northeastern Univ, Dept Polit Sci, Cambridge, MA 02115 USA.	d.lazer@neu.edu						Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Dimmick J, 2003, MEDIA COMPETITION CO, DOI DOI 10.4324/9781410606211; Habermas Jeurgen, 1989, STRUCTURAL TRANSFORM; Hannak A., 2013, P 22 INT C WORLD WID, P527, DOI [https://doi.org/10.1145/2488388.2488435, 10.1145/2488388.2488435]; Hannak A, 2014, PROCEEDINGS OF THE 2014 ACM INTERNET MEASUREMENT CONFERENCE (IMC'14), P305, DOI 10.1145/2663716.2663744; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Pariser E., 2011, FILTER BUBBLE WHAT I; Shoemaker Pamela J., 2009, GATEKEEPING THEORY; Tufekci Zeynep, 2014, First Monday, V19, P152, DOI 10.5210/fm.v19i7.4901	11	63	64	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1090	1091		10.1126/science.aab1422	http://dx.doi.org/10.1126/science.aab1422			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ6FY	25953819				2022-12-28	WOS:000355590500024
J	Nakano, A				Nakano, Akihiko			CELL BIOLOGY Polarized transport in the Golgi apparatus	NATURE			English	Editorial Material							CDC42		[Nakano, Akihiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Nakano, Akihiko] RIKEN Ctr Adv Photon, Live Cell Super Resolut Imaging Res Team, Wako, Saitama, Japan	University of Tokyo; RIKEN	Nakano, A (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan.	nakano@riken.jp	Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/A-6420-2016	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X				Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Nakano A, 2010, CURR OPIN CELL BIOL, V22, P471, DOI 10.1016/j.ceb.2010.05.003; Park SY, 2015, NATURE, V521, P529, DOI 10.1038/nature14457; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273	8	2	2	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					427	428		10.1038/nature14521	http://dx.doi.org/10.1038/nature14521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25945742				2022-12-28	WOS:000355286600025
J	Zervou, FN; Zacharioudakis, IM; Mylonakis, E				Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios			6 weeks of antibiotics was noninferior to 12 weeks for clinical cure in pyogenic vertebral osteomyelitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios] Brown Univ, Providence, RI 02912 USA	Brown University	Zervou, FN (corresponding author), Brown Univ, Providence, RI 02912 USA.							Caro JJ, 2012, J COMP EFFECT RES, V1, P319, DOI [10.2217/cer.12.37, 10.2217/CER.12.37]; Landman GW, 2010, NEW ENGL J MED, V362, P2335, DOI 10.1056/NEJMc1004659; Rice LB, 2008, CLIN INFECT DIS, V46, P491, DOI 10.1086/526535	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC7	10.7326/ACPJC-2015-162-10-007	http://dx.doi.org/10.7326/ACPJC-2015-162-10-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984880				2022-12-28	WOS:000355015200009
J	Hennawi, JF; Prochaska, JX; Cantalupo, S; Arrigoni-Battaia, F				Hennawi, Joseph F.; Prochaska, J. Xavier; Cantalupo, Sebastiano; Arrigoni-Battaia, Fabrizio			Quasar quartet embedded in giant nebula reveals rare massive structure in distant universe	SCIENCE			English	Article							OPTICALLY THICK ABSORBERS; LY-ALPHA NEBULA; LUMINOUS QUASARS; GALAXY FORMATION; CIRCUMGALACTIC MEDIUM; PROBING QUASARS; SPACE-TELESCOPE; REDSHIFT; EMISSION; ABSORPTION	All galaxies once passed through a hyperluminous quasar phase powered by accretion onto a supermassive black hole. But because these episodes are brief, quasars are rare objects typically separated by cosmological distances. In a survey for Lyman-alpha emission at redshift z approximate to 2, we discovered a physical association of four quasars embedded in a giant nebula. Located within a substantial overdensity of galaxies, this system is probably the progenitor of a massive galaxy cluster. The chance probability of finding a quadruple quasar is estimated to be similar to 10(-7), implying a physical connection between Lyman-alpha nebulae and the locations of rare protoclusters. Our findings imply that the most massive structures in the distant universe have a tremendous supply (similar or equal to 10(11) solar masses) of cool dense (volume density similar or equal to 1 cm(-3)) gas, which is in conflict with current cosmological simulations.	[Hennawi, Joseph F.; Arrigoni-Battaia, Fabrizio] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Prochaska, J. Xavier; Cantalupo, Sebastiano] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Cantalupo, Sebastiano] ETH, Inst Astron, CH-8092 Zurich, Switzerland	Max Planck Society; University of California System; University of California Santa Cruz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hennawi, JF (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	joe@mpia.de		Arrigoni Battaia, Fabrizio/0000-0002-4770-6137; Cantalupo, Sebastiano/0000-0001-5804-1428; Prochaska, J. Xavier/0000-0002-7738-6875	Alexander von Humboldt foundation; German Federal Ministry for Education and Research; NSF [AST-1010004]; W. M. Keck Foundation; Division Of Astronomical Sciences [1010004] Funding Source: National Science Foundation	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the staff of the W. M. Keck Observatory for their support during the installation and testing of our custom-built narrow-band filter. We are grateful to B. Venemans and M. Prescott for providing us with catalogs of LAE positions around giant nebulae in electronic format. We also thank the members of the ENIGMA group (http://www.mpia-hd.mpg.de/ENIGMA/) at the Max Planck Institute for Astronomy for helpful discussions. J.F.H. acknowledges generous support from the Alexander von Humboldt foundation in the context of the Sofja Kovalevskaja Award. The Humboldt foundation is funded by the German Federal Ministry for Education and Research. J.X.P. acknowledges support from NSF grant AST-1010004. The data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The observatory was made possible by the financial support of the W. M. Keck Foundation. We acknowledge the cultural role that the summit of Mauna Kea has within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. The data reported in this paper are available through the Keck Observatory Archive.	Bahcall JN, 1997, ASTROPHYS J, V479, P642, DOI 10.1086/303926; Cantalupo S, 2014, NATURE, V506, P63, DOI 10.1038/nature12898; Chiang YK, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/127; Ciardullo R, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/110; Crighton NHM, 2015, MON NOT R ASTRON SOC, V446, P18, DOI 10.1093/mnras/stu2088; Dey A, 2005, ASTROPHYS J, V629, P654, DOI 10.1086/430775; DJORGOVSKI S, 1991, ASTR SOC P, V21, P349; Djorgovski SG, 2007, ASTROPHYS J, V662, pL1, DOI 10.1086/519162; Fanidakis N, 2013, MON NOT R ASTRON SOC, V436, P315, DOI 10.1093/mnras/stt1567; Farina EP, 2013, MON NOT R ASTRON SOC, V431, P1019, DOI 10.1093/mnras/stt209; Faucher-Giguere CA, 2015, MON NOT R ASTRON SOC, V449, P987, DOI 10.1093/mnras/stv336; Ferrarese L, 2002, ASTROPHYS J, V578, P90, DOI 10.1086/342308; Francis PJ, 1996, ASTROPHYS J, V457, P490, DOI 10.1086/176747; Fumagalli M, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/74; HAEHNELT MG, 1993, MON NOT R ASTRON SOC, V263, P168, DOI 10.1093/mnras/263.1.168; HECKMAN TM, 1989, ASTROPHYS J, V338, P48, DOI 10.1086/167181; Hennawi JF, 2006, ASTRON J, V131, P1, DOI 10.1086/498235; Hennawi JF, 2007, ASTROPHYS J, V655, P735, DOI 10.1086/509770; Hennawi JF, 2006, ASTROPHYS J, V651, P61, DOI 10.1086/507069; Hennawi JF, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/58; Kayo I, 2012, MON NOT R ASTRON SOC, V424, P1363, DOI 10.1111/j.1365-2966.2012.21321.x; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627, DOI 10.1093/mnras/262.3.627; Lehmer BD, 2009, ASTROPHYS J, V691, P687, DOI 10.1088/0004-637X/691/1/687; Lopez S, 2008, ASTROPHYS J, V679, P1144, DOI 10.1086/587678; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Maller AH, 2004, MON NOT R ASTRON SOC, V355, P694, DOI 10.1111/j.1365-2966.2004.08349.x; Martin DC, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/106; McDonald M, 2010, ASTROPHYS J, V721, P1262, DOI 10.1088/0004-637X/721/2/1262; Mo HJ, 1996, ASTROPHYS J, V469, P589, DOI 10.1086/177808; Mostardi RE, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/65; Overzier RA, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/89; Prescott MKM, 2008, ASTROPHYS J LETT, V678, pL77, DOI 10.1086/588606; Prescott MKM, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/32; Prochaska JX, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/140; Prochaska JX, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/136; Prochaska JX, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/2/L19; Prochaska JX, 2009, ASTROPHYS J, V690, P1558, DOI 10.1088/0004-637X/690/2/1558; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; Trainor RF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/39; Venemans BP, 2007, ASTRON ASTROPHYS, V461, P823, DOI 10.1051/0004-6361:20053941; White M, 2012, MON NOT R ASTRON SOC, V424, P933, DOI 10.1111/j.1365-2966.2012.21251.x; Yang YJ, 2009, ASTROPHYS J, V693, P1579, DOI 10.1088/0004-637X/693/2/1579	42	147	147	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					779	783		10.1126/science.aaa5397	http://dx.doi.org/10.1126/science.aaa5397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977547	Green Submitted			2022-12-28	WOS:000354428700038
J	Vohra, S; Shamseer, L; Sampson, M; Bukutu, C; Schmid, CH; Tate, R; Nikles, J; Zucker, DR; Kravitz, R; Guyatt, G; Altman, DG; Moher, D				Vohra, Sunita; Shamseer, Larissa; Sampson, Margaret; Bukutu, Cecilia; Schmid, Christopher H.; Tate, Robyn; Nikles, Jane; Zucker, Deborah R.; Kravitz, Richard; Guyatt, Gordon; Altman, Douglas G.; Moher, David		CENT Grp	CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; EXPLANATION; QUALITY; INTERVENTIONS; DESIGNS	N-of-1 trials provide a mechanism for making evidence based treatment decisions for an individual patient. They use key methodological elements of group clinical trials to evaluate treatment effectiveness in a single patient, for situations that cannot always accommodate large scale trials: rare diseases, comorbid conditions, or in patients using concurrent therapies. Improvement in the reporting and clarity of methods and findings in N-of-1 trials is essential for reader to gauge the validity of trials and to replicate successful findings. A CONSORT extension for N-of-1 trials (CENT 2015) provides guidance on the reporting of individual and series of N-of-1 trials. CENT provides additional guidance for 14 of the 25 items of the CONSORT 2010 checklist and recommends a diagram for depicting an individual N-of-1 trial and modifies the CONSORT flow diagram to address the flow of a series of N-of-1 trials. The rationale, development process, and CENT 2015 checklist and diagrams are reported in this document.	[Vohra, Sunita] Univ Alberta, Edmonton, AB T6G 2M7, Canada; [Shamseer, Larissa; Moher, David] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Shamseer, Larissa; Moher, David] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Sampson, Margaret] Childrens Hosp Eastern Ontario, Lib Serv, Toronto, ON, Canada; [Bukutu, Cecilia] Alberta Ctr Child Family & Community Res, Edmonton, AB, Canada; [Schmid, Christopher H.] Brown Univ, Ctr Evidence Based Med, Providence, RI 02912 USA; [Tate, Robyn] Univ Sydney, Sydney Med Sch Northern, Rehabil Res Ctr, Sydney, NSW 2006, Australia; [Nikles, Jane] Univ Queensland, Brisbane, Qld 4072, Australia; [Zucker, Deborah R.] Tufts Univ, Sch Med, Medford, MA USA; [Kravitz, Richard] Univ Calif Davis, Davis, CA 95616 USA; [Guyatt, Gordon] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England	University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Brown University; University of Sydney; University of Queensland; Tufts University; University of California System; University of California Davis; McMaster University; University of Oxford	Vohra, S (corresponding author), Univ Alberta, Edmonton, AB T6G 2M7, Canada.	svohra@ualberta.ca	Nikles, Jane/F-4572-2010; Shamseer, Larissa/E-9645-2017; Vohra, Sunita/F-5755-2016; Bukutu, Cecilia/GWZ-4823-2022; Schmid, Christopher H./J-2398-2014; Kravitz, Richard/AAF-7425-2021; Moher, David/I-3408-2019	Nikles, Jane/0000-0001-5356-2291; Shamseer, Larissa/0000-0003-3690-3378; Vohra, Sunita/0000-0002-6210-7933; Schmid, Christopher H./0000-0002-0855-5313; Moher, David/0000-0003-2434-4206; Marles, Robin/0000-0003-2268-838X; Bukutu, Cecilia/0000-0002-2612-4904; Clark, Jocalyn/0000-0002-8014-3989; Kravitz, Richard/0000-0001-5575-529X	Alberta Innovates - Health Solutions (AHIS); Afexa Life Sciences; Hecht Foundation; HEEL; Pfizer USA; Schwabe Pharma; Canadian Institutes for Health Research [86766]; AHIS as a health scholar; MRC [MR/J004871/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J004871/1] Funding Source: researchfish	Alberta Innovates - Health Solutions (AHIS); Afexa Life Sciences; Hecht Foundation; HEEL; Pfizer USA(Pfizer); Schwabe Pharma; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); AHIS as a health scholar; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors have completed the ICMJE uniform disclosure form and declare: the development of CENT was funded by Alberta Advanced Education and Technology, Alberta Heritage Foundation for Medical Research (now Alberta Innovates - Health Solutions (AHIS)), Boiron, CV Technologies (now Afexa Life Sciences), Hecht Foundation, HEEL, Pfizer USA, Schwabe Pharma, and in part, through operational funding awarded by the Canadian Institutes for Health Research (Reference No 86766); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; representatives from industry partners were present and participated at the CENT consensus meeting and were offered the opportunity to provide input on this manuscript, which none did. SV receives salary support from AHIS as a health scholar.	[Anonymous], 2013, NAT METHODS, V10, P367, DOI 10.1038/nmeth.2471; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; EDGINGTON ES, 1967, J PSYCHOL, V65, P195, DOI 10.1080/00223980.1967.10544864; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gitterman DP, 2008, PEDIATR RES, V64, P462, DOI 10.1203/PDR.0b013e31818912fd; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Guyatt GH, 2002, USERS GUIDES MED LIT, P275; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Oxford Centre for Evidence-Based Medicine Work Group, 2011, OXF LEV EV 2; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Punja S, 2014, SYSEMATIC REV METHOD; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Shamseer L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1793; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Tate R. L., 2012, BRAIN IMPAIR, V13, P135; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	27	110	117	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h1738	10.1136/bmj.h1738	http://dx.doi.org/10.1136/bmj.h1738			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CI	25976398	Green Published, hybrid			2022-12-28	WOS:000354770100001
J	Gibson, G				Gibson, Greg			GTEx detects genetic effects	SCIENCE			English	Editorial Material							TRANSCRIPTOME; VARIANTS		Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Gibson, G (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	greg.gibson@biology.gatech.edu						Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	15	32	32	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					640	641		10.1126/science.aab3002	http://dx.doi.org/10.1126/science.aab3002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953996				2022-12-28	WOS:000354045700030
J	Legenstein, R				Legenstein, Robert			COMPUTER SCIENCE Nanoscale connections for brain-like circuits	NATURE			English	Editorial Material									Graz Univ Technol, Inst Theoret Comp Sci, A-8010 Graz, Austria	Graz University of Technology	Legenstein, R (corresponding author), Graz Univ Technol, Inst Theoret Comp Sci, A-8010 Graz, Austria.	robert.legenstein@igi.tugraz.at		Legenstein, Robert/0000-0002-8724-5507	Austrian Science Fund (FWF) [I 753] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		BACKUS J, 1978, COMMUN ACM, V21, P613, DOI 10.1145/359576.359579; Indiveri G, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/384010; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Prezioso M, 2015, NATURE, V521, P61, DOI 10.1038/nature14441; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003	6	16	17	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					37	38		10.1038/521037a	http://dx.doi.org/10.1038/521037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951279				2022-12-28	WOS:000354040900024
J	Perkel, JM				Perkel, Jeffrey M.			THE TROUBLE WITH REFERENCE ROT	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				Klein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115253	1	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					111	112		10.1038/521111a	http://dx.doi.org/10.1038/521111a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH4YS	25951286	Bronze			2022-12-28	WOS:000354040900044
J	Stock, S				Stock, Stephanie			INTERNATIONAL HEALTH CARE SYSTEMS Integrated Ambulatory Specialist Care - Germany's New Health Care Sector	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Inst Hlth Econ & Clin Epidemiol, Cologne, Germany		Stock, S (corresponding author), Inst Hlth Econ & Clin Epidemiol, Cologne, Germany.							[Anonymous], 2012, EARL EV PAT CENT MED; [Anonymous], 2013, HLTH INF TECHN US BE; Nolte E, 2012, HEALTH ECON POLICY L, V7, P125, DOI 10.1017/S1744133111000338; Stock S, 2010, HEALTH AFFAIR, V29, P2197, DOI 10.1377/hlthaff.2009.0799	4	6	6	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1781	1785		10.1056/NEJMp1413625	http://dx.doi.org/10.1056/NEJMp1413625			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946277				2022-12-28	WOS:000353974700001
J	Eycleshymer, AC				Eycleshymer, Albert C.			Anatomic Nomenclature (Reprinted from JAMA, vol 64, pg 1569-1570, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Eycleshymer AC, 1915, J AMER MED ASSOC, V64, P1569	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1760	1760		10.1001/jama.2014.11730	http://dx.doi.org/10.1001/jama.2014.11730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942741				2022-12-28	WOS:000353921000034
J	Arndt, EM; Moore, W; Lee, WK; Ortiz, C				Arndt, Eric M.; Moore, Wendy; Lee, Wah-Keat; Ortiz, Christine			Mechanistic origins of bombardier beetle (Brachinini) explosion-induced defensive spray pulsation	SCIENCE			English	Article							INSECT CUTICLE; BIOCHEMISTRY; ARTHROPODS	Bombardier beetles (Brachinini) use a rapid series of discrete explosions inside their pygidial gland reaction chambers to produce a hot, pulsed, quinone-based defensive spray. The mechanism of brachinines' spray pulsation was explored using anatomical studies and direct observation of explosions inside living beetles using synchrotron x-ray imaging. Quantification of the dynamics of vapor inside the reaction chamber indicates that spray pulsation is controlled by specialized, contiguous cuticular structures located at the junction between the reservoir (reactant) and reaction chambers. Kinematics models suggest passive mediation of spray pulsation by mechanical feedback from the explosion, causing displacement of these structures.	[Arndt, Eric M.; Ortiz, Christine] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Lee, Wah-Keat] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA	Massachusetts Institute of Technology (MIT); University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory	Ortiz, C (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	cortiz@mit.edu	Lee, Wah-Keat/GRR-9734-2022	Moore, Wendy/0000-0003-4441-6203; Arndt, Emily/0000-0003-0099-743X	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, DE-SC0012704]; U.S. Army Research Laboratory; U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies [W911NF-13-D-0001]; National Science Foundation through the MIT Center for Materials Science and Engineering [DMR-08-19762]; U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship [N00244-09-1-0064]; National Science Foundation [DEB-0908187]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies; National Science Foundation through the MIT Center for Materials Science and Engineering; U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship(United States Department of Defense); National Science Foundation(National Science Foundation (NSF))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. This work was supported in part by the U.S. Army Research Laboratory and the U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies under contract W911NF-13-D-0001 and in part by the National Science Foundation through the MIT Center for Materials Science and Engineering under contract DMR-08-19762. This research was funded in part by the U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship awarded to C.O. under contract N00244-09-1-0064; in part by the National Science Foundation through funding awarded to W.M. under contract DEB-0908187; and in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-SC0012704. Experiment data are available for download from DSpace@MIT (https://dspace.mit.edu); please cite this collection using the handle hdl.handle.net/1721.1/96123.	ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; ANESHANSLEY DJ, 1969, SCIENCE, V165, P61, DOI 10.1126/science.165.3888.61; [Anonymous], 1981, CHEM DEFENSES ARTHRO; Beheshti N, 2007, BIOINSPIR BIOMIM, V2, P57, DOI 10.1088/1748-3182/2/4/001; DEAN J, 1990, SCIENCE, V248, P1219, DOI 10.1126/science.2349480; Eisner T, 1999, P NATL ACAD SCI USA, V96, P9705, DOI 10.1073/pnas.96.17.9705; EISNER T, 1958, J INSECT PHYSIOL, V2, P215, DOI 10.1016/0022-1910(58)90006-4; EISNER T, 1977, J INSECT PHYSIOL, V23, P1383, DOI 10.1016/0022-1910(77)90162-7; James A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0801; Lee Wah-Keat, 2009, BMC Physiology, V9, P2, DOI 10.1186/1472-6793-9-2; SCHILDKNECHT H, 1970, Angewandte Chemie International Edition in English, V9, P1, DOI 10.1002/anie.197000011; SCHILDKNECHT H, 1964, ANGEW CHEM INT EDIT, V3, P73, DOI 10.1002/anie.196400731; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; Socha JJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-6; SOTAVALTA O, 1953, BIOL BULL, V104, P439, DOI 10.2307/1538496; VINCENT JFV, 1979, J INSECT PHYSIOL, V25, P653, DOI 10.1016/0022-1910(79)90115-X; VINCENT JFV, 1975, PROC R SOC SER B-BIO, V188, P189, DOI 10.1098/rspb.1975.0012; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008	20	40	41	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					563	567		10.1126/science.1261166	http://dx.doi.org/10.1126/science.1261166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931557	Green Submitted			2022-12-28	WOS:000353778100039
J	Bridier-Nahmias, A; Tchalikian-Cosson, A; Baller, JA; Menouni, R; Fayol, H; Flores, A; Saib, A; Werner, M; Voytas, DF; Lesage, P				Bridier-Nahmias, Antoine; Tchalikian-Cosson, Aurelie; Baller, Joshua A.; Menouni, Rachid; Fayol, Helene; Flores, Amando; Saib, Ali; Werner, Michel; Voytas, Daniel F.; Lesage, Pascale			An RNA polymerase III subunit determines sites of retrotransposon integration	SCIENCE			English	Article							LEUKEMIA-VIRUS INTEGRATION; POSITION-SPECIFIC INTEGRATION; NUCLEAR-LOCALIZATION SIGNAL; TRANSCRIPTION START SITES; SACCHAROMYCES-CEREVISIAE; TRANSPOSABLE ELEMENTS; TY1 RETROTRANSPOSON; CHROMATIN; YEAST; GENES	Mobile genetic elements are ubiquitous. Their integration site influences genome stability and gene expression. The Ty1 retrotransposon of the yeast Saccharomyces cerevisiae integrates upstream of RNA polymerase III (Pol III)-transcribed genes, yet the primary determinant of target specificity has remained elusive. Here we describe an interaction between Ty1 integrase and the AC40 subunit of Pol III and demonstrate that AC40 is the predominant determinant targeting Ty1 integration upstream of Pol III-transcribed genes. Lack of an integrase-AC40 interaction dramatically alters target site choice, leading to a redistribution of Ty1 insertions in the genome, mainly to chromosome ends. The mechanism of target specificity allows Ty1 to proliferate and yet minimizes genetic damage to its host.	[Bridier-Nahmias, Antoine; Tchalikian-Cosson, Aurelie; Menouni, Rachid; Fayol, Helene; Saib, Ali; Lesage, Pascale] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Inst Univ Hematol,Hop St Louis,CNRS,U944,UMR 7212, F-75010 Paris, France; [Bridier-Nahmias, Antoine] Dept CASER Conservatoire Natl Arts & Metie, F-75003 Paris, France; [Baller, Joshua A.] Univ Minnesota, Dept enet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Baller, Joshua A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Baller, Joshua A.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Flores, Amando; Werner, Michel] Univ Paris Sud, CEA Saclay, Commissariat Energie Atom & Energies Alternat CEA, IBiTec S,Inst Biol Integrat Cellule I2BC,CNRS, F-91191 Gif Sur Yvette, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lesage, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Inst Univ Hematol,Hop St Louis,CNRS,U944,UMR 7212, F-75010 Paris, France.	pascale.lesage@inserm.fr	LESAGE, Pascale/AAQ-8821-2021; Flores, Amando/K-9283-2017	Flores, Amando/0000-0002-1887-0659; Bridier-Nahmias, Antoine/0000-0002-0376-6840; LESAGE, Pascale/0000-0002-4221-8038; Voytas, Daniel/0000-0002-4944-1224; Baller, Joshua/0000-0003-3936-7953	CNRS; INSERM; Universite Paris Diderot Sorbonne Paris Cite; Agence nationale de recherches sur le sida et les hepatites virales [AO 2008-01]; Agence Nationale de la Recherche [13-BSV3-0012-01]; European Union through the FP7 project HIVINNOV [305137]; European Molecular Biology Organization Short-Term Fellowship [ASTF 17-2013]; Ministere de l'Enseignement Superieur et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot Sorbonne Paris Cite; Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union through the FP7 project HIVINNOV; European Molecular Biology Organization Short-Term Fellowship; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	We thank J. Boeke, S. Moore, and M. Riva for reagents; C. Conesa, J. Curcio, O. Lefebvre, and members of the laboratory for stimulating discussions; M. Bazin, D. Davoine, M. Saunier, and M. Zitouni for contributions during their training; and E. Fabre, H. de The, and J. Recht for critical reading of the manuscript. This work was supported by CNRS, INSERM, Universite Paris Diderot Sorbonne Paris Cite, Agence nationale de recherches sur le sida et les hepatites virales (grant AO 2008-01), Agence Nationale de la Recherche (grant 13-BSV3-0012-01), and the European Union through the FP7 project HIVINNOV (grant 305137). A.B.-N. was supported by a CNRS Ph.D. fellowship and a European Molecular Biology Organization Short-Term Fellowship (ASTF 17-2013) (to work in D.F.V.'s lab) and A. T.-C. by a Ph.D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Bachman N, 2005, GENE DEV, V19, P955, DOI 10.1101/gad.1299105; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Kumar Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-402; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Rattray AJ, 2000, GENETICS, V154, P543; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; SHARON G, 1994, MOL CELL BIOL, V14, P6540, DOI 10.1128/MCB.14.10.6540; Shpakovski GV, 1999, CURR GENET, V36, P208, DOI 10.1007/s002940050492; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200	30	46	47	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					585	588		10.1126/science.1259114	http://dx.doi.org/10.1126/science.1259114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931562				2022-12-28	WOS:000353778100045
J	Brown, RC; Wyllie, R; Koller, SB; Goldschmidt, EA; Foss-Feig, M; Porto, JV				Brown, R. C.; Wyllie, R.; Koller, S. B.; Goldschmidt, E. A.; Foss-Feig, M.; Porto, J. V.			Two-dimensional superexchange-mediated magnetization dynamics in an optical lattice	SCIENCE			English	Article							MANY-BODY SYSTEM; QUANTUM; PROPAGATION; ATOMS	The interplay of magnetic exchange interactions and tunneling underlies many complex quantum phenomena observed in real materials. We study nonequilibrium magnetization dynamics in an extended two-dimensional (2D) system by loading effective spin-1/2 bosons into a spin-dependent optical lattice and use the lattice to separately control the resonance conditions for tunneling and superexchange. After preparing a nonequilibrium antiferromagnetically ordered state, we observe relaxation dynamics governed by two well-separated rates, which scale with the parameters associated with superexchange and tunneling. With tunneling off-resonantly suppressed, we observe superexchange-dominated dynamics over two orders of magnitude in magnetic coupling strength. Our experiment will serve as a benchmark for future theoretical work as the detailed dynamics of this 2D, strongly correlated, and far-from-equilibrium quantum system remain out of reach of current computational techniques.	[Porto, J. V.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; Univ Maryland, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Porto, JV (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	porto@jqi.umd.edu	Porto, Trey/AAH-2101-2021; Goldschmidt, Elizabeth/N-3777-2018; Brown, Roger/AAD-3893-2019; Brown, Roger/A-9630-2009	Goldschmidt, Elizabeth/0000-0002-6553-9731; Brown, Roger/0000-0002-8228-4283; Brown, Roger/0000-0002-8228-4283; Porto, James/0000-0002-6290-7535	Army Research Office's atomtronics Multidisciplinary University Research Initiative; NIST; National Research Council Research Associateship program	Army Research Office's atomtronics Multidisciplinary University Research Initiative; NIST(National Institute of Standards & Technology (NIST) - USA); National Research Council Research Associateship program	This work was partially supported by the Army Research Office's atomtronics Multidisciplinary University Research Initiative and NIST. M.F.F. and E.A.G. acknowledge support from the National Research Council Research Associateship program. We thank B. Grinkemeyer for his contributions to the data taking effort, E. Tiesinga and S. Paul for discussions about tight-binding models, and A. V. Gorshkov and S. Sugawa for a critical reading of the manuscript.	Auerbach A., 1994, INTERACTING ELECT QU; Barmettler P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130603; Boninsegni M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087201; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115301; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Hart RA, 2015, NATURE, V519, P211, DOI 10.1038/nature14223; Hild S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.147205; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Lee PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.020402; Lubasch M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.165301; Meinert F, 2014, SCIENCE, V344, P1259, DOI 10.1126/science.1248402; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Sebby-Strabley J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033605; Sorensen AS, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.061603; Spielman IB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120402; Strohmaier N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.080401; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	29	38	38	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					540	544		10.1126/science.aaa1385	http://dx.doi.org/10.1126/science.aaa1385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931552	Green Submitted			2022-12-28	WOS:000353778100033
J	Ciocchi, S; Passecker, J; Malagon-Vina, H; Mikus, N; Klausberger, T				Ciocchi, S.; Passecker, J.; Malagon-Vina, H.; Mikus, N.; Klausberger, T.			Selective information routing by ventral hippocampal CA1 projection neurons	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; PYRAMIDAL CELLS; SPATIAL MEMORY; ANXIETY; DORSAL; AMYGDALA; ORGANIZATION; BEHAVIORS; UNITS; FEAR	The hippocampus computes diverse information involving spatial memory, anxiety, or reward and directly projects to several brain areas. Are different computations transmitted to all downstream targets uniformly, or does the hippocampus selectively route information according to content and target region? By recording from ventral hippocampal CA1 neurons in rats during different behavioral tasks and determining axonal projections with optogenetics, we observed subsets of neurons changing firing at places of elevated anxiety or changing activity during goal approach. Anxiety-related firing was selectively increased in neurons projecting to the prefrontal cortex. Goal-directed firing was most prominent in neurons targeting the nucleus accumbens; and triple-projecting neurons, targeting the prefrontal cortex, amygdala, and nucleus accumbens, were most active during tasks and sharp wave/ripples. Thus, hippocampal neurons route distinct behavior-contingent information selectively to different target areas.	[Ciocchi, S.; Passecker, J.; Malagon-Vina, H.; Mikus, N.; Klausberger, T.] Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, A-1090 Vienna, Austria; [Klausberger, T.] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	Medical University of Vienna; University of Oxford	Ciocchi, S (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, Spitalgasse 4, A-1090 Vienna, Austria.	stephane.ciocchi@meduniwien.ac.at; thomas.klausberger@meduniwien.ac.at	Passecker, Johannes/AAW-4357-2021	Passecker, Johannes/0000-0002-4366-2691; Malagon-Vina, Hugo/0000-0001-5029-8464; Ciocchi, Stephane/0000-0002-5701-9250; Mikus, Nace/0000-0002-3445-9464	European Research Council [242689]; Vienna Science and Technology Fund [SCIC03]; MRC [MC_UU_12020/6] Funding Source: UKRI; Medical Research Council [MC_UU_12020/6] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Vienna Science and Technology Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Schonenberger [Institute of Science and Technology (IST), Klosterneuburg, Austria] and S. Wolff (Harvard Medical School, Boston, USA) for helpful discussions on the optogenetic strategy; T. Asenov (IST) for three-dimensional printing of microdrives; R. Tomioka (Kumamoto University, Japan) for help in setting up the behavioral and electrophysiological experiments; E. Borok and R. Hauer for technical help with histology; all the members of the Klausberger lab for insightful discussions; and P. Somogyi, T. Viney, and M. Lagler for commenting on an earlier version of the manuscript. We thank Penn Vector Core from the University of Pennsylvania for the adeno-associated virus (AAV). The use of the AAV is disclosed by an materials transfer agreement between the University of Pennsylvania and the Medical University of Vienna. This work was supported in part by grant 242689 of the European Research Council and grant SCIC03 of the Vienna Science and Technology Fund. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Some of the original data are shown in the supplementary materials; all other data are available upon request from the corresponding authors.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Arszovszki A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00053; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; CARR GD, 1983, LIFE SCI, V33, P2551, DOI 10.1016/0024-3205(83)90165-0; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Hussaini SA, 2011, NEURON, V72, P643, DOI 10.1016/j.neuron.2011.09.007; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; JUNG MW, 1994, J NEUROSCI, V14, P7347; Keinath AT, 2014, HIPPOCAMPUS, V24, P1533, DOI 10.1002/hipo.22333; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Ruediger S, 2012, NAT NEUROSCI, V15, P1563, DOI 10.1038/nn.3224; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	30	171	172	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					560	563		10.1126/science.aaa3245	http://dx.doi.org/10.1126/science.aaa3245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931556				2022-12-28	WOS:000353778100038
J	Lewandowski, JR; Halse, ME; Blackledge, M; Emsley, L				Lewandowski, Jozef R.; Halse, Meghan E.; Blackledge, Martin; Emsley, Lyndon			Direct observation of hierarchical protein dynamics	SCIENCE			English	Article							GLASS-TRANSITION; HEAT-CAPACITY; MOTIONS; RELAXATION; MYOGLOBIN; SOLVENT; NMR	One of the fundamental challenges of physical biology is to understand the relationship between protein dynamics and function. At physiological temperatures, functional motions arise from the complex interplay of thermal motions of proteins and their environments. Here, we determine the hierarchy in the protein conformational energy landscape that underlies these motions, based on a series of temperature-dependent magic-angle spinning multinuclear nuclear-magnetic-resonance relaxation measurements in a hydrated nanocrystalline protein. The results support strong coupling between protein and solvent dynamics above 160 kelvin, with fast solvent motions, slow protein side-chain motions, and fast protein backbone motions being activated consecutively. Low activation energy, small-amplitude local motions dominate at low temperatures, with larger-amplitude, anisotropic, and functionally relevant motions involving entire peptide units becoming dominant at temperatures above 220 kelvin.	[Lewandowski, Jozef R.; Halse, Meghan E.; Emsley, Lyndon] UCB Lyon 1, Inst Sci Analyt, CNRS, ENS Lyon, F-69100 Villeurbanne, France; [Blackledge, Martin] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38044 Grenoble, France; [Blackledge, Martin] CEA, IBS, F-38044 Grenoble, France; [Emsley, Lyndon] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lewandowski, JR (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	j.r.lewandowski@warwick.ac.uk; martin.blackledge@ibs.fr; lyndon.emsley@epfl.ch	Emsley, Lyndon/AAS-6384-2020; Emsley, Lyndon/C-6108-2008; Halse, Meghan/AAA-9131-2020; Lewandowski, Józef/F-3480-2011	Emsley, Lyndon/0000-0003-1360-2572; Emsley, Lyndon/0000-0003-1360-2572; Halse, Meghan/0000-0002-3605-5551; Lewandowski, Józef/0000-0001-6525-7083	Agence Nationale de la Recherche (ANR); European Commission [BioNMR 261863]; Swiss National Science Foundation [31-132857]; European Union [PIRG03-GA-2008-231026]; University of Warwick; BBSRC [BB/L022761/1] Funding Source: UKRI; EPSRC [EP/L025906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L022761/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L025906/1] Funding Source: researchfish	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); University of Warwick; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Grzesiek and H. J. Sass for providing [U-<SUP>13</SUP>C,<SUP>15</SUP>N]GB1. We acknowledge support from Agence Nationale de la Recherche (ANR PCV 2007 Protein Motion, ComplexDynamics ANR Blanc 2012 SIMI7), the Access to Research Infrastructures Activity in the Seventh Framework Program of the European Commission (BioNMR 261863), and Swiss National Science Foundation grant 31-132857. J.R.L. acknowledges support from the European Union International Reintegration Grant (PIRG03-GA-2008-231026) and startup funds from University of Warwick. All data used to support conclusions in this manuscript are provided in the supplementary materials.	ANDREW ER, 1978, BIOPOLYMERS, V17, P1913, DOI 10.1002/bip.1978.360170808; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Daniel RM, 1998, BIOPHYS J, V75, P2504, DOI 10.1016/S0006-3495(98)77694-5; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Doster W, 2008, EUR BIOPHYS J BIOPHY, V37, P591, DOI 10.1007/s00249-008-0274-3; Fenimore PW, 2013, CHEM PHYS, V424, P2, DOI 10.1016/j.chemphys.2013.06.023; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Giraud N, 2005, J AM CHEM SOC, V127, P18190, DOI 10.1021/ja055182h; Idiyatullin D, 2003, J MOL BIOL, V325, P149, DOI 10.1016/S0022-2836(02)01155-5; Jansson H, 2011, J PHYS CHEM B, V115, P4099, DOI 10.1021/jp1089867; Knab JR, 2007, P IEEE, V95, P1605, DOI 10.1109/JPROC.2007.898906; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lewandowski JR, 2011, J AM CHEM SOC, V133, P16762, DOI 10.1021/ja206815h; Lewandowski JR, 2013, ACCOUNTS CHEM RES, V46, P2018, DOI 10.1021/ar300334g; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; Mollica L, 2012, J PHYS CHEM LETT, V3, P3657, DOI 10.1021/jz3016233; PARAK F, 1971, ACTA CRYSTALL A-CRYS, VA 27, P573, DOI 10.1107/S0567739471001281; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Tarek M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138101; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Wood K, 2008, J AM CHEM SOC, V130, P4586, DOI 10.1021/ja710526r	24	172	174	6	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					578	581		10.1126/science.aaa6111	http://dx.doi.org/10.1126/science.aaa6111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931561	Green Accepted			2022-12-28	WOS:000353778100043
J	Nelson, B				Nelson, Bryn			Behind a vaccine	NATURE			English	Editorial Material																			0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					711	713		10.1038/nj7549-711a	http://dx.doi.org/10.1038/nj7549-711a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25932490				2022-12-28	WOS:000353689700059
J	Liddell, AM; Davey, RT; Mehta, AK; Varkey, JB; Kraft, CS; Tseggay, GK; Badidi, O; Faust, AC; Brown, KV; Suffredini, AF; Barrett, K; Wolcott, MJ; Marconi, VC; Lyon, GM; Weinstein, GL; Weinmeister, K; Sutton, S; Hazbun, M; Albarino, CG; Reed, Z; Cannon, D; Stroher, U; Feldman, M; Ribner, BS; Lane, HC; Fauci, AS; Uyeki, TM				Liddell, Allison M.; Davey, Richard T., Jr.; Mehta, Aneesh K.; Varkey, Jay B.; Kraft, Colleen S.; Tseggay, Gebre K.; Badidi, Oghenetega; Faust, Andrew C.; Brown, Katia V.; Suffredini, Anthony F.; Barrett, Kevin; Wolcott, Mark J.; Marconi, Vincent C.; Lyon, G. Marshall, III; Weinstein, Gary L.; Weinmeister, Kenney; Sutton, Shelby; Hazbun, Munir; Albarino, Cesar G.; Reed, Zachary; Cannon, Debi; Stroeher, Ute; Feldman, Mark; Ribner, Bruce S.; Lane, H. Clifford; Fauci, Anthony S.; Uyeki, Timothy M.			Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States	ANNALS OF INTERNAL MEDICINE			English	Article								Background: More than 26 000 cases of Ebola virus disease (EVD) have been reported in western Africa, with high mortality. Several patients have been medically evacuated to hospitals in the United States and Europe. Detailed clinical data are limited on the clinical course and management of patients with EVD outside western Africa. Objective: To describe the clinical characteristics and management of a cluster of patients with EVD, including the first cases of Ebola virus (EBOV) infection acquired in the United States. Design: Retrospective clinical case series. Setting: Three U.S. hospitals in September and October 2014. Patients: First imported EVD case identified in the United States and 2 secondary EVD cases acquired in the United States in critical care nurses who cared for the index case patient. Measurements: Clinical recovery, EBOV RNA level, resolution of Ebola viremia, survival with discharge from hospital, or death. Results: The index patient had high EBOV RNA levels, developed respiratory and renal failure requiring critical care support, and died. Both patients with secondary EBOV infection had nonspecific signs and symptoms and developed moderate illness; EBOV RNA levels were moderate, and both patients recovered. Limitation: Both surviving patients received uncontrolled treatment with multiple investigational agents, including convalescent plasma, which limits generalizability of the results. Conclusion: Early diagnosis, prompt initiation of supportive medical care, and moderate clinical illness likely contributed to successful outcomes in both survivors. The inability to determine the potential benefit of investigational therapies and the effect of patient-specific factors that may have contributed to less severe illness highlight the need for controlled clinical studies of these interventions, especially in the setting of a high level of supportive medical care.	[Liddell, Allison M.] Texas Hlth Presbyterian Hosp Dallas, Dallas, TX 75231 USA; NIH, Ctr Clin, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Atlanta, GA USA; Ctr Dis Control & Prevent, Atlanta, GA USA; US Army, Med Res Inst Infect Dis, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Emory University; Centers for Disease Control & Prevention - USA	Liddell, AM (corresponding author), Texas Hlth Presbyterian Hosp Dallas, 8230 Walnut Hill Lane,Suite 308, Dallas, TX 75231 USA.	allisonliddell@texashealth.org	Marconi, Vincent/AFK-5812-2022; Mehta, Aneesh/B-8054-2012; Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022; Kraft, Colleen S/M-2347-2013	Mehta, Aneesh/0000-0002-6552-9162; Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Kraft, Colleen S/0000-0003-1757-8477; HAZBUN, MUNIR/0000-0003-2083-315X	National Center for Advancing Translational Sciences of the National Institutes of Health [Atlanta Clinical and Translational Science Institute] [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984, ZIAAI000936] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health [Atlanta Clinical and Translational Science Institute]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the entire staff of Texas Health Presbyterian Hospital Dallas, particularly Edward Goodman, MD, Beverly Dickson, MD, Otto Javier Marquez-Kerguelen, MD, Sarah S. Way, MD, Mark Till, MD, Glen Owen, MD, Bruce Wall, MD, Elaine Whitaker, MD, David Gonzales, MD, and Sarita Sharma-Louys, MD; Texas Health Resources for its unwavering support; William Dorman and Samantha Tostenson of the U.S. Army Medical Research Institute of Infectious Diseases for technical work on RT-PCR assays; David Henderson, MD, and Tara Palmore, MD, of the National Institutes of Health Clinical Center for their infection control leadership; the nursing and hospital epidemiology staff at the National Institutes of Health Clinical Center for their outstanding patient care; Anne Winkler, MD, of the Emory University Hospital Serious Communicable Diseases Unit for coordinating the convalescent plasma collection and administration; all of the members of the Emory University Hospital Serious Communicable Diseases Unit team for their outstanding contributions to the patient's excellent care (supported by award UL1TR000454 from the National Center for Advancing Translational Sciences of the National Institutes of Health [Atlanta Clinical and Translational Science Institute]); and Tara Sealy, MS, Aridith Gibbons, and Bobbie Rae Erickson, MPH, of the Centers for Disease Control and Prevention for their technical support on the laboratory assays.	Ansumana R, 2015, NEW ENGL J MED, V372, P587, DOI 10.1056/NEJMc1413685; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Centers for Disease Control and Prevention, 2014, WHAT US HOSP NEED KN; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Parra JM, 2014, NEW ENGL J MED, V371, P2439, DOI 10.1056/NEJMc1412662; Marty FM, 2013, NEW ENGL J MED, V369, P1227, DOI 10.1056/NEJMoa1303688; Naval Medical Research Center, 2014, EB ZAIR EZ1 RRT PCR; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; WHO, 2015, EB SIT REP; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992; Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9	19	90	96	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					81	+		10.7326/M15-0530	http://dx.doi.org/10.7326/M15-0530			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	25961438	Green Accepted			2022-12-28	WOS:000358407500015
J	Finisguerra, V; Di Conza, G; Di Matteo, M; Serneels, J; Costa, S; Thompson, AAR; Wauters, E; Walmsley, S; Prenen, H; Granot, Z; Casazza, A; Mazzone, M				Finisguerra, Veronica; Di Conza, Giusy; Di Matteo, Mario; Serneels, Jens; Costa, Sandra; Thompson, A. A. Roger; Wauters, Els; Walmsley, Sarah; Prenen, Hans; Granot, Zvi; Casazza, Andrea; Mazzone, Massimiliano			MET is required for the recruitment of anti-tumoural neutrophils	NATURE			English	Article							HEPATOCYTE GROWTH-FACTOR; ONCOGENE ADDICTION; CELL; PROTOONCOGENE; INFLAMMATION; EXPRESSION; DIFFERENTIATION; MOBILIZATION; MODULATION; INHIBITORS	Mutations or amplification of the MET proto-oncogene are involved in the pathogenesis of several tumours(1-4), which rely on the constitutive engagement of this pathway for their growth and survival(1,5). However, MET is expressed not only by cancer cells but also by tumour-associated stromal cells, although its precise role in this compartment is not well characterized(6-11). Here we show that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor (HGF). Met deletion in mouse neutrophils enhances tumour growth and metastasis. This phenotype correlates with reduced neutrophil infiltration to both the primary tumour and metastatic sites. Similarly, Met is necessary for neutrophil transudation during colitis, skin rash or peritonitis. Mechanistically, Met is induced by tumour-derived tumour necrosis factor (TNF)-alpha or other inflammatory stimuli in both mouse and human neutrophils. This induction is instrumental for neutrophil transmigration across an activated endothelium and for inducible nitric oxide synthase production upon HGF stimulation. Consequently, HGF/MET-dependent nitric oxide release by neutrophils promotes cancer cell killing, which abates tumour growth and metastasis. After systemic administration of a MET kinase inhibitor, we prove that the therapeutic benefit of MET targeting in cancer cells is partly countered by the pro-tumoural effect arising from MET blockade in neutrophils. Our work identifies an unprecedented role of MET in neutrophils, suggests a potential 'Achilles' heel' of MET-targeted therapies in cancer, and supports the rationale for evaluating anti-MET drugs in certain inflammatory diseases.	[Finisguerra, Veronica; Di Conza, Giusy; Di Matteo, Mario; Serneels, Jens; Costa, Sandra; Casazza, Andrea; Mazzone, Massimiliano] VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Leuven, Belgium; [Finisguerra, Veronica; Di Conza, Giusy; Di Matteo, Mario; Serneels, Jens; Costa, Sandra; Casazza, Andrea; Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Leuven, Belgium; [Costa, Sandra] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Costa, Sandra] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal; [Thompson, A. A. Roger; Walmsley, Sarah] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2RX, S Yorkshire, England; [Wauters, Els] Univ Hosp Gasthuisberg, Resp Div, B-3000 Leuven, Belgium; [Wauters, Els] VIB, Vesalius Res Ctr, Lab Translat Genet, B-3000 Leuven, Belgium; [Wauters, Els] Katholieke Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Translat Genet, B-3000 Leuven, Belgium; [Prenen, Hans] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Leuven, Belgium; [Granot, Zvi] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel	Flanders Institute for Biotechnology (VIB); KU Leuven; Universidade do Minho; University of Sheffield; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Hebrew University of Jerusalem	Mazzone, M (corresponding author), VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Leuven, Belgium.	andrea.casazza@vib-kuleuven.be; massimiliano.mazzone@vib-kuleuven.be	Thompson, Roger/G-7397-2018; Finisguerra, Veronica/AGS-6956-2022; Costa, Sandra/B-4253-2011; Di Conza, Giusy/AAU-9661-2020; Di Conza, Giusy/GPP-1438-2022; Costa, Sandra/AAV-7175-2020	Thompson, Roger/0000-0002-0717-4551; Costa, Sandra/0000-0001-6795-4245; Costa, Sandra/0000-0001-6795-4245; Di Conza, Giusy/0000-0003-1353-5867; Walmsley, Sarah/0000-0001-9584-174X; Prenen, Hans/0000-0001-8802-7352; Mazzone, Massimiliano/0000-0001-8824-4015; Wauters, Els/0000-0002-0115-0030; Di Matteo, Mario/0000-0001-7811-7450	Fonds Wetenschappelijk Onderzoek (FWO); Fondazione Umberto Veronesi; Wellcome Trust; European Research Council; MRC [G0802255] Funding Source: UKRI; Medical Research Council [G0802255] Funding Source: researchfish; National Institute for Health Research [ACF-2006-04-005] Funding Source: researchfish	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank: R. Stirparo, M. Mambretti and Y. Jonsson for technical assistance; G. Serini, L. Trusolino and P. Bruhns for comments; and E. Radaelli for valuable advice on histological analyses. V.F. and G.D.C. were supported by grants from the Fonds Wetenschappelijk Onderzoek (FWO), A.C. by the Fondazione Umberto Veronesi. S.W. is supported by a Wellcome Trust Senior Clinical Fellowship Award. M. M. is supported by a European Research Council starting grant.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chen QY, 1996, CELL GROWTH DIFFER, V7, P821; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dai JY, 2009, J CELL BIOCHEM, V107, P1222, DOI 10.1002/jcb.22226; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Garber K, 2014, NAT REV DRUG DISCOV, V13, P563, DOI 10.1038/nrd4406; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hamm A, 2013, EMBO MOL MED, V5, P843, DOI 10.1002/emmm.201302695; HASLETT C, 1985, AM J PATHOL, V119, P101; Kishi Y, 2009, CANCER SCI, V100, P1351, DOI 10.1111/j.1349-7006.2009.01184.x; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Liu Y, 2007, J PATHOL, V212, P12, DOI 10.1002/path.2155; MOGHUL A, 1994, ONCOGENE, V9, P2045; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Schira J, 2012, BRAIN, V135, P431, DOI 10.1093/brain/awr222; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	35	274	284	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					349	+		10.1038/nature14407	http://dx.doi.org/10.1038/nature14407			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25985180	Green Accepted, Green Published			2022-12-28	WOS:000356425400055
J	Bell, RJA; Rube, HT; Kreig, A; Mancini, A; Fouse, SD; Nagarajan, RP; Choi, S; Hong, C; He, D; Pekmezci, M; Wiencke, JK; Wrensch, MR; Chang, SM; Walsh, KM; Myong, S; Song, JS; Costello, JF				Bell, Robert J. A.; Rube, H. Tomas; Kreig, Alex; Mancini, Andrew; Fouse, Shaun D.; Nagarajan, Raman P.; Choi, Serah; Hong, Chibo; He, Daniel; Pekmezci, Melike; Wiencke, John K.; Wrensch, Margaret R.; Chang, Susan M.; Walsh, Kyle M.; Myong, Sua; Song, Jun S.; Costello, Joseph F.			The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer	SCIENCE			English	Article							MACROPHAGE DIFFERENTIATION; TELOMERASE ACTIVITY; DISEASE RECURRENCE; HIGHLY RECURRENT; ETS-FAMILY; MUTATIONS; IDENTIFICATION; REPRESSOR; SUBUNITS; COMPLEX	Reactivation of telomerase reverse transcriptase (TERT) expression enables cells to overcome replicative senescence and escape apoptosis, which are fundamental steps in the initiation of human cancer. Multiple cancer types, including up to 83% of glioblastomas (GBMs), harbor highly recurrent TERT promoter mutations of unknown function but specific to two nucleotide positions. We identified the functional consequence of these mutations in GBMs to be recruitment of the multimeric GA-binding protein (GABP) transcription factor specifically to the mutant promoter. Allelic recruitment of GABP is consistently observed across four cancer types, highlighting a shared mechanism underlying TERT reactivation. Tandem flanking native E26 transformation-specific motifs critically cooperate with these mutations to activate TERT, probably by facilitating GABP heterotetramer binding. GABP thus directly links TERT promoter mutations to aberrant expression in multiple cancers.	[Bell, Robert J. A.; Mancini, Andrew; Fouse, Shaun D.; Nagarajan, Raman P.; Hong, Chibo; He, Daniel; Chang, Susan M.; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Bell, Robert J. A.; Song, Jun S.] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Rube, H. Tomas; Song, Jun S.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Rube, H. Tomas; Kreig, Alex; Myong, Sua; Song, Jun S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kreig, Alex; Myong, Sua; Song, Jun S.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Choi, Serah] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Pekmezci, Melike] Univ Calif San Francisco, Dept Anat Pathol, Sch Med, San Francisco, CA 94143 USA; [Wiencke, John K.; Wrensch, Margaret R.; Walsh, Kyle M.] Univ Calif San Francisco, Dept Neurol Surg, Div Neuroepidemiol, San Francisco, CA 94158 USA; [Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Song, JS (corresponding author), Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA.	songj@illinois.edu; joseph.costello@ucsf.edu	Song, Jun S/E-2526-2016	Song, Jun S/0000-0002-0422-2175; Walsh, Kyle/0000-0002-5879-9981	National Cancer Institute (NCI) [R01CA163336]; Sontag Foundation Distinguished Scientist Award; NCI [P50CA097257, P01CA118816-06, R01CA169316-01, R25CA112355, R01CA52689]; Grove Foundation; Karen Osney Brownstein Endowed Chair; Anne and Jason Farber Foundation; Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research; Robert Magnin Newman Endowed Chair in Neuro-oncology; NATIONAL CANCER INSTITUTE [R01CA052689, R01CA163336, P50CA097257, R01CA169316, P01CA118816, R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105453, T32GM008568] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sontag Foundation Distinguished Scientist Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grove Foundation; Karen Osney Brownstein Endowed Chair; Anne and Jason Farber Foundation; Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research; Robert Magnin Newman Endowed Chair in Neuro-oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by National Cancer Institute (NCI) grant R01CA163336 (J.S.S.), the Sontag Foundation Distinguished Scientist Award (J.S.S.), NCI grants P50CA097257 and P01CA118816-06 (M.S.B., S.M.C., J.F.C.); NCI grant R01CA169316-01 (J.F.C.), the Grove Foundation, the Karen Osney Brownstein Endowed Chair (J.F.C.), the Anne and Jason Farber Foundation, and a gift from the Dabbiere family. Additional support was provided by NCI grants R25CA112355 (K.M.W.), R01CA52689 (K.M.W., J.K.W., M.R.W.), and P50CA097257 (K.M.W., M.R.W.); the Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research; the Robert Magnin Newman Endowed Chair in Neuro-oncology; the Founder Professorship from the Grainger Engineering Breakthroughs Initiative (J. S. S.); and donations from families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper, and William Martinusen. Provisional patent application (application number 62/145,579) has been filed by the University of California, San Francisco, and the University of Illinois. All transcriptome sequencing data have been deposited in the European Genome-phenome Archive under accession number EGAS00001001242.	Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Castelo-Branco P, 2013, LANCET ONCOL, V14, P534, DOI 10.1016/S1470-2045(13)70110-4; DELABROUSSE FC, 1994, GENE DEV, V8, P1853, DOI 10.1101/gad.8.15.1853; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Nagarajan RP, 2014, GENOME RES, V24, P761, DOI 10.1101/gr.164707.113; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Quaas A, 2014, VIRCHOWS ARCH, V465, P673, DOI 10.1007/s00428-014-1658-7; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Remke M, 2013, ACTA NEUROPATHOL, V126, P917, DOI 10.1007/s00401-013-1198-2; SAWADA J, 1994, EMBO J, V13, P1396, DOI 10.1002/j.1460-2075.1994.tb06393.x; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Simon M, 2015, NEURO-ONCOLOGY, V17, P45, DOI 10.1093/neuonc/nou158; Spiegl-Kreinecker S, 2015, NEUROONCOL; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498	32	337	343	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1036	1039		10.1126/science.aab0015	http://dx.doi.org/10.1126/science.aab0015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25977370	Green Accepted			2022-12-28	WOS:000355276600049
J	Rajkumar, R; Press, MJ; Conway, PH				Rajkumar, Rahul; Press, Matthew J.; Conway, Patrick H.			The CMS Innovation Center - A Five-Year Self-Assessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rajkumar, Rahul; Press, Matthew J.; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Rajkumar, R (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.							[Anonymous], 2014, REP C; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Taylor E. F., 2015, EVALUATION COMPREHEN	4	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1981	1983		10.1056/NEJMp1501951	http://dx.doi.org/10.1056/NEJMp1501951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5PD	25992744				2022-12-28	WOS:000354809300003
J	Savage, N				Savage, Neil			AERODYNAMICS Vortices and robobees	NATURE			English	Editorial Material																		Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Dillon ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0922; Vance JT, 2014, PHYSIOL BIOCHEM ZOOL, V87, P870, DOI 10.1086/678955	3	4	4	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S64	S65		10.1038/521S64a	http://dx.doi.org/10.1038/521S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992677	Bronze			2022-12-28	WOS:000354816500012
J	Wilson, D; Adams, ME; Robertson, F; Murphy, M; Werring, DJ				Wilson, Duncan; Adams, Matthew E.; Robertson, Fergus; Murphy, Mary; Werring, David J.			Investigating intracerebral haemorrhage	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSTIC CEREBRAL-ANGIOGRAPHY; COMPUTED-TOMOGRAPHY; COMPLICATIONS		[Wilson, Duncan; Werring, David J.] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Grp, London WC1N 3BG, England; [Adams, Matthew E.; Robertson, Fergus] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol RJ, London WC1N 3BG, England; [Murphy, Mary] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Werring, DJ (corresponding author), Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Grp, Queen Sq, London WC1N 3BG, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019	Werring, David/0000-0003-2074-1861	Stroke Association [TSABHF2009/01] Funding Source: researchfish	Stroke Association		ATLAS SW, 1987, RADIOLOGY, V164, P71, DOI 10.1148/radiology.164.1.3588929; Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Coutinho JM, 2014, ANN NEUROL, V75, P908, DOI 10.1002/ana.24180; Dawkins AA, 2007, NEURORADIOLOGY, V49, P753, DOI 10.1007/s00234-007-0252-y; Evans AL, 2005, ACTA RADIOL, V46, P625, DOI 10.1080/02841850510021779; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Goldstein LB, 2005, JAMA-J AM MED ASSOC, V293, P2391, DOI 10.1001/jama.293.19.2391; HALPIN SFS, 1994, J NEUROL NEUROSUR PS, V57, P1180, DOI 10.1136/jnnp.57.10.1180; HANKEY GJ, 1990, J NEUROL NEUROSUR PS, V53, P542, DOI 10.1136/jnnp.53.7.542; Hopyan JJ, 2008, AM J NEURORADIOL, V29, P1826, DOI 10.3174/ajnr.A1257; Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536; Lovelock CE, 2009, STROKE, V40, P3763, DOI 10.1161/STROKEAHA.109.553933; Lummel N, 2012, NEURORADIOLOGY, V54, P673, DOI 10.1007/s00234-011-0953-0; Ma JP, 2012, NEUROL INDIA, V60, P299, DOI 10.4103/0028-3886.98515; Meckel S, 2010, AM J NEURORADIOL, V31, P527, DOI 10.3174/ajnr.A1869; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wasay M, 2005, J NEUROIMAGING, V15, P118, DOI 10.1177/1051228404272883; Wetzel SG, 1999, AM J NEURORADIOL, V20, P249; Wong GKC, 2010, J CLIN NEUROSCI, V17, P601, DOI 10.1016/j.jocn.2009.09.022; Wong GKC, 2012, J CLIN NEUROSCI, V19, P498, DOI 10.1016/j.jocn.2011.08.017; Zhu XL, 1997, STROKE, V28, P1406, DOI 10.1161/01.STR.28.7.1406	25	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2484	10.1136/bmj.h2484	http://dx.doi.org/10.1136/bmj.h2484			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YZ	25994363				2022-12-28	WOS:000355128700004
J	Rao, RC; Ballard, TNS; Chen, TC				Rao, Rajesh C.; Ballard, Tiffany N. S.; Chen, Teresa C.			Iris Heterochromia and Unilateral Eyelash Hypertrichosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIMATOPROST; GLAUCOMA; MECHANISM; GROWTH		[Rao, Rajesh C.] Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Rao, Rajesh C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48105 USA; [Ballard, Tiffany N. S.] Univ Michigan, Dept Surg, Sect Plast Surg, Ann Arbor, MI 48105 USA; [Chen, Teresa C.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rao, RC (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, 1000 Wall St,Brehm Room 8326, Ann Arbor, MI 48105 USA.	rajeshr@med.umich.edu	Rao, Rajesh C./N-1107-2017	Rao, Rajesh C./0000-0002-5776-8366; Chen, Teresa/0000-0001-5327-2016	NATIONAL EYE INSTITUTE [K12EY022299] Funding Source: NIH RePORTER; NEI NIH HHS [K12EY022299, K12 EY022299] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Braiteh F, 2008, J CLIN ONCOL, V26, P3460, DOI 10.1200/JCO.2008.16.9391; Cohen JL, 2010, DERMATOL SURG, V36, P1361, DOI 10.1111/j.1524-4725.2010.01522.x; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Higginbotham EJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P1286, DOI 10.1001/archopht.120.10.1286; Kapur R, 2005, ARCH OPHTHALMOL-CHIC, V123, P1541, DOI 10.1001/archopht.123.11.1541; Kucukevcilioglu M, 2014, CLIN EXP OPHTHALMOL, V42, P126, DOI 10.1111/ceo.12163; Radcliffe NA, 2009, SURV OPHTHALMOL, V54, P47, DOI 10.1016/j.survophthal.2008.10.002; Rehman HU, 2008, CAN MED ASSOC J, V179, P447, DOI 10.1503/cmaj.070497; Stjernschantz JW, 2002, SURV OPHTHALMOL, V47, pS162, DOI 10.1016/S0039-6257(02)00292-8; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	10	1	1	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1967	1968		10.1001/jama.2015.1348	http://dx.doi.org/10.1001/jama.2015.1348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988467	Green Accepted			2022-12-28	WOS:000354691200019
J	Embley, TM; Williams, TA				Embley, T. Martin; Williams, Tom A.			Steps on the road to eukaryotes	NATURE			English	Editorial Material							DOMAINS; ORIGIN; LIFE	A new archaeal phylum represents the closest known relatives of eukaryotes, the group encompassing all organisms that have nucleated cells. The discovery holds promise for a better understanding of eukaryotic origins. SEE ARTICLE P.173	[Embley, T. Martin; Williams, Tom A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Embley, TM (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	martin.embley@ncl.ac.uk; tom.williams2@ncl.ac.uk		Williams, Tom/0000-0003-1072-0223				Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Jorgensen SL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00299; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	9	32	34	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					169	170		10.1038/nature14522	http://dx.doi.org/10.1038/nature14522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25945740				2022-12-28	WOS:000354377800047
J	Flum, DR				Flum, David R.			Acute Appendicitis - Appendectomy or the "Antibiotics First" Strategy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALVARADO SCORE; CONTROLLED-TRIAL; UNITED-STATES; RISK; EPIDEMIOLOGY; MANAGEMENT; CONVERSION; DIAGNOSIS; OUTCOMES; THERAPY	A 56-year-old man presents with a 2-day history of abdominal pain. The pain began centrally but has moved to the right lower quadrant of his abdomen in the past 6 hours. He has a body-mass index (the weight in kilograms divided by the square of the height in meters) of 33, a body temperature of 100 degrees F (37.8 degrees C), and a white-cell count of 11,500 per cubic millimeter. The right side of his lower abdomen is tender to palpation. A computed tomographic (CT) scan was ordered by his primary care physician after he was examined in the clinic, and the results are consistent with appendicitis. He has had three prior surgical procedures: an open Nissen fundoplication complicated by a pulmonary embolism and two incisional hernia repairs with mesh. After receiving the results of his CT scan, he found information online about doctors in Europe who are using antibiotics alone to treat appendicitis, and he asks specifically about that option. How would you manage this case?	Univ Washington, Dept Surg, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Flum, DR (corresponding author), Univ Washington, Dept Surg, 1959 NE Pacific St,Box 356410, Seattle, WA 98105 USA.	sorce@uw.edu	Flum, David/GPX-7976-2022		BenchMark Medical; Pacira Pharmaceuticals	BenchMark Medical; Pacira Pharmaceuticals	Dr. Flum reports receiving consulting fees from BenchMark Medical and Pacira Pharmaceuticals and providing expert testimony related to medical malpractice cases for Surgical Consulting. No other potential conflict of interest relevant to this article was reported.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; American College of Surgeons, 2014, OP BROCH APP; ANDERSSON R, 1994, BRIT MED J, V308, P107, DOI 10.1136/bmj.308.6921.107; Andersson RE, 2014, BRIT J SURG, V101, P1135, DOI 10.1002/bjs.9552; ARNBJORNSSON E, 1983, ACTA CHIR SCAND, V149, P789; Buckius MT, 2012, J SURG RES, V175, P185, DOI 10.1016/j.jss.2011.07.017; Drake FT, 2014, JAMA SURG, V149, P837, DOI 10.1001/jamasurg.2014.77; Drake Frederick Thurston, 2013, Adv Surg, V47, P299; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Haas L, 2012, EUR J HEALTH ECON, V13, P549, DOI 10.1007/s10198-011-0355-6; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Hlibczuk V, 2010, ANN EMERG MED, V55, P51, DOI 10.1016/j.annemergmed.2009.06.509; Im GY, 2011, CLIN GASTROENTEROL H, V9, P1072, DOI 10.1016/j.cgh.2011.06.006; Ingraham AM, 2010, SURGERY, V148, P625, DOI 10.1016/j.surg.2010.07.025; Jackson HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095414; Jones RP, 2015, AM J ROENTGENOL, V204, P519, DOI 10.2214/AJR.14.12864; Katkhouda N, 2005, ANN SURG, V242, P439, DOI 10.1097/01.sla.0000179648.75373.2f; Leeuwenburgh MMN, 2013, RADIOLOGY, V268, P135, DOI 10.1148/radiol.13121753; Masoomi H, 2014, AM SURGEON, V80, P1074; McCutcheon BA, 2014, J AM COLL SURGEONS, V218, P905, DOI 10.1016/j.jamcollsurg.2014.01.003; Morino M, 2006, ANN SURG, V244, P881, DOI 10.1097/01.sla.0000246886.80424.ad; Ohle R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-139; Olsen J, 2014, DAN MED J, V61; Papandria D, 2013, AM SURGEON, V79, P914; Petroianu A, 2012, INT J SURG, V10, P115, DOI 10.1016/j.ijsu.2012.02.006; Pinto A, 2013, CRIT ULTRASOUND J, V5, DOI 10.1186/2036-7902-5-S1-S11; Sakpal SV, 2012, J SURG RES, V176, P42, DOI 10.1016/j.jss.2011.07.019; Sanders NL, 2013, WORLD J GASTROENTERO, V19, P5607, DOI 10.3748/wjg.v19.i34.5607; Sartelli M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-3; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Singh JP, 2013, ANN ROY COLL SURG, V95, P48, DOI 10.1308/003588413X13511609954851; Smith HF, 2013, CR PALEVOL, V12, P339, DOI 10.1016/j.crpv.2012.12.001; Society for Surgery of the Alimentary Tract, SOC SURG AL TRACT; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Tan WJ, 2013, ANZ J SURG, V83, P748, DOI 10.1111/ans.12076; Teixeira PG, 2012, ANN SURG, V256, P538, DOI 10.1097/SLA.0b013e318265ea13; Theilen LH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.002; Turhan AN, 2009, ULUS TRAVMA ACIL CER, V15, P459; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Wangensteen OH, 1939, ANN SURG, V110, P629, DOI 10.1097/00000658-193910000-00011; Weiss AJ, 2014, HEALTHCARE COST UTIL; Wojciechowicz KH, 2010, INT MARIT HEALTH, V61, P265	44	116	125	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1937	1943		10.1056/NEJMcp1215006	http://dx.doi.org/10.1056/NEJMcp1215006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970051				2022-12-28	WOS:000354493300009
J	Mayer, RJ; Van Cutsem, E; Falcone, A; Yoshino, T; Garcia-Carbonero, R; Mizunuma, N; Yamazaki, K; Shimada, Y; Tabernero, J; Komatsu, Y; Sobrero, A; Boucher, E; Peeters, M; Tran, B; Lenz, HJ; Zaniboni, A; Hochster, H; Cleary, JM; Prenen, H; Benedetti, F; Mizuguchi, H; Makris, L; Ito, M; Ohtsu, A				Mayer, Robert J.; Van Cutsem, Eric; Falcone, Alfredo; Yoshino, Takayuki; Garcia-Carbonero, Rocio; Mizunuma, Nobuyuki; Yamazaki, Kentaro; Shimada, Yasuhiro; Tabernero, Josep; Komatsu, Yoshito; Sobrero, Alberto; Boucher, Eveline; Peeters, Marc; Tran, Ben; Lenz, Heinz-Josef; Zaniboni, Alberto; Hochster, Howard; Cleary, James M.; Prenen, Hans; Benedetti, Fabio; Mizuguchi, Hirokazu; Makris, Lukas; Ito, Masanobu; Ohtsu, Atsushi		RECOURSE Study Grp	Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLID TUMORS; PHASE-I; FLUORINATED PYRIMIDINES; ANTITUMOR-ACTIVITY; ANTIMETABOLITE; MECHANISM; CELLS; DNA	BACKGROUND Early clinical trials conducted primarily in Japan have shown that TAS-102, an oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment of refractory colorectal cancer. We conducted a phase 3 trial to further assess the efficacy and safety of TAS-102 in a global population of such patients. METHODS In this double-blind study, we randomly assigned 800 patients, in a 2: 1 ratio, to receive TAS-102 or placebo. The primary end point was overall survival. RESULTS The median overall survival improved from 5.3 months with placebo to 7.1 months with TAS-102, and the hazard ratio for death in the TAS-102 group versus the placebo group was 0.68 (95% confidence interval [CI], 0.58 to 0.81; P<0.001). The most frequently observed clinically significant adverse events associated with TAS-102 were neutropenia, which occurred in 38% of those treated, and leukopenia, which occurred in 21%; 4% of the patients who received TAS-102 had febrile neutropenia, and one death related to TAS-102 was reported. The median time to worsening performance status (a change in Eastern Cooperative Oncology Group performance status [on a scale of 0 to 5, with 0 indicating no symptoms and higher numbers indicating increasing degrees of disability] from 0 or 1 to 2 or more) was 5.7 months with TAS-102 versus 4.0 months with placebo (hazard ratio, 0.66; 95% CI, 0.56 to 0.78; P<0.001). CONCLUSIONS In patients with refractory colorectal cancer, TAS-102, as compared with placebo, was associated with a significant improvement in overall survival.	[Mayer, Robert J.; Cleary, James M.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Van Cutsem, Eric; Prenen, Hans] Univ Hosp, Leuven, Belgium; [Van Cutsem, Eric; Prenen, Hans] Katholieke Univ Leuven, Leuven, Belgium; [Peeters, Marc] Univ Ziekenhuizen Antwerp, Edegem, Belgium; [Falcone, Alfredo] Univ Pisa, Pisa, Italy; [Sobrero, Alberto] IRCCS Azienda Osped Univ San Martino, Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Zaniboni, Alberto] Fdn Poliambulanza Ist Osped, Brescia, Italy; [Yoshino, Takayuki; Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Chiba, Japan; [Mizunuma, Nobuyuki] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Shizuoka, Japan; [Shimada, Yasuhiro] Natl Canc Ctr, Tokyo, Japan; [Komatsu, Yoshito] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan; [Ito, Masanobu] Taiho Pharmaceut, Tokyo, Japan; [Garcia-Carbonero, Rocio] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Tabernero, Josep] Vall dHebron Univ Hosp, Barcelona, Spain; [Tabernero, Josep] Vall dHebron Inst Oncol, Barcelona, Spain; [Boucher, Eveline] Ctr Eugene Marquis, Rennes, France; [Tran, Ben] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lenz, Heinz-Josef] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Hochster, Howard] Yale Canc Ctr, New Haven, CT USA; [Benedetti, Fabio; Mizuguchi, Hirokazu] Taiho Oncol, Princeton, NJ USA; [Makris, Lukas] Stathmi, New Hope, PA USA	Harvard University; Dana-Farber Cancer Institute; KU Leuven; University of Pisa; University of Genoa; IRCCS AOU San Martino IST; National Cancer Center - Japan; Japanese Foundation for Cancer Research; Shizuoka Cancer Center; National Cancer Center - Japan; Hokkaido University; Taiho Pharmaceutical; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); UNICANCER; Centre Eugene Marquis; Royal Melbourne Hospital; University of Southern California; Yale University	Mayer, RJ (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.		Sobrero, Alberto/AAF-9742-2019; Van+Cutsem, Eric/ABE-1762-2021; Peeters, Marc/C-5525-2013; Tabernero, Josep/AAG-5026-2019; Falcone, Alfredo/G-5217-2013; Folprecht, Gunnar/F-8638-2011	Sobrero, Alberto/0000-0001-7764-673X; Peeters, Marc/0000-0003-4969-2303; Tabernero, Josep/0000-0002-2495-8139; Samuel, Leslie/0000-0002-8402-8670; McDermott, Ray/0000-0002-8952-4315; salud, antonia/0000-0002-7399-7484; Garcia-Carbonero, Rocio/0000-0002-3342-397X; Falcone, Alfredo/0000-0001-5840-2529; Andre, Thierry/0000-0002-5103-7095; Folprecht, Gunnar/0000-0002-9321-9911; Prenen, Hans/0000-0001-8802-7352	Taiho Oncology-Taiho Pharmaceutical	Taiho Oncology-Taiho Pharmaceutical	Funded by Taiho Oncology-Taiho Pharmaceutical; RECOURSE ClinicalTrials.gov number, NCT01607957.	DEXTER DL, 1972, CANCER RES, V32, P247; Doi T, 2012, BRIT J CANCER, V107, P429, DOI 10.1038/bjc.2012.274; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emura T, 2004, INT J ONCOL, V25, P571; Emura T, 2004, INT J MOL MED, V13, P545; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Green MC, 2006, P AN M AM SOC CLIN, V24, P10576; HEIDELBE.C, 1965, CANCER RES, V25, P377; HEIDELBERGER C, 1964, CANCER RES, V24, P1979; Hong DS, 2006, CANCER-AM CANCER SOC, V107, P1383, DOI 10.1002/cncr.22125; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Overman MJ, 2008, CANCER INVEST, V26, P794, DOI 10.1080/07357900802087242; Overman MJ, 2008, INVEST NEW DRUG, V26, P445, DOI 10.1007/s10637-008-9142-3; Patel MR, 2012, J CLIN ONCOL, V30; Sobrero A, 2000, SEMIN ONCOL, V27, P72; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; Van Cutsem E, 2014, ANN ONCOL, V25, piii1; Venook AP, 2014, J CLIN ONCOL S, V32; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5	19	777	789	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1909	1919		10.1056/NEJMoa1414325	http://dx.doi.org/10.1056/NEJMoa1414325			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970050	Green Published			2022-12-28	WOS:000354493300006
J	Spang, A; Saw, JH; Jorgensen, SL; Zaremba-Niedzwiedzka, K; Martijn, J; Lind, AE; van Eijk, R; Schleper, C; Guy, L; Ettema, TJG				Spang, Anja; Saw, Jimmy H.; Jorgensen, Steffen L.; Zaremba-Niedzwiedzka, Katarzyna; Martijn, Joran; Lind, Anders E.; van Eijk, Roel; Schleper, Christa; Guy, Lionel; Ettema, Thijs J. G.			Complex archaea that bridge the gap between prokaryotes and eukaryotes	NATURE			English	Article							PHYLOGENETIC TREE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; ARCTIC MIDOCEAN RIDGE; RIBOSOMAL-RNA GENES; GENOME ANNOTATION; ESCRT MACHINERY; COMMON ANCESTOR; CELL-DIVISION; ORIGIN; EVOLUTION	The origin of the eukaryotic cell remains one of the most contentious puzzles in modern biology. Recent studies have provided support for the emergence of the eukaryotic host cell from within the archaeal domain of life, but the identity and nature of the putative archaeal ancestor remain a subject of debate. Here we describe the discovery of 'Lokiarchaeota', a novel candidate archaeal phylum, which forms a monophyletic group with eukaryotes in phylogenomic analyses, and whose genomes encode an expanded repertoire of eukaryotic signature proteins that are suggestive of sophisticated membrane remodelling capabilities. Our results provide strong support for hypotheses in which the eukaryotic host evolved from a bona fide archaeon, and demonstrate that many components that underpin eukaryote-specific features were already present in that ancestor. This provided the host with a rich genomic 'starter-kit' to support the increase in the cellular and genomic complexity that is characteristic of eukaryotes.	[Spang, Anja; Saw, Jimmy H.; Zaremba-Niedzwiedzka, Katarzyna; Martijn, Joran; Lind, Anders E.; van Eijk, Roel; Guy, Lionel; Ettema, Thijs J. G.] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden; [Saw, Jimmy H.; Schleper, Christa] Univ Bergen, Dept Biol, Ctr Geobiol, N-5020 Bergen, Norway; [Schleper, Christa] Univ Vienna, Div Archaea Biol & Ecogen, Dept Ecogen & Syst Biol, A-1090 Vienna, Austria; [Guy, Lionel] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University; University of Bergen; University of Vienna; Uppsala University	Ettema, TJG (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden.	lionel.guy@imbim.uu.se; thijs.ettema@icm.uu.se	Saw, Jimmy/J-1360-2019; Guy, Lionel/B-4501-2008; Jørgensen, Steffen Leth/ABB-7303-2021; Jørgensen, Steffen Leth/N-4599-2015; Schleper, Christa M/C-2567-2013	Saw, Jimmy/0000-0001-8353-3854; Guy, Lionel/0000-0001-8354-2398; Jørgensen, Steffen Leth/0000-0003-0240-7907; Jørgensen, Steffen Leth/0000-0003-0240-7907; Spang, Anja/0000-0002-6518-8556; Schleper, Christa/0000-0002-1918-2735; Zaremba-Niedzwiedzka, Katarzyna/0000-0003-1030-8212; Martijn, Joran/0000-0001-7651-5252	Swedish Research Council (VR) [621-2009-4813]; European Research Council (ERC) [310039-PUZZLE_CELL]; Swedish Foundation for Strategic Research [SSF-FFL5]; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Wenner-Gren Stiftelserna; Marie Curie IIF [331291]; IEF by the European Union [625521]; H2DEEP project through the EuroMARC program; Research Council of Norway through the Centre for Geobiology, University of Bergen; Austrian Science Fund (FWF) [P27017]	Swedish Research Council (VR)(Swedish Research Council); European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Tryggers Stiftelse for Vetenskaplig Forskning; Wenner-Gren Stiftelserna; Marie Curie IIF(European Commission); IEF by the European Union; H2DEEP project through the EuroMARC program; Research Council of Norway through the Centre for Geobiology, University of Bergen; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We dedicate this paper to the memory of Rolf Bernander. We thank P. Offre and I. de Bruijn for technical advice and useful discussions, and A. Denny for image processing. We also acknowledge the help from chief scientist R.B. Pedersen, the scientific party and the entire crew on board the Norwegian research vessel G.O. Sars during the summer 2010 expedition. All sequencing was performed by the National Genomics Infrastructure sequencing platforms at the Science for Life Laboratory at Uppsala University, a national infrastructure supported by the Swedish Research Council (VR-RFI) and the Knut and Alice Wallenberg Foundation. We thank the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) at Uppsala University and the Swedish National Infrastructure for Computing (SNIC) at the PDC Center for High-Performance Computing for providing computational resources. This work was supported by grants of the Swedish Research Council (VR grant 621-2009-4813), the European Research Council (ERC Starting grant 310039-PUZZLE_CELL) and the Swedish Foundation for Strategic Research (SSF-FFL5) to T.J.G.E., and by grants of the Carl Tryggers Stiftelse for Vetenskaplig Forskning (to A.S.), the Wenner-Gren Stiftelserna (to J.H.S.), and by Marie Curie IIF (331291 to J.H.S.) and IEF (625521 to A.S.) grants by the European Union. S.L.J received financial support from the H2DEEP project through the EuroMARC program, and by the Research Council of Norway through the Centre for Geobiology, University of Bergen. C.S. is supported by the Austrian Science Fund (FWF grant P27017).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, R LANG ENV STAT COMP; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernander Rolf, 2011, Commun Integr Biol, V4, P664; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Deschamps P, 2014, GENOME BIOL EVOL, V6, P1549, DOI 10.1093/gbe/evu127; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; Durbin AM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00168; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ettema TJG, 2011, MOL MICROBIOL, V80, P1052, DOI 10.1111/j.1365-2958.2011.07635.x; Field MC, 2009, CURR OPIN CELL BIOL, V21, P4, DOI 10.1016/j.ceb.2008.12.004; Foster PG, 2009, PHILOS T R SOC B, V364, P2197, DOI 10.1098/rstb.2009.0034; Goodson HV, 2002, J CELL SCI, V115, P2619; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Guy L, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016022; Guy L, 2014, ISME J, V8, P1353, DOI 10.1038/ismej.2014.6; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; HENDERSON E, 1984, SCIENCE, V225, P510, DOI 10.1126/science.6429855; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Jorgensen SL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00299; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawai M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00080; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kostelansky MS, 2006, CELL, V125, P113, DOI 10.1016/j.cell.2006.01.049; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lasek-Nesselquist E, 2013, MOL PHYLOGENET EVOL, V69, P17, DOI 10.1016/j.ympev.2013.05.006; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Martijn J, 2013, BIOCHEM SOC T, V41, P451, DOI 10.1042/BST20120292; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Morono Y, 2014, APPL ENVIRON MICROB, V80, P1985, DOI 10.1128/AEM.04150-13; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poole AM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015990; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Venables WN., 2002, MODERN APPL STAT S; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Von Schnurbein S., 2000, HIST RELIGIONS, V40, P109, DOI DOI 10.1086/463618; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-10; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	98	639	665	22	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					173	+		10.1038/nature14447	http://dx.doi.org/10.1038/nature14447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25945739	Green Accepted			2022-12-28	WOS:000354377800049
J	Marcovitch, H				Marcovitch, Harvey			Governance and Professionalism in Medicine A UK Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												h.marcovitch@btinternet.com						Elkin K, 2012, BMJ QUAL SAF, V21, P1027, DOI 10.1136/bmjqs-2012-000941; General Medical Council, GOOD MED PRACT; Mid-Staffordshire NHS Foundation Trust, PUBL INQ REP; Murphy DJ, 2012, BMJ QUAL SAF, V21, P649, DOI 10.1136/bmjqs-2011-000429; UK Department of Health, LEARN TRAG KEEP PAT; UK Department of Health, REP PUBL INQ CHILDR; United Kingdom Department of Health, ORG MEM	7	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1823	1824		10.1001/jama.2015.3187	http://dx.doi.org/10.1001/jama.2015.3187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965226				2022-12-28	WOS:000354391000021
J	Dean, J				Dean, John			Private practice is unethical-and doctors should give it up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Devon & Exeter NHS Fdn Trust Hosp, Exeter EX2 5DS, Devon, England		Dean, J (corresponding author), Royal Devon & Exeter NHS Fdn Trust Hosp, Exeter EX2 5DS, Devon, England.	lub.dub@virgin.net							0	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2015	350								h2299	10.1136/bmj.h2299	http://dx.doi.org/10.1136/bmj.h2299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0FV	25944061				2022-12-28	WOS:000354413100003
J	Schleussner, E; Kamin, G; Seliger, G; Rogenhofer, N; Ebner, S; Toth, B; Schenk, M; Henes, M; Bohlmann, MK; Fischer, T; Brosteanu, O; Bauersachs, R; Petroff, D				Schleussner, Ekkehard; Kamin, Gabriele; Seliger, Gregor; Rogenhofer, Nina; Ebner, Susanne; Toth, Bettina; Schenk, Michael; Henes, Melanie; Bohlmann, Michael K.; Fischer, Thorsten; Brosteanu, Oana; Bauersachs, Rupert; Petroff, David		ETHIG 2 Grp	Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss A Multicenter Trial With a Minimization Randomization Scheme	ANNALS OF INTERNAL MEDICINE			English	Article							INHERITED THROMBOPHILIA; MISCARRIAGE; THROMBOPROPHYLAXIS; LIPOPROTEIN; PREVENTION; ASPIRIN	Background: A daily injection of low-molecular-weight heparin (LMWH) is often prescribed to women with unexplained recurrent pregnancy loss (RPL), although evidence suggesting a benefit is questionable. Objective: To determine whether LMWH increases ongoing pregnancy and live-birth rates in women with unexplained RPL. Design: Controlled, multicenter trial with randomization using minimization conducted from 2006 to 2013. (ClinicalTrials.gov: NCT00400387) Setting: 14 university hospitals and perinatal care centers in Germany and Austria. Patients: 449 women with at least 2 consecutive early miscarriages or 1 late miscarriage were included during 5 to 8 weeks' gestation after a viable pregnancy was confirmed by ultrasonography. Intervention: Women in the control group received multivitamin pills, and the intervention group received vitamins and 5000 IU of dalteparin-sodium for up to 24 weeks' gestation. Measurements: Primary outcome was ongoing pregnancy at 24 weeks' gestation. Secondary outcomes included the live-birth rate and late pregnancy complications. Results: At 24 weeks' gestation, 191 of 220 pregnancies (86.8%) and 188 of 214 pregnancies (87.9%) were intact in the interven-tion and control groups, respectively (absolute difference, -1.1 percentage points [95% CI, -7.4 to 5.3 percentage points]). The live-birth rates were 86.0% (185 of 215 women) and 86.7% (183 of 211 women) in the intervention and control groups, respectively (absolute difference, -0.7 percentage point [CI, -7.3 to 5.9 percentage points]). There were 3 intrauterine fetal deaths (1 woman had used LMWH); 9 cases of preeclampsia or the hemolysis, elevated liver enzyme level, and low platelet count (HELLP) syndrome (3 women had used LMWH); and 11 cases of intrauterine growth restriction or placental insufficiency (5 women had used LMWH). Limitation: Placebo injections were not used, and neither trial staff nor patients were blinded. Conclusion: Daily LMWH injections do not increase ongoing pregnancy or live-birth rates in women with unexplained RPL. Given the burden of the injections, they are not recommended for preventing miscarriage.	Friedrich Schiller Univ Hosp, Jena, Germany; Univ Hosp Carl Gustav Carus, Dresden, Germany; St Elisabeth & St Barbara Hosp, Halle, Saale, Germany; Univ Munich, Munich, Germany; Ctr Human Genet, Regensburg, Germany; Heidelberg Univ, Heidelberg, Germany; Univ Tubingen, Tubingen, Germany; Univ Hosp Schleswig Holstein, Lubeck, Germany; Univ Leipzig, D-04017 Leipzig, Germany; Klinikum Darmstadt, Darmstadt, Germany; Ctr Thrombosis & Hemostasis, Mainz, Germany; Das Kinderwunsch Inst, Dobl, Austria; Paracelsus Med Univ, Salzburg, Austria	Friedrich Schiller University of Jena; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; University of Kiel; Schleswig Holstein University Hospital; Leipzig University; Klinikum Darmstadt; Paracelsus Private Medical University	Petroff, D (corresponding author), Univ Leipzig, Clin Trial Ctr, D-04017 Leipzig, Germany.	david.petroff@zks.uni-leipzig.de		Ebner, Susanne/0000-0002-0394-9620	Pfizer Pharma	Pfizer Pharma(Pfizer)	Pfizer Pharma.	American College of Obstetricians and Gynecologists, 2002, Int J Gynaecol Obstet, V78, P179; Arias F, 1998, J Matern Fetal Med, V7, P277; Badawy AM, 2008, J OBSTET GYNAECOL, V28, P280, DOI 10.1080/01443610802042688; Bauersachs RM, 2007, THROMB HAEMOSTASIS, V98, P1237, DOI 10.1160/TH07-OS-0329; Baumann K, 2013, AM J REPROD IMMUNOL, V70, P518, DOI 10.1111/aji.12144; Brenner B, 2000, THROMB HAEMOSTASIS, V83, P693; Buchholz T, 2003, AM J REPROD IMMUNOL, V50, P20, DOI 10.1034/j.1600-0897.2003.00049.x; Carp H, 2003, J THROMB HAEMOST, V1, P433, DOI 10.1046/j.1538-7836.2003.00066.x; Clark P, 2010, BLOOD, V115, P4162, DOI 10.1182/blood-2010-01-267252; D'Ippolito S, 2012, FERTIL STERIL, V98, P1028, DOI 10.1016/j.fertnstert.2012.06.042; de Jong PG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004734.pub4; DEBRAEKELEER M, 1990, HUM REPROD, V5, P519, DOI 10.1093/oxfordjournals.humrep.a137135; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Fawzy M, 2008, ARCH GYNECOL OBSTET, V278, P33, DOI 10.1007/s00404-007-0527-x; Grandone E, 2002, FERTIL STERIL, V78, P371, DOI 10.1016/S0015-0282(02)03222-3; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; KOOPMAN PAR, 1984, BIOMETRICS, V40, P513, DOI 10.2307/2531405; Krause M, 2005, THROMB HAEMOSTASIS, V93, P867, DOI 10.1160/TH04-08-0519; Kupferminc MJ, 2003, SEMIN THROMB HEMOST, V29, P185, DOI 10.1055/s-2003-38834; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Luxembourg B., 2007, DTSCH ARZTEBL INT, V104, P1489; Mantha S, 2010, J THROMB HAEMOST, V8, P263, DOI 10.1111/j.1538-7836.2009.03687.x; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pandey Manoj Kumar, 2005, Archives of Gynecology and Obstetrics, V272, P95, DOI 10.1007/s00404-004-0706-y; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Rodger MA, 2014, LANCET, V384, P1673, DOI 10.1016/S0140-6736(14)60793-5; Rodger MA, 2014, BLOOD, V123, P822, DOI 10.1182/blood-2013-01-478958; Sarto A, 2001, MEDICINA-BUENOS AIRE, V61, P406; Schleussner E, 2013, DTSCH ARZTEBL INT, V110, P227, DOI 10.3238/arztebl.2013.0227; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Visser J, 2011, THROMB HAEMOSTASIS, V105, P295, DOI 10.1160/TH10-05-0334; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283; von Depka M, 2000, BLOOD, V96, P3364; Walker MC, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003580, DOI 10.1002/14651858.CD003580]; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	38	61	68	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					601	U193		10.7326/M14-2062	http://dx.doi.org/10.7326/M14-2062			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938990				2022-12-28	WOS:000354119100004
J	Rennard, SI; Drummond, MB				Rennard, Stephen I.; Drummond, M. Bradley			Early chronic obstructive pulmonary disease: definition, assessment, and prevention	LANCET			English	Article							AIR-FLOW OBSTRUCTION; QUALITY-OF-LIFE; LUNG-FUNCTION; RISK-FACTORS; CIGARETTE-SMOKING; NATURAL-HISTORY; OSCILLATORY IMPEDANCE; PHYSICAL-ACTIVITY; PARENTAL SMOKING; NHLBI WORKSHOP	Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes, pathogenic mechanisms, and physiological effects. Therefore a comprehensive approach to COPD prevention will need to address the complexity of COPD. Advances in the understanding of the natural history of COPD and the development of strategies to assess COPD in its early stages make prevention a reasonable, if ambitious, goal.	[Rennard, Stephen I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Internal Med, Omaha, NE 69198 USA; [Drummond, M. Bradley] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Nebraska System; University of Nebraska Medical Center; Johns Hopkins University	Rennard, SI (corresponding author), Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Internal Med, Omaha, NE 69198 USA.	srennard@unmc.edu		Drummond, Michael/0000-0002-6968-4610	American Board of Internal Medicine; Almirall; APT Pharma; American Thoracic Society; AstraZeneca; Baxter; Boerhinger Ingelheim; Chiesi; Cipla; Cleveland Clinic; COPD Foundation; CSA; CSL; California Thoracic Society; Daiichi Sankyo; Elevation Pharma; Forest; GSK; Gilead; Johnson Johnson; MedImmune; Novartis; Pearl; Pfizer; Pulmatrix; Regeneron; Takeda; Theron; National Heart, Lung and Blood Institute; Nebraska Department of Health and Human Services; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103192] Funding Source: NIH RePORTER	American Board of Internal Medicine; Almirall(Almirall); APT Pharma; American Thoracic Society; AstraZeneca(AstraZeneca); Baxter; Boerhinger Ingelheim; Chiesi(Chiesi Pharmaceuticals Inc); Cipla; Cleveland Clinic; COPD Foundation; CSA; CSL; California Thoracic Society; Daiichi Sankyo(Daiichi Sankyo Company Limited); Elevation Pharma; Forest; GSK(GlaxoSmithKline); Gilead(Gilead Sciences); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); MedImmune(AstraZenecaMedimmune); Novartis(Novartis); Pearl(Luxembourg National Research Fund); Pfizer(Pfizer); Pulmatrix; Regeneron(Regeneron); Takeda(Takeda Pharmaceutical Company Ltd); Theron; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nebraska Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Since 2012, SIR has received honoraria, consultation fees or research funding from the American Board of Internal Medicine, Almirall, APT Pharma, the American Thoracic Society, AstraZeneca, Baxter, Boerhinger Ingelheim, Chiesi, Cipla, the Cleveland Clinic, the COPD Foundation, CSA, CSL, the California Thoracic Society, Daiichi Sankyo, Elevation Pharma, Forest, GSK, Gilead, Johnson & Johnson, MedImmune, Novartis, Pearl, Pfizer, Pulmatrix, Regeneron, Takeda, Theron, the National Heart, Lung and Blood Institute, and the Nebraska Department of Health and Human Services. MBD has no relevant financial competing interests related to this Series paper. MBD has served as a consultant for Lupin Pharmaceuticals and has received institutional grant funding from the National Institutes of Health for studies related to COPD.	[Anonymous], 2015, GLOB STRAT DIAGN MAN; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Barr RG, 2009, AM J MED, V122, P348, DOI 10.1016/j.amjmed.2008.09.042; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Beyer D, 2009, EUR J MED RES, V14, P27, DOI 10.1186/2047-783X-14-S4-27; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Boes JL, 2015, ACAD RADIOL, V22, P186, DOI 10.1016/j.acra.2014.08.015; BRADBURNE RM, 1989, THORAX, V44, P591, DOI 10.1136/thx.44.7.591; Buist AS, 1994, TXB RESP MED, P1259; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; BURROWS B, 1981, MED CLIN N AM, V65, P455, DOI 10.1016/S0025-7125(16)31509-7; Camargo Carlos A Jr, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS125, DOI 10.1513/AnnalsATS.201312-451LD; Camp PG, 2014, EUR RESPIR J, V43, P725, DOI 10.1183/09031936.00206112; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chin RC, 2013, AM J RESP CRIT CARE, V187, P1315, DOI 10.1164/rccm.201211-1970OC; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Colom AJ, 2015, THORAX, V70, P169, DOI 10.1136/thoraxjnl-2014-205328; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Coxson HO, 2004, AM J RESP CRIT CARE, V170, P748, DOI 10.1164/rccm.200405-651OC; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Dobbels F, 2014, EUR RESPIR J, V44, P1223, DOI 10.1183/09031936.00004814; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Drummond M Bradley, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS154, DOI 10.1513/AnnalsATS.201312-432LD; Easley RB, 2006, ACAD RADIOL, V13, P916, DOI 10.1016/j.acra.2006.02.055; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Ferrer M, 2002, EUR RESPIR J, V19, P405, DOI 10.1183/09031936.02.00213202; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fletcher CM, 1976, NATURAL HIST CHRONIC; Frantz S, 2012, RESP MED, V106, P1116, DOI 10.1016/j.rmed.2012.04.010; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Grydeland TB, 2011, RESP MED, V105, P343, DOI 10.1016/j.rmed.2010.10.018; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hanson C, 2014, INT J CHRONIC OBSTR, V9, P723, DOI 10.2147/COPD.S50111; Hegewald MJ, 2010, TXB RESP MED, P522; Hersh CP, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-42; Holme J, 2007, CHEST, V132, P909, DOI 10.1378/chest.07-0341; Janson C, 2013, EUR RESPIR J, V42, P1472, DOI 10.1183/09031936.00153712; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; JONES PW, 1995, CHEST, V107, pS187, DOI 10.1378/chest.107.5_Supplement.187S; Kim V, 2015, ANN AM THORAC SOC, V12, P332, DOI 10.1513/AnnalsATS.201411-518OC; Kitaguchi Y, 2014, INT J CHRONIC OBSTR, V9, P805, DOI 10.2147/COPD.S65621; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Leidy NK, 2010, VALUE HEALTH, V13, P965, DOI 10.1111/j.1524-4733.2010.00772.x; Leidy NK, 2003, CHEST, V124, P2182, DOI 10.1378/chest.124.6.2182; Maleki-Yazdi M Reza, 2007, COPD, V4, P313, DOI 10.1080/15412550701595740; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2007, THORAX, V62, P237, DOI 10.1136/thx.2006.068379; Mannino DM, 2003, J INTERN MED, V254, P540, DOI 10.1111/j.1365-2796.2003.01211.x; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Niewoehner D, 2007, CHRONIC OBSTRUCTIVE, P3; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Probst-Hensch NM, 2010, THORAX, V65, P150, DOI 10.1136/thx.2009.115063; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Ramirez-Venegas A, 2014, AM J RESP CRIT CARE, V190, P996, DOI 10.1164/rccm.201404-0720OC; Redlich CA, 2014, AM J RESP CRIT CARE, V189, P984, DOI 10.1164/rccm.201402-0337ST; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Rennard SI, 2008, CHEST, V134, P623, DOI 10.1378/chest.07-3059; RODARTE JR, 1977, CHEST, V72, P762, DOI 10.1378/chest.72.6.762; Rutten EPA, 2011, PULM MED, V2011, DOI 10.1155/2011/419328; Saey D, 2003, AM J RESP CRIT CARE, V168, P425, DOI 10.1164/rccm.200208-856OC; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; SCHWARTZ J, 1989, ENVIRON RES, V50, P309, DOI 10.1016/S0013-9351(89)80012-X; Shannon JM, 2010, TXB RESP MED, P26; Shapiro SD, 2010, TXB RESP MED, P919; SHERRILL DL, 1992, EUR RESPIR J, V5, P452; SHERRILL DL, 1991, AM REV RESPIR DIS, V144, P17, DOI 10.1164/ajrccm/144.1.17; Silverman EK, 1996, MED CLIN N AM, V80, P501, DOI 10.1016/S0025-7125(05)70451-X; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Smith BM, 2014, THORAX, V69, P987, DOI 10.1136/thoraxjnl-2014-205160; SNIDER GL, 1989, AM REV RESPIR DIS, V140, pS3, DOI 10.1164/ajrccm/140.3_Pt_2.S3; Soriano JB, 2012, PRIM CARE RESP J, V21, P187, DOI 10.4104/pcrj.2012.00027; Stein J, 1946, MALADIE FAMINE RECHE, P21; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thomashow B, 2014, COPD-J COPD FDN, V1, P83, DOI 10.15326/jcopdf.1.1.2014.0124; Timmins SC, 2014, RESP MED, V108, P344, DOI 10.1016/j.rmed.2013.10.004; Timmins SC, 2013, RESP PHYSIOL NEUROBI, V185, P416, DOI 10.1016/j.resp.2012.08.017; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; US Public Health Service Office of the Surgeon General and Office on Smoking and Health, 1990, HLTH BEN SMOK CESS; Van Remoortel H, 2014, AM J RESP CRIT CARE, V189, P30, DOI 10.1164/rccm.201307-1240OC; Van Remoortel H, 2013, THORAX, V68, P962, DOI 10.1136/thoraxjnl-2013-203534; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vogiatzis I, 2013, J APPL PHYSIOL, V115, P16, DOI 10.1152/japplphysiol.00195.2013; Vollsaeter M, 2013, THORAX, V68, P767, DOI 10.1136/thoraxjnl-2012-202980; Wan ES, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0089-y; Wan ES, 2011, AM J RESP CRIT CARE, V184, P57, DOI 10.1164/rccm.201101-0021OC; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011; WANG XB, 1994, AM J RESP CRIT CARE, V149, P1420, DOI 10.1164/ajrccm.149.6.8004293; World Health Organization, 2014, TOP 10 CAUS DEATH; Wyrwich KW, 2003, J GEN INTERN MED, V18, P196, DOI 10.1046/j.1525-1497.2003.20203.x; Yablonskiy DA, 2002, P NATL ACAD SCI USA, V99, P3111, DOI 10.1073/pnas.052594699; Yablonskiy DA, 2009, J APPL PHYSIOL, V107, P1258, DOI 10.1152/japplphysiol.00386.2009	113	146	157	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1778	1788		10.1016/S0140-6736(15)60647-X	http://dx.doi.org/10.1016/S0140-6736(15)60647-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943942	Green Accepted			2022-12-28	WOS:000353726000034
J	Case, S; Johnston, TJ; O'Sullivan, M; Thomas, W; Wiseman, OJ				Case, Sarah; Johnston, Thomas J.; O'Sullivan, Michael; Thomas, Will; Wiseman, Oliver J.			CASE REVIEW A man with rust coloured urine and normocytic anaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSTHETIC REGURGITATION; INTRAVASCULAR HEMOLYSIS; CLINICAL PRESENTATION; RHABDOMYOLYSIS; ENDOCARDITIS; MANAGEMENT; DIAGNOSIS; OUTCOMES; REPAIR		[Case, Sarah] Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 0QQ, England; [Johnston, Thomas J.; Wiseman, Oliver J.] Addenbrookes Hosp, Urol Dept, Cambridge, England; [O'Sullivan, Michael] Addenbrookes Hosp, Cardiol Dept, Cambridge, England; [Thomas, Will] Addenbrookes Hosp, Haematol Dept, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Johnston, TJ (corresponding author), Addenbrookes Hosp, Urol Dept, Cambridge, England.	thomasjohnston1@nhs.net						AbouRjaili G, 2012, EXP CLIN CARDIOL, V17, P248; Alhadi SA, 2014, AM J EMERG MED, V32, P260, DOI 10.1016/j.ajem.2013.10.045; Anderson MJ, 2008, JOINT CONSENSUS STAT; Butchart EG, 2005, EUR HEART J, V26, P2463, DOI 10.1093/eurheartj/ehi426; Crump A, 2009, BJU INT; Dukkipati R, 2009, NAT CLIN PRACT NEPHR, V5, P112, DOI 10.1038/ncpneph1019; Garcia MJ, 1996, J AM COLL CARDIOL, V27, P399, DOI 10.1016/0735-1097(95)00403-3; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Hoffbrand AV, 2005, POSTGRADUATE HAEMATOLOGY, 5TH EDITION, P1, DOI 10.1002/9780470987056; Joseph JV, 2002, BJU INT, V89, P324; KHANDHERIA BK, 1994, MAYO CLIN PROC, V69, P856, DOI 10.1016/S0025-6196(12)61788-1; Kini V, 2010, J AM SOC ECHOCARDIOG, V23, P396, DOI 10.1016/j.echo.2009.12.017; Koc F, 2010, TURK KARDIYOL DERN A, V38, P429; Luck RP, 2008, PEDIATR EMERG CARE, V24, P262, DOI 10.1097/PEC.0b013e31816bc7b7; LUZZATTO L, 1994, BRIT MED J, V309, P410; Ohkado A, 1995, Kyobu Geka, V48, P1013; OKITA Y, 1988, ANN THORAC SURG, V46, P89, DOI 10.1016/S0003-4975(10)65860-2; Provan D, 2009, OXFORD HDB CLIN HAEM, P16; Qian Q, 2010, AM J KIDNEY DIS, V56, P780, DOI 10.1053/j.ajkd.2010.03.025; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ruiz CE, 2011, J AM COLL CARDIOL, V58, P2210, DOI 10.1016/j.jacc.2011.03.074; Sing RI, 2012, CAN J UROL, V19, P36; Sorajja P, 2011, CIRC-CARDIOVASC INTE, V4, P314, DOI 10.1161/CIRCINTERVENTIONS.110.960955; Steddon S, 2006, OXFORD HDB NEPHROLOG, P657; Ucar K, 2002, ONCOLOGY-NY, V16, P163; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Walker BR, 2014, DAVIDSONS PRINCIPLES, P1372; Young SE, 2009, AM J EMERG MED, V27, P875, DOI 10.1016/j.ajem.2008.06.020	28	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2015	350								h2113	10.1136/bmj.h2113	http://dx.doi.org/10.1136/bmj.h2113			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UX	25934684				2022-12-28	WOS:000353957100001
J	Fernandez-Sanchez, ME; Barbier, S; Whitehead, J; Bealle, G; Michel, A; Latorre-Ossa, H; Rey, C; Fouassier, L; Claperon, A; Brulle, L; Girard, E; Servant, N; Rio-Frio, T; Marie, H; Lesieur, S; Housset, C; Gennisson, JL; Tanter, M; Menager, C; Fre, S; Robine, S; Farge, E				Fernandez-Sanchez, Maria Elena; Barbier, Sandrine; Whitehead, Joanne; Bealle, Gaelle; Michel, Aude; Latorre-Ossa, Heldmuth; Rey, Colette; Fouassier, Laura; Claperon, Audrey; Brulle, Laura; Girard, Elodie; Servant, Nicolas; Rio-Frio, Thomas; Marie, Helene; Lesieur, Sylviane; Housset, Chantal; Gennisson, Jean-Luc; Tanter, Mickael; Menager, Christine; Fre, Silvia; Robine, Sylvie; Farge, Emmanuel			Mechanical induction of the tumorigenic beta-catenin pathway by tumour growth pressure	NATURE			English	Article							SHEAR-WAVE ELASTOGRAPHY; SUPERPARAMAGNETIC LIPOSOMES; POTENT INHIBITOR; KINASE INHIBITOR; ELASTICITY; PONATINIB; CELLS; MODEL; APC	The tumour microenvironment may contribute to tumorigenesis owing to mechanical forces such as fibrotic stiffness or mechanical pressure caused by the expansion of hyper-proliferative cells(1,2). Here we explore the contribution of the mechanical pressure exerted by tumour growth onto non-tumorous adjacent epithelium. In the early stage of mouse colon tumour development in the Notch(+)Apc(+/1638N) mouse model, we observed mechanistic pressure stress in the non-tumorous epithelial cells caused by hyper-proliferative adjacent crypts overexpressing active Notch, which is associated with increased Ret and beta-catenin signalling. We thus developed a method that allows the delivery of a defined mechanical pressure in vivo, by subcutaneously inserting a magnet close to the mouse colon. The implanted magnet generated a magnetic force on ultra-magnetic liposomes, stabilized in the mesenchymal cells of the connective tissue surrounding colonic crypts after intravenous injection. The magnetically induced pressure quantitatively mimicked the endogenous early tumour growth stress in the order of 1,200 Pa, without affecting tissue stiffness, as monitored by ultrasound strain imaging and shear wave elastography. The exertion of pressure mimicking that of tumour growth led to rapid Ret activation and downstream phosphorylation of beta-catenin on Tyr654, imparing its interaction with the E-cadherin in adherens junctions, and which was followed by beta-catenin nuclear translocation after 15 days. As a consequence, increased expression of beta-catenin-target genes was observed at 1 month, together with crypt enlargement accompanying the formation of early tumorous aberrant crypt foci. Mechanical activation of the tumorigenic beta-catenin pathway suggests unexplored modes of tumour propagation based on mechanical signalling pathways in healthy epithelial cells surrounding the tumour, which may contribute to tumour heterogeneity.	[Fernandez-Sanchez, Maria Elena; Barbier, Sandrine; Whitehead, Joanne; Farge, Emmanuel] PSL Res Univ, Inst Curie,Ctr Rech,CNRS,UMR 168, Physicochim Curie Mech & Genet Embryon & Tumour D, INSERM,Fdn Pierre Gilles de Gennes, F-75005 Paris, France; [Bealle, Gaelle; Michel, Aude; Menager, Christine] Sorbonne Univ, UPMC, Lab PHENIX Physicochim Electrolytes & Nanosyst In, CNRS UMR 8234, F-75005 Paris, France; [Latorre-Ossa, Heldmuth; Gennisson, Jean-Luc; Tanter, Mickael] PSL Res Univ, Waves & Images ESPCI ParisTech, Langevin Inst, CNRS UMR7587,Inserm U979, F-75005 Paris, France; [Rey, Colette; Fouassier, Laura; Claperon, Audrey; Housset, Chantal] Sorbonne Univ, UPMC, F-75012 Paris, France; [Rey, Colette; Fouassier, Laura; Claperon, Audrey; Housset, Chantal] INSERM, UMR S 938, CDR St Antoine, F-75012 Paris, France; [Brulle, Laura] Inst Curie, Ctr Rech, CNRS UMR3666, INSERM Endocyt Trafficking & Therapeut Delivery U, F-75005 Paris, France; [Girard, Elodie; Servant, Nicolas] Inst Curie, MINES ParisTech, Bioinformat Platform, U900, F-75005 Paris, France; [Rio-Frio, Thomas] Inst Curie, Next Generat Sequencing Platform, F-75005 Paris, France; [Marie, Helene; Lesieur, Sylviane] Univ Paris Sud, Lab Physicochim Syst Polyphases, Fac Pharm, CNRS UMR 8612,Inst Galien Paris Sud,LabEx LERMIT, F-92296 Chatenay Malabry, France; [Fre, Silvia] Inst Curie, Unite Genet & Biol Dev, Notch Signaling Stem Cells & Tumors, CNRS UMR 3215,INSERM U934,Ctr Rech, F-75005 Paris, France; [Robine, Sylvie] Inst Curie, Ctr Rech, CNRS Compartimentat & Dynam Cellulaires Morphogen, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Farge, E (corresponding author), PSL Res Univ, Inst Curie,Ctr Rech,CNRS,UMR 168, Physicochim Curie Mech & Genet Embryon & Tumour D, INSERM,Fdn Pierre Gilles de Gennes, F-75005 Paris, France.	efarge@curie.fr	Whitehead, Joanne/A-8597-2008; gennisson, jean-luc/AAM-2471-2020; Fre, Silvia/C-7540-2017; Mickael, Tanter/H-4657-2012; Fouassier, Laura/M-7556-2017; Farge, Emmanuel/G-3213-2015	Whitehead, Joanne/0000-0002-9602-2081; Fre, Silvia/0000-0002-7209-7636; Mickael, Tanter/0000-0001-7739-8051; Fouassier, Laura/0000-0001-6377-5610; Farge, Emmanuel/0000-0002-5063-7179; Housset, Chantal/0000-0001-6469-0651; Menager, Christine/0000-0002-4080-3508; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863; gennisson, jean-luc/0000-0001-8318-8237; Servant, Nicolas/0000-0003-1678-7410	CNRS; INSERM; ARC [5030, 29324]; ANR [09PIRI0013-01, 11 BSV5014-01]; Labex CelTisPhyBio [11-LBX-0038]; Fonds CSP; Fondation Pierre-Gille de Gennes; Fondation de France; Inca [PLBIO13-172]; Agence Nationale de la Recherche (investissements d'avenir) [ANR-10-EQPX-03, ANR10-INBS-09-08]; Canceropole Ile-de-France	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARC(Australian Research Council); ANR(French National Research Agency (ANR)); Labex CelTisPhyBio; Fonds CSP; Fondation Pierre-Gille de Gennes; Fondation de France(Fondation de France); Inca(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (investissements d'avenir)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France)	This research was funded by the CNRS, INSERM, ARC (grant no.s 5030 and 29324), ANR (grant no.s 09PIRI0013-01 and 11 BSV5014-01), the Labex CelTisPhyBio (grant no. 11-LBX-0038), Fonds CSP, Fondation Pierre-Gille de Gennes, Fondation de France and the Inca (grant no. PLBIO13-172). High-throughput sequencing was supported by the grants ANR-10-EQPX-03 and ANR10-INBS-09-08 from the Agence Nationale de la Recherche (investissements d'avenir) and by the Canceropole Ile-de-France. We thank the members of the Animal House Facility of Institut Curie, particularly Stephanie Boissel, Virginie Dangles-Marie and Isabelle Grandjean, the IC Imaging facility members of PICT-IBiSA at BDD (UMR3215/U934) and Cell and Tissue Imaging Facility (UMR144 CNRS), Olivier Renaud's team and Francois Waharte, Thibaut Brunet for discussions on GSK3 phosphorylation, Pierre Gestraud for NGS analysis help, Jean-Michel Frapart and Sonia Lajnev for help in the RPE experiments, and Didier Meseure (IChospital) for anathomo-pathological analyses of the mechanically induced tumours.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bealle G, 2012, LANGMUIR, V28, P11843, DOI 10.1021/la3024716; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2008, ULTRASON, P321, DOI 10.1109/ULTSYM.2008.0079; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chamming's F, 2013, EUR RADIOL, V23, P2079, DOI 10.1007/s00330-013-2828-8; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Falco V, 2013, J CLIN ENDOCR METAB, V98, pE811, DOI 10.1210/jc.2012-2672; Delarue M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138103; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gennisson JL, 2006, IEEE T ULTRASON FERR, V53, P716, DOI 10.1109/TUFFC.2006.1621498; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kahlert UD, 2012, CANCER LETT, V325, P42, DOI 10.1016/j.canlet.2012.05.024; Kim DW, 2006, J CLIN ENDOCR METAB, V91, P4070, DOI 10.1210/jc.2005-2845; Langmuir PB, 2012, CLIN PHARMACOL THER, V91, P71, DOI 10.1038/clpt.2011.272; Latorre-Ossa H, 2012, IEEE T ULTRASON FERR, V59, P833, DOI 10.1109/TUFFC.2012.2262; Levy M, 2011, BIOMATERIALS, V32, P3988, DOI 10.1016/j.biomaterials.2011.02.031; Madsen EL, 2006, ULTRASOUND MED BIOL, V32, P857, DOI 10.1016/j.ultrasmedbio.2006.02.1428; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Martina MS, 2008, BIOMATERIALS, V29, P4137, DOI 10.1016/j.biomaterials.2008.07.011; Martina MS, 2007, MOL IMAGING, V6, P140, DOI 10.2310/7290.2007.00004; Martina MS, 2005, J AM CHEM SOC, V127, P10676, DOI 10.1021/ja0516460; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; Mologni L, 2013, MOL CELL ENDOCRINOL, V377, P1, DOI 10.1016/j.mce.2013.06.025; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Plassat V, 2007, INT J PHARMACEUT, V344, P118, DOI 10.1016/j.ijpharm.2007.05.018; Plassat V, 2011, ADV FUNCT MATER, V21, P83, DOI 10.1002/adfm.201001450; Righetti R, 2007, PHYS MED BIOL, V52, P6525, DOI 10.1088/0031-9155/52/21/013; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Sarvazyan A. P., 1995, ACOUST IMAGING, P223, DOI [10.1007/978-1-4615-1943-0_23, DOI 10.1007/978-1-4615-1943-0_23]; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smits R, 1997, CARCINOGENESIS, V18, P321, DOI 10.1093/carcin/18.2.321; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; SWANSON CA, 1993, NUTR CANCER, V20, P153, DOI 10.1080/01635589309514282; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Whitehead J, 2008, HFSP J, V2, P286, DOI 10.2976/1.2955566; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592	51	202	209	9	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					92	+		10.1038/nature14329	http://dx.doi.org/10.1038/nature14329			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25970250				2022-12-28	WOS:000357169500038
J	Hassona, Y; Scully, C				Hassona, Yazan; Scully, Crispian			Verrucous Tongue Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hassona, Yazan] Univ Jordan, Amman, Jordan; [Scully, Crispian] UCL, London, England	University of Jordan; University of London; University College London	Hassona, Y (corresponding author), Univ Jordan, Amman, Jordan.	yazan@ju.edu.jo							0	0	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2049	2049		10.1056/NEJMicm1408030	http://dx.doi.org/10.1056/NEJMicm1408030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25992749				2022-12-28	WOS:000354809300011
J	Loh, KM; Lim, B				Loh, Kyle M.; Lim, Bing			STEM CELLS Equilibrium established	NATURE			English	Editorial Material							PLURIPOTENCY; INDUCTION	Pluripotent cells can produce all cell types in the body. It emerges that this state of potential is endowed by cues, including inhibition of Wnt signalling, that maintain a balance between diverse cellular outcomes. SEE ARTICLE P.316	[Loh, Kyle M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Loh, Kyle M.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lim, Bing] Merck Res Labs, Translat Med Res Ctr, Singapore 138665, Singapore	Stanford University; Stanford University	Loh, KM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	kyleloh@stanford.edu; bing.lim@merck.com		Loh, Kyle/0000-0002-8042-0149				Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Kurek D, 2015, STEM CELL REP, V4, P114, DOI 10.1016/j.stemcr.2014.11.007; Loh KM, 2015, PHYSIOL REV, V95, P245, DOI 10.1152/physrev.00001.2014; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Sugimoto M, 2015, STEM CELL REP, V4, P744, DOI 10.1016/j.stemcr.2015.02.014; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737	13	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					299	300		10.1038/521299a	http://dx.doi.org/10.1038/521299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993958				2022-12-28	WOS:000354816500044
J	Cheng, GL; Tomczyk, M; Lu, SC; Veazey, JP; Huang, MC; Irvin, P; Ryu, S; Lee, H; Eom, CB; Hellberg, CS; Levy, J				Cheng, Guanglei; Tomczyk, Michelle; Lu, Shicheng; Veazey, Joshua P.; Huang, Mengchen; Irvin, Patrick; Ryu, Sangwoo; Lee, Hyungwoo; Eom, Chang-Beom; Hellberg, C. Stephen; Levy, Jeremy			Electron pairing without superconductivity	NATURE			English	Article							FIELD; GAS; TRANSITION; POLARONS; SYSTEMS; MODEL; STATE	Strontium titanate (SrTiO3) is the first and best known superconducting semiconductor(1). It exhibits an extremely low carrier density threshold for superconductivity(2), and possesses a phase diagram similar to that of high-temperature superconductors(3,4)-two factors that suggest an unconventional pairing mechanism. Despite sustained interest for 50 years, direct experimental insight into the nature of electron pairing in SrTiO3 has remained elusive. Here we perform transport experiments with nanowire-based single-electron transistors at the interface between SrTiO3 and a thin layer of lanthanum aluminate, LaAlO3. Electrostatic gating reveals a series of two-electron conductance resonances-paired electron states-that bifurcate above a critical pairing field B-p of about 1-4 tesla, an order of magnitude larger than the superconducting critical magnetic field. For magnetic fields below B-p, these resonances are insensitive to the applied magnetic field; for fields in excess of B-p, the resonances exhibit a linear Zeeman-like energy splitting. Electron pairing is stable at temperatures as high as 900 millikelvin, well above the superconducting transition temperature (about 300 millikelvin). These experiments demonstrate the existence of a robust electronic phase in which electrons pair without forming a superconducting state. Key experimental signatures are captured by a model involving an attractive Hubbard interaction that describes real-space electron pairing as a precursor to superconductivity.	[Cheng, Guanglei; Tomczyk, Michelle; Lu, Shicheng; Veazey, Joshua P.; Huang, Mengchen; Irvin, Patrick; Levy, Jeremy] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Cheng, Guanglei; Tomczyk, Michelle; Lu, Shicheng; Huang, Mengchen; Irvin, Patrick; Levy, Jeremy] Pittsburgh Quantum Inst, Pittsburgh, PA 15260 USA; [Ryu, Sangwoo; Lee, Hyungwoo; Eom, Chang-Beom] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; [Hellberg, C. Stephen] Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; United States Department of Defense; United States Navy; Naval Research Laboratory	Levy, J (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	jlevy@pitt.edu	Irvin, Patrick/E-2159-2012; Eom, Chang-Beom/I-5567-2014; Levy, Jeremy/A-2081-2009	Irvin, Patrick/0000-0002-0248-2758; Levy, Jeremy/0000-0002-5700-2977; Veazey, Joshua/0000-0002-5089-1935; Tomczyk, Michelle/0000-0003-4770-2117	ARO MURI [W911NF-08-1-0317]; AFOSR MURI [FA9550-10-1-0524, FA9550-12-1-0342]; National Science Foundation [DMR-1104191, DMR-1124131, DMR-1234096]; Office of Naval Research through the Naval Research Laboratory's Basic Research Program; Direct For Mathematical & Physical Scien [1124131, 1234096] Funding Source: National Science Foundation	ARO MURI(MURI); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research through the Naval Research Laboratory's Basic Research Program(Office of Naval Research); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Akhmerov, A. Annadi, S. Frolov, R. Lutchyn, C. Nayak and D. Pekker for discussions. This work was supported by ARO MURI W911NF-08-1-0317 (J.L.), AFOSR MURI FA9550-10-1-0524 (C.-B.E., J.L.) and FA9550-12-1-0342 (C.-B.E.), grants from the National Science Foundation DMR-1104191 (J.L.), DMR-1124131 (C.-B.E., J.L.) and DMR-1234096 (C.-B.E.), and the Office of Naval Research through the Naval Research Laboratory's Basic Research Program (C.S.H.).	Alexandrov AS, 2007, SPRINGER SER MATER S, V103, P257; ALT HC, 1990, PHYS REV LETT, V65, P3421, DOI 10.1103/PhysRevLett.65.3421; ANDERSON PW, 1959, J PHYS CHEM SOLIDS, V11, P26, DOI 10.1016/0022-3697(59)90036-8; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; ANDERSON PW, 1975, PHYS REV LETT, V34, P953, DOI 10.1103/PhysRevLett.34.953; ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; AVERIN DV, 1992, PHYS REV LETT, V69, P1993, DOI 10.1103/PhysRevLett.69.1993; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; Ben Shalom M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.126802; Bi F, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3506509; BINNIG G, 1980, PHYS REV LETT, V45, P1352, DOI 10.1103/PhysRevLett.45.1352; Bolotin KI, 2004, APPL PHYS LETT, V84, P3154, DOI 10.1063/1.1695203; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Caviglia AD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.126803; Cen C, 2008, NAT MATER, V7, P298, DOI 10.1038/nmat2136; Cen C, 2009, SCIENCE, V323, P1026, DOI 10.1126/science.1168294; Cheng GL, 2011, NAT NANOTECHNOL, V6, P343, DOI [10.1038/nnano.2011.56, 10.1038/NNANO.2011.56]; Costi TA, 2000, PHYS REV LETT, V85, P1504, DOI 10.1103/PhysRevLett.85.1504; CULLUM J, 1981, J COMPUT PHYS, V44, P329, DOI 10.1016/0021-9991(81)90056-5; CULLUM J, 1985, J COMPUT APPL MATH, V12-3, P37, DOI 10.1016/0377-0427(85)90006-8; Dzero M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157003; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; Geballe T. H., 2014, PREPRINT; GERVAIS F, 1993, PHYS REV B, V47, P8187, DOI 10.1103/PhysRevB.47.8187; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; HELLBERG CS, 1995, PHYS REV B, V52, P4639, DOI 10.1103/PhysRevB.52.4639; Hellberg CS, 2001, SPRINGER PROC PHYS, V86, P43; Hellberg CS, 2001, J APPL PHYS, V89, P6627, DOI 10.1063/1.1358326; Hofheinz M, 2006, EUR PHYS J B, V54, P299, DOI 10.1140/epjb/e2006-00452-x; Irvin P, 2010, NAT PHOTONICS, V4, P849, DOI 10.1038/nphoton.2010.238; Jung SW, 2004, APPL PHYS LETT, V85, P768, DOI 10.1063/1.1777802; Kim M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085121; Kolodiazhnyi T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246404; Levy A., 2014, JOVE-J VIS EXP, V89; LIN HQ, 1991, PHYS REV B, V44, P4674, DOI 10.1103/PhysRevB.44.4674; Lin X, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021002; Ma YJ, 2013, NANO LETT, V13, P2884, DOI 10.1021/nl401219v; Matsushita Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157002; MICNAS R, 1990, REV MOD PHYS, V62, P113, DOI 10.1103/RevModPhys.62.113; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; RALPH DC, 1995, PHYS REV LETT, V74, P3241, DOI 10.1103/PhysRevLett.74.3241; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Richter C, 2013, NATURE, V502, P528, DOI 10.1038/nature12494; Santander-Syro AF, 2011, NATURE, V469, P189, DOI 10.1038/nature09720; Schlottmann P, 1997, INT J MOD PHYS B, V11, P355, DOI 10.1142/S0217979297000368; SCHOOLEY JF, 1964, PHYS REV LETT, V12, P474, DOI 10.1103/PhysRevLett.12.474; Stashans A, 2003, J LOW TEMP PHYS, V130, P415, DOI 10.1023/A:1022260822806; Tinkham M, 1996, CZECH J PHYS, V46, P3139, DOI 10.1007/BF02548121; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; van Mechelen JLM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226403; Veazey JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375201; vonDelft J, 1996, PHYS REV LETT, V77, P3189, DOI 10.1103/PhysRevLett.77.3189; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	56	120	120	3	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					196	+		10.1038/nature14398	http://dx.doi.org/10.1038/nature14398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971511				2022-12-28	WOS:000354377800053
J	Feist, A; Echternkamp, KE; Schauss, J; Yalunin, SV; Schafer, S; Ropers, C				Feist, Armin; Echternkamp, Katharina E.; Schauss, Jakob; Yalunin, Sergey V.; Schaefer, Sascha; Ropers, Claus			Quantum coherent optical phase modulation in an ultrafast transmission electron microscope	NATURE			English	Article							LIGHT; DIFFRACTION; PHOTOEMISSION; FIELDS; PULSES	Coherent manipulation of quantum systems with light is expected to be a cornerstone of future information and communication technology, including quantum computation and cryptography(1). The transfer of an optical phase onto a quantum wavefunction is a defining aspect of coherent interactions and forms the basis of quantum state preparation, synchronization and metrology. Light-phase-modulated electron states near atoms and molecules are essential for the techniques of attosecond science, including the generation of extreme-ultraviolet pulses and orbital tomography(2,3). In contrast, the quantum-coherent phase-modulation of energetic free-electron beams has not been demonstrated, although it promises direct access to ultrafast imaging and spectroscopy with tailored electron pulses on the attosecond scale. Here we demonstrate the coherent quantum state manipulation of free-electron populations in an electron microscope beam. We employ the interaction of ultrashort electron pulses with optical nearfields(4-9) to induce Rabi oscillations in the populations of electron momentum states, observed as a function of the optical driving field. Excellent agreement with the scaling of an equal-Rabi multi-level quantum ladder is obtained(10), representing the observation of a light-driven 'quantum walk'(5) coherently reshaping electron density in momentum space(11). We note that, after the interaction, the optically generated superposition of momentum states evolves into a train of attosecond electron pulses. Our results reveal the potential of quantum control for the precision structuring of electron densities, with possible applications ranging from ultrafast electron spectroscopy and microscopy to accelerator science and free-electron lasers.	[Feist, Armin; Echternkamp, Katharina E.; Schauss, Jakob; Yalunin, Sergey V.; Schaefer, Sascha; Ropers, Claus] Univ Gottingen, Inst Phys 4, Solids & Nanostruct, D-37077 Gottingen, Germany	University of Gottingen	Schafer, S (corresponding author), Univ Gottingen, Inst Phys 4, Solids & Nanostruct, D-37077 Gottingen, Germany.	schaefer@ph4.physik.uni-goettingen.de; cropers@gwdg.de	SchÃfer, Sascha/AAV-3086-2021; Feist, Armin/K-3050-2017; Ropers, Claus/D-4843-2015	Feist, Armin/0000-0003-1434-8895; Ropers, Claus/0000-0002-9539-3817; Schafer, Sascha/0000-0003-1908-8316; Priebe, Katharina/0000-0002-1808-3188	Deutsche Forschungsgemeinschaft [DFG-SFB 1073]; VolkswagenStiftung; Lower Saxony Ministry of Science and Culture	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen); Lower Saxony Ministry of Science and Culture	We thank M. Sivis and B. Schroder for help with sample preparation. We also thank our colleagues within the Gottingen UTEM initiative (C. Jooss, M. Munzenberg, K. Samwer, M. Seibt, C.A. Volkert). This work was supported by the Deutsche Forschungsgemeinschaft (DFG-SFB 1073/project A05), the VolkswagenStiftung, and the Lower Saxony Ministry of Science and Culture. We thank JEOL Ltd and JEOL Germany for their continuing support during the development of the Gottingen Ultrafast Transmission Electron Microscope.	Asenjo-Garcia A, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/10/103021; Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; Baum P, 2007, P NATL ACAD SCI USA, V104, P18409, DOI 10.1073/pnas.0709019104; Bouwmeester D, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.013410; Bouwmeester D., 2000, PHYS QUANTUM INFORM; Breuer J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.134803; Case WB, 2009, OPT EXPRESS, V17, P20966, DOI 10.1364/OE.17.020966; Egerton RF, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/1/016502; Flannigan DJ, 2010, P NATL ACAD SCI USA, V107, P9933, DOI 10.1073/pnas.1005653107; Freimund DL, 2001, NATURE, V413, P142, DOI 10.1038/35093065; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; Gulde M, 2014, SCIENCE, V345, P200, DOI 10.1126/science.1250658; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; Hemsing E, 2014, REV MOD PHYS, V86, P897, DOI 10.1103/RevModPhys.86.897; Herink G, 2012, NATURE, V483, P190, DOI 10.1038/nature10878; Hommelhoff P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247402; IBE JP, 1990, J VAC SCI TECHNOL A, V8, P3570, DOI 10.1116/1.576509; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; Kirchner FO, 2014, NAT PHOTONICS, V8, P52, DOI [10.1038/NPHOTON.2013.315, 10.1038/nphoton.2013.315]; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; Mandel L, 1995, OPTICAL COHERENCE QU; MIZUNO K, 1987, NATURE, V328, P45, DOI 10.1038/328045a0; MOHARAM MG, 1978, APPL OPTICS, V17, P1757, DOI 10.1364/AO.17.001757; Park ST, 2012, J PHYS CHEM A, V116, P11128, DOI 10.1021/jp304534n; Park ST, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053046; Park ST, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123028; Peralta EA, 2013, NATURE, V503, P91, DOI 10.1038/nature12664; Piazza L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7407; Piglosiewicz B, 2014, NAT PHOTONICS, V8, P38, DOI [10.1038/NPHOTON.2013.288, 10.1038/nphoton.2013.288]; Plemmons DA, 2014, ULTRAMICROSCOPY, V146, P97, DOI 10.1016/j.ultramic.2014.08.001; Ropers C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043907; Schafer J, 2012, J QUANT SPECTROSC RA, V113, P2113, DOI 10.1016/j.jqsrt.2012.05.019; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schmidt S, 2012, ACS NANO, V6, P6040, DOI 10.1021/nn301121h; SHORE BW, 1978, OPT COMMUN, V24, P83, DOI 10.1016/0030-4018(78)90272-9; SMITH SJ, 1953, PHYS REV, V92, P1069, DOI 10.1103/PhysRev.92.1069; Stockman MI, 2007, NAT PHOTONICS, V1, P539, DOI 10.1038/nphoton.2007.169; Wimmer L, 2014, NAT PHYS, V10, P432, DOI [10.1038/NPHYS2974, 10.1038/nphys2974]; Yurtsever A, 2012, SCIENCE, V335, P59, DOI 10.1126/science.1213504	42	306	311	15	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					200	+		10.1038/nature14463	http://dx.doi.org/10.1038/nature14463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971512				2022-12-28	WOS:000354377800054
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			A 4-Drug Combination (Viekira Pak) for Hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							ABT-450/R-OMBITASVIR; DASABUVIR; RIBAVIRIN; HCV; INTERFERON						Pflomm, Jean-Marie/HDO-0765-2022					American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society-USA, 2015, REC TEST MAN TREAT H; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; [Anonymous], 2014, MED LETT DRUGS THER, V56, P111; [Anonymous], 2014, MED LETT DRUGS THER, V56, P1; [Anonymous], 2013, Med Lett Drugs Ther, V55, pe44; [Anonymous], 2011, Med Lett Drugs Ther, V53, P57; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Wyles D, 2014, 65 ANN M AASLD BOST; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	13	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1857	1858						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965236				2022-12-28	WOS:000354391000031
J	Sintchenko, V; Holmes, EC				Sintchenko, Vitali; Holmes, Edward C.			The role of pathogen genomics in assessing disease transmission	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; MYCOBACTERIUM-TUBERCULOSIS; CLINICAL MICROBIOLOGY; EVOLUTIONARY DYNAMICS; PATIENT TRANSMISSION; POPULATION GENOMICS; MOLECULAR EVOLUTION; BACTERIAL PATHOGENS; YERSINIA-PESTIS; SHIGELLA-SONNEI	Whole genome sequencing (WGS) of pathogens enables the sources and patterns of transmission to be identified during specific disease outbreaks and promises to transform epidemiological research on communicable diseases. This review discusses new insights into disease spread and transmission that have come from the use of WGS, particularly when combined with genomic scale phylogenetic analyses. These include elucidation of the mechanisms of cross species transmission, the potential modes of pathogen transmission, and which people in the population contribute most to transmission. Particular attention is paid to the ability of WGS to resolve individual patient to patient transmission events. Importantly, WGS data seem to be sufficiently discriminatory to target cases linked to community or hospital contacts and hence prevent further spread, and to investigate genetically related cases without a clear epidemiological link. Approaches to combine evidence from epidemiological with genomic sequencing observations are summarised. Ongoing genomic surveillance can identify determinants of transmission, monitor pathogen evolution and adaptation, ensure the accurate and timely diagnosis of infections with epidemic potential, and refine strategies for their control.	[Sintchenko, Vitali; Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Sintchenko, Vitali; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Inst Clin Pathol & Med Res Pathol West, Sydney, NSW 2145, Australia; [Holmes, Edward C.] Univ Sydney, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Sintchenko, V (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.	vitali.sintchenko@sydney.edu.au	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019	Holmes, Edward/0000-0001-9596-3552; Sintchenko, Vitali/0000-0002-9261-3650	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Both authors were supported by the Australian National Health and Medical Research Council.	Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Aziz N, 2014, ARCH PATHOL LAB MED; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barry JD, 2012, ANN NY ACAD SCI, V1267, P11, DOI 10.1111/j.1749-6632.2012.06654.x; Barzon L, 2013, J CLIN VIROL, V58, P346, DOI 10.1016/j.jcv.2013.03.003; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Chen C, 2013, J CLIN MICROBIOL, V51, P2582, DOI 10.1128/JCM.00535-13; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cody AJ, 2013, J CLIN MICROBIOL, V51, P2526, DOI 10.1128/JCM.00066-13; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Creamer E, 2012, EUR J CLIN MICROBIOL, V31, P3151, DOI 10.1007/s10096-012-1678-7; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Cruz-Rivera M, 2013, J CLIN MICROBIOL, V51, P629, DOI 10.1128/JCM.03042-12; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Dash PK, 2015, VIRUS RES, V195, P124, DOI 10.1016/j.virusres.2014.08.018; Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121; Didelot X, 2013, P NATL ACAD SCI USA, V110, P13880, DOI 10.1073/pnas.1304681110; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585; Dutilh BE, 2013, BRIEF FUNCT GENOMICS, V12, P366, DOI 10.1093/bfgp/elt008; Engelthaler DM, 2014, MBIO, V5, DOI 10.1128/mBio.01464-14; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Howden BP, 2013, MBIO, V4, DOI 10.1128/mBio.00412-13; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; Jombart T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003457; Junemann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107014; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Knobloch JKM, 2014, EMERG INFECT DIS, V20, P732, DOI 10.3201/eid2004.131782; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Lindsay JA, 2014, INFECT GENET EVOL, V21, P548, DOI 10.1016/j.meegid.2013.04.017; Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Liu QF, 2014, J VIROL, V88, P8153, DOI 10.1128/JVI.00894-14; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; Mcdonnell J, 2013, EPIDEMIOL INFECT, V141, P2568, DOI 10.1017/S0950268813000137; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1383, DOI 10.1007/s10096-009-0796-3; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Munier S, 2010, Pathol Biol (Paris), V58, pe59, DOI 10.1016/j.patbio.2010.01.012; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Nubel U, 2011, INT J MED MICROBIOL, V301, P614, DOI 10.1016/j.ijmm.2011.09.007; Octavia S, 2015, J CLIN MICROBIOL; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Palmer GH, 2013, CELL MICROBIOL, V15, P1969, DOI 10.1111/cmi.12182; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Perez-Lago L, 2013, INFECT GENET EVOL, V16, P326, DOI 10.1016/j.meegid.2013.02.016; Price J, 2013, CLIN MICROBIOL INFEC, V19, P784, DOI 10.1111/1469-0691.12109; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Prosperi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01902; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rashed SM, 2014, EMERG INFECT DIS, V20, P54, DOI 10.3201/eid2001.130796; Reeves PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026907; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Sherry Norelle L, 2013, J Clin Microbiol, V51, P1396, DOI 10.1128/JCM.03332-12; Sintchenko V, 2014, METHODS MOL BIOL, V1168, P173, DOI 10.1007/978-1-4939-0847-9_10; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Turner CE, 2013, J CLIN MICROBIOL, V51, P2089, DOI 10.1128/JCM.00679-13; Underwood AP, 2013, J CLIN MICROBIOL, V51, P232, DOI 10.1128/JCM.01696-12; Vaughan G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074546; Verhagen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089541; Vinatzer BA, 2014, ANNU REV PHYTOPATHOL, V52, P19, DOI 10.1146/annurev-phyto-102313-045907; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Wright CF, 2013, INFECT GENET EVOL, V20, P230, DOI 10.1016/j.meegid.2013.09.009; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Xia XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100081; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Ypma RJF, 2013, GENETICS, V195, P1055, DOI 10.1534/genetics.113.154856; Ypma RJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069875; Ypma RJF, 2013, J INFECT DIS, V207, P730, DOI 10.1093/infdis/jis757; Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13	137	39	40	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2015	350								h1314	10.1136/bmj.h1314	http://dx.doi.org/10.1136/bmj.h1314			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BT	25964672				2022-12-28	WOS:000354768600001
J	Sun, LC				Sun, Licheng			A closer mimic of the oxygen evolution complex of photosystem II	SCIENCE			English	Editorial Material							ARTIFICIAL PHOTOSYNTHESIS; CRYSTAL-STRUCTURE		[Sun, Licheng] Dalian Univ Technol, State Key Lab Fine Chem, DUT KTH Joint Educ & Res Ctr Mol Devices, Dalian 116024, Peoples R China; [Sun, Licheng] KTH Royal Inst Technol, Dept Chem, S-10044 Stockholm, Sweden	Dalian University of Technology; Royal Institute of Technology	Sun, LC (corresponding author), Dalian Univ Technol, State Key Lab Fine Chem, DUT KTH Joint Educ & Res Ctr Mol Devices, Dalian 116024, Peoples R China.	lichengs@kth.se	Sun, Licheng/AAY-7909-2020; Sun, Licheng/A-7357-2017; Sun, Licheng/N-7820-2014; Sun, Licheng/P-2657-2019	Sun, Licheng/0000-0002-4521-2870; 				Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Duan LL, 2012, NAT CHEM, V4, P418, DOI [10.1038/NCHEM.1301, 10.1038/nchem.1301]; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Karkas MD, 2014, CHEM REV, V114, P11863, DOI 10.1021/cr400572f; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sun LC, 2001, CHEM SOC REV, V30, P36, DOI 10.1039/a801490f; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zhang CX, 2015, SCIENCE, V348, P690, DOI 10.1126/science.aaa6550; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	12	25	27	4	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					635	636		10.1126/science.aaa9094	http://dx.doi.org/10.1126/science.aaa9094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953993				2022-12-28	WOS:000354045700027
J	Zhao, Y; Wyrick, J; Natterer, FD; Rodriguez-Nieva, JF; Lewandowski, C; Watanabe, K; Taniguchi, T; Levitov, LS; Zhitenev, NB; Stroscio, JA				Zhao, Yue; Wyrick, Jonathan; Natterer, Fabian D.; Rodriguez-Nieva, Joaquin F.; Lewandowski, Cyprian; Watanabe, Kenji; Taniguchi, Takashi; Levitov, Leonid S.; Zhitenev, Nikolai B.; Stroscio, Joseph A.			Creating and probing electron whispering-gallery modes in graphene	SCIENCE			English	Article							QUANTUM; INTERFERENCE; CONFINEMENT; SCATTERING	The design of high-finesse resonant cavities for electronic waves faces challenges due to short electron coherence lengths in solids. Complementing previous approaches to confine electronic waves by carefully positioned adatoms at clean metallic surfaces, we demonstrate an approach inspired by the peculiar acoustic phenomena in whispering galleries. Taking advantage of graphene's gate-tunable light-like carriers, we create whispering-gallery mode (WGM) resonators defined by circular pn junctions, induced by a scanning tunneling probe. We can tune the resonator size and the carrier concentration under the probe in a back-gated graphene device over a wide range. The WGM-type confinement and associated resonances are a new addition to the quantum electron-optics toolbox, paving the way to develop electronic lenses and resonators.	[Zhao, Yue; Wyrick, Jonathan; Natterer, Fabian D.; Zhitenev, Nikolai B.; Stroscio, Joseph A.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Zhao, Yue] Univ Maryland, Maryland NanoCtr, College Pk, MD 20742 USA; [Rodriguez-Nieva, Joaquin F.; Levitov, Leonid S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lewandowski, Cyprian] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); Imperial College London; National Institute for Materials Science	Zhitenev, NB (corresponding author), NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA.	nikolai.zhitenev@nist.gov; joseph.stroscio@nist.gov	Natterer, Fabian Donat/Y-6493-2019; Natterer, Fabian Donat/I-4016-2012; TANIGUCHI, Takashi/H-2718-2011; Zhitenev, Nikolai/N-1780-2014; WATANABE, Kenji/H-2825-2011; Zhao, Yue/C-7680-2011	Natterer, Fabian Donat/0000-0002-2488-5988; Zhitenev, Nikolai/0000-0002-7477-6341; WATANABE, Kenji/0000-0003-3701-8119; Zhao, Yue/0000-0002-9174-0519; Levitov, Leonid/0000-0002-4268-731X; Lewandowski, Cyprian/0000-0002-6944-9805; Rodriguez Nieva, Joaquin/0000-0002-3023-396X	University of Maryland; National Institute of Standards and Technology Center for Nanoscale Science and Technology, through the University of Maryland [70NANB10H193]; Nation Research Council Fellowship; Swiss National Science Foundation [148891, 158468]; STC [CIQM/NSF-1231319]	University of Maryland; National Institute of Standards and Technology Center for Nanoscale Science and Technology, through the University of Maryland; Nation Research Council Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); STC	Y.Z. acknowledges support under the Cooperative Research Agreement between the University of Maryland and the National Institute of Standards and Technology Center for Nanoscale Science and Technology, grant 70NANB10H193, through the University of Maryland. J.W. acknowledges support from the Nation Research Council Fellowship. F.D.N. greatly appreciates support from the Swiss National Science Foundation under project numbers 148891 and 158468. L.S.L. acknowledges support from STC CIQM/NSF-1231319. We thank S. Blankenship and A. Band for their contributions to this project and M. Stiles and P. First for valuable discussions.	Agrawal N, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/15/155301; Bardarson JH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226803; Campos LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2243; Chae JS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116802; Cheianov VV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041403; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; CHRISTMANN K, 1988, SURF SCI REP, V9, P1, DOI 10.1016/0167-5729(88)90009-X; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Cserti J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246801; Heinisch RL, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155409; Jung SY, 2011, NAT PHYS, V7, P245, DOI 10.1038/NPHYS1866; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Matsko AB, 2006, IEEE J SEL TOP QUANT, V12, P3, DOI 10.1109/JSTQE.2005.862952; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Nesvizhevsky VV, 2010, NAT PHYS, V6, P114, DOI 10.1038/NPHYS1478; Park CH, 2008, NANO LETT, V8, P2920, DOI 10.1021/nl801752r; Pollinger M, 2009, PHYS REV LETT, V103, DOI [10.1103/PhysRevLett.103.053901, 10.1109/CLEOE-EQEC.2009.5192376]; Rayleigh L., 1910, PHILOS MAG, V20, P1001; Reecht G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.056802; Rutter GM, 2007, SCIENCE, V317, P219, DOI 10.1126/science.1142882; Shytov AV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156804; Tersoff J., 1993, SCANNING TUNNELING M; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Varlet A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.116601; Williams JR, 2011, NAT NANOTECHNOL, V6, P222, DOI 10.1038/nnano.2011.3; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198	26	141	142	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					672	675		10.1126/science.aaa7469	http://dx.doi.org/10.1126/science.aaa7469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954005	Green Submitted			2022-12-28	WOS:000354045700040
J	Finnegan, S; Anderson, SC; Harnik, PG; Simpson, C; Tittensor, DP; Byrnes, JE; Finkel, ZV; Lindberg, DR; Liow, LH; Lockwood, R; Lotze, HK; McClain, CR; McGuire, JL; O'Dea, A; Pandolfi, JM				Finnegan, Seth; Anderson, Sean C.; Harnik, Paul G.; Simpson, Carl; Tittensor, Derek P.; Byrnes, Jarrett E.; Finkel, Zoe V.; Lindberg, David R.; Liow, Lee Hsiang; Lockwood, Rowan; Lotze, Heike K.; McClain, Craig R.; McGuire, Jenny L.; O'Dea, Aaron; Pandolfi, John M.			Paleontological baselines for evaluating extinction risk in the modern oceans	SCIENCE			English	Article							MARINE BIODIVERSITY; SPECIES RICHNESS; GLOBAL PATTERNS; DIVERSITY; HOTSPOTS; VULNERABILITY; CONSERVATION; PREDICTORS; DRIVERS; CLIMATE	Marine taxa are threatened by anthropogenic impacts, but knowledge of their extinction vulnerabilities is limited. The fossil record provides rich information on past extinctions that can help predict biotic responses. We show that over 23 million years, taxonomic membership and geographic range size consistently explain a large proportion of extinction risk variation in six major taxonomic groups. We assess intrinsic risk-extinction risk predicted by paleontologically calibrated models-for modern genera in these groups. Mapping the geographic distribution of these genera identifies coastal biogeographic provinces where fauna with high intrinsic risk are strongly affected by human activity or climate change. Such regions are disproportionately in the tropics, raising the possibility that these ecosystems may be particularly vulnerable to future extinctions. Intrinsic risk provides a prehuman baseline for considering current threats to marine biodiversity.	[Finnegan, Seth; Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Anderson, Sean C.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Harnik, Paul G.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA; [Simpson, Carl] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Tittensor, Derek P.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Tittensor, Derek P.] Microsoft Res, Sci Computat Lab, Cambridge CB1 2FB, England; [Tittensor, Derek P.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Byrnes, Jarrett E.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB E4L 1A5, Canada; [Liow, Lee Hsiang] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Lockwood, Rowan] Coll William & Mary, Dept Geol, Williamsburg, VA 23187 USA; [McClain, Craig R.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [McGuire, Jenny L.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [O'Dea, Aaron] Smithsonian Trop Res Inst, Balboa 084303092, Panama; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld 4072, Australia	University of California System; University of California Berkeley; Simon Fraser University; Franklin & Marshall College; Smithsonian Institution; Smithsonian National Museum of Natural History; Microsoft; Dalhousie University; University of Massachusetts System; University of Massachusetts Boston; Mount Allison University; University of Oslo; William & Mary; The National Evolutionary Synthesis Center; University of Washington; University of Washington Seattle; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Queensland	Finnegan, S (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	sethf@berkeley.edu	Liow, Lee Hsiang/E-3481-2010; Anderson, Sean C./AFN-3267-2022; McGuire, Jenny L./G-8819-2011; Pandolfi, John M/A-3121-2009; Tittensor, Derek P./AAV-1117-2021; Lindberg, David R/D-8138-2011; Finkel, Zoe/B-9626-2008	Liow, Lee Hsiang/0000-0002-3732-6069; Anderson, Sean C./0000-0001-9563-1937; McGuire, Jenny L./0000-0002-0663-6902; Pandolfi, John M/0000-0003-3047-6694; Tittensor, Derek P./0000-0002-9550-3123; McClain, Craig/0000-0003-0574-428X; Lotze, Heike/0000-0001-6258-1304; Harnik, Paul/0000-0001-6931-9931; O'Dea, Aaron/0000-0001-5495-4764; Simpson, Carl/0000-0003-0719-4437; Byrnes, Jarrett/0000-0002-9791-9472; Finkel, Zoe/0000-0003-4212-3917	National Evolutionary Synthesis Center (NSF) [EF-0905606]; Natural Sciences and Engineering Research Council of Canada; National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama; Australian Research Council Centre of Excellence for Coral Reef Studies; Deutsche Forschungsgemeinschaft [KI 806/7-1]; Directorate For Geosciences [1325379] Funding Source: National Science Foundation	National Evolutionary Synthesis Center (NSF); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is a product of the Determinants of Extinction in Ancient and Modern Seas Working Group supported by the National Evolutionary Synthesis Center (NSF grant EF-0905606). Additional support was provided by the Natural Sciences and Engineering Research Council of Canada (to H.K.L., S.C.A., and Z.V.F.); the National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama (to A.O.); the Australian Research Council Centre of Excellence for Coral Reef Studies (to J.M.P.); and the Deutsche Forschungsgemeinschaft (grant KI 806/7-1 to C.S.). We thank the contributors to the Paleobiology Database and to OBIS. We also thank four anonymous reviewers for insightful comments that substantially improved the quality of the manuscript. This article is Paleobiology Database contribution no. 227. All scripts and data used to conduct analyses are available at https://github.com/seananderson/paleobaselines	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Bromham L, 2012, P ROY SOC B-BIOL SCI, V279, P4024, DOI 10.1098/rspb.2012.1437; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; CBIS, DAT OC BIOG INF SYST; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy Nicholas K., 2009, P129; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Foote M, 2008, PALEOBIOLOGY, V34, P421, DOI 10.1666/08023.1; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harnik PG, 2012, P ROY SOC B-BIOL SCI, V279, P4969, DOI 10.1098/rspb.2012.1902; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parravicini V, 2014, ECOL LETT, V17, P1101, DOI 10.1111/ele.12316; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; Purvis A., 2005, PHYLOGENY CONSERVATI; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ronov A.B., 1982, INT GEOL REV, V24, P509, DOI [DOI 10.1080/10643389.2012.728825, 10.1080/00206818209451555]; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2013, PALEOBIOLOGY, V39, P1, DOI 10.1666/0094-8373-39.1.1; Vilhena DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074470; Wang SC, 2008, PALEOBIOLOGY, V34, P434, DOI 10.1666/07060.1; Webb TJ, 2015, CURR BIOL, V25, P506, DOI 10.1016/j.cub.2014.12.023	43	82	82	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					567	570		10.1126/science.aaa6635	http://dx.doi.org/10.1126/science.aaa6635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931558				2022-12-28	WOS:000353778100040
J	Hogl, B; Heidbreder, A; Santamaria, J; Graus, F; Poewe, W				Hoegl, Birgit; Heidbreder, Anna; Santamaria, Joan; Graus, Francesc; Poewe, Werner			IgLON5 autoimmunity and abnormal behaviours during sleep	LANCET			English	Editorial Material									[Hoegl, Birgit; Heidbreder, Anna; Poewe, Werner] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Santamaria, Joan; Graus, Francesc] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Santamaria, Joan; Graus, Francesc] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain	Medical University of Innsbruck; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Hogl, B (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	birgit.ho@i-med.ac.at	Heidbreder, Anna/GLR-3355-2022; Graus, Francesc/K-9904-2018	Heidbreder, Anna/0000-0002-9552-7619; Graus, Francesc/0000-0002-8924-8322; Hogl, Birgit/0000-0003-1894-7641				Balas A, 2011, TISSUE ANTIGENS, V77, P45, DOI 10.1111/j.1399-0039.2010.01578.x; Sabater L, 2014, LANCET NEUROL, V13, P575, DOI 10.1016/S1474-4422(14)70051-1	2	34	37	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1590	1590						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25933285				2022-12-28	WOS:000353220000040
J	Laurance, J				Laurance, Jeremy			Dan Tunstall Pedoe Obituary	LANCET			English	Biographical-Item																		PEDOE DT, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1504	1504		10.1016/S0140-6736(15)60743-7	http://dx.doi.org/10.1016/S0140-6736(15)60743-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25933271				2022-12-28	WOS:000353220000018
J	Ghayumi, MA; Fallahi, MJ; Masoompour, SM; Roozbeh, J				Ghayumi, Mohammad Ali; Fallahi, Mohammad Javad; Masoompour, Seyed Masoom; Roozbeh, Jamshid			Tension hydropneumopericardium after routine intubation	LANCET			English	Editorial Material									[Ghayumi, Mohammad Ali; Fallahi, Mohammad Javad; Masoompour, Seyed Masoom; Roozbeh, Jamshid] Shiraz Univ Med Sci, Dept Internal Med, Shiraz 7134846114, Iran	Shiraz University of Medical Science	Fallahi, MJ (corresponding author), Shiraz Univ Med Sci, Sch Med, Faghihi Teaching Hosp, Dept Internal Med, Shiraz 7134846114, Iran.	fallahimj@sums.ac.ir	Roozbeh, Jamshid/AAR-3525-2021; Fallahi, Mohammad Javad/T-3897-2017; Masoompour, Seyed Masoom/B-8165-2018	Roozbeh, Jamshid/0000-0002-4268-1727; Fallahi, Mohammad Javad/0000-0002-8562-5637; Masoompour, Seyed Masoom/0000-0002-0129-7155; Ghayumi, Seiyed Mohammad Ali/0000-0003-2553-5311					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					E13	E13		10.1016/S0140-6736(15)60028-9	http://dx.doi.org/10.1016/S0140-6736(15)60028-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	25937294				2022-12-28	WOS:000361368000003
J	Daniel, H; Butkus, R				Daniel, Hilary; Butkus, Renee		Amer Coll Phys	Lesbian, Gay, Bisexual, and Transgender Health Disparities: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							SAME-SEX; RISK; CARE; MEN; MARRIAGE	In this position paper, the American College of Physicians examines the health disparities experienced by the lesbian, gay, bisexual, and transgender (LGBT) community and makes a series of recommendations to achieve equity for LGBT individuals in the health care system. These recommendations include enhancing physician understanding of how to provide culturally and clinically competent care for LGBT individuals, addressing environmental and social factors that can affect their mental and physical well-being, and supporting further research into understanding their unique health needs.	[Daniel, Hilary; Butkus, Renee; Amer Coll Phys] Amer Coll Physicians, Washington, DC 20037 USA	American College of Physicians	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20037 USA.	HDaniel@mail.acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	American Civil Liberties Union, 2014, NOND LAWS STAT STAT; American College of Physicians, 2010, RAC ETHN DISP HLTH C; American Medical Association, AMA POL LGBT ISS GEN; American Medical Association, 2010, AMA POL LGBT ISS; American Psychiatric Association, LGBT SEX OR; American Psychiatric Association, 2013, GEND DYSPH; American Psychological Association, JUST FACTS SEX OR YO; American Psychological Association Task Force on Appropriate Therapeutic Responses to Sexual Orientation, 2009, REP AM PSYCH ASS TAS; [Anonymous], 2011, Obstet Gynecol, V118, P1454, DOI 10.1097/AOG.0b013e31823ed1c1; [Anonymous], 2010, Jt Comm Perspect, V30, P5; [Anonymous], 2014, IMPL CURR I CLIM CHA; [Anonymous], 2013, BROK BARG DISCR FEW; [Anonymous], 2014, COMMUNICATION; Ard KL., 2012, IMPROVING HLTH CARE; Bockting WO, SIECUS REPORT, V28, P3; Brown J, 2008, CANCER CAUSE CONTROL, V19, P1009, DOI 10.1007/s10552-008-9176-z; Buchmueller T, 2010, AM J PUBLIC HEALTH, V100, P489, DOI 10.2105/AJPH.2009.160804; Buffie WC, 2011, AM J PUBLIC HEALTH, V101, P986, DOI 10.2105/AJPH.2010.300112; CAL. DEP'T OF INS, 2012, EC IMP ASS GEND NOND; Center of Excellence for Transgender Health; University of California San Francisco, TRANSG PAT; Centers for Medicare & Medicaid Services, 2011, MED STEPS ENF EQ VIS; Cha A.E., 2014, WASH POST; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Cray A, 2012, DISCRIMINATORY DONOR; Cray A, 2012, FAQ HLTH INS NEEDS T; Davison KL, 2013, VOX SANG, V105, P85, DOI 10.1111/vox.12024; Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; Deutsch MB, 2013, J AM MED INFORM ASSN, V20, P700, DOI 10.1136/amiajnl-2012-001472; Dilley JA, 2010, AM J PUBLIC HEALTH, V100, P460, DOI 10.2105/AJPH.2007.130336; Flanagan P, 2012, BIOLOGICALS, V40, P173, DOI 10.1016/j.biologicals.2011.10.009; Fredriksen-Goldsen Karen I, 2012, Am J Public Health, V102, pe16, DOI 10.2105/AJPH.2011.300379; Freedom to Marry, STAT; Gates GJ, 2013, LGBT PAR US; Grant JM, INJUSTICE EVERY TURN; Hartmann M, STATES STAND FIGHT B; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Herdt G., 2006, SEX RES SOC POLICY, V3, P33; Herman J. L., 2013, COSTS BENEFITS PROVI; Human Rights Campaign, 2014, RES WORKPL DISCR LAW; Hurley L, US TOP COURT REJECTS; Institute for Patientand Family-Centered Care, 2010, CHANG HOSP VIS POL P; Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities, 2011, HLTH LESB GAY BIS TR; Kates J, 2014, HLTH CAR ACC COV LES; Krehely J, 2009, CLOSE LGBT HLTH DISP; Lee Badgett M. V., 2013, NEW PATTERNS POVERTY; Lee Kathreen P, 2014, J Surg Educ, V71, pe47, DOI 10.1016/j.jsurg.2014.05.008; Makadon HJ, 2006, NEW ENGL J MED, V354, P895, DOI 10.1056/NEJMp058259; Makadon HJ, 2015, FENWAY GUIDE LGBT HL; Millman J., 2014, WASHINGTON POST; Movement Advancement Project Family Equality Council and Center for American Progress, 2011, ALL CHILDR MATT LEG; National Alliance on Mental Illness, 2007, MENT HLTH ISS GAY LE; National Center for Transgender Equality & National Gay and Lesbian Task Force, 2010, NAT TRANSG DISCR SUR; Obama Barack, 2010, COMMUNICATION; Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255; Pan American Health Organization, CUR ILLN DOES NOT EX; Pew Research Center, 2013, GROW SUPP GAY MARR C; Ranji U., 2014, HLTH ACCESS CARE COV; Reisner SL, 2014, LGBT HEALTH, V1, P177, DOI 10.1089/lgbt.2014.0009; Riou Garrett, 2014, HOSP VISITATION MED; Ryan C., 2009, SUPPORTIVE FAMILIES; Sanchez NF, 2006, FAM MED, V38, P21; Schuster MA, 2012, ACAD PEDIATR, V12, P75, DOI 10.1016/j.acap.2012.01.005; Schwartz John, 2013, NY TIMES; Seed CR, 2010, TRANSFUSION, V50, P2722, DOI 10.1111/j.1537-2995.2010.02793.x; Sequeira GM, 2012, OCHSNER J, V12, P379; Snowdon S, RECOMMENDATIONS ENHA; Spitzer RL, 2012, ARCH SEX BEHAV, V41, P757, DOI 10.1007/s10508-012-9966-y; The Human Rights Campaign, 2014, LGBT INCL DEF FAM; The National LGBT Health Education Center, AFF CAR TRANSG GEND; U.S. Census Bureau Fertility and Family Statistics Branch, FREQ ASK QUEST SAM S; U.S. Department of Health and Human Services, HLTH PEOPL 2020 LESB; U.S. Equal Employment Opportunity Commission, 2014, WHAT YOU SHOULD KNOW; U.S. Food and Drug Administration, BLOOD DON MEN WHO HA; University of San Francisco LGBT Center, LGBT CONC MED ED TOO; Ward Brian W, 2014, Natl Health Stat Report, P1; Wight RG, 2013, AM J PUBLIC HEALTH, V103, P339, DOI 10.2105/AJPH.2012.301113	77	153	153	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					135	+		10.7326/M14-2482	http://dx.doi.org/10.7326/M14-2482			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN4NS	25961598				2022-12-28	WOS:000358407500021
J	Baker, RP; Urban, S				Baker, Rosanna P.; Urban, Sinisa			Cytosolic extensions directly regulate a rhomboid protease by modulating substrate gating	NATURE			English	Article							INTRAMEMBRANE PROTEOLYSIS; ACTIVE-SITE; FAMILY; MEMBRANE; IDENTIFICATION; TRAFFICKING; MECHANISM; PROTEINS; REVEALS; RELEASE	Intramembrane proteases catalyse the signal-generating step of various cell signalling pathways, and continue to be implicated in diseases ranging from malaria infection to Parkinsonian neuro-degeneration(1-3). Despite playing such decisive roles, it remains unclear whether or how these membrane-immersed enzymes might be regulated directly. To address this limitation, here we focus on intramembrane proteases containing domains known to exert regulatory functions in other contexts, and characterize a rhomboid protease that harbours calcium-binding EF-hands. We find calcium potently stimulates proteolysis by endogenous rhomboid-4 in Drosophila cells, and, remarkably, when rhomboid-4 is purified and reconstituted in liposomes. Interestingly, deleting the amino-terminal EF-hands activates proteolysis prematurely, while residues in cytoplasmic loops connecting distal transmembrane segments mediate calcium stimulation. Rhomboid regulation is not orchestrated by either dimerization or substrate interactions. Instead, calcium increases catalytic rate by promoting substrate gating. Substrates with cleavage sites outside the membrane can be cleaved but lose the capacity to be regulated. These observations indicate substrate gating is not an essential step in catalysis, but instead evolved as a mechanism for regulating proteolysis inside the membrane. Moreover, these insights provide new approaches for studying rhomboid functions by investigating upstream inputs that trigger proteolysis.	[Baker, Rosanna P.; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Urban, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Room 507 PCTB,725 North Wolfe St, Baltimore, MD 21205 USA.	surban@jhmi.edu		Baker, Rosanna/0000-0002-9970-6278	National Institutes of Health [2R01AI066025]; Howard Hughes Medical Institute; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 2R01AI066025, the Howard Hughes Medical Institute, and the David and Lucile Packard Foundation. We are grateful to our colleague and friend A. Holland for use of his deconvolution microscope.	Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brooks CL, 2013, BBA-BIOMEMBRANES, V1828, P2862, DOI 10.1016/j.bbamem.2013.05.003; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Jaszai J, 2002, MECH DEVELOP, V113, P73, DOI 10.1016/S0925-4773(01)00655-4; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Morohashi Y, 2013, BBA-BIOMEMBRANES, V1828, P2855, DOI 10.1016/j.bbamem.2013.06.001; Sampathkumar P, 2012, BBA-BIOMEMBRANES, V1818, P3090, DOI 10.1016/j.bbamem.2012.08.004; Sheiner L, 2008, TRAFFIC, V9, P665, DOI 10.1111/j.1600-0854.2008.00736.x; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Xue Y, 2013, J BIOL CHEM, V288, P16645, DOI 10.1074/jbc.M112.438127	32	28	28	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					101	+		10.1038/nature14357	http://dx.doi.org/10.1038/nature14357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25970241	Green Accepted			2022-12-28	WOS:000357169500040
J	Chew, J; Gendron, TF; Prudencio, M; Sasaguri, H; Zhang, YJ; Castanedes-Casey, M; Lee, C; Jansen-West, K; Kurti, A; Murray, ME; Bieniek, KF; Bauer, PO; Whitelaw, EC; Rousseau, L; Stankowski, JN; Stetler, C; Daughrity, LM; Perkerson, EA; Desaro, P; Johnston, A; Overstreet, K; Edbauer, D; Rademakers, R; Boylan, KB; Dickson, DW; Fryer, JD; Petrucelli, L				Chew, Jeannie; Gendron, Tania F.; Prudencio, Mercedes; Sasaguri, Hiroki; Zhang, Yong-Jie; Castanedes-Casey, Monica; Lee, ChrisW.; Jansen-West, Karen; Kurti, Aishe; Murray, Melissa E.; Bieniek, Kevin F.; Bauer, Peter O.; Whitelaw, Ena C.; Rousseau, Linda; Stankowski, Jeannette N.; Stetler, Caroline; Daughrity, Lillian M.; Perkerson, Emilie A.; Desaro, Pamela; Johnston, Amelia; Overstreet, Karen; Edbauer, Dieter; Rademakers, Rosa; Boylan, Kevin B.; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard			C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits	SCIENCE			English	Article							HEXANUCLEOTIDE REPEAT; RNA FOCI; FRONTOTEMPORAL DEMENTIA; GGGGCC REPEAT; PROTEINS; TRANSLATION; TRANSCRIPTS; INCLUSIONS; TOXICITY; FEATURES	The major genetic cause of frontotemporal dementia and amyotrophic lateral sclerosis is a G(4)C(2) repeat expansion in C9ORF72. Efforts to combat neurodegeneration associated with "c9FTD/ALS" are hindered by a lack of animal models recapitulating disease features. We developed a mouse model to mimic both neuropathological and clinical c9FTD/ALS phenotypes. We expressed (G(4)C(2))(66) throughout the murine central nervous system by means of somatic brain transgenesis mediated by adeno-associated virus. Brains of 6-month-old mice contained nuclear RNA foci, inclusions of poly(Gly-Pro), poly(Gly-Ala), and poly(Gly-Arg) dipeptide repeat proteins, as well as TDP-43 pathology. These mouse brains also exhibited cortical neuron and cerebellar Purkinje cell loss, astrogliosis, and decreased weight. (G(4)C(2))(66) mice also developed behavioral abnormalities similar to clinical symptoms of c9FTD/ALS patients, including hyperactivity, anxiety, antisocial behavior, and motor deficits.	[Chew, Jeannie; Gendron, Tania F.; Prudencio, Mercedes; Sasaguri, Hiroki; Zhang, Yong-Jie; Castanedes-Casey, Monica; Lee, ChrisW.; Jansen-West, Karen; Kurti, Aishe; Murray, Melissa E.; Bieniek, Kevin F.; Bauer, Peter O.; Whitelaw, Ena C.; Rousseau, Linda; Stankowski, Jeannette N.; Stetler, Caroline; Daughrity, Lillian M.; Perkerson, Emilie A.; Rademakers, Rosa; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Chew, Jeannie; Bieniek, Kevin F.; Rademakers, Rosa; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard] Mayo Clin, Coll Med, Mayo Grad Sch, Neurobiol Dis Grad Program, Rochester, MN 55905 USA; [Desaro, Pamela; Johnston, Amelia; Overstreet, Karen; Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Edbauer, Dieter] German Ctr Neurodegenerat Dis DZNE Munich, D-81337 Munich, Germany; [Edbauer, Dieter] Univ Munich, Inst Metab Biochem, D-81337 Munich, Germany; [Edbauer, Dieter] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	Edbauer, Dieter/M-9906-2019; Murray, Melissa E/C-2763-2015; Bauer, Peter O./AAD-6502-2022	Edbauer, Dieter/0000-0002-7186-4653; Murray, Melissa E/0000-0001-7379-2545; Bauer, Peter O./0000-0003-2811-1354; Lee, Chris/0000-0001-9068-5274; Prudencio, Mercedes/0000-0002-4894-4858; Bieniek, Kevin/0000-0003-4922-864X	National Institute on Aging, NIH [P50AG016574]; National Institute of Neurological Disorders and Stroke, NIH [R21NS089979, R21NS084528, R21NS079807, R01NS088689, R01NS063964, R01NS077402, P01NS084974]; National Institute of Environmental Health Services, NIH [R01ES20395]; U.S. Department of Defense [ALS Research Program] [AL130125]; Mayo Clinic Foundation; Mayo Clinic Center for Regenerative Medicine; Mayo Graduate School; ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Alzheimer's Association [NIRP-14-304425, NIRP-12-259289]; European Research Council under European Union [617198]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS084974, R01NS077402, R21NS084528, R01NS063964, R21NS089979, R01NS088689, R21NS079807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574] Funding Source: NIH RePORTER	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Services, NIH; U.S. Department of Defense [ALS Research Program]; Mayo Clinic Foundation; Mayo Clinic Center for Regenerative Medicine; Mayo Graduate School; ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Alzheimer's Association(Alzheimer's Association); European Research Council under European Union(European Research Council (ERC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging, NIH [P50AG016574 (L.P.)]; National Institute of Neurological Disorders and Stroke, NIH [R21NS089979 (T.F.G. and K.B.B.), R21NS084528 (L.P.), R21NS079807 (Y.-J.Z.), R01NS088689 (L.P.), R01NS063964 (L.P.), R01NS077402 (L.P.), and P01NS084974 (L.P., D.W.D., R.R., and K.B.B.)]; National Institute of Environmental Health Services, NIH [R01ES20395 (L.P.)]; U.S. Department of Defense [ALS Research Program AL130125 (L.P.)]; Mayo Clinic Foundation (L.P.); Mayo Clinic Center for Regenerative Medicine (P.O.B.); Mayo Graduate School (J.C. and K.F.B.); ALS Association (T.F.G., Y.-J.Z., P.O.B., K.B.B., and L.P.); Robert Packard Center for ALS Research at Johns Hopkins (L.P.); Target ALS (L.P.); Alzheimer's Association [NIRP-14-304425 (Y.-J.Z.) and NIRP-12-259289 (J.D.F.)]; and European Research Council under European Union's Seventh Framework Programme [FP7/2014-2019 no. 617198 [DPR-MODELS] (D.E.)]. L.P. and T.F.G. have filed a patent (no. 14/162,570) in the United States regarding the use of poly(GP) immunoassays as a diagnostic for C9ORF72 repeat expansion-related diseases. The data are tabulated in the manuscript and the supplementary materials.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Boeve BF, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt132; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gil-Bea FJ, 2007, BEHAV NEUROSCI, V121, P340, DOI 10.1037/0735-7044.121.2.340; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mann DMA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-68; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5	27	270	273	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1151	1154		10.1126/science.aaa9344	http://dx.doi.org/10.1126/science.aaa9344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25977373	Green Accepted			2022-12-28	WOS:000355590500052
J	Kelsic, ED; Zhao, J; Vetsigian, K; Kishony, R				Kelsic, Eric D.; Zhao, Jeffrey; Vetsigian, Kalin; Kishony, Roy			Counteraction of antibiotic production and degradation stabilizes microbial communities	NATURE			English	Article							RESISTANCE; PROMOTES; BACTERIA; IDENTIFICATION; BIODIVERSITY; COEXISTENCE; COMPETITION; STRAINS; MODEL; GAME	A major challenge in theoretical ecology is understanding how natural microbial communities support species diversity(1-8), and in particular how antibiotic-producing, -sensitive and -resistant species coexist(9-15). While cyclic 'rock-paper-scissors' interactions can stabilize communities in spatial environments(9-11), coexistence in unstructured environments remains unexplained(12,16). Here, using simulations and analytical models, we show that the opposing actions of antibiotic production and degradation enable coexistence even in well-mixed environments. Coexistence depends on three-way interactions in which an antibiotic-degrading species attenuates the inhibitory interactions between two other species. These interactions enable coexistence that is robust to substantial differences in inherent species growth rates and to invasion by 'cheating' species that cease to produce or degrade antibiotics. At least two antibiotics are required for stability, with greater numbers of antibiotics enabling more complex communities and diverse dynamic behaviours ranging from stable fixed points to limit cycles and chaos. Together, these results show how multi-species antibiotic interactions can generate ecological stability in both spatially structured and mixed microbial communities, suggesting strategies for engineering synthetic ecosystems and highlighting the importance of toxin production and degradation for microbial biodiversity.	[Kelsic, Eric D.; Zhao, Jeffrey; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Vetsigian, Kalin] Univ Wisconsin, Dept Bacteriol, Madison, WI 53715 USA; [Vetsigian, Kalin] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Kishony, Roy] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, IL-3200003 Haifa, Israel	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Vetsigian, K (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53715 USA.	kalin@discovery.wisc.edu; rkishony@technion.ac.il		Kelsic, Eric/0000-0002-5331-5204	Department of Defense, Office of Naval Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; Research Science Institute at MIT; University of Wisconsin-Madison; James S. McDonnell Foundation 21st Century Science Initiative in Studying Complex Systems Research [220020169]; National Institutes of Health [R01GM081617]; European Research Council [281891]; Israeli Centers of Research Excellence I-CORE Program ISF [152/11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	Department of Defense, Office of Naval Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship; Research Science Institute at MIT; University of Wisconsin-Madison; James S. McDonnell Foundation 21st Century Science Initiative in Studying Complex Systems Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Israeli Centers of Research Excellence I-CORE Program ISF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Ward, S. Levin, M. Elowitz, G. Bunin, A. Amir, S. Kryazhimskiy, Y. Gerardin, J. Meyer, N. Yin, E. Bairey, H. Chung and A. Palmer for critical feedback and discussions; M. Baym, M. Fischbach, M. Traxler, R. Chait, L. Stone and E. Gontag for strains. E.D.K. acknowledges government support under and awarded by the Department of Defense, Office of Naval Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. J.Z. acknowledges support from the Research Science Institute at MIT during the summer of 2011. K.V. acknowledges start-up funds from University of Wisconsin-Madison. R.K. acknowledges the support of a James S. McDonnell Foundation 21st Century Science Initiative in Studying Complex Systems Research Award 220020169, National Institutes of Health Grant R01GM081617, European Research Council Seventh Framework Programme ERC Grant 281891, Israeli Centers of Research Excellence I-CORE Program ISF Grant No. 152/11.	ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Brook I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-202; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Conlin PL, 2014, CURR OPIN MICROBIOL, V21, P35, DOI 10.1016/j.mib.2014.09.004; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoshino Y, 2010, J ANTIBIOT, V63, P23, DOI 10.1038/ja.2009.116; Hsu SB, 2004, MATH BIOSCI, V187, P53, DOI 10.1016/j.mbs.2003.07.004; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LENSKI RE, 1986, J THEOR BIOL, V122, P83, DOI 10.1016/S0022-5193(86)80226-0; LEVIN BR, 1972, SCIENCE, V175, P1272, DOI 10.1126/science.175.4027.1272; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; LEVIN SA, 1990, THEOR POPUL BIOL, V37, P171, DOI 10.1016/0040-5809(90)90034-S; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Ohgushi T, 2012, TRAIT MEDIATED INDIR; Perlin MH, 2009, P ROY SOC B-BIOL SCI, V276, P3759, DOI 10.1098/rspb.2009.0997; Rafii F, 1998, ANTIMICROB AGENTS CH, V42, P1121, DOI 10.1128/AAC.42.5.1121; Raynaud X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087217; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shoresh N, 2008, P NATL ACAD SCI USA, V105, P12365, DOI 10.1073/pnas.0803032105; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; Walsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065567; Wetzstein HG, 1999, APPL ENVIRON MICROB, V65, P1556; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002; Yurtsev EA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.39	40	177	181	6	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					516	U208		10.1038/nature14485	http://dx.doi.org/10.1038/nature14485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25992546	Green Accepted			2022-12-28	WOS:000355286600042
J	Hovers, E				Hovers, Erella			ARCHAEOLOGY Tools go back in time	NATURE			English	Editorial Material							WEST TURKANA; STONE TOOLS; OLDOWAN; ORIGINS; AFAR	The finding of 3.3-million-year-old stone flints, cores, hammers and anvils in Kenya suggests that the first stone tools were made by human ancestors that pre-dated the earliest known members of the genus Homo. See Article p.310	Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel	Hebrew University of Jerusalem	Hovers, E (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel.	hovers@mail.huji.ac.il	Hovers, Erella/AAA-9234-2019; Hovers, Erella/B-7211-2008	Hovers, Erella/0000-0002-7855-6573				Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; de la Torre I, 2011, PHILOS T R SOC B, V366, P1028, DOI 10.1098/rstb.2010.0350; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hovers E, 2012, DEV QUATER SCI, V16, P51, DOI 10.1016/B978-0-444-53821-5.00005-1; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Potts R, 2012, CURR ANTHROPOL, V53, pS299, DOI 10.1086/667704; Read D, 2008, PHILOS T R SOC B, V363, P1959, DOI 10.1098/rstb.2008.0002; Rolian C, 2013, AM J PHYS ANTHROPOL, V152, P393, DOI 10.1002/ajpa.22365; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; VRBA ES, 1993, NAT HIST, V102, P47	18	7	8	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					294	295		10.1038/521294a	http://dx.doi.org/10.1038/521294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CI5RM	25993954				2022-12-28	WOS:000354816500040
J	Vihinen, M				Vihinen, Mauno			No more hidden solutions in bioinformatics	NATURE			English	Editorial Material									Lund Univ, Med Struct Biol, S-22100 Lund, Sweden	Lund University	Vihinen, M (corresponding author), Lund Univ, Med Struct Biol, S-22100 Lund, Sweden.	mauno.vihinen@med.lu.se	Vihinen, Mauno/A-8452-2012	Vihinen, Mauno/0000-0002-9614-7976					0	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					261	261		10.1038/521261a	http://dx.doi.org/10.1038/521261a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993922	Green Submitted, Bronze			2022-12-28	WOS:000354816500020
J	Rosenbaum, L				Rosenbaum, Lisa			Understanding Bias - The Case for Careful Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; PHYSICIANS											Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Dana J., 2009, CONFLICT INTEREST ME, P358; Epstein R., 2010, FORBES; Gilovich T., 1991, WE KNOW WHAT ISNT SO; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lo B, 2009, CONFLICT INTEREST ME; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; RELMAN AS, 1980, NEW ENGL J MED, V303, P963, DOI 10.1056/NEJM198010233031703; RELMAN AS, 1984, NEW ENGL J MED, V310, P1182, DOI 10.1056/NEJM198405033101809; ROTHMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P2782, DOI 10.1001/jama.269.21.2782; Shaywitz D A, 2009, WALL STREET J; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	19	63	63	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1959	1963		10.1056/NEJMms1502497	http://dx.doi.org/10.1056/NEJMms1502497			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25970055				2022-12-28	WOS:000354493300015
J	Berwick, DM				Berwick, Donald M.			Postgraduate Education of Physicians Professional Self-regulation and External Accountability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	donberwick@gmail.com						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Berwick DM, 2009, BRIT J GEN PRACT, V59, P128, DOI 10.3399/bjgp08X376438; Bisognano M., 2014, PERSON FAMILY CTR CA; Committee on the Governance and Financing of Graduate Medical Education Board on Health Care Services Institute of Medicine, 2015, GRAD MED ED MEETS NA; Freidson E., 1988, PROFESSION MED STUDY; Gabow PA., 2015, LEAN PRESCRIPTION PO; Kenney C., 2011, TRANSFORMING HLTH CA	7	6	6	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1803	1804		10.1001/jama.2015.4048	http://dx.doi.org/10.1001/jama.2015.4048			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965216				2022-12-28	WOS:000354391000011
J	Fuchs, VR; Cullen, MR				Fuchs, Victor R.; Cullen, Mark R.			The Transformation of US Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Fuchs, Victor R.; Cullen, Mark R.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, 366 Galvez St, Stanford, CA 94305 USA.	vfuchs@stanford.edu		cullen, mark/0000-0001-7996-1864				Boulding Kenneth E., 1989, 3 FACES OF POWER; EBERT RH, 1986, DAEDALUS, V115, P55; Hamilton WH, 1945, PRACTICAL COGITATOR, P266; Hartman M, 2015, HEALTH AFFAIR, V34, P150, DOI 10.1377/hlthaff.2014.1107; ROGERS DE, 1977, DAEDALUS, V106, P81; Starr Paul, 1982, SOCIAL TRANSFORMATIO, P118; Thomas L., 1983, YOUNGEST SCI NOTES M, P6; WEISBROD BA, 1991, J ECON LIT, V29, P523	8	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1821	1822		10.1001/jama.2015.2915	http://dx.doi.org/10.1001/jama.2015.2915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH9XW	25965225				2022-12-28	WOS:000354391000020
J	van Zanten, ARH				van Zanten, Arthur R. H.			Chlorhexidine Bathing and Infections in Critically Ill Patients RESPONSE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TRIAL		[van Zanten, Arthur R. H.] Gelderse Vallei Hosp, Dept Intens Care, NL-6716 RP Ede, Netherlands	Gelderse Vallei Hospital	van Zanten, ARH (corresponding author), Gelderse Vallei Hosp, Dept Intens Care, Care Div, Willy Brandtlaan 10, NL-6716 RP Ede, Netherlands.	zantena@zgv.nl	van Zanten, Arthur R.H./ABB-1169-2021	van Zanten, Arthur R.H./0000-0001-6276-7192				Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; Noto MJ, 2015, JAMA-J AM MED ASSOC, V313, P369, DOI 10.1001/jama.2014.18400; Pittet D, 2015, JAMA-J AM MED ASSOC, V313, P365, DOI 10.1001/jama.2014.18482	3	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1862	1863		10.1001/jama.2015.3527	http://dx.doi.org/10.1001/jama.2015.3527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965238				2022-12-28	WOS:000354391000033
J	Ellingford, JM; Sergouniotis, PI; Lennon, R; Bhaskar, S; Williams, SG; Hillman, KA; O'Sullivan, J; Hall, G; Ramsden, SC; Lloyd, IC; Woolf, AS; Black, GCM				Ellingford, Jamie M.; Sergouniotis, Panagiotis I.; Lennon, Rachel; Bhaskar, Sanjeev; Williams, Simon G.; Hillman, Kate A.; O'Sullivan, James; Hall, Georgina; Ramsden, Simon C.; Lloyd, I. Christopher; Woolf, Adrian S.; Black, Graeme C. M.			Pinpointing clinical diagnosis through whole exome sequencing to direct patient care: a case of Senior-Loken syndrome	LANCET			English	Editorial Material							DISEASE		[Ellingford, Jamie M.; Bhaskar, Sanjeev; Williams, Simon G.; O'Sullivan, James; Hall, Georgina; Ramsden, Simon C.; Black, Graeme C. M.] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Ctr Genom Med, Manchester, Lancs, England; [Sergouniotis, Panagiotis I.; Lloyd, I. Christopher] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Manchester, Lancs, England; [Lennon, Rachel; Woolf, Adrian S.] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Paediat Nephrol, Manchester, Lancs, England; [Hillman, Kate A.] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Renal Med, Manchester, Lancs, England	University of Manchester; Manchester Royal Eye Hospital; University of Manchester; University of Manchester; University of Manchester	Black, GCM (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England.	graeme.black@manchester.ac.uk	wei, wei/HHR-8613-2022; Ellingford, Jamie M/AAZ-7474-2020; Woolf, Adrian S./AAZ-1075-2020; Lennon, Rachel/AAJ-2134-2020; Black, Graeme/K-7374-2015	Ellingford, Jamie M/0000-0003-1137-9768; Woolf, Adrian S./0000-0001-5541-1358; Lennon, Rachel/0000-0001-6400-0227; Williams, Simon/0000-0001-7396-4108; Black, Graeme/0000-0001-8727-6592	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [MR/L002744/1] Funding Source: Medline; Wellcome Trust [088785] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [1355439, 1626609] Funding Source: researchfish; National Institute for Health Research [ACF-2013-06-009, NF-SI-0509-10185] Funding Source: researchfish; Fight for Sight [1801/02] Funding Source: researchfish; MRC [MR/L002744/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330	4	21	22	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1916	1916		10.1016/S0140-6736(15)60496-2	http://dx.doi.org/10.1016/S0140-6736(15)60496-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25987160				2022-12-28	WOS:000354184500036
J	Behrmann, E; Loerke, J; Budkevich, TV; Yamamoto, K; Schmidt, A; Penczek, PA; Vos, MR; Burger, J; Mielke, T; Scheerer, P; Spahn, CMT				Behrmann, Elmar; Loerke, Justus; Budkevich, Tatyana V.; Yamamoto, Kaori; Schmidt, Andrea; Penczek, Pawel A.; Vos, Matthijn R.; Buerger, Joerg; Mielke, Thorsten; Scheerer, Patrick; Spahn, Christian M. T.			Structural Snapshots of Actively Translating Human Ribosomes	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; MESSENGER-RNA; 70S RIBOSOME; E-SITE; EF-TU; MECHANISM; DYNAMICS; SUBUNIT; COMPLEX	Macromolecular machines, such as the ribosome, undergo large-scale conformational changes during their functional cycles. Although their mode of action is often compared to that of mechanical machines, a crucial difference is that, at the molecular dimension, thermodynamic effects dominate functional cycles, with proteins fluctuating stochastically between functional states defined by energetic minima on an energy landscape. Here, we have used cryo-electron microscopy to image ex-vivo-derived human polysomes as a source of actively translating ribosomes. Multiparticle refinement and 3D variability analysis allowed us to visualize a variety of native translation intermediates. Significantly populated states include not only elongation cycle intermediates in pre- and post-translocational states, but also eEF1A-containing decoding and termination/recycling complexes. Focusing on the post-translocational state, we extended this assessment to the single-residue level, uncovering striking details of ribosome-ligand interactions and identifying both static and functionally important dynamic elements.	[Behrmann, Elmar; Loerke, Justus; Budkevich, Tatyana V.; Yamamoto, Kaori; Schmidt, Andrea; Buerger, Joerg; Mielke, Thorsten; Scheerer, Patrick; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Schmidt, Andrea; Scheerer, Patrick] Charite, Inst Med Phys & Biophys, AG Prot X Ray Crystallog, D-10117 Berlin, Germany; [Penczek, Pawel A.] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Vos, Matthijn R.] FEI Co, Nanoport Europe, NL-5651 GG Eindhoven, Netherlands; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Health Science Center Houston; Thermo Fisher Scientific; FEI Company; Max Planck Society	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Charite Pl 1, D-10117 Berlin, Germany.	christian.spahn@charite.de	Behrmann, Elmar/I-5808-2015	Behrmann, Elmar/0000-0001-6794-3669; Burger, Jorg/0000-0002-4326-5047; Scheerer, Patrick/0000-0001-5028-2075; Yamamoto, Kaori/0000-0001-8441-841X; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft DFG [SFB 740, SFB 1078]; DFG Cluster of Excellence "Unifying Concepts in Catalysis'' [D3/E3-1]; HSFP; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite; NIH [R01 GM60635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); DFG Cluster of Excellence "Unifying Concepts in Catalysis''(German Research Foundation (DFG)); HSFP; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Helena Seibel and Brian Bauer for technical support during sample preparation and Alina Bretfeld and Mathias Brunner for initial structural work. The present work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 740 to C.M.T.S., P.S., and T.M.; SFB 1078 to P.S), DFG Cluster of Excellence "Unifying Concepts in Catalysis'' (Research Field D3/E3-1) to P.S., HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite (Rahel-Hirsch stipend to T.V.B.), and by the NIH (R01 GM60635) to P.A.P. E.B. holds a Freigeist-Fellowship from the Volkswagen Foundation. The authors acknowledge the North-German Supercomputing Alliance (HLRN) and the Texas Advanced Computing Center (TACC) at the University of Texas at Austin for providing high-performance computing resources that have contributed to the research results reported in this paper.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Burnett BJ, 2014, J BIOL CHEM, V289, P23917, DOI 10.1074/jbc.M114.583385; Burnett BJ, 2013, J BIOL CHEM, V288, P13917, DOI 10.1074/jbc.M113.460014; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; des Georges A, 2014, NUCLEIC ACIDS RES, V42, P3409, DOI 10.1093/nar/gkt1279; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Frank J, 2013, BIOPOLYMERS, V99, P832, DOI 10.1002/bip.22274; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Moore PB, 2012, ANNU REV BIOPHYS, V41, P1, DOI 10.1146/annurev-biophys-050511-102314; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Myasnikov AG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6294; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Petrov A, 2011, CURR OPIN STRUC BIOL, V21, P137, DOI 10.1016/j.sbi.2010.11.007; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; RICH A, 1963, COLD SPRING HARB SYM, V28, P269, DOI 10.1101/SQB.1963.028.01.043; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stephens S, 2007, THEATER HEUTE, P47; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4	57	111	121	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					845	857		10.1016/j.cell.2015.03.052	http://dx.doi.org/10.1016/j.cell.2015.03.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957688	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000354175200017
J	Gozalo, P; Plotzke, M; Mor, V; Miller, SC; Teno, JM				Gozalo, Pedro; Plotzke, Michael; Mor, Vincent; Miller, Susan C.; Teno, Joan M.			Changes in Medicare Costs with the Growth of Hospice Care in Nursing Homes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE; END; EXPENDITURES; RESIDENTS; DEMENTIA; QUALITY; PROGRAM; IMPROVE	BACKGROUND Nursing home residents' use of hospice has substantially increased. Whether this increase in hospice use reduces end-of-life expenditures is unknown. METHODS The expansion of hospice between 2004 and 2009 created a natural experiment, allowing us to conduct a difference-in-differences matched analysis to examine changes in Medicare expenditures in the last year of life that were associated with this expansion. We also assessed intensive care unit (ICU) use in the last 30 days of life and, for patients with advanced dementia, feeding-tube use and hospital transfers within the last 90 days of life. We compared a subset of hospice users from 2009, whose use of hospice was attributed to hospice expansion, with a matched subset of non-hospice users from 2004, who were considered likely to have used hospice had they died in 2009. RESULTS Of 786,328 nursing home decedents, 27.6% in 2004 and 39.8% in 2009 elected to use hospice. The 2004 and 2009 matched hospice and nonhospice cohorts were similar (mean age, 85 years; 35% male; 25% with cancer). The increase in hospice use was associated with significant decreases in the rates of hospital transfers (2.4 percentage-point reduction), feeding-tube use (1.2 percentage-point reduction), and ICU use (7.1 percentage-point reduction). The mean length of stay in hospice increased from 72.1 days in 2004 to 92.6 days in 2009. Between 2004 and 2009, the expansion of hospice was associated with a mean net increase in Medicare expenditures of $6,761 (95% confidence interval, 6,335 to 7,186), reflecting greater additional spending on hospice care ($10,191) than reduced spending on hospital and other care ($3,430). CONCLUSIONS The growth in hospice care for nursing home residents was associated with less aggressive care near death but at an overall increase in Medicare expenditures. (Funded by the Centers for Medicare and Medicaid Services and the National Institute on Aging.)	[Gozalo, Pedro; Mor, Vincent; Miller, Susan C.; Teno, Joan M.] Brown Univ, Sch Publ Hlth, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Gozalo, Pedro; Mor, Vincent; Miller, Susan C.; Teno, Joan M.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Mor, Vincent] Providence Vet Affairs Med Ctr, Hlth Serv Res, Providence, RI USA; [Plotzke, Michael] Abt Associates Inc, Cambridge, MA USA	Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; ABT Associates	Gozalo, P (corresponding author), Brown Univ, Sch Publ Hlth, Ctr Gerontol & Hlth Care Res, Box G-S121-6, Providence, RI 02912 USA.	pedro_gozalo@brown.edu			Centers for Medicare and Medicaid Services; National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	Centers for Medicare and Medicaid Services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the Centers for Medicare and Medicaid Services and the National Institute on Aging.	[Anonymous], 2011, MED HOSP FOC NURS FA; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; Banaszak-Holl J, 1996, Hosp J, V11, P1, DOI 10.1300/J011v11n03_01; Bureau of Labor Statistics, 2013, CONS PRIC IND MED CA; Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Centers for Medicare Medicaid Services, PROV SERV CURR FIL; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; FRIES JF, 1993, NEW ENGL J MED, V329, P321, DOI 10.1056/NEJM199307293290506; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Gozalo PL, 2008, HEALTH SERV RES, V43, P134, DOI 10.1111/j.1475-6773.2007.00746.x; Kelley AS, 2013, HEALTH AFFAIR, V32, P552, DOI 10.1377/hlthaff.2012.0851; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; Medicare Payment Advisory Committee, 2014, REP C MED PAYM POL; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2010, J AM GERIATR SOC, V58, P1481, DOI 10.1111/j.1532-5415.2010.02968.x; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Newhouse J P, 1989, Health Care Financ Rev, V10, P41; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Plotzke M, 2014, MEDICARE HOSPICE PAY; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; SINGER PA, 1992, ARCH INTERN MED, V152, P478, DOI 10.1001/archinte.152.3.478; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Teno JM, 2011, J AM GERIATR SOC, V59, P1531, DOI 10.1111/j.1532-5415.2011.03505.x	25	64	64	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1823	1831		10.1056/NEJMsa1408705	http://dx.doi.org/10.1056/NEJMsa1408705			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946281	Green Accepted, Bronze			2022-12-28	WOS:000353974700007
J	McInnes, CW; Bellan, L				McInnes, Colin W.; Bellan, Lorne			Conjunctival Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McInnes, Colin W.; Bellan, Lorne] Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba	McInnes, CW (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	lbellan@misericordia.mb.ca		Bellan, Lorne/0000-0002-4649-2739					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1844	1844		10.1056/NEJMicm1405612	http://dx.doi.org/10.1056/NEJMicm1405612			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25946283				2022-12-28	WOS:000353974700009
J	Seehausen, O				Seehausen, Ole			EVOLUTION Beauty varies with the light	NATURE			English	Editorial Material							SEXUAL SELECTION; COLOR PATTERNS		[Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Seehausen, Ole] Swiss Fed Inst Aquat Sci & Technol Eawag, Kastanienbaum, Switzerland	University of Bern; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Seehausen, O (corresponding author), Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland.	ole.seehausen@eawag.ch	Seehausen, Ole/C-8272-2011	Seehausen, Ole/0000-0001-6598-1434				Andersson Malte, 1994; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Cole GL, 2015, AM NAT, V185, P452, DOI 10.1086/680022; Darwin C., 1871, P475; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; Fuller RC, 2010, ANIM BEHAV, V80, P23, DOI 10.1016/j.anbehav.2010.03.017; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Johnston SE, 2013, NATURE, V502, P93, DOI 10.1038/nature12489; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285	17	6	6	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					34	35		10.1038/521034a	http://dx.doi.org/10.1038/521034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951278				2022-12-28	WOS:000354040900022
J	Walther, DM; Kasturi, P; Zheng, M; Pinkert, S; Vecchi, G; Ciryam, P; Morimoto, RI; Dobson, CM; Vendruscolo, M; Mann, M; Hartl, FU				Walther, Dirk M.; Kasturi, Prasad; Zheng, Min; Pinkert, Stefan; Vecchi, Giulia; Ciryam, Prajwal; Morimoto, Richard I.; Dobson, Christopher M.; Vendruscolo, Michele; Mann, Matthias; Hartl, F. Ulrich			Widespread Proteome Remodeling and Aggregation in Aging C-elegans	CELL			English	Article							HEAT-SHOCK PROTEINS; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; PROTEOTOXIC STRESS; GENE-EXPRESSION; AMINO-ACIDS; LIFE-SPAN; PROTEOSTASIS; LONGEVITY	Aging has been associated with a progressive decline of proteostasis, but how this process affects proteome composition remains largely unexplored. Here, we profiled more than 5,000 proteins along the lifespan of the nematode C. elegans. We find that one-third of proteins change in abundance at least 2-fold during aging, resulting in a severe proteome imbalance. These changes are reduced in the long-lived daf-2 mutant but are enhanced in the short-lived daf-16 mutant. While ribosomal proteins decline and lose normal stoichiometry, proteasome complexes increase. Proteome imbalance is accompanied by widespread protein aggregation, with abundant proteins that exceed solubility contributing most to aggregate load. Notably, the properties by which proteins are selected for aggregation differ in the daf-2 mutant, and an increased formation of aggregates associated with small heat-shock proteins is observed. We suggest that sequestering proteins into chaperone-enriched aggregates is a protective strategy to slow proteostasis decline during nematode aging.	[Walther, Dirk M.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Kasturi, Prasad; Zheng, Min; Pinkert, Stefan; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Vecchi, Giulia; Ciryam, Prajwal; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ciryam, Prajwal; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Max Planck Society; Max Planck Society; University of Cambridge; Northwestern University	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Kasturi, Prasad/GLT-6507-2022; Hartl, F. Ulrich/Y-8206-2019; Vendruscolo, Michele/F-5901-2012	Kasturi, Prasad/0000-0002-3611-5489; Vendruscolo, Michele/0000-0002-3616-1610	European Commission [ERC-2012-SyG_318987]; Wellcome Trust [094425/Z/10/Z]; Center for Integrated Protein Science Munich (CIPSM); Munich Cluster for Systems Neurology (SyNergy); NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026647, R01AG026647] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Center for Integrated Protein Science Munich (CIPSM); Munich Cluster for Systems Neurology (SyNergy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Caenorhabditis Genetics Center for providing most of the strains used in this study. hsp-16.1:: gfp transgenic worms were provided by Dr. Junho Lee, Seoul National University. This work was supported by the European Commission under FP7 GA number ERC-2012-SyG_318987-Toxic Protein Aggregation in Neurodegeneration (ToPAG), the Wellcome Trust (094425/Z/10/Z), the Center for Integrated Protein Science Munich (CIPSM), and the Munich Cluster for Systems Neurology (SyNergy). We would further like to thank Igor Paron and Korbinian Mayr for excellent technical assistance with MS instrumentation, as well as Daniel Hornburg, Manajit Hayer-Hartl, and members of the Hartl laboratory for critically reading this manuscript.	Andersson V, 2013, AGING-US, V5, P802, DOI 10.18632/aging.100613; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Sormanni P, 2015, J MOL BIOL, V427, P982, DOI 10.1016/j.jmb.2014.12.007; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vendruscolo M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a010454; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	61	326	331	1	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					919	932		10.1016/j.cell.2015.03.032	http://dx.doi.org/10.1016/j.cell.2015.03.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957690	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000354175200023
J	Watts, G				Watts, Geoff			Henry Harris Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1616	1616		10.1016/S0140-6736(15)60785-1	http://dx.doi.org/10.1016/S0140-6736(15)60785-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25943809				2022-12-28	WOS:000353418000022
J	Beyrer, C; Bekker, LG; Pozniak, A; Barre-Sinoussi, F				Beyrer, Chris; Bekker, Linda-Gail; Pozniak, Anton; Barre-Sinoussi, Francoise			Pre-exposure prophylaxis works-it's time to deliver	LANCET			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS; HIV; WOMEN; MEN		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Pozniak, Anton] Chelsea & Westminster NHS Fdn Trust, London, England; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386				AVAC, 2015, PREV LIN AVA C REP 2; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bukusi, 2015, C RETR OPP INF 2015; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme for HIV/ AIDS (UNAIDS), 2014, THE GAP REP 2014; McCormack SDD, 2015, C RETR OPP INF 2015; Molina JMCC., 2015, C RETR OPP INF 2015; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; US Public Health Service, 2014, PREEXP PROPH PREV HI; World Health Organization, ANT THER ART COV ALL	12	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1482	1484		10.1016/S0140-6736(15)60724-3	http://dx.doi.org/10.1016/S0140-6736(15)60724-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25933264				2022-12-28	WOS:000353220000006
J	Roberts, TE; Harden, RM				Roberts, Trudie E.; Harden, Ronald M.			Coalition: the way forward for medical education	LANCET			English	Editorial Material									[Roberts, Trudie E.] Univ Leeds, Leeds Inst Med Educ, Leeds LS2 9JT, W Yorkshire, England; [Harden, Ronald M.] Assoc Med Educ Europe, Dundee, Scotland	University of Leeds	Roberts, TE (corresponding author), Univ Leeds, Leeds Inst Med Educ, Leeds LS2 9JT, W Yorkshire, England.	t.e.roberts@leeds.ac.uk						[Anonymous], 2015, OXFORD ENGLISH DICT; Berlin Anne C, 2014, Acad Med, V89, P1573, DOI 10.1097/ACM.0000000000000473; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; General Medical Council, 2009, TOM DOCT OUTC STAND; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Min, 2011, HLTH MEDICAL TECHNOL	6	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1479	1480		10.1016/S0140-6736(15)60685-7	http://dx.doi.org/10.1016/S0140-6736(15)60685-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25933263				2022-12-28	WOS:000353220000004
J	MacKay, CR; Torguson, R; Waksman, R				MacKay, Charles R.; Torguson, Rebecca; Waksman, Ron			Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?	LANCET			English	Article							BIVALIRUDIN; HEAT		[MacKay, Charles R.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Torguson, Rebecca; Waksman, Ron] MedStar Washington Hosp Ctr, Washington, DC 20010 USA	MedStar Health Research Institute; MedStar Washington Hospital Center	Waksman, R (corresponding author), MedStar Washington Hosp Ctr, Cardiovasc Res & Adv Educ, Washington, DC 20010 USA.	Ron.waksman@medstar.net						[Anonymous], 1979, BELM REP ETH PRINC G; [Anonymous], 2014, MEDSCAPE SPECIAL REP; Berger PB, 2014, LANCET, V384, P1824, DOI 10.1016/S0140-6736(14)61041-2; Council for International Organizations of Medical Sciences, 2002, Bull Med Ethics, P17; Department of Health and Human Services (DHHS), 1996, FED REGISTER, V61, P51531; Department of Health and Human Services National Institutes of Health, 1998, FED REGISTER, V63, P60364; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Shaw D, 2014, LANCET, V384, P1826, DOI 10.1016/S0140-6736(14)61040-0; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; World Medical Association, DECL HELS ETH PRINC	16	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					714	716		10.1016/S0140-6736(15)60077-0	http://dx.doi.org/10.1016/S0140-6736(15)60077-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	25960111				2022-12-28	WOS:000359849200038
J	Frat, JP; Thille, AW; Mercat, A; Girault, C; Ragot, S; Perbet, S; Prat, G; Boulain, T; Morawiec, E; Cottereau, A; Devaquet, J; Nseir, S; Razazi, K; Mira, JP; Argaud, L; Chakarian, JC; Ricard, JD; Wittebole, X; Chevalier, S; Herbland, A; Fartoukh, M; Constantin, JM; Tonnelier, JM; Pierrot, M; Mathonnet, A; Beduneau, G; Deletage-Metreau, C; Richard, JCM; Brochard, L; Robert, R				Frat, Jean-Pierre; Thille, Arnaud W.; Mercat, Alain; Girault, Christophe; Ragot, Stephanie; Perbet, Sebastien; Prat, Gwenael; Boulain, Thierry; Morawiec, Elise; Cottereau, Alice; Devaquet, Jerome; Nseir, Saad; Razazi, Keyvan; Mira, Jean-Paul; Argaud, Laurent; Chakarian, Jean-Charles; Ricard, Jean-Damien; Wittebole, Xavier; Chevalier, Stephanie; Herbland, Alexandre; Fartoukh, Muriel; Constantin, Jean-Michel; Tonnelier, Jean-Marie; Pierrot, Marc; Mathonnet, Armelle; Beduneau, Gaetan; Deletage-Metreau, Celine; Richard, Jean-Christophe M.; Brochard, Laurent; Robert, Rene		FLORALI Study Grp; REVA Network	High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; BERLIN DEFINITION; DISTRESS-SYNDROME; CLINICAL-TRIALS; THERAPY; ARDS	BACKGROUND Whether noninvasive ventilation should be administered in patients with acute hypoxemic respiratory failure is debated. Therapy with high-flow oxygen through a nasal cannula may offer an alternative in patients with hypoxemia. METHODS We performed a multicenter, open-label trial in which we randomly assigned patients without hypercapnia who had acute hypoxemic respiratory failure and a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 300 mm Hg or less to high-flow oxygen therapy, standard oxygen therapy delivered through a face mask, or noninvasive positive-pressure ventilation. The primary outcome was the proportion of patients intubated at day 28; secondary outcomes included all-cause mortality in the intensive care unit and at 90 days and the number of ventilator-free days at day 28. RESULTS A total of 310 patients were included in the analyses. The intubation rate (primary outcome) was 38% (40 of 106 patients) in the high-flow-oxygen group, 47% (44 of 94) in the standard group, and 50% (55 of 110) in the noninvasive-ventilation group (P = 0.18 for all comparisons). The number of ventilator-free days at day 28 was significantly higher in the high-flow-oxygen group (24 +/- 8 days, vs. 22 +/- 10 in the standard-oxygen group and 19 +/- 12 in the noninvasive-ventilation group; P = 0.02 for all comparisons). The hazard ratio for death at 90 days was 2.01 (95% confidence interval [CI], 1.01 to 3.99) with standard oxygen versus high-flow oxygen (P = 0.046) and 2.50 (95% CI, 1.31 to 4.78) with noninvasive ventilation versus high-flow oxygen (P = 0.006). CONCLUSIONS In patients with nonhypercapnic acute hypoxemic respiratory failure, treatment with high-flow oxygen, standard oxygen, or noninvasive ventilation did not result in significantly different intubation rates. There was a significant difference in favor of high-flow oxygen in 90-day mortality.	[Frat, Jean-Pierre; Thille, Arnaud W.; Deletage-Metreau, Celine; Robert, Rene] Ctr Hosp Univ Poitiers, Serv Reanimat Med, F-86021 Poitiers, France; [Frat, Jean-Pierre; Thille, Arnaud W.; Ragot, Stephanie; Robert, Rene] Univ Poitiers, INSERM, Ctr Invest Clin 1402, Poitiers, France; [Mercat, Alain; Pierrot, Marc] CHU Angers, Serv Reanimat Med & Med Hyperbare, Angers, France; [Girault, Christophe; Beduneau, Gaetan] CHU Rouen, Hop Charles Nicolle, Serv Reanimat Med, Rouen, France; [Girault, Christophe; Beduneau, Gaetan] Univ Rouen, Inst Biomed Res & Innovat, Rouen, France; [Perbet, Sebastien; Constantin, Jean-Michel] CHU Clermont Ferrand, Pole Med Perioperatoire, Clermont Ferrand, France; [Perbet, Sebastien; Constantin, Jean-Michel] Auvergne Univ, Clermont Ferrand, France; [Prat, Gwenael; Tonnelier, Jean-Marie] CHU Cavale Blanche, Serv Reanimat Med, Brest, France; [Mercat, Alain; Boulain, Thierry] Ctr Hosp Reg Orleans, Reanimat Medicochirurg, Orleans, France; [Morawiec, Elise] Grp Hosp Univ Pitie Salpetriere, Serv Pneumol & Reanimat Med, Paris, France; [Morawiec, Elise] Univ Paris 06, Paris, France; [Mira, Jean-Paul] Hop Cochin, Grp Hosp Univ Paris Ctr, AP HP, Reanimat Med, F-75674 Paris, France; [Mira, Jean-Paul] Univ Paris 05, Paris, France; [Ricard, Jean-Damien] Univ Paris Diderot, Paris, France; [Ricard, Jean-Damien] INSERM, Infect Antimicrobiens Modelisat Evolut 1137, Paris, France; [Fartoukh, Muriel] Hop Tenon, Serv Reanimat, AP HP, F-75970 Paris, France; [Cottereau, Alice] Ctr Hosp Dept La Roche Yon, Serv Reanimat Polyvalente, La Roche Sur Yon, France; [Devaquet, Jerome] Hop Foch, Reanimat Polyvalente, Suresnes, France; [Nseir, Saad] CHU Lille, Ctr Reanimat, F-59037 Lille, France; [Razazi, Keyvan] CHU Henri Mondor, AP HP, Serv Reanimat Med, F-94010 Creteil, France; [Razazi, Keyvan] Univ Paris Est Creteil, Grp Rech Clin, Creteil, France; [Razazi, Keyvan; Richard, Jean-Christophe M.; Brochard, Laurent] Hop Henri Mondor, INSERM, UMR 955, F-94010 Creteil, France; [Argaud, Laurent] Hosp Civils Lyon, Grp Hosp Univ Edouard Herriot, Serv Reanimat Med, Lyon, France; [Chakarian, Jean-Charles] Ctr Hosp Roanne, Reanimat Polyvalente, Roanne, France; [Ricard, Jean-Damien] Hop Louis Mourier, AP HP, Serv Reanimat Medicochirurg, F-92701 Colombes, France; [Chevalier, Stephanie] Ctr Hosp St Malo, Serv Reanimat Polyvalente, St Malo, France; [Herbland, Alexandre] Ctr Hosp La Rochelle, Hop St Louis, Serv Reanimat, La Rochelle, France; [Richard, Jean-Christophe M.] Ctr Hosp Reg Annecy, Serv Urgences, Annecy, France; [Wittebole, Xavier] Clin Univ St Luc, Serv Soins Intensifs, B-1200 Brussels, Belgium; [Brochard, Laurent] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Toronto, ON, Canada; [Brochard, Laurent] Univ Toronto, St Michaels Hosp, Crit Care Dept, Toronto, ON, Canada; [Brochard, Laurent] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Rouen; Universite de Rouen Normandie; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Brest; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Annecy Genevois; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Frat, JP (corresponding author), Ctr Hosp Univ Poitiers, Serv Reanimat Med, 2 Rue Miletrie,CS 90577, F-86021 Poitiers, France.	jean-pierre.frat@chu-poitiers.fr	Boulain, Thierry/M-3309-2019; Wittebole, Xavier/ABC-2036-2021; Mercat, Alain/AFU-4426-2022; Asfar, Pierre/K-1402-2015; Carmen, Team3/Y-7384-2019	Boulain, Thierry/0000-0003-4664-3661; Wittebole, Xavier/0000-0002-0621-8727; Carmen, Team3/0000-0002-3614-0924; DANIN, Pierre-Eric/0000-0003-4234-7726; Nseir, Saad/0000-0002-7618-0357; Lab, Carmen/0000-0002-5935-3236; Coudroy, Remi/0000-0002-0036-1899	Programme Hospitalier de Recherche Clinique Interregional of the French Ministry of Health; FLORALI	Programme Hospitalier de Recherche Clinique Interregional of the French Ministry of Health; FLORALI	Funded by the Programme Hospitalier de Recherche Clinique Interregional 2010 of the French Ministry of Health; FLORALI ClinicalTrials.gov number, NCT01320384.	Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Chanques G, 2013, MINERVA ANESTESIOL, V79, P1344; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; Cuquemelle E, 2012, RESP CARE, V57, P1571, DOI 10.4187/respcare.01681; de Prost N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-28; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Demoule A, 2006, INTENS CARE MED, V32, P1756, DOI 10.1007/s00134-006-0324-1; DREYFUSS D, 1993, AM REV RESPIR DIS, V148, P1194, DOI 10.1164/ajrccm/148.5.1194; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Frat JP, 2015, RESP CARE, V60, P170, DOI 10.4187/respcare.03075; Hashemian SM, 2014, NEW ENGL J MED, V370, P979, DOI 10.1056/NEJMc1400293; Keenan SP, 2003, ANN INTERN MED, V138, P861, DOI 10.7326/0003-4819-138-11-200306030-00007; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Martin TJ, 2000, AM J RESP CRIT CARE, V161, P807, DOI 10.1164/ajrccm.161.3.9808143; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Messika J, 2015, RESP CARE, V60, P162, DOI 10.4187/respcare.03423; Pham T. M., 2014, PEDIAT PULMONOL; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Roca O, 2010, RESP CARE, V55, P408; Schettino G, 2008, CRIT CARE MED, V36, P441, DOI 10.1097/01.CCM.0000300084.67277.90; Sztrymf B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.075; Sztrymf B, 2011, INTENS CARE MED, V37, P1780, DOI 10.1007/s00134-011-2354-6; Thille AW, 2013, CRIT CARE, V17, DOI 10.1186/cc13103; Ugurlu AO, 2014, CHEST, V145, P964, DOI 10.1378/chest.13-1707; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761	34	1141	1253	3	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2185	2196		10.1056/NEJMoa1503326	http://dx.doi.org/10.1056/NEJMoa1503326			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	25981908				2022-12-28	WOS:000355955100003
J	Casalino, LP; Bishop, TF				Casalino, Lawrence P.; Bishop, Tara F.			Symbol of Health System Transformation? Assessing the CMS Innovation Center	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Casalino, Lawrence P.; Bishop, Tara F.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA	Cornell University	Casalino, LP (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA.		Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859	NATIONAL INSTITUTE ON AGING [K23AG043499] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG043499] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2012, GAO1312 CMS INN CTR; Centers for Medicare and Medicaid Innovation, 2014, REP C; Pronovost P, 2014, NEW ENGL J MED, V371, P691, DOI 10.1056/NEJMp1405800; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Shrank W, 2013, HEALTH AFFAIR, V32, P807, DOI 10.1377/hlthaff.2013.0216	5	4	4	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1984	1985		10.1056/NEJMp1500457	http://dx.doi.org/10.1056/NEJMp1500457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5PD	25992745	Green Accepted			2022-12-28	WOS:000354809300004
J	Mevius, L				Mevius, Lucas			Dutch government in court for violating international tobacco treaty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												l.mevius@ntvg.nl						World Health Organization, WHO FRAM CONV TOB CO; Youth Smoking Prevention Foundation, ANN REP 2014; Youth Smoking Prevention Foundation, 5 YEARS ACT	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2519	10.1136/bmj.h2519	http://dx.doi.org/10.1136/bmj.h2519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YZ	25994792				2022-12-28	WOS:000355128700006
J	Lenzer, J				Lenzer, Jeanne			Centers for Disease Control and Prevention: protecting the private good?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC KIDNEY-DISEASE; CENTRAL-AMERICA; OSELTAMIVIR; INFLUENZA; EPIDEMIC; ADULTS					jlenzer@bmj.com						CDC, 2015, WHY CDC REC INFL ANT; Chavkin S, 2014, GLOBAL MUCKRAKER; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Koretz R, 2014, BMJ-BRIT MED J, V350, pg7809; Lenzer J, 2015, HEALTHNEWSREVIE 0210; Lenzer J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h658; Levinson DR, 2009, CDCS ETHICS PROGRAM; Mandrola J, 2015, PUBLIC TRUST CDC TAM; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Ordunez P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003019; Ramirez-Rubio O, 2013, POSTGRAD MED J, V89, P123, DOI 10.1136/postgradmedj-2012-201141rep; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1	14	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2015	350								h2362	10.1136/bmj.h2362	http://dx.doi.org/10.1136/bmj.h2362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CN	25979454				2022-12-28	WOS:000354770600001
J	Mohn, F; Handler, D; Brennecke, J				Mohn, Fabio; Handler, Dominik; Brennecke, Julius			piRNA-guided slicing specifies transcripts for Zucchini-dependent, phased piRNA biogenesis	SCIENCE			English	Article							SMALL RNAS; NUAGE FORMATION; MOUSE TESTES; DROSOPHILA; GERMLINE; PROTEIN; SPERMATOGENESIS; MITOPLD; COMPLEX; GENOME	In animal gonads, PIWI-clade Argonaute proteins repress transposons sequence-specifically via bound Piwi-interacting RNAs (piRNAs). These are processed from single-stranded precursor RNAs by largely unknown mechanisms. Here we show that primary piRNA biogenesis is a 3'-directed and phased process that, in the Drosophila germ line, is initiated by secondary piRNA-guided transcript cleavage. Phasing results from consecutive endonucleolytic cleavages catalyzed by Zucchini, implying coupled formation of 3' and 5' ends of flanking piRNAs. Unexpectedly, Zucchini also participates in 3' end formation of secondary piRNAs. Its function can, however, be bypassed by downstream piRNA-guided precursor cleavages coupled to exonucleolytic trimming. Our data uncover an evolutionarily conserved piRNA biogenesis mechanism in which Zucchini plays a central role in defining piRNA 5' and 3' ends.	[Mohn, Fabio; Handler, Dominik; Brennecke, Julius] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Brennecke, J (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Mohn, Fabio/0000-0001-9889-5225; Handler, Dominik/0000-0002-1059-4960	Austrian Academy of Sciences; European Community (European Research Council) [260711EU]; Austrian Science Fund [Y 510-B12]; Swiss National Science Foundation; Human Frontier Science Program fellowships; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community (European Research Council)(European CommissionEuropean Research Council (ERC)); Austrian Science Fund(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program fellowships; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. Gokcezade for fly injections, Harvard TRiP and Bloomington stock centers for flies, D. Jurczak for bioinformatics support, the Campus Science Support Facilities Next Generation Sequencing unit for Illumina sequencing, and P. Zamore for sharing unpublished data. This work was supported by the Austrian Academy of Sciences, the European Community (European Research Council grant 260711EU), the Austrian Science Fund (grant Y 510-B12), and Swiss National Science Foundation and Human Frontier Science Program fellowships to F.M. Sequencing data sets are deposited at Gene Expression Omnibus (accession numbers GSE64802 and GSE55842).	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Shpiz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004138; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030	28	205	206	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					812	817		10.1126/science.aaa1039	http://dx.doi.org/10.1126/science.aaa1039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977553	Green Accepted			2022-12-28	WOS:000354428700047
J	Teirstein, PS; Topol, EJ				Teirstein, Paul S.; Topol, Eric J.			The Role of Maintenance of Certification Programs in Governance and Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BOARD CERTIFICATION; ASSOCIATION		[Teirstein, Paul S.; Topol, Eric J.] Scripps Hlth, Scripps Clin, Scripps Prebys Cardiovasc Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Res Inst, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Genom Med, Scripps Translat Sci Inst, 3344 N Torrey Pines Ct, La Jolla, CA 92037 USA.	etopol@scripps.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001114] Funding Source: Medline; NCRR NIH HHS [UL1 RR025774, 5 UL1RR025774] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Board of Medical Specialities, STEPS IN CERT MOC; Federation of State Medical Boards, REP MAINT LIC IMPL G; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Hayes J, 2014, JAMA-J AM MED ASSOC, V312, P2358, DOI 10.1001/jama.2014.13992; Hershberger PJ, 2014, JAMA-J AM MED ASSOC, V312, P2613, DOI 10.1001/jama.2014.13304; Lipner RS, 2013, J CONTIN EDUC HEALTH, V33, pS20, DOI 10.1002/chp.21203; National Board of Physicians and Surgeons, TERST COMM REC DEB M; Nora LM, 2013, J CONTIN EDUC HEALTH, V33, pS5, DOI 10.1002/chp.21199; Physicians for Certification Change, PET PLEDG NONC; Topol EJ, 2015, PATIENT WILL SEE YOU, P31	10	35	35	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1809	1810		10.1001/jama.2015.3576	http://dx.doi.org/10.1001/jama.2015.3576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965219	Green Accepted			2022-12-28	WOS:000354391000014
J	Koren, E; Lortscher, E; Rawlings, C; Knoll, AW; Duerig, U				Koren, Elad; Loertscher, Emanuel; Rawlings, Colin; Knoll, Armin W.; Duerig, Urs			Adhesion and friction in mesoscopic graphite contacts	SCIENCE			English	Article							CARBON NANOTUBES; SUPERLUBRICITY; NANOSCALE; GRAPHENE; ENERGY	The weak interlayer binding in two-dimensional layered materials such as graphite gives rise to poorly understood low-friction characteristics. Accurate measurements of the adhesion forces governing the overall mechanical stability have also remained elusive. We report on the direct mechanical measurement of line tension and friction forces acting in sheared mesoscale graphite structures. We show that the friction is fundamentally stochastic in nature and is attributable to the interaction between the incommensurate interface lattices. We also measured an adhesion energy of 0.227 +/- 0.005 joules per square meter, in excellent agreement with theoretical models. In addition, bistable all-mechanical memory cell structures and rotational bearings have been realized by exploiting position locking, which is provided solely by the adhesion energy.	[Koren, Elad; Loertscher, Emanuel; Rawlings, Colin; Knoll, Armin W.; Duerig, Urs] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland	International Business Machines (IBM)	Duerig, U (corresponding author), IBM Res Zurich, Saumerstasse 4, CH-8803 Ruschlikon, Switzerland.	drg@zurich.ibm.com	Knoll, Armin W/F-3553-2011	Knoll, Armin W/0000-0003-2301-3149; Duerig, Urs/0000-0003-4017-1894	FP7 Marie Curie Actions of the European Commission; ITN fellowship cQOM [290161]	FP7 Marie Curie Actions of the European Commission; ITN fellowship cQOM	We thank U. Drechsler and M. Tschudy for invaluable technical support and M. Despont, D. Grogg, O. Hod, and R. Allenspach for stimulating discussions. Supported by the FP7 Marie Curie Actions of the European Commission and ITN fellowship cQOM (Project ID 290161) (E.K.). Data are available in the supplementary materials or upon request.	Barreiro A, 2008, SCIENCE, V320, P775, DOI 10.1126/science.1155559; Benedict LX, 1998, CHEM PHYS LETT, V286, P490, DOI 10.1016/S0009-2614(97)01466-8; BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; Chen XB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03046; Cumings J, 2000, SCIENCE, V289, P602, DOI 10.1126/science.289.5479.602; Wijn AS, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085429; de Wijn AS, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046105; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Dietzel D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.235502; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Filippov AE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046102; Gnecco E., 2007, FUNDAMENTALS FRICTIO; Kis A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025501; Kolmogorov AN, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235415; Koren E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6837; Lebegue S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196401; Liu Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205503; Liu Z, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205418; MARTIN JM, 1993, PHYS REV B, V48, P10583, DOI 10.1103/PhysRevB.48.10583; Muser MH, 2001, PHYS REV LETT, V86, P1295, DOI 10.1103/PhysRevLett.86.1295; San-Jose P, 2014, NANO LETT, V14, P2052, DOI 10.1021/nl500230a; Spanu L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.196401; Tartaglino U, 2006, J PHYS-CONDENS MAT, V18, P4143, DOI 10.1088/0953-8984/18/17/004; Vanossi A, 2013, REV MOD PHYS, V85, P529, DOI 10.1103/RevModPhys.85.529; Zacharia R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155406	26	163	167	12	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					679	683		10.1126/science.aaa4157	http://dx.doi.org/10.1126/science.aaa4157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954007				2022-12-28	WOS:000354045700042
J	Brunham, RC; Gottlieb, SL; Paavonen, J				Brunham, Robert C.; Gottlieb, Sami L.; Paavonen, Jorma			Pelvic Inflammatory Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRACHOMATIS GENITAL-INFECTION; CHLAMYDIA-TRACHOMATIS; MYCOPLASMA-GENITALIUM; TREATMENT STRATEGIES; BACTERIAL VAGINOSIS; CONTROLLED-TRIAL; INFERTILE WOMEN; UNITED-STATES; GONORRHEA; RISK	Pelvic inflammatory disease is an infection-induced inflammation of the female upper reproductive tract (the endometrium, fallopian tubes, ovaries, or pelvic peritoneum); it has a wide range of clinical manifestations.(1) Inflammation spreads from the vagina or cervix to the upper genital tract, with endometritis as an intermediate stage in the pathogenesis of disease.(2) The hallmark of the diagnosis is pelvic tenderness combined with inflammation of the lower genital tract; women with pelvic inflammatory disease often have very subtle symptoms and signs. 3 Many women have clinically silent spread of infection to the upper genital tract, which results in subclinical pelvic inflammatory disease.(1,4) Pelvic inflammatory disease is a major concern because it can result in long-term reproductive disability, including infertility, ectopic pregnancy, and chronic pelvic pain. After the introduction of laparoscopy in the 1960s, research on pelvic inflammatory disease proliferated through the 1970s, 1980s, and 1990s, leading to major breakthroughs in the understanding of the microbial causes of the disease and its relationship to reproductive disability, as well as enabling the standardization of antimicrobial treatment. According to a national estimate, in 2001 more than 750,000 cases of pelvic inflammatory disease occurred in the United States.(5) Over the past two decades, the rates and severity of pelvic inflammatory disease have declined in North America and western Europe.(6-9) These declines have occurred in association with public health efforts to control Chlamydia trachomatis and Neisseria gonorrhoeae infection.(6,10,11) Despite progress, however, pelvic inflammatory disease remains a problem because reproductive outcomes among treated patients are still suboptimal, subclinical pelvic inflammatory disease remains poorly controlled, and programs aimed at the prevention of pelvic inflammatory disease are not feasible in much of the developing world.	[Brunham, Robert C.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 4R4, Canada; [Gottlieb, Sami L.] WHO, Dept Reproduct Hlth & Res, Geneva, Switzerland; [Paavonen, Jorma] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland	University of British Columbia; World Health Organization; University of Helsinki	Brunham, RC (corresponding author), Univ British Columbia, Dept Med, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada.	robert.brunham@bccdc.ca	Griffin, Jeff/AAH-6994-2020	Paavonen, Jorma/0000-0003-4775-606X				AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], 2013, SEX TRANSM INF EUR 1; Anschuetz GL, 2012, J ADOLESCENT HEALTH, V51, P80, DOI 10.1016/j.jadohealth.2011.11.002; Bender N, 2011, SEX TRANSM INFECT, V87, P601, DOI 10.1136/sextrans-2011-050205; Bjartling C, 2010, BJOG-INT J OBSTET GY, V117, P361, DOI 10.1111/j.1471-0528.2009.02455.x; Bjartling C, 2012, AM J OBSTET GYNECOL, V206; Bohm MK, 2010, SEX TRANSM DIS, V37, P131, DOI 10.1097/OLQ.0b013e3181bf576f; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; BRUNHAM RC, 1984, NEW ENGL J MED, V311, P1, DOI 10.1056/NEJM198407053110101; BRUNHAM RC, 1988, J INFECT DIS, V158, P510, DOI 10.1093/infdis/158.3.510; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Burnett AM, 2012, AM J EMERG MED, V30, P1114, DOI 10.1016/j.ajem.2011.07.014; CATES W, 1985, LANCET, V2, P596; *CDCP, 2013, 2011 ASS REPR TECHN; Centers for Disease Control and Prevention, 2013, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2010, PELV INFL DIS STD TR; Cohen CR, 1998, J INFECT DIS, V178, P1352, DOI 10.1086/314465; Darville T, 2013, SEX TRANSM DIS, V40, P761, DOI 10.1097/OLQ.0000000000000028; Dhasmana D, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-79; Dhont N, 2011, TROP DOCT, V41, P96, DOI 10.1258/td.2011.100410; Draper DL, 2000, AM J OBSTET GYNECOL, V183, P1243, DOI 10.1067/mob.2000.107383; Eschenbach DA, 1997, OBSTET GYNECOL, V89, P184, DOI 10.1016/S0029-7844(96)00429-2; ESCHENBACH DA, 1975, NEW ENGL J MED, V293, P166, DOI 10.1056/NEJM197507242930403; French CE, 2011, SEX TRANSM DIS, V38, P158, DOI 10.1097/OLQ.0b013e3181f22f3e; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Gottlieb SL, 2013, SEX TRANSM DIS, V40, P97, DOI 10.1097/OLQ.0b013e31827bd637; Goyal M, 2013, J ADOLESCENT HEALTH, V53, P249, DOI 10.1016/j.jadohealth.2013.03.016; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hebb JK, 2004, J INFECT DIS, V190, P2109, DOI 10.1086/425929; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; Kirkcaldy RD, 2013, JAMA-J AM MED ASSOC, V309, P185, DOI 10.1001/jama.2012.205107; KIVIAT NB, 1990, AM J SURG PATHOL, V14, P167, DOI 10.1097/00000478-199002000-00008; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Miguel RDV, 2011, PATHOL RES PRACT, V207, P680, DOI 10.1016/j.prp.2011.08.007; Molander P, 2003, OBSTET GYNECOL, V101, P875, DOI 10.1016/S0029-7844(03)00013-9; Molander P, 2001, ULTRASOUND OBST GYN, V17, P233, DOI 10.1046/j.1469-0705.2001.00353.x; Ness RB, 2005, OBSTET GYNECOL, V106, P573, DOI 10.1097/01.AOG.0000175193.37531.6e; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Ness RB, 2004, AM J PUBLIC HEALTH, V94, P1327, DOI 10.2105/AJPH.94.8.1327; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; PAAVONEN J, 1989, BRIT J OBSTET GYNAEC, V96, P574, DOI 10.1111/j.1471-0528.1989.tb03259.x; Paavonen J., 2007, SEX TRANSM DIS, V4th; PATTON DL, 1989, OBSTET GYNECOL, V73, P622; Peeling RW, 2011, SEX TRANSM INFECT, V87, pII28, DOI 10.1136/sti.2010.047647; Peipert JF, 1996, OBSTET GYNECOL, V87, P730, DOI 10.1016/0029-7844(96)00040-3; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Reighard SD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.031; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; ROBERTSON JN, 1987, J CLIN PATHOL, V40, P377, DOI 10.1136/jcp.40.4.377; Ross JDC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1538; Sakhel K, 2013, J ULTRAS MED, V32, P381; Schappert Susan M, 2008, Natl Health Stat Report, P1; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; SELLORS J, 1991, AM J OBSTET GYNECOL, V164, P113, DOI 10.1016/0002-9378(91)90639-9; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; SOPER DE, 1994, AM J OBSTET GYNECOL, V170, P1008, DOI 10.1016/S0002-9378(94)70094-X; Sutton MY, 2005, SEX TRANSM DIS, V32, P778, DOI 10.1097/01.olq.0000175375.60973.cb; Tepper NK, 2013, CONTRACEPTION, V87, P655, DOI 10.1016/j.contraception.2012.08.011; Tsai HT, 2013, FERTIL STERIL, V99, P490, DOI 10.1016/j.fertnstert.2012.10.010; Tukeva TA, 1999, RADIOLOGY, V210, P209, DOI 10.1148/radiology.210.1.r99ja04209; WASSERHEIT JN, 1986, ANN INTERN MED, V104, P187, DOI 10.7326/0003-4819-104-2-187; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WHO, 2012, GLOB INC PREV SEL CU; Wiesenfeld H, 2008, SEXUALLY TRANSMITTED; Wiesenfeld HC, 2012, OBSTET GYNECOL, V120, P37, DOI 10.1097/AOG.0b013e31825a6bc9; Wiesenfeld HC, 2005, SEX TRANSM DIS, V32, P400, DOI 10.1097/01.olq.0000154508.26532.6a; WOLNERHANSSEN P, 1995, OBSTET GYNECOL, V86, P321, DOI 10.1016/0029-7844(95)00177-S; Zakher B, 2014, ANN INTERN MED, V161, P884, DOI 10.7326/M14-1022	73	213	234	5	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2039	2048		10.1056/NEJMra1411426	http://dx.doi.org/10.1056/NEJMra1411426			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25992748				2022-12-28	WOS:000354809300010
J	Garnham, CP; Vemu, A; Wilson-Kubalek, EM; Yu, I; Szyk, A; Lander, GC; Milligan, RA; Roll-Mecak, A				Garnham, Christopher P.; Vemu, Annapurna; Wilson-Kubalek, Elizabeth M.; Yu, Ian; Szyk, Agnieszka; Lander, Gabriel C.; Milligan, Ronald A.; Roll-Mecak, Antonina			Multivalent Microtubule Recognition by Tubulin Tyrosine Ligase-like Family Glutamylases	CELL			English	Article							ALPHA-BETA-TUBULIN; STRUCTURAL BASIS; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; POLYGLUTAMYLATION; PROTEIN; MOTILITY; BINDING; RESOLUTION; BRAIN	Glutamylation, the most prevalent tubulin posttranslational modification, marks stable microtubules and regulates recruitment and activity of microtubule-interacting proteins. Nine enzymes of the tubulin tyrosine ligase-like (TTLL) family catalyze glutamylation. TTLL7, the most abundant neuronal glutamylase, adds glutamates preferentially to the beta-tubulin tail. Coupled with ensemble and single-molecule biochemistry, our hybrid X-ray and cryo-electron microscopy structure of TTLL7 bound to the microtubule delineates a tripartite microtubule recognition strategy. The enzyme uses its core to engage the disordered anionic tails of alpha-and beta-tubulin, and a flexible cationic domain to bind the microtubule and position itself for beta-tail modification. Furthermore, we demonstrate that all single-chain TTLLs with known glutamylase activity utilize a cationic microtubule-binding domain analogous to that of TTLL7. Therefore, our work reveals the combined use of folded and intrinsically disordered substrate recognition elements as the molecular basis for specificity among the enzymes primarily responsible for chemically diversifying cellular microtubules.	[Garnham, Christopher P.; Vemu, Annapurna; Yu, Ian; Szyk, Agnieszka; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; [Wilson-Kubalek, Elizabeth M.; Lander, Gabriel C.; Milligan, Ronald A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Roll-Mecak, Antonina] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA.	antonina@mail.nih.gov		Lander, Gabriel C./0000-0003-4921-1135; Roll-Mecak, Antonina/0000-0003-2621-7307	NIGMS [P41 GM103310]; NINDS postdoctoral fellowship; Damon Runyon Cancer Research Foundation (DFS) [07-13]; Pew Scholars program; Searle Scholars program; NIH [DP2 EB020402, GM-052468, GM095573]; Searle Scholar program; National Institute of Neurological Disorders and Stroke; National Heart, Lung and Blood Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB020402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R37GM052468, R01GM095573, R01GM052468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS postdoctoral fellowship; Damon Runyon Cancer Research Foundation (DFS); Pew Scholars program; Searle Scholars program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank staff at beamlines 24-ID (Advanced Photon Source) and 5.0.1 and 5.0.2 (Advanced Light Source) for support, D.-Y. Lee for access to mass spectrometers, and A. Ferre-D'Amare, E. Giniger, and S. Gottesman for critical reading of the manuscript. TEM studies were conducted at the National Resource for Automated Molecular Microscopy, supported by NIGMS (P41 GM103310). C.P.G. is supported by an NINDS postdoctoral fellowship. G.C.L. is supported by the Damon Runyon Cancer Research Foundation (DFS-#07-13), the Pew Scholars program, the Searle Scholars program, and NIH (DP2 EB020402). R.A.M. is supported by NIH (GM-052468). E.M.W.-K is partly supported by NIH (GM095573). A.R.-M. is supported by the Searle Scholar program and the intramural programs of the National Institute of Neurological Disorders and Stroke and National Heart, Lung and Blood Institute.	ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; Bulinski JC, 1997, J CELL SCI, V110, P3055; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Geimer S, 1997, CELL MOTIL CYTOSKEL, V37, P72; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kubo T, 2014, MOL BIOL CELL, V25, P107, DOI 10.1091/mbc.E13-07-0424; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mukai M, 2009, BIOCHEMISTRY-US, V48, P1084, DOI 10.1021/bi802047y; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; RAYBIN D, 1975, BIOCHEM BIOPH RES CO, V65, P1088, DOI 10.1016/S0006-291X(75)80497-9; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; RUDIGER M, 1994, EUR J BIOCHEM, V220, P309, DOI 10.1111/j.1432-1033.1994.tb18627.x; Schneider A, 1998, FEBS LETT, V429, P399, DOI 10.1016/S0014-5793(98)00644-9; Sergouniotis PI, 2014, AM J HUM GENET, V94, P760, DOI 10.1016/j.ajhg.2014.04.003; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2013, J MOL BIOL, V425, P2412, DOI 10.1016/j.jmb.2013.04.017; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Tomita K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00036; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vemu A, 2014, METHOD ENZYMOL, V540, P149, DOI 10.1016/B978-0-12-397924-7.00009-1; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	53	56	61	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1112	1123		10.1016/j.cell.2015.04.003	http://dx.doi.org/10.1016/j.cell.2015.04.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959773	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000355152600018
J	Gornall, J				Gornall, Jonathan			Tickets to Glyndebourne or the Oval? Big tobacco's bid to woo parliamentarians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						British American Tobacco, 2014, OUR RESP UK PLAIN PA; Cancer Research UK, LOC CANC STAT; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2052; JTI, 2014, RESP UK DEP HLTH CON; Public Health England, 2011, LOC TOB CONTR PROF E, P2011; WHO, FRAM CONV TOB CONTR; World Health Organization, GUID IMPL ART 5 3 WH	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2509	10.1136/bmj.h2509	http://dx.doi.org/10.1136/bmj.h2509			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YZ	25994454				2022-12-28	WOS:000355128700005
J	Banerjee, A; Duflo, E; Goldberg, N; Karlan, D; Osei, R; Pariente, W; Shapiro, J; Thuysbaert, B; Udry, C				Banerjee, Abhijit; Duflo, Esther; Goldberg, Nathanael; Karlan, Dean; Osei, Robert; Pariente, William; Shapiro, Jeremy; Thuysbaert, Bram; Udry, Christopher			A multifaceted program causes lasting progress for the very poor: Evidence from six countries	SCIENCE			English	Article							MICROFINANCE EVIDENCE; MICROCREDIT EVIDENCE; IMPACTS; TRANSFERS; CASH	We present results from six randomized control trials of an integrated approach to improve livelihoods among the very poor. The approach combines the transfer of a productive asset with consumption support, training, and coaching plus savings encouragement and health education and/or services. Results from the implementation of the same basic program, adapted to a wide variety of geographic and institutional contexts and with multiple implementing partners, show statistically significant cost-effective impacts on consumption (fueled mostly by increases in self-employment income) and psychosocial status of the targeted households. The impact on the poor households lasted at least a year after all implementation ended. It is possible to make sustainable improvements in the economic status of the poor with a relatively short-term intervention.	[Banerjee, Abhijit; Duflo, Esther] MIT, Cambridge, MA 02139 USA; [Banerjee, Abhijit; Duflo, Esther; Karlan, Dean; Udry, Christopher] CEPR, Washington, DC 20009 USA; [Banerjee, Abhijit; Duflo, Esther; Karlan, Dean; Udry, Christopher] NBER, Cambridge, MA 02138 USA; [Banerjee, Abhijit; Duflo, Esther; Karlan, Dean; Pariente, William; Udry, Christopher] MIT, J PAL, Cambridge, MA 02139 USA; [Goldberg, Nathanael; Karlan, Dean; Thuysbaert, Bram] IPA, New Haven, CT USA; [Karlan, Dean; Udry, Christopher] Yale Univ, New Haven, CT USA; [Osei, Robert] Univ Ghana Legon, Accra, Ghana; [Pariente, William] Catholic Univ Louvain, IRES, Louvain La Neuve, Belgium; [Shapiro, Jeremy] Princeton Univ, Princeton, NJ 08544 USA; [Thuysbaert, Bram] Univ Ghent, B-9000 Ghent, Belgium	Massachusetts Institute of Technology (MIT); Center for Economic & Policy Research (CEPR); National Bureau of Economic Research; Massachusetts Institute of Technology (MIT); Yale University; Universite Catholique Louvain; Princeton University; Ghent University	Karlan, D (corresponding author), CEPR, Washington, DC 20009 USA.	dean.karlan@yale.edu	Osei, Robert Darko/K-3822-2019	karlan, dean/0000-0003-0164-1398; Udry, Christopher/0000-0002-1605-1916	Ford Foundation; 3ie; U.S. Agency for International Development (USAID) through Financial Integration, Economic Leveraging, broad-based Dissemination and Support Leader with Associates (FIELD-Support LwA)	Ford Foundation; 3ie; U.S. Agency for International Development (USAID) through Financial Integration, Economic Leveraging, broad-based Dissemination and Support Leader with Associates (FIELD-Support LwA)(United States Agency for International Development (USAID))	This study received approval from the Yale University Human Subjects Committee, IRB 0705002656, 1002006308, 1006007026, and 1011007628; the MIT Human Subjects Committee, IRB 0701002099; and from the Innovations for Poverty Action Human Subjects Committee, IRB Protocol 19.08January-002, 09December-003, 59.10June-002, and 10November-003.494. Thanks to the Ford Foundation, 3ie, and U.S. Agency for International Development (USAID) [through the Financial Integration, Economic Leveraging, broad-based Dissemination and Support Leader with Associates (FIELD-Support LwA) managed by FHI 360] for funding. The contents of this paper are the responsibility of the authors and do not necessarily reflect the views of FHI 360, USAID, or the United States Government. Thanks to A. Agarwal, N. Barker, A. Kemmis Betty, C. Brewster, A. Bukari, D. Bullon Patton, S. De Marco, S. Devnani, M. Dieci, S. Fontenay, A. Garcia, Y. Guy, J. Manuel Hernandez-Agramonte, S. Kant, S. Khan, H. Koizumi, M. Lowes, L. Luhana, J. Prasad Mukhopadhyay, E. Naah, M. Polansky, E. Safran, E. Salgado Chavez, D. Sanchez Liste, J. Severski, R. Strohm, H. Trachtman, and S. Vedder for outstanding research assistance and project management. The authors thank the leadership and staff at the implementing institutions for their partnership: Bandhan, Pakistan Poverty Alleviation Fund, Aga Khan Planning and Building Services Pakistan, Badin Rural Development Society, Indus Earth Trust, Sindh Agricultural and Forestry Workers Coordinating Organization, PLAN International Honduras, Organizacion de Desarollo Empresarial Feminino Social, Relief Society of Tigray, Presbyterian Agricultural Services (PAS), Asociacion Arariwa, and PLAN International Peru. Thanks to F. DeGiovanni (Ford Foundation), S. Hashemi (BRAC University), and A. de Montesquiou and A. Latortue (CGAP) for their support and encouragement of the research. No authors have any real or apparent conflicts of interest, except that D.K. is on the Board of Directors of Innovations for Poverty Action, which participated in oversight of the implementation of the Ghana site. All data and code are available at the IPA Dataverse (doi: 10.7910/DVN/NHIXNT).	Ahmed A. U., 2009, BRAC RES MONOGR SER, V39; Alatas V, 2012, AM ECON REV, V102, P1206, DOI 10.1257/aer.102.4.1206; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; Angelucci M, 2015, AM ECON J-APPL ECON, V7, P151, DOI 10.1257/app.20130537; Angelucci M, 2009, AM ECON REV, V99, P486, DOI 10.1257/aer.99.1.486; Ashley S, 1999, LIVESTOCK POVERTY FO; Attanasio O, 2015, AM ECON J-APPL ECON, V7, P90, DOI 10.1257/app.20130489; Augsburg B, 2015, AM ECON J-APPL ECON, V7, P183, DOI 10.1257/app.20130272; Bandiera Oriana., 2013, CAN ENTREPRENEURSHIP; Banerjee A., 2011, POOR EC RADICAL RETH; Banerjee A., 2010, NATL BUR EC RES, V15973; Banerjee A, 2015, AM ECON J-APPL ECON, V7, P22, DOI 10.1257/app.20130533; Banerjee AbhijitV., 2000, J POLIT ECON, V26, P129; BANERJEE AV, 1993, J POLIT ECON, V101, P274, DOI 10.1086/261876; Bernheim B. D., 2013, NATL BUR EC RES, V18742; Blattman C, 2014, Q J ECON, V129, P697, DOI 10.1093/qje/qjt057; Brickman P., 1971, ADAPTATION LEVEL THE, P287, DOI DOI 10.3389/FPSYG.2018.01158; Crepon B, 2015, AM ECON J-APPL ECON, V7, P123, DOI 10.1257/app.20130535; Das N. C., 2010, BRAC CFPR WORK PAP, V19; DASGUPTA P, 1986, ECON J, V96, P1011, DOI 10.2307/2233171; de Mel S, 2012, SCIENCE, V335, P962, DOI 10.1126/science.1212973; Deaton A, 2011, AM ECON J-APPL ECON, V3, P137, DOI 10.1257/app.3.2.137; Dreze J., 1990, EC POLIT WKLY, V25; Emran MS, 2014, ECON DEV CULT CHANGE, V62, P339, DOI 10.1086/674110; GALOR O, 1993, REV ECON STUD, V60, P35, DOI 10.2307/2297811; Haushofer J, 2013, WELFARE EFFECTS UNCO; Horowitz JL, 2000, J AM STAT ASSOC, V95, P77, DOI 10.2307/2669526; Jamison Julian C., 2014, RETURNS CASH MICROEN; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Lee DS, 2009, REV ECON STUD, V76, P1071, DOI 10.1111/j.1467-937X.2009.00536.x; McKenzie D., 2012, WORLD BANK POLICY RE; Morduch J., 2012, CEI WORKING PAPER SE, V2012-05; Pulley R. V., 1989, WORLD BANK DISCUSS P, V58; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Subramanian S, 1996, J POLIT ECON, V104, P133, DOI 10.1086/262020; Tarozzi A, 2015, AM ECON J-APPL ECON, V7, P54, DOI 10.1257/app.20130475; UN High-Level Panel, 2013, NEW GLOB PARTN ER PO; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Food Programme, 2013, STAT SCH FEED WORLDW, P1	40	322	325	11	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236							1260799	10.1126/science.1260799	http://dx.doi.org/10.1126/science.1260799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977558	Green Submitted			2022-12-28	WOS:000354428700035
J	Nora, LM; Wynia, MK; Granatir, T				Nora, Lois Margaret; Wynia, Matthew K.; Granatir, Thomas			Of the Profession, by the Profession, and for Patients, Families, and Communities ABMS Board Certification and Medicine's Professional Self-regulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nora, Lois Margaret; Granatir, Thomas] Amer Board Med Specialties, Chicago, IL 60654 USA; [Wynia, Matthew K.] Univ Colorado, Ctr Bioeth & Humanities, Denver, CO USA	University of Colorado System; University of Colorado Denver	Nora, LM (corresponding author), Amer Board Med Specialties, 353 N Clark St, Chicago, IL 60654 USA.	lmnora@ABMS.org	Wynia, Matthew/T-2210-2019					American Board of Medical Specialties, MULT MOC PORTF APPR; American Board of Medical Specialties, 2015, STAND PROGR MOC; Archer J, 2013, J CONTIN EDUC HEALTH, V33, pS48, DOI 10.1002/chp.21206; Lipner RS, 2013, J CONTIN EDUC HEALTH, V33, pS20, DOI 10.1002/chp.21203; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Wynia MK, 2014, ACAD MED, V89, P712, DOI 10.1097/ACM.0000000000000212	7	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1805	1806		10.1001/jama.2015.4025	http://dx.doi.org/10.1001/jama.2015.4025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965217				2022-12-28	WOS:000354391000012
J	Boggs, SE; Harrison, FA; Miyasaka, H; Grefenstette, BW; Zoglauer, A; Fryer, CL; Reynolds, SP; Alexander, DM; An, H; Barret, D; Christensen, FE; Craig, WW; Forster, K; Giommi, P; Hailey, CJ; Hornstrup, A; Kitaguchi, T; Koglin, JE; Madsen, KK; Mao, PH; Mori, K; Perri, M; Pivovaroff, MJ; Puccetti, S; Rana, V; Stern, D; Westergaard, NJ; Zhang, WW				Boggs, S. E.; Harrison, F. A.; Miyasaka, H.; Grefenstette, B. W.; Zoglauer, A.; Fryer, C. L.; Reynolds, S. P.; Alexander, D. M.; An, H.; Barret, D.; Christensen, F. E.; Craig, W. W.; Forster, K.; Giommi, P.; Hailey, C. J.; Hornstrup, A.; Kitaguchi, T.; Koglin, J. E.; Madsen, K. K.; Mao, P. H.; Mori, K.; Perri, M.; Pivovaroff, M. J.; Puccetti, S.; Rana, V.; Stern, D.; Westergaard, N. J.; Zhang, W. W.			Ti-44 gamma-ray emission lines from SN1987A reveal an asymmetric explosion	SCIENCE			English	Article							CORE-COLLAPSE SUPERNOVAE; SN 1987A; LIGHT-CURVE; CHANDRA OBSERVATIONS; NEUTRINO BURST; SN-1987A; EJECTA; PROFILES; SPECTRUM	In core-collapse supernovae, titanium-44 (Ti-44) is produced in the innermost ejecta, in the layer of material directly on top of the newly formed compact object. As such, it provides a direct probe of the supernova engine. Observations of supernova 1987A (SN1987A) have resolved the 67.87- and 78.32-kilo-electron volt emission lines from decay of Ti-44 produced in the supernova explosion. These lines are narrow and redshifted with a Doppler velocity of similar to 700 kilometers per second, direct evidence of large-scale asymmetry in the explosion.	[Boggs, S. E.; Zoglauer, A.; Craig, W. W.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Harrison, F. A.; Miyasaka, H.; Grefenstette, B. W.; Forster, K.; Madsen, K. K.; Mao, P. H.; Rana, V.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Fryer, C. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Reynolds, S. P.] NC State Univ, Dept Phys, Raleigh, NC 27695 USA; [Alexander, D. M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [An, H.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Barret, D.] Univ Toulouse, UPS OMP, IRAP, Toulouse, France; [Barret, D.] CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Christensen, F. E.; Hornstrup, A.; Westergaard, N. J.] Tech Univ Denmark, Natl Space Inst, DTU Space, DK-2800 Lyngby, Denmark; [Craig, W. W.; Pivovaroff, M. J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Giommi, P.; Perri, M.; Puccetti, S.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00133 Rome, Italy; [Hailey, C. J.; Mori, K.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Kitaguchi, T.] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan; [Koglin, J. E.] SLAC Natl Accelerator Lab, Kavli Inst Particle Astrophys & Cosmol, Menlo Pk, CA 94025 USA; [Perri, M.; Puccetti, S.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Stern, D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Zhang, W. W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Berkeley; California Institute of Technology; United States Department of Energy (DOE); Los Alamos National Laboratory; University of North Carolina; North Carolina State University; Durham University; McGill University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Agenzia Spaziale Italiana (ASI); Columbia University; RIKEN; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale Astrofisica (INAF); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Boggs, SE (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	boggs@berkeley.edu	Alexander, David/K-5544-2019; Rana, Vikram/R-9180-2018; Barret, Didier/AAV-2771-2020; Mori, Kaya/ABH-2066-2021; christensen, finn/AAB-8622-2020; Boggs, Steven E/E-4170-2015; giommi, paolo/L-1006-2018; Pivovaroff, Michael/M-7998-2014	Alexander, David/0000-0002-5896-6313; Boggs, Steven E/0000-0001-9567-4224; Puccetti, Simonetta/0000-0002-2734-7835; Hornstrup, Allan/0000-0002-3363-0936; Stern, Daniel/0000-0003-2686-9241; giommi, paolo/0000-0002-2265-5003; Pivovaroff, Michael/0000-0001-6780-6816; Perri, Matteo/0000-0003-3613-4409	NASA [NNG08FD60C]; National Aeronautics and Space Administration; French Space Agency (CNES); Japan Society for the Promotion of Science [24740185]; Technical University of Denmark; STFC [ST/L00075X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L00075X/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); French Space Agency (CNES)(Centre National D'etudes Spatiales); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Technical University of Denmark; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported under NASA Contract no. NNG08FD60C and made use of data from the NuSTAR mission, a project led by the California Institute of Technology, managed by the Jet Propulsion Laboratory, and funded by the National Aeronautics and Space Administration. We thank the NuSTAR Operations, Software, and Calibration teams for support with the execution and analysis of these observations. This research has made use of the NuSTAR Data Analysis Software (NuSTARDAS) jointly developed by the ASI Science Data Center (ASDC, Italy) and the California Institute of Technology (USA). D.B. acknowledges funding from the French Space Agency (CNES). T.K. was supported by Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) (no. 24740185). N.J.W. acknowledges funding from the Technical University of Denmark. NuSTAR data are accessible from NASA's High Energy Astrophysics Science Archive Research Center (HEASARC, http://heasarc.gsfc.nasa.gov/).	Ahmad I, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.065803; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; BOUCHET P, 1991, ASTRON ASTROPHYS, V245, P490; Chugai NN, 1997, ASTROPHYS J, V483, P925, DOI 10.1086/304253; FRANSSON C, 1993, ASTROPHYS J, V408, pL25, DOI 10.1086/186822; Fryer C, 1998, ASTROPHYS J, V496, P333, DOI 10.1086/305348; Grefenstette BW, 2014, NATURE, V506, P339, DOI 10.1038/nature12997; Haas R., 1990, ASTROPHYS J, V360, P257; Helder EA, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/11; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; Hungerford AL, 2005, ASTROPHYS J, V635, P487, DOI 10.1086/497323; Hungerford AL, 2003, ASTROPHYS J, V594, P390, DOI 10.1086/376776; Jerkstrand A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015937; KURFESS JD, 1992, ASTROPHYS J, V399, pL137, DOI 10.1086/186626; Larsson J, 2011, NATURE, V474, P484, DOI 10.1038/nature10090; Leising MD, 2006, ASTROPHYS J, V651, P1019, DOI 10.1086/507602; LEISING MD, 1990, ASTROPHYS J, V357, P638, DOI 10.1086/168952; Magkotsios G, 2010, ASTROPHYS J SUPPL S, V191, P66, DOI 10.1088/0067-0049/191/1/66; MATZ SM, 1988, NATURE, V331, P416, DOI 10.1038/331416a0; Motizuki Y, 2004, NEW ASTRON REV, V48, P69, DOI 10.1016/j.newar.2003.11.009; Park S, 2004, ADV SPACE RES, V33, P386, DOI 10.1016/j.asr.2003.08.017; SPYROMILIO J, 1990, MON NOT R ASTRON SOC, V242, P669, DOI 10.1093/mnras/242.4.669; TEEGARDEN BJ, 1991, ADV SPACE RES-SERIES, V11, P217, DOI 10.1016/0273-1177(91)90174-I; TUELLER J, 1990, ASTROPHYS J, V351, pL41, DOI 10.1086/185675; Wang LF, 2008, ANNU REV ASTRON ASTR, V46, P433, DOI 10.1146/annurev.astro.46.060407.145139; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	32	84	87	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					670	671		10.1126/science.aaa2259	http://dx.doi.org/10.1126/science.aaa2259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954004	Green Submitted			2022-12-28	WOS:000354045700039
J	Ploug, T; Holm, S				Ploug, Thomas; Holm, Soren			Meta consent: a flexible and autonomous way of obtaining informed consent for secondary research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BROAD CONSENT; ROUTINISATION		[Ploug, Thomas] Aalborg Univ, Dept Commun, Ctr Appl Eth & Philosophy Sci, Appl Eth, DK-2450 Copenhagen SV, Denmark; [Holm, Soren] Univ Manchester, Sch Law, Bioeth, Manchester M13 9PL, Lancs, England	Aalborg University; University of Manchester	Ploug, T (corresponding author), Aalborg Univ, Dept Commun, Ctr Appl Eth & Philosophy Sci, Appl Eth, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark.	ploug@hum.aau.dk		Holm, Soren/0000-0002-7200-5607; Ploug, Thomas/0000-0002-3693-0547				Arnason V, 2004, BIOETHICS, V18, P27, DOI 10.1111/j.1467-8519.2004.00377.x; Committee on the Learning Health Care System in America. Institute of Medicine, 2013, BEST CAR LOW COST PA; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Helgesson G, 2012, CAMB Q HEALTHC ETHIC, V21, P40, DOI 10.1017/S096318011100048X; Hofmann B, 2009, J MED ETHICS, V35, P125, DOI 10.1136/jme.2008.024851; Hofmann B, 2009, ETHICS OF RESEARCH BIOBANKING, P3, DOI 10.1007/978-0-387-93872-1_1; Holm S, 2009, LIMITS CONSENT, P11; Information Commisioner's Office, 2014, BIG DAT DAT PROT; Karlsen JR, 2011, CAMB Q HEALTHC ETHIC, V20, P572, DOI 10.1017/S0963180111000314; Kaye J, 2011, BMJ; Kaye Jane, 2015, Eur J Hum Genet, V23, P141, DOI 10.1038/ejhg.2014.71; Kaye J, 2012, NAT REV GENET, V13, P371, DOI 10.1038/nrg3218; Kho Michelle E, 2009, BMJ, V338, pb866, DOI 10.1136/bmj.b866; Narayanan A, 2010, COMMUN ACM, V53, P24, DOI 10.1145/1743546.1743558; Otlowski MFA, 2009, PRINCIPLES PRACTICE, P79; Ploug T, 2015, INT J MED INFORM, V84, P229, DOI 10.1016/j.ijmedinf.2015.01.003; Ploug T, 2014, SCI ENG ETHICS, V20, P1097, DOI 10.1007/s11948-013-9492-x; Ploug T, 2013, J MED ETHICS, V39, P214, DOI 10.1136/medethics-2012-101056; Steinsbekk KS, 2013, EUR J HUM GENET, V21, P897, DOI 10.1038/ejhg.2012.282; Tasse AM, 2010, EUR J HUM GENET, V18, P741, DOI 10.1038/ejhg.2010.30	21	42	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2015	350								h2146	10.1136/bmj.h2146	http://dx.doi.org/10.1136/bmj.h2146			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI0GJ	25952952				2022-12-28	WOS:000354414800003
J	Schoenthaler, R				Schoenthaler, Robin			Lessons in Medicine, Mortality, and Reflexive Verbs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Schoenthaler, R (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1787	1789		10.1056/NEJMp1413815	http://dx.doi.org/10.1056/NEJMp1413815			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946278				2022-12-28	WOS:000353974700003
J	Drekonja, D; Reich, J; Gezahegn, S; Greer, N; Shaukat, A; MacDonald, R; Rutks, I; Wilt, TJ				Drekonja, Dimitri; Reich, Jon; Gezahegn, Selome; Greer, Nancy; Shaukat, Aasma; MacDonald, Roderick; Rutks, Indy; Wilt, Timothy J.			Fecal Microbiota Transplantation for Clostridium difficile Infection A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							TERM-FOLLOW-UP; TEMPERED ENTHUSIASM; RECURRENT; DIARRHEA; VANCOMYCIN; THERAPY; COLITIS; DISEASE; BACTERIOTHERAPY; COLONOSCOPY	Background: The role of fecal microbiota transplantation (FMT) for Clostridium difficile infection (CDI) is not well-known. Purpose: To assess the efficacy, comparative effectiveness, and harms of FMT for CDI. Data Sources: MEDLINE (1980 to January 2015), Cochrane Library, and ClinicalTrials.gov, followed by hand-searching references from systematic reviews and identified studies. Study Selection: Any study of FMT to treat adult patients with CDI; case reports were only used to report harms. Data Extraction: Data were extracted by 1 author and verified by another; 2 authors independently assessed risk of bias and strength of evidence. Data Synthesis: Two randomized, controlled trials (RCTs); 28 case-series studies; and 5 case reports were included. Two RCTs and 21 case-series studies (516 patients receiving FMT) reported using FMT for patients with recurrent CDI. A high proportion of treated patients had symptom resolution; however, the role of previous antimicrobials is unclear. One RCT comparing FMT with 2 control groups (n = 43) reported resolution of symptoms in 81%, 31%, and 23% of the FMT, vancomycin, or vancomycin-plus-bowel lavage groups, respectively (P < 0.001 for both control groups vs. FMT). An RCT comparing FMT route (n = 20) reported no difference between groups (60% in the nasogastric tube group and 80% in the colonoscopy group; P = 0.63). Across all studies for recurrent CDI, symptom resolution was seen in 85% of cases. In 7 case-series studies of patients with refractory CDI, symptom resolution ranged from 0% to 100%. Among 7 patients treated with FMT for initial CDI, results were mixed. Limitation: Most studies were uncontrolled case-series studies; only 2 RCTs were available for analysis. Conclusion: Fecal microbiota transplantation may have a substantial effect with few short-term adverse events for recurrent CDI. Evidence is insufficient on FMT for refractory or initial CDI treatment and on whether effects vary by donor, preparation, or delivery method.	Minneapolis Vet Affairs Hlth Care Syst, Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Drekonja, D (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, 1 Vet Dr,Mail Code 111-F, Minneapolis, MN 55417 USA.	drek0002@umn.edu			U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; BOWDEN TA, 1981, AM SURGEON, V47, P178; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Cammarota G, 2014, DIGEST LIVER DIS, V46, P475, DOI 10.1016/j.dld.2013.12.011; CDC, 2013, ANTIBIOTIC RESISTANC; De Leon LM, 2013, CLIN GASTROENTEROL H, V11, P1036, DOI 10.1016/j.cgh.2013.04.045; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Dutta SK, 2014, CLIN GASTROENTEROL H, V12, P1572, DOI 10.1016/j.cgh.2013.12.032; EISEMAN B, 1958, SURGERY, V44, P854; Emanuelsson F, 2014, SCAND J INFECT DIS, V46, P89, DOI 10.3109/00365548.2013.858181; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Gustafsson A, 1999, SCAND J GASTROENTERO, V34, P580, DOI 10.1080/003655299750026038; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Johnson S, 2007, CLIN INFECT DIS, V44, P846, DOI 10.1086/511870; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; Khan MA, 2014, CAN J GASTROENTEROL, V28, P434, DOI 10.1155/2014/695029; Kleger A, 2013, DTSCH ARZTEBL INT, V110, P108, DOI 10.3238/arztebl.2013.0108; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; LARSON HE, 1978, LANCET, V1, P1063; Lee CH, 2014, EUR J CLIN MICROBIOL, V33, P1425, DOI 10.1007/s10096-014-2088-9; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mellow Mark H, 2011, J Okla State Med Assoc, V104, P89; Moore TA, 2014, CLIN INFECT DIS, V59, P319, DOI 10.1093/cid/ciu279; Nieuwdorp M, 2008, Ned Tijdschr Geneeskd, V152, P1927; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Patel NC, 2013, MAYO CLIN PROC, V88, P799, DOI 10.1016/j.mayocp.2013.04.022; PATERSON DL, 1994, MED J AUSTRALIA, V160, P232, DOI 10.5694/j.1326-5377.1994.tb126619.x; Pathak R, 2014, CLIN EXP GASTROENTER, V7, P1, DOI 10.2147/CEG.S53410; Polak Pavel, 2011, Klin Mikrobiol Infekc Lek, V17, P214; Quera R, 2014, J CROHNS COLITIS, V8, P252, DOI 10.1016/j.crohns.2013.10.002; Redberg RF, 2014, NEW ENGL J MED, V371, P892, DOI 10.1056/NEJMp1406388; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Rubin TA, 2013, ANAEROBE, V19, P22, DOI 10.1016/j.anaerobe.2012.11.004; Schwartz M, 2013, AM J GASTROENTEROL, V108, P1367, DOI 10.1038/ajg.2013.164; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Solari PR, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu278; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; TEDESCO FJ, 1985, AM J GASTROENTEROL, V80, P867; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Weingarden AR, 2013, J CLIN GASTROENTEROL, V47, P735, DOI 10.1097/MCG.0b013e31829004ae; WILSON KH, 1993, CLIN INFECT DIS, V16, pS214, DOI 10.1093/clinids/16.Supplement_4.S214; Yoon SS, 2010, J CLIN GASTROENTEROL, V44, P562, DOI 10.1097/MCG.0b013e3181dac035; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zainah H, 2015, DIGEST DIS SCI, V60, P181, DOI 10.1007/s10620-014-3296-y	59	240	258	4	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					630	U230		10.7326/M14-2693	http://dx.doi.org/10.7326/M14-2693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938992				2022-12-28	WOS:000354119100007
J	Smith, CD; Levinson, WS				Smith, Cynthia D.; Levinson, Wendy S.		Internal Med HVC Advisory Board	A Commitment to High-Value Care Education From the Internal Medicine Community	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS; COST	The Alliance for Academic Internal Medicine, American Board of Internal Medicine (ABIM), ABIM Foundation, and American College of Physicians are collaborating to enhance the education of physicians in high-value care (HVC) and make its practice an essential competency in undergraduate and postgraduate education by 2017. This article serves as the organizations' formal commitment to providing a foundation of HVC education on which others may build. The 5 key targets for HVC education are experiential learning and curriculum, environment and culture, clinical support, regulatory requirements, and sustainability. The goal is to train future health care professionals for whom HVC is part of normal practice, thus providing patients with improved clinical outcomes at a lower cost.	[Smith, Cynthia D.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Toronto, Toronto, ON, Canada	American College of Physicians; University of Toronto	Smith, CD (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.			Lang, Valerie J/0000-0003-1119-5029				Asch DA, 2014, ACAD MED, V89, P24, DOI 10.1097/ACM.0000000000000067; CUMMINGS KM, 1982, MED CARE, V20, P293, DOI 10.1097/00005650-198203000-00006; Dine C Jessica, 2010, J Grad Med Educ, V2, P175, DOI 10.4300/JGME-D-10-00021.1; Levy AE, 2014, ACAD MED, V89, P1440, DOI 10.1097/ACM.0000000000000496; Ryskina KL, 2014, ANN INTERN MED, V161, P733, DOI 10.7326/M14-0444; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; Stiefel MN K., 2012, GUIDE MEASURING TRIP; Weinberger SE, 2014, ANN INTERN MED, V161, P73, DOI 10.7326/M13-2993; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007; Young P., 2010, HEALTHC IMP LOW COST	10	14	16	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					639	U233		10.7326/M14-2610	http://dx.doi.org/10.7326/M14-2610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938993				2022-12-28	WOS:000354119100008
J	Koh, CM; Bezzi, M; Low, DHP; Ang, WX; Teo, SX; Gay, FPH; Al-Haddawi, M; Tan, SY; Osato, M; Sabo, A; Amati, B; Wee, KB; Guccione, E				Koh, Cheryl M.; Bezzi, Marco; Low, Diana H. P.; Ang, Wei Xia; Teo, Shun Xie; Gay, Florence P. H.; Al-Haddawi, Muthafar; Tan, Soo Yong; Osato, Motomi; Sabo, Arianna; Amati, Bruno; Wee, Keng Boon; Guccione, Ernesto			MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis	NATURE			English	Article							FACTOR SRSF1; PATHWAY; COMPLEX; MOUSE; PRMT5; MUTATIONS; PROTEINS; GENOME; TARGET	Deregulated expression of the MYC transcription factor occurs in most human cancers and correlates with high proliferation, reprogrammed cellular metabolism and poor prognosis(1). Overexpressed MYC binds to virtually all active promoters within a cell, although with different binding affinities(2-4), and modulates the expression of distinct subsets of genes(1,2,4,5). However, the critical effectors of MYC in tumorigenesis remain largely unknown. Here we show that during lymphomagenesis in Em-myc transgenic mice, MYC directly upregulates the transcription of the core small nuclear ribonucleoprotein particle assembly genes, including Prmt5, an arginine methyltransferase that methylates Sm proteins(6,7). This coordinated regulatory effect is critical for the core biogenesis of small nuclear ribonucleoprotein particles, effective pre-messenger-RNA splicing, cell survival and proliferation. Our results demonstrate that MYC maintains the splicing fidelity of exons with a weak 5' donor site. Additionally, we identify pre-messenger-RNAs that are particularly sensitive to the perturbation of the MYC-PRMT5 axis, resulting in either intron retention (for example, Dvl1) or exon skipping (for example, Atr, Ep400). Using antisense oligonucleotides, we demonstrate the contribution of these splicing defects to the anti-proliferative/apoptotic phenotype observed in PRMT5-depleted E mu-myc B cells. We conclude that, in addition to its well-documented oncogenic functions in transcription(2-5) and translation(8), MYC also safeguards proper pre-messenger-RNA splicing as an essential step in lymphomagenesis.	[Koh, Cheryl M.; Bezzi, Marco; Low, Diana H. P.; Ang, Wei Xia; Teo, Shun Xie; Gay, Florence P. H.; Al-Haddawi, Muthafar; Tan, Soo Yong; Guccione, Ernesto] ASTAR, IMCB, Singapore 138673, Singapore; [Bezzi, Marco; Guccione, Ernesto] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Osato, Motomi; Guccione, Ernesto] Natl Univ Singapore, Canc Sci Inst Singapore CSI, Singapore 117599, Singapore; [Sabo, Arianna; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Wee, Keng Boon] ASTAR, IHPC, Singapore 138632, Singapore; [Wee, Keng Boon] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Guccione, E (corresponding author), ASTAR, IMCB, Singapore 138673, Singapore.	eguccione@imcb.a-star.edu.sg	Osato, Motomi/N-5056-2014; Amati, Bruno/AAM-3418-2020; Sabò, Arianna/J-9531-2018	Osato, Motomi/0000-0003-3982-9054; Sabò, Arianna/0000-0002-9542-0045; Low, Diana/0000-0002-6054-8524; Bezzi, Marco/0000-0001-9376-690X; Tan, Soo-Yong/0000-0002-6348-2823; Amati, Bruno/0000-0002-2958-1799	AGA-SINGA (SINgapore Graduate Award); IMCB, A-STAR; JCO-ASTAR [1134c001, 11/03/FG/07/04]; European Research Council; Italian health ministry; Italian Association for Cancer Research (AIRC)	AGA-SINGA (SINgapore Graduate Award); IMCB, A-STAR; JCO-ASTAR(Agency for Science Technology & Research (A*STAR)); European Research Council(European Research Council (ERC)European Commission); Italian health ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank S. Campaner, M. Pelizzola, D. Messerschmidt and P. R. Kaldis for sharing protocols and for discussions; F. B. M. Ibrahimand V. S. Y. Tay for help with histopathology work; BRC Shared Facilities for technical support; D. Bararia for help in the fluorescence-activated cell sorting analysis. We are grateful to X. Ruan, W. Soon and the GIS Genome Sequencing Team for help with the Solexa high-throughput sequencing, and to the entire E.G. laboratory for discussion. This work was supported by an AGA-SINGA (SINgapore Graduate Award) fellowship to M.B. and by IMCB, A-STAR. E.G. acknowledges support from JCO-ASTAR grants 1134c001 and 11/03/FG/07/04. B.A. acknowledges support from the European Research Council, the Italian health ministry and the Italian Association for Cancer Research (AIRC).	Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Fujii T, 2010, J BIOL CHEM, V285, P30214, DOI 10.1074/jbc.M110.104513; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Pao PW, 2014, MOL THER, V22, P854, DOI 10.1038/mt.2013.276; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pramono Z. A., 2011, WO Patent, Patent No. [WO/2011/078,797, 2011078797]; Pramono ZAD, 2012, HUM GENE THER, V23, P781, DOI 10.1089/hum.2011.205; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Van Dang Chi, 2010, Genes Cancer, V1, P560; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	33	220	227	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					96	+		10.1038/nature14351	http://dx.doi.org/10.1038/nature14351			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25970242				2022-12-28	WOS:000357169500039
J	Ashley, EA				Ashley, Euan A.			The Precision Medicine Initiative A New National Effort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ashley, Euan A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ashley, Euan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Ashley, EA (corresponding author), Stanford Univ, Falk CVRB, Dept Med, 870 Quarry Rd, Stanford, CA 94305 USA.	euan@stanford.edu						Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Basile Jan, 2009, Ther Adv Cardiovasc Dis, V3, P157, DOI 10.1177/1753944708101552; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ross JS, 2015, JAMA ONCOL, V1, P40, DOI 10.1001/jamaoncol.2014.216	8	323	345	2	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2119	2120		10.1001/jama.2015.3595	http://dx.doi.org/10.1001/jama.2015.3595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	25928209				2022-12-28	WOS:000355430900006
J	Gould, J				Gould, Julie			Meet our prime pollinators	NATURE			English	Editorial Material																		Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Kuhlmann M, 2009, S AFR J BOT, V75, P726, DOI 10.1016/j.sajb.2009.06.016; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007	4	2	3	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S48	S49		10.1038/521S48a	http://dx.doi.org/10.1038/521S48a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992670	Bronze			2022-12-28	WOS:000354816500066
J	James, RD				James, Richard D.			MATERIALS SCIENCE Magnetic alloys break the rules	NATURE			English	Editorial Material								A family of alloys has been discovered that undergoes unexpected changes of shape when magnetized. This strange behaviour might help in unravelling the mystery of a phenomenon called magnetic hysteresis. SEE LETTER P.340	Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	James, RD (corresponding author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	james@umn.edu		James, Richard/0000-0001-6019-6613				Bertotti G., 2006, SCI HYSTERESIS; Bozorth R.M., 1951, FERROMAGNETISM; BOZORTH RM, 1953, REV MOD PHYS, V25, P42, DOI 10.1103/RevModPhys.25.42; Chopra HD, 2015, NATURE, V521, P340, DOI 10.1038/nature14459; Coey JMD, 2011, IEEE T MAGN, V47, P4671, DOI 10.1109/TMAG.2011.2166975; Gutfleisch O, 2011, ADV MATER, V23, P821, DOI 10.1002/adma.201002180; Hubert A., 2008, MAGNETIC DOMAINS ANA	7	13	14	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					298	299		10.1038/521298a	http://dx.doi.org/10.1038/521298a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993957				2022-12-28	WOS:000354816500043
J	Chou, R; Cuevas, C; Fu, RW; Devine, B; Wasson, N; Ginsburg, A; Zakher, B; Pappas, M; Graham, E; Sullivan, SD				Chou, Roger; Cuevas, Carlos; Fu, Rongwei; Devine, Beth; Wasson, Ngoc; Ginsburg, Alexander; Zakher, Bernadette; Pappas, Miranda; Graham, Elaine; Sullivan, Sean D.			Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CONTRAST-ENHANCED ULTRASOUND; DOUBLE ARTERIAL-PHASE; FOCAL LIVER-LESIONS; GD-EOB-DTPA; DIGITAL-SUBTRACTION-ANGIOGRAPHY; HELICAL COMPUTED-TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; C-ARM CT; MAGNETIC-RESONANCE; MULTIDETECTOR CT	Background: Several imaging modalities are available for diagnosis of hepatocellular carcinoma (HCC). Purpose: To evaluate the test performance of imaging modalities for HCC. Data Sources: MEDLINE (1998 to December 2014), the Co-chrane Library Database, Scopus, and reference lists. Study Selection: Studies on test performance of ultrasonography, computed tomography (CT), or magnetic resonance imaging (MRI). Data Extraction: One investigator abstracted data, and a second investigator confirmed them; 2 investigators independently assessed study quality and strength of evidence. Data Synthesis: Few studies have evaluated imaging for HCC in surveillance settings. In nonsurveillance settings, sensitivity for detection of HCC lesions was lower for ultrasonography without contrast than for CT or MRI (pooled difference based on direct comparisons, 0.11 to 0.22), and MRI was associated with higher sensitivity than CT (pooled difference, 0.09 [95% CI, 0.07 to 12]). For evaluation of focal liver lesions, there were no clear differences in sensitivity among ultrasonography with contrast, CT, and MRI. Specificity was generally 0.85 or higher across imaging modalities, but this item was not reported in many studies. Factors associated with lower sensitivity included use of an explanted liver reference standard, and smaller or more well-differentiated HCC lesions. For MRI, sensitivity was slightly higher for hepatic-specific than nonspecific contrast agents. Limitations: Only English-language articles were included, there was statistical heterogeneity in pooled analyses, and costs were not assessed. Most studies were conducted in Asia and had methodological limitations. Conclusion: CT and MRI are associated with higher sensitivity than ultrasonography without contrast for detection of HCC; sensitivity was higher for MRI than CT. For evaluation of focal liver lesions, the sensitivities of ultrasonography with contrast, CT, and MRI for HCC are similar.	Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA; Univ Washington, Ctr Comparat & Hlth Syst Effectiveness CHASE Alli, Seattle, WA 98195 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Mayo Clinic	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [290-2007-10057-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract 290-2007-10057-I, task order 8).	Addley HC, 2011, CLIN RADIOL, V66, P349, DOI 10.1016/j.crad.2010.11.012; Akai H, 2011, EUR J RADIOL, V80, P310, DOI 10.1016/j.ejrad.2010.07.026; Alaboudy A, 2011, ONCOLOGY-BASEL, V81, P66, DOI 10.1159/000333264; Altenbernd J, 2011, EUR RADIOL, V21, P738, DOI 10.1007/s00330-010-1964-7; [Anonymous], 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17160; Baccarani U, 2006, TRANSPL P, V38, P1111, DOI 10.1016/j.transproceed.2006.02.015; Baek CK, 2012, CLIN RADIOL, V67, P148, DOI 10.1016/j.crad.2011.08.011; Barr RG, 2013, J ULTRAS MED, V32, P7; Bartolozzi C, 2000, EUR RADIOL, V10, P1697, DOI 10.1007/s003300000564; Bhattacharjya S, 2004, DIGEST SURG, V21, P152, DOI 10.1159/000078741; Blake MA, 2011, RADIOGRAPHICS, V31, P1047, DOI 10.1148/rg.314105159; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burrel M, 2003, HEPATOLOGY, V38, P1034, DOI 10.1053/jhep.2003.50409; Catala V, 2007, EUR RADIOL, V17, P1066, DOI 10.1007/s00330-006-0444-6; Chalasani N, 1999, AM J GASTROENTEROL, V94, P2988, DOI 10.1016/S0002-9270(99)00504-3; Chang SM, 2012, AHRQ PUBLICATION; Cheung TT, 2013, J NUCL MED, V54, P192, DOI 10.2967/jnumed.112.107516; Chou R, 2014, IMAGING TECHNIQUES D; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Colagrande S, 2000, J COMPUT ASSIST TOMO, V24, P878, DOI 10.1097/00004728-200011000-00010; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Dai Y, 2008, HEPATOL RES, V38, P281, DOI 10.1111/j.1872-034X.2007.00269.x; de Ledinghen V, 2002, EUR J GASTROEN HEPAT, V14, P159, DOI 10.1097/00042737-200202000-00010; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Denecke T, 2009, TRANSPL INT, V22, P395, DOI 10.1111/j.1432-2277.2008.00793.x; Di Martino M, 2013, EUR RADIOL, V23, P887, DOI 10.1007/s00330-012-2691-z; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; Doyle DJ, 2007, J COMPUT ASSIST TOMO, V31, P86, DOI 10.1097/01.rct.0000233126.21303.f0; Egger C, 2012, ULTRASCHALL MED, V33, P587, DOI 10.1055/s-0032-1325545; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Fracanzani AL, 2001, HEPATOLOGY, V34, P1109, DOI 10.1053/jhep.2001.29373; Freeman RB, 2006, LIVER TRANSPLANT, V12, P1504, DOI 10.1002/lt.20847; Freeny PC, 2003, ABDOM IMAGING, V28, P333, DOI 10.1007/s00261-002-0053-z; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V35, P492, DOI 10.1002/jmri.22833; Furuse J, 2000, EUR J RADIOL, V36, P20, DOI 10.1016/S0720-048X(00)00185-6; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Giorgio A, 2004, AM J ROENTGENOL, V183, P1319, DOI 10.2214/ajr.183.5.1831319; Golfieri R, 2009, RADIOL MED, V114, P1239, DOI 10.1007/s11547-009-0439-x; Goto E, 2012, J GASTROENTEROL, V47, P477, DOI 10.1007/s00535-011-0512-9; Graham E, 2013, CRD42013005246 PROSP; Greenbaum L, 2007, J ULTRAS MED, V26, P705, DOI 10.7863/jum.2007.26.6.705; Guang Y, 2011, J CANCER RES CLIN, V137, P1595, DOI 10.1007/s00432-011-1035-8; Hanna RF, 2014, CLIN IMAG, V38, P693, DOI 10.1016/j.clinimag.2014.05.014; Haradome H, 2011, J MAGN RESON IMAGING, V34, P69, DOI 10.1002/jmri.22588; Herzog CA, 2008, JAMA-J AM MED ASSOC, V299, P2023, DOI [10.1001/jama.299.17.2023, DOI 10.1001/JAMA.299.177.2023]; Hidaka M, 2012, HEPATOL INT, P1; Higashihara H, 2012, EUR RADIOL, V22, P872, DOI 10.1007/s00330-011-2324-y; Hirakawa M, 2011, JPN J RADIOL, V29, P129, DOI 10.1007/s11604-010-0528-8; Hori M, 1998, ACTA RADIOL, V39, P144; Hori M, 2002, J COMPUT ASSIST TOMO, V26, P701, DOI 10.1097/00004728-200209000-00007; Hunt CH, 2009, AM J ROENTGENOL, V193, P1124, DOI 10.2214/AJR.09.2520; Hwang J, 2012, BRIT J RADIOL, V85, pE314, DOI 10.1259/bjr/27727228; Hwang J, 2014, LIVER TRANSPLANT, V20, P1436, DOI 10.1002/lt.23974; Iannaccone R, 2005, RADIOLOGY, V234, P460, DOI 10.1148/radiol.2342031202; Iavarone M, 2010, HEPATOLOGY, V52, P1723, DOI 10.1002/hep.23903; Ichikawa T, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790751; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; Iwazawa J, 2010, AM J ROENTGENOL, V195, P882, DOI 10.2214/AJR.10.4417; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jang HJ, 2000, RADIOLOGY, V215, P373, DOI 10.1148/radiology.215.2.r00ma30373; Jang HJ, 2013, AM J ROENTGENOL, V201, P314, DOI 10.2214/AJR.12.9341; Jeng CM, 2002, J FORMOS MED ASSOC, V101, P588; Kakihara D, 2014, J MAGN RESON IMAGING, V40, P1112, DOI 10.1002/jmri.24454; Kang BK, 2003, RADIOLOGY, V226, P79, DOI 10.1148/radiol.2261011827; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; Kawada N, 2010, HEPATOL RES, V40, P930, DOI 10.1111/j.1872-034X.2010.00697.x; Kawaoka T, 2009, HEPATOL RES, V39, P134, DOI 10.1111/j.1872-034X.2008.00416.x; Kawata S, 2002, AM J ROENTGENOL, V179, P61, DOI 10.2214/ajr.179.1.1790061; Khalili K, 2011, J HEPATOL, V54, P723, DOI 10.1016/j.jhep.2010.07.025; Khan MA, 2000, J HEPATOL, V32, P792, DOI 10.1016/S0168-8278(00)80248-2; Kim AY, 2012, ACTA RADIOL, V53, P830, DOI 10.1258/ar.2012.120099; Kim KW, 2009, RADIOLOGY, V250, P425, DOI 10.1148/radiol.2501072196; Kim PN, 2012, J VASC INTERV RADIOL, V23, P627, DOI 10.1016/j.jvir.2011.12.026; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Kim SH, 2005, AM J ROENTGENOL, V184, P1069, DOI 10.2214/ajr.184.4.01841069; Kim SK, 2002, J COMPUT ASSIST TOMO, V26, P691, DOI 10.1097/00004728-200209000-00005; Kim SJ, 2008, J COMPUT ASSIST TOMO, V32, P379, DOI 10.1097/RCT.0b013e3180de5c80; Kim T, 2002, AM J ROENTGENOL, V178, P899, DOI 10.2214/ajr.178.4.1780899; Kim YK, 2006, RADIOLOGY, V238, P531, DOI 10.1148/radiol.2381042193; Kim YK, 2006, AM J ROENTGENOL, V186, P149, DOI 10.2214/AJR.04.1206; Kim YK, 2009, J COMPUT ASSIST TOMO, V33, P844, DOI 10.1097/RCT.0b013e3181a7e3c7; Kitamura T, 2008, J COMPUT ASSIST TOMO, V32, P724, DOI 10.1097/RCT.0b013e318154b1f5; Krinsky GA, 2002, LIVER TRANSPLANT, V8, P1156, DOI 10.1053/jlts.2002.35670; Krinsky GA, 2001, RADIOLOGY, V219, P445, DOI 10.1148/radiology.219.2.r01ma40445; Kumano S, 2009, JPN J RADIOL, V27, P229, DOI 10.1007/s11604-009-0327-2; Kunishi Y, 2012, AM J ROENTGENOL, V198, P106, DOI 10.2214/AJR.10.6039; Laghi A, 2003, RADIOLOGY, V226, P543, DOI 10.1148/radiol.2262012043; Lauenstein TC, 2007, AM J ROENTGENOL, V189, P663, DOI 10.2214/AJR.07.2171; Lee CH, 2012, EUR J RADIOL, V81, pE605, DOI 10.1016/j.ejrad.2011.12.033; Lee DH, 2009, INVEST RADIOL, V44, P311, DOI 10.1097/RLI.0b013e31819c9f44; Lee JE, 2012, WORLD J GASTROENTERO, V18, P2979, DOI 10.3748/wjg.v18.i23.2979; Lee JM, 2003, KOREAN J RADIOL, V4, P1, DOI 10.3348/kjr.2003.4.1.1; Lee J, 2008, KOREAN J RADIOL, V9, P325, DOI 10.3348/kjr.2008.9.4.325; Lencioni R, 2008, J HEPATOL, V48, P848, DOI 10.1016/j.jhep.2008.02.005; Li CS, 2006, BRIT J RADIOL, V79, P659, DOI 10.1259/bjr/12699987; Li R, 2007, J CLIN ULTRASOUND, V35, P109, DOI 10.1002/jcu.20310; Libbrecht L, 2002, LIVER TRANSPLANT, V8, P749, DOI 10.1053/jlts.2002.34922; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lim JH, 2006, CLIN RADIOL, V61, P191, DOI 10.1016/j.crad.2005.10.005; Lim JH, 2002, AM J ROENTGENOL, V179, P67, DOI 10.2214/ajr.179.1.1790067; Lim JH, 2000, AM J ROENTGENOL, V175, P693, DOI 10.2214/ajr.175.3.1750693; Lin MT, 2011, J GASTROEN HEPATOL, V26, P745, DOI 10.1111/j.1440-1746.2010.06501.x; Liu WC, 2003, EUR RADIOL, V13, P1693, DOI 10.1007/s00330-002-1814-3; Liu YYI, 2013, AM J ROENTGENOL, V200, P84, DOI 10.2214/AJR.11.7171; Liu YYI, 2012, J COMPUT ASSIST TOMO, V36, P213, DOI 10.1097/RCT.0b013e318247c8f0; Lu CH, 2010, TRANSPL P, V42, P830, DOI 10.1016/j.transproceed.2010.03.006; Luca A, 2010, EUR RADIOL, V20, P898, DOI 10.1007/s00330-009-1622-0; Luo W, 2009, RADIOLOGY, V251, P287, DOI 10.1148/radiol.2511081324; Lv PJ, 2012, EUR RADIOL, V22, P2117, DOI 10.1007/s00330-012-2485-3; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Maetani YS, 2008, INTERVIROLOGY, V51, P46, DOI 10.1159/000122597; Maiwald B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111935; Marin D, 2009, AM J ROENTGENOL, V192, P180, DOI 10.2214/AJR.07.3652; Marin D, 2009, RADIOLOGY, V251, P85, DOI 10.1148/radiol.2511080400; Mita K, 2010, WORLD J GASTROENTERO, V16, P4187, DOI 10.3748/wjg.v16.i33.4187; Mok TSK, 2004, AM J ROENTGENOL, V183, P453, DOI 10.2214/ajr.183.2.1830453; Monzawa S, 2007, AM J ROENTGENOL, V188, P147, DOI 10.2214/AJR.05.0512; Moriyasu F, 2009, AM J ROENTGENOL, V193, P86, DOI 10.2214/AJR.08.1618; Mortele KJ, 2001, EUR RADIOL, V11, P1631, DOI 10.1007/s003300100834; Mucelli RMP, 2006, RADIOL MED, V111, P181, DOI 10.1007/s11547-006-0019-2; Murakami T, 2003, INVEST RADIOL, V38, P497, DOI 10.1097/01.rli.0000074584.12494.e3; Murakami T, 2001, RADIOLOGY, V218, P763, DOI 10.1148/radiology.218.3.r01mr39763; Nagaoka S, 2006, LIVER INT, V26, P781, DOI 10.1111/j.1478-3231.2006.01296.x; Nakamura H, 2000, J GASTROENTEROL, V35, P849, DOI 10.1007/s005350070022; Nakamura Y, 2013, J MAGN RESON IMAGING, V37, P684, DOI 10.1002/jmri.23855; Nakayama A, 2001, ANN SURG, V234, P56, DOI 10.1097/00000658-200107000-00009; National Cancer Institute, LIV BIL DUCT CANC; NELSON KL, 1995, RADIOLOGY, V196, P439, DOI 10.1148/radiology.196.2.7617858; Nelson TR, 2007, J ULTRAS MED, V26, P703, DOI 10.7863/jum.2007.26.6.703; NIENDORF HP, 1991, MAGNET RESON MED, V22, P222, DOI 10.1002/mrm.1910220212; Noguchi Y, 2003, AM J ROENTGENOL, V180, P455, DOI 10.2214/ajr.180.2.1800455; Noguchi Y, 2002, J COMPUT ASSIST TOMO, V26, P981, DOI 10.1097/00004728-200211000-00022; Numata K, 2014, EUR J RADIOL, V83, P95, DOI [10.1016/j.ejrad.2013.09.025, DOI 10.1016/J.EJRAD.09.025]; Onishi H, 2012, EUR RADIOL, V22, P845, DOI 10.1007/s00330-011-2316-y; Park JH, 2011, EUR J RADIOL, V80, pE76, DOI 10.1016/j.ejrad.2010.08.018; Park MJ, 2012, RADIOLOGY, V264, P761, DOI 10.1148/radiol.12112517; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Paul SB, 2007, ONCOLOGY-BASEL, V72, P117, DOI 10.1159/000111717; Peterson MS, 2000, RADIOLOGY, V217, P743, DOI 10.1148/radiology.217.3.r00dc28743; Piscaglia F, 2006, ULTRASOUND MED BIOL, V32, P1369, DOI 10.1016/j.ultrasmedbio.2006.05.031; Pitton MB, 2009, WORLD J GASTROENTERO, V15, P6044, DOI 10.3748/wjg.15.6044; Pugacheva O, 2011, EUR J RADIOL, V80, pE201, DOI 10.1016/j.ejrad.2010.08.036; Quaia E, 2009, EUR RADIOL, V19, P651, DOI 10.1007/s00330-008-1179-3; Radiological Society of North America, PAT SAF RAD DOS XRAY; Rizvi S, 2006, TRANSPLANT P, V38, P2993, DOI 10.1016/j.transproceed.2006.08.125; Rode A, 2001, J COMPUT ASSIST TOMO, V25, P327, DOI 10.1097/00004728-200105000-00001; Ronzoni A, 2007, AM J ROENTGENOL, V189, P792, DOI 10.2214/AJR.07.2040; Sangiovanni A, 2010, GUT, V59, P638, DOI 10.1136/gut.2009.187286; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Schima W, 2006, AM J ROENTGENOL, V186, P1571, DOI 10.2214/AJR.05.1226; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Secil M, 2008, DIAGN INTERV RADIOL, V14, P200; Seitz K, 2009, ULTRASCHALL MED, V30, P383, DOI 10.1055/s-0028-1109673; Serste T, 2012, HEPATOLOGY, V55, P800, DOI 10.1002/hep.24746; Shah SA, 2006, TRANSPLANTATION, V81, P1633, DOI 10.1097/01.tp.0000226069.66819.7e; Singh P, 2007, GASTROINTEST ENDOSC, V66, P265, DOI 10.1016/j.gie.2006.10.053; Singh S, 2012, J GEN INTERN MED, V27, pS47, DOI 10.1007/s11606-012-2021-9; Sofue K, 2011, EUR J RADIOL, V80, pE237, DOI 10.1016/j.ejrad.2010.10.006; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Takwoingi Y, 2013, ANN INTERN MED, V158, P544, DOI 10.7326/0003-4819-158-7-201304020-00006; Tang Y, 1999, AM J ROENTGENOL, V172, P1547, DOI 10.2214/ajr.172.6.10350287; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Toyota Naoyuki, 2013, Hiroshima Journal of Medical Sciences, V62, P55; Trikalinos TA, 2012, J GEN INTERN MED, V27, pS56, DOI 10.1007/s11606-012-2029-1; Trojan J, 1999, AM J GASTROENTEROL, V94, P3314, DOI 10.1111/j.1572-0241.1999.01544.x; U.S. Food and Drug Administration, 2013, MICR CONTR AG MARK D; Valls C, 2004, AM J ROENTGENOL, V182, P1011, DOI 10.2214/ajr.182.4.1821011; Van Thiel DH, 2004, LIVER TRANSPLANT, V10, P631, DOI 10.1002/lt.20120; Wagnetz U, 2011, AM J ROENTGENOL, V196, P562, DOI 10.2214/AJR.10.4729; Wald C, 2013, RADIOLOGY, V266, P376, DOI 10.1148/radiol.12121698; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553; Xiao XG, 2005, CHINESE MED J-PEKING, V118, P844; Xie LM, 2011, ULTRASOUND MED BIOL, V37, P854, DOI 10.1016/j.ultrasmedbio.2011.03.006; Xu HX, 2012, BRIT J RADIOL, V85, P1376, DOI 10.1259/bjr/19932596; Xu HX, 2008, J CLIN ULTRASOUND, V36, P257, DOI 10.1002/jcu.20433; Yamamoto K, 2002, ONCOL REP, V9, P789; Yan Fu-Hua, 2002, Hepatobiliary Pancreat Dis Int, V1, P420; Yoo SH, 2013, ANN SURG ONCOL, V20, P2893, DOI 10.1245/s10434-013-3001-y; Yu MH, 2014, RADIOLOGY, V271, P748, DOI 10.1148/radiol.14131996; Yu NC, 2011, CLIN GASTROENTEROL H, V9, P161, DOI 10.1016/j.cgh.2010.09.017; Yukisawa S, 2007, EUR J RADIOL, V61, P279, DOI 10.1016/j.ejrad.2006.09.011; Zacherl J, 2002, ANN SURG, V235, P528, DOI 10.1097/00000658-200204000-00011; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhao H, 2003, WORLD J GASTROENTERO, V9, P2198; Zhao H, 2007, WORLD J GASTROENTERO, V13, P1252, DOI 10.3748/wjg.v13.i8.1252; Zhao Hong, 2004, Hepatobiliary Pancreat Dis Int, V3, P204; Zheng XH, 2005, WORLD J GASTROENTERO, V11, P200, DOI 10.3748/wjg.v11.i2.200; Zhou Kang-Rong, 2002, Hepatobiliary Pancreat Dis Int, V1, P68; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	192	109	110	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					697	+		10.7326/M14-2509	http://dx.doi.org/10.7326/M14-2509			41	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984845				2022-12-28	WOS:000355015200019
J	Lenzer, J				Lenzer, Jeanne			Ending "corrupt" practices in medicine: Harvard conference report	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK					jlenzer@bmj.com						Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2015	350								h2618	10.1136/bmj.h2618	http://dx.doi.org/10.1136/bmj.h2618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CN	25979225				2022-12-28	WOS:000354770600002
J	Scudellari, M				Scudellari, Megan			DRUG DEVELOPMENT Mix and match	NATURE			English	Editorial Material							COLORECTAL-CANCER											Dienstmann R., 2014, ANN ONCOL         S2, V25, pii115; Johnsson A, 2013, ANN ONCOL, V24, P2335, DOI 10.1093/annonc/mdt236; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Witek M, 2014, INT J RADIAT ONCOL, V88, P1188, DOI 10.1016/j.ijrobp.2013.12.043	6	8	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S12	S14		10.1038/521S12a	http://dx.doi.org/10.1038/521S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25970452	Bronze			2022-12-28	WOS:000354377800006
J	Willyard, C				Willyard, Cassandra			SCREENING Early alert	NATURE			English	Editorial Material							ASYMPTOMATIC ADULTS; COLORECTAL-CANCER											Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Potter N. T., 2014, CLIN CHEM	5	9	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S4	S5		10.1038/521S4a	http://dx.doi.org/10.1038/521S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25970456				2022-12-28	WOS:000354377800002
J	Crosson, FJ				Crosson, Francis J.			Physician Professionalism in Employed Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL PROFESSIONALISM					fjcrosson@gmail.com						Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Hawkins M., 2014, REV PHYS ADV PRACTIT; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; McCarthy D, 2009, MAYO CLIN MULTIDISCI; McCarthy DM, 2009, KAISER PERMANENTE BR; Qaseem A, 2010, ANN INTERN MED, V152, P366, DOI 10.7326/0003-4819-152-6-201003160-00006; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	7	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1817	1818		10.1001/jama.2015.3742	http://dx.doi.org/10.1001/jama.2015.3742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965223				2022-12-28	WOS:000354391000018
J	Kirch, DG; Gusic, ME; Ast, C				Kirch, Darrell G.; Gusic, Maryellen E.; Ast, Cori			Undergraduate Medical Education and the Foundation of Physician Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-PROFESSIONS; COMPETENCES; STUDENTS; SCHOOL		[Kirch, Darrell G.; Gusic, Maryellen E.; Ast, Cori] Assoc Amer Med Coll, Washington, DC 20001 USA	Association of American Medical Colleges	Ast, C (corresponding author), Assoc Amer Med Coll, Off President, 655 K St NW,Ste 100, Washington, DC 20001 USA.	cast@aamc.org						Boon K, 2004, J MED ETHICS, V30, P221, DOI 10.1136/jme.2002.002618; Englander R, 2013, ACAD MED, V88, P1088, DOI 10.1097/ACM.0b013e31829a3b2b; Kirch DG, 2013, JAMA-J AM MED ASSOC, V310, P2243, DOI 10.1001/jama.2013.282093; Koenig TW, 2013, ACAD MED, V88, P603, DOI 10.1097/ACM.0b013e31828b3389; Liaison Committee on Medical Education (LCME), 2014, STAND 3 5 FUNCT STRU; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Pau A, 2013, MED TEACH, V35, P1027, DOI 10.3109/0142159X.2013.829912	7	16	17	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1797	1798		10.1001/jama.2015.4019	http://dx.doi.org/10.1001/jama.2015.4019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965213				2022-12-28	WOS:000354391000008
J	Toll, E				Toll, Elizabeth			Back to the Heart of the Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toll, Elizabeth] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA; [Toll, Elizabeth] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Toll, Elizabeth] Med Pediat Primary Care Ctr, Providence, RI USA	Brown University; Brown University	Toll, E (corresponding author), Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA.	etoll@lifespan.org						Detsky AS, 2013, JAMA-J AM MED ASSOC, V309, P987, DOI 10.1001/jama.2013.620; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531	2	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1829	1830		10.1001/jama.2015.1672	http://dx.doi.org/10.1001/jama.2015.1672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965229				2022-12-28	WOS:000354391000024
J	Barry, C				Barry, Clifton			More than just bugs in spit	SCIENCE			English	Editorial Material							TREHALOSE ANALOGS; TUBERCULOSIS; MOXIFLOXACIN; LESIONS		[Barry, Clifton] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Barry, Clifton] Univ Cape Town, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Barry, Clifton] Univ Stellenbosch, Dept Mol Biol & Human Genet, ZA-7600 Stellenbosch, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Stellenbosch University	Barry, C (corresponding author), NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@niaid.nih.gov	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI001214-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Coleman MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009500; Dartois V, 2014, NAT REV MICROBIOL, V12, P159, DOI 10.1038/nrmicro3200; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Mahapatra S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-53; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Urbanek BL, 2014, CHEMBIOCHEM, V15, P2066, DOI 10.1002/cbic.201402288; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	12	2	2	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					633	634		10.1126/science.aaa2886	http://dx.doi.org/10.1126/science.aaa2886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953992	Green Accepted			2022-12-28	WOS:000354045700026
J	Mina, MJ; Metcalf, CJE; de Swart, RL; Osterhaus, ADME; Grenfell, BT				Mina, Michael J.; Metcalf, C. Jessica E.; de Swart, Rik L.; Osterhaus, A. D. M. E.; Grenfell, Bryan T.			Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality	SCIENCE			English	Article							CELL-MEDIATED-IMMUNITY; GUINEA-BISSAU; RURAL BANGLADESH; EXCESS MORTALITY; T-CELLS; VACCINATION; VIRUS; MEMORY; COMMUNITY; REDUCTION	Immunosuppression after measles is known to predispose people to opportunistic infections for a period of several weeks to months. Using population-level data, we show that measles has a more prolonged effect on host resistance, extending over 2 to 3 years. We find that nonmeasles infectious disease mortality in high-income countries is tightly coupled to measles incidence at this lag, in both the pre- and post-vaccine eras. We conclude that long-term immunologic sequelae of measles drive interannual fluctuations in nonmeasles deaths. This is consistent with recent experimental work that attributes the immunosuppressive effects of measles to depletion of B and T lymphocytes. Our data provide an explanation for the long-term benefits of measles vaccination in preventing all-cause infectious disease. By preventing measles-associated immune memory loss, vaccination protects polymicrobial herd immunity.	[Mina, Michael J.; Metcalf, C. Jessica E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Mina, Michael J.] Emory Univ, Sch Med, Med Scientist Training Program, Atlanta, GA USA; [Metcalf, C. Jessica E.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [de Swart, Rik L.; Osterhaus, A. D. M. E.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands	Princeton University; Emory University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC	Mina, MJ (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	michael.j.mina@gmail.com	de Swart, Rik L./E-6508-2011	de Swart, Rik L./0000-0003-3599-8969; Mina, Michael/0000-0002-0674-5762	Bill and Melinda Gates Foundation; Science and Technology Directorate of the Department of Homeland Security [HSHQDC-12-C-00058]; RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science and Technology Directorate of the Department of Homeland Security(United States Department of Homeland Security (DHS)); RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for analyses regarding England and Wales were retrieved from the Office of Population Censuses and Surveys and the Office for National Statistics (www.ons.gov.uk). We thank P. Rohani for supplying us with historical data on pertussis, as originally described in (34). Data for U.S. analyses were retrieved from the U.S. Centers for Disease Control and Prevention, National Center for Health Statistics (www.cdc.gov/nchs). Data for Denmark was retrieved from Statistics Denmark (www.statbank.dk) and WHO (www.apps.who.int). This work is funded by the Bill and Melinda Gates Foundation, the Science and Technology Directorate of the Department of Homeland Security [contract HSHQDC-12-C-00058 (B.T.G. and C.J.E.M.)], and the RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security and the Fogarty International Center, National Institutes of Health (C.J.E.M. and B.T.G).	AABY P, 1990, AM J EPIDEMIOL, V132, P211, DOI 10.1093/oxfordjournals.aje.a115650; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 1996, AM J EPIDEMIOL, V143, P1035, DOI 10.1093/oxfordjournals.aje.a008667; Aaby P, 1996, PEDIATR INFECT DIS J, V15, P39, DOI 10.1097/00006454-199601000-00009; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961; CLARKSON JA, 1985, INT J EPIDEMIOL, V14, P153, DOI 10.1093/ije/14.1.153; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; de Vries RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004482; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Flanagan KL, 2013, CLIN INFECT DIS, V57, P283, DOI 10.1093/cid/cit209; Hahm B, 2009, CURR TOP MICROBIOL, V330, P271; Hinman AR, 2004, J INFECT DIS, V189, pS17, DOI 10.1086/377694; HOLT EA, 1990, PEDIATRICS, V85, P188; HORWITZ O, 1974, AM J EPIDEMIOL, V100, P136, DOI 10.1093/oxfordjournals.aje.a112016; Kabir Z, 2003, B WORLD HEALTH ORGAN, V81, P244; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; Kipps A., 1996, S AFR MED J, V86, P104; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schneider-Schaulies S, 2009, CURR TOP MICROBIOL, V330, P243; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shaheen SO, 1996, BRIT MED J, V313, P969, DOI 10.1136/bmj.313.7063.969; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; WHO, 2011, GLOB REV DISTR PNEUM; WHO, 2014, STST REV NONSP EFF B	40	216	222	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					694	699		10.1126/science.aaa3662	http://dx.doi.org/10.1126/science.aaa3662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954009	Green Accepted			2022-12-28	WOS:000354045700046
J	Ramirez, A				Ramirez, Ainissa			The making of a science evangelist	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					726	726		10.1126/science.348.6235.726	http://dx.doi.org/10.1126/science.348.6235.726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25954013				2022-12-28	WOS:000354045700051
J	Fu, Y; Luo, GZ; Chen, K; Deng, X; Yu, M; Han, DL; Hao, ZY; Liu, JZ; Lu, XY; Dore, LC; Weng, XC; Ji, QJ; Mets, L; He, C				Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; Mets, Laurens; He, Chuan			N-6-Methyldeoxyadenosine Marks Active Transcription Start Sites in Chlamydomonas	CELL			English	Article							DNA METHYLATION; ADENINE METHYLATION; GENE-EXPRESSION; RNA; WIDE; RESTRICTION; METHYLOMES; REVEALS; PLANTS; ROLES	N-6-methyldeoxyadenosine (6mA or m(6)A) is a DNA modification preserved in prokaryotes to eukaryotes. It is widespread in bacteria and functions in DNA mismatch repair, chromosome segregation, and virulence regulation. In contrast, the distribution and function of 6mA in eukaryotes have been unclear. Here, we present a comprehensive analysis of the 6mA landscape in the genome of Chlamydomonas using new sequencing approaches. We identified the 6mA modification in 84% of genes in Chlamydomonas. We found that 6mA mainly locates at ApT dinucleotides around transcription start sites (TSS) with a bimodal distribution and appears to mark active genes. A periodic pattern of 6mA deposition was also observed at base resolution, which is associated with nucleosome distribution near the TSS, suggesting a possible role in nucleosome positioning. The new genome-wide mapping of 6mA and its unique distribution in the Chlamydomonas genome suggest potential regulatory roles of 6mA in gene expression in eukaryotic organisms.	[Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Mets, Laurens] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Dore, Louis/A-5689-2009; Han, Dali/I-4145-2016; Ji, Quanjiang/AAZ-9793-2020; Liu, Jianzhao/AAO-2359-2020; Liu, Jianzhao/E-9165-2011; Ji, Quanjiang/AAP-9111-2020	Dore, Louis/0000-0002-7837-5887; Ji, Quanjiang/0000-0002-2321-8462; Liu, Jianzhao/0000-0001-9465-6075; Liu, Jianzhao/0000-0001-9465-6075; Ji, Quanjiang/0000-0002-2321-8462; Fu, Ye/0000-0003-4434-6014; Fu, Ye/0000-0002-3807-9717	National Institutes of Health [R01 HG006827]; National Science Foundation [CHE-1048528]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Dr. Q. Jin for help with HPLC-QQQ-MS/MS and Dr. Pieter W. Faber for help with high-throughput sequencing. This work is partially supported by National Institutes of Health (R01 HG006827 to C.H.), and C.H. is a Howard Hughes Medical Institute investigator. The Mass Spectrometry Facility of the University of Chicago is funded by National Science Foundation (CHE-1048528). S.F. Reichard, MA edited the manuscript.	Babinger P, 2001, NUCLEIC ACIDS RES, V29, P1261, DOI 10.1093/nar/29.6.1261; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bisova K, 2005, PLANT PHYSIOL, V137, P475, DOI 10.1104/pp.104.054155; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; CUMMINGS DJ, 1974, BIOCHIM BIOPHYS ACTA, V374, P1, DOI 10.1016/0005-2787(74)90194-4; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ehrlich M., 1990, J CHROMATOGRAPHY LIB, pB327; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; ENGEL JD, 1978, J BIOL CHEM, V253, P927; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; HATTMAN S, 1978, J BACTERIOL, V135, P1156, DOI 10.1128/JB.135.3.1156-1157.1978; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; RAE PMM, 1978, P NATL ACAD SCI USA, V75, P4992, DOI 10.1073/pnas.75.10.4992; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Rhee H. S., 2012, CURR PROTOC MOL BIOL; ROGERS JC, 1995, PLANT J, V7, P221, DOI 10.1046/j.1365-313X.1995.7020221.x; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; STERNBERG N, 1985, J BACTERIOL, V164, P490, DOI 10.1128/JB.164.1.490-493.1985; VOVIS GF, 1977, J MOL BIOL, V115, P525, DOI 10.1016/0022-2836(77)90169-3; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHANG YP, 1992, NUCLEIC ACIDS RES, V20, P5351, DOI 10.1093/nar/20.20.5351	39	310	325	7	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					879	892		10.1016/j.cell.2015.04.010	http://dx.doi.org/10.1016/j.cell.2015.04.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936837	Bronze, Green Accepted			2022-12-28	WOS:000354175200020
J	Sayer, AA; Kirkwood, TBL				Sayer, Avan Aihie; Kirkwood, Thomas B. L.			Grip strength and mortality: a biomarker of ageing?	LANCET			English	Editorial Material							MUSCLE STRENGTH; DECLINE		[Sayer, Avan Aihie] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England; [Sayer, Avan Aihie; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Southampton; Newcastle University - UK	Sayer, AA (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England.	aas@mrc.soton.ac.uk		Aihie Sayer, Avan/0000-0003-1283-6457	MRC [MC_UU_12011/2, MC_UP_A620_1015] Funding Source: UKRI; Medical Research Council [U1475000002] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1015, MC_UU_12011/2] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Kirkwood TBL, 2013, CELL METAB, V18, P303, DOI 10.1016/j.cmet.2013.08.013; Leong DP, 2015, LANCET; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	13	115	118	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					226	227		10.1016/S0140-6736(14)62349-7	http://dx.doi.org/10.1016/S0140-6736(14)62349-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25982159				2022-12-28	WOS:000358213700008
J	Hall, AB; Basu, S; Jiang, XF; Qi, YM; Timoshevskiy, VA; Biedler, JK; Sharakhova, MV; Elahi, R; Anderson, MAE; Chen, XG; Sharakhov, IV; Adelman, ZN; Tu, ZJ				Hall, Andrew Brantley; Basu, Sanjay; Jiang, Xiaofang; Qi, Yumin; Timoshevskiy, Vladimir A.; Biedler, James K.; Sharakhova, Maria V.; Elahi, Rubayet; Anderson, Michelle A. E.; Chen, Xiao-Guang; Sharakhov, Igor V.; Adelman, Zach N.; Tu, Zhijian			A male-determining factor in the mosquito Aedes aegypti	SCIENCE			English	Article							YELLOW-FEVER MOSQUITO; SEX DETERMINATION; DOUBLESEX GENE; DROSOPHILA; DIFFERENTIATION; CHROMOSOME; PATHWAY; DENGUE	Sex determination in the mosquito Aedes aegypti is governed by a dominant male-determining factor (M factor) located within a Y chromosome-like region called the M locus. Here, we show that an M-locus gene, Nix, functions as an M factor in A. aegypti. Nix exhibits persistent M linkage and early embryonic expression, two characteristics required of an M factor. Nix knockout with clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 resulted in largely feminized genetic males and the production of female isoforms of two key regulators of sexual differentiation: doublesex and fruitless. Ectopic expression of Nix resulted in genetic females with nearly complete male genitalia. Thus, Nix is both required and sufficient to initiate male development. This study provides a foundation for mosquito control strategies that convert female mosquitoes into harmless males.	[Hall, Andrew Brantley; Jiang, Xiaofang; Sharakhov, Igor V.; Adelman, Zach N.; Tu, Zhijian] Virginia Polytech Inst & State Univ, Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA 24061 USA; [Hall, Andrew Brantley; Jiang, Xiaofang; Qi, Yumin; Biedler, James K.; Elahi, Rubayet; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Hall, Andrew Brantley; Basu, Sanjay; Jiang, Xiaofang; Qi, Yumin; Timoshevskiy, Vladimir A.; Biedler, James K.; Sharakhova, Maria V.; Elahi, Rubayet; Anderson, Michelle A. E.; Sharakhov, Igor V.; Adelman, Zach N.; Tu, Zhijian] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA; [Basu, Sanjay; Timoshevskiy, Vladimir A.; Sharakhova, Maria V.; Anderson, Michelle A. E.; Sharakhov, Igor V.; Adelman, Zach N.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Chen, Xiao-Guang] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Southern Medical University - China	Adelman, ZN (corresponding author), Virginia Polytech Inst & State Univ, Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA 24061 USA.	zachadel@vt.edu; jaketu@vt.edu	Sharakhov, Igor/B-1972-2008; Elahi, Rubayet/ABG-7783-2021; Elahi, Rubayet/AAB-5652-2019	Sharakhov, Igor/0000-0003-0752-3747; Elahi, Rubayet/0000-0002-1561-5257; Basu, Sanjay/0000-0003-2098-7423; Anderson, Michelle/0000-0003-1510-2942; Adelman, Zach/0000-0001-5901-7171; Jiang, Xiaofang/0000-0002-0955-8284	National Institutes of Health [AI113643]; National Science Foundation Graduate Research Fellowship [DGE-1519168]; National Natural Science Foundation [81420108024]; Fralin Life Science Institute; Virginia Agriculture Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fralin Life Science Institute; Virginia Agriculture Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. James and C. Barillas-Mury for critical review of the manuscript. We thank R. Saunders for mosquito care. Sequencing data used in this study have been submitted to the National Center for Biotechnology Information under accession numbers KF732822, KP765684, KP842989-KP843003, SRP044709, SRP046160, SRP047470, SRP047401, SRP034669, SRP055126, and SRP055127. The authors declare no competing financial interests. This research was supported by the National Institutes of Health grant AI113643, the National Science Foundation Graduate Research Fellowship grant DGE-1519168, the National Natural Science Foundation grant 81420108024, the Fralin Life Science Institute, and the Virginia Agriculture Experimental Station. This study was considered by the Virginia Tech Institutional Biosafety Committee and was determined not to fall under dual-use research of concern (DURC).	Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002; Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x; [Anonymous], 2003, MOSQUITOES THEIR CON; Ashman TL, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.15; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; GILCHRIST BM, 1947, HEREDITAS, V33, P175; Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hoskins RA, 2002, GENOME BIOL, V3; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; McClelland G. A. H, 1962, T ROY SOC TROP MED H, V56, P4; NEWTON ME, 1978, GENETICA, V48, P137, DOI 10.1007/BF00127510; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Salvemini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048554; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6	24	182	199	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1268	1270		10.1126/science.aaa2850	http://dx.doi.org/10.1126/science.aaa2850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	25999371	Green Accepted			2022-12-28	WOS:000356011500058
J	Klotz, L; Norman, S; Vieira, JM; Masters, M; Rohling, M; Dube, KN; Bollini, S; Matsuzaki, F; Carr, CA; Riley, PR				Klotz, Linda; Norman, Sophie; Vieira, Joaquim Miguel; Masters, Megan; Rohling, Mala; Dube, Karina N.; Bollini, Sveva; Matsuzaki, Fumio; Carr, Carolyn A.; Riley, Paul R.			Cardiac lymphatics are heterogeneous in origin and respond to injury	NATURE			English	Article							VASCULAR ENDOTHELIAL-CELLS; VESSEL DEVELOPMENT; TRANSGENIC MICE; PROX1; VEGF; LYMPHANGIOGENESIS; PROGENITORS; EXPRESSION; LINEAGE; HEART	The lymphatic vasculature is a blind-ended network crucial for tissue-fluid homeostasis, immune surveillance and lipid absorption from the gut. Recent evidence has proposed an entirely venous-derived mammalian lymphatic system. By contrast, here we show that cardiac lymphatic vessels in mice have a heterogeneous cellular origin, whereby formation of at least part of the cardiac lymphatic network is independent of sprouting from veins. Multiple Cre-lox-based lineage tracing revealed a potential contribution from the putative haemogenic endothelium during development, and discrete lymphatic endothelial progenitor populations were confirmed by conditional knockout of Prox1 in Tie2(+) and Vav1(+) compartments. In the adult heart, myocardial infarction promoted a significant lymphangiogenic response, which was augmented by treatment with VEGF-C, resulting in improved cardiac function. These data prompt the re-evaluation of a century-long debate on the origin of lymphatic vessels and suggest that lymphangiogenesis may represent a therapeutic target to promote cardiac repair following injury.	[Klotz, Linda; Dube, Karina N.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Norman, Sophie; Vieira, Joaquim Miguel; Masters, Megan; Rohling, Mala; Carr, Carolyn A.; Riley, Paul R.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Bollini, Sveva] Univ Genoa, Regenerat Med Lab, I-16132 Genoa, Italy; [Bollini, Sveva] IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Matsuzaki, Fumio] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Chuou Ku, Kobe, Hyogo 6500047, Japan	University of London; University College London; University of Oxford; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; RIKEN	Riley, PR (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3PT, England.	paul.riley@dpag.ox.ac.uk	Bollini, Sveva/J-6004-2016	Bollini, Sveva/0000-0003-1076-0823; Vieira, Joaquim/0000-0003-2023-6304	Wellcome Trust; EU FP7 Marie Curie ITN (CardioNet); British Heart Foundation; British Heart Foundation [PG/13/34/30216, RG/13/9/30269, RG/08/003/25264] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EU FP7 Marie Curie ITN (CardioNet); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by the Wellcome Trust (L.K.), EU FP7 Marie Curie ITN (CardioNet; M.M.) and the British Heart Foundation (S.N., J.M.V., M.R., K.D., S.B., C.A.C., P.R.R.). We thank M. Fruttiger for providing the Pdgfb-creER<SUP>T2</SUP> line, J. Pollard for providing the Csf1r-creER mouse line, K. Alitalo for providing the Vegfr3<SUP>lacZ/+</SUP> mouse line, T. Makinen for providing Pdgfrb-cre embryos and the transgenic services at the University of Oxford for re-deriving the Prox1<SUP>fl/+</SUP> mouse line from RIKEN (accession number CDB0482K). We are grateful to B. Vernay and A. Eddaoudi for assistance with confocal microscopy and flow cytometry, respectively.	Brade T., 2013, COLD SPRING HARB PER, V3; Breslin JW, 2007, AM J PHYSIOL-HEART C, V293, pH709, DOI 10.1152/ajpheart.00102.2007; Buttler K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-43; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Flaht A, 2012, DEV DYNAM, V241, P1473, DOI 10.1002/dvdy.23827; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hamada K, 2000, BLOOD, V96, P3793, DOI 10.1182/blood.V96.12.3793.h8003793_3793_3800; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huntington GS, 1910, AM J ANAT, V10, P177, DOI 10.1002/aja.1000100108; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2001, TRENDS MOL MED, V7, P18, DOI 10.1016/S1471-4914(00)01864-5; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kim H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-72; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Okuda KS, 2012, DEVELOPMENT, V139, P2381, DOI 10.1242/dev.077701; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yang Y, 2012, BLOOD, V120, P2340, DOI 10.1182/blood-2012-05-428607; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	49	272	281	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					62	U126		10.1038/nature14483	http://dx.doi.org/10.1038/nature14483			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25992544	Green Accepted			2022-12-28	WOS:000355543400029
J	Deisseroth, K; Etkin, A; Malenka, RC				Deisseroth, Karl; Etkin, Amit; Malenka, Robert C.			Optogenetics and the Circuit Dynamics of Psychiatric Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Deisseroth, Karl; Etkin, Amit; Malenka, Robert C.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr W,W083 Clark Ctr, Stanford, CA 94305 USA.	deissero@stanford.edu	Etkin, Amit/ABD-5761-2021		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012	8	26	27	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2019	2020		10.1001/jama.2015.2544	http://dx.doi.org/10.1001/jama.2015.2544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0DC	25974025	Green Accepted			2022-12-28	WOS:000355142400010
J	Olfson, M; Druss, BG; Marcus, SC				Olfson, Mark; Druss, Benjamin G.; Marcus, Steven C.			Trends in Mental Health Care among Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PSYCHOSOCIAL TREATMENTS; MEDICATION; IMPAIRMENT; DEPRESSION; DISORDERS	BACKGROUND Increasing mental health treatment of young people and broadening conceptualizations of psychopathology have triggered concerns about a disproportionate increase in the treatment of youths with low levels of mental health impairment. METHODS We analyzed the 1996-1998, 2003-2005, and 2010-2012 Medical Expenditure Panel Surveys, which were nationally representative surveys of U.S. households, for trends in outpatient use of mental health services by persons 6 to 17 years of age; 53,622 persons were included in the analysis. Mental health impairment was measured with the use of the Columbia Impairment Scale (range, 0 to 52, with higher scores indicating more severe impairment); we classified youths with scores of 16 or higher as having more severe impairment and those with scores of less than 16 as having less severe impairment. RESULTS The percentage of youths receiving any outpatient mental health service increased from 9.2% in 1996-1998 to 13.3% in 2010-2012 (odds ratio, 1.52; 95% confidence interval, 1.35 to 1.72). The proportionate increase in the use of mental health services among youths with more severe impairment (from 26.2% to 43.9%) was larger than that among youths with less severe or no impairment (from 6.7% to 9.6%). However, the absolute increase in annual service use was larger among youths with less severe or no impairment (from 2.74 million to 4.19 million) than among those with more severe impairment (from 1.56 million to 2.28 million). Significant overall increases occurred in the use of psychotherapy (from 4.2% to 6.0%) and psychotropic medications (from 5.5% to 8.9%), including stimulants and related medications (from 4.0% to 6.6%), antidepressants (from 1.5% to 2.6%), and antipsychotic drugs (from 0.2% to 1.2%). CONCLUSIONS Outpatient mental health treatment and psychotropic-medication use in children and adolescents increased in the United States between 1996-1998 and 2010-2012. Although youths with less severe or no impairment accounted for most of the absolute increase in service use, youths with more severe impairment had the greatest relative increase in use, yet fewer than half accessed services in 2010-2012.	[Olfson, Mark] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Olfson, Mark] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Druss, Benjamin G.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; [Marcus, Steven C.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; [Marcus, Steven C.] Univ Penn, Sch Social Practice & Policy, Philadelphia, PA 19104 USA	Columbia University; New York State Psychiatry Institute; Emory University; Rollins School Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Olfson, M (corresponding author), Columbia Univ, New York State Psychiat Inst, Dept Psychiat, Coll Phys & Surg, 1051 Riverside Dr, New York, NY 10032 USA.	mo49@cumc.columbia.edu	Olfson, Mark/AAA-8547-2021		Agency for Healthcare Research and Quality [U19 HS021112]; New York State Psychiatric Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021112] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New York State Psychiatric Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant (U19 HS021112) from the Agency for Healthcare Research and Quality and by the New York State Psychiatric Institute.	Agency for Healthcare Research and Quality, 2014, MEPS HC 036 1996 201; Agency for Healthcare Research and Quality, MED EXP PAN SURV MEP; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2013, CHOOS WIS; Angold A, 1999, J AM ACAD CHILD PSY, V38, P129, DOI 10.1097/00004583-199902000-00011; BIRD HR, 1993, INT J METH PSYCH RES, V3, P167; Bird HR, 1996, INT J METH PSYCH RES, V6, P295, DOI 10.1002/(SICI)1234-988X(199612)6:4<295::AID-MPR173>3.3.CO;2-5; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Centers for Disease Control and Prevention, 1991, AD SCH HLTH ALC US T; David-Ferdon C, 2008, J CLIN CHILD ADOLESC, V37, P62, DOI 10.1080/15374410701817865; DosReis S, 2003, J DEV BEHAV PEDIATR, V24, P155, DOI 10.1097/00004703-200306000-00004; Erath SA, 2009, J DEV BEHAV PEDIATR, V30, P481, DOI 10.1097/DBP.0b013e3181c35938; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Grills AE, 2002, CLIN CHILD FAM PSYCH, V5, P57, DOI 10.1023/A:1014573708569; Harris ES, 1996, J AM ACAD CHILD PSY, V35, P1025, DOI 10.1097/00004583-199608000-00013; Kirby JB, 2010, DEMOGRAPHY, V47, P1035, DOI 10.1007/BF03213738; Kovshoff H, 2013, EUR CHILD ADOLES PSY, V22, P533, DOI 10.1007/s00787-013-0393-y; Lewandowski RE, 2013, PEDIATRICS, V132, pE996, DOI 10.1542/peds.2013-0600; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Medicine PLoS, 2013, PLOS MED, V10; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Mojtabai R, 2007, PSYCHIAT SERV, V58, P642, DOI 10.1176/appi.ps.58.5.642; Morris J, 2011, J MARITAL FAM THER, V37, P299, DOI 10.1111/j.1752-0606.2009.00178.x; Muzina DJ, 2014, TURNING ATTENTION AD; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Olfson M, 2014, JAMA PSYCHIAT, V71, P81, DOI 10.1001/jamapsychiatry.2013.3074; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Pierre JM, 2012, CAN J PSYCHIAT, V57, P651, DOI 10.1177/070674371205701102; Rapee RM, 2012, J CHILD PSYCHOL PSYC, V53, P454, DOI 10.1111/j.1469-7610.2011.02479.x; Roberts RE, 2005, J BEHAV HEALTH SER R, V32, P1, DOI 10.1007/BF02287324; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P105, DOI 10.1080/15374410701817907; Smiga SM, 2011, PEDIATR CLIN N AM, V58, P155, DOI 10.1016/j.pcl.2010.11.007; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; United States, 1993, FED REGISTER, V58, P29425; Weiss C, 2013, 13001 AG HEALTHC RES; Wille N, 2008, EUR CHILD ADOLES PSY, V17, P42, DOI 10.1007/s00787-008-1005-0; Winterstein AG, 2008, ANN PHARMACOTHER, V42, P24, DOI 10.1345/aph.1K143; Wun LM, 2007, STAT MED, V26, P1875, DOI 10.1002/sim.2809; Zisook S, 2007, AM J PSYCHIAT, V164, P1539, DOI 10.1176/appi.ajp.2007.06101757	39	213	215	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2029	2038		10.1056/NEJMsa1413512	http://dx.doi.org/10.1056/NEJMsa1413512			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5PD	25992747	Bronze			2022-12-28	WOS:000354809300009
J	Sibley, CR; Emmett, W; Blazquez, L; Faro, A; Haberman, N; Briese, M; Trabzuni, D; Ryten, M; Weale, ME; Hardy, J; Modic, M; Curk, T; Wilson, SW; Plagnol, V; Ule, J				Sibley, Christopher R.; Emmett, Warren; Blazquez, Lorea; Faro, Ana; Haberman, Nejc; Briese, Michael; Trabzuni, Daniah; Ryten, Mina; Weale, Michael E.; Hardy, John; Modic, Miha; Curk, Tomaz; Wilson, Stephen W.; Plagnol, Vincent; Ule, Jernej			Recursive splicing in long vertebrate genes	NATURE			English	Article							EXON DEFINITION; LARGE INTRON; HUMAN GENOME; REVEALS; TRANSCRIPTION; EXPRESSION; ULTRAFAST; ALIGNMENT; NONSENSE; TDP-43	It is generally believed that splicing removes introns as single units from precursor messenger RNA transcripts. However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing(1,2). The extent to which recursive splicing occurs in other species and its mechanistic basis have not been examined. Here we identify highly conserved RS-sites in genes expressed in the mammalian brain that encode proteins functioning in neuronal development. Moreover, the RS-sites are found in some of the longest introns across vertebrates. We find that vertebrate recursive splicing requires initial definition of an 'RS-exon' that follows the RS-site. The RS-exon is then excluded from the dominant mRNA isoform owing to competition with a reconstituted 59 splice site formed at the RS-site after the first splicing step. Conversely, the RS-exon is included when preceded by cryptic promoters or exons that fail to reconstitute an efficient 59 splice site. Most RS-exons contain a premature stop codon such that their inclusion can decrease mRNA stability. Thus, by establishing a binary splicing switch, RS-sites demarcate different mRNA isoforms emerging from long genes by coupling cryptic elements with inclusion of RS-exons.	[Sibley, Christopher R.; Blazquez, Lorea; Haberman, Nejc; Trabzuni, Daniah; Ryten, Mina; Hardy, John; Ule, Jernej] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Sibley, Christopher R.; Briese, Michael; Modic, Miha; Ule, Jernej] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Emmett, Warren; Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Faro, Ana; Wilson, Stephen W.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Briese, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Ryten, Mina; Weale, Michael E.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England; [Modic, Miha] Helmholtz Ctr Munich, Inst Stem Cell Res, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana 1000, Slovenia	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Wurzburg; King Faisal Specialist Hospital & Research Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Ljubljana	Ule, J (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	v.plagnol@ucl.ac.uk; j.ule@ucl.ac.uk	Hardy, John/C-2451-2009; Blazquez, Lorea/U-1090-2018; Trabzuni, Daniah/AAI-2037-2021; Wilson, Stephen W/B-9404-2008; Ryten, Mina/Q-8419-2016; Curk, Tomaž/D-9836-2015; Trabzuni, Daniah M/C-4034-2012; Haberman, Nejc/AFI-2162-2022; Weale, Michael E/F-2587-2010; Ule, Jernej/C-6315-2013; Zebrafish, UCL/A-3125-2009	Hardy, John/0000-0002-3122-0423; Blazquez, Lorea/0000-0003-2885-3286; Trabzuni, Daniah/0000-0003-4826-9570; Wilson, Stephen W/0000-0002-8557-5940; Curk, Tomaž/0000-0003-4888-7256; Trabzuni, Daniah M/0000-0003-4826-9570; Haberman, Nejc/0000-0001-9247-4139; Weale, Michael E/0000-0003-4593-1186; Ule, Jernej/0000-0002-2452-4277; Modic, Miha/0000-0002-2894-7218; Briese, Michael/0000-0001-7137-8260; Plagnol, Vincent/0000-0002-5597-9215; Sibley, Christopher/0000-0002-8286-4683	European Research Council [206726-CLIP, 617837-Translate]; Marie Curie Post-doctoral Research Fellowship (627783-NeuroCRYSP); Slovenian Research Agency [J7-5460]; UK NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Wellcome Trust; UK Medical Research Council (MRC) [U105185858]; MRC [G0901254, G0802462]; MRC Sudden Death Brain Bank; MRC [MC_U105185858] Funding Source: UKRI; Medical Research Council [G0802462, MC_U105185858, G0901254] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Marie Curie Post-doctoral Research Fellowship (627783-NeuroCRYSP); Slovenian Research Agency(Slovenian Research Agency - Slovenia); UK NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Sudden Death Brain Bank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank S. El-Andaloussi for technical support, J. Witten, J. Konig and Ule laboratory members for comments on the manuscript, and remaining members of the UK Brain Expression Consortium: S. Guelfi, K. D'Sa, M. Matarin, J. Vandrovcova, A. Ramasamy, J. A. Botia, C. Smith and P. Forabosco. This work was supported by the European Research Council (206726-CLIP and 617837-Translate) to J.U.; Marie Curie Post-doctoral Research Fellowship (627783-NeuroCRYSP) to L.B.; the Slovenian Research Agency (J7-5460) to J.U. and T.C.; the UK NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology to V.P. and W.E.; the Wellcome Trust to S.W.W. and A.F.; the UK Medical Research Council (MRC) (U105185858) to J. U.; MRC training fellowships to C.R.S. and M.B.; and MRC project grant (G0901254), MRC training fellowship (G0802462) and MRC Sudden Death Brain Bank.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Herrera FJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02559; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Ke SD, 2011, RNA BIOL, V8, P384, DOI 10.4161/rna.8.3.14458; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Roy M, 2008, RNA, V14, P2261, DOI 10.1261/rna.1024908; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Thakurela S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3478; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	31	87	89	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					371	+		10.1038/nature14466	http://dx.doi.org/10.1038/nature14466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25970246	Green Submitted, Green Accepted			2022-12-28	WOS:000354816500060
J	Shapiro, NM; Koulakov, I				Shapiro, Nikolai M.; Koulakov, Ivan			Probing the underbelly of a supervolcano	SCIENCE			English	Editorial Material							BENEATH		[Shapiro, Nikolai M.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, CNRS UMR7154, 1 Rue Jussieu, F-75238 Paris 5, France; [Shapiro, Nikolai M.] Inst Volcanol & Seismol FEB RAS, Petropavlovsk Kamchatski, Russia; [Koulakov, Ivan] SB RAS, Trofimuk Inst Petr Geol & Geophys, Novosibirsk 630090, Russia; [Koulakov, Ivan] Novosibirsk State Univ, Novosibirsk 630090, Russia	UDICE-French Research Universities; Universite Paris Cite; Institute of Volcanology & Seismology, Far Eastern Branch, RAS; Russian Academy of Sciences; Russian Academy of Sciences; Trofimuk Institute of Petroleum Geology & Geophysics; Novosibirsk State University	Shapiro, NM (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, CNRS UMR7154, 1 Rue Jussieu, F-75238 Paris 5, France.	nshapiro@ipgp.fr; koulakovIY@ipgg.sbras.ru	Koulakov, Ivan/AAT-6109-2021; Koulakov, Ivan/C-1942-2018; Shapiro, Nikolai M/G-1049-2010	Shapiro, Nikolai M/0000-0002-0144-723X	Russian Science Foundation [14-47-00002] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF))		Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Chesner CA, 2012, QUATERN INT, V258, P5, DOI 10.1016/j.quaint.2011.09.025; CHRISTIANSEN RL, 2001, US GEOL SURV PROF G, V729, P145; Decker R.W., 1987, VOLCANISM HAWAII; Fouch MJ, 2012, GEOLOGY, V40, P479, DOI 10.1130/focus052012.1; Gardner JE, 2002, GEOLOGY, V30, P347, DOI 10.1130/0091-7613(2002)030<0347:PVXITY>2.0.CO;2; Hill GJ, 2009, NAT GEOSCI, V2, P785, DOI 10.1038/NGEO661; Huang HH, 2015, SCIENCE, V348, P773, DOI 10.1126/science.aaa5648; Jaxybulatov K, 2014, SCIENCE, V346, P617, DOI 10.1126/science.1258582; Mason BG, 2004, B VOLCANOL, V66, P735, DOI 10.1007/s00445-004-0355-9; Michaut C, 2011, TECTONOPHYSICS, V500, P34, DOI 10.1016/j.tecto.2009.08.019; Wilson CJN, 2001, J VOLCANOL GEOTH RES, V112, P133, DOI 10.1016/S0377-0273(01)00239-6	12	4	4	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					758	759		10.1126/science.aab1828	http://dx.doi.org/10.1126/science.aab1828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977537				2022-12-28	WOS:000354428700021
J	Desai, RJ; Huybrechts, KF; Hernandez-Diaz, S; Mogun, H; Patorno, E; Kaltenbach, K; Kerzner, LS; Bateman, BT				Desai, Rishi J.; Huybrechts, Krista F.; Hernandez-Diaz, Sonia; Mogun, Helen; Patorno, Elisabetta; Kaltenbach, Karol; Kerzner, Leslie S.; Bateman, Brian T.			Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WITHDRAWAL SYNDROME; INFANTS BORN; DRUG-USE; PREGNANCY; METHADONE; PREVALENCE; PAIN; INCREASE; COCAINE; MOTHERS	OBJECTIVE To provide absolute and relative risk estimates of neonatal abstinence syndrome (NAS) based on duration and timing of prescription opioid use during pregnancy in the presence or absence of additional NAS risk factors of history of opioid misuse or dependence, misuse of other substances, non-opioid psychotropic drug use, and smoking. DESIGN Observational cohort study. SETTING Medicaid data from 46 US states. PARTICIPANTS Pregnant women filling at least one prescription for an opioid analgesic at any time during pregnancy for whom opioid exposure characteristics including duration of therapy: short term (<30 days) or long term (>= 30 days); timing of use: early use (only in the first two trimesters) or late use (extending into the third trimester); and cumulative dose (in morphine equivalent milligrams) were assessed. MAIN OUTCOME MEASURE Diagnosis of NAS in liveborn infants. RESULTS 1705 cases of NAS were identified among 290 605 pregnant women filling opioid prescriptions, corresponding to an absolute risk of 5.9 per 1000 deliveries (95% confidence interval 5.6 to 6.2). Long term opioid use during pregnancy resulted in higher absolute risk of NAS per 1000 deliveries in the presence of additional risk factors of known opioid misuse (220.2 (200.8 to 241.0)), alcohol or other drug misuse (30.8 (26.1 to 36.0)), exposure to other psychotropic medications (13.1 (10.6 to 16.1)), and smoking (6.6 (4.3 to 9.6)) than in the absence of any of these risk factors (4.2 (3.3 to 5.4)). The corresponding risk estimates for short term use were 192.0 (175.8 to 209.3), 7.0 (6.0 to 8.2), 2.0 (1.5 to 2.6), 1.5 (1.0 to 2.0), and 0.7 (0.6 to 0.8) per 1000 deliveries, respectively. In propensity score matched analyses, long term prescription opioid use compared with short term use and late use compared with early use in pregnancy demonstrated greater risk of NAS (risk ratios 2.05 (95% confidence interval 1.81 to 2.33) and 1.24 (1.12 to 1.38), respectively). CONCLUSIONS Use of prescription opioids during pregnancy is associated with a low absolute risk of NAS in the absence of additional risk factors. Long term use compared with short term use and late use compared with early use of prescription opioids are associated with increased NAS risk independent of additional risk factors.	[Desai, Rishi J.; Huybrechts, Krista F.; Mogun, Helen; Patorno, Elisabetta; Bateman, Brian T.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Desai, Rishi J.; Huybrechts, Krista F.; Mogun, Helen; Patorno, Elisabetta; Bateman, Brian T.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kaltenbach, Karol] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA; [Kerzner, Leslie S.] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Bateman, Brian T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Jefferson University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Desai, RJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	rdesai2@partners.org	Desai, Rishi/AAH-8988-2021		National Institute of Mental Health [K01 MH099141]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH [K08HD075831]; Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KH is supported by a career development award from the National Institute of Mental Health (K01 MH099141); BB is supported by a career development award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH (K08HD075831). MAX pregnancy cohort creation was supported by the Agency for Healthcare Research and Quality (AHRQ) (Grant R01HS018533). SH-D has consulted for GlaxoSmithKline-Biologics (Middlesex, UK) and AstraZeneca (London, UK) for unrelated projects. The other authors declare no other relationships or activities that could appear to have influenced the submitted work.	ALROOMI LG, 1988, ARCH DIS CHILD, V63, P81, DOI 10.1136/adc.63.1.81; Babb M, 2010, CAN FAM PHYSICIAN, V56, P25; Bateman BT, 2014, ANESTHESIOLOGY, V120, P1216, DOI 10.1097/ALN.0000000000000172; Choo RE, 2004, DRUG ALCOHOL DEPEN, V75, P253, DOI 10.1016/j.drugalcdep.2004.03.012; Cleary BJ, 2010, ADDICTION, V105, P2071, DOI 10.1111/j.1360-0443.2010.03120.x; COLES CD, 1992, NEUROTOXICOL TERATOL, V14, P23, DOI 10.1016/0892-0362(92)90025-6; Creanga AA, 2012, OBSTET GYNECOL, V119, P924, DOI 10.1097/AOG.0b013e31824ea276; Desai RJ, 2014, OBSTET GYNECOL, V123, P997, DOI 10.1097/AOG.0000000000000208; Dryden C, 2009, BJOG-INT J OBSTET GY, V116, P665, DOI 10.1111/j.1471-0528.2008.02073.x; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Fischer B, 2011, PHARMACOEPIDEM DR S, V20, P1269, DOI 10.1002/pds.2190; Flood P, 2014, ANESTHESIOLOGY, V120, P1063, DOI 10.1097/ALN.0000000000000173; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hartenstein S, 2010, J PERINAT MED, V38, P695, DOI 10.1515/jpm.2010.102; Jansson LM, 2012, DRUG ALCOHOL DEPEN, V122, P213, DOI 10.1016/j.drugalcdep.2011.10.003; Jansson LM, 2012, CURR OPIN PEDIATR, V24, P252, DOI 10.1097/MOP.0b013e32834fdc3a; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kaltenbach K, 2012, ADDICTION, V107, P45, DOI 10.1111/j.1360-0443.2012.04038.x; Kellogg A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.050; Logan J, 2013, MED CARE, V51, P646, DOI 10.1097/MLR.0b013e318293c2c0; Louis GB, 2006, STAT METHODS MED RES, V15, P103, DOI 10.1191/0962280206sm434oa; MANGURTEN HH, 1980, PEDIATRICS, V65, P159; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Mayes LC, 1996, SUBST USE MISUSE, V31, P241, DOI 10.3109/10826089609045811; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Nair V, 2012, PAED CHILD HEALT-CAN, V17, pE40, DOI 10.1093/pch/17.5.e40; O'Donnell M, 2009, PEDIATRICS, V123, pE614, DOI 10.1542/peds.2008-2888; Osborn DA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002059.pub3; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Ponizovsky AM, 2011, EUR J CLIN PHARMACOL, V67, P165, DOI 10.1007/s00228-010-0932-0; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Schubert I, 2013, DTSCH ARZTEBL INT, V110, P45, DOI 10.3238/arztebl.2013.0045; Sharpe C, 2004, ARCH DIS CHILD-FETAL, V89, pF33, DOI 10.1136/fn.89.1.F33; Wachman EM, 2011, J ADDICT MED, V5, P293, DOI 10.1097/ADM.0b013e3182266a3a; Wang SM, 2004, OBSTET GYNECOL, V104, P65, DOI 10.1097/01.AOG.0000129403.54061.0e; Willaschek C, 2009, EUR J CLIN PHARMACOL, V65, P429, DOI 10.1007/s00228-008-0598-z; Zin CS, 2014, EUR J PAIN, V18, P1343, DOI 10.1002/j.1532-2149.2014.496.x	38	105	105	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h2102	10.1136/bmj.h2102	http://dx.doi.org/10.1136/bmj.h2102			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CI	25975601	Green Published, hybrid			2022-12-28	WOS:000354770100003
J	Seelig, JD; Jayaraman, V				Seelig, Johannes D.; Jayaraman, Vivek			Neural dynamics for landmark orientation and angular path integration	NATURE			English	Article							DROSOPHILA CENTRAL COMPLEX; PROTOCEREBRAL BRIDGE; DIRECTION; INSECT; BRAIN; MELANOGASTER; DISSECTION; BEHAVIOR; MOTION; MEMORY	Many animals navigate using a combination of visual landmarks and path integration. In mammalian brains, head direction cells integrate these two streams of information by representing an animal's heading relative to landmarks, yet maintaining their directional tuning in darkness based on self-motion cues. Here we use two-photon calcium imaging in head-fixed Drosophila melanogaster walking on a ball in a virtual reality arena to demonstrate that landmark-based orientation and angular path integration are combined in the population responses of neurons whose dendrites tile the ellipsoid body, a toroidal structure in the centre of the fly brain. The neural population encodes the fly's azimuth relative to its environment, tracking visual landmarks when available and relying on self-motion cues in darkness. When both visual and self-motion cues are absent, a representation of the animal's orientation is maintained in this network through persistent activity, a potential substrate for short-term memory. Several features of the population dynamics of these neurons and their circular anatomical arrangement are suggestive of ring attractors, network structures that have been proposed to support the function of navigational brain circuits.	[Seelig, Johannes D.; Jayaraman, Vivek] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Jayaraman, V (corresponding author), Janelia Res Campus, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA.	vivek@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank T. Wolff and G. Rubin for sharing information about CX neuron morphology. We thank Janelia Fly Core, and in particular K. Hibbard and S. Coffman, for support, J. Liu for technical support, and V. Iyer for ScanImage support. We are grateful to A. Karpova, A. Leonardo, S. S. Kim, H. Haberkern, D. Turner-Evans, C. Dan, S. Wegener and R. Franconville for discussions and comments on the manuscript. We thank W. Denk, S. Druckmann, J. Dudman, A. Lee, K. Longden, M. Reiser, S. Romani, G. Rubin, Y. Sun, and T. Wolff for feedback on the manuscript. This work was supported by the Howard Hughes Medical Institute.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Arena P, 2013, INT JOINT C NEUR NET; Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; BAUSENWEIN B, 1994, J COMP NEUROL, V340, P255, DOI 10.1002/cne.903400210; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bockhorst T, 2015, J NEUROPHYSIOL; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collett TS, 2004, CURR BIOL, V14, pR475, DOI 10.1016/j.cub.2004.06.013; Collett TS, 2000, CURR OPIN NEUROBIOL, V10, P757, DOI 10.1016/S0959-4388(00)00150-1; Dombeck DA, 2012, CURR OPIN NEUROBIOL, V22, P3, DOI 10.1016/j.conb.2011.10.015; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Guo PY, 2013, J EXP BIOL, V216, P992, DOI 10.1242/jeb.080473; Haferlach T, 2007, ADAPT BEHAV, V15, P273, DOI 10.1177/1059712307082080; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Heinze S, 2009, J NEUROSCI, V29, P11783, DOI 10.1523/JNEUROSCI.1870-09.2009; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kathman ND, 2014, J EXP BIOL, V217, P4079, DOI 10.1242/jeb.112391; Knierim JJ, 2012, ANNU REV NEUROSCI, V35, P267, DOI 10.1146/annurev-neuro-062111-150351; KOCH C, 1985, HUM NEUROBIOL, V4, P219; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; Lin CY, 2013, CELL REP, V3, P1739, DOI 10.1016/j.celrep.2013.04.022; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MIZUMORI SJY, 1993, J NEUROSCI, V13, P4015; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008	47	334	335	10	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					186	+		10.1038/nature14446	http://dx.doi.org/10.1038/nature14446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971509	Green Accepted			2022-12-28	WOS:000354377800051
J	Suding, K; Higgs, E; Palmer, M; Callicott, JB; Anderson, CB; Baker, M; Gutrich, JJ; Hondula, KL; LaFevor, MC; Larson, BMH; Randall, A; Ruhl, JB; Schwartz, KZS				Suding, Katharine; Higgs, Eric; Palmer, Margaret; Callicott, J. Baird; Anderson, Christopher B.; Baker, Matthew; Gutrich, John J.; Hondula, Kelly L.; LaFevor, Matthew C.; Larson, Brendon M. H.; Randall, Alan; Ruhl, J. B.; Schwartz, Katrina Z. S.			Committing to ecological restoration	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BENEFITS		[Suding, Katharine] Univ Colorado, Boulder, CO 80309 USA; [Higgs, Eric] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Palmer, Margaret] Univ Maryland, College Pk, MD 20742 USA; [Callicott, J. Baird] Univ N Texas, Denton, TX 76203 USA; [Anderson, Christopher B.] Consejo Nacl Invest Cient & Tecn, RA-9410 Ushuaia, Tdf, Argentina; [Anderson, Christopher B.] Natl Univ Tierra del Fuego, RA-9410 Ushuaia, Tdf, Argentina; [Baker, Matthew] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA; [Gutrich, John J.] Southern Oregon Univ, Ashland, OR 97520 USA; [Hondula, Kelly L.; LaFevor, Matthew C.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA; [Larson, Brendon M. H.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Randall, Alan] Ohio State Univ, Columbus, OH 43210 USA; [Randall, Alan] Univ Sydney, Sydney, NSW 2006, Australia; [Ruhl, J. B.] Vanderbilt Univ, Sch Law, Nashville, TN 37203 USA; [Schwartz, Katrina Z. S.] Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA	University of Colorado System; University of Colorado Boulder; University of Victoria; University System of Maryland; University of Maryland College Park; University of North Texas System; University of North Texas Denton; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University System of Maryland; University of Maryland Baltimore County; University of Waterloo; University System of Ohio; Ohio State University; University of Sydney; Vanderbilt University	Suding, K (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	suding@colorado.edu	Anderson, Christopher/V-4882-2019; Suding, Katharine/O-6290-2017; Palmer, Margaret A/F-9648-2013; Randall, Alan/N-4153-2019; Callicott, Joseph/C-9102-2009	Anderson, Christopher/0000-0001-8120-5689; Suding, Katharine/0000-0002-5357-0176; Palmer, Margaret A/0000-0003-1468-7993; Callicott, Joseph/0000-0003-1298-3334; LaFevor, Matthew/0000-0002-0988-4768; Hondula, Kelly/0000-0002-1928-1442; Ruhl, J.B./0000-0003-3866-733X; Randall, Alan/0000-0003-1028-5903	National Socio-Environmental Synthesis Center (SESYNC) under U.S. National Science Foundation [DBI-1052875]; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) under U.S. National Science Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank anonymous reviewers, N. Barger, R. Hobbs, and S. Murphy for comments. This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the U.S. National Science Foundation DBI-1052875.	[Anonymous], 2014, ECONOMIST; Balaguer L, 2014, BIOL CONSERV, V176, P12, DOI 10.1016/j.biocon.2014.05.007; Biron C., 2014, INTERPRESS SERV 1003; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Callicott J. B., 2006, PRINCIPLES CONSERVAT; Chazdon R., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CB09781107415324.004; Ciccarese L, 2012, NEW FOREST, V43, P543, DOI 10.1007/s11056-012-9350-8; Craig RK, 2010, HARVARD ENVIRON LAW, V34, P9; De Groot RS, 2013, CONSERV BIOL, V27, P1286, DOI 10.1111/cobi.12158; Falk D. A., 2007, FDN RESTORATION ECOL; Hallett LM, 2013, RESTOR ECOL, V21, P312, DOI 10.1111/rec.12007; Higgs E., 2003, NATURE DESIGN; Higgs E, 2014, FRONT ECOL ENVIRON, V12, P499, DOI 10.1890/110267; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; Keeneleyside KA., 2012, ECOLOGICAL RESTORATI, DOI [10.25607/OBP-171, DOI 10.25607/OBP-171]; Lin BB, 2013, BIOSCIENCE, V63, P793, DOI 10.1525/bio.2013.63.10.6; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Palmer MA, 2014, ENVIRON SCI TECHNOL, V48, P10552, DOI 10.1021/es503052f; Palmer MA, 2014, ECOL ENG, V65, P62, DOI 10.1016/j.ecoleng.2013.07.059; Salzman J, 2000, STANFORD LAW REV, V53, P607, DOI 10.2307/1229470; Science and Policy Working Group Society for Ecological Restoration, 2004, SER INT PRIM EC REST; Shackelford N, 2013, RESTOR ECOL, V21, P297, DOI 10.1111/rec.12012; Suckling K., 2012, TIME TARGET ENDANGER; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Telesetsky A., 2013, VERMONT J ENV LAW, V14, P494; Temperton VM, 2014, RESTOR ECOL, V22, P271, DOI 10.1111/rec.12095; Veldman JW, 2015, SCIENCE, V347, P484, DOI 10.1126/science.347.6221.484-c	27	313	326	19	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					638	640		10.1126/science.aaa4216	http://dx.doi.org/10.1126/science.aaa4216			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953995				2022-12-28	WOS:000354045700029
J	Dean, BJF				Dean, Benjamin J. F.			GMC's supposedly independent training review included secret meetings with politicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nuffield Orthopaed Ctr, Inst Musculoskeletal Sci, NDORMS, Botnar Res Ctr,Musculoskeletal Sci, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre; University of Oxford	Dean, BJF (corresponding author), Nuffield Orthopaed Ctr, Inst Musculoskeletal Sci, NDORMS, Botnar Res Ctr,Musculoskeletal Sci, Oxford OX3 7LD, England.	bendean1979@gmail.com		Dean, Benjamin/0000-0002-8969-8868				[Anonymous], 2015, BBC; [Anonymous], 2015, GUARDIAN; BMA, 2015, PAUS MED TRAIN OV; Greenaway D, 2013, SECURING FUTURE EXCE	4	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2015	350								h2400	10.1136/bmj.h2400	http://dx.doi.org/10.1136/bmj.h2400			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GJ	25953326				2022-12-28	WOS:000354414800011
J	Kornilov, O				Kornilov, Oleg			The quantum halo state of the helium trimer	SCIENCE			English	Editorial Material							EFIMOV STATE; ATOMS		Max Born Inst, D-12489 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Kornilov, O (corresponding author), Max Born Inst, D-12489 Berlin, Germany.	kornilov@mbi-berlin.de						Braaten E, 2006, PHYS REP, V428, P259, DOI 10.1016/j.physrep.2006.03.001; Bruhl R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063002; EFIMOV V, 1970, PHYS LETT B, VB 33, P563, DOI 10.1016/0370-2693(70)90349-7; Esry BD, 1999, PHYS REV LETT, V83, P1751, DOI 10.1103/PhysRevLett.83.1751; Jensen AS, 2004, REV MOD PHYS, V76, P215, DOI 10.1103/RevModPhys.76.215; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Kunitski M, 2015, SCIENCE, V348, P551, DOI 10.1126/science.aaa5601; LIM TK, 1977, PHYS REV LETT, V38, P341, DOI 10.1103/PhysRevLett.38.341; Nielsen E, 1999, PHYS REV LETT, V82, P2844, DOI 10.1103/PhysRevLett.82.2844; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345	10	8	8	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					498	499		10.1126/science.aaa9102	http://dx.doi.org/10.1126/science.aaa9102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931538				2022-12-28	WOS:000353778100019
J	Wen, LS; Sharfstein, JM				Wen, Leana S.; Sharfstein, Joshua M.			Unrest in Baltimore The Role of Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wen, Leana S.] Baltimore City Dept Hlth, Baltimore, MD USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,W-1033D, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu						[Anonymous], CHILDH BLOOD LEAD SU; [Anonymous], MAR VIT STAT ANN REP; [Anonymous], UN CRIM REP STAT; [Anonymous], 2014, DRUG ALC REL INT DEA; Baltimore City Health Department, NEIGHB HLTH PROF REP; Rothstein R, FERGUSON BALTIMORE F; Webster DW, EVALUATION BALTIMORE; Wong WF, 2015, JAMA-J AM MED ASSOC, V313, P1417, DOI 10.1001/jama.2015.2434	8	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2425	2426		10.1001/jama.2015.5561	http://dx.doi.org/10.1001/jama.2015.5561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	25950149				2022-12-28	WOS:000356663600008
J	Hoppler, S; Wheeler, GN				Hoppler, Stefan; Wheeler, Grant N.			It's about time for neural crest	SCIENCE			English	Editorial Material							VERTEBRATES; IDENTIFICATION		[Hoppler, Stefan] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Wheeler, Grant N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Aberdeen; University of East Anglia	Hoppler, S (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill Hlth Campus, Aberdeen AB25 2ZD, Scotland.	s.p.hoppler@abdn.ac.uk	Wheeler, Grant N/D-3023-2009	Wheeler, Grant N/0000-0002-4335-8577; Hoppler, Stefan/0000-0003-0730-4798	Biotechnology and Biological Sciences Research Council [BB/M001695/1, BB/I022252/1, BB/I003746/1] Funding Source: researchfish; BBSRC [BB/M001695/1, BB/I003746/1, BB/I022252/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gurdon J. B., EGG NUCL BATTLE SUPR; Hall BK, 2000, EVOL DEV, V2, P3, DOI 10.1046/j.1525-142x.2000.00032.x; Le Douarin N.M., 1982, NEURAL CREST; NIEUWKOOP P D, 1969, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V162, P341, DOI 10.1007/BF00578701; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Thorogood P, 1989, TRENDS NEUROSCI, V12, P38; Wada H, 2006, INT J BIOL SCI, V2, P133; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0	14	8	10	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1316	1317		10.1126/science.aab2719	http://dx.doi.org/10.1126/science.aab2719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	25931447				2022-12-28	WOS:000356449500028
J	Kapheim, KM; Pan, HL; Li, C; Salzberg, SL; Puiu, D; Magoc, T; Robertson, HM; Hudson, ME; Venkat, A; Fischman, BJ; Hernandez, A; Yandell, M; Ence, D; Holt, C; Yocum, GD; Kemp, WP; Bosch, J; Waterhouse, RM; Zdobnov, EM; Stolle, E; Kraus, FB; Helbing, S; Moritz, RFA; Glastad, KM; Hunt, BG; Goodisman, MAD; Hauser, F; Grimmelikhuijzen, CJP; Pinheiro, DG; Nunes, FMF; Soares, MPM; Tanaka, ED; Simoes, ZLP; Hartfelder, K; Evans, JD; Barribeau, SM; Johnson, RM; Massey, JH; Southey, BR; Hasselmann, M; Hamacher, D; Biewer, M; Kent, CF; Zayed, A; Blatti, C; Sinha, S; Johnston, JS; Hanrahan, SJ; Kocher, SD; Wang, J; Robinson, GE; Zhang, GJ				Kapheim, Karen M.; Pan, Hailin; Li, Cai; Salzberg, Steven L.; Puiu, Daniela; Magoc, Tanja; Robertson, Hugh M.; Hudson, Matthew E.; Venkat, Aarti; Fischman, Brielle J.; Hernandez, Alvaro; Yandell, Mark; Ence, Daniel; Holt, Carson; Yocum, George D.; Kemp, William P.; Bosch, Jordi; Waterhouse, Robert M.; Zdobnov, Evgeny M.; Stolle, Eckart; Kraus, F. Bernhard; Helbing, Sophie; Moritz, Robin F. A.; Glastad, Karl M.; Hunt, Brendan G.; Goodisman, Michael A. D.; Hauser, Frank; Grimmelikhuijzen, Cornelis J. P.; Pinheiro, Daniel Guariz; Franco Nunes, Francis Morais; Miranda Soares, Michelle Prioli; Tanaka, Erica Donato; Paulino Simoes, Zila Luz; Hartfelder, Klaus; Evans, Jay D.; Barribeau, Seth M.; Johnson, Reed M.; Massey, Jonathan H.; Southey, Bruce R.; Hasselmann, Martin; Hamacher, Daniel; Biewer, Matthias; Kent, Clement F.; Zayed, Amro; Blatti, Charles, III; Sinha, Saurabh; Johnston, J. Spencer; Hanrahan, Shawn J.; Kocher, Sarah D.; Wang, Jun; Robinson, Gene E.; Zhang, Guojie			Genomic signatures of evolutionary transitions from solitary to group living	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; POPULATION GENOMICS; POSITIVE SELECTION; SOCIAL INSECTS; PATTERNS; BEHAVIOR; PROTEIN; GENES; RATES	The evolution of eusociality is one of the major transitions in evolution, but the underlying genomic changes are unknown. We compared the genomes of 10 bee species that vary in social complexity, representing multiple independent transitions in social evolution, and report three major findings. First, many important genes show evidence of neutral evolution as a consequence of relaxed selection with increasing social complexity. Second, there is no single road map to eusociality; independent evolutionary transitions in sociality have independent genetic underpinnings. Third, though clearly independent in detail, these transitions do have similar general features, including an increase in constrained protein evolution accompanied by increases in the potential for gene regulation and decreases in diversity and abundance of transposable elements. Eusociality may arise through different mechanisms each time, but would likely always involve an increase in the complexity of gene networks.	[Kapheim, Karen M.; Robertson, Hugh M.; Hudson, Matthew E.; Venkat, Aarti; Fischman, Brielle J.; Blatti, Charles, III; Sinha, Saurabh; Robinson, Gene E.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Kapheim, Karen M.; Robertson, Hugh M.; Massey, Jonathan H.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Kapheim, Karen M.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Pan, Hailin; Li, Cai; Wang, Jun; Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Li, Cai] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21218 USA; [Salzberg, Steven L.; Puiu, Daniela; Magoc, Tanja] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Computat Biol, Sch Med, Baltimore, MD 21205 USA; [Hudson, Matthew E.; Venkat, Aarti] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Venkat, Aarti] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Fischman, Brielle J.] Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA; [Fischman, Brielle J.] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [Hernandez, Alvaro] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Yandell, Mark; Ence, Daniel; Holt, Carson] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA; [Yandell, Mark; Holt, Carson] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT 84112 USA; [Yocum, George D.; Kemp, William P.] ARS, USDA, Red River Valley Agr Res Ctr, Biosci Res Lab, Fargo, ND 58102 USA; [Bosch, Jordi] Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat CREAF, Bellaterra 08193, Spain; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Waterhouse, Robert M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Stolle, Eckart; Kraus, F. Bernhard; Helbing, Sophie; Moritz, Robin F. A.] Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06099 Halle, Saale, Germany; [Stolle, Eckart] Mary Univ London, Sch Biol & Chem Sci, Organismal Biol Res Grp, London E1 4NS, England; [Kraus, F. Bernhard] Univ Hosp Halle, Dept Lab Med, D-06120 Halle, Saale, Germany; [Moritz, Robin F. A.] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Glastad, Karl M.; Goodisman, Michael A. D.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hunt, Brendan G.] Univ Georgia, Dept Entomol, Griffin, GA 30223 USA; [Hauser, Frank; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Ctr Funct & Comparat Insect Genom, Copenhagen, Denmark; [Pinheiro, Daniel Guariz; Miranda Soares, Michelle Prioli; Paulino Simoes, Zila Luz] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14040901 Ribeirao Preto, SP, Brazil; [Pinheiro, Daniel Guariz] Univ Estadual Paulista UNESP, Fac Ciencias Agr & Vet, Dept Tecnol, BR-14884900 Jaboticabal, SP, Brazil; [Franco Nunes, Francis Morais] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13565905 Sao Carlos, SP, Brazil; [Tanaka, Erica Donato] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049900 Ribeirao Preto, SP, Brazil; [Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil; [Evans, Jay D.] ARS, USDA, Bee Res Lab, Beltsville, MD 20705 USA; [Barribeau, Seth M.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Johnson, Reed M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Massey, Jonathan H.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Southey, Bruce R.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Hasselmann, Martin; Hamacher, Daniel; Biewer, Matthias] Univ Hohenheim, Inst Anim Husb & Anim Breeding, Dept Populat Genom, Stuttgart, Germany; [Kent, Clement F.; Zayed, Amro] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Kent, Clement F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Blatti, Charles, III; Sinha, Saurabh] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Johnston, J. Spencer; Hanrahan, Shawn J.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kocher, Sarah D.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Robinson, Gene E.] Univ Illinois, Ctr Adv Study Prof Entomol & Neurosci, Urbana, IL 61801 USA; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; Utah State University; Beijing Genomics Institute (BGI); University of Copenhagen; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; United States Department of Agriculture (USDA); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Geneva; Swiss Institute of Bioinformatics; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Martin Luther University Halle Wittenberg; University of London; Queen Mary University London; Martin Luther University Halle Wittenberg; University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; University of Copenhagen; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; United States Department of Agriculture (USDA); University of North Carolina; East Carolina University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign; University Hohenheim; York University - Canada; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Texas A&M University System; Texas A&M University College Station; Harvard University; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Illinois System; University of Illinois Urbana-Champaign; University of Copenhagen	Kapheim, KM (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	karen.kapheim@usu.edu; wangj@genomics.org.cn; generobi@illinois.edu; zhanggj@genomics.org.cn	Zdobnov, Evgeny M/K-1133-2012; Nunes, Francis M. F./F-5871-2010; Hauser, Frank/M-2952-2014; Hudson, Matthew E/A-4438-2008; Kraus, Bernhard/B-8172-2011; Evans, Jay D/C-8408-2012; Hunt, Brendan G/B-9816-2009; Johnson, Reed M./H-3742-2011; Waterhouse, Robert M/A-1858-2010; Salzberg, Steven/Q-6514-2019; Stolle, Eckart/G-3780-2011; Zayed, Amro/G-6405-2011; Salzberg, Steven L/F-6162-2011; Hasselmann, Martin/ABB-6485-2021; Hartfelder, Klaus/L-2300-2019; Kapheim, Karen Marie/AAA-6124-2019; Moritz, Robin FA/K-6053-2012; Kent, Clement F./B-9982-2008; Zdobnov, Evgeny/AAB-2745-2022; Zhang, Guojie/B-6188-2014; Guariz Pinheiro, Daniel/H-4604-2012; Zhang, Guojie/J-7273-2019; Hartfelder, Klaus/A-4293-2009; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Bosch, Jordi/K-8752-2016	Nunes, Francis M. F./0000-0002-7769-3058; Hauser, Frank/0000-0001-5563-2345; Hudson, Matthew E/0000-0002-4737-0936; Kraus, Bernhard/0000-0003-4354-9952; Evans, Jay D/0000-0002-0036-4651; Hunt, Brendan G/0000-0002-0030-9302; Johnson, Reed M./0000-0002-2431-0180; Waterhouse, Robert M/0000-0003-4199-9052; Salzberg, Steven/0000-0002-8859-7432; Stolle, Eckart/0000-0001-7638-4061; Zayed, Amro/0000-0003-3233-4585; Salzberg, Steven L/0000-0002-8859-7432; Hasselmann, Martin/0000-0003-3305-4024; Hartfelder, Klaus/0000-0001-7981-8427; Kapheim, Karen Marie/0000-0002-8140-7712; Moritz, Robin FA/0000-0003-0791-887X; Kent, Clement F./0000-0003-4994-0098; Zdobnov, Evgeny/0000-0002-5178-1498; Zhang, Guojie/0000-0001-6860-1521; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Zhang, Guojie/0000-0001-6860-1521; Hartfelder, Klaus/0000-0001-7981-8427; Wang, Jun/0000-0002-2113-5874; Southey, Bruce/0000-0002-8959-7709; Wang, Jun/0000-0002-8540-8931; Li, Cai/0000-0001-7843-2151; Glastad, Karl/0000-0002-8142-1821; Barribeau, Seth/0000-0001-6643-0562; Pan, Hailin/0000-0001-6785-9862; Bosch, Jordi/0000-0002-8088-9457; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Simoes, Zila Luz Paulino/0000-0003-2363-6178	BGI, a U.S. National Institutes of Health Pioneer Award [DP1 OD006416]; European Union [300837]; U.S. National Science Foundation [DEB-0640690, DEB-0743154]; Danish Council for Independent Research [10-081390, 0602-01170B]; Lundbeck Foundation; Georgia Tech-Elizabeth Smithgall Watts endowment; Marie Curie International Outgoing Fellowship [PIOF-GA-2011-303312]; Swiss National Science Foundation [31003A-125350]; Commission Informatique of the University of Geneva; Schmidheiny Foundation; Swiss Institute of Bioinformatics; Natural Sciences and Engineering Research Council of Canada; i5K Initiative; Lundbeck Foundation [R83-2011-7610] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006416] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1257543] Funding Source: National Science Foundation	BGI, a U.S. National Institutes of Health Pioneer Award; European Union(European Commission); U.S. National Science Foundation(National Science Foundation (NSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Georgia Tech-Elizabeth Smithgall Watts endowment; Marie Curie International Outgoing Fellowship(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission Informatique of the University of Geneva; Schmidheiny Foundation; Swiss Institute of Bioinformatics; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); i5K Initiative; Lundbeck Foundation(Lundbeckfonden); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Data deposition at National Center for Biotechnology Information: H. laboriosa, D. novaeangliae, E. mexicana, M. quadrifasciata, and M. rotundata genome assemblies accession numbers PRJNA279436, PRJNA279825, PRJNA279814, PRJNA279820, and PRJNA66515. Funding for genome sequencing and analysis: BGI, a U.S. National Institutes of Health Pioneer Award (DP1 OD006416) to G.E.R., and European Union Marie Curie International Incoming Fellowship (300837) to G.Z. Additional funding: U.S. National Science Foundation grant DEB-0640690 (M.A.D.G.) and DEB-0743154 (G.E.R. and M.E.H); Danish Council for Independent Research grants 10-081390 (C.L.) and 0602-01170B (C.J.P.G.); Lundbeck Foundation (C.J.P.G); Georgia Tech-Elizabeth Smithgall Watts endowment (M.A.D.G.); Marie Curie International Outgoing Fellowship PIOF-GA-2011-303312 (R.M.W.); Swiss National Science Foundation award 31003A-125350, Commission Informatique of the University of Geneva, Schmidheiny Foundation, and Swiss Institute of Bioinformatics (E.M.Z.); and Natural Sciences and Engineering Research Council of Canada Discovery Grant and Early Research Award (A.Z.). This project was conducted under the auspices of the i5K Initiative. We thank the Roy J. Carver Biotechnology Center (sequencing services); N. Lartillot (advice on Coevol); T. Newman (assistance with DNA extractions); and E. Hadley (assistance with figures). Computational support: D. Davidson, N. Band, D. Slater (University of Illinois), J. H. Kidner and H. Scharpenberg (Martin-Luther-University Halle-Wittenberg); Compute Canada; and Center for High Performance Computing at the University of Utah. J. Himes created the illustrations in Fig. 1. We are grateful to T. Pitts-Singer, H. G. Hall, B. N. Danforth, J. Gibbs, and S. Cardinal for providing bee specimens; R. Ayala for identification of E. mexicana; J. Vega and the staff at Estacion de Biologia Chamela, Universidad Nacional Autonoma de Mexico (UNAM), for support during collecting trips; and S. A. Cameron for insightful discussion.	Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Dolgin ES, 2008, GENETICS, V178, P2169, DOI 10.1534/genetics.107.082743; Feldmeyer B, 2014, MOL ECOL, V23, P151, DOI 10.1111/mec.12490; Ferreira PG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r20; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Gould S. J., 1989, WONDERFUL LIFE BURGE; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Holldobler H, 2009, SUPERORGANISM BEAUTY; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Johnson BR, 2010, Q REV BIOL, V85, P57, DOI 10.1086/650290; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lartillot N, 2011, MOL BIOL EVOL, V28, P729, DOI 10.1093/molbev/msq244; MICHENER CD, 1974, SOCIAL BEHAV BEES; Molodtsova D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00431; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Pfaff DW, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1; Romiguier J, 2014, J EVOLUTION BIOL, V27, P593, DOI 10.1111/jeb.12331; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Szathmary E, 1995, MAJOR TRANSITIONS EV; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Yan H, 2015, ANNU REV ENTOMOL, V60, P435, DOI 10.1146/annurev-ento-010814-020803; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	28	229	233	10	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1139	1143		10.1126/science.aaa4788	http://dx.doi.org/10.1126/science.aaa4788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25977371	Green Accepted			2022-12-28	WOS:000355590500049
J	Nyweide, DJ; Lee, W; Cuerdon, TT; Pham, HH; Cox, M; Rajkumar, R; Conway, PH				Nyweide, David J.; Lee, Woolton; Cuerdon, Timothy T.; Pham, Hoangmai H.; Cox, Megan; Rajkumar, Rahul; Conway, Patrick H.			Association of Pioneer Accountable Care Organizations vs Traditional Medicare Fee for Service With Spending, Utilization, and Patient Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALTERNATIVE QUALITY; CONTRACT; BENEFICIARIES; PERFORMANCE; GROWTH	IMPORTANCE The Pioneer Accountable Care Organization (ACO) Model aims to drive health care organizations to reduce expenditures while improving quality for fee-for-service (FFS) Medicare beneficiaries. OBJECTIVE To determine whether FFS beneficiaries aligned with Pioneer ACOs had smaller increases in spending and utilization than other FFS beneficiaries while retaining similar levels of care satisfaction in the first 2 years of the Pioneer ACO Model. DESIGN, SETTING, AND PARTICIPANTS Participants were FFS Medicare beneficiaries aligned with 32 ACOs (n = 675 712 in 2012; n = 806 258 in 2013) and a comparison group of alignment-eligible beneficiaries in the same markets (n = 13 203 694 in 2012; n = 12 134 154 in 2013). Analyses comprised difference-in-differences multivariable regression with Oaxaca-Blinder reweighting to model expenditure and utilization outcomes over a 2-year performance period (2012-2013) and 2-year baseline period (2010-2011) as well as adjusted analyses of Consumer Assessment of Healthcare Providers & Systems (CAHPS) survey responses among random samples of beneficiaries in Pioneer ACOs (n = 13 097), FFS (n = 116 255), or Medicare Advantage (n = 203 736) for 2012 care. EXPOSURES Beneficiary alignment with a Pioneer ACO in 2012 or 2013. MAIN OUTCOMES AND MEASURES Medicare spending, utilization, and CAHPS domain scores. RESULTS Total spending for beneficiaries aligned with Pioneer ACOs in 2012 or 2013 increased from baseline to a lesser degree relative to comparison populations. Differential changes in spending were approximately -$ 35.62 (95% CI, -$ 40.12 to -$ 31.12) per-beneficiary-per-month (PBPM) in 2012 and -$ 11.18 (95% CI, -$ 15.84 to -$ 6.51) PBPM in 2013, which amounted to aggregate reductions in increases of approximately -$ 280 (95% CI, -$ 315 to -$ 244) million in 2012 and -$ 105 (95% CI, -$ 148 to -$ 61) million in 2013. Inpatient spending showed the largest differential change of any spending category (-$ 14.40 [95% CI, -$ 17.31 to -$ 11.49] PBPM in 2012; -$ 6.46 [95% CI, -$ 9.26 to -$ 3.66] PBPM in 2013). Changes in utilization of physician services, emergency department, and postacute care followed a similar pattern. Compared with other Medicare beneficiaries, ACO-aligned beneficiaries reported higher mean scores for timely care (77.2 [ACO] vs 71.2 [FFS] vs 72.7 [MA]) and for clinician communication (91.9 [ACO] vs 88.3 [FFS] vs 88.7 [MA]). CONCLUSIONS AND RELEVANCE In the first 2 years of the Pioneer ACO Model, beneficiaries aligned with Pioneer ACOs, as compared with general Medicare FFS beneficiaries, exhibited smaller increases in total Medicare expenditures and differential reductions in utilization of different health services, with little difference in patient experience.	[Nyweide, David J.; Lee, Woolton; Cuerdon, Timothy T.; Pham, Hoangmai H.; Cox, Megan; Rajkumar, Rahul; Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD 21244 USA; [Nyweide, David J.; Lee, Woolton; Cuerdon, Timothy T.; Pham, Hoangmai H.; Cox, Megan; Rajkumar, Rahul; Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD 21244 USA; [Nyweide, David J.; Lee, Woolton; Cuerdon, Timothy T.; Pham, Hoangmai H.; Cox, Megan; Rajkumar, Rahul; Conway, Patrick H.] Ctr Medicare & Medicaid Innovat, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Rajkumar, R (corresponding author), Ctr Medicare Serv, Ctr Medicare & Medicaid Innovat, 7500 Secur Blvd,Mailstop WB-06-05, Baltimore, MD 21244 USA.	rahul.rajkumar@cms.hhs.gov			Centers for Medicare & Medicaid Services (CMS) [HHSM-500-2011-00019i/HHSM-500-T0002]	Centers for Medicare & Medicaid Services (CMS)	CMS contracted L&M Policy Research LLC and its partners-Abt Associates, Avalere Health, Social & Scientific Systems, and Truven Health Analytics-to conduct the claims and CAHPS analyses. SAS EG (version 5.1) was used to create the claims files, and STATA (version 13.0) was used to analyze claims and CAHPS data. CMS provided guidance with performing and interpreting the analyses and designed and wrote the manuscript. This article is based on the work of the evaluation contractors for the Evaluation of CMMI Accountable Care Organization Initiative performed under Contract HHSM-500-2011-00019i/HHSM-500-T0002 with the Centers for Medicare & Medicaid Services (CMS). CMS provided access to the data to the evaluation contractors to perform analyses under the guidance of Drs Nyweide, Lee, and Cuerdon. In conjunction with the contractors, Drs Nyweide, Lee, and Cuerdon designed the study and helped with interpretation of the data.	Agency for Healthcare Research and Quality. (n.d.), CONS ASS HEALTHC PRO; American Institutes for Research, 2008, REP RES CAHPS CLIN G; ANDERSON JA, 1984, J R STAT SOC B, V46, P1; Anhang Price R, 2012, DEV PATIENT EXPERIEN; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bott DM, 2009, HEALTH AFFAIR, V28, P86, DOI 10.1377/hlthaff.28.1.86; Casalino LP, 2014, NEW ENGL J MED, V371, P1750, DOI 10.1056/NEJMe1410660; Centers for Medicare and Medicaid Services (CMS), 2014, PION ACO AL FIN REC; Centers for Medicare and Medicaid Services (CMS), ACC CAR ORG ACOS GEN; Centers for Medicare & Medicaid Services (CMS), 2014, MED PION ACO MOD PER; CMS, NEXT GEN ACO MOD; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Dartmouth Institute for Health Policy and Clinical Practice, 2008, TRACK CAR PAT SEV CH; Fisher ES, 2012, HEALTH AFFAIR, V31, P2368, DOI 10.1377/hlthaff.2012.0544; GILLIES RR, 2003, HLTH AFF MILLWOOD; Hartman M, 2015, HEALTH AFFAIR, V34, P150, DOI 10.1377/hlthaff.2014.1107; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Pham HH, 2014, JAMA-J AM MED ASSOC, V312, P1635, DOI 10.1001/jama.2014.13109; ROBINSON JC, 1995, NEW ENGL J MED, V333, P1684, DOI 10.1056/NEJM199512213332506; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416	25	185	186	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2152	2161		10.1001/jama.2015.4930	http://dx.doi.org/10.1001/jama.2015.4930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	25938875	Bronze			2022-12-28	WOS:000355430900015
J	Verkuijl, N; Perkins, M; Fazel, M				Verkuijl, Nienke; Perkins, Marian; Fazel, Mina			Childhood attention-deficit/hyperactivity disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DEFICIT HYPERACTIVITY DISORDER; EARLY INSTITUTIONAL DEPRIVATION; ATOMOXETINE TREATMENT; STIMULANT TREATMENT; FOLLOW-UP; CHILDREN; ADHD; PREVALENCE; ADOLESCENTS; RISK		[Verkuijl, Nienke; Fazel, Mina] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Perkins, Marian] Oxford Hlth NHS Fdn Trust, Child & Adolescent Neuropsychiat Serv, Oxford, England; [Fazel, Mina] Oxford Univ Hosp NHS Trust, Childrens Hosp, Childrens Psychol Med, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Fazel, M (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	mina.fazel@psych.ox.ac.uk		Fazel, Mina/0000-0001-9342-2365				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; Antshel KM, 2014, J ATTEN DISORD, V18, P483, DOI 10.1177/1087054712443155; Asherson P, 2015, J AM ACAD CHILD PSY, V54, P249, DOI 10.1016/j.jaac.2015.01.014; Babinski LM, 1999, J CHILD PSYCHOL PSYC, V40, P347, DOI 10.1017/S002196309800362X; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Bangs ME, 2008, DRUG SAFETY, V31, P345, DOI 10.2165/00002018-200831040-00008; Batstra L, 2014, ACTA PAEDIATR, V103, P696, DOI 10.1111/apa.12642; Biederman J, 1996, J AM ACAD CHILD PSY, V35, P997, DOI 10.1097/00004583-199608000-00010; Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164; CHILDS KE, 1994, J APPL BEHAV ANAL, V27, P7, DOI 10.1901/jaba.1994.27-7; Collett BR, 2003, J AM ACAD CHILD PSY, V42, P1015, DOI 10.1097/01.CHI.0000070245.24125.B6; Cortese S, 2013, J CHILD PSYCHOL PSYC, V54, P227, DOI 10.1111/jcpp.12036; Cortese S, 2009, J AM ACAD CHILD PSY, V48, P894, DOI 10.1097/CHI.0b013e3181ac09c9; Cunningham CE, 1998, J CHILD PSYCHOL PSYC, V39, P653, DOI 10.1111/1469-7610.00365; del Campo N, 2013, BRAIN, V136, P3252, DOI 10.1093/brain/awt263; DUPAUL GJ, 1992, BEHAV MODIF, V16, P204, DOI 10.1177/01454455920162004; DuPaul GJ, 1998, J APPL BEHAV ANAL, V31, P579, DOI 10.1901/jaba.1998.31-579; DuPaul GJ., 2006, INT J DISABIL DEV ED, V532, P161, DOI [10.1080/10349120600716141, DOI 10.1080/10349120600716141]; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; First MB, 2009, BRIT J PSYCHIAT, V195, P382, DOI 10.1192/bjp.bp.108.060822; Fliers E, 2009, J AM ACAD CHILD PSY, V48, P25, DOI 10.1097/CHI.0b013e31818b1ca2; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Frances A, 2013, WORLD PSYCHIATRY, V12, P111, DOI 10.1002/wps.20027; Gardner DM, 2013, J ATTEN DISORD; Hammerness PG, 2011, J AM ACAD CHILD PSY, V50, P978, DOI 10.1016/j.jaac.2011.07.018; Hassan A, 2011, BRIT J PSYCHIAT, V198, P195, DOI 10.1192/bjp.bp.110.078741; Hazell P, 2011, CURR OPIN PSYCHIATR, V24, P286, DOI 10.1097/YCO.0b013e32834742db; Jensen PS, 2004, PEDIATRICS, V113, P754; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Pimentel MJ, 2011, ADHD-ATTEND DEFICIT, V3, P61, DOI 10.1007/s12402-011-0053-3; King S, 2006, HEALTH TECHNOL ASSES, V10, P1; Klasen H, 2000, BRIT J GEN PRACT, V50, P199; Kratochvil CJ, 2006, J AM ACAD CHILD PSY, V45, P919, DOI 10.1097/01.chi.0000222788.34229.68; Kreppner JM, 2007, DEV PSYCHOL, V43, P931, DOI 10.1037/0012-1649.43.4.931; Larsson H, 2012, J CHILD PSYCHOL PSYC, V53, P73, DOI 10.1111/j.1469-7610.2011.02467.x; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Miller AC, 2013, J ABNORM CHILD PSYCH, V41, P473, DOI 10.1007/s10802-012-9686-8; Mitchell J, 2012, CLIN CHILD PSYCHOL P, V17, P121, DOI 10.1177/1359104510396432; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Moncrieff J, 2013, ANTHROPOL MED, V20, P59, DOI 10.1080/13648470.2012.747591; Monynihan R, 2011, BMJ-BRIT MED J, V342, P1136; Moore D, 2015, J ATTENTION DIS; National Collaborating Centre for Mental Health (UK), 2018, BR PSYCHOL SOC; National Institute for Health and Care Excellence, 2013, ANT BEH COND DIS CHI; Parens Erik, 2009, Child Adolesc Psychiatry Ment Health, V3, P1, DOI 10.1186/1753-2000-3-1; Parker C, 2015, EMOT BEHAV DIFFIC, V20, P229, DOI 10.1080/13632752.2014.945741; Peadon E, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-35; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Poulton Alison, 2012, Int J Pediatr Endocrinol, V2012, P30, DOI 10.1186/1687-9856-2012-30; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; Riddle MA, 2013, J AM ACAD CHILD PSY, V52, P264, DOI 10.1016/j.jaac.2012.12.007; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Russell G, 2014, J AUTISM DEV DISORD, V44, P31, DOI 10.1007/s10803-013-1849-0; Rutter M, 2007, EUR J DEV PSYCHOL, V4, P332, DOI 10.1080/17405620701401846; Sarver DE, 2015, J ABNORM CHILD PSYCH; Sayal K, 2002, BRIT J PSYCHIAT, V181, P43, DOI 10.1192/bjp.181.1.43; Sayal K, 2006, J CHILD PSYCHOL PSYC, V47, P744, DOI 10.1111/j.1469-7610.2005.01553.x; Sayal K, 2015, J AM ACAD CHILD PSY, V54, P360, DOI 10.1016/j.jaac.2015.02.007; Schwarz A, 2013, NY TIMES; Shafer E., 1998, HDB PARENT TRAINING; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shah PJ, 2013, BRIT J PSYCHIAT, V203, P317, DOI 10.1192/bjp.bp.113.126474; Singh I, 2004, SOC SCI MED, V59, P1193, DOI 10.1016/j.socscimed.2004.01.011; Singh I, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0385-0; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Sonuga-Barke EJS, 2001, J AM ACAD CHILD PSY, V40, P402, DOI 10.1097/00004583-200104000-00008; Stergiakouli E, 2015, J AM ACAD CHILD PSY, V54, P322, DOI 10.1016/j.jaac.2015.01.010; Storebo O. J., 2011, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD003018.PUB3; Sung V, 2008, ARCH PEDIAT ADOL MED, V162, P336, DOI 10.1001/archpedi.162.4.336; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; United Nations, 2022, BRIEF HIST DRUG ADDI; van Emmerik-van Oortmerssen K, 2012, DRUG ALCOHOL DEPEN, V122, P11, DOI 10.1016/j.drugalcdep.2011.12.007; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Yemula C, 2013, CUT EDGE PSYCHIAT PR, V2, P35; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x; Zwi M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003018.pub3	87	19	20	1	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2168	10.1136/bmj.h2168	http://dx.doi.org/10.1136/bmj.h2168			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI9YZ	25994532	Green Published			2022-12-28	WOS:000355128700001
J	Belknap, SM				Belknap, Steven M.			Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				Joy TR, 2014, ANN INTERN MED, V160, P301, DOI 10.7326/M13-1921; McDonagh J, 2014, JAMA INTERN MED, V174, P1889, DOI 10.1001/jamainternmed.2014.5376; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Swiger KJ, 2013, MAYO CLIN PROC, V88, P1213, DOI 10.1016/j.mayocp.2013.07.013	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC6	10.7326/ACPJC-2015-162-10-006	http://dx.doi.org/10.7326/ACPJC-2015-162-10-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984879				2022-12-28	WOS:000355015200008
J	Standley, CJ; Sorrell, EM; Kornblet, S; Vaught, A; Fischer, JE; Katz, R				Standley, C. J.; Sorrell, E. M.; Kornblet, S.; Vaught, A.; Fischer, J. E.; Katz, R.			Linking funds to actions for global health emergencies	SCIENCE			English	Editorial Material									[Standley, C. J.; Sorrell, E. M.; Kornblet, S.; Vaught, A.; Fischer, J. E.; Katz, R.] George Washington Univ, Dept Hlth Policy & Management, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA	George Washington University	Katz, R (corresponding author), George Washington Univ, Dept Hlth Policy & Management, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.	rlkatz@gwu.edu		Katz, Rebecca/0000-0002-7596-431X				Chan M, 2015, REPORT DIRECTOR GEN; Jonas O., 2014, FINANC DEV, V51, P16; UN Mission for Ebola Emergency Response, 2015, EXT SIT REP; WBG, 2015, PAND EM FAC FREQ ASK; WHO Regional Office for Africa, 2014, SIT REP 1 EB VIR DIS; WHO Regional Office for Africa, 2013, AFR PUBL HLTH EM FUN; World Bank Group, 2014, WOLD BANK GROUP PRES; World Health Organization, 2014, EB VIR DIS GUIN; World Health Organization World Organisation for Animal Health, 2014, WHO OIE OP FRAM GOOD	9	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					762	763		10.1126/science.aaa5521	http://dx.doi.org/10.1126/science.aaa5521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977540				2022-12-28	WOS:000354428700024
J	Pandolfino, JE; Gawron, AJ				Pandolfino, John E.; Gawron, Andrew J.			Achalasia A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HIGH-RESOLUTION MANOMETRY; LAPAROSCOPIC HELLER MYOTOMY; ESOPHAGEAL MOTILITY DISORDERS; PERORAL ENDOSCOPIC MYOTOMY; RANDOMIZED CONTROLLED-TRIAL; SINGLE-CENTER EXPERIENCE; IDIOPATHIC ACHALASIA; PNEUMATIC DILATION; BOTULINUM TOXIN; SMOOTH-MUSCLE	IMPORTANCE Achalasia significantly affects patients' quality of life and can be difficult to diagnose and treat. OBJECTIVE To review the diagnosis and management of achalasia, with a focus on phenotypic classification pertinent to therapeutic outcomes. EVIDENCE REVIEW Literature review and MEDLINE search of articles from January 2004 to February 2015. A total of 93 articles were included in the final literature review addressing facets of achalasia epidemiology, pathophysiology, diagnosis, treatment, and outcomes. Nine randomized controlled trials focusing on endoscopic or surgical therapy for achalasia were included (734 total patients). FINDINGS A diagnosis of achalasia should be considered when patients present with dysphagia, chest pain, and refractory reflux symptoms after an endoscopy does not reveal a mechanical obstruction or an inflammatory cause of esophageal symptoms. Manometry should be performed if achalasia is suspected. Randomized controlled trials support treatments focused on disrupting the lower esophageal sphincter with pneumatic dilation (70%-90% effective) or laparoscopic myotomy (88%-95% effective). Patients with achalasia have a variable prognosis after endoscopic or surgical myotomy based on subtypes, with type II (absent peristalsis with abnormal pan-esophageal high-pressure patterns) having a very favorable outcome (96%) and type I (absent peristalsis without abnormal pressure) having an intermediate prognosis (81%) that is inversely associated with the degree of esophageal dilatation. In contrast, type III (absent peristalsis with distal esophageal spastic contractions) is a spastic variant with less favorable outcomes (66%) after treatment of the lower esophageal sphincter. CONCLUSIONS AND RELEVANCE Achalasia should be considered when dysphagia is present and not explained by an obstruction or inflammatory process. Responses to treatment vary based on which achalasia subtype is present.	[Pandolfino, John E.] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; [Gawron, Andrew J.] Univ Utah, Div Gastroenterol Hepatol & Nutr, Salt Lake City, UT USA	Northwestern University; Feinberg School of Medicine; Utah System of Higher Education; University of Utah	Pandolfino, JE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gastroenterol & Hepatol, 676 N St Clair St,Ste 1409, Chicago, IL 60611 USA.	j-pandolfino@northwestern.edu			Given Imaging/Covidien; Sandhill Scientific	Given Imaging/Covidien; Sandhill Scientific	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Pandolfino reported receiving consulting and speaking fees from Given Imaging/Covidien and Sandhill Scientific. Dr Gawron reported no disclosures.	Annese V, 2000, GUT, V46, P597, DOI 10.1136/gut.46.5.597; ASK P, 1980, AM J PHYSIOL, V238, pG485, DOI 10.1152/ajpgi.1980.238.6.G485; Bakhshipour Alireza, 2010, Acta Med Iran, V48, P107; Bhattacharyya N, 2014, OTOLARYNG HEAD NECK, V151, P765, DOI 10.1177/0194599814549156; Bhayani NH, 2014, ANN SURG, V259, P1098, DOI 10.1097/SLA.0000000000000268; Birgisson S, 2007, DIGEST DIS SCI, V52, P1855, DOI 10.1007/s10620-006-9286-y; Boeckxstaens GE, 2008, AM J GASTROENTEROL, V103, P1610, DOI 10.1111/j.1572-0241.2008.01967.x; Boeckxstaens GE, 2011, NEW ENGL J MED, V364, P1807, DOI 10.1056/NEJMoa1010502; Bogte A, 2011, NEUROGASTROENT MOTIL, V23, pE271, DOI 10.1111/j.1365-2982.2011.01713.x; Bonatti H, 2005, AM J SURG, V190, P874, DOI 10.1016/j.amjsurg.2005.08.012; Booy JD, 2012, DIS ESOPHAGUS, V25, P209, DOI 10.1111/j.1442-2050.2011.01249.x; Bortolotti M, 2000, GASTROENTEROLOGY, V118, P253, DOI 10.1016/S0016-5085(00)70206-X; Broad J, 2014, NEUROGASTROENT MOTIL, V26, P1311, DOI 10.1111/nmo.12394; Campos GM, 2009, ANN SURG, V249, P45, DOI 10.1097/SLA.0b013e31818e43ab; Costantini M, 2005, SURG ENDOSC, V19, P345, DOI 10.1007/s00464-004-8941-7; de Leon AR, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01497.x; de Leon AR, 2010, HUM IMMUNOL, V22, pe218; DEOLIVEIRA RB, 1995, AM J GASTROENTEROL, V90, P1119; Eckardt VF, 2008, EUR J GASTROEN HEPAT, V20, P956, DOI 10.1097/MEG.0b013e3282fbf5e5; Enestvedt BK, 2011, ALIMENT PHARM THER, V33, P33, DOI 10.1111/j.1365-2036.2010.04493.x; Farhoomand K, 2004, CLIN GASTROENTEROL H, V2, P389, DOI 10.1016/S1542-3565(04)00123-5; Farrukh A, 2008, DYSPHAGIA, V23, P161, DOI 10.1007/s00455-007-9116-1; Fox M, 2004, NEUROGASTROENT MOTIL, V16, P533, DOI 10.1111/j.1365-2982.2004.00539.x; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; Gennaro N, 2011, J GASTROINTEST SURG, V15, P423, DOI 10.1007/s11605-010-1392-7; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V290, pG988, DOI 10.1152/ajpgi.00510.2005; Ghosh SK, 2007, AM J PHYSIOL-GASTR L, V293, pG878, DOI 10.1152/ajpgi.00252.2007; GIDDA JS, 1985, GASTROENTEROLOGY, V89, P843, DOI 10.1016/0016-5085(85)90582-7; Gockel I, 2006, J GASTROEN HEPATOL, V21, P727, DOI 10.1111/j.1440-1746.2006.04250.x; Gockel I, 2008, AM J GASTROENTEROL, V103, P856, DOI 10.1111/j.1572-0241.2007.01667.x; GOLDBLUM JR, 1994, AM J SURG PATHOL, V18, P327, DOI 10.1097/00000478-199404000-00001; Gordillo-Gonzalez G, 2011, DIS ESOPHAGUS, V24, pE1, DOI 10.1111/j.1442-2050.2010.01124.x; Gupta M, 2014, DIGEST DIS SCI, V59, P744, DOI 10.1007/s10620-013-2971-8; Hong SJ, 2010, GASTROENTEROLOGY, V139, P102, DOI 10.1053/j.gastro.2010.03.058; Hungness ES, 2013, J GASTROINTEST SURG, V17, P228, DOI 10.1007/s11605-012-2030-3; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Inoue Haruhiro, 2010, Nihon Rinsho, V68, P1749; Johnston BT, 2001, DYSPHAGIA, V16, P186, DOI 10.1007/s00455-001-0063-y; Jung KW, 2011, J NEUROGASTROENTEROL, V17, P169, DOI 10.5056/jnm.2011.17.2.169; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P160, DOI 10.1111/nmo.12477; Kostic S, 2007, SURG ENDOSC, V21, P1184, DOI 10.1007/s00464-007-9310-0; Kraichely RE, 2010, DIGEST DIS SCI, V55, P307, DOI 10.1007/s10620-009-0838-9; Krishnan K, 2014, NEUROGASTROENT MOTIL, V26, P1172, DOI 10.1111/nmo.12379; Kumbhari V, 2015, GASTROINTEST ENDOSC, V81, P1000, DOI 10.1016/j.gie.2014.10.038; Lecea B, 2012, NEUROGASTROENT MOTIL, V24, P779, DOI 10.1111/j.1365-2982.2012.01936.x; Leeuwenburgh I, 2010, AM J GASTROENTEROL, V105, P2144, DOI 10.1038/ajg.2010.263; Lynch KL, 2012, AM J GASTROENTEROL, V107, P1817, DOI 10.1038/ajg.2012.332; Mikaeli J, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-12; Min M, 2012, J DIGEST DIS, V13, P504, DOI 10.1111/j.1751-2980.2012.00622.x; Mittal RK, 2013, J NEUROGASTROENTEROL, V19, P126, DOI 10.5056/jnm.2013.19.2.126; MITTAL RK, 1990, AM J PHYSIOL, V258, pG208, DOI 10.1152/ajpgi.1990.258.2.G208; Muinuddin A, 2001, AM J PHYSIOL-GASTR L, V281, pG1460, DOI 10.1152/ajpgi.2001.281.6.G1460; Nenshi R, 2010, SURG INNOV, V17, P291, DOI 10.1177/1553350610376392; Ng K. Y., 2010, Hong Kong Medical Journal, V16, P362; Novais PA, 2010, ALIMENT PHARM THER, V32, P1257, DOI 10.1111/j.1365-2036.2010.04461.x; Nunez C, 2011, HUM IMMUNOL, V72, P749, DOI 10.1016/j.humimm.2011.05.017; Pandolfino JE, 2006, AM J PHYSIOL-GASTR L, V290, pG0133, DOI 10.1152/ajpgi.00444.2005; Pandolfino JE, 2005, GASTROENTEROLOGY, V128, P209, DOI 10.1053/j.gastro.2004.11.008; Pandolfino JE, 2008, GASTROENTEROLOGY, V135, P1526, DOI 10.1053/j.gastro.2008.07.022; Pandolfino JE, 2008, AM J GASTROENTEROL, V103, P27, DOI 10.1111/j.1572-0241.2007.01532.x; Pasricha PJ, 2007, ENDOSCOPY, V39, P761, DOI 10.1055/s-2007-966764; Pasricha PJ, 1996, GASTROENTEROLOGY, V110, P1410, DOI 10.1053/gast.1996.v110.pm8613045; Persson J, 2015, WORLD J SURG, V39, P713, DOI 10.1007/s00268-014-2869-4; Pratap N, 2011, J NEUROGASTROENTEROL, V17, P205, DOI 10.5056/jnm.2011.17.2.205; Rakita SS, 2007, SURG ENDOSC, V21, P258, DOI 10.1007/s00464-006-0113-5; Ravi K, 2015, DIS ESOPHAGUS, V28, P299, DOI 10.1111/dote.12196; Rawlings A, 2012, SURG ENDOSC, V26, P18, DOI 10.1007/s00464-011-1822-y; Rebecchi F, 2008, ANN SURG, V248, P1023, DOI 10.1097/SLA.0b013e318190a776; Richards WO, 2004, ANN SURG, V240, P403, DOI 10.1097/01.sla.0000136940.32255.51; Rohof WO, 2013, GASTROENTEROLOGY, V144, P718, DOI 10.1053/j.gastro.2012.12.027; Roman S, 2013, JAMA SURG, V148, P157, DOI 10.1001/2013.jamasurg.38; Roman S, 2012, DIGEST LIVER DIS, V44, P976, DOI 10.1016/j.dld.2012.07.019; Sadowski DC, 2010, NEUROGASTROENT MOTIL, V22, pe256, DOI 10.1111/j.1365-2982.2010.01511.x; Salvador R, 2010, J GASTROINTEST SURG, V14, P1635, DOI 10.1007/s11605-010-1318-4; Sarathi V, 2010, ADV EXP MED BIOL, V685, P1; Schechter Rosana B., 2011, Arq. Gastroenterol., V48, P19, DOI 10.1590/S0004-28032011000100005; Scherer JR, 2009, J GASTROINTEST SURG, V13, P2219, DOI 10.1007/s11605-009-0975-7; Sinan H, 2011, DIS ESOPHAGUS, V24, P224, DOI 10.1111/j.1442-2050.2010.01126.x; Smith CD, 2006, ANN SURG, V243, P579, DOI 10.1097/01.sla.0000217524.75529.2d; Sonnenberg A, 2009, DIGEST DIS SCI, V54, P1680, DOI 10.1007/s10620-009-0863-8; STUCKEY BG, 1987, ANN INTERN MED, V106, P62, DOI 10.7326/0003-4819-106-1-62; Swanstrom LL, 2011, J AM COLL SURGEONS, V213, P751, DOI 10.1016/j.jamcollsurg.2011.09.001; Tsuboi K, 2012, DIGESTION, V85, P236, DOI 10.1159/000336072; Vaezi MF, 1999, GUT, V44, P231, DOI 10.1136/gut.44.2.231; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196; VANEK AW, 1987, GASTROENTEROLOGY, V92, P643, DOI 10.1016/0016-5085(87)90012-6; Vigo AG, 2009, AM J GASTROENTEROL, V104, P1326, DOI 10.1038/ajg.2009.72; von Renteln D, 2012, AM J GASTROENTEROL, V107, P411, DOI 10.1038/ajg.2011.388; Worl J, 2005, HISTOCHEM CELL BIOL, V123, P117, DOI 10.1007/s00418-005-0764-7; Wuller C, 2011, ANZ J SURG, V81, P590, DOI 10.1111/j.1445-2197.2010.05577.x; Zaninotto G, 2004, ANN SURG, V239, P364, DOI 10.1097/01.sla.0000114217.52941.c5; Zaninotto G, 2007, J GASTROINTEST SURG, V11, P1138, DOI 10.1007/s11605-007-0195-y; Zaninotto G, 2008, ANN SURG, V248, P986, DOI 10.1097/SLA.0b013e3181907bdd; Zarate N, 1999, AM J GASTROENTEROL, V94, P1674	94	225	248	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1841	1852		10.1001/jama.2015.2996	http://dx.doi.org/10.1001/jama.2015.2996			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965233				2022-12-28	WOS:000354391000028
J	Falk, SJ; Guo, LY; Sekulic, N; Smoak, EM; Mani, T; Logsdon, GA; Gupta, K; Jansen, LET; Van Duyne, GD; Vinogradov, SA; Lampson, MA; Black, BE				Falk, Samantha J.; Guo, Lucie Y.; Sekulic, Nikolina; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Gupta, Kushol; Jansen, Lars E. T.; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Lampson, Michael A.; Black, Ben E.			CENP-C reshapes and stabilizes CENP-A nucleosomes at the centromere	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CHROMATIN; PROPAGATION; RECOGNITION; MECHANISM; FEATURES; REVEALS; OCTAMER	Inheritance of each chromosome depends upon its centromere. A histone H3 variant, centromere protein A (CENP-A), is essential for epigenetically marking centromere location. We find that CENP-A is quantitatively retained at the centromere upon which it is initially assembled. CENP-C binds to CENP-A nucleosomes and is a prime candidate to stabilize centromeric chromatin. Using purified components, we find that CENP-C reshapes the octameric histone core of CENP-A nucleosomes, rigidifies both surface and internal nucleosome structure, and modulates terminal DNA to match the loose wrap that is found on native CENP-A nucleosomes at functional human centromeres. Thus, CENP-C affects nucleosome shape and dynamics in a manner analogous to allosteric regulation of enzymes. CENP-C depletion leads to rapid removal of CENP-A from centromeres, indicating their collaboration in maintaining centromere identity.	[Falk, Samantha J.; Guo, Lucie Y.; Sekulic, Nikolina; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Gupta, Kushol; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Black, Ben E.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Falk, Samantha J.; Lampson, Michael A.; Black, Ben E.] Univ Penn, Grad Program Cell & Mol Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guo, Lucie Y.; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Lampson, Michael A.; Black, Ben E.] Univ Penn, Grad Program Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smoak, Evan M.; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Jansen, Lars E. T.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Instituto Gulbenkian de Ciencia	Black, BE (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu	Mani, Tomoyasu/B-2241-2012; Sekulic, Nikolina/N-5550-2016; Gupta, Kushol/GOE-5620-2022; MANI, TOMOYASU/AAS-5058-2021	Mani, Tomoyasu/0000-0002-4125-5195; Sekulic, Nikolina/0000-0001-7555-3222; Gupta, Kushol/0000-0002-7006-2667; MANI, TOMOYASU/0000-0002-4125-5195; Logsdon, Glennis/0000-0003-2396-0656; Jansen, Lars/0000-0002-2158-0345	NIH [GM082989, CA186430, GM008275, GM008216, GM007229]; European Research Council [ERC-2013-CoG-615638]; American Heart Association; American Cancer Society; NSF [DMR-0944772]; NATIONAL CANCER INSTITUTE [F30CA186430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, T32GM008216, T32GM008275, R01GM082989, S06GM008216, R01GM083988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our University of Pennsylvania colleagues (J. Bell, C. Bialas, J. DeNizio, Y. Goldman, W. Hu, L. Lippert, L. Mayne, T. Panchenko, B. Turegun, and Z. Zhao) and S. Krueger and K. Sarachan [National Institute of Standards and Technology (NIST)] for assistance and advice with experiments; A. Straight (Stanford) for reagents and advice; and D. Cleveland (University of California, San Diego), J. Lippincott-Schwartz (NIH), K. Luger (Colorado State University), and E. Makeyev (Nanyang Technical University) for reagents. This work was supported by NIH grant GM082989 (B. E. B.), European Research Council grant ERC-2013-CoG-615638 (L. E. T. J.), predoctoral fellowships from the American Heart Association (E.M.S.) and NIH (CA186430, L.Y.G.), and a postdoctoral fellowship from the American Cancer Society (N.S.). We acknowledge support from NIH grants GM008275 (UPenn Structural Biology Training Grant, L.Y.G. and E.M.S), GM008216 (UPenn Genetics Training Grant, S.J.F.), and GM007229 (UPenn Cell and Molecular Biology Training Grant, G.A.L.). This work used facilities supported in part by NSF (agreement DMR-0944772). We acknowledge the support of NIST in providing the neutron research facilities used in this work.	Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bodor DL, 2013, MOL BIOL CELL, V24, P923, DOI 10.1091/mbc.E13-01-0034; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Harp JM, 1996, ACTA CRYSTALLOGR D, V52, P283, DOI 10.1107/S0907444995009139; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258	16	135	136	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					699	703		10.1126/science.1259308	http://dx.doi.org/10.1126/science.1259308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954010	Green Accepted, Green Submitted			2022-12-28	WOS:000354045700047
J	Loudon, K; Treweek, S; Sullivan, F; Donnan, P; Thorpe, KE; Zwarenstein, M				Loudon, Kirsty; Treweek, Shaun; Sullivan, Frank; Donnan, Peter; Thorpe, Kevin E.; Zwarenstein, Merrick			The PRECIS-2 tool: designing trials that are fit for purpose	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; EXTERNAL VALIDITY; PRAGMATIC ATTITUDES; THERAPEUTIC TRIALS; ASTHMA	PRECIS is a tool to help trialists make design decisions consistent with the intended purpose of their trial. This paper gives guidance on how to use an improved, validated version, PRECIS-2, which has been developed with the help of over 80 international trialists, clinicians, and policymakers. Keeping the original simple wheel format, PRECIS-2 has nine domains-eligibility criteria, recruitment, setting, organisation, flexibility (delivery), flexibility (adherence), follow-up, primary outcome, and primary analysis-scored from 1 (very explanatory) to 5 (very pragmatic) to facilitate domain discussion and consensus. It is hoped PRECIS-2 will be valuable in supporting the explicit matching of design decisions to how the trial results are intended to be used	[Loudon, Kirsty; Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland; [Sullivan, Frank] North York Gen Hosp, Toronto, ON M2K 1E1, Canada; [Donnan, Peter] Univ Dundee, Div Populat Hlth Sci, Dundee DD2 4BF, Scotland; [Thorpe, Kevin E.] Li Ka Shing Knowledge Inst St Michaels, AHRC, Toronto, ON, Canada; [Thorpe, Kevin E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Zwarenstein, Merrick] Univ Western Ontario, Western Ctr Publ Hlth & Family Med, Schulich Sch Med & Dent, Ctr Studies Family Med, London, ON N6A 3K7, Canada	University of Aberdeen; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Dundee; University of Toronto; Western University (University of Western Ontario)	Loudon, K (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland.	kirsty.loudon@abdn.ac.uk	Treweek, Shaun/AAE-8006-2019; Zwarenstein, Merrick F/P-5210-2014; Loudon, Kirsty/A-1951-2019; Sullivan, Frank/L-8286-2019; Loudon, Kirsty/M-1979-2015	Treweek, Shaun/0000-0002-7239-7241; Zwarenstein, Merrick F/0000-0003-0162-7027; Sullivan, Frank/0000-0002-6623-4964; Loudon, Kirsty/0000-0002-4449-6226; Thorpe, Kevin/0000-0002-7586-3893; Donnan, Peter/0000-0001-7828-0610	Chief Scientist Office (CSO) of Scotland [CZH/4/773]; UK Medical Research Council; University of Dundee; Health Services Research Unit at the University of Aberdeen - CSO of the Scottish Government Health Directories; Medical Research Council [1415468] Funding Source: researchfish; Chief Scientist Office [NMAHP2, HSRU1, CZH/4/773] Funding Source: researchfish	Chief Scientist Office (CSO) of Scotland; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Dundee; Health Services Research Unit at the University of Aberdeen - CSO of the Scottish Government Health Directories; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	All authors have completed the ICMJ uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this work was supported by the Chief Scientist Office (CSO) of Scotland grant CZH/4/773, the UK Medical Research Council and the University of Dundee work through the provision of a PhD stipend for KL and from the Health Services Research Unit at the University of Aberdeen, which is core funded by the CSO of the Scottish Government Health Directories.	Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cochrane AL, 1972, EFFECTIVENESS EFFICI; Concannon TW, 2014, CTS-CLIN TRANSL SCI, V7, P164, DOI 10.1111/cts.12143; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Geretsegger M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-2; Jolly SS, 2011, AM HEART J, V161, P254, DOI 10.1016/j.ahj.2010.11.021; Jolly SS, 2011, AM HEART J, V161, pe1; Karanicolas PJ, 2009, J CLIN EPIDEMIOL, V62, P489, DOI 10.1016/j.jclinepi.2008.08.013; Loudon K, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-115; Oxman AD, 2009, J CLIN EPIDEMIOL, V62, P485, DOI 10.1016/j.jclinepi.2008.08.015; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Raymond J, 2014, J CLIN EPIDEMIOL, V67, P1150, DOI 10.1016/j.jclinepi.2014.04.010; Rothwell PM, 2010, INT J EPIDEMIOL, V39, P94, DOI 10.1093/ije/dyp305; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sackett DL, 2013, CLIN TRIALS, V10, P633, DOI 10.1177/1740774513491339; Saunders C, 2013, DIABETIC MED, V30, P300, DOI 10.1111/dme.12047; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Tripathy P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-182; Vickers AJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3438; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	23	834	837	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2015	350								h2147	10.1136/bmj.h2147	http://dx.doi.org/10.1136/bmj.h2147			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GP	25956159	Green Published, Bronze			2022-12-28	WOS:000354415400001
J	Zhang, CX; Chen, CH; Dong, HX; Shen, JR; Dau, H; Zhao, JQ				Zhang, Chunxi; Chen, Changhui; Dong, Hongxing; Shen, Jian-Ren; Dau, Holger; Zhao, Jingquan			A synthetic Mn4Ca-cluster mimicking the oxygen-evolving center of photosynthesis	SCIENCE			English	Article							PHOTOSYSTEM-II; SPECTROSCOPIC PROPERTIES; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; PROTON-TRANSFER; WATER; COMPLEX; BINDING; CLUSTER; MODELS	Photosynthetic splitting of water into oxygen by plants, algae, and cyanobacteria is catalyzed by the oxygen-evolving center (OEC). Synthetic mimics of the OEC, which is composed of an asymmetric manganese-calcium-oxygen cluster bound to protein groups, may promote insight into the structural and chemical determinants of biological water oxidation and lead to development of superior catalysts for artificial photosynthesis. We synthesized a Mn4Ca-cluster similar to the native OEC in both the metal-oxygen core and the binding protein groups. Like the native OEC, the synthetic cluster can undergo four redox transitions and shows two magnetic resonance signals assignable to redox and structural isomerism. Comparison with previously synthesized Mn3CaO4-cubane clusters suggests that the fourth Mn ion determines redox potentials and magnetic properties of the native OEC.	[Zhang, Chunxi; Zhao, Jingquan] Chinese Acad Sci, Inst Chem, Lab Photochem, Beijing 100190, Peoples R China; [Chen, Changhui; Dong, Hongxing] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China; [Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan; [Dau, Holger] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	Chinese Academy of Sciences; Institute of Chemistry, CAS; Harbin Engineering University; Okayama University; Free University of Berlin	Zhang, CX (corresponding author), Chinese Acad Sci, Inst Chem, Lab Photochem, Beijing 100190, Peoples R China.	chunxizhang@iccas.ac.cn; dhongxing@hrbeu.edu.cn; holger.dau@fu-berlin.de	Shen, Jian-Ren/B-2558-2011; zhao, jing/B-3868-2019; Zhang, Chunxi/H-9435-2017	Zhang, Chunxi/0000-0002-8483-6897; Chen, Changhui/0000-0001-5703-5894; Dau, Holger/0000-0001-6482-7494	National Natural Science Foundation of China [20973186, 31070216, 21076049, 91427303]; Chinese Academy of Sciences [KJCX2-YW-W25]; Japan Society for the Promotion of Science [24000018/Shen]; Deutsche Forschungsgemeinschaft [CRC 1078, A4/Dau]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the National Natural Science Foundation of China (nos. 20973186, 31070216, 21076049, and 91427303), Chinese Academy of Sciences (KJCX2-YW-W25), Japan Society for the Promotion of Science (no. 24000018/Shen), and by the Deutsche Forschungsgemeinschaft (CRC 1078, A4/Dau). We thank A. Zouni and W. Junge for their suggestions. Crystallographic data have been deposited at the Cambridge Crystallographic Database Centre, and the deposition numbers are 1042697(I), 1042515 (II), and 1042514 (III).	Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Boussac A, 2000, BBA-BIOENERGETICS, V1457, P145, DOI 10.1016/S0005-2728(00)00073-6; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Kanady JS, 2014, J AM CHEM SOC, V136, P14373, DOI 10.1021/ja508160x; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Krewald V, 2013, J AM CHEM SOC, V135, P5726, DOI 10.1021/ja312552f; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Mullins CS, 2008, COORDIN CHEM REV, V252, P416, DOI 10.1016/j.ccr.2007.07.021; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Nilsson H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5305; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Tsui EY, 2013, P NATL ACAD SCI USA, V110, P10084, DOI 10.1073/pnas.1302677110; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	347	358	32	745	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					690	693		10.1126/science.aaa6550	http://dx.doi.org/10.1126/science.aaa6550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954008				2022-12-28	WOS:000354045700045
J	Urban, MC				Urban, Mark C.			Accelerating extinction risk from climate change	SCIENCE			English	Article							ECOLOGICAL RESPONSES; WESTERN-HEMISPHERE; BIODIVERSITY	Current predictions of extinction risks from climate change vary widely depending on the specific assumptions and geographic and taxonomic focus of each study. I synthesized published studies in order to estimate a global mean extinction rate and determine which factors contribute the greatest uncertainty to climate change-induced extinction risks. Results suggest that extinction risks will accelerate with future global temperatures, threatening up to one in six species under current policies. Extinction risks were highest in South America, Australia, and New Zealand, and risks did not vary by taxonomic group. Realistic assumptions about extinction debt and dispersal capacity substantially increased extinction risks. We urgently need to adopt strategies that limit further climate change if we are to avoid an acceleration of global extinctions.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Urban, MC (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, 75 North Eagleville Rd,Unit 3043, Storrs, CT 06269 USA.	mark.urban@uconn.edu	Urban, Mark Christopher/Y-2430-2019		NSF [DEB-1119877, PLR-1417754]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation	The data reported in this paper are tabulated in the supplementary materials. Research was supported by NSF DEB-1119877 and PLR-1417754 and the James S. McDonnell Foundation. I thank M. Tingley, J. Urban, and all the authors of the studies who made this meta-analysis possible.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stanton JC, 2015, GLOBAL CHANGE BIOL, V21, P1066, DOI 10.1111/gcb.12721; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Warren R, 2011, CLIMATIC CHANGE, V106, P141, DOI 10.1007/s10584-010-9923-5; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464	27	1054	1100	82	843	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					571	573		10.1126/science.aaa4984	http://dx.doi.org/10.1126/science.aaa4984			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931559	Green Submitted			2022-12-28	WOS:000353778100041
J	Hu, FB; Satija, A; Manson, JE				Hu, Frank B.; Satija, Ambika; Manson, JoAnn E.			Curbing the Diabetes Pandemic The Need for Global Policy Solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Hu, Frank B.; Satija, Ambika] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA 02215 USA; [Hu, Frank B.; Satija, Ambika] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02215 USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manson, JE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu			NATIONAL CANCER INSTITUTE [U54CA155626] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK046200] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA155626] Funding Source: Medline; NHLBI NIH HHS [HL34594, R01 HL060712, R01 HL034594] Funding Source: Medline; NIDDK NIH HHS [P30 DK046200, R01 DK058845, DK58845, P30 DK46200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bauman A, 2005, WHO WORKSH PHYS ACT; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Institute of Medicine, 2012, ACC PROGR OB PREV SO; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Qi L, 2009, AM J CLIN NUTR, V89, P1453, DOI 10.3945/ajcn.2008.27249; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Secretaria de Salud, RES PREL EF IMP BEB	9	77	79	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2319	2320		10.1001/jama.2015.5287	http://dx.doi.org/10.1001/jama.2015.5287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	25996138	Green Accepted			2022-12-28	WOS:000356300200012
J	Sawaya, GF; Kulasingam, S; Denberg, TD; Qaseem, A				Sawaya, George F.; Kulasingam, Shalini; Denberg, Thomas D.; Qaseem, Amir		Amer Coll Phys	Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; COST-EFFECTIVENESS; MEDICAL-RECORD; PAP; PREVENTION; SERVICES; OLDER; COLPOSCOPY; STRATEGIES; MANAGEMENT	Description: The purpose of this best practice advice article is to describe the indications for screening for cervical cancer in asymptomatic, average-risk women aged 21 years or older. Methods: The evidence reviewed in this work is a distillation of relevant publications (including systematic reviews) used to support current guidelines. Best Practice Advice 1: Clinicians should not screen average-risk women younger than 21 years for cervical cancer. Best Practice Advice 2: Clinicians should start screening average-risk women for cervical cancer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [HPV] tests). Best Practice Advice 3: Clinicians should not screen average-risk women for cervical cancer with cytology more often than once every 3 years. Best Practice Advice 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-risk women aged 30 years or older who prefer screening less often than every 3 years. Best Practice Advice 5: Clinicians should not perform HPV testing in average-risk women younger than 30 years. Best Practice Advice 6: Clinicians should stop screening average-risk women older than 65 years for cervical cancer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the most recent test performed within 5 years. Best Practice Advice 7: Clinicians should not screen average-risk women of any age for cervical cancer if they have had a hysterectomy with removal of the cervix.			Sawaya, GF (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 550 16th St,Floor 7,Box 0132, San Francisco, CA 94158 USA.			Kulasingam, Shalini/0000-0002-0932-9166; Chou, Roger/0000-0001-9889-8610	ACP operating budget	ACP operating budget	Financial support for the development of this paper comes exclusively from the ACP operating budget.	American Cancer Society, 2015, WHAT AR KEY STAT CER; [Anonymous], 2015, CHOOS WIS WEB SIT; [Anonymous], 2015, SEER STAT FACT SHEET; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Bellizzi KM, 2011, ARCH INTERN MED, V171, P2031, DOI 10.1001/archinternmed.2011.570; Berkowitz Z, 2013, JAMA INTERN MED, V173, P922, DOI 10.1001/jamainternmed.2013.368; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Castle PE, 2009, OBSTET GYNECOL, V113, P595, DOI 10.1097/AOG.0b013e3181996ffa; Centers for Disease Control and Prevention (CDC), 2014, VIT SIGNS CERV CANC; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Committee on Practice BulletinsGynecology, 2012, Obstet Gynecol, V120, P1222, DOI http://10.1097/AOG.0b013e318277c92a; Conner SN, 2014, OBSTET GYNECOL, V123, P752, DOI 10.1097/AOG.0000000000000174; Corbelli J, 2014, J WOMENS HEALTH, V23, P397, DOI 10.1089/jwh.2013.4475; Crane Joan, 2012, Evid Based Med, V17, P92, DOI 10.1136/ebm.2011.100238; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, OBSTET GYNECOL, V103, P619, DOI 10.1097/01.AOG.0000120143.50098.c7; Grimm C, 2012, OBSTET GYNECOL, V120, P152, DOI 10.1097/AOG.0b013e31825bc6e8; Henderson JT, 2013, PREV MED, V56, P25, DOI 10.1016/j.ypmed.2012.10.025; Hill DA, 2012, OBSTET GYNECOL, V119, P227, DOI 10.1097/AOG.0b013e3182426275; Howard M, 2009, CANCER CAUSE CONTROL, V20, P1, DOI 10.1007/s10552-008-9228-4; Howlader N, 2013, SEER CANC STAT REV 1; Huang AJ, 2008, J GEN INTERN MED, V23, P1324, DOI 10.1007/s11606-008-0633-x; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Kim JJ, 2013, JAMA INTERN MED, V173, P241, DOI 10.1001/2013.jamainternmed.1034; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Kulasingam SL, 2013, J LOW GENIT TRACT DI, V17, P193, DOI 10.1097/LGT.0b013e3182616241; Kulasingam SL, 2011, AHRQ PUBLICATION; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Martin-Hirsch PPL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001421.pub3; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Mathias JS, 2012, J AM MED INFORM ASSN, V19, pE96, DOI 10.1136/amiajnl-2011-000536; Meissner HI, 2010, MED CARE, V48, P249, DOI 10.1097/MLR.0b013e3181ca4015; Merrill RM, 2008, MED SCI MONITOR, V14, pCR24; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Patel Divya A, 2013, J Registry Manag, V40, P84; Perkins RB, 2012, OBSTET GYNECOL, V119, P1157, DOI 10.1097/AOG.0b013e31824e9f2f; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Roland KB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.001; Saint M, 2005, AM J OBSTET GYNECOL, V192, P414, DOI 10.1016/j.ajog.2004.09.026; Saraiya M, 2010, ARCH INTERN MED, V170, P977, DOI 10.1001/archinternmed.2010.134; Saraiya M, 2010, AM J MANAG CARE, V16, pE137; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Sawaya GF, 2008, ANN INTERN MED, V148, P557, DOI 10.7326/0003-4819-148-7-200804010-00013; Sawaya GF, 2015, OBSTET GYNECOL, V125, P308, DOI 10.1097/AOG.0000000000000670; Sawaya GF, 2004, ARCH INTERN MED, V164, P243, DOI 10.1001/archinte.164.3.243; Schiffman M, 2013, NEW ENGL J MED, V369, P2324, DOI 10.1056/NEJMcp1210379; Schleifer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052552; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sharp L, 2009, BJOG-INT J OBSTET GY, V116, P1506, DOI 10.1111/j.1471-0528.2009.02263.x; Sirovich BE, 2005, AM J MED, V118, P151, DOI 10.1016/j.amjmed.2004.08.021; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Uygur D, 2012, J AM BOARD FAM MED, V25, P798, DOI 10.3122/jabfm.2012.06.120021; Vesco K, 2011, AHRQ PUBLICATION; Watson M, 2013, MMWR-MORBID MORTAL W, V61, P1043; Weitlauf JC, 2010, J WOMENS HEALTH, V19, P1271, DOI 10.1089/jwh.2009.1673; White P, 2013, J LOW GENIT TRACT DI, V17, P175, DOI 10.1097/LGT.0b013e3182607137; Wright TC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.024	64	49	51	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					851	+		10.7326/M14-2426	http://dx.doi.org/10.7326/M14-2426			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	25928075				2022-12-28	WOS:000356516300020
J	Nicenboim, J; Malkinson, G; Lupo, T; Asaf, L; Sela, Y; Mayseless, O; Gibbs-Bar, L; Senderovich, N; Hashimshony, T; Shin, M; Jerafi-Vider, A; Avraham-Davidi, I; Krupalnik, V; Hofi, R; Almog, G; Astin, JW; Golani, O; Ben-Dor, S; Crosier, PS; Herzog, W; Lawson, ND; Hanna, JH; Yanai, I; Yaniv, K				Nicenboim, J.; Malkinson, G.; Lupo, T.; Asaf, L.; Sela, Y.; Mayseless, O.; Gibbs-Bar, L.; Senderovich, N.; Hashimshony, T.; Shin, M.; Jerafi-Vider, A.; Avraham-Davidi, I.; Krupalnik, V.; Hofi, R.; Almog, G.; Astin, J. W.; Golani, O.; Ben-Dor, S.; Crosier, P. S.; Herzog, W.; Lawson, N. D.; Hanna, J. H.; Yanai, I.; Yaniv, K.			Lymphatic vessels arise from specialized angioblasts within a venous niche	NATURE			English	Article							ACTS DOWNSTREAM; GENE-EXPRESSION; BETA-CATENIN; STEM-CELLS; COUP-TFII; ZEBRAFISH; MECHANISMS; REVEALS; ORIGIN; PROX1	How cells acquire their fate is a fundamental question in developmental and regenerative biology. Multipotent progenitors undergo cell-fate restriction in response to cues from the microenvironment, the nature of which is poorly understood. In the case of the lymphatic system, venous cells from the cardinal vein are thought to generate lymphatic vessels through trans-differentiation. Here we show that in zebrafish, lymphatic progenitors arise from a previously uncharacterized niche of specialized angioblasts within the cardinal vein, which also generates arterial and venous fates. We further identify Wnt5b as a novel lymphatic inductive signal and show that it also promotes the 'angioblast-to-lymphatic' transition in human embryonic stem cells, suggesting that this process is evolutionarily conserved. Our results uncover a novel mechanism of lymphatic specification, and provide the first characterization of the lymphatic inductive niche. More broadly, our findings highlight the cardinal vein as a heterogeneous structure, analogous to the haematopoietic niche in the aortic floor.	[Nicenboim, J.; Malkinson, G.; Lupo, T.; Asaf, L.; Sela, Y.; Mayseless, O.; Gibbs-Bar, L.; Jerafi-Vider, A.; Avraham-Davidi, I.; Hofi, R.; Almog, G.; Yaniv, K.] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel; [Senderovich, N.; Hashimshony, T.; Yanai, I.] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Shin, M.; Lawson, N. D.] Univ Massachusetts Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Krupalnik, V.; Hanna, J. H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Astin, J. W.; Crosier, P. S.] Univ Auckland, Sch Med Sci, Auckland 1142, New Zealand; [Golani, O.; Ben-Dor, S.] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Herzog, W.] Univ Munster, D-48149 Munster, Germany; [Herzog, W.] Max Plank Inst Mol Biomed, D-48149 Munster, Germany	Weizmann Institute of Science; Technion Israel Institute of Technology; University of Massachusetts System; University of Massachusetts Worcester; Weizmann Institute of Science; University of Auckland; Weizmann Institute of Science; University of Munster; Max Planck Society	Yaniv, K (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.	karina.yaniv@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019; Hanna, Jacob/K-1339-2012	BEN-DOR, SHIFRA/0000-0001-9604-1939; Hanna, Jacob/0000-0003-2042-9974; Herzog, Wiebke/0000-0002-9843-3458; Mayseless, Oded/0000-0002-9556-8541; Astin, Jonathan/0000-0002-3554-0133; Moss, Lihee/0000-0003-1111-8699; Lawson, Nathan/0000-0001-7788-9619; Malkinson, Guy/0000-0001-7339-3659	Marie Curie Actions-International Reintegration grants [FP7-PEOPLE-2009-RG 256393]; Minerva Foundation [711128]; German-Israeli Foundation [1967/2009]; Israel Cancer Research Foundation; Lymphatic Research and Education Network; Northrine Westphalia Return fellowship; US National Institutes of Health (NIH) [R01 HL122599]; JSPS; ERC [310927]; Karen Siem Fellowship for Women in Science; Willner Family Center for Vascular Biology; estate of Paul Ourieff; Carolito Stiftung; Adelis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122599] Funding Source: NIH RePORTER	Marie Curie Actions-International Reintegration grants; Minerva Foundation; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Cancer Research Foundation; Lymphatic Research and Education Network; Northrine Westphalia Return fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERC(European Research Council (ERC)European Commission); Karen Siem Fellowship for Women in Science; Willner Family Center for Vascular Biology; estate of Paul Ourieff; Carolito Stiftung; Adelis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank B. Cohen, N. Strasser, R. Solomon and F. Bochner for technical assistance, N. Stettner and A. Harmelin for animal care, G. Beck and E. Ainbinder for assistance with hESC experiments, E. Winter for RNA-Seq analyses, F. Argenton for providing the Tg(7xTCF-Xla.Siam:nlsmCherry)<SUP>ia5</SUP> transgenic line, G. Weidinger for the Tg(hsp70l:wnt5b-GFP)<SUP>w33</SUP> line, E. Ober for the TgBAC(prox1a:KalT4-UAS:uncTagRFP)<SUP>nim5</SUP> line, S. Schulte-Merker for the Tg(flt4BAC:mCitrine)<SUP>hu7135</SUP> line, S. Sumanas for the Tg(etv2:GFP)<SUP>ci1</SUP> line, M. Affolter and H. G. Belting for the Tg(fli1:gal4<SUP>ubs3</SUP>;uasKaede<SUP>rk8</SUP>) line, A. Inbal for the pCS2-axin plasmid, B. Weinstein for the pME-nr2f2 plasmid and the cas mutants, M. Beltrame for the pCMV sox18 plasmid, and E. Tzahor, E. Zelzer, M. Neeman and B. Shilo for critical reading of the manuscript. The authors are grateful to all the members of the Yaniv laboratory for discussion, technical assistance and continuous support. This work was supported in part by Marie Curie Actions-International Reintegration grants FP7-PEOPLE-2009-RG 256393 (to K.Y.), Minerva Foundation 711128 (to K.Y.), German-Israeli Foundation Young Investigator Program 1967/2009 (to K.Y.), Israel Cancer Research Foundation Postdoctoral Fellowship (to G.M.), Lymphatic Research and Education Network postdoctoral fellowship (to G.M.), Northrine Westphalia Return fellowship (to W.H.), US National Institutes of Health (NIH) R01 HL122599 (to N.D.L.), JSPS Postdoctoral Fellowships for Research Abroad (to M.S.), ERC 310927 (to I.Y.). K.Y. is supported by the Karen Siem Fellowship for Women in Science; the Willner Family Center for Vascular Biology; the estate of Paul Ourieff; the Carolito Stiftung; Lois Rosen, Los Angeles, CA; and the Adelis Foundation. K.Y. is the incumbent of the Louis and Ida Rich Career Development Chair.	Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Cermenati S, 2013, ARTERIOSCL THROM VAS, V33, P1238, DOI 10.1161/ATVBAHA.112.300254; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dunworth WP, 2014, CIRC RES, V114, P56, DOI 10.1161/CIRCRESAHA.114.302452; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Huntington GS, 1910, AM J ANAT, V10, P177, DOI 10.1002/aja.1000100108; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kim HJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-23; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Levin M, 2004, J BIOCHEM BIOPH METH, V58, P85, DOI 10.1016/S0165-022X(03)00149-0; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Lim AH, 2011, DEVELOPMENT, V138, P3847, DOI 10.1242/dev.068403; Lindskog H, 2014, DEVELOPMENT, V141, P1120, DOI 10.1242/dev.101808; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Nyholm MK, 2007, DEVELOPMENT, V134, P735, DOI 10.1242/dev.02756; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Okuda KS, 2012, DEVELOPMENT, V139, P2381, DOI 10.1242/dev.077701; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; van Impel A, 2014, DEVELOPMENT, V141, P1228, DOI 10.1242/dev.105031; Vatine GD, 2013, J BIOL CHEM, V288, P169, DOI 10.1074/jbc.M112.413831; Veien ES, 2005, DEV DYNAM, V233, P233, DOI 10.1002/dvdy.20330; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wilting Jorg, 2003, Lymphat Res Biol, V1, P33, DOI 10.1089/15396850360495673; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	60	140	144	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					56	U100		10.1038/nature14425	http://dx.doi.org/10.1038/nature14425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25992545				2022-12-28	WOS:000355543400028
J	Cusanovich, DA; Daza, R; Adey, A; Pliner, HA; Christiansen, L; Gunderson, KL; Steemers, FJ; Trapnell, C; Shendure, J				Cusanovich, Darren A.; Daza, Riza; Adey, Andrew; Pliner, Hannah A.; Christiansen, Lena; Gunderson, Kevin L.; Steemers, Frank J.; Trapnell, Cole; Shendure, Jay			Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing	SCIENCE			English	Article							RNA-SEQ; HUMAN GENOME; IN-VITRO; TRANSPOSITION; CONTIGUITY; EXPRESSION; FATE	Technical advances have enabled the collection of genome and transcriptome data sets with single-cell resolution. However, single-cell characterization of the epigenome has remained challenging. Furthermore, because cells must be physically separated before biochemical processing, conventional single-cell preparatory methods scale linearly. We applied combinatorial cellular indexing to measure chromatin accessibility in thousands of single cells per assay, circumventing the need for compartmentalization of individual cells. We report chromatin accessibility profiles from more than 15,000 single cells and use these data to cluster cells on the basis of chromatin accessibility landscapes. We identify modules of coordinately regulated chromatin accessibility at the level of single cells both between and within cell types, with a scalable method that may accelerate progress toward a human cell atlas.	[Cusanovich, Darren A.; Daza, Riza; Pliner, Hannah A.; Trapnell, Cole; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Adey, Andrew] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Christiansen, Lena; Gunderson, Kevin L.; Steemers, Frank J.] Illumina Inc, Adv Res Grp, San Diego, CA USA	University of Washington; University of Washington Seattle; Oregon Health & Science University; Illumina	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Horwitz, Marshall/AAE-8376-2021; wang, edwin/G-5372-2010; Daza, Riza M./HCH-4047-2022; Pliner, Hannah Andersen/F-3608-2015	Cusanovich, Darren/0000-0001-6889-0095; Pliner, Hannah Andersen/0000-0003-1484-6501	NIH [1DP1HG007811]; Paul G. Allen Family Foundation; Damon Runyon Cancer Research Foundation (DFS) [10-14]; Illumina, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283, DP1HG007811] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; Damon Runyon Cancer Research Foundation (DFS); Illumina, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Trapnell and Shendure laboratories, particularly R. Hause, C. Lee, V. Ramani, R. Qiu, Z. Duan, and J. Kitzman, for helpful discussions; D. Prunkard, J. Fredrickson, and L. Gitari in the Rabinovitch laboratory for their exceptional assistance in flow sorting; and C. Disteche for the Patski cell line. This work was funded by an NIH Director's Pioneer Award (1DP1HG007811 to J.S.) and a grant from the Paul G. Allen Family Foundation (J.S.). C.T. is supported in part by the Damon Runyon Cancer Research Foundation (DFS-#10-14). All sequencing data are available from the NIH National Center for Biotechnology Information Gene Expression Omnibus (accession number GSE68103). L.C., K.L.G., and F.J.S. declare competing financial interests in the form of stock ownership and paid employment by Illumina, Inc. One or more embodiments of one or more patents and patent applications filed by Illumina may encompass the methods, reagents, and data disclosed in this manuscript. All methods for making the transposase complexes are described in (18); however, Illumina will provide transposase complexes in response to reasonable requests from the scientific community subject to a material transfer agreement. Some work in this study is related to technology described in patent applications WO2014142850, 2014/0194324, 2010/0120098, 2011/0287435, 2013/0196860, and 2012/0208705.	Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pan Xinghua, 2014, Single Cell Biol, V3; Regev A., THE HUMAN CELL ATLAS; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	22	590	654	7	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					910	914		10.1126/science.aab1601	http://dx.doi.org/10.1126/science.aab1601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25953818	Green Accepted			2022-12-28	WOS:000354877900044
J	Kerlikowske, K; Zhu, WW; Tosteson, ANA; Sprague, BL; Tice, JA; Lehman, CD; Miglioretti, DL				Kerlikowske, Karla; Zhu, Weiwei; Tosteson, Anna N. A.; Sprague, Brian L.; Tice, Jeffrey A.; Lehman, Constance D.; Miglioretti, Diana L.		Breast Canc Surveillance	Identifying Women With Dense Breasts at High Risk for Interval Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; SCREENING MAMMOGRAPHY; DIGITAL MAMMOGRAPHY; TOMOSYNTHESIS; PERFORMANCE; ULTRASOUND; OUTCOMES; VALIDATION; FILM; AGE	Background: Twenty-one states have laws requiring that women be notified if they have dense breasts and that they be advised to discuss supplemental imaging with their provider. Objective: To better direct discussions of supplemental imaging by determining which combinations of breast cancer risk and Breast Imaging Reporting and Data System (BI-RADS) breast density categories are associated with high interval cancer rates. Design: Prospective cohort. Setting: Breast Cancer Surveillance Consortium (BCSC) breast imaging facilities. Patients: 365 426 women aged 40 to 74 years who had 831 455 digital screening mammography examinations. Measurements: BI-RADS breast density, BCSC 5-year breast cancer risk, and interval cancer rate (invasive cancer <= 12 months after a normal mammography result) per 1000 mammography examinations. High interval cancer rate was defined as more than 1 case per 1000 examinations. Results: High interval cancer rates were observed for women with 5-year risk of 1.67% or greater and extremely dense breasts or 5-year risk of 2.50% or greater and heterogeneously dense breasts (24% of all women with dense breasts). The interval rate of advanced-stage disease was highest (> 0.4 case per 1000 examinations) among women with 5-year risk of 2.50% or greater and heterogeneously or extremely dense breasts (21% of all women with dense breasts). Five-year risk was low to average (0% to 1.66%) for 51.0% of women with heterogeneously dense breasts and 52.5% with extremely dense breasts, with interval cancer rates of 0.58 to 0.63 and 0.72 to 0.89 case per 1000 examinations, respectively. Limitation: The benefit of supplemental imaging was not assessed. Conclusion: Breast density should not be the sole criterion for deciding whether supplemental imaging is justified because not all women with dense breasts have high interval cancer rates. BCSC 5-year risk combined with BI-RADS breast density can identify women at high risk for interval cancer to inform patientprovider discussions about alternative screening strategies.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA 98109 USA; Geisel Sch Med Dartmouth, Lebanon, NH 03756 USA; Univ Vermont, Burlington, VT USA; Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California San Francisco; Group Health Cooperative; University of Washington; University of Washington Seattle; Dartmouth College; University of Vermont; University of California System; University of California Davis	Kerlikowske, K (corresponding author), San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.			Tice, Jeffrey/0000-0002-9857-2028	National Cancer Institute [P01 CA154292, HHSN261201100031C, U54 CA163303]; NATIONAL CANCER INSTITUTE [P30CA093373, P01CA154292, U54CA163303, P30CA023108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute-funded BCSC (P01 CA154292, HHSN261201100031C, and U54 CA163303). The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. A full description of these sources is available at http://breastscreening.cancer.gov/work/acknowledgement.html.	American College of Radiology (ACR), 2003, ILL BREAST IM REP DA; American Joint Committee on Cancer, 2002, MANUAL STAGING CANC; Antoni S, 2013, BREAST CANCER RES TR, V137, P337, DOI 10.1007/s10549-012-2362-4; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Bertrand KA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3570; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Drukker CA, 2014, BREAST CANCER RES TR, V144, P103, DOI 10.1007/s10549-013-2830-5; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Hooley RJ, 2012, RADIOLOGY, V265, P59, DOI 10.1148/radiol.12120621; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Kerlikowske K, 2010, J CLIN ONCOL, V28, P3830, DOI 10.1200/JCO.2009.26.4770; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McCarthy AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju316; Nederend J, 2014, EUR J CANCER, V50, P31, DOI 10.1016/j.ejca.2013.09.018; Nothacker M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-335; Parris T, 2013, BREAST J, V19, P64, DOI 10.1111/tbj.12053; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Saadatmand S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-440; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Vachon CM, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju397; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Weigert J, 2012, BREAST J, V18, P517, DOI 10.1111/tbj.12003; Yaghjyan L, 2011, J NATL CANCER I, V103, P1179, DOI 10.1093/jnci/djr225; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048	40	169	171	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					673	+		10.7326/M14-1465	http://dx.doi.org/10.7326/M14-1465			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984843	Green Accepted			2022-12-28	WOS:000355015200016
J	Molyneaux, E; Trevillion, K; Howard, LM				Molyneaux, Emma; Trevillion, Kylee; Howard, Louise M.			Antidepressant Treatment for Postnatal Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Are antidepressants associated with improved outcomes for postnatal depression? BOTTOM LINE Compared with placebo, selective serotonin reuptake inhibitors (SSRIs) are associated with better response and remission rates for postnatal depression. However, few studies included women with severe depression or suicidal ideation. There are insufficient data to conclude whether antidepressants are associated with better outcomes than psychological interventions.	[Molyneaux, Emma; Trevillion, Kylee; Howard, Louise M.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England	University of London; King's College London	Howard, LM (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, PO31 De Crespigny Pk, London SE5 8AF, England.	louise.howard@kcl.ac.uk	Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; Molyneaux, Emma/0000-0002-0696-5511	Department of Health [NIHR-RP-R3-12-011] Funding Source: Medline	Department of Health		Howard LM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7394; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Molyneaux E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002018.pub2	3	12	13	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1965	1966		10.1001/jama.2015.2276	http://dx.doi.org/10.1001/jama.2015.2276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988466	Green Accepted			2022-12-28	WOS:000354691200018
J	Costello, RC; Whittet, CR; Browning, ST				Costello, R. C.; Whittet, C. R.; Browning, S. T.			CASE REVIEW A puzzling airway problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOREIGN-BODY ASPIRATION; DIAGNOSIS; BODIES		[Costello, R. C.; Browning, S. T.] Singleton Hosp, Ear Nose & Throat Dept, Swansea SA2 8QA, W Glam, Wales; [Whittet, C. R.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Singleton Hospital; Cardiff University	Costello, RC (corresponding author), Singleton Hosp, Ear Nose & Throat Dept, Swansea SA2 8QA, W Glam, Wales.	RCCostello@me.com						ABDULMAJID O, 1976, THORAX, V31, P635, DOI 10.1136/thx.31.6.635; Blair D, 2014, INT J PEDIATR OTORHI, V78, P2262, DOI 10.1016/j.ijporl.2014.10.029; Chiu CY, 2005, PEDIATR EMERG CARE, V21, P161; Couriel J, 2002, BRIT MED BULL, V61, P115, DOI 10.1093/bmb/61.1.115; Diaz G A, 2000, Bol Asoc Med P R, V92, P124; Passali D, 2010, ACTA OTORHINOLARYNGO, V30, P27; Reilly J, 1997, LARYNGOSCOPE, V107, P17, DOI 10.1097/00005537-199701000-00006; Rovin J D, 2000, Pediatr Rev, V21, P86; Warshawsky ME, MEDSCAPE; WISEMAN NE, 1984, J PEDIATR SURG, V19, P531, DOI 10.1016/S0022-3468(84)80097-4	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2015	350								h2250	10.1136/bmj.h2250	http://dx.doi.org/10.1136/bmj.h2250			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YL	25985330				2022-12-28	WOS:000355126800001
J	Bogaards, JA; Wallinga, J; Brakenhoff, RH; Meijer, CJLM; Berkhof, J				Bogaards, Johannes A.; Wallinga, Jacco; Brakenhoff, Ruud H.; Meijer, Chris J. L. M.; Berkhof, Johannes			Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK HUMAN-PAPILLOMAVIRUS; SQUAMOUS-CELL CARCINOMAS; AGE-SPECIFIC PREVALENCE; HPV VACCINATION; ANAL CANCER; COST-EFFECTIVENESS; HEPATITIS-B; ORAL-CAVITY; INFECTION; MEN	OBJECTIVE To assess the reduction in the vaccine preventable burden of cancer in men if boys are vaccinated along with girls against oncogenic human papillomavirus (HPV). DESIGN Bayesian evidence synthesis approach used to evaluate the impact of vaccination against HPV types 16 and 18 on the burden of anal, penile, and oropharyngeal carcinomas among heterosexual men and men who have sex with men. The reduced transmission of vaccine-type HPV from vaccination of girls was assumed to lower the risk of HPV associated cancer in all men but not to affect the excess risk of HPV associated cancers among men who have sex with men. SETTING General population in the Netherlands. INTERVENTION Inclusion of boys aged 12 into HPV vaccination programmes. MAIN OUTCOME MEASURES Quality adjusted life years (QALYs) and numbers needed to vaccinate. RESULTS Before HPV vaccination, 14.9 (95% credible interval 12.2 to 18.1) QALYs per thousand men were lost to vaccine preventable cancers associated with HPV in the Netherlands. This burden would be reduced by 37% (28% to 48%) if the vaccine uptake among girls remains at the current level of 60%. To prevent one additional case of cancer among men, 795 boys (660 to 987) would need to be vaccinated; with tumour specific numbers for anal, penile, and oropharyngeal cancer of 2162, 3486, and 1975, respectively. The burden of HPV related cancer in men would be reduced by 66% (53% to 805) if vaccine uptake among girls increases to 90%. In that case, 1735 boys (1240 to 2900) would need to be vaccinated to prevent an additional case; with tumour specific numbers for anal, penile, and oropharyngeal cancer of 2593, 29107, and 6484, respectively. CONCLUSIONS Men will benefit indirectly from vaccination of girls but remain at risk of cancers associated with HPV. The incremental benefit of vaccinating boys when vaccine uptake among girls is high is driven by the prevention of anal carcinomas, which underscores the relevance of HPV prevention efforts for men who have sex with men.	[Bogaards, Johannes A.; Berkhof, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; [Bogaards, Johannes A.; Wallinga, Jacco] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Brakenhoff, Ruud H.] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands; [Meijer, Chris J. L. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bogaards, JA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, POB 7057, NL-1007 MB Amsterdam, Netherlands.	hans.bogaards@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627; Bogaards, Johannes/0000-0002-3389-5141	EU Seventh Framework Programme of DG Research through the PREHDICT project; EU Seventh Framework Programme of DG Research through COHEAHR project; Health Research and Development Council of the Netherlands Organization for Scientific Research [ZonMW 121030032]	EU Seventh Framework Programme of DG Research through the PREHDICT project; EU Seventh Framework Programme of DG Research through COHEAHR project; Health Research and Development Council of the Netherlands Organization for Scientific Research	This research was supported by the EU Seventh Framework Programme of DG Research through the PREHDICT and COHEAHR projects, which received co-funding by the Health Research and Development Council of the Netherlands Organization for Scientific Research (ZonMW 121030032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker F, 2006, SEXUAL HLTH NETHERLA; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Burger EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089974; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4127; Centers for Disease C Prevention, 2011, MMWR MORB MORTAL WKL, V60, P1705; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Conway EL, 2012, SEX TRANSM INFECT, V88, P517, DOI 10.1136/sextrans-2011-050161; Coupe VMH, 2009, INT J CANCER, V124, P970, DOI 10.1002/ijc.24000; Cuschieri K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4921; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; de Melker Hester, 2012, Ned Tijdschr Geneeskd, V156, pA5410; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Del Amo J, 2013, J INFECT DIS, V207, P1235, DOI 10.1093/infdis/jit028; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2011, INT J CANCER, V128, P2765, DOI 10.1002/ijc.25915; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Georgousakis M, 2012, LANCET INFECT DIS, V12, P627, DOI 10.1016/S1473-3099(12)70031-2; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Herrero R, 2013, PLOS ONE; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; Hibbitts S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4928; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Kirby T, 2012, LANCET ONCOL, V13, pE333, DOI 10.1016/S1470-2045(12)70328-5; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Laprise JF, 2014, VACCINE, V32, P5845, DOI 10.1016/j.vaccine.2014.07.099; Lawton MD, 2013, SEX TRANSM INFECT, V89, P342, DOI 10.1136/sextrans-2013-051176; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Lont AP, 2006, INT J CANCER, V119, P1078, DOI 10.1002/ijc.21961; Low GMI, 2012, VIRAL IMMUNOL, V25, P174, DOI 10.1089/vim.2011.0083; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McDonald SA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1046; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; O'Rorke MA, 2012, ORAL ONCOL, V48, P1191, DOI 10.1016/j.oraloncology.2012.06.019; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Reuschenbach M, 2013, ORAL ONCOL, V49, P937, DOI 10.1016/j.oraloncology.2013.03.451; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; Stanley M, 2012, NATURE, V488, pS10, DOI 10.1038/488S10a; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; van der Loeff MFS, 2014, CURR HIV-AIDS REP, V11, P250, DOI 10.1007/s11904-014-0224-x; van Rijckevorsel G, 2013, J HEPATOL, V59, P1177, DOI 10.1016/j.jhep.2013.08.002; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Vogt SL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00303; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696	71	52	55	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2015	350								h2016	10.1136/bmj.h2016	http://dx.doi.org/10.1136/bmj.h2016			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BX	25985328	hybrid, Green Published			2022-12-28	WOS:000354769000001
J	Krol, J; Roska, B				Krol, Jacek; Roska, Botond			Rods Feed Cones to Keep them Alive	CELL			English	Editorial Material							NEURONAL SURVIVAL	Cone photoreceptors, responsible for high-resolution and color vision, progressively degenerate following the death of rod photoreceptors in the blinding disease retinitis pigmentosa. Ait-Ali et al. describe a molecular mechanism by which RdCVF, a factor normally released by rods, controls glucose entry into cones, enhancing their survival.	[Krol, Jacek; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Roska, Botond] Univ Basel, Fac Med, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Geneva	Krol, J (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	jacek.krol@fmi.ch; botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021					Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Venkatesh A, 2015, J CLIN INVEST, V125, P1446, DOI 10.1172/JCI79766; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735	9	9	10	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					706	708		10.1016/j.cell.2015.04.031	http://dx.doi.org/10.1016/j.cell.2015.04.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957678	Bronze			2022-12-28	WOS:000354175200004
J	Rosenbaum, L				Rosenbaum, Lisa			Conflicts of Interest - Part 1 Reconnecting the Dots - Reinterpreting Industry-Physician Relations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Abramson JD, 2013, NY TIMES; Abramson JD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3329; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], 2001, MVX VIOXX DWA USHH F; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Stolberg S. G., 1999, NY TIMES MAGAZINE; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thomas K., 2012, NY TIMES; Wilson RF, 2010, AM J LAW MED, V36, P295, DOI 10.1177/009885881003600202; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	12	82	83	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1860	1864		10.1056/NEJMms1502493	http://dx.doi.org/10.1056/NEJMms1502493			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946288				2022-12-28	WOS:000353974700017
J	Perkisas, SMT; Vandewoude, MFJ				Perkisas, Stany M. T.; Vandewoude, Maurits F. J.			Ramelteon for Prevention of Delirium in Hospitalized Older Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; ELDERLY-PEOPLE; ANTIPSYCHOTICS; DEMENTIA	IMPORTANCE No highly effective interventions to prevent delirium have been identified. OBJECTIVE To examine whether ramelteon, a melatonin agonist, is effective for the prevention of delirium. DESIGN, SETTING, AND PARTICIPANTS A multicenter, rater-blinded, randomized placebo-controlled trial was performed in intensive care units and regular acute wards of 4 university hospitals and 1 general hospital. Eligible patients were 65 to 89 years old, newly admitted due to serious medical problems, and able to take medicine orally. Patients were excluded from the study if they had an expected stay or life expectancy of less than 48 hours. INTERVENTIONS Sixty-seven patients were randomly assigned using the sealed envelope method to receive ramelteon (8 mg/d; 33 patients) or placebo (34 patients) every night for 7 days. MAIN OUTCOMES AND MEASURES Incidence of delirium, as defined by the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). RESULTS Ramelteon was associated with a lower risk of delirium (3% vs 32%; P = .003), with a relative risk of 0.09 (95% CI, 0.01-0.69). Even after risk factors were controlled for, ramelteon was still associated with a lower incidence of delirium (P = .01; odds ratio, 0.07 [95% CI, 0.008-0.54]). The Kaplan-Meier estimates of time to development of delirium were 6.94 (95% CI, 6.82-7.06) days for ramelteon and 5.74 (5.05-6.42) days for placebo. Comparison by log-rank test showed that the frequency of delirium was significantly lower in patients taking ramelteon than in those taking placebo (chi(2) = 9.83; P = .002). CONCLUSIONS AND RELEVANCE Ramelteon administered nightly to elderly patients admitted for acute care may provide protection against delirium. This finding supports a possible pathogenic role of melatonin neurotransmission in delirium.	[Perkisas, Stany M. T.; Vandewoude, Maurits F. J.] Univ Antwerp, Dept Geriatr, Sch Med, B-2000 Antwerp, Belgium	University of Antwerp	Vandewoude, MFJ (corresponding author), Univ Antwerp, Dept Geriatr, ZNA St Elisabeth, Leopoldstr 26, B-2000 Antwerp, Belgium.	maurits.vandewoude@zna.be	Perkisas, Stany/AAZ-4532-2020	Perkisas, Stany/0000-0002-4192-327X				Al-Aama T, 2011, INT J GERIATR PSYCH, V26, P687, DOI 10.1002/gps.2582; Gareri P, 2014, J CLIN PSYCHOPHARM, V34, P109, DOI 10.1097/JCP.0b013e3182a6096e; Hatta K, 2014, JAMA PSYCHIAT, V71, P397, DOI 10.1001/jamapsychiatry.2013.3320; Howland RH, 2014, J PSYCHOSOC NURS MEN, V52, P13, DOI 10.3928/02793695-20140423-02; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Langballe EM, 2014, AM J GERIAT PSYCHIAT, V22, P321, DOI 10.1016/j.jagp.2013.06.007	6	10	10	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1745	+		10.1001/jama.2014.17394	http://dx.doi.org/10.1001/jama.2014.17394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942725	Green Published			2022-12-28	WOS:000353921000020
J	Davis, D; Brayne, C				Davis, Daniel; Brayne, Carol			Ageing, health, and social care: reframing the discussion	LANCET			English	Editorial Material									[Davis, Daniel] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Brayne, Carol] Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England	University of London; University College London; University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Cambridge Biomed Campus, Cambridge CB2 0SR, England.	cb105@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Davis, Daniel/F-9995-2012	Brayne, Carol/0000-0001-5307-663X; Davis, Daniel/0000-0002-1560-1955	Medical Research Council [MC_UU_12019/1] Funding Source: Medline; MRC [MC_UU_12019/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; British Geriatrics Society, 2015, CALL BRIT GER SOC IN; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; NHS England Care Quality Commission Public Health England Monitor NHS Trust Development Authority Health Education England, 2014, NHS 5 YEAR FORW VIEW; Oliver D., 2014, MAKING OUR HLTH CARE; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Pollock AM, 2015, LANCET, V385, P1171; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; YUDKIN JS, 2014, BMJ-BRIT MED J, V349, pNIL11, DOI [10.1136/bmj.g4485, DOI 10.1136/BMJ.G4485]	14	6	6	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1699	1700		10.1016/S0140-6736(15)60466-4	http://dx.doi.org/10.1016/S0140-6736(15)60466-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25943920	Green Accepted			2022-12-28	WOS:000353726000004
J	de la Rosette, J; Laguna, MP				de la Rosette, Jean; Laguna, M. Pilar			Ureteric colic: evidence empowers responsible treatment	LANCET			English	Editorial Material							CLINICAL-RESEARCH OFFICE; OUTCOMES; COMPLICATIONS; SILODOSIN; THERAPY; PASSAGE		[de la Rosette, Jean; Laguna, M. Pilar] AMC Univ Hosp, Dept Urol, NL-1105 AZ Amsterdam Z O, Netherlands		de la Rosette, J (corresponding author), AMC Univ Hosp, Dept Urol, NL-1105 AZ Amsterdam Z O, Netherlands.	j.j.delarosette@amc.uva.nl						Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; de la Rosette J, 2014, J ENDOUROL, V28, P131, DOI 10.1089/end.2013.0436; de la Rosette J, 2011, J ENDOUROL, V25, P11, DOI 10.1089/end.2010.0424; de la Rosette J, 2009, J ENDOUROL, V23, P1551, DOI 10.1089/end.2009.1560; Gupta S, 2013, J CLIN DIAGN RES, V7, P1672, DOI 10.7860/JCDR/2013/6141.3241; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Opondo D, 2014, J ENDOUROL, V28, P767, DOI 10.1089/end.2014.0057; Pickard R, 2015, LANCET; Preminger GM, 2007, MANAGEMENT URETERAL; Sur RL, 2015, EUR UROL, V67, P959, DOI 10.1016/j.eururo.2014.10.049	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					315	316		10.1016/S0140-6736(15)60965-5	http://dx.doi.org/10.1016/S0140-6736(15)60965-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	25998581	hybrid			2022-12-28	WOS:000358448400005
J	Arabi, YM; Aldawood, AS; Haddad, SH; Al-Dorzi, HM; Tamim, HM; Jones, G; Mehta, S; McIntyre, L; Solaiman, O; Sakkijha, MH; Sadat, M; Afesh, L				Arabi, Yaseen M.; Aldawood, Abdulaziz S.; Haddad, Samir H.; Al-Dorzi, Hasan M.; Tamim, Hani M.; Jones, Gwynne; Mehta, Sangeeta; McIntyre, Lauralyn; Solaiman, Othman; Sakkijha, Maram H.; Sadat, Musharaf; Afesh, Lara		PermiT Trial Grp	Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALORIE RESTRICTION; PARENTERAL-NUTRITION; SURGICAL-PATIENTS; CARE; INJURY; MULTICENTER; GUIDELINES; THERAPY; SUPPORT; TRIAL	BACKGROUND The appropriate caloric goal for critically ill adults is unclear. We evaluated the effect of restriction of nonprotein calories (permissive underfeeding), as compared with standard enteral feeding, on 90-day mortality among critically ill adults, with maintenance of the full recommended amount of protein in both groups. METHODS At seven centers, we randomly assigned 894 critically ill adults with a medical, surgical, or trauma admission category to permissive underfeeding (40 to 60% of calculated caloric requirements) or standard enteral feeding (70 to 100%) for up to 14 days while maintaining a similar protein intake in the two groups. The primary outcome was 90-day mortality. RESULTS Baseline characteristics were similar in the two groups; 96.8% of the patients were receiving mechanical ventilation. During the intervention period, the permissive-underfeeding group received fewer mean (+/- SD) calories than did the standard-feeding group (835 +/- 297 kcal per day vs. 1299 +/- 467 kcal per day, P< 0.001; 46 +/- 14% vs. 71 +/- 22% of caloric requirements, P< 0.001). Protein intake was similar in the two groups (57 +/- 24 g per day and 59 +/- 25 g per day, respectively; P = 0.29). The 90-day mortality was similar: 121 of 445 patients (27.2%) in the permissive-underfeeding group and 127 of 440 patients (28.9%) in the standard-feeding group died (relative risk with permissive underfeeding, 0.94; 95% confidence interval [CI], 0.76 to 1.16; P = 0.58). No serious adverse events were reported; there were no significant between-group differences with respect to feeding intolerance, diarrhea, infections acquired in the intensive care unit (ICU), or ICU or hospital length of stay. CONCLUSIONS Enteral feeding to deliver a moderate amount of nonprotein calories to critically ill adults was not associated with lower mortality than that associated with planned delivery of a full amount of nonprotein calories.	[Arabi, Yaseen M.; Aldawood, Abdulaziz S.; Haddad, Samir H.; Al-Dorzi, Hasan M.; Tamim, Hani M.; Sakkijha, Maram H.; Sadat, Musharaf; Afesh, Lara] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh 11426, Saudi Arabia; [Arabi, Yaseen M.; Aldawood, Abdulaziz S.; Haddad, Samir H.; Al-Dorzi, Hasan M.; Tamim, Hani M.; Sakkijha, Maram H.; Sadat, Musharaf; Afesh, Lara] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Solaiman, Othman] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Tamim, Hani M.] Amer Univ Beirut, Beirut Med Ctr, Dept Internal Med, Beirut, Lebanon; [Jones, Gwynne; McIntyre, Lauralyn] Univ Ottawa, Dept Med, Div Crit Care Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Mehta, Sangeeta] Univ Toronto, Interdept Div Crit Care Med, Dept Med, Div Respirol, Toronto, ON, Canada; [Mehta, Sangeeta] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Faisal Specialist Hospital & Research Center; American University of Beirut; Beirut Medical Center; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Arabi, YM (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Dept Intens Care, King Abdullah Int Med Res Ctr, ICU 1425,POB 22490, Riyadh 11426, Saudi Arabia.	arabi@ngha.med.sa	McIntyre, Lauralyn/AAR-7710-2021; Mehta, Sangeeta/C-4623-2015; Arabi, Yaseen/ABF-3316-2020	McIntyre, Lauralyn/0000-0001-7421-1407; Arabi, Yaseen/0000-0001-5735-6241; Deeb, Ahmad/0000-0002-3680-7338; Al-Dorzi, Hasan M/0000-0002-3772-8949	King Abdullah International Medical Research Center	King Abdullah International Medical Research Center	Funded by the King Abdullah International Medical Research Center; PermiT Current Controlled Trials number, ISRCTN68144998.	Ahrens CL, 2005, CRIT CARE MED, V33, P2507, DOI 10.1097/01.CCM.0000186746.64572.8A; [Anonymous], 2015, CDC NHSN SURV DEF HE; Arabi YM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-191; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; Arabi YM, 2010, JPEN-PARENTER ENTER, V34, P280, DOI 10.1177/0148607109353439; Boitano Megan, 2006, Nutr Clin Pract, V21, P617, DOI 10.1177/0115426506021006617; Briet F, 2001, AM J CLIN NUTR, V73, P975; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Charles EJ, 2014, AM J CLIN NUTR, V100, P1337, DOI 10.3945/ajcn.114.088609; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Dickerson RN, 2002, NUTRITION, V18, P241, DOI 10.1016/S0899-9007(01)00793-6; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Frankenfield D, 2004, JPEN-PARENTER ENTER, V28, P259, DOI 10.1177/0148607104028004259; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; IRETON-JONES C S, 1992, Journal of Burn Care and Rehabilitation, V13, P330, DOI 10.1097/00004630-199205000-00005; Klein J A, 1996, Nutr Clin Pract, V11, P206, DOI 10.1177/0115426596011005206; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krishnan JA, 2003, CHEST, V124, P297, DOI 10.1378/chest.124.1.297; Lempiainen J, 2013, ACTA PHYSIOL, V208, P410, DOI 10.1111/apha.12120; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; McCowen KC, 2000, CRIT CARE MED, V28, P3606, DOI 10.1097/00003246-200011000-00007; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Ning YC, 2013, NEPHRON EXP NEPHROL, V124, P19, DOI 10.1159/000357380; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, CRIT CARE MED, V39, P967, DOI 10.1097/CCM.0b013e31820a905a; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Singer P, 2014, CLIN NUTR, V33, P246, DOI 10.1016/j.clnu.2013.12.004; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walker RN, 2009, RESP CARE, V54, P509; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0591-0	40	346	377	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2398	2408		10.1056/NEJMoa1502826	http://dx.doi.org/10.1056/NEJMoa1502826			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	25992505				2022-12-28	WOS:000356354600006
J	Yatsenko, AN; Georgiadis, AP; Ropke, A; Berman, AJ; Jaffe, T; Olszewska, M; Westernstroer, B; Sanfilippo, J; Kurpisz, M; Rajkovic, A; Yatsenko, SA; Kliesch, S; Schlatt, S; Tuttelmann, F				Yatsenko, Alexander N.; Georgiadis, Andrew P.; Roepke, Albrecht; Berman, Andrea J.; Jaffe, Thomas; Olszewska, Marta; Westernstroeer, Birgit; Sanfilippo, Joseph; Kurpisz, Maciej; Rajkovic, Aleksandar; Yatsenko, Svetlana A.; Kliesch, Sabine; Schlatt, Stefan; Tuettelmann, Frank			X-Linked TEX11 Mutations, Meiotic Arrest, and Azoospermia in Infertile Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-STRUCTURE; I-TASSER; ASSOCIATION; VARIANTS; SERVER; AGE	BACKGROUND The genetic basis of nonobstructive azoospermia is unknown in the majority of infertile men. METHODS We performed array comparative genomic hybridization testing in blood samples obtained from 15 patients with azoospermia, and we performed mutation screening by means of direct Sanger sequencing of the testis-expressed 11 gene (TEX11) open reading frame in blood and semen samples obtained from 289 patients with azoospermia and 384 controls. RESULTS We identified a 99-kb hemizygous loss on chromosome Xq13.2 that involved three TEX11 exons. This loss, which was identical in 2 patients with azoospermia, predicts a deletion of 79 amino acids within the meiosis-specific sporulation domain SPO22. Our subsequent mutation screening showed five novel TEX11 mutations: three splicing mutations and two missense mutations. These mutations, which occurred in 7 of 289 men with azoospermia (2.4%), were absent in 384 controls with normal sperm concentrations (P = 0.003). Notably, five of those TEX11 mutations were detected in 33 patients (15%) with azoospermia who received a diagnosis of azoospermia with meiotic arrest. Meiotic arrest in these patients resembled the phenotype of Tex11-deficient male mice. Immunohistochemical analysis showed specific cytoplasmic TEX11 expression in late spermatocytes, as well as in round and elongated spermatids, in normal human testes. In contrast, testes of patients who had azoospermia with TEX11 mutations had meiotic arrest and lacked TEX11 expression. CONCLUSIONS In our study, hemizygous TEX11 mutations were a common cause of meiotic arrest and azoospermia in infertile men. (Funded by the National Institutes of Health and others.)	[Yatsenko, Alexander N.; Georgiadis, Andrew P.; Sanfilippo, Joseph; Rajkovic, Aleksandar; Yatsenko, Svetlana A.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Jaffe, Thomas] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15213 USA; [Berman, Andrea J.] Univ Pittsburgh, Kenneth P Dietrich Sch Arts & Sci, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Roepke, Albrecht; Tuettelmann, Frank] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Westernstroeer, Birgit; Kliesch, Sabine; Schlatt, Stefan] Univ Munster, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Olszewska, Marta; Kurpisz, Maciej] Polish Acad Sci, Inst Human Genet, Dept Reprod Biol & Stem Cells, PL-60479 Poznan, Poland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munster; University of Munster; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Yatsenko, AN (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, 204 Craft Ave,Rm A206, Pittsburgh, PA 15213 USA.	yatsenkoan@mwri.magee.edu; frank.tuettelmann@ukmuenster.de	Tüttelmann, Frank/ABH-8185-2020; Olszewska, Marta/ABD-3226-2020	Tüttelmann, Frank/0000-0003-2745-9965; Olszewska, Marta/0000-0002-2337-4545; Kurpisz, Maciej/0000-0003-3275-3245; Yatsenko, Alexander/0000-0002-1690-0172	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080755, K08HD058073] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adelman CA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000042; American Urological Association, 2011, EV AZ MAL AUA BEST P; Archer NP, 2007, BIRTH DEFECTS RES A, V79, P27, DOI 10.1002/bdra.20316; Aston KI, 2012, SYST BIOL REPROD MED, V58, P71, DOI 10.3109/19396368.2011.635751; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Hu ZB, 2012, NAT GENET, V44, P183, DOI 10.1038/ng.1040; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Imken L, 2009, MOL HUM REPROD, V15, P733, DOI 10.1093/molehr/gap056; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lee JY, 2011, UROLOGY, V77, P598, DOI 10.1016/j.urology.2010.10.001; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Madden HR, 2009, HUM MUTAT, V30, P22, DOI 10.1002/humu.20806; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Mou LS, 2013, HUM GENET, V132, P159, DOI 10.1007/s00439-012-1234-7; Muhle Christiane, 2007, Hum Mutat, V28, P1045, DOI 10.1002/humu.9506; Nieschlag E, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P1, DOI 10.1007/978-3-540-78355-8; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Pan JY, 2009, DEV BIOL, V330, P167, DOI 10.1016/j.ydbio.2009.03.022; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ropke A, 2013, EUR J HUM GENET, V21, P1012, DOI 10.1038/ejhg.2012.290; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tang Lin, 2011, Spermatogenesis, V1, P147, DOI 10.4161/spmg.1.2.16680; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; Tuttelmann F, 2011, INT J ANDROL, V34, P291, DOI 10.1111/j.1365-2605.2010.01087.x; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; World Health Organization, 2010, WHO LAB MAN EX PROC, P56; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao H, 2012, AM J HUM GENET, V90, P900, DOI 10.1016/j.ajhg.2012.04.001	39	184	192	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2097	2107		10.1056/NEJMoa1406192	http://dx.doi.org/10.1056/NEJMoa1406192			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	25970010	Green Accepted			2022-12-28	WOS:000355146800005
J	Ataya, A; Harman, E				Ataya, Ali; Harman, Eloise			Hemichoreoathetosis in Neurosarcoidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ataya, Ali] Univ Florida, Gainesville, FL 32611 USA; [Harman, Eloise] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA	State University System of Florida; University of Florida	Ataya, A (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	aliataya@gmail.com		Ataya, Ali/0000-0001-8505-1680					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21							e27	10.1056/NEJMicm1407763	http://dx.doi.org/10.1056/NEJMicm1407763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25992763				2022-12-28	WOS:000354809300012
J	Paxton, R				Paxton, Robert			ENTOMOLOGY The bee-all and end-all	NATURE			English	Editorial Material									Univ Halle Wittenberg, Gen Zool, Halle, Germany	Martin Luther University Halle Wittenberg	Paxton, R (corresponding author), Univ Halle Wittenberg, Gen Zool, Halle, Germany.		Paxton, Robert John/D-7082-2015	Paxton, Robert John/0000-0003-2517-1351	BBSRC [BB/I000100/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000100/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))			0	6	8	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S57	S57		10.1038/521S57a	http://dx.doi.org/10.1038/521S57a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992674	Bronze			2022-12-28	WOS:000354816500003
J	Suomalainen, A				Suomalainen, Anu			STEM CELLS Asymmetric rejuvenation	NATURE			English	Editorial Material							MITOCHONDRIA; INHERITANCE; MICE	Organelles called mitochondria are asymmetrically apportioned to the daughters of dividing stem cells according to mitochondrial age. This finding sheds light on the mechanisms underlying asymmetric stem-cell division.	Univ Helsinki, Biomed Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland	University of Helsinki	Suomalainen, A (corresponding author), Univ Helsinki, Biomed Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.	anu.wartiovaara@helsinki.fi		Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Mukherjee S, 2015, STEM CELLS DEV, V24, P405, DOI 10.1089/scd.2014.0442; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517	12	6	6	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					296	298		10.1038/521296a	http://dx.doi.org/10.1038/521296a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993956				2022-12-28	WOS:000354816500042
J	Benitez-Nelson, C				Benitez-Nelson, Claudia			The missing link in oceanic phosphorus cycling?	SCIENCE			English	Editorial Material							MARINE; SEA; PRODUCTIVITY; PLANKTON; METHANE		[Benitez-Nelson, Claudia] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Benitez-Nelson, C (corresponding author), Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA.	cbnelson@geol.sc.edu		Benitez-Nelson, Claudia/0000-0002-1004-5048				Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; DeVries T, 2014, NAT GEOSCI, V7, P890, DOI 10.1038/NGEO2300; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Karl DM, 2014, ANNU REV MAR SCI, V6, P279, DOI 10.1146/annurev-marine-010213-135046; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Martin P, 2014, P NATL ACAD SCI USA, V111, P8089, DOI 10.1073/pnas.1321719111; Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; Planavsky NJ, 2014, NAT GEOSCI, V7, P855, DOI 10.1038/ngeo2307; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Van Mooy BAS, 2015, SCIENCE, V348, P783, DOI 10.1126/science.aaa8181; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; Young CL, 2010, AQUAT GEOCHEM, V16, P563, DOI 10.1007/s10498-009-9087-y	15	16	17	8	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					759	760		10.1126/science.aab2801	http://dx.doi.org/10.1126/science.aab2801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25977538				2022-12-28	WOS:000354428700022
J	Lunshof, J				Lunshof, Jeantine			Regulate gene editing in wild animals	NATURE			English	Editorial Material									[Lunshof, Jeantine] Univ Groningen, NL-9700 AB Groningen, Netherlands	University of Groningen	Lunshof, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jelunshof@genetics.med.harvard.edu		Lunshof, Jeantine E/0000-0002-5630-7947				Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945	1	20	20	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					127	127		10.1038/521127a	http://dx.doi.org/10.1038/521127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971471	Bronze			2022-12-28	WOS:000354377800011
J	Wallis, A; Spinks, K				Wallis, Adam; Spinks, Katherine			The diagnosis and management of interstitial lung diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; INTERNATIONAL-SOCIETY; CHRONIC SARCOIDOSIS; DOUBLE-BLIND; WALK TEST; SURVIVAL; THERAPY; TRIAL; CYCLOPHOSPHAMIDE; AZATHIOPRINE		[Wallis, Adam; Spinks, Katherine] Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Wallis, A (corresponding author), Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England.	adam.wallis@porthosp.nhs.uk			Intermune/Roche	Intermune/Roche	We have read and understood the BMJ policy on declaration of interests and declare the following interests: KS has received consultancy fees from Intermune/Roche.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245; Baltzan M, 1999, AM J RESP CRIT CARE, V160, P192, DOI 10.1164/ajrccm.160.1.9809024; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60; Fell CD, 2010, AM J RESP CRIT CARE, V181, P832, DOI 10.1164/rccm.200906-0959OC; Garcia-Sancho C, 2011, RESP MED, V105, P1902, DOI 10.1016/j.rmed.2011.08.022; Gottlieb J, 2011, EUR RESPIR MONOGR, P332, DOI 10.1183/1025448x.10009010; Hallstrand TS, 2005, EUR RESPIR J, V25, P96, DOI 10.1183/09031936.04.00137203; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Holland A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006322.pub2; Holland AE, 2008, THORAX, V63, P549, DOI 10.1136/thx.2007.088070; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; ISRAEL HL, 1954, JAMA-J AM MED ASSOC, V156, P461, DOI 10.1001/jama.1954.02950050001001; Jenkins RG, 2015, LANCET RESP MED; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Lamas DJ, 2011, AM J RESP CRIT CARE, V184, P842, DOI 10.1164/rccm.201104-0668OC; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Lota HK, 2013, THORAX, V68, DOI 10.1136/thoraxjnl-2013-203265; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; MCLOUD TC, 1983, RADIOLOGY, V149, P353, DOI 10.1148/radiology.149.2.6622676; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Morimoto T, 2008, EUR RESPIR J, V31, P372, DOI 10.1183/09031936.00075307; Muller-Quernheim J, 1999, EUR RESPIR J, V14, P1117, DOI 10.1183/09031936.99.14511179; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; National Institute for Health and Care Excellence, 2013, ID PULM FIBR DIAGN M; National Institute for Health and Care Excellence, 2013, PIRF TREATM ID PULM; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Nguyen W, 2013, SARCOIDOSIS VASC DIF, V30, P3; Nicholson AG, 2004, THORAX, V59, P500, DOI 10.1136/thx.2003.011734; Nishiyama O, 2008, RESPIROLOGY, V13, P394, DOI 10.1111/j.1440-1843.2007.01205.x; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Paramothayan S, 2002, JAMA-J AM MED ASSOC, V287, P1301, DOI 10.1001/jama.287.10.1301; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912; Shah PL, 2000, THORAX, V55, P67, DOI 10.1136/thorax.55.1.67; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Thomeer M, 2001, EUR RESPIR J, V32, P114, DOI DOI 10.1016/S1010-7940(01)00915-0; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Valapour M, 2013, AM J TRANSPLANT, V13, P149, DOI 10.1111/ajt.12024; Vorselaars ADM, 2013, CHEST, V144, P805, DOI 10.1378/chest.12-1728; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	53	32	41	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2015	350								h2072	10.1136/bmj.h2072	http://dx.doi.org/10.1136/bmj.h2072			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GJ	25952322				2022-12-28	WOS:000354414800002
J	Gigerenzer, G				Gigerenzer, Gerd			Towards a paradigm shift in cancer screening: informed citizens instead of greater participation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BENEFITS; BREAST; HARMS		[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 				Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2636; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Helou A, 2014, BUNDESGESUNDHEITSBLA, V57, P288, DOI 10.1007/s00103-013-1902-3; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; NHS Cancer Screening Programmes, NHS BREAST SCREEN PR; Richter-Kuhlmann E, 2015, DTSCH ARZTEBLATT, V112, pA; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004	9	10	10	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2015	350								h2175	10.1136/bmj.h2175	http://dx.doi.org/10.1136/bmj.h2175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0FV	25943239	Green Submitted			2022-12-28	WOS:000354413100002
J	Mandel, J				Mandel, Jess			Update in Pulmonary Medicine: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESPIRATORY-TRACT COMPLICATIONS; EOSINOPHILIC ASTHMA; METAANALYSIS; OSELTAMIVIR; INFLUENZA; FIBROSIS; EXACERBATIONS; AZITHROMYCIN; MEPOLIZUMAB; TRIAL		[Mandel, Jess] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Mandel, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Pulm & Crit Care Med, 9500 Gilman Dr,Mail Code 0606, La Jolla, CA 92093 USA.	jmandel@ucsd.edu		Mandel, Jess/0000-0002-2658-6025				Al Deeb M, 2014, ACAD EMERG MED, V21, P843, DOI 10.1111/acem.12435; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; *CENT MED MED SERV, 2014, PROP DEC MEM SCREEN, DOI DOI 10.1059/0003-4819-156-7-201204030-00411; George TJ, 2011, ARCH SURG-CHICAGO, V146, P1204, DOI 10.1001/archsurg.2011.239; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; JEFFERSON T, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858CD008965.PUB3; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; 2014, NEW ENGL J MED, V370, P2093, DOI DOI 10.1056/NEJMOA1401739	20	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W117	W121		10.7326/M15-0262	http://dx.doi.org/10.7326/M15-0262			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927873				2022-12-28	WOS:000379893300008
J	Kmietowicz, Z				Kmietowicz, Zosia			REGENERATION A herculean task for the Olympics borough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Kmietowicz, Z (corresponding author), BMJ, London, England.	zkmietowicz@bmj.com						Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2015	350								h2347	10.1136/bmj.h2347	http://dx.doi.org/10.1136/bmj.h2347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UX	25934659				2022-12-28	WOS:000353957100005
J	Walmsley, IA				Walmsley, I. A.			Quantum optics: Science and technology in a new light	SCIENCE			English	Review							PHOTONS	Light facilitates exploration of quantum phenomena that illuminate the basic properties of nature and also enables radical new technologies based on these phenomena. The critical features of quantum light that underpin the opportunities for discovery and application are exceptionally low noise and strong correlations. Rapid progress in both science and technology has been stimulated by adopting components developed for optical telecommunications and networking, such as highly efficient detectors, integrated photonic circuits, and waveguide- or nanostructure-based nonlinear optical devices. These provide the means to generate new quantum states of light and matter of unprecedented scale, containing many photons with quantum correlations across space and time. Notably, networks with only several tens of photons are already beyond what can be efficiently analyzed by current computers.	Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Walmsley, IA (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	walmsley@physics.ox.ac.uk		Walmsley, Ian/0000-0002-4714-0575	UK Engineering and Physical Sciences Research Council; UK Quantum Technology Network; European Commission through the Marie Curie Actions; European Research Council; U.S. European Office of Aerospace Research and Development	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Quantum Technology Network; European Commission through the Marie Curie Actions; European Research Council(European Research Council (ERC)European Commission); U.S. European Office of Aerospace Research and Development	I acknowledge support from the UK Engineering and Physical Sciences Research Council, the UK Quantum Technology Network, the European Commission through the Marie Curie Actions, the European Research Council, and the U.S. European Office of Aerospace Research and Development. I thank J. Nunn and W. S. Kolthammer for insightful discussions and helpful comments on the manuscript.	Aaronson S, 2011, ACM S THEORY COMPUT, P333; Ali-Khan I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060503; Boitier F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.183901; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; Calarco T, 2008, NAT PHYS, V4, P2, DOI 10.1038/nphys818; Chang DE, 2014, NAT PHOTONICS, V8, P685, DOI [10.1038/NPHOTON.2014.192, 10.1038/nphoton.2014.192]; Chaves R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.120401; Crespi A, 2013, NAT PHOTONICS, V7, P545, DOI [10.1038/nphoton.2013.112, 10.1038/NPHOTON.2013.112]; Demkowicz-Dobrzanski R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.250801; Ding DS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3527; Dudin YO, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.031801; England DG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.243601; Fortsch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2838; Garnerone S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230506; Genoni MG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.153603; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/NPHOTON.2011.35, 10.1038/nphoton.2011.35]; Grote H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.181101; Humphreys PC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.070403; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Lang MD, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.025802; Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032; Lo HK, 2014, NAT PHOTONICS, V8, P595, DOI 10.1038/NPHOTON.2014.149; Munro WJ, 2015, IEEE J SEL TOP QUANT, V21, DOI 10.1109/JSTQE.2015.2392076; Nauerth S, 2013, NAT PHOTONICS, V7, P382, DOI [10.1038/nphoton.2013.46, 10.1038/NPHOTON.2013.46]; Nunn J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133601; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Renema JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.117604; Ringbauer M, 2015, NAT PHYS, V11, P249, DOI 10.1038/NPHYS3233; Salter CL, 2010, NATURE, V465, P594, DOI 10.1038/nature09078; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Sanguinetti B, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031056; Specht HP, 2011, NATURE, V473, P190, DOI 10.1038/nature09997; Spring JB, 2013, OPT EXPRESS, V21, P13522, DOI 10.1364/OE.21.013522; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692; Tillmann M, 2013, NAT PHOTONICS, V7, P540, DOI [10.1038/nphoton.2013.102, 10.1038/NPHOTON.2013.102]; Walenta N, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013047; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07390; Zhong T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/022002	43	79	81	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					525	530		10.1126/science.aab0097	http://dx.doi.org/10.1126/science.aab0097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931550				2022-12-28	WOS:000353778100030
J	Pickard, R; Starr, K; MacLennan, G; Lam, T; Thomas, R; Burr, J; McPherson, G; McDonald, A; Anson, K; N'Dow, J; Burgess, N; Clark, T; Kilonzo, M; Gillies, K; Shearer, K; Boachie, C; Cameron, S; Norrie, J; McClinton, S				Pickard, Robert; Starr, Kathryn; MacLennan, Graeme; Lam, Thomas; Thomas, Ruth; Burr, Jennifer; McPherson, Gladys; McDonald, Alison; Anson, Kenneth; N'Dow, James; Burgess, Neil; Clark, Terry; Kilonzo, Mary; Gillies, Katie; Shearer, Kirsty; Boachie, Charles; Cameron, Sarah; Norrie, John; McClinton, Samuel			Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial	LANCET			English	Article							EMERGENCY-DEPARTMENT VISITS; STONE PASSAGE; MANAGEMENT; FACILITATE; DRUG	Background Meta-analyses of previous randomised controlled trials concluded that the smooth muscle relaxant drugs tamsulosin and nifedipine assisted stone passage for people managed expectantly for ureteric colic, but emphasised the need for high-quality trials with wide inclusion criteria. We aimed to fulfil this need by testing effectiveness of these drugs in a standard clinical care setting. Methods For this multicentre, randomised, placebo-controlled trial, we recruited adults (aged 18-65 years) undergoing expectant management for a single ureteric stone identified by CT at 24 UK hospitals. Participants were randomly assigned by a remote randomisation system to tamsulosin 400 mu g, nifedipine 30 mg, or placebo taken daily for up to 4 weeks, using an algorithm with centre, stone size (<= 5 mm or >5 mm), and stone location (upper, mid, or lower ureter) as minimisation covariates. Participants, clinicians, and trial personnel were masked to treatment assignment. The primary outcome was the proportion of participants who did not need further intervention for stone clearance within 4 weeks of randomisation, analysed in a modified intention-to-treat population defined as all eligible patients for whom we had primary outcome data. This trial is registered with the European Clinical Trials Database, EudraCT number 2010-019469-26, and as an International Standard Randomised Controlled Trial, number 69423238. Findings Between Jan 11, 2011, and Dec 20, 2013, we randomly assigned 1167 participants, 1136 (97%) of whom were included in the primary analysis (17 were excluded because of ineligibility and 14 participants were lost to follow-up). 303 (80%) of 379 participants in the placebo group did not need further intervention by 4 weeks, compared with 307 (81%) of 378 in the tamsulosin group (adjusted risk difference 1.3% [95% CI-5.7 to 8.3]; p=0.73) and 304 (80%) of 379 in the nifedipine group (0.5% [-5.6 to 6.5]; p=0.88). No difference was noted between active treatment and placebo (p=0.78), or between tamsulosin and nifedipine (p=0.77). Serious adverse events were reported in three participants in the nifedipine group (one had right loin pain, diarrhoea, and vomiting; one had malaise, headache, and chest pain; and one had severe chest pain, difficulty breathing, and left arm pain) and in one participant in the placebo group (headache, dizziness, lightheadedness, and chronic abdominal pain). Interpretation Tamsulosin 400 mu g and nifedipine 30 mg are not effective at decreasing the need for further treatment to achieve stone clearance in 4 weeks for patients with expectantly managed ureteric colic. Copyright (C) Pickard et al. Open Access article distributed under the terms of CC BY.	[Pickard, Robert] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Starr, Kathryn; MacLennan, Graeme; Thomas, Ruth; McPherson, Gladys; McDonald, Alison; Gillies, Katie; Shearer, Kirsty; Boachie, Charles; Cameron, Sarah; Norrie, John] Univ Aberdeen, Hlth Serv Res Unit, Ctr Healthcare Randomised Trials, Aberdeen, Scotland; [Lam, Thomas; N'Dow, James; McClinton, Samuel] Univ Aberdeen, Acad Urol Unit, Aberdeen, Scotland; [Kilonzo, Mary] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Burr, Jennifer] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Anson, Kenneth] St Georges Healthcare NHS Trust, London, England; [Burgess, Neil] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England; [Clark, Terry] British Assoc Urol Surg, Sect Endourol, Stone Patient Advisory Grp, London, England; [McClinton, Samuel] NHS Grampian, Aberdeen Royal Infirm, Aberdeen, Scotland	Newcastle University - UK; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of St Andrews; St Georges University London; Norfolk & Norwich University Hospitals NHS Foundation Trust; University of Aberdeen	McClinton, S (corresponding author), Aberdeen Royal Infirm, Dept Urol, Aberdeen AB25 2ZB, Scotland.	smcclinton@nhs.net		Gillies, Katie/0000-0001-7890-2854; Kilonzo, Mary/0000-0002-3450-4536; MacLennan, Graeme/0000-0002-1039-5646; Burr, Jennifer/0000-0002-9478-738X	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme [08/71/01]; Chief Scientist Office of the Scottish Government Health and Social Care Directorates; National Institute for Health Research [08/71/01] Funding Source: researchfish; Chief Scientist Office [HERU1, HSRU1] Funding Source: researchfish	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	Special thanks must go to all of the SUSPEND trial participants and staff at each of our recruiting centres for taking part in this trial. We thank our collaborators at the SUSPEND sites, and participating National Health Service (NHS) trusts and boards (NHS Grampian, Plymouth Hospitals NHS Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, NHS Highland, South Tees Hospitals NHS Foundation Trust, City Hospitals Sunderland NHS Foundation Trust, The Leeds Teaching Hospitals NHS Trust, North Bristol NHS Trust, University Hospitals Bristol NHS Trust, Norfolk and Norwich University Hospitals NHS Foundation Trust, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, NHS Lothian, Guy's and St Thomas' NHS Foundation Trust, St George's Healthcare NHS Trust, Abertawe Bro Morgannwg University Health Board, Mid Yorkshire Hospitals NHS Trust, South Devon Healthcare NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Gloucestershire Hospitals NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, Central Manchester University Hospitals NHS Foundation Trust, Southampton University Hospitals NHS Trust, and The University Hospital of South Manchester NHS Foundation Trust). We thank the staff at the SUSPEND trial office based in the Centre for Healthcare Randomised Trials (CHaRT) within the Health Services Research Unit, University of Aberdeen. This report presents independent research funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme, Project Number 08/71/01. The views and opinions expressed in this report are those of the authors and do not necessarily reflect those of the HTA Programme, the NIHR, the NHS, or the Department of Health. The Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates; however, the opinions expressed in this publication are those of the authors, and might not be shared by the Chief Scientist Office.	[Anonymous], 2014, 16 COMM MED ASP RAD; Bader MJ, 2012, EUR UROL, V61, P764, DOI 10.1016/j.eururo.2012.01.009; Bagga H, 2013, J UROLOGY, V189, pE925, DOI 10.1016/j.juro.2013.02.2166; Bos D, 2014, CUAJ-CAN UROL ASSOC, V8, P442, DOI 10.5489/cuaj.2472; British Association of Urology, GUID AC MAN PRES REN; Bultitude M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5499; Campschroer T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008509.pub2; Chua ME, 2013, UROLITHIASIS, V41, P143, DOI 10.1007/s00240-012-0538-3; Dechartres A, 2014, JAMA-J AM MED ASSOC, V312, P623, DOI 10.1001/jama.2014.8166; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Dell'Atti L, 2014, UROLOGIA, V82, P54; Fulgham PF, 2012, AM UROLOGICAL ASS AU; Fwu CW, 2013, KIDNEY INT, V83, P479, DOI 10.1038/ki.2012.419; Ghani KR, 2014, J UROLOGY, V191, P90, DOI 10.1016/j.juro.2013.07.098; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; Hollingsworth JM, 2010, J UROLOGY, V184, P2368, DOI 10.1016/j.juro.2010.08.013; Itoh Y, 2013, INT UROL NEPHROL, V45, P675, DOI 10.1007/s11255-013-0429-8; McClinton S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-238; Miller OF, 1999, J UROLOGY, V162, P688, DOI 10.1097/00005392-199909010-00014; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; Preminger GM, 2007, GUIDELINE MANAGEMENT; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Sur RL, 2015, EUR UROL, V67, P959, DOI 10.1016/j.eururo.2014.10.049; Tchey DU, 2011, KOREAN J UROL, V52, P847, DOI 10.4111/kju.2011.52.12.847; Turk C., EUROPEAN ASS UROLOGY; UK Government Department of Health, NHS REF COSTS 2012 2; Weissman J, 2012, PSYCHIAT RES, V197, P221, DOI 10.1016/j.psychres.2012.02.015; White IR, 2011, STAT MED, V30, P3192, DOI 10.1002/sim.4360	28	217	222	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					341	349		10.1016/S0140-6736(15)60933-3	http://dx.doi.org/10.1016/S0140-6736(15)60933-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	25998582	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000358448400023
J	Wainwright, CE; Elborn, JS; Ramsey, BW; Marigowda, G; Huang, X; Cipolli, M; Colombo, C; Davies, JC; De Boeck, K; Flume, PA; Konstan, MW; McColley, SA; Mccoy, K; McKone, EF; Munck, A; Ratjen, F; Rowe, SM; Waltz, D; Boyle, MP				Wainwright, C. E.; Elborn, J. S.; Ramsey, B. W.; Marigowda, G.; Huang, X.; Cipolli, M.; Colombo, C.; Davies, J. C.; De Boeck, K.; Flume, P. A.; Konstan, M. W.; McColley, S. A.; Mccoy, K.; McKone, E. F.; Munck, A.; Ratjen, F.; Rowe, S. M.; Waltz, D.; Boyle, M. P.		TRAFFIC Study Grp; TRANSPORT Study Grp	Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; POTENTIATOR IVACAFTOR; IN-VITRO; F508DEL-CFTR; MUTATION; EFFICACY; SAFETY; STABILITY	BACKGROUND Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) protein activity. Phe508del is the most common CFTR mutation. METHODS We conducted two phase 3, randomized, double-blind, placebo-controlled studies that were designed to assess the effects of lumacaftor (VX-809), a CFTR corrector, in combination with ivacaftor (VX-770), a CFTR potentiator, in patients 12 years of age or older who had cystic fibrosis and were homozygous for the Phe508del CFTR mutation. In both studies, patients were randomly assigned to receive either lumacaftor (600 mg once daily or 400 mg every 12 hours) in combination with ivacaftor (250 mg every 12 hours) or matched placebo for 24 weeks. The primary end point was the absolute change from baseline in the percentage of predicted forced expiratory volume in 1 second (FEV 1) at week 24. RESULTS A total of 1108 patients underwent randomization and received study drug. The mean baseline FEV 1 was 61% of the predicted value. In both studies, there were significant improvements in the primary end point in both lumacaftor-ivacaftor dose groups; the difference between active treatment and placebo with respect to the mean absolute improvement in the percentage of predicted FEV 1 ranged from 2.6 to 4.0 percentage points (P< 0.001), which corresponded to a mean relative treatment difference of 4.3 to 6.7% (P< 0.001). Pooled analyses showed that the rate of pulmonary exacerbations was 30 to 39% lower in the lumacaftor-ivacaftor groups than in the placebo group; the rate of events leading to hospitalization or the use of intravenous antibiotics was lower in the lumacaftor-ivacaftor groups as well. The incidence of adverse events was generally similar in the lumacaftor-ivacaftor and placebo groups. The rate of discontinuation due to an adverse event was 4.2% among patients who received lumacaftor-ivacaftor versus 1.6% among those who received placebo. CONCLUSIONS These data show that lumacaftor in combination with ivacaftor provided a benefit for patients with cystic fibrosis homozygous for the Phe508del CFTR mutation.	[Wainwright, C. E.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Elborn, J. S.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Davies, J. C.] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Davies, J. C.] Univ London Imperial Coll Sci Technol & Med, London, England; [Ramsey, B. W.] Seattle Childrens Hosp, Seattle, WA USA; [Ramsey, B. W.] Univ Washington, Sch Med, Seattle, WA USA; [Marigowda, G.; Huang, X.; Waltz, D.] Vertex Pharmaceut, Boston, MA USA; [Cipolli, M.] Azienda Osped Univ Integrata, Cyst Fibrosis Ctr, Verona, Italy; [Colombo, C.] Univ Milan, Osped Maggiore Policlinico, Fdn IRCCS Ca Granda, Milan, Italy; [De Boeck, K.] Univ Hosp Gasthuisberg, Leuven, Belgium; [Flume, P. A.] Med Univ S Carolina, Charleston, SC USA; [Konstan, M. W.] Case Western Reserve Univ, Sch Med, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Mccoy, K.] Nationwide Childrens Hosp, Dept Pediat, Div Pulm, Columbus, OH USA; [Mccoy, K.] Ohio State Univ, Columbus, OH 43210 USA; [McColley, S. A.] Northwestern Univ, Stanley Manne Childrens Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [McKone, E. F.] St Vincents Univ Hosp, Dublin 4, Ireland; [McKone, E. F.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Munck, A.] Univ Paris 07, AP HP, Hop Robert Debre, Paediat Gastroenterol & Resp Dept,CF Ctr, Paris, France; [Ratjen, F.] Univ Toronto, Hosp Sick Children, Div Resp Med, Dept Pediat Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Rowe, S. M.] Univ Alabama Birmingham, Birmingham, AL USA; [Boyle, M. P.] Johns Hopkins Med, Baltimore, MD USA	University of Queensland; Queens University Belfast; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Vertex Pharmaceuticals; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; KU Leuven; University Hospital Leuven; Medical University of South Carolina; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Northwestern University; Feinberg School of Medicine; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Medicine	Wainwright, CE (corresponding author), Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, 501 Stanley St, South Brisbane, Qld 4101, Australia.	claire.wainwright@health.qld.gov.au	Wainwright, Claire E/G-4218-2013; McColley, Susanna A/L-8756-2019; Bell, Scott/AAJ-4298-2020; Lascano, Jorge/AAR-5731-2020; Reynaud-Gaubert, Martine LM/P-6958-2016; McColley, Susanna/AAW-4603-2020; Bell, Scott C/A-7241-2011; Merkus, P.J.F.M./L-4523-2015; McNally, Paul/AAL-4407-2021; Cipolli, Marco/AAL-1419-2020; Moss, Richard B./S-9218-2019	Wainwright, Claire E/0000-0001-8389-3809; McColley, Susanna A/0000-0003-0842-728X; Bell, Scott/0000-0001-8651-7139; Lascano, Jorge/0000-0002-9546-1867; McColley, Susanna/0000-0003-0842-728X; Bell, Scott C/0000-0001-8651-7139; McNally, Paul/0000-0001-7102-1712; Cipolli, Marco/0000-0001-5652-7248; Moss, Richard B./0000-0003-3611-4221; Rehman, Abdul/0000-0002-8398-7810; Konstan, Michael/0000-0002-0557-7277; Davies, Jane/0000-0003-3506-1199; Nash, Edward/0000-0002-4521-4307; Middleton, Peter G/0000-0003-3361-4941; Boyle, Michael/0000-0002-9740-1630; Salathe, Matthias/0000-0001-9092-4861; Ratjen, Felix/0000-0003-4057-6592; elborn, joseph/0000-0002-2323-442X	Vertex Pharmaceuticals; Children's Hospital Foundation, Brisbane, Queensland, Australia; Northern Ireland Clinical Research Network (Respiratory Health) in Belfast Health and Social Care Trust; Institute of Translational Health Sciences, National Institutes of Health (NIH) [UL1TR000423]; Cystic Fibrosis Translational Research Center, NIH [P30DK089507]; National Institute for Health Research Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; South Carolina Clinical and Translational Research Institute, Medical University of South Carolina [UL1TR000062]; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; Cystic Fibrosis Core Center [DK027651]; Cystic Fibrosis Foundation Therapeutics Development Network to Case Western Reserve University School of Medicine; Northwestern University Clinical and Translational Sciences Institute [UL1RR025741]; Cystic Fibrosis Foundation Therapeutics Development Network [MCCOLL14YO]; UAB Center for Clinical and Translational Science [UL1TR000165]; UAB Cystic Fibrosis Research Center [DK072482]; Cystic Fibrosis Foundation; Johns Hopkins Institute for Clinical and Translational Research - NIH [UL1TR001079]; Medscape; Vertex; Novartis; GlaxoSmithKline; Novo Nordisk; Boehringer Ingelheim; Achaogen; Apartia; Bayer Healthcare; Breathe Easy; Bristol-Myers Squibb; Catabasis; 12th Man Technologies; Caltaxsys; Corbus Pharmaceuticals; Cornerstone Therapeutics; CSL Behring; CURx Pharmaceuticals; Eli Lilly; Flatley Discovery Lab; Genentech; Gilead Sciences; GlycoMimetics; Grifols Therapeutics; INC Research; Insmed; KaloBios; Kamada; Mpex Pharmaceuticals; N30 Pharmaceuticals; Nordmark; Parion Sciences; PharmagenesisPharmagenesis (Cornerstone 281); Pharmaxis; ProQR Therapeutics; Pulmatrix; PulmoFlow; Respira Therapeutics; Savara Pharmaceuticals; Proteostasis; Gilead; Ablynx; Galapagos; PTC Therapeutics; Celtaxys; Digestive Care; Chiesi; Celtaxsys; AbbVie; Janssen; N30 Pharmceuticals; Bayer; Talecris; Roche; Forest Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423, UL1TR000165, UL1TR000062, UL1TR000427, UL1TR001079, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507, P30DK027651, P30DK072482] Funding Source: NIH RePORTER	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Children's Hospital Foundation, Brisbane, Queensland, Australia; Northern Ireland Clinical Research Network (Respiratory Health) in Belfast Health and Social Care Trust; Institute of Translational Health Sciences, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Translational Research Center, NIH; National Institute for Health Research Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; South Carolina Clinical and Translational Research Institute, Medical University of South Carolina; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cystic Fibrosis Core Center; Cystic Fibrosis Foundation Therapeutics Development Network to Case Western Reserve University School of Medicine; Northwestern University Clinical and Translational Sciences Institute; Cystic Fibrosis Foundation Therapeutics Development Network; UAB Center for Clinical and Translational Science; UAB Cystic Fibrosis Research Center; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Johns Hopkins Institute for Clinical and Translational Research - NIH; Medscape; Vertex(Vertex Pharmaceuticals); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Boehringer Ingelheim(Boehringer Ingelheim); Achaogen; Apartia; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Breathe Easy; Bristol-Myers Squibb(Bristol-Myers Squibb); Catabasis; 12th Man Technologies; Caltaxsys; Corbus Pharmaceuticals; Cornerstone Therapeutics; CSL Behring; CURx Pharmaceuticals; Eli Lilly(Eli Lilly); Flatley Discovery Lab; Genentech(Roche HoldingGenentech); Gilead Sciences(Gilead Sciences); GlycoMimetics; Grifols Therapeutics; INC Research; Insmed; KaloBios; Kamada; Mpex Pharmaceuticals; N30 Pharmaceuticals; Nordmark; Parion Sciences; PharmagenesisPharmagenesis (Cornerstone 281); Pharmaxis; ProQR Therapeutics; Pulmatrix; PulmoFlow; Respira Therapeutics; Savara Pharmaceuticals; Proteostasis; Gilead(Gilead Sciences); Ablynx(Ablynx); Galapagos(Galapagos NV); PTC Therapeutics; Celtaxys; Digestive Care; Chiesi(Chiesi Pharmaceuticals Inc); Celtaxsys; AbbVie(AbbVie); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); N30 Pharmceuticals; Bayer(Bayer AG); Talecris; Roche(Roche Holding); Forest Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Vertex Pharmaceuticals; a program grant from the Children's Hospital Foundation, Brisbane, Queensland, Australia (to Dr. Wainwright); the Northern Ireland Clinical Research Network (Respiratory Health) in Belfast Health and Social Care Trust (to Dr. Elborn); grants from the Institute of Translational Health Sciences, National Institutes of Health (NIH) (UL1TR000423) and the Cystic Fibrosis Translational Research Center, NIH (P30DK089507, both to Dr. Ramsey); the National Institute for Health Research Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London (to Dr. Davies); the South Carolina Clinical and Translational Research Institute, Medical University of South Carolina (UL1TR000062 to Dr. Flume); the Clinical and Translational Science Collaborative of Cleveland (UL1TR000439), a grant from the Cystic Fibrosis Core Center (DK027651), and a grant from the Cystic Fibrosis Foundation Therapeutics Development Network to Case Western Reserve University School of Medicine (all to Dr. Konstan); grants from the Northwestern University Clinical and Translational Sciences Institute (UL1RR025741) and the Cystic Fibrosis Foundation Therapeutics Development Network (MCCOLL14YO) (both to Dr. McColley); grants from the UAB Center for Clinical and Translational Science (UL1TR000165), the UAB Cystic Fibrosis Research Center (DK072482), and the Cystic Fibrosis Foundation (all to Dr. Rowe); and the Johns Hopkins Institute for Clinical and Translational Research, which is funded in part by a grant from the NIH (UL1TR001079, to Dr. Boyle).; Dr. Wainwright reports receiving consulting fees from Medscape and Vertex, lecture fees and travel support from Vertex and Novartis, grant support from Vertex, GlaxoSmithKline, and Novo Nordisk, and fees on a per patient basis as principal investigator of a clinical study from Boehringer Ingelheim. Dr. Ramsey reports receiving grant support from Achaogen, Apartia, Bayer Healthcare, Breathe Easy, Bristol-Myers Squibb, Catabasis, 12th Man Technologies, Caltaxsys, Corbus Pharmaceuticals, Cornerstone Therapeutics, CSL Behring, CURx Pharmaceuticals, Eli Lilly, Flatley Discovery Lab, Genentech, Gilead Sciences, GlycoMimetics, Grifols Therapeutics, INC Research, Insmed, KaloBios, Kamada, Mpex Pharmaceuticals, N30 Pharmaceuticals, Nordmark, Novartis, Parion Sciences, Pharmagenesis (Cornerstone 281), Pharmaxis, ProQR Therapeutics, Pulmatrix, PulmoFlow, Respira Therapeutics, Savara Pharmaceuticals, and Vertex. Dr. Colombo reports receiving fees for serving on advisory boards from Vertex. Dr. Davies reports receiving fees through her institution for serving on advisory boards for Vertex, Proteostasis, Novartis, and Gilead; she has also received fees through her institution from Vertex for participation in educational activities and acting as lead investigator in other trials. Dr. De Boeck reports receiving fees for serving on an advisory board from Pharmaxis and KaloBios, fees for serving on a data monitoring committee from Aptalis, and consulting fees from Ablynx, Galapagos, Gilead, PTC Therapeutics, Celtaxys, and Boehringer Ingelheim; she has also served as principal investigator in studies funded by Gilead, Pharmaxis, and PTC Therapeutics. Dr. Flume reports receiving consulting fees and grant support from Vertex. Dr. Konstan reports receiving fees for serving on advisory boards from Genentech, Gilead Sciences, Insmed, and Savara Pharmaceuticals, consulting fees from Digestive Care, Novartis, PTC Therapeutics, Chiesi, KaloBios, and Celtaxsys, lecture fees from Novartis, travel support from Genentech, Gilead Sciences, Insmed, Novartis, PTC Therapeutics, and Celtaxsys, and grant support through his institution from Genentech, Insmed, Novartis, PTC Therapeutics, Savara Pharmaceuticals, and KaloBios. Dr. McCoy reports receiving travel support from Novartis and Pharmaxis, and grant support through her institution from Aptalis, KaloBios, Novartis, Gilead Sciences, Pharmaxis, Savara Pharmaceuticals, Genentech, AbbVie, Janssen, and N30 Pharmceuticals. Dr. McKone reports receiving fees for serving on advisory boards from Novartis and Vertex, consulting fees from Vertex, lecture fees from Gilead Sciences, travel support from Gilead Sciences and Novartis, and grant support from Vertex. Dr. Munck reports receiving fees for serving on advisory boards from Novartis. Dr. Ratjen reports receiving consulting fees from Bayer, Talecris, CSL Behring, Roche, Gilead Sciences, Genentech, and KaloBios, travel support from PARI Pharma, and grant support from Novartis. Dr. Rowe reports receiving grant support from Vertex, PTC Therapeutics, Novartis, and the Forest Research Institute. Dr. Boyle reports receiving fees for serving on advisory boards for Savara Pharmaceuticals, Vertex, Genentech, and Novartis. Dr. Marigowda, Dr. Huang, and Dr. Waltz are employees of and hold stock or stock options in Vertex. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2002, MOL GEN EP CYST FIBR, P24; [Anonymous], 2010, EUR CYST FIBR PAT RE; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cystic Fibrosis Foundation, 2013, PAT REG ANN DAT REP; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; De Boeck K, 2014, J CYST FIBROS, V13, P674, DOI 10.1016/j.jcf.2014.09.005; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; McKone EF, 2014, LANCET RESP MED, V2, P902, DOI [10.1016/S2213-2600(14)70218-8, 10.1016/s2213-2600(14)70218-8]; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Quittner AL, 2009, CHEST, V135, P1610, DOI 10.1378/chest.08-1190; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; US CF Foundation Johns Hopkins University the Hospital for Sick Children, 2011, CLIN FUNCT TRANSL CF; VAISMAN N, 1987, J PEDIATR-US, V111, P496, DOI 10.1016/S0022-3476(87)80107-5; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	33	933	962	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					220	231		10.1056/NEJMoa1409547	http://dx.doi.org/10.1056/NEJMoa1409547			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	25981758	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000357956200005
J	Bennett, JE; Li, GQ; Foreman, K; Best, N; Kontis, V; Pearson, C; Hambly, P; Ezzati, M				Bennett, James E.; Li, Guangquan; Foreman, Kyle; Best, Nicky; Kontis, Vasilis; Pearson, Clare; Hambly, Peter; Ezzati, Majid			The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting	LANCET			English	Article							SOCIAL CARE BILL; HEALTH-CARE; MORTALITY; DEPRIVATION; MIGRATION; CONVERGENCE; PROJECTIONS; MOVEMENT; OUTCOMES; DISEASE	Background To plan for pensions and health and social services, future mortality and life expectancy need to be forecast. Consistent forecasts for all subnational units within a country are very rare. Our aim was to forecast mortality and life expectancy for England and Wales' districts. Methods We developed Bayesian spatiotemporal models for forecasting of age-specific mortality and life expectancy at a local, small-area level. The models included components that accounted for mortality in relation to age, birth cohort, time, and space. We used geocoded mortality and population data between 1981 and 2012 from the Office for National Statistics together with the model with the smallest error to forecast age-specific death rates and life expectancy to 2030 for 375 of England and Wales' 376 districts. We measured model performance by withholding recent data and comparing forecasts with this withheld data. Findings Life expectancy at birth in England and Wales was 79.5 years (95% credible interval 79.5-79.6) for men and 83.3 years (83.3-83.4) for women in 2012. District life expectancies ranged between 75.2 years (74.9-75.6) and 83.4 years (82.1-84.8) for men and between 80.2 years (79.8-80.5) and 87.3 years (86.0-88.8) for women. Between 1981 and 2012, life expectancy increased by 8.2 years for men and 6.0 years for women, closing the female-male gap from 6.0 to 3.8 years. National life expectancy in 2030 is expected to reach 85.7 (84.2-87.4) years for men and 87.6 (86.7-88.9) years for women, further reducing the female advantage to 1.9 years. Life expectancy will reach or surpass 81.4 years for men and reach or surpass 84.5 years for women in every district by 2030. Longevity inequality across districts, measured as the difference between the 1st and 99th percentiles of district life expectancies, has risen since 1981, and is forecast to rise steadily to 8.3 years (6.8-9.7) for men and 8.3 years (7.1-9.4) for women by 2030. Interpretation Present forecasts underestimate the expected rise in life expectancy, especially for men, and hence the need to provide improved health and social services and pensions for elderly people in England and Wales. Health and social policies are needed to curb widening life expectancy inequalities, help deprived districts catch up in longevity gains, and avoid a so-called grand divergence in health and longevity.	[Bennett, James E.; Li, Guangquan; Foreman, Kyle; Best, Nicky; Kontis, Vasilis; Pearson, Clare; Hambly, Peter; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Bennett, James E.; Li, Guangquan; Foreman, Kyle; Best, Nicky; Kontis, Vasilis; Pearson, Clare; Hambly, Peter; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Pearson, Clare; Hambly, Peter] Univ London Imperial Coll Sci Technol & Med, UK Small Area Hlth Stat Unit, London W2 1PG, England; [Li, Guangquan] Northumbria Univ, Dept Math & Informat Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Best, Nicky] GlaxoSmithKline, London, England	Imperial College London; Imperial College London; Imperial College London; Northumbria University; GlaxoSmithKline	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Pearson, Clare/S-6372-2019; Li, Guangquan/AAW-6920-2021; Pearson, Clare/H-9030-2013	Li, Guangquan/0000-0002-8736-5349; Kontis, Vasilis/0000-0002-0485-1561; Bennett, James Elston/0000-0002-9616-6878; Pearson, Clare/0000-0002-1941-4735	UK Medical Research Council; Public Health England; Public Health England as part of the MRC-PHE Centre for Environment and Health; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; Public Health England as part of the MRC-PHE Centre for Environment and Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council and Public Health England.; The work of the UK Small Area Health Statistics Unit is funded by Public Health England as part of the MRC-PHE Centre for Environment and Health, funded also by the UK Medical Research Council. Methods development was supported by a Strategic Award from the UK Medical Research Council. We thank Margaret Douglas and Daniela Fecht for information and assistance with mortality and population data, and Colin Mathers for technical discussions and sample computer code on the Kannisto-Thatcher method.	[Anonymous], HIST PROJ MORT DAT P; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Bell W.R., 1997, J OFF STAT, V13, P279; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boe C, 1999, N AM ACT J, V2, P13; Booth H, 2008, ANN ACTUAR SCI, V3, P3, DOI 10.1017/S1748499500000440; Boyle PJ, 2009, SOC SCI MED, V68, P1835, DOI 10.1016/j.socscimed.2009.02.051; Brimblecombe N, 2000, SOC SCI MED, V50, P861, DOI 10.1016/S0277-9536(99)00371-8; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CarrHill RA, 1996, BRIT MED J, V312, P1008; Connolly S, 2007, SOC SCI MED, V64, P2008, DOI 10.1016/j.socscimed.2007.02.021; Connolly S, 2011, HEALTH PLACE, V17, P1007, DOI 10.1016/j.healthplace.2011.02.005; Department of Health Statistics and information Systems WHO G, 2014, WHO METH LIF EXP HLT; Dixon A., 2003, LSE HLTH SOCIAL CARE, V11, P1; Edwards RD, 2011, POPUL DEV REV, V37, P499, DOI 10.1111/j.1728-4457.2011.00432.x; ELFORD J, 1989, LANCET, V1, P343; Etxeberria J, 2014, BIOMETRICAL J, V56, P383, DOI 10.1002/bimj.201200259; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Girosi F., 2008, DEMOGRAPHIC FORECAST; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; Hamilton FL, 2010, J AMBUL CARE MANAG, V33, P336, DOI 10.1097/JAC.0b013e3181f68f1d; House of Commons Health Committee, 2009, 3 HOUS COMM HLTH COM, VI; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Manton KG, 1993, FORECASTING HLTH ELD; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; McKee M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6535; Millett C, 2007, J ROY SOC MED, V100, P275, DOI 10.1258/jrsm.100.6.275; Mitchell R., 2000, INEQUALITIES LIFE DE; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Office for National Statistics, 2014, METH 2012 BAS SUBN P; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pollock AM, 2012, LANCET, V379, P387, DOI 10.1016/S0140-6736(12)60119-6; Preston S., 2000, DEMOGRAPHY MEASURING; Raftery AE, 2013, DEMOGRAPHY, V50, P777, DOI 10.1007/s13524-012-0193-x; Reynolds L, 2012, J ROY SOC MED, V105, P7, DOI 10.1258/jrsm.2011.110195; RUE H., 2005, GAUSSIAN MARKOV RAND; Smith GD, 1998, LANCET, V352, P1439, DOI 10.1016/S0140-6736(05)61261-5; Soneji S, 2012, DEMOGRAPHY, V49, P1037, DOI 10.1007/s13524-012-0106-z; Tabeau K, 2001, FORECASTING MORTALIT; Thatcher A. R., 1998, FORCE MORTALITY AGES; Torri T, 2012, INT J FORECASTING, V28, P519, DOI 10.1016/j.ijforecast.2011.01.009; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; University of Manchester, 2015, COAL SOC POL REC POL; Vallin Jacques, 2004, SPECIAL COLLECTION, V2, P11, DOI [10.4054/DemRes.2004.S2.2, DOI 10.4054/DEMRES.2004.S2.2]; Wilmoth JR, 2007, METHODS PROTOCOL HUM; World Health Organization, 2014, WORLD HLTH STAT 2014	51	79	80	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					163	170		10.1016/S0140-6736(15)60296-3	http://dx.doi.org/10.1016/S0140-6736(15)60296-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	25935825	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000357742200033
J	Bartter, T				Bartter, Thaddeus			Electronic Cigarettes: Aggregate Harm	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AWARENESS		Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bartter, T (corresponding author), Univ Arkansas Med Sci, 4301 West Markham,Mail Slot 555, Little Rock, AR 72205 USA.	tbartter@uams.edu						Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Centers for Disease Control and Prevention, NICOTINE SYST AG; Crowley RA, 2015, ANN INTERN MED, V162, P583, DOI 10.7326/M14-2481; Duke JC, 2014, PEDIATRICS, V134, pE29, DOI 10.1542/peds.2014-0269; Kandel D B, 2000, Nicotine Tob Res, V2, P263; King AC, 2015, TOB CONTROL, V24, P501, DOI 10.1136/tobaccocontrol-2014-051563; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Leone Frank T, 2014, Ann Am Thorac Soc, V11, P216, DOI 10.1513/AnnalsATS.201312-428ED; Pepper JK, 2013, J ADOLESCENT HEALTH, V52, P144, DOI 10.1016/j.jadohealth.2012.09.014; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	10	8	9	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					59	60		10.7326/M15-0450	http://dx.doi.org/10.7326/M15-0450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25962126				2022-12-28	WOS:000357442000007
J	Bretheau, L; Campagne-Ibarcq, P; Flurin, E; Mallet, F; Huard, B				Bretheau, L.; Campagne-Ibarcq, P.; Flurin, E.; Mallet, F.; Huard, B.			Quantum dynamics of an electromagnetic mode that cannot contain N photons	SCIENCE			English	Article							STATE	Electromagnetic modes are instrumental in building quantum machines. In this experiment, we introduce a method to manipulate these modes by effectively controlling their phase space. Preventing access to a single energy level, corresponding to a number of photons N, confined the dynamics of the field to levels 0 to N - 1. Under a resonant drive, the level occupation was found to oscillate in time, similarly to an N-level system. Performing a direct Wigner tomography of the field revealed its nonclassical features, including a Schrodinger cat-like state at half period in the evolution. This fine control of the field in its phase space may enable applications in quantum information and metrology.	[Bretheau, L.; Campagne-Ibarcq, P.; Flurin, E.; Mallet, F.; Huard, B.] Univ Paris 06, Sorbonne Univ, Univ Paris Diderot,Sorbonne Paris Cite, PSL Res Univ,Lab Pierre Aigrain,CNRS,Ecole Normal, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Universite Paris Cite	Huard, B (corresponding author), Univ Paris 06, Sorbonne Univ, Univ Paris Diderot,Sorbonne Paris Cite, PSL Res Univ,Lab Pierre Aigrain,CNRS,Ecole Normal, 24 Rue Lhomond, F-75231 Paris 05, France.	benjamin.huard@ens.fr	mallet, francois/O-5956-2016; Huard, Benjamin/A-7393-2015; Bretheau, Landry/Q-5468-2018	Huard, Benjamin/0000-0002-9848-3658; Bretheau, Landry/0000-0001-5628-934X; Mallet, Francois/0000-0001-8618-6819	ANR [ANR-12-JCJC-TIQS]; Qumotel grant Emergences of Ville de Paris; Direction Generale de l'Armement	ANR(French National Research Agency (ANR)); Qumotel grant Emergences of Ville de Paris; Direction Generale de l'Armement	We thank M. Devoret, C. Girit, T. Kontos, Z. Leghtas, V. Manucharyan, M. Mirrahimi, S. Pascazio, the Quantronics Group, J. -M. Raimond, P. Rouchon, S. Dhillon, and J. Viennot. Nanofabrication has been made within the consortium Salle Blanche Paris Centre. This work was supported by the ANR contract ANR-12-JCJC-TIQS and the Qumotel grant Emergences of Ville de Paris. L.B. acknowledges support from Direction Generale de l'Armement.	Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Bourassa J, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013814; Facchi P, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032314; Facchi P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.080401; Facchi P, 2000, PHYS LETT A, V275, P12, DOI 10.1016/S0375-9601(00)00566-1; Haroche S., 2006, EXPLORING QUANTUM; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; Maniscalco S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.090503; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Raimond JM, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032120; Raimond JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.213601; Schafer F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4194; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Shao XQ, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/16/165507; Shi ZC, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2012-20733-1; Signoles A, 2014, NAT PHYS, V10, P715, DOI [10.1038/nphys3076, 10.1038/NPHYS3076]; Solgun F, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134504; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wang XB, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.062339	23	53	53	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					776	779		10.1126/science.1259345	http://dx.doi.org/10.1126/science.1259345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977546	Green Submitted			2022-12-28	WOS:000354428700037
J	Paul, M; Bishara, J; Yahav, D; Goldberg, E; Neuberger, A; Ghanem-Zoubi, N; Dickstein, Y; Nseir, W; Dan, M; Leibovici, L				Paul, Mical; Bishara, Jihad; Yahav, Dafna; Goldberg, Elad; Neuberger, Ami; Ghanem-Zoubi, Nesrin; Dickstein, Yaakov; Nseir, William; Dan, Michael; Leibovici, Leonard			Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOFT-TISSUE INFECTIONS; ANTIMICROBIAL SUSCEPTIBILITY; BACTEREMIA; THERAPY; COTRIMOXAZOLE; SKIN; TRIMETHOPRIM/SULFAMETHOXAZOLE; ENDOCARDITIS; COMBINATION; DAPTOMYCIN	OBJECTIVE To show non-inferiority of trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of severe infections due to meticillin resistant Staphylococcus aureus (MRSA). DESIGN Parallel, open label, randomised controlled trial. SETTING Four acute care hospitals in Israel. PARTICIPANTS Adults with severe infections caused by MRSA susceptible to trimethoprim-sulfamethoxazole and vancomycin. Patients with left sided endocarditis, meningitis, chronic haemodialysis, and prolonged neutropenia were excluded. INTERVENTIONS Trimethoprim-sulfamethoxazole 320 mg/1600 mg twice daily versus vancomycin 1 g twice daily for a minimum of seven days and then by indication. MAINOUTCOME MEASURES The primary efficacy outcome was treatment failure assessed at day 7, consisting of death, persistence of haemodynamic instability or fever, stable or worsening Sequential Organ Failure Assessment score, and persistence of bacteraemia. The primary safety outcome was all cause mortality at day 30. Non-inferiority was defined by a difference of less than 15% for treatment failure. RESULTS 252 patients were included in the trial, of whom 91 (36%) had bacteraemia. No significant difference in treatment failure was seen for trimethoprimsulfamethoxazole (51/135, 38%) versus vancomycin (32/117, 27%)-risk ratio 1.38 (95% confidence interval 0.96 to 1.99). However, trimethoprim-sulfamethoxazole did not meet the non-inferiority criterion-absolute difference 10.4% (95% confidence interval -1.2% to 21.5%). For patients with bacteraemia, the risk ratio was 1.40 (0.91 to 2.16). In a multivariable logistic regression analysis, trimethoprim-sulfamethoxazole was significantly associated with treatment failure (adjusted odds ratio 2.00, 1.09 to 3.65). The 30 day mortality rate was 32/252 (13%), with no significant difference between arms. Among patients with bacteraemia, 14/41 (34%) treated with trimethoprimsulfamethoxazole and 9/50 (18%) with vancomycin died (risk ratio 1.90, 0.92 to 3.93). CONCLUSIONS High dose trimethoprim-sulfamethoxazole did not achieve non-inferiority to vancomycin in the treatment of severe MRSA infections. The difference was particularly marked for patients with bacteraemia.	[Paul, Mical; Bishara, Jihad] Beilinson Med Ctr, Rabin Med Ctr, Unit Infect Dis, Petah Tiqwa, Israel; [Paul, Mical; Bishara, Jihad; Yahav, Dafna; Goldberg, Elad; Dan, Michael; Leibovici, Leonard] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Yahav, Dafna; Leibovici, Leonard] Beilinson Med Ctr, Rabin Med Ctr, Unit Infect Dis, Med E, Petah Tiqwa, Israel; [Goldberg, Elad] Beilinson Med Ctr, Rabin Med Ctr, Unit Infect Dis, Med F, Petah Tiqwa, Israel; [Neuberger, Ami] Rambam Hlth Care Campus, Div Infect Dis, Med B, IL-31096 Haifa, Israel; [Neuberger, Ami; Dickstein, Yaakov] Technion Israel Inst Technol, Haifa, Israel; [Neuberger, Ami; Dickstein, Yaakov] Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Paul, Mical; Ghanem-Zoubi, Nesrin] Rambam Hlth Care Campus, Div Infect Dis, IL-31096 Haifa, Israel; [Dickstein, Yaakov] Rambam Hlth Care Campus, Div Infect Dis, Med A, IL-31096 Haifa, Israel; [Nseir, William] Holy Family Hosp, Internal Med Dept, Nazareth, Israel; [Nseir, William] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Dan, Michael] E Wolfson Hosp, Infect Dis Unit, Holon, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus; Bar Ilan University	Paul, M (corresponding author), Rambam Hlth Care Campus, Div Infect Dis, IL-31096 Haifa, Israel.	paulm@post.tau.ac.il	Yahav, Dafna/AAX-9961-2020; Bishara, Jihad/AAV-1519-2021	Yahav, Dafna/0000-0003-3181-9791; Dickstein, Yaakov/0000-0002-1063-5478	Sima Lior scholarship; Rabin Medical Center Young Investigator scholarship	Sima Lior scholarship; Rabin Medical Center Young Investigator scholarship	The study was partially funded by the Sima Lior scholarship 2008 (MP) and Rabin Medical Center Young Investigator scholarship 2009 (DY). The funders had no role in trial design; data collection, analysis, or interpretation; or manuscript preparation.	Australian Group on Antimicrobial Resistance (AGAR), SAP 2012 ANT SUSC RE; Australian Group on Antimicrobial Resistance (AGAR), SAP 2011 ANT SUSC RE; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Campbell ML, 2012, ANN PHARMACOTHER, V46, P1587, DOI 10.1345/aph.1R211; Carnicer-Pont D, 2006, EPIDEMIOL INFECT, V134, P1167, DOI 10.1017/S0950268806006327; Cenizal MJ, 2007, ANTIMICROB AGENTS CH, V51, P2628, DOI 10.1128/AAC.00206-07; DEGORGOLAS M, 1995, ANTIMICROB AGENTS CH, V39, P953, DOI 10.1128/AAC.39.4.953; ELWELL LP, 1986, ANTIMICROB AGENTS CH, V29, P1092, DOI 10.1128/AAC.29.6.1092; Euba G, 2009, ANTIMICROB AGENTS CH, V53, P2672, DOI 10.1128/AAC.01504-08; Farrell DJ, 2014, ANTIMICROB AGENTS CH, V58, P3882, DOI 10.1128/AAC.02465-14; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Goldberg E, 2010, J ANTIMICROB CHEMOTH, V65, P1779, DOI 10.1093/jac/dkq179; Hanaki H, 2014, J INFECT CHEMOTHER, V20, P527, DOI 10.1016/j.jiac.2014.06.012; Harbarth S, 2015, J ANTIMICROB CHEMOTH, V70, P264, DOI 10.1093/jac/dku352; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kali A, 2013, J CLIN DIAGN RES, V7, P1979, DOI 10.7860/JCDR/2013/6142.3377; Kalil AC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003912; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; Levesque S, 2015, EPIDEMIOL INFECT, V143, P1511, DOI 10.1017/S095026881400209X; LEVITZ RE, 1984, ANN INTERN MED, V100, P881, DOI 10.7326/0003-4819-100-6-881; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; MARKOWITZ N, 1992, ANN INTERN MED, V117, P390, DOI 10.7326/0003-4819-117-5-390; Muileboom J, 2013, CAN J INFECT DIS MED, V24, pE42, DOI 10.1155/2013/169409; Nathwani D, 2010, BMJ CLIN EVID, V2010; Nurjadi D, 2014, J ANTIMICROB CHEMOTH, V69, P2361, DOI 10.1093/jac/dku174; Pappas G, 2009, J CHEMOTHERAPY, V21, P115, DOI 10.1179/joc.2009.21.2.115; Richter SS, 2011, ANTIMICROB AGENTS CH, V55, P4154, DOI 10.1128/AAC.00315-11; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Rubinstein E, 2011, CLIN INFECT DIS, V52, P31, DOI 10.1093/cid/ciq031; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, pO554, DOI 10.1111/1469-0691.12519; SCHELD WM, 1987, J ANTIMICROB CHEMOTH, V19, P647, DOI 10.1093/jac/19.5.647; Sharma NK, 2013, J CLIN DIAGN RES, V7, P2178, DOI 10.7860/JCDR/2013/6750.3463; SPICEHANDLER J, 1982, REV INFECT DIS, V4, P562; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Wackett A, 2012, J EMERG MED, V43, P754, DOI 10.1016/j.jemermed.2011.08.018; Wood JB, 2012, ANTIMICROB AGENTS CH, V56, P5655, DOI 10.1128/AAC.01011-12; Zhanel GG, 2013, J ANTIMICROB CHEMOTH, V68, pi7, DOI 10.1093/jac/dkt022	41	83	84	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h2219	10.1136/bmj.h2219	http://dx.doi.org/10.1136/bmj.h2219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5CI	25977146	hybrid, Green Published			2022-12-28	WOS:000354770100005
J	Hawkes, N				Hawkes, Nigel			Dangers of rising indemnity insurance costs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2015	350								h2542	10.1136/bmj.h2542	http://dx.doi.org/10.1136/bmj.h2542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5BX	25985335				2022-12-28	WOS:000354769000008
J	Lehrman, EK; Stevens, B				Lehrman, Emily K.; Stevens, Beth			Shedding Light on Glioma Growth	CELL			English	Editorial Material							NEUROLIGIN-1; CLEAVAGE	Cancer is known for opportunistically utilizing resources from its surroundings for its own growth and survival. In this issue of Cell, Venkatesh et al. demonstrate that this also occurs in the brain, identifying neuronal activity-induced secretion of neuroligin-3 as a novel mechanism promoting glioma proliferation.	[Lehrman, Emily K.; Stevens, Beth] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Stevens, B (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu						Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Khan T, 2011, J NEUROL NEUROSUR PS, V82, P1041, DOI 10.1136/jnnp.2010.228130; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	9	5	5	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					704	706		10.1016/j.cell.2015.04.036	http://dx.doi.org/10.1016/j.cell.2015.04.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957677	Bronze			2022-12-28	WOS:000354175200003
J	Savage, N				Savage, Neil			In Tight Times, Companies Fill the Funding Gap	CELL			English	Editorial Material								With federal budgets under pressure, scientists turn to corporations for research support.											0	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					699	701		10.1016/j.cell.2015.04.035	http://dx.doi.org/10.1016/j.cell.2015.04.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957675	Bronze			2022-12-28	WOS:000354175200001
J	Arie, S				Arie, Sophie			VACCINES Ebola: a game changer for vaccines, or a scare that will soon be forgotten?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com							0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h1938	10.1136/bmj.h1938	http://dx.doi.org/10.1136/bmj.h1938			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25948574				2022-12-28	WOS:000354414000003
J	Allen, JI; Weinberg, DS				Allen, John I.; Weinberg, David S.			Update in Gastroenterology and Hepatology: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLORECTAL-CANCER; UNITED-STATES; COHORT; RISK		[Allen, John I.] Yale Univ, Sch Med, 40 Temple St,Suite 1A, New Haven, CT 06510 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Yale University; Fox Chase Cancer Center	Allen, JI (corresponding author), Yale Univ, Sch Med, 40 Temple St,Suite 1A, New Haven, CT 06510 USA.	john.i.allen@yale.edu						Bang UC, 2014, GASTROENTEROLOGY, V146, P989, DOI 10.1053/j.gastro.2013.12.033; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P589, DOI 10.1016/j.cgh.2013.09.008; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Kabiri M, 2014, ANN INTERN MED, V161, P170, DOI 10.7326/M14-0095; Kappelman MD, 2014, CLIN GASTROENTEROL H, V12, P265, DOI 10.1016/j.cgh.2013.03.034; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Morris AM, 2014, JAMA-J AM MED ASSOC, V311, P287, DOI 10.1001/jama.2013.282025; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Russo MW, 2014, HEPATOLOGY, V60, P679, DOI 10.1002/hep.27157	12	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W96	W101		10.7326/M15-0242	http://dx.doi.org/10.7326/M15-0242			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927479				2022-12-28	WOS:000379893300004
J	Costanzo, P; Cleland, JGF; Pellicori, P; Clark, AL; Hepburn, D; Kilpatrick, ES; Perrone-Filardi, P; Zhang, JF; Atkin, SL				Costanzo, Pierluigi; Cleland, John G. F.; Pellicori, Pierpaolo; Clark, Andrew L.; Hepburn, David; Kilpatrick, Eric S.; Perrone-Filardi, Pasquale; Zhang, Jufen; Atkin, Stephen L.			The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; CARDIORESPIRATORY FITNESS; TRANSLATING RESEARCH; INSULIN-RESISTANCE; VASCULAR-DISEASE; MORTALITY; WEIGHT; PREDICTORS; OVERWEIGHT	Background: Whether obesity is associated with a better prognosis in patients with type 2 diabetes mellitus is controversial. Objective: To investigate the association between body weight and prognosis in a large cohort of patients with type 2 diabetes followed for a prolonged period. Design: Prospective cohort. Setting: National Health Service, England. Patients: Patients with diabetes. Measurements: The relationship between body mass index (BMI) and prognosis in patients with type 2 diabetes without known cardiovascular disease at baseline was investigated. Information on all-cause mortality and cardiovascular morbidity (such as the acute coronary syndrome, cerebrovascular accidents, and heart failure) was collected. Cox regression survival analysis, corrected for potential modifiers, including cardiovascular risk factors and comorbid conditions (such as cancer, chronic kidney disease, and lung disease), was done. Results: 10 568 patients were followed for a median of 10.6 years (interquartile range, 7.8 to 13.4). Median age was 63 years (interquartile range, 55 to 71), and 54% of patients were men. Overweight or obese patients (BMI >25 kg/m(2)) had a higher rate of cardiac events (such as the acute coronary syndrome and heart failure) than those of normal weight (BMI, 18.5 to 24.9 kg/m(2)). However, being overweight (BMI, 25 to 29.9 kg/m2) was associated with a lower mortality risk, whereas obese patients (BMI >30 kg/m(2)) had a mortality risk similar to that of normal-weight persons. Patients with low body weight had the worst prognosis. Limitation: Data about cause of death were not available. Conclusion: In this cohort, patients with type 2 diabetes who were overweight or obese were more likely to be hospitalized for cardiovascular reasons. Being overweight was associated with a lower mortality risk, but being obese was not.	Univ Hull, York Med Sch, Kingston Upon Hull, Yorks, England; Castle Hill Hosp, Cottingham, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ Naples Federico II, Naples, Italy	University of Hull; University of Hull; Imperial College London; University of Naples Federico II	Costanzo, P (corresponding author), Univ Hull, Acad Cardiol Unit, Hull York Med Sch, Castle Hill Hosp, Cottingham HU16 5JQ, England.	pierluigicostanzo83@gmail.com	Cleland, John G./AAZ-4185-2020; Atkin, stephen/ABE-7047-2020; Perrone Filardi, Pasquale/AAC-7590-2022; Pellicori, Pierpaolo/N-1880-2013; Atkin, Stephen/D-7400-2014	Cleland, John G./0000-0002-1471-7016; Pellicori, Pierpaolo/0000-0001-7175-0464; Atkin, Stephen/0000-0002-5887-7257	National Institute for Health Research; University of Hull; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Hull; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research and University of Hull.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; BALKAU B, 1993, BRIT MED J, V307, P295, DOI 10.1136/bmj.307.6899.295; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; CHATURVEDI N, 1995, DIABETES CARE, V18, P766, DOI 10.2337/diacare.18.6.766; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Czernichow S, 2011, EUR J CARDIOV PREV R, V18, P312, DOI 10.1097/HJR.0b013e32833c1aa3; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Dorner TE, 2012, INT J CARDIOL, V155, P56, DOI 10.1016/j.ijcard.2011.01.076; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FORD ES, 1991, AM J EPIDEMIOL, V133, P1220, DOI 10.1093/oxfordjournals.aje.a115834; Futter JE, 2011, EUR J HEART FAIL, V13, P207, DOI 10.1093/eurjhf/hfq218; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jackson CL, 2014, J GEN INTERN MED, V29, P25, DOI 10.1007/s11606-013-2553-7; Jahangir E, 2014, PROG CARDIOVASC DIS, V57, P127, DOI 10.1016/j.pcad.2014.01.001; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Khalangot M, 2009, HEART, V95, P454, DOI 10.1136/hrt.2008.150524; Knowler WC, 2014, LANCET DIABETES ENDO, V2, P801, DOI 10.1016/S2213-8587(14)70156-1; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; McEwen LN, 2007, DIABETES CARE, V30, P1736, DOI 10.2337/dc07-0305; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; MORRISH NJ, 1990, DIABETOLOGIA, V33, P538, DOI 10.1007/BF00404141; Morse SA, 2010, CURR HYPERTENS REP, V12, P120, DOI 10.1007/s11906-010-0099-1; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; PETTITT DJ, 1982, AM J EPIDEMIOL, V115, P359, DOI 10.1093/oxfordjournals.aje.a113313; Public Health England, 2015, INT COMP; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; ROSENGREN A, 1989, BRIT MED J, V299, P1127, DOI 10.1136/bmj.299.6708.1127; Ross C, 1997, DIABETES CARE, V20, P650, DOI 10.2337/diacare.20.4.650; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; SASAKI A, 1989, DIABETES RES CLIN PR, V7, P33, DOI 10.1016/0168-8227(89)90042-9; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Vittinghoff E, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b138825; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Zoppini G, 2003, INT J OBESITY, V27, P281, DOI 10.1038/sj.ijo.802199	51	119	122	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					610	U208		10.7326/M14-1551	http://dx.doi.org/10.7326/M14-1551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938991				2022-12-28	WOS:000354119100005
J	Loxterkamp, D				Loxterkamp, David			Fishing upstream: health and the social history	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, Maine, North Ireland		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, Maine, North Ireland.	david.loxterkamp@gmail.com						[Anonymous], 2015, WHAT SHAP HLTH; Behforouz HL, 2014, NEW ENGL J MED, V371, P1277, DOI 10.1056/NEJMp1404846; Bradley E., 2013, AM HLTH CARE PARADOX; Gawande Atul, 2011, New Yorker, P40; Gladwell, 2006, NEW YORKER; Kelto A., 2015, NPR             0312; Manchada R., 2014, WHAT MAKES US SICK L; Rigotti NA, 2015, OVERVIEW SMOKING CES; Schroeder SA, 2013, NEW ENGL J MED, V368, P389, DOI 10.1056/NEJMe1213751	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2015	350								h2378	10.1136/bmj.h2378	http://dx.doi.org/10.1136/bmj.h2378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0FV	25943330				2022-12-28	WOS:000354413100006
J	Kunitski, M; Zeller, S; Voigtsberger, J; Kalinin, A; Schmidt, LPH; Schoffler, M; Czasch, A; Schollkopf, W; Grisenti, RE; Jahnke, T; Blume, D; Dorner, R				Kunitski, Maksim; Zeller, Stefan; Voigtsberger, Joerg; Kalinin, Anton; Schmidt, Lothar Ph H.; Schoeffler, Markus; Czasch, Achim; Schoellkopf, Wieland; Grisenti, Robert E.; Jahnke, Till; Blume, Doerte; Doerner, Reinhard			Observation of the Efimov state of the helium trimer	SCIENCE			English	Article							SELECTION	Quantum theory dictates that upon weakening the two-body interaction in a three-body system, an infinite number of three-body bound states of a huge spatial extent emerge just before these three-body states become unbound. Three helium (He) atoms have been predicted to form a molecular system that manifests this peculiarity under natural conditions without artificial tuning of the attraction between particles by an external field. Here we report experimental observation of this long-predicted but experimentally elusive Efimov state of He-4(3) by means of Coulomb explosion imaging. We show spatial images of an Efimov state, confirming the predicted size and a typical structure where two atoms are close to each other while the third is far away.	[Kunitski, Maksim; Zeller, Stefan; Voigtsberger, Joerg; Kalinin, Anton; Schmidt, Lothar Ph H.; Schoeffler, Markus; Czasch, Achim; Grisenti, Robert E.; Jahnke, Till; Doerner, Reinhard] Goethe Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; [Schoellkopf, Wieland] Fritz Haber Inst, Dept Mol Phys, D-14195 Berlin, Germany; [Grisenti, Robert E.] GSI Helmholtz Ctr Heavy Ion Res, D-64291 Darmstadt, Germany; [Blume, Doerte] Washington State Univ, Dept Phys & Astron, Pullman, WA 99164 USA	Goethe University Frankfurt; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Washington State University	Kunitski, M (corresponding author), Goethe Univ Frankfurt, Inst Kernphys, Max von Laue Str 1, D-60438 Frankfurt, Germany.	kunitski@atom.uni-frankfurt.de; doerner@atom.uni-frankfurt.de	Doerner, Reinhard/A-5340-2008; Kunitski, Maksim/W-5272-2018; Jahnke, Till/AGE-4901-2022; Schöllkopf, Wieland/AAI-2477-2019; Schoeffler, Markus/B-6261-2008	Doerner, Reinhard/0000-0002-3728-4268; Kunitski, Maksim/0000-0001-6543-8722; Schoeffler, Markus/0000-0001-9214-6848; Schollkopf, Wieland/0000-0003-0564-203X	Reinhart Koselleck project of the Deutsche Forschungsgemeinschaft; Goethe-University Frankfurt am Main; U.S. National Science Foundation [PHY-1205443]	Reinhart Koselleck project of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe-University Frankfurt am Main; U.S. National Science Foundation(National Science Foundation (NSF))	The experimental work was supported by a Reinhart Koselleck project of the Deutsche Forschungsgemeinschaft. The financial support of the Goethe-University Frankfurt am Main is gratefully acknowledged. D.B. acknowledges support by the U.S. National Science Foundation through grant number PHY-1205443. Authors thank J. Williams for the proofreading of the manuscript. Raw data are archived at the Goethe-University Frankfurt am Main and are available upon request.	Bedaque PF, 2000, NUCL PHYS A, V676, P357, DOI 10.1016/S0375-9474(00)00205-0; Blume D, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892564; Blume D, 2000, J CHEM PHYS, V112, P8053, DOI 10.1063/1.481404; Blume D, 2000, J CHEM PHYS, V113, P2145, DOI 10.1063/1.482027; Braaten E, 2006, PHYS REP, V428, P259, DOI 10.1016/j.physrep.2006.03.001; Bruch LW, 2002, J CHEM PHYS, V117, P1544, DOI 10.1063/1.1486442; Bruhl R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063002; Cencek W, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4712218; CORNELIUS T, 1986, J CHEM PHYS, V85, P3906, DOI 10.1063/1.450912; EFIMOV V, 1970, PHYS LETT B, VB 33, P563, DOI 10.1016/0370-2693(70)90349-7; Esry BD, 1996, PHYS REV A, V54, P394, DOI 10.1103/PhysRevA.54.394; Hegerfeldt GC, 2000, PHYS REV LETT, V84, P3215, DOI 10.1103/PhysRevLett.84.3215; Hiyama E, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062505; Hiyama E, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022502; Jagutzki O, 2002, IEEE T NUCL SCI, V49, P2477, DOI 10.1109/TNS.2002.803889; Kolganova EA, 2011, FEW-BODY SYST, V51, P249, DOI 10.1007/s00601-011-0233-x; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; LIM TK, 1977, PHYS REV LETT, V38, P341, DOI 10.1103/PhysRevLett.38.341; Lompe T, 2010, SCIENCE, V330, P940, DOI 10.1126/science.1193148; Naidon P, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012502; Nakajima S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143201; Nielsen E, 1998, J PHYS B-AT MOL OPT, V31, P4085, DOI 10.1088/0953-4075/31/18/008; Nishida Y, 2013, NAT PHYS, V9, P93, DOI 10.1038/nphys2523; Pal T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028105; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; VAGER Z, 1989, SCIENCE, V244, P426, DOI 10.1126/science.244.4903.426; Voigtsberger J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6765; Wintgen D, 1992, CHAOS, V2, P19, DOI 10.1063/1.165920	29	163	166	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					551	555		10.1126/science.aaa5601	http://dx.doi.org/10.1126/science.aaa5601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931554	Green Submitted			2022-12-28	WOS:000353778100036
J	Doherty, RB				Doherty, Robert B.			Goodbye, Sustainable Growth Rate-Hello, Merit-Based Incentive Payment System	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.							McClellan M., 2015, HLTH POLICY ISSUE BR; Reschovsky JD, 2015, HEALTH AFFAIR, V34, P689, DOI 10.1377/hlthaff.2014.1429	2	27	27	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					138	+		10.7326/M15-0992	http://dx.doi.org/10.7326/M15-0992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	25961185				2022-12-28	WOS:000358407500022
J	Wall, SP; Plunkett, C; Caplan, A				Wall, Stephen P.; Plunkett, Carolyn; Caplan, Arthur			A Potential Solution to the Shortage of Solid Organs for Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DONATION		[Wall, Stephen P.] NYU, Ronald O Perelman Dept Emergency Med, Bellevue Hosp Center, Sch Med, New York, NY 10016 USA; [Plunkett, Carolyn; Caplan, Arthur] NYU, Div Med Eth, Sch Med, New York, NY 10016 USA; [Plunkett, Carolyn] CUNY, Grad Ctr, Philosophy Program, New York, NY USA	New York University; New York University; City University of New York (CUNY) System	Wall, SP (corresponding author), NYU, Ronald O Perelman Dept Emergency Med, Bellevue Hosp Center, Sch Med, OBV Ste 345A, New York, NY 10016 USA.	Stephen.Wall@nyumc.org		Wall, Stephen/0000-0003-3965-5074	OSTLTS CDC HHS [R38OT08761] Funding Source: Medline	OSTLTS CDC HHS		*CDC, INJ PREV CONTR DAT S; Childress JF., 2006, ORGAN DONATION OPPOR; Organ Procurement and Transplantation Network (OPTN), 2015, ORG PROC TRANSPL DAT; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x; Rudge C, 2012, BRIT J ANAESTH, V108, pI48, DOI 10.1093/bja/aer399; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Wall SR, 2014, ANN EMERG MED, V63, P392, DOI 10.1016/j.annemergmed.2013.10.014	7	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2321	2322		10.1001/jama.2015.5328	http://dx.doi.org/10.1001/jama.2015.5328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	25961717	Bronze			2022-12-28	WOS:000356300200013
J	Xie, XS				Xie, Xiaoliang Sunney			Single Molecules Meet Genomics Pinpointing Precision Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		[Xie, Xiaoliang Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Xie, Xiaoliang Sunney] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Harvard University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			NATIONAL CANCER INSTITUTE [DP1CA186693] Funding Source: NIH RePORTER; NCI NIH HHS [DP1 CA186693] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, NAT METHODS, V11, P1; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Heger M., 2015, PEKING U REPORTS 1 S; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	10	3	4	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2021	2022		10.1001/jama.2015.5533	http://dx.doi.org/10.1001/jama.2015.5533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	25974149				2022-12-28	WOS:000355142400011
J	Katsnelson, A				Katsnelson, Alla			MICROBIOME The puzzle in a bee's gut	NATURE			English	Editorial Material							HONEY-BEE											Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lee FJ, 2014, ENV MICROBIOL; Tarpy DR, 2015, APPL ENVIRON MICROB, V81, P3182, DOI 10.1128/AEM.00307-15	5	3	3	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S56	S56		10.1038/521S56a	http://dx.doi.org/10.1038/521S56a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992673				2022-12-28	WOS:000354816500002
J	Manglik, A; Kim, TH; Masureel, M; Altenbach, C; Yang, ZY; Hilger, D; Lerch, MT; Kobilka, TS; Thian, FS; Hubbell, WL; Prosser, RS; Kobilka, BK				Manglik, Aashish; Kim, Tae Hun; Masureel, Matthieu; Altenbach, Christian; Yang, Zhongyu; Hilger, Daniel; Lerch, Michael T.; Kobilka, Tong Sun; Thian, Foon Sun; Hubbell, Wayne L.; Prosser, R. Scott; Kobilka, Brian K.			Structural Insights into the Dynamic Process of beta(2)-Adrenergic Receptor Signaling	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; CONFORMATIONAL STATES; ACTIVATION; RHODOPSIN; ADRENOCEPTOR; EQUILIBRIUM; MECHANISM; KINETICS; COMPLEX	G-protein-coupled receptors (GPCRs) transduce signals from the extracellular environment to intracellular proteins. To gain structural insight into the regulation of receptor cytoplasmic conformations by extracellular ligands during signaling, we examine the structural dynamics of the cytoplasmic domain of the beta(2)-adrenergic receptor (beta(2)AR) using (19) F-fluorine NMR and double electron-electron resonance spectroscopy. These studies show that unliganded and inverse-agonist-bound beta(2)AR exists predominantly in two inactive conformations that exchange within hundreds of microseconds. Although agonists shift the equilibrium toward a conformation capable of engaging cytoplasmic G proteins, they do so incompletely, resulting in increased conformational heterogeneity and the coexistence of inactive, intermediate, and active states. Complete transition to the active conformation requires subsequent interaction with a G protein or an intracellular G protein mimetic. These studies demonstrate a loose allosteric coupling of the agonist-binding site and G-protein-coupling interface that may generally be responsible for the complex signaling behavior observed for many GPCRs.	[Manglik, Aashish; Masureel, Matthieu; Hilger, Daniel; Kobilka, Tong Sun; Thian, Foon Sun; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Tae Hun; Prosser, R. Scott] Univ Toronto, UTM, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Altenbach, Christian; Yang, Zhongyu; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Altenbach, Christian; Yang, Zhongyu; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Stanford University; University of Toronto; University Toronto Mississauga; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu	Lerch, Michael/AAC-8551-2019	Lerch, Michael/0000-0002-2406-9972; Kobilka, Brian/0000-0001-5958-3990	American Heart Association Award [12PRE8120001, 15POST22700020]; Natural Sciences and Engineering Research Council of Canada [261980]; National Institutes of Health [R01EY005216, P30EY00331, R01GM083118, R01NS028571]; Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics; German Academic Exchange Service (DAAD); Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation; Research Accelerator Award; NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	American Heart Association Award(American Heart Association); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation; Research Accelerator Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Award 12PRE8120001 (A.M.) and 15POST22700020 (M.M.); by the Natural Sciences and Engineering Research Council of Canada under a Discovery Award (261980) and Research Accelerator Award (R.S.P.); and by the National Institutes of Health under award numbers R01EY005216 and P30EY00331 (W.L.H.), R01GM083118, and R01NS028571 (B.K.K.). We would also like to acknowledge support from the Jules Stein Professor endowment (W.L.H.). T.H.K. was supported by the Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics. D.H. was supported by the German Academic Exchange Service (DAAD). M.M. was supported by a Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DeLange F, 1997, EUR J BIOCHEM, V243, P174, DOI 10.1111/j.1432-1033.1997.0174a.x; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Klein-Seetharaman J, 1999, P NATL ACAD SCI USA, V96, P13744, DOI 10.1073/pnas.96.24.13744; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Lohse MJ, 2014, CURR OPIN CELL BIOL, V27, P87, DOI 10.1016/j.ceb.2013.11.009; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reich H.J., 1995, J CHEM EDUC, V72, P1; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Shi LC, 2014, P NATL ACAD SCI USA, V111, P2140, DOI 10.1073/pnas.1318476111; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	35	411	419	8	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1101	1111		10.1016/j.cell.2015.04.043	http://dx.doi.org/10.1016/j.cell.2015.04.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25981665	Bronze, Green Accepted			2022-12-28	WOS:000355152600017
J	Schimmel, P				Schimmel, Paul			Alexander Rich (1924-2015) OBITUARY	NATURE			English	Biographical-Item									[Schimmel, Paul] Scripps Res Inst, Cell & Mol Biol, Jupiter, FL 33458 USA; [Schimmel, Paul] Scripps Res Inst, Cell & Mol Biol, La Jolla, CA 92037 USA; [Schimmel, Paul] MIT, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT)	Schimmel, P (corresponding author), Scripps Res Inst, Cell & Mol Biol, Jupiter, FL 33458 USA.	schimmel@scripps.edu						RICH A, PUBLICATION LIST	1	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					291	291		10.1038/521291a	http://dx.doi.org/10.1038/521291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25993953	Bronze			2022-12-28	WOS:000354816500039
J	Chan, JFW; Yuen, KY				Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung			A new ASPECT for complicated urinary tract infections	LANCET			English	Editorial Material							CEFTOLOZANE-TAZOBACTAM		[Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Carol Yu Ctr Infect, State Key Lab Emerging Infect, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Chan, JFW (corresponding author), Univ Hong Kong, Dept Microbiol, Carol Yu Ctr Infect, State Key Lab Emerging Infect, Pokfulam, Hong Kong, Peoples R China.	jfwchan@hku.hk	Chan, Jasper F. W./D-8007-2013	Chan, Jasper F. W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552				Farrell DJ, 2013, ANTIMICROB AGENTS CH, V57, P6305, DOI 10.1128/AAC.01802-13; Hoban DJ, 2011, DIAGN MICR INFEC DIS, V70, P507, DOI 10.1016/j.diagmicrobio.2011.03.021; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Sandberg T, 2012, LANCET, V380, P484, DOI 10.1016/S0140-6736(12)60608-4; To KKW, 2013, INT J INFECT DIS, V17, pE120, DOI 10.1016/j.ijid.2012.09.008; Umeh O, 2010, 50 INT C ANT AG CHEM; Wagenlehner FME, 2008, EUR J CLIN INVEST, V38, P45, DOI 10.1111/j.1365-2362.2008.02008.x; Wagenlehner FM, 2015, LANCET; Wooley M, 2014, ANTIMICROB AGENTS CH, V58, P2249, DOI 10.1128/AAC.02151-13; Zhanel GG, 2014, DRUGS, V74, P31, DOI 10.1007/s40265-013-0168-2	10	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1920	1922		10.1016/S0140-6736(14)62482-X	http://dx.doi.org/10.1016/S0140-6736(14)62482-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	25931245				2022-12-28	WOS:000354541700005
J	Gravitz, L				Gravitz, Lauren			PREVENTION Tending the gut	NATURE			English	Editorial Material							COLORECTAL-CANCER								NATIONAL CANCER INSTITUTE [UG1CA189974] Funding Source: NIH RePORTER; NCI NIH HHS [UG1 CA189974] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Joshu CE, 2012, CANCER PREV RES, V5, P138, DOI 10.1158/1940-6207.CAPR-11-0322; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Orlich M. J., 2015, JAMA INTERN MED	5	8	8	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					S6	S8		10.1038/521S6a	http://dx.doi.org/10.1038/521S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25970457	Bronze			2022-12-28	WOS:000354377800003
J	Reilly, S; McKean, C; Morgan, A; Wake, M				Reilly, Sheena; McKean, Cristina; Morgan, Angela; Wake, Melissa			Identifying and managing common childhood language and speech impairments	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREDICTING TREATMENT TIME; QUALITY-OF-LIFE; FOLLOW-UP; PRESCHOOL-CHILDREN; LIDCOMBE PROGRAM; YOUNG-CHILDREN; AGE; PREVALENCE; DISORDERS; OUTCOMES		[Reilly, Sheena; McKean, Cristina; Morgan, Angela; Wake, Melissa] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Reilly, Sheena; McKean, Cristina; Morgan, Angela; Wake, Melissa] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [McKean, Cristina] Newcastle Univ, Speech & Language Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wake, Melissa] Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; Newcastle University - UK; Royal Children's Hospital Melbourne	Reilly, S (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	sheena.reilly@mcri.edu.au	Wake, Melissa/J-1396-2012; Reilly, Sheena/A-7035-2016; Morgan, Angela/J-5235-2017	Wake, Melissa/0000-0001-7501-9257; Reilly, Sheena/0000-0001-6506-4767; Morgan, Angela/0000-0003-1147-7405; McKean, Cristina/0000-0001-9058-9813				Andrews G, 1964, CLIN DEV MED, V17; Baird G, 2008, UNDERSTANDING DEV LA, P1; Baker E, 2011, LANG SPEECH HEAR SER, V42, P140, DOI 10.1044/0161-1461(2010/10-0023); BEITCHMAN JH, 1986, J SPEECH HEAR DISORD, V51, P98, DOI 10.1044/jshd.5102.98; Bernthal JE, 1998, ARTICULATION PHONOLO; Blood GW, 2010, J FLUENCY DISORD, V35, P92, DOI 10.1016/j.jfludis.2010.03.003; Bricker-Katz G, 2009, DISABIL REHABIL, V31, P1742, DOI 10.1080/09638280902738672; Cirrin FM, 2010, LANG SPEECH HEAR SER, V41, P233, DOI 10.1044/0161-1461(2009/08-0128); Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Dodd B., 2005, DIFFERENTIAL DIAGNOS, V2nd; Eadie P, 2014, DEV MED CHILD NEUROL; Ebbels SH, 2014, INT J LANG COMM DIS, V49, P30, DOI 10.1111/1460-6984.12047; Fenson L., 1993, MACARTHUR COMMUNICAT; Foy JG, 2012, READ WRIT, V25, P799, DOI 10.1007/s11145-011-9300-4; Gunther T, 2010, INT J LANG COMM DIS, V45, P345, DOI [10.3109/13682820903026762, 10.1080/13682820903026762]; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Jones M, 2005, BMJ-BRIT MED J, V331, P659, DOI 10.1136/bmj.38520.451840.E0; Jones M, 2000, J SPEECH LANG HEAR R, V43, P1440, DOI 10.1044/jslhr.4306.1440; Kefalianos E, 2014, J SPEECH LANG HEAR R, V57, P1314, DOI 10.1044/2014_JSLHR-S-13-0069; Kingston M, 2003, INT J LANG COMM DIS, V38, P165, DOI 10.1080/1368282031000062882; Law J, 2003, Cochrane Database Syst Rev, pCD004110, DOI 10.1002/14651858.CD004110; Levickis P, 2014, LATE TALKING DOES PA, V4; Lewis BA, 2011, J SPEECH LANG HEAR R, V54, P1628, DOI 10.1044/1092-4388(2011/10-0124); Liegeois Frederique, 2014, Curr Dev Disord Rep, V1, P215; Mansson H, 2000, J FLUENCY DISORD, V25, P47, DOI 10.1016/S0094-730X(99)00023-6; Mayes AK, 2015, DEV MED CHILD NEUROL; McAllister J, 2012, J FLUENCY DISORD, V37, P106, DOI 10.1016/j.jfludis.2012.01.002; McCartney E, INT J LANG COMMUN DI, V46, P74; McCormack J, 2011, J SPEECH LANG HEAR R, V54, P1328, DOI 10.1044/1092-4388(2011/10-0155); McCormick DP, 2006, AMBUL PEDIATR, V6, P280, DOI 10.1016/j.ambp.2006.04.010; Messenger M, 2004, J FLUENCY DISORD, V29, P201, DOI 10.1016/j.jfludis.2004.06.002; Morgan AT, 2008, COCHRANE DB SYST REV, V3; Morgan AT, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD006279.PUB2; Nelson HD, 2006, PEDIATRICS, V117, pE298, DOI 10.1542/peds.2005-1467; Nye C, 2013, J SPEECH LANG HEAR R, V56, P921, DOI 10.1044/1092-4388(2012/12-0036); Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Pennington L, 2009, COCHRANE DB SYST REV, V4; Proctor A, 2008, J SPEECH LANG HEAR R, V51, P1465, DOI 10.1044/1092-4388(2008/07-0057); Reilly S, 2007, PEDIATRICS, V120, pE1441, DOI 10.1542/peds.2007-0045; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Reilly S, 2013, PEDIATRICS, V132, P460, DOI 10.1542/peds.2012-3067; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; Reilly S, 2009, PEDIATRICS, V123, P270, DOI 10.1542/peds.2007-3219; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; Sandler AD, 2001, PEDIATRICS, V107; Schoon I, 2010, PEDIATRICS, V126, pE73, DOI 10.1542/peds.2009-3282; Schoon I, 2010, PEDIATRICS, V125, pE459, DOI 10.1542/peds.2008-2111; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; SHRIBERG LD, 1994, J SPEECH HEAR RES, V37, P1100, DOI 10.1044/jshr.3705.1100; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; The Royal Children's Hospital Melbourne Centre for Community Child Health, 2014, PRACTICE BRIEF   MAR; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Ukoumunne OC, 2012, CHILD CARE HLTH DEV, V38, P341, DOI 10.1111/j.1365-2214.2011.01234.x; Wake M, 2013, PEDIATRICS, V132, pE895, DOI 10.1542/peds.2012-3878; Wake M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-96; YAIRI E, 1993, J SPEECH HEAR RES, V36, P521, DOI 10.1044/jshr.3603.521	56	27	27	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2015	350								h2318	10.1136/bmj.h2318	http://dx.doi.org/10.1136/bmj.h2318			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI5CI	25976972	Green Published			2022-12-28	WOS:000354770100006
J	Kruk, ME; Myers, M; Varpilah, ST; Dahn, BT				Kruk, Margaret E.; Myers, Michael; Varpilah, S. Tornorlah; Dahn, Bernice T.			What is a resilient health system? Lessons from Ebola	LANCET			English	Editorial Material							CRISIS; MANAGEMENT		[Kruk, Margaret E.] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Myers, Michael] Rockefeller Fdn, New York, NY USA; [Varpilah, S. Tornorlah] Natl Port Author, Monrovia, Liberia; [Dahn, Bernice T.] Minist Hlth & Social Welf, Monrovia, Liberia	Harvard University; Harvard T.H. Chan School of Public Health	Kruk, ME (corresponding author), Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	mkruk@hsph.harvard.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432				Allenby B, 2005, SCIENCE, V309, P1034, DOI 10.1126/science.1111534; Anderies JM, 2002, ECOSYSTEMS, V5, P23, DOI 10.1007/s10021-001-0053-9; Anderies JM, 2006, ECOSYSTEMS, V9, P865, DOI 10.1007/s10021-006-0017-1; [Anonymous], 2014, LANCET, V384, P1321, DOI 10.1016/S0140-6736(14)61697-4; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Dalziell EP, 2004, 1 INT FOR ENG DEC MA; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Kimball AM, 2014, LANCET, V384, P2023, DOI 10.1016/S0140-6736(14)62330-8; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Perkins D.D., 2002, COMMUNITY DEV, V33, P33, DOI DOI 10.1080/15575330209490141; Rockefeller Foundation, 2014, CIT RES FRAM; Rodin Judith, 2014, RESILIENCE DIVIDEND, P6; Thomas S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-450; World Health Organization, 2015, WHO GLOB HLTH OBS DA	18	268	274	3	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1910	1912		10.1016/S0140-6736(15)60755-3	http://dx.doi.org/10.1016/S0140-6736(15)60755-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25987159				2022-12-28	WOS:000354184500034
J	Egan, ES; Jiang, RHY; Moechtar, MA; Barteneva, NS; Weekes, MP; Nobre, LV; Gygi, SP; Paulo, JA; Frantzreb, C; Tani, Y; Takahashi, J; Watanabe, S; Goldberg, J; Paul, AS; Brugnara, C; Root, DE; Wiegand, RC; Doench, JG; Duraisingh, MT				Egan, Elizabeth S.; Jiang, Rays H. Y.; Moechtar, Mischka A.; Barteneva, Natasha S.; Weekes, Michael P.; Nobre, Luis V.; Gygi, Steven P.; Paulo, Joao A.; Frantzreb, Charles; Tani, Yoshihiko; Takahashi, Junko; Watanabe, Seishi; Goldberg, Jonathan; Paul, Aditya S.; Brugnara, Carlo; Root, David E.; Wiegand, Roger C.; Doench, John G.; Duraisingh, Manoj T.			A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion	SCIENCE			English	Article							RED-BLOOD-CELLS; GROUP-A STREPTOCOCCUS; RESISTANCE LOCI; INAB PHENOTYPE; GENOME-WIDE; MALARIA; RECEPTOR; ASSOCIATION; ATTACHMENT; PARASITES	Efforts to identify host determinants for malaria have been hindered by the absence of a nucleus in erythrocytes, which precludes genetic manipulation in the cell in which the parasite replicates. We used cultured red blood cells derived from hematopoietic stem cells to carry out a forward genetic screen for Plasmodium falciparum host determinants. We found that CD55 is an essential host factor for P. falciparum invasion. CD55-null erythrocytes were refractory to invasion by all isolates of P. falciparum because parasites failed to attach properly to the erythrocyte surface. Thus, CD55 is an attractive target for the development of malaria therapeutics. Hematopoietic stem cell-based forward genetic screens may be valuable for the identification of additional host determinants of malaria pathogenesis.	[Egan, Elizabeth S.; Jiang, Rays H. Y.; Moechtar, Mischka A.; Frantzreb, Charles; Goldberg, Jonathan; Paul, Aditya S.; Duraisingh, Manoj T.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Egan, Elizabeth S.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Jiang, Rays H. Y.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Jiang, Rays H. Y.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA; [Barteneva, Natasha S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Barteneva, Natasha S.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Weekes, Michael P.; Nobre, Luis V.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gygi, Steven P.; Paulo, Joao A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Tani, Yoshihiko; Takahashi, Junko] Japanese Red Cross Kinki Block Blood Ctr, Osaka, Japan; [Watanabe, Seishi] Japanese Red Cross Kyushu Block Blood Ctr, Fukuoka, Japan; [Brugnara, Carlo] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston, MA USA; [Root, David E.; Wiegand, Roger C.; Doench, John G.; Duraisingh, Manoj T.] Broad Inst Harvard & Massachussetts Insititute Te, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Cambridge; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Duraisingh, MT (corresponding author), Broad Inst Harvard & Massachussetts Insititute Te, Cambridge, MA 02142 USA.	mduraisi@hsph.harvard.edu	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022; Paulo, Joao/AAO-3981-2020; Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Paulo, Joao/0000-0002-4291-413X; Barteneva, Natalie/0000-0002-8109-1754; Weekes, Michael/0000-0003-3196-5545; Nobre, Luis/0000-0003-0467-8989	Foundation Grand Challenges Exploration Award [OPP1035276]; NIH [R01AI091787, K08 1K08AI103034-01A1, K01DK098285]; Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]; Boston Children's Hospital Faculty Development Award; Cambridge Biomedical Research Center, UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI103034, R01AI091787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER	Foundation Grand Challenges Exploration Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Boston Children's Hospital Faculty Development Award; Cambridge Biomedical Research Center, UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Wirth, M. Ganter, A. Nicholson-Weller, M. Waldor, S. Lux, R. Husson, B. Burleigh, and members of the Duraisingh Laboratory for helpful discussions and reading of the manuscript. We thank C. Westhoff and C. Lomas-Francis of the New York Blood Center for gift of the second Inab sample. We thank U. Kanjee for technical assistance and D. Ndiaye, S. Mboup, and S. Volkman for P. falciparum clinical isolates from Senegal. This work was supported by a Gates Foundation Grand Challenges Exploration Award OPP1035276 (M.T.D.), NIH grant R01AI091787 (M.T.D.), a Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development K12-HD000850 (E.S.E), NIH grant K08 1K08AI103034-01A1 (E.S.E.), Boston Children's Hospital Faculty Development Award (E.S.E.), NIH grant K01DK098285 (J.A.P.), and the Cambridge Biomedical Research Center, UK (M.P.W. and L.V.N.). Additional data can be found in the supplementary materials.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Fairhurst RM, 2010, PRINCIPLES PRACTICE, V2, P3437; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gwamaka M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-386; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hue-Roye K, 2005, Immunohematology, V21, P53; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MERRY AH, 1989, BRIT J HAEMATOL, V73, P248, DOI 10.1111/j.1365-2141.1989.tb00260.x; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NOWICKI B, 1988, AM J PATHOL, V133, P1; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; REID ME, 1991, BLOOD, V78, P3291; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Storry J R, 2010, Immunohematology, V26, P109; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Takahashi J., 2008, JAPAN J TRANSF CELL, V54, P359; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Taylor SM, 2014, CURR OPIN HEMATOL, V21, P193, DOI 10.1097/MOH.0000000000000039; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	35	76	76	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					711	714		10.1126/science.aaa3526	http://dx.doi.org/10.1126/science.aaa3526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954012	Green Accepted			2022-12-28	WOS:000354045700050
J	Zhang, GQ; Huang, H; Liu, D; Cheng, Y; Liu, XL; Zhang, WX; Yin, RC; Zhang, DP; Zhang, P; Liu, JZ; Li, CY; Liu, BD; Luo, YW; Zhu, YX; Zhang, N; He, SM; He, C; Wang, HL; Chen, DH				Zhang, Guoqiang; Huang, Hua; Liu, Di; Cheng, Ying; Liu, Xiaoling; Zhang, Wenxin; Yin, Ruichuan; Zhang, Dapeng; Zhang, Peng; Liu, Jianzhao; Li, Chaoyi; Liu, Baodong; Luo, Yuewan; Zhu, Yuanxiang; Zhang, Ning; He, Shunmin; He, Chuan; Wang, Hailin; Chen, Dahua			N-6-Methyladenine DNA Modification in Drosophila	CELL			English	Article							STEM-CELL NICHE; ADAPTIVE RESPONSE; MAMMALIAN DNA; METHYLATION; 5-METHYLCYTOSINE; DEMETHYLATION; 5-CARBOXYLCYTOSINE; BASE; 5-HYDROXYMETHYLCYTOSINE; METHYLTRANSFERASE	DNA N-6-methyladenine (6mA) modification is commonly found in microbial genomes and plays important functions in regulating numerous biological processes in bacteria. However, whether 6mA occurs and what its potential roles are in higher-eukaryote cells remain unknown. Here, we show that 6mA is present in Drosophila genome and that the 6mA modification is dynamic and is regulated by the Drosophila Tet homolog, DNA 6mA demethylase ( DMAD), during embryogenesis. Importantly, our biochemical assays demonstrate that DMAD directly catalyzes 6mA demethylation in vitro. Further genetic and sequencing analyses reveal that DMAD is essential for development and that DMAD removes 6mA primarily from transposon regions, which correlates with transposon suppression in Drosophila ovary. Collectively, we uncover a DNA modification in Drosophila and describe a potential role of the DMAD-6mA regulatory axis in controlling development in higher eukaryotes.	[Zhang, Guoqiang; Cheng, Ying; Zhang, Wenxin; Li, Chaoyi; Luo, Yuewan; Zhu, Yuanxiang; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Huang, Hua; Liu, Di; Liu, Xiaoling; Yin, Ruichuan; Zhang, Dapeng; Liu, Baodong; Zhang, Ning; Wang, Hailin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Zhang, Peng; He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Chicago, IL 60637 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Zoology, CAS; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Chen, DH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	hlwang@rcees.ac.cn; chendh@ioz.ac.cn	Cheng, Ying/GOK-0705-2022; Liu, Jianzhao/AAO-2359-2020; Yin, Ruichuan/Q-7045-2016; Liu, Xiaoling/HGD-3566-2022; He, Shunmin/B-8037-2011; Liu, Jianzhao/E-9165-2011; Yin, Ruichuan/AAZ-4569-2021	Liu, Jianzhao/0000-0001-9465-6075; Yin, Ruichuan/0000-0001-8478-7100; He, Shunmin/0000-0002-7294-0865; Liu, Jianzhao/0000-0001-9465-6075; Yin, Ruichuan/0000-0001-8478-7100; Luo, Yuewan/0000-0002-8964-5301; Cheng, Ying/0000-0002-4233-5330; Zhang, Peng/0000-0001-9303-1639; huang, hua/0000-0002-9881-4197	National Basic Research Program of China [2013CB945002]; Natural Science Foundation of China [31130036, 21125523, 21327006, 91019022]; Chinese Academy of Sciences [XDB14030200, XDA01010306, YSW2013A01]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National Basic Research Program of China (2013CB945002), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB14030200 and XDA01010306), Natural Science Foundation of China (31130036, 21125523, 21327006, and 91019022), and the Chinese Academy of Sciences (YSW2013A01).	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang HD, 2014, J CELL BIOL, V206, P217, DOI 10.1083/jcb.201401002; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LAWLEY PD, 1972, BIOCHEM J, V128, P133, DOI 10.1042/bj1280133; Li DY, 2012, J AM CHEM SOC, V134, P8896, DOI 10.1021/ja3010094; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	350	373	13	209	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					893	906		10.1016/j.cell.2015.04.018	http://dx.doi.org/10.1016/j.cell.2015.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936838	Bronze			2022-12-28	WOS:000354175200021
J	Bryan, CS				Bryan, Charles S.			Osler redux: the American College of Physicians at 100	LANCET			English	Editorial Material									Univ S Carolina, Sch Med, Sisters Char Providence Hosp, Columbia, SC 29204 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bryan, CS (corresponding author), Univ S Carolina, Sch Med, Sisters Char Providence Hosp, Columbia, SC 29204 USA.	charles.bryan@providencehospitals.com						Gourevitch D, 1999, LANCET, V354, P33, DOI 10.1016/S0140-6736(99)90376-8; STEVENS R, 1986, ANN INTERN MED, V105, P592, DOI 10.7326/0003-4819-105-4-592; Tooker J, 2015, SERVING OUR PATIENTS	3	0	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1720	1721		10.1016/S0140-6736(15)60881-9	http://dx.doi.org/10.1016/S0140-6736(15)60881-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25943928				2022-12-28	WOS:000353726000015
J	Woodruff, PG; Agusti, A; Roche, N; Singh, D; Martinez, FJ				Woodruff, Prescott G.; Agusti, Alvar; Roche, Nicolas; Singh, Dave; Martinez, Fernando J.			Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management	LANCET			English	Article							INHALED FLUTICASONE FUROATE; SHORT-TERM RESPONSE; C-REACTIVE PROTEIN; AIRWAY INFLAMMATION; NETWORK MEDICINE; DOUBLE-BLIND; SPUTUM-EOSINOPHILIA; CORTICOSTEROID TREATMENT; BACTERIAL-COLONIZATION; GENE-EXPRESSION	Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous disorder that is responsible for substantial and growing morbidity, mortality, and health-care expense worldwide. Of imperative importance to decipher the complexity of COPD is to identify groups of patients with similar clinical characteristics, prognosis, or therapeutic needs, the so-called clinical phenotypes. This strategy is logical for research but might be of little clinical value because clinical phenotypes can overlap in the same patient and the same clinical phenotype could result from different biological mechanisms. With the goal to match assessment with treatment choices, the latest iteration of guidelines from the Global Initiative for Chronic Obstructive Lung Disease reorganised treatment objectives into two categories: to improve symptoms (ie, dyspnoea and health status) and to decrease future risk (as predicted by forced expiratory volume in 1 s level and exacerbations history). This change thus moves treatment closer to individualised medicine with available bronchodilators and anti-inflammatory drugs. Yet, future treatment options are likely to include targeting endotypes that represent subtypes of patients defined by a distinct pathophysiological mechanism. Specific biomarkers of these endotypes would be particularly useful in clinical practice, especially in patients in which clinical phenotype alone is insufficient to identify the underlying endotype. A few series of potential COPD endotypes and biomarkers have been suggested. Empirical knowledge will be gained from proof-of-concept trials in COPD with emerging drugs that target specific inflammatory pathways. In every instance, specific endotype and biomarker efforts will probably be needed for the success of these trials, because the pathways are likely to be operative in only a subset of patients. Network analysis of human diseases offers the possibility to improve understanding of disease pathobiological complexity and to help with the development of new treatment alternatives and, importantly, a reclassification of complex diseases. All these developments should pave the way towards personalised treatment of patients with COPD in the clinic.	[Woodruff, Prescott G.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Sleep & Allergy, San Francisco, CA USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA USA; [Agusti, Alvar] Univ Barcelona, CIBERES, IDIBAPS, Thorax Inst,Hosp Clin, Barcelona, Spain; [Roche, Nicolas] Univ Paris 05, Cochin Hosp Grp, Assistance Publ Hop Paris, EA2511, Paris, France; [Singh, Dave] Univ Manchester, Univ Hosp South Manchester Fdn Trust, Manchester, Lancs, England; [Martinez, Fernando J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Weill Dept Med, New York, NY 10065 USA; [Martinez, Fernando J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Cornell University; NewYork-Presbyterian Hospital; University of Michigan System; University of Michigan	Martinez, FJ (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Weill Dept Med, New York, NY 10065 USA.	fjm2003@med.cornell.edu	Roche, Nicolas/AAP-4445-2021; Singh, Dave/AAH-4342-2020; Garcia-Navarro, Alvar Agusti/F-4474-2015; Roche, Nicolas/AAE-9206-2021	Singh, Dave/0000-0001-8918-7075; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; roche, nicolas/0000-0002-3162-5033	Genentech; National Institute of Health [HL126493, HL107202, AI077439, HL114447, HHSN268200900014C]; National Heart, Lung, and Blood Institute; Boehringer Ingelheim; Novartis; Pfizer; Teva; GSK; AstraZeneca; Chiesi; Mundipharma; Almirall; Aerocrine; Stallergenes; Merck Sharp Dohme (MSD); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114055] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); GSK(GlaxoSmithKline); AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Mundipharma; Almirall(Almirall); Aerocrine; Stallergenes; Merck Sharp Dohme (MSD)(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	PGW has received a grant from Genentech to study interleukin 13 in asthma. PGW has received personal fees for being on the advisory board for Genentech, Johnson and Johnson, and Neostem, and received personal fees for being a consultant for Roche, AstraZeneca, and Novartis, all outside the submitted work. PGW has a pending patent (12/935822) for compositions and methods for treating and diagnosing asthma. PGW is supported by grants from the National Institute of Health (HL126493, HL107202, AI077439, HL114447, and SPIROMICS contract HHSN268200900014C). DS has received grants and personal fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline (GSK), Glenmark, Johnson and Johnson, Merck, NAPP, Novartis, Pfizer, Takeda, Teva, Therevance, and Verona, outside the submitted work. DS has received personal fees from Genentech and Skyepharma, outside the submitted work. FJM has received grants from National Heart, Lung, and Blood Institute for studies into chronic obstructive pulmonary disease. FJM has received personal fees from Actelion, American College of Chest Physicians, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carden Jennings, CME Incite, Center for Healthcare Education, CSA Medical, Forest, Genentech, Grey Healthcare, GSK, Ikaria, Informa, Inova Health System, Janssens, MedScape, Merck, Merion, Miller Medical, National Association for Continuing Education, Nycomed/Takeda, Paradigm, Peer Voice, Pearl, Pfizer, Projects in Knowledge, St John's Hospital (Livonia, MI, USA), St Mary's Hospital (Detroit, MI, USA), Sudler and Hennessey, Roche, University of Illinois (Chicago, USA), University of Virginia (Virginia, USA), UpToDate, Wayne State University (Detroit, USA), and Western Society of Allergy and Clinical Immunology, all outside the submitted work. NR has received grants from Boehringer Ingelheim, Novartis, and Pfizer. NR has received personal fees from Boehringer Ingelheim, Novartis, Pfizer, Teva, GSK, AstraZeneca, Chiesi, Mundipharma, Almirall, Aerocrine, Stallergenes, and Merck Sharp & Dohme (MSD). AA has received grants from Almirall, GSK, MSD, AstraZeneca, Menarini, Instituto de Salud Carlos III (PI12/01117), Recercaixa-2012 (AA084096), SEPAR (PI065/2013, PI192/2012), and FUCAP 2012, outside the submitted work. AA has received personal fees from Almirall, GSK, Teva, Novartis, AstraZeneca, and Menarini, outside the submitted work.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Agusti A, 2015, AM J RESP CRIT CARE, V191, P391, DOI 10.1164/rccm.201410-1935PP; Agusti A, 2014, LANCET RESP MED, V2, P869, DOI 10.1016/S2213-2600(14)70227-9; Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2013, THORAX, V68, P687, DOI 10.1136/thoraxjnl-2012-202772; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bafadhel M, 2014, EUR RESPIR J, V44, P789, DOI 10.1183/09031936.00062614; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bafadhel M, 2011, CHEST, V139, P1410, DOI 10.1378/chest.10-1747; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barker BL, 2015, CHEST, V147, P46, DOI 10.1378/chest.14-0764; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Brusselle G, 2014, ANN AM THORAC SOC S5, V11, pS322; Bujarski S, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0509-6; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Burgel PR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/420134; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; Castaldi PJ, 2014, THORAX, V69, P415, DOI 10.1136/thoraxjnl-2013-203601; Celli BR, 2015, AM J RESP CRIT CARE, V191, P831, DOI 10.1164/rccm.201501-0044ST; Chanez P, 1997, AM J RESP CRIT CARE, V155, P1529, DOI 10.1164/ajrccm.155.5.9154853; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Chung WS, 2014, INT J CLIN PRACT, V68, P1193, DOI 10.1111/ijcp.12459; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crim C, 2015, ANN AM THORAC SOC, V12, P27, DOI 10.1513/AnnalsATS.201409-413OC; Criner GJ, 2011, AM J RESP CRIT CARE, V184, P881, DOI 10.1164/rccm.201103-0455CI; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; De-Torres JP, 2015, AM J RESP CRIT CARE, V191, P285, DOI 10.1164/rccm.201407-1210OC; Diez D, 2014, AM J RESP CRIT CARE, V190, P981, DOI 10.1164/rccm.201403-0421PP; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Faner R, 2014, EUR RESPIR J, V44, P775, DOI 10.1183/09031936.00078714; Frampton JE, 2014, DRUGS, V74, P465, DOI 10.1007/s40265-014-0194-8; Gaga M, 2013, AM J RESP CRIT CARE, V188, P503, DOI 10.1164/rccm.201307-1269ST; Gershon A, 2013, JAMA INTERN MED, V173, P1175, DOI 10.1001/jamainternmed.2013.1016; Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Global Initiative for Chronic Obstructive Lung Disease, 2006, GLOB STRAT DIAGN MAN; Global Initiative for Chronic Obstructive Lung Disease, 2001, GLOB STRAT DIAGN MAN; Groenwold RHH, 2011, PHARMACOEPIDEM DR S, V20, P1130, DOI 10.1002/pds.2251; Grosdidier S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0111-4; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hill AT, 2000, AM J MED, V109, P288, DOI 10.1016/S0002-9343(00)00507-6; Hood L, 2012, BIOTECHNOL J, V7, P992, DOI 10.1002/biot.201100306; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Nannini LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006826.pub2; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Karner C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008532.pub2; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010844.pub2; Koblizek V, 2013, BIOMED PAP, V157, P189, DOI 10.5507/bp.2013.039; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Leigh R, 2006, EUR RESPIR J, V27, P964, DOI 10.1183/09031936.06.00072105; Lin FJ, 2013, J EVAL CLIN PRACT, V19, P953, DOI 10.1111/j.1365-2753.2012.01892.x; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Magnussen H, 2015, NEW ENGL J MED, V372, P93, DOI 10.1056/NEJMc1413308; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Martinez FJ, 2015, LANCET, V385, P857, DOI 10.1016/S0140-6736(14)62410-7; Martinez FJ, 2007, CHEST, V131, P1, DOI 10.1378/chest.06-2567; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Menche J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S8; Miravitlles M, 2013, PRIM CARE RESP J, V22, P117, DOI 10.4104/pcrj.2013.00016; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Nadeem NJ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-107; Price D, 2013, PRIM CARE RESP J, V22, P92, DOI 10.4104/pcrj.2012.00092; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabe Klaus F, 2010, Expert Rev Respir Med, V4, P543, DOI 10.1586/ers.10.56; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Roche N, 2013, LANCET RESP MED, V1, pE29, DOI 10.1016/S2213-2600(13)70199-1; Rossi A, 2014, EUR RESPIR J, V44, P1548, DOI 10.1183/09031936.00126814; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sibila O, 2014, RESP MED, V108, P1608, DOI 10.1016/j.rmed.2014.09.008; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Singh D, 2014, EUR RESPIR J, V44, P1697, DOI 10.1183/09031936.00162414; Singh R, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0114-1; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Stockley RA, 2014, TRENDS MOL MED, V20, P105, DOI 10.1016/j.molmed.2013.11.006; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tashkin DP, 2009, COPD, V6, P17, DOI 10.1080/15412550902724073; van den Berge M, 2014, THORAX, V69, P14, DOI 10.1136/thoraxjnl-2012-202878; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; Vanfleteren LEGW, 2014, THORAX, V69, P72, DOI 10.1136/thoraxjnl-2013-203602; Verhamme KMC, 2013, EUR RESPIR J, V42, P606, DOI 10.1183/09031936.00005813; Vestbo J, 2014, AM J RESP CRIT CARE, V189, P1022, DOI 10.1164/rccm.201311-2006PP; Vogelmeier CF, 2013, LANCET RESP MED, V1, P51, DOI 10.1016/S2213-2600(12)70052-8; Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949; Wedzicha JA, 2014, RESP MED, V108, P1153, DOI 10.1016/j.rmed.2014.05.013; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Welsh EJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007891.pub3; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342; Woodruff PG, 2014, EUR RESPIR J, V43, P295, DOI 10.1183/09031936.00140613; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280; Yang IA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub3	107	165	172	2	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1789	1798		10.1016/S0140-6736(15)60693-6	http://dx.doi.org/10.1016/S0140-6736(15)60693-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25943943	Green Accepted			2022-12-28	WOS:000353726000035
J	Pendry, JB; Luo, Y; Zhao, RK				Pendry, J. B.; Luo, Yu; Zhao, Rongkuo			Transforming the optical landscape	SCIENCE			English	Review							REFRACTION; GEOMETRY	Electromagnetism provides us with some of the most powerful tools in science, encompassing lasers, optical microscopes, magnetic resonance imaging scanners, radar, and a host of other techniques. To understand and develop the technology requires more than a set of formal equations. Scientists and engineers have to form a vivid picture that fires their imaginations and enables intuition to play a full role in the process of invention. It is to this end that transformation optics has been developed, exploiting Faraday's picture of electric and magnetic fields as lines of force, which can be manipulated by the electrical permittivity and magnetic permeability of surrounding materials. Transformation optics says what has to be done to place the lines of force where we want them to be.	[Pendry, J. B.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England; [Luo, Yu] Nanyang Technol Univ, Sch Elect & Elect Engn, Photon Ctr Excellence OPTIMUS, Singapore 639798, Singapore; [Zhao, Rongkuo] Univ Calif Berkeley, Natl Sci Fdn Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA	Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Science Foundation (NSF); University of California System; University of California Berkeley	Pendry, JB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England.	j.pendry@imperial.ac.uk	Yu, Luo/C-7799-2009; Zhao, Rongkuo/B-5731-2008	Yu, Luo/0000-0003-2925-682X; Zhao, Rongkuo/0000-0001-5408-9782; Pendry, John/0000-0001-5145-5441	Gordon and Betty Moore Foundation; Royal Commission for the Exhibition of 1851; Leverhulme Trust; EPSRC [EP/L024926/1] Funding Source: UKRI	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Royal Commission for the Exhibition of 1851; Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the following for support: the Gordon and Betty Moore Foundation (J.B.P.), the Royal Commission for the Exhibition of 1851 (R.Z.), and the Leverhulme Trust (Y.L. and J.B.P.). Helpful discussions with S. A. Maier and A. I. Fernandez-Dominguez are gratefully acknowledged.	Aubry A, 2013, ACTIVE PLASMONICS AND TUNEABLE PLASMONIC METAMATERIALS, P105; Brule S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.133901; Chen HY, 2010, NAT MATER, V9, P387, DOI [10.1038/nmat2743, 10.1038/NMAT2743]; Chen HY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/11/113001; Coenen T, 2014, ACS NANO, V8, P7350, DOI 10.1021/nn502469r; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kildishev AV, 2011, PHYS-USP+, V54, P53, DOI 10.3367/UFNe.0181.201101e.0059; Kraft M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245125; Kundtz NB, 2011, P IEEE, V99, P1622, DOI 10.1109/JPROC.2010.2089664; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Leonhardt U, 2009, PROG OPTICS, V53, P69, DOI 10.1016/S0079-6638(08)00202-3; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Luo Y, 2014, P NATL ACAD SCI USA, V111, P18422, DOI 10.1073/pnas.1420551111; Luo Y, 2013, SCI CHINA INFORM SCI, V56, DOI 10.1007/s11432-013-5031-2; Magnus F, 2008, NAT MATER, V7, P295, DOI 10.1038/nmat2126; McCall M, 2013, CONTEMP PHYS, V54, P273, DOI 10.1080/00107514.2013.847678; Narayana S, 2012, ADV MATER, V24, P71, DOI 10.1002/adma.201104012; Nicolet A, 2008, OPT LETT, V33, P1584, DOI 10.1364/OL.33.001584; Olmon RL, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235147; Palik E D, 1985, HDB OPTICAL CONSTANT; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2012, SCIENCE, V337, P549, DOI 10.1126/science.1220600; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2003, J PHYS-CONDENS MAT, V15, P6345, DOI 10.1088/0953-8984/15/37/004; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Post E. G., 1962, FORMAL STRUCTURE ELE; Rodriguez AW, 2011, NAT PHOTONICS, V5, P211, DOI [10.1038/NPHOTON.2011.39, 10.1038/nphoton.2011.39]; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Ward AJ, 1996, J MOD OPTIC, V43, P773, DOI 10.1080/09500349608232782; Wee WH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073033; Wood B, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/7/076208	34	91	93	1	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					521	524		10.1126/science.1261244	http://dx.doi.org/10.1126/science.1261244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931549	Green Accepted			2022-12-28	WOS:000353778100029
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What are the odds?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2012, BMJ-BRIT MED J, V345, P5613; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6859; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960; Sheehan SR, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4661	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2015	350								h2327	10.1136/bmj.h2327	http://dx.doi.org/10.1136/bmj.h2327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UX	25934660				2022-12-28	WOS:000353957100004
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: "within subject" versus "between subject" designs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GROUPS NUMERICAL DATA; STATISTICAL QUESTION; CROSSOVER TRIAL; TESTS		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3191; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2674; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g124; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7951; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2537	8	5	5	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6435	10.1136/bmj.g6435	http://dx.doi.org/10.1136/bmj.g6435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25954990				2022-12-28	WOS:000343768700007
J	Mikkelsen, L; Phillips, DE; AbouZahr, C; Setel, PW; de Savigny, D; Lozano, R; Lopez, AD				Mikkelsen, Lene; Phillips, David E.; AbouZahr, Carla; Setel, Philip W.; de Savigny, Don; Lozano, Rafael; Lopez, Alan D.			A global assessment of civil registration and vital statistics systems: monitoring data quality and progress	LANCET			English	Article							OF-DEATH STATISTICS; MORTALITY; HOSPITALS; DISEASE	Increasing demand for better quality data and more investment to strengthen civil registration and vital statistics (CRVS) systems will require increased emphasis on objective, comparable, cost-effective monitoring and assessment methods to measure progress. We apply a composite index (the vital statistics performance index [VSPI]) to assess the performance of CRVS systems in 148 countries or territories during 1980-2012 and classify them into five distinct performance categories, ranging from rudimentary (with scores close to zero) to satisfactory (with scores close to one), with a mean VSPI score since 2005 of 0.61 (SD 0.31). As expected, the best performing systems were mostly in the European region, the Americas, and Australasia, with only two countries from east Asia and Latin America. Most low-scoring countries were in the African or Asian regions. Globally, only modest progress has been made since 2000, with the percentage of deaths registered increasing from 36% to 38%, and the percentage of children aged under 5 years whose birth has been registered increasing from 58% to 65%. However, several individual countries have made substantial improvements to their CRVS systems in the past 30 years by capturing more deaths and improving accuracy of cause-of-death information. Future monitoring of the effects of CRVS strengthening will greatly benefit from application of a metric like the VSPI, which is objective, costless to compute, and able to identify components of the system that make the largest contributions to good or poor performance.	[Mikkelsen, Lene] LM Consulting, Brisbane, Qld 4169, Australia; [Phillips, David E.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [AbouZahr, Carla] CAZ Consulting, Geneva, Switzerland; [Setel, Philip W.] Union North Amer, New York, NY USA; [de Savigny, Don] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Lozano, Rafael] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Basel; Swiss Tropical & Public Health Institute; Instituto Nacional de Salud Publica; University of Melbourne	Mikkelsen, L (corresponding author), LM Consulting, Cairns St, Brisbane, Qld 4169, Australia.	l.mikkelsen@unimelb.edu.au	Lopez, Alan D/F-1487-2010; Setel, Philip/ABD-6362-2020; Lopez, Alan/AAA-2734-2022; Lozano, Rafael/T-5352-2018	Lopez, Alan D/0000-0001-5818-6512; Setel, Philip/0000-0002-9042-5699; Lozano, Rafael/0000-0002-7356-8823				Abouzahr C., 2014, Asia-Pacific Population Journal, V29, P99; Abouzahr C, 2014, ASIA PAC POPUL J, V29, P2014; Abouzahr C, 2015, LANCET; Aung E, 2009, 02 U QUEENSL SCH POP; Danel I, 2008, ASSESSMENT LACS VITA; Fleck F, 2013, B WORLD HEALTH ORGAN, V91, P904, DOI 10.2471/BLT.13.031213; GAETEDARBO A, 1964, MILBANK FUND Q, V42, P86, DOI 10.2307/3348659; Gamage S, 2009, 01 U QUEENSL SCH POP; Hernandez B, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-38; Khosravi A, 2008, B WORLD HEALTH ORGAN, V86, P688, DOI 10.2471/BLT.07.046532; Lopez A, 2013, LANCET, V381, P1275, DOI 10.1016/S0140-6736(13)60838-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mikkelsen L, 2014, POLICY BRIEF WORLD H, V3; Mikkelsen L., 2012, 10 U QUEENSL SCH POP; Mikkelsen L., 2012, 24 U QUEENSL SCH POP; Mikkelsen L., 2009, 08 U QUEENSL SCH POP; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJ, 1996, GLOBAL BURDEN DIS; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Naidu S, 2013, 35 U QUEENSL SCH POP; Office of The Registrar General of India, 2011, VIT STAT IND BAS CIV; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Polprasert W, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-13; Rampatige R, 2014, B WORLD HEALTH ORGAN, V92, P807, DOI 10.2471/BLT.14.137935; Rampatige R, 2013, HEALTH INF MANAG J, V42, P20, DOI 10.1177/183335831304200302; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; RUZICKA L T, 1990, World Health Statistics Quarterly, V43, P249; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; UN Department of International Economic and Social Affairs. Statistical Office, 1985, HDB VIT STAT SYST F, VII; UN DESA Statistics Division, 2013, STESASTATSERA259 UN; UN ESCAP, 2014, EESCAPMCCRVS12 UN EC; UNICEF, 2009, GOOD PRACT INT BIRTH; UNICEF, 2013, PASSP PROT GUID BIRT; UNICEF Bangladesh, 2002, BIRTH REG VEH CHILD; UNICEF Cote d'Ivoire, 2007, BIRTH REG DET BAS MU; UNICEF Fiji, 2005, BIRTH REG PAC; UNICEF Ghana, 2008, ASS BIRTH REG SYST G; UNICEF Madagascar and Ministry of Interior of the Government of Madagascar, 2009, EV IMPL SUGG GUID SC; UNICEF Mozambique Metier Research, 2008, IMPL BIRTH REG NAT A; UNICEF. United Nations Children's Fund, 2013, EV CHILDS BIRTH RIGH; United Nations, 2013, NEW GLOB PARTN ER PO; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, 2010, INT STAT CLASS DIS R; WHO University of Queensland School of Population Health, 2010, RAP ASS NAT CIV REG; World Health Organization, 2010, IMPR QUAL US BIRTH D; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2013, STRENGTH CIV REG VIT	50	277	295	3	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1395	1406		10.1016/S0140-6736(15)60171-4	http://dx.doi.org/10.1016/S0140-6736(15)60171-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	25971218				2022-12-28	WOS:000362316200033
J	Schnabel, RB; Yin, XY; Gona, P; Larson, MG; Beiser, AS; McManus, DD; Newton-Cheh, C; Lubitz, SA; Magnani, JW; Ellinor, PT; Seshadri, S; Wolf, PA; Vasan, RS; Benjamin, EJ; Levy, D				Schnabel, Renate B.; Yin, Xiaoyan; Gona, Philimon; Larson, Martin G.; Beiser, Alexa S.; McManus, David D.; Newton-Cheh, Christopher; Lubitz, Steven A.; Magnani, Jared W.; Ellinor, Patrick T.; Seshadri, Sudha; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel			50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study	LANCET			English	Article							LEFT-VENTRICULAR HYPERTROPHY; MEDICARE BENEFICIARIES; US; ANTICOAGULATION; HYPERTENSION; SURVIVAL; DISEASE	Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years. Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex. Findings During 50 years of observation (202 417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20.4 to 96.2 cases per 1000 person-years in men and from 13.7 to 49.4 cases per 1000 person-years in women; age-adjusted incidence increased from 3.7 to 13.4 new cases per 1000 person-years in men and from 2.5 to 8.6 new cases per 1000 person-years in women (p(trend) < 0.0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12.6 in 1958-67 to 25.7 in 1998-2007 in men, p(trend) = 0.0007; 8.1 to 11.8 in women, p(trend) = 0.009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3.77, 95% CI 1.98-7.20 in 1958-1967 compared with 1998-2007; p(trend) = 0.0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1.34, 95% CI 0.97-1.86 in 1958-1967 compared with 1998-2007; p(trend) = 0.003) in 20 years following atrial fibrillation onset. Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.	[Schnabel, Renate B.; Yin, Xiaoyan; Gona, Philimon; Larson, Martin G.; Beiser, Alexa S.; Newton-Cheh, Christopher; Seshadri, Sudha; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel] Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Larson, Martin G.; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Evans Mem Med Dept, Boston, MA 02118 USA; [Magnani, Jared W.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Beiser, Alexa S.; Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiol, Boston, MA 02125 USA; [Gona, Philimon] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Biostat & Hlth Serv Res, Boston, MA 02125 USA; [Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Newton-Cheh, Christopher; Lubitz, Steven A.; Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Broad Inst Harvard & MIT, Program Med Populat Genet, Cambridge, MA USA; [Schnabel, Renate B.] Deutsch Zentrum Herz Kreislauf Forsch, Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schnabel, RB (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany.	r.schnabel@uke.de	Schnabel, Renate B/ABE-6668-2021; Ramachandran, Vasan/Y-2527-2019; Gona, Philimon/K-1477-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011; Levy, Daniel/ABF-6873-2021	Schnabel, Renate B/0000-0001-7170-9509; Ramachandran, Vasan/0000-0001-7357-5970; Benjamin, Emelia/0000-0003-4076-2336; Levy, Daniel/0000-0003-1843-8724; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Ellinor, Patrick/0000-0002-2067-0533	NIH; NHLBI; NINDS; Deutsche Forschungsgemeinschaft; NIH/NHLBI [N01-HC-25195, 1K23HL114724]; NIH [1RC1HL101056, HL102214, AG028321, 2R01HL092577, 1R01HL092577, 1R01HL102214, 1R01AG028321, R01HL104156, 1K24HL105780, HL080124, HL077477, HL71039, HL093328, 6RO1-NS-17950, HL080025, 1U01HL105268-01, KL2RR031981]; Fondation Leducq [14CVD01]; American Heart Association [13EIA14220013]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/3-2]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080124, K24HL105780, R01HL104156, R01HL071039, R01HL093328, R01HL092577, K23HL114724, K23HL080025, RC1HL101056, R01HL102214, U01HL105268, RC1HL099452, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321, R01AG008122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.; EJB was supported by NIH/NHLBI contract N01-HC-25195 and NIH grants 1RC1HL101056, HL102214, and AG028321. EJB and PTE were supported by NIH grant 2R01HL092577. PTE was supported by Fondation Leducq (14CVD01) and NIH grants 1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780 and received the American Heart Association Established Investigator Award 13EIA14220013. RSV was supported by NIH grants HL080124, HL077477, HL71039, and HL093328. PAW, SS, and ASB were supported by NIH grant 6RO1-NS-17950. RBS was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-2. CNC was supported by the NIH grant HL080025 and received the Doris Duke Charitable Foundation Clinical Scientist Development Award and the Burroughs Wellcome Fund Career Award for Medical Scientists. SAL was supported by the NIH/NHLBI grant 1K23HL114724. DDM received additional partial salary support by NIH grants 1U01HL105268-01 and KL2RR031981.	Abbott RD, 1987, FRAMINGHAM STUDY EPI; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Friberg L, 2007, EUR HEART J, V28, P2346, DOI 10.1093/eurheartj/ehm308; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Koton S, 2014, JAMA-J AM MED ASSOC; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Miyasaka Y, 1980, SECULAR TRENDS INCID; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Okin PM, 2006, JAMA-J AM MED ASSOC, V296, P1242, DOI 10.1001/jama.296.10.1242; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Rowan SB, 2007, J AM COLL CARDIOL, V49, P1561, DOI 10.1016/j.jacc.2006.11.045; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Wattigney WA, 2002, AM J EPIDEMIOL, V155, P819, DOI 10.1093/aje/155.9.819	30	756	797	14	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					154	162		10.1016/S0140-6736(14)61774-8	http://dx.doi.org/10.1016/S0140-6736(14)61774-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	25960110	Green Accepted			2022-12-28	WOS:000357742200032
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			Progress and Hurdles for Follow-on Biologics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				*FOOD DRUG ADM, 2010, GEN COMP DRUG PRIC; Gleason PP, 2009, J MANAGE CARE PHARM, V15, P648, DOI 10.18553/jmcp.2009.15.8.648; Hunt D, 2014, NEW ENGL J MED, V370, P1270, DOI 10.1056/NEJMc1316118; IMS Institute for Healthcare Informatics, 2014, ASS BIOS UPT COMP EU	4	39	42	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2380	2382		10.1056/NEJMp1504672	http://dx.doi.org/10.1056/NEJMp1504672			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK6RF	25946143				2022-12-28	WOS:000356354600003
J	Lupianez, DG; Kraft, K; Heinrich, V; Krawitz, P; Brancati, F; Klopocki, E; Hom, D; Kayserili, H; Opitz, JM; Laxova, R; Santos-Simarro, F; Gilbert-Dussardier, B; Wittler, L; Borschiwer, M; Haas, SA; Osterwalder, M; Franke, M; Timmermann, B; Hecht, J; Spielmann, M; Visel, A; Mundlos, S				Lupianez, Dario G.; Kraft, Katerina; Heinrich, Verena; Krawitz, Peter; Brancati, Francesco; Klopocki, Eva; Hom, Denise; Kayserili, Hulya; Opitz, John M.; Laxova, Renata; Santos-Simarro, Fernando; Gilbert-Dussardier, Brigitte; Wittler, Lars; Borschiwer, Marina; Haas, Stefan A.; Osterwalder, Marco; Franke, Martin; Timmermann, Bernd; Hecht, Jochen; Spielmann, Malte; Visel, Axel; Mundlos, Stefan			Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions	CELL			English	Article							HUMAN GENOME; REGULATORY LANDSCAPE; SPECIFICITY; EXPRESSION; PRINCIPLES; VARIANTS; CIS; MAP	Mammalian genomes are organized into megabase-scale topologically associated domains (TADs). We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes. We show that distinct human limb malformations are caused by deletions, inversions, or duplications altering the structure of the TAD-spanning WNT6/IHH/EPHA4/PAX3 locus. Using CRISPR/Cas genome editing, we generated mice with corresponding rearrangements. Both in mouse limb tissue and patient-derived fibroblasts, disease-relevant structural changes cause ectopic interactions between promoters and non-coding DNA, and a cluster of limb enhancers normally associated with Epha4 is misplaced relative to TAD boundaries and drives ectopic limb expression of another gene in the locus. This rewiring occurred only if the variant disrupted a CTCF-associated boundary domain. Our results demonstrate the functional importance of TADs for orchestrating gene expression via genome architecture and indicate criteria for predicting the pathogenicity of human structural variants, particularly in non-coding regions of the human genome.	[Lupianez, Dario G.; Kraft, Katerina; Krawitz, Peter; Borschiwer, Marina; Franke, Martin; Hecht, Jochen; Spielmann, Malte; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, D-14195 Berlin, Germany; [Lupianez, Dario G.; Kraft, Katerina; Heinrich, Verena; Krawitz, Peter; Hom, Denise; Franke, Martin; Spielmann, Malte; Mundlos, Stefan] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Brancati, Francesco] Policlin Tor Vergata Univ Hosp, Med Genet Unit, I-00133 Rome, Italy; [Klopocki, Eva] Univ Wurzburg, Inst Human Genet, Biozentrum, D-97070 Wurzburg, Germany; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Opitz, John M.; Laxova, Renata] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84108 USA; [Santos-Simarro, Fernando] Hosp Univ La Paz, IdiPAZ, Inst Genet Med Mol INGEMM, Madrid 28046, Spain; [Santos-Simarro, Fernando] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades, U753, Madrid 28046, Spain; [Gilbert-Dussardier, Brigitte] CHU Poitiers, F-86021 Poitiers, France; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Osterwalder, Marco; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, MS 84 171, Berkeley, CA 94720 USA; [Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, D-14195 Berlin, Germany; [Hecht, Jochen; Spielmann, Malte; Mundlos, Stefan] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rome Tor Vergata; Policlin Tor Vergata; University of Wurzburg; Istanbul University; Utah System of Higher Education; University of Utah; Hospital Universitario La Paz; Instituto de Salud Carlos III; CHU Poitiers; Universite de Poitiers; Max Planck Society; Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, D-14195 Berlin, Germany.	mundlos@molgen.mpg.de	Brancati, Francesco/AAC-3778-2022; Krawitz, Peter M/F-3142-2012; Spielmann, Malte/H-2230-2018; Kayserili, Hülya/AAA-5593-2021; Visel, Axel/A-9398-2009; Klopocki, Eva/B-6823-2017; Mundlos, Stefan/ABH-9585-2020; Franke, Martin/AAX-6027-2021; Lupiáñez, Darío G./AAH-3405-2019; Osterwalder, Marco/AAU-4478-2021; Franke, Martin/O-8986-2017; Kayserili, Hülya/M-3791-2015; Santos-Simarro, Fernando/L-3063-2014; Osterwalder, Marco/T-1817-2018	Brancati, Francesco/0000-0003-3624-2354; Krawitz, Peter M/0000-0002-3194-8625; Spielmann, Malte/0000-0002-0583-4683; Kayserili, Hülya/0000-0003-0376-499X; Visel, Axel/0000-0002-4130-7784; Klopocki, Eva/0000-0003-1438-2081; Franke, Martin/0000-0002-4626-3290; Lupiáñez, Darío G./0000-0002-3165-036X; Franke, Martin/0000-0002-4626-3290; Kraft, Katerina/0000-0002-2011-6946; Kulik, Marina/0000-0003-4885-4059; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Haas, Stefan/0000-0003-3418-3688; Santos-Simarro, Fernando/0000-0002-1201-9118; Mundlos, Stefan/0000-0002-9788-3166; Osterwalder, Marco/0000-0002-1969-2313	Fundacion Alfonso Martin Escudero; Deutsche Forschungsgemeinschaft; Berlin Institute for Health; Max Planck Foundation; Swiss National Science Foundation (SNSF) fellowship; NIH [R01HG003988, U54HG006997, U01DE024427]; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988, U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024427] Funding Source: NIH RePORTER	Fundacion Alfonso Martin Escudero; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berlin Institute for Health; Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation (SNSF) fellowship(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	D.G.L. is supported by the Fundacion Alfonso Martin Escudero. This research was supported by grants from the Deutsche Forschungsgemeinschaft, from the Berlin Institute for Health, and the Max Planck Foundation to S.M. M.O. was supported by a Swiss National Science Foundation (SNSF) fellowship. A.V. was supported by NIH grants R01HG003988, U54HG006997, and U01DE024427. Research conducted at the E.O. Lawrence Berkeley National Laboratory was performed under Department of Energy Contract DE-AC02-05CH11231, University of California. We thank Daniel Ibrahim and Guillaume Andrey for comments on the manuscript. We also thank Nicole Rosener, Asita Stiege, Karol Macura, Nadine Lehmann, Anne Hess, and Christin Franke for technical support.	Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; CAMERA G, 1995, AM J MED GENET, V57, P472, DOI 10.1002/ajmg.1320570322; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Geetha-Loganathan P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-32; GOULDING M, 1994, DEVELOPMENT, V120, P957; GROSSE F R, 1969, Birth Defects Original Article Series, V5, P48; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Montavon T, 2012, P NATL ACAD SCI USA, V109, P20204, DOI 10.1073/pnas.1217659109; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Spielmann M, 2013, BIOESSAYS, V35, P533, DOI 10.1002/bies.201200178; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Thiele H, 2004, J MED GENET, V41, P213, DOI 10.1136/jmg.2003.014894; Tsujimura T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004897; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yuksel-Apak M, 2012, EUR J HUM GENET, V20, P639, DOI 10.1038/ejhg.2011.250; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	34	922	942	5	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1012	1025		10.1016/j.cell.2015.04.004	http://dx.doi.org/10.1016/j.cell.2015.04.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959774	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000355152600010
J	Etheridge, Z; Gatland, E				Etheridge, Zac; Gatland, Emma			When and how to discuss "do not resuscitate" decisions with patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Etheridge, Zac] Stoke Mandeville Hosp, Med Older People, Aylesbury HP21 8AL, Bucks, England; [Gatland, Emma] Harcourt Chambers, London, England		Etheridge, Z (corresponding author), Stoke Mandeville Hosp, Med Older People, Aylesbury HP21 8AL, Bucks, England.	zac.etheridge@yahoo.co.uk						[Anonymous], 2014, DEC REL CARD RES GUI; General Medical Council, 2010, TREATM CAR END LIF G	2	25	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2015	350								h2640	10.1136/bmj.h2640	http://dx.doi.org/10.1136/bmj.h2640			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9YZ	25994629				2022-12-28	WOS:000355128700008
J	de Mestier, L; Hentic, O; Cros, J; Walter, T; Roquin, G; Brixi, H; Lombard-Bohas, C; Hammel, P; Diebold, MD; Couvelard, A; Ruszniewski, P; Cadiot, G				de Mestier, Louis; Hentic, Olivia; Cros, Jerome; Walter, Thomas; Roquin, Guillaume; Brixi, Hedia; Lombard-Bohas, Catherine; Hammel, Pascal; Diebold, Marie-Daniele; Couvelard, Anne; Ruszniewski, Philippe; Cadiot, Guillaume			Metachronous Hormonal Syndromes in Patients With Pancreatic Neuroendocrine Tumors A Case-Series Study	ANNALS OF INTERNAL MEDICINE			English	Article							ENETS CONSENSUS GUIDELINES; ZOLLINGER-ELLISON-SYNDROME; ENDOCRINE TUMORS; LIVER METASTASES; LABELING INDEX; NEOPLASMS; EPIDEMIOLOGY; MANAGEMENT; EVOLUTION; DISEASE	Background: Pancreatic neuroendocrine tumors (PNETs) may evolve and cause hormonal hypersecretion-related symptoms that were not present at the initial diagnosis, termed metachronous hormonal syndromes (MHSs). Their setting, characteristics, and outcomes are not well-described. Objective: To describe MHSs in patients with sporadic PNETs. Design: Retrospective, multicenter study. Setting: 4 French referral centers. Patients: Patients with PNETs who developed MHSs related to hypersecretion of insulin, gastrin, vasoactive intestinal peptide, or glucagon between January 2009 and January 2014. Measurements: Tumor extension, biological markers, and treatments at initial PNET diagnosis and MHS onset. Pathologic specimens were evaluated centrally, including Ki-67 index and hormone immunolabeling. Results: Of 435 patients with PNETs, 15 (3.4%) were identified as having MHSs involving the hypersecretion of insulin (5 patients), vasoactive intestinal peptide (5 patients), gastrin (2 patients), or glucagon (4 patients). Metachronous hormonal syndromes developed after a median of 55 months (range, 7 to 219) and in the context of PNET progression, stability, and tumor response in 8, 6, and 1 patients, respectively. The median Ki-67 index was 7% (range, 1% to 19%) at PNET diagnosis and 17.5% (range, 2.0% to 70.0%) at MHS onset. Immunolabeling of MHS-related peptides was retrospectively found in 8 of 14 of pathologic PNET specimens obtained before MHS diagnosis. Median survival after MHS onset was 28 months (range, 3 to 56). Seven patients with MHSs died during follow-up, all due to PNETs, including 4 patients with insulin-related MHSs. Limitation: Retrospective data collection and heterogeneity of pathologic specimen size and origin. Conclusion: Metachronous hormonal syndromes were identified more often in the context of PNET progression and increased Ki-67 indices. Patients with insulin-related MHSs may have decreased survival rates.	Robert Debre Univ Hosp, F-51092 Reims, France; Beaujon Univ Hosp, F-92118 Clichy, France; Edouard Herriot Univ Hosp, F-69437 Lyon 03, France; Angers Univ Hosp, F-49933 Angers 9, France; Xavier Bichat Univ Hosp, Paris, France	CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; UDICE-French Research Universities; Universite Paris Cite	Cadiot, G (corresponding author), Robert Debre Univ Hosp, Dept Hepatogastroenterol & Digest Oncol, Ave Gen Koenig, F-51092 Reims, France.	gcadiot@chu-reims.fr	Cros, Jerome/X-7677-2019	Cros, Jerome/0000-0002-4935-3865; de Mestier, Louis/0000-0001-9715-9189; Anne, Couvelard/0000-0002-6316-1210; Hammel, Pascal/0000-0002-4630-4996				Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Bilimoria KY, 2008, ANN SURG, V247, P490, DOI 10.1097/SLA.0b013e31815b9cae; CHIANG HCV, 1990, GASTROENTEROLOGY, V99, P1565, DOI 10.1016/0016-5085(90)90459-E; Couvelard A, 2009, MODERN PATHOL, V22, P273, DOI 10.1038/modpathol.2008.177; Crona J, 2014, 11 ANN EUR NEUR TUM; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falconi M, 2012, NEUROENDOCRINOLOGY, V95, P120, DOI 10.1159/000335587; Halfdanarson TR, 2008, ENDOCR-RELAT CANCER, V15, P409, DOI 10.1677/ERC-07-0221; Jensen RT, 2012, NEUROENDOCRINOLOGY, V95, P98, DOI 10.1159/000335591; Kulke MH, 2010, PANCREAS, V39, P735, DOI 10.1097/MPA.0b013e3181ebb168; Lepage C, 2013, EUR J ENDOCRINOL, V168, pR77, DOI 10.1530/EJE-12-0418; LIND SE, 1985, AM J MED SCI, V290, P107, DOI 10.1097/00000441-198509000-00005; Lombard-Bohas C, 2009, NEUROENDOCRINOLOGY, V89, P217, DOI 10.1159/000151562; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Miller HC, 2014, WORLD J SURG, V38, P1353, DOI 10.1007/s00268-014-2451-0; Mizuno N, 2001, INTERNAL MED, V40, P386, DOI 10.2169/internalmedicine.40.386; Rindi G, 2010, WHO CLASSIFICATION T, V3, P13; Rustagi T, 2010, J PANCREAS, V11, P486; Singh S, 2014, EJSO-EUR J SURG ONC, V40, P1517, DOI 10.1016/j.ejso.2014.06.016; Sobin L, 2009, TNM CLASSIFICATION M; Vashi PG, 2011, PANCREAS, V40, P781, DOI 10.1097/MPA.0b013e318212c42d; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; WYNICK D, 1988, NEW ENGL J MED, V319, P605, DOI 10.1056/NEJM198809083191003; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zen Y, 2013, PATHOL INT, V63, P532, DOI 10.1111/pin.12108	25	20	20	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					682	+		10.7326/M14-2132	http://dx.doi.org/10.7326/M14-2132			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984844				2022-12-28	WOS:000355015200017
J	Fedorkow, DM				Fedorkow, Donna M.			Review: In peri- or postmenopausal women, DHEA does not improve symptoms and increases androgenic side effects	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BENEFITS		McMaster Univ, Hamilton, ON, Canada	McMaster University	Fedorkow, DM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Elraiyah T, 2014, J CLIN ENDOCR METAB, V99, P3536, DOI 10.1210/jc.2014-2261; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10							JC9	10.7326/ACPJC-2015-162-10-009	http://dx.doi.org/10.7326/ACPJC-2015-162-10-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IF	25984882				2022-12-28	WOS:000355015200011
J	Peng, Y; Maiolino, R; Cochrane, R				Peng, Y.; Maiolino, R.; Cochrane, R.			Strangulation as the primary mechanism for shutting down star formation in galaxies	NATURE			English	Article							MASS-METALLICITY RELATION; AGN FEEDBACK; BLACK-HOLES; EVOLUTION; ORIGIN; STELLAR; GAS; OUTFLOWS; MODEL; II.	Local galaxies are broadly divided into two main classes, star-forming (gas-rich) and quiescent (passive and gas-poor). The primary mechanism responsible for quenching star formation in galaxies and transforming them into quiescent and passive systems is still unclear. Sudden removal of gas through outflows(1-6) or stripping(7-9) is one of the mechanisms often proposed. An alternative mechanism is so-called "strangulation''(10-14), in which the supply of cold gas to the galaxy is halted. Here we report an analysis of the stellar metallicity (the fraction of elements heavier than helium in stellar atmospheres) in local galaxies, from 26,000 spectra, that clearly reveals that strangulation is the primary mechanism responsible for quenching star formation, with a typical timescale of four billion years, at least for local galaxies with a stellar mass less than 10(11) solar masses. This result is further supported independently by the stellar age difference between quiescent and star-forming galaxies, which indicates that quiescent galaxies of less than 10(11) solar masses are on average observed four billion years after quenching due to strangulation.	[Peng, Y.; Maiolino, R.; Cochrane, R.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Peng, Y.; Maiolino, R.] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Cochrane, R.] Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	Peng, Y (corresponding author), Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England.	yp244@mrao.cam.ac.uk	Cochrane, Rachel/GRO-2994-2022	Cochrane, Rachel/0000-0001-8855-6107; Maiolino, Roberto/0000-0002-4985-3819	STFC [ST/M001172/1, ST/K003119/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K003119/1, ST/M001172/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abadi MG, 1999, MON NOT R ASTRON SOC, V308, P947, DOI 10.1046/j.1365-8711.1999.02715.x; Baldry IK, 2008, MON NOT R ASTRON SOC, V388, P945, DOI 10.1111/j.1365-2966.2008.13348.x; Balogh ML, 2000, MON NOT R ASTRON SOC, V318, P703, DOI 10.1046/j.1365-8711.2000.03826.x; Balogh ML, 2000, ASTROPHYS J, V540, P113, DOI 10.1086/309323; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; Blanton MR, 2007, ASTRON J, V133, P734, DOI 10.1086/510127; Boselli A, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322312; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Carollo C. M, ASTROPHYS J UNPUB; Dave R, 2012, MON NOT R ASTRON SOC, V421, P98, DOI 10.1111/j.1365-2966.2011.20148.x; Dave R, 2011, MON NOT R ASTRON SOC, V416, P1354, DOI 10.1111/j.1365-2966.2011.19132.x; De Lucia G, 2004, MON NOT R ASTRON SOC, V349, P1101, DOI 10.1111/j.1365-2966.2004.07584.x; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Diamond-Stanic AM, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L26; Gallazzi A, 2005, MON NOT R ASTRON SOC, V362, P41, DOI 10.1111/j.1365-2966.2005.09321.x; Hirschmann M, 2014, MON NOT R ASTRON SOC, V444, P2938, DOI 10.1093/mnras/stu1609; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; LARSON RB, 1980, ASTROPHYS J, V237, P692, DOI 10.1086/157917; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Maiolino R, 2012, MON NOT R ASTRON SOC, V425, pL66, DOI 10.1111/j.1745-3933.2012.01303.x; Oppenheimer BD, 2010, MON NOT R ASTRON SOC, V406, P2325, DOI 10.1111/j.1365-2966.2010.16872.x; Peeples MS, 2011, MON NOT R ASTRON SOC, V417, P2962, DOI 10.1111/j.1365-2966.2011.19456.x; Peng YJ, 2014, MON NOT R ASTRON SOC, V443, P3643, DOI 10.1093/mnras/stu1288; Peng YJ, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/4; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; PETROSIAN V, 1976, ASTROPHYS J, V209, pL1, DOI 10.1086/182253; Quilis V, 2000, SCIENCE, V288, P1617, DOI 10.1126/science.288.5471.1617; Santini P, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322835; Schawinski K, 2014, MON NOT R ASTRON SOC, V440, P889, DOI 10.1093/mnras/stu327; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Wetzel AR, 2013, MON NOT R ASTRON SOC, V432, P336, DOI 10.1093/mnras/stt469; Woo J, 2015, MON NOT R ASTRON SOC, V448, P237, DOI 10.1093/mnras/stu2755	40	333	335	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					192	+		10.1038/nature14439	http://dx.doi.org/10.1038/nature14439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25971510	Green Submitted			2022-12-28	WOS:000354377800052
J	Roth, A; Diederichs, S				Roth, Anna; Diederichs, Sven			Rap and chirp about X inactivation	NATURE			English	Editorial Material							XIST RNA; CHROMOSOME INACTIVATION; BINDING; GENE; PROTEINS; CANCER	Two new techniques identify proteins that directly interact with a non-protein-coding RNA called Xist to mediate inactivation of one X chromosome in female mammals. SEE LETTER P.232	[Roth, Anna; Diederichs, Sven] German Canc Res Ctr, RNA Biol & Canc Div, D-69120 Heidelberg, Germany; [Roth, Anna; Diederichs, Sven] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Roth, A (corresponding author), German Canc Res Ctr, RNA Biol & Canc Div, D-69120 Heidelberg, Germany.	s.diederichs@dkfz.de	Diederichs, Sven/J-6237-2012	Diederichs, Sven/0000-0001-7901-4752				BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	13	14	15	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					170	171		10.1038/521170a	http://dx.doi.org/10.1038/521170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH9SY	25971508				2022-12-28	WOS:000354377800048
J	Song, JY				Song, Ji-Young			Intraoral Malignant Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Jeju Natl Univ, Sch Med, Jeju, South Korea	Jeju National University	Song, JY (corresponding author), Jeju Natl Univ, Sch Med, Jeju, South Korea.	2460song@naver.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1944	1944		10.1056/NEJMicm1410451	http://dx.doi.org/10.1056/NEJMicm1410451			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25970052				2022-12-28	WOS:000354493300010
J	Naylor, CD; Gerace, R; Redelmeier, DA				Naylor, C. David; Gerace, Rocco; Redelmeier, Donald A.			Maintaining Physician Competence and Professionalism Canada's Fine Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Naylor, C. David; Gerace, Rocco; Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gerace, Rocco] Coll Phys & Surg Ontario, Toronto, ON, Canada; [Redelmeier, Donald A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Naylor, CD (corresponding author), 4 Shorncliffe Ave, Toronto, ON M4V 1T1, Canada.	david.naylor@utoronto.ca							0	5	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1825	1826		10.1001/jama.2015.3705	http://dx.doi.org/10.1001/jama.2015.3705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965227				2022-12-28	WOS:000354391000022
J	Steinert, EM; Schenkel, JM; Fraser, KA; Beura, LK; Manlove, LS; Igyarto, BZ; Southern, PJ; Masopust, D				Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Manlove, Luke S.; Igyarto, Botond Z.; Southern, Peter J.; Masopust, David			Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance	CELL			English	Article							RESIDENT MEMORY; NONLYMPHOID TISSUE; VIRUS-INFECTION; CUTTING EDGE; LYMPHOCYTES; MIGRATION; DIFFERENTIATION; MICE; GUT; IMMUNITY	Memory CD8 T cells protect against intracellular pathogens by scanning host cell surfaces; thus, infection detection rates depend on memory cell number and distribution. Population analyses rely on cell isolation from whole organs, and interpretation is predicated on presumptions of near complete cell recovery. Paradigmatically, memory is parsed into central, effector, and resident subsets, ostensibly defined by immunosurveillance patterns but in practice identified by phenotypic markers. Because isolation methods ultimately inform models of memory T cell differentiation, protection, and vaccine translation, we tested their validity via parabiosis and quantitative immunofluorescence microscopy of a mouse memory CD8 T cell population. We report three major findings: lymphocyte isolation fails to recover most cells and biases against certain subsets, residents greatly outnumber recirculating cells within non-lymphoid tissues, and memory subset homing to inflammation does not conform to previously hypothesized migration patterns. These results indicate that most host cells are surveyed for reinfection by segregated residents rather than by recirculating cells that migrate throughout the blood and body.	[Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Southern, Peter J.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Manlove, Luke S.; Igyarto, Botond Z.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Manlove, Luke S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Igyarto, Botond Z.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019; Schenkel, Jason/AAV-8184-2020	Schenkel, Jason/0000-0003-4641-6872; Igyarto, Botond/0000-0002-9770-800X; Steinert, Elizabeth/0000-0002-6947-2271	NIH [R01-AI084913, R01-AI111671, T32-AI083196, F30-DK100159-02, F31-CA183226]; NATIONAL CANCER INSTITUTE [F31CA183226, P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084913, R01AI111671, T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (R01-AI084913 and R01-AI111671 to D.M., T32-AI083196 to E.M.S., F30-DK100159-02 to J.M.S., and F31-CA183226 to L.S.M.).	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Doctor RB, 2010, NEPHROL DIAL TRANSPL, V25, P3496, DOI 10.1093/ndt/gfq195; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Horbul JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022638; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; NUTTER RL, 1980, ANAT REC, V197, P363, DOI 10.1002/ar.1091970310; Peaudecerf L, 2011, IMMUNOL LETT, V140, P1, DOI 10.1016/j.imlet.2011.05.009; Pires MD, 2001, ANAL QUANT CYTOL, V23, P427; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; SELBY WS, 1984, GUT, V25, P32, DOI 10.1136/gut.25.1.32; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Suvas PK, 2007, J IMMUNOL, V179, P8122, DOI 10.4049/jimmunol.179.12.8122; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180	44	433	439	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					737	749		10.1016/j.cell.2015.03.031	http://dx.doi.org/10.1016/j.cell.2015.03.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957682	Green Accepted, Bronze			2022-12-28	WOS:000354175200009
J	Meddings, J; Saint, S; Fowler, KE; Gaies, E; Hickner, A; Krein, SL; Bernstein, SJ				Meddings, Jennifer; Saint, Sanjay; Fowler, Karen E.; Gaies, Elissa; Hickner, Andrew; Krein, Sarah L.; Bernstein, Steven J.			The Ann Arbor Criteria for Appropriate Urinary Catheter Use in Hospitalized Medical Patients: Results Obtained by Using the RAND/UCLA Appropriateness Method	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASES-SOCIETY; TERTIARY-CARE CENTER; TRACT-INFECTIONS; REDUCING USE; RISK-FACTORS; PREVENTION; GUIDELINES; INCONTINENCE; MANAGEMENT; DURATION	Interventions to reduce urinary catheter use involve lists of "appropriate" indications developed from limited evidence without substantial multidisciplinary input. Implementing these lists, however, is challenging given broad interpretation of indications, such as "critical illness." To refine criteria for appropriate catheter use-defined as use in which benefits outweigh risks the RAND/UCLA Appropriateness Method was applied. After reviewing the literature, a 15-member multidisciplinary panel of physicians, nurses, and specialists in infection prevention rated scenarios for catheter use as appropriate, inappropriate, or of uncertain appropriateness by using a standardized, multiround rating process. The appropriateness of Foley catheters, intermittent straight catheters (ISCs), and external condom catheters for hospitalized adults on medical services was assessed in 299 scenarios, including urinary retention, incontinence, wounds, urine volume measurement, urine sample collection, and comfort. The scenarios included patient-specific issues, such as difficulty turning and catheter placement challenges. The panel rated 105 Foley scenarios (43 appropriate, 48 inappropriate, 14 uncertain), 97 ISC scenarios (15 appropriate, 66 inappropriate, 16 uncertain), and 97 external catheter scenarios (30 appropriate, 51 inappropriate, 16 uncertain). The refined criteria clarify that Foley catheters are appropriate for measuring and collecting urine only when fluid status or urine cannot be assessed by other means; specify that patients in the intensive care unit (ICU) need specific medical indications for catheters because ICU location alone is not an appropriate indication; and recognize that Foley and external catheters may be pragmatically appropriate to manage urinary incontinence in select patients. These new appropriateness criteria can inform large-scale collaborative and bedside efforts to reduce inappropriate urinary catheter use.	Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Yale Univ, Cushing Whitney Med Lib, New Haven, CT USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University	Meddings, J (corresponding author), Univ Michigan, North Campus Res Complex Bldg 16,Room 427W,2800 P, Ann Arbor, MI 48109 USA.	Meddings@umich.edu	Fowler, Karen/B-5383-2015; Saint, Sanjay/AAF-5126-2019; Krein, Sarah L/E-2742-2014	Fowler, Karen/0000-0001-8274-8407; Krein, Sarah L/0000-0003-2111-8131; Hickner, Andy/0000-0003-1922-3813; Bernstein, Steven/0000-0003-3359-7168	Department of Veterans Affairs National Center for Patient Safety; Ann Arbor Patient Safety Center of Inquiry; Agency for Healthcare Research and Quality (AHRQ) [HHSA290201000025I/HHSA29032001T]; AHRQ [K08 HS19767]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019767] Funding Source: NIH RePORTER	Department of Veterans Affairs National Center for Patient Safety(US Department of Veterans Affairs); Ann Arbor Patient Safety Center of Inquiry; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Department of Veterans Affairs National Center for Patient Safety, Ann Arbor Patient Safety Center of Inquiry, and a contract through the Agency for Healthcare Research and Quality (AHRQ) (contract HHSA290201000025I/HHSA29032001T). Dr. Meddings' effort on this project was funded by concurrent effort from AHRQ (K08 HS19767). AHRQ provided funding for the publication of this supplement.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Adams D., 2012, Journal of Infection Prevention, V13, P44; Addison R., 2012, CATHETER CARE RCN GU; Altpeter T., 2012, AM J INFECT CONTROL, V40, pE92; American Urological Association, AM UR ASS GUID OV BL; Andreessen L, 2012, J NURS CARE QUAL, V27, P209, DOI 10.1097/NCQ.0b013e318248b0b1; [Anonymous], 2006, J SPINAL CORD MED, V29, P527; Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P594, DOI 10.1016/j.ajic.2006.11.007; Apisarnthanarak A, 2007, INFECT CONT HOSP EP, V28, P791, DOI 10.1086/518453; Australian and New Zealand Urological Nurses Society, 2006, CATH CAR GUID 2006; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Brook RH, 1994, CLIN PRACTICE GUIDEL; Bruminhent J, 2010, AM J INFECT CONTROL, V38, P689, DOI 10.1016/j.ajic.2010.05.028; Capezuti E, 2007, EVIDENCE BASED GERIA, P403; Centers for Disease Control and Prevention, GET SMART HEALTHC; Centers for Medicare and Medicaid Services, HOSP COMP READM COMP; Cornia PB, 2003, AM J MED, V114, P404, DOI 10.1016/S0002-9343(02)01568-1; Cravens DD, 2000, AM FAM PHYSICIAN, V61, P369; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; De Ruz AE, 2000, J UROLOGY, V164, P1285, DOI 10.1016/S0022-5347(05)67157-1; Department of Health and Human Services, HOSP ACQ COND PRES A; Dolin SJ, 2005, BRIT J ANAESTH, V95, P584, DOI 10.1093/bja/aei227; Doughty D, 2012, J WOUND OSTOMY CONT, V39, P303, DOI 10.1097/WON.0b013e3182549118; Dumigan D G, 1998, Clin Perform Qual Health Care, V6, P172; East Coast Community Healthcare Infection Prevention and Control Team/Continence Team, POL CATH MAN; Elpern EH, 2009, AM J CRIT CARE, V18, P535, DOI 10.4037/ajcc2009938; European Pressure Ulcer Advisory Panel National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance, PREV TREATM PRESS UL; Fakih MG, 2008, INFECT CONT HOSP EP, V29, P815, DOI 10.1086/589584; Fakih MG, 2012, ARCH INTERN MED, V172, P255, DOI 10.1001/archinternmed.2011.627; Fakih MG, 2010, AM J INFECT CONTROL, V38, P683, DOI 10.1016/j.ajic.2010.04.219; Fakih MG, 2010, ACAD EMERG MED, V17, P337, DOI 10.1111/j.1553-2712.2009.00677.x; Fantl J, 1996, 960682 AG HLTH CAR P, V2; Fitch K., 2001, RAND UCLA APPROPRIAT; Fuchs MA, 2011, J NURS CARE QUAL, V26, P101, DOI 10.1097/NCQ.0b013e3181fb7847; Gammack Julie K, 2002, J Am Med Dir Assoc, V3, P162, DOI 10.1097/00130535-200205000-00007; Gardam M A, 1998, Clin Perform Qual Health Care, V6, P99; Geng V., 2012, CATHETERISATION INDW; Gokula RRM, 2004, AM J INFECT CONTROL, V32, P196, DOI 10.1016/j.ajic.2003.08.007; Gotelli John M, 2008, Urol Nurs, V28, P465; Gould C, 2014, PATIENT HARM SERIES; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Gray M, 2007, OSTOMY WOUND MANAG, V53, P28; Greene LR., APIC GUIDE ELIMINATI; Greene MT, 2014, INFECT CONT HOSP EP, V35, pS96, DOI 10.1086/677823; Greene MT, 2014, INFECT CONT HOSP EP, V35, pS99, DOI 10.1086/677825; Griffiths R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004011.pub3; Hart Sarah, 2008, Nurs Stand, V22, P44; HARTSTEIN AI, 1981, INFECT CONT HOSP EP, V2, P380, DOI 10.1017/S0195941700055533; Health Research & Educational Trust (HRET), 2014, EL CAUTI INT DAT REP; Highton P, 2008, FDN YEARS, V4, P214; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Huang WC, 2004, INFECT CONT HOSP EP, V25, P974, DOI 10.1086/502329; Jain M, 2006, QUAL SAF HEALTH CARE, V15, P235, DOI 10.1136/qshc.2005.016576; JAIN P, 1995, ARCH INTERN MED, V155, P1425, DOI 10.1001/archinte.155.13.1425; Kalbheim-Gapp E., 1997, KRANKENHAUS ARZT, V70, P48; Knoll BM, 2011, CLIN INFECT DIS, V52, P1283, DOI 10.1093/cid/cir188; Lamont T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d924; Larsen LD, 1997, UROLOGY, V50, P418, DOI 10.1016/S0090-4295(97)00224-0; Lawson EH, 2012, J CLIN EPIDEMIOL, V65, P1133, DOI 10.1016/j.jclinepi.2012.07.002; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Loeb M, 2008, J GEN INTERN MED, V23, P816, DOI 10.1007/s11606-008-0620-2; Marklew Anna, 2004, Nurs Crit Care, V9, P21, DOI 10.1111/j.1362-1017.2004.0048.x; McGuire E, PROGNOSIS MANAGEMENT; Meddings J, 2013, REDUCING UNNECESSARY; Meddings J, 2014, BMJ QUAL SAF, V23, P277, DOI 10.1136/bmjqs-2012-001774; Meddings J, 2010, CLIN INFECT DIS, V51, P550, DOI 10.1086/655133; MERRICK NJ, 1987, AM J PUBLIC HEALTH, V77, P187, DOI 10.2105/AJPH.77.2.187; Munasinghe RL, 2001, INFECT CONT HOSP EP, V22, P647, DOI 10.1086/501837; Murphy Deborah, 2007, Pa Nurse, V62, P20; National Guideline Clearinghouse, GUID SYNTH PREV PRES; National Health Service Birmingham East and North: Primary Care Trust, SUPR CATH POL; Newman DK, 2006, OSTOMY WOUND MANAG, V52, P34; Newman DK., 2006, OSTOMY WOUND MANAG, V52, P40; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Niel-Weise BS, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004203.pub2, 10.1002/14651828.CD004201.pub2]; NORDQVIST P, 1984, J HOSP INFECT, V5, P298, DOI 10.1016/0195-6701(84)90079-3; OUSLANDER JG, 1987, J AM GERIATR SOC, V35, P1063, DOI 10.1111/j.1532-5415.1987.tb04922.x; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; Patrizzi K, 2009, J EMERG NURS, V35, P536, DOI 10.1016/j.jen.2009.04.017; Phipps S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004374.pub2; RANNIKKO S, 1986, J INFECTION, V12, P221, DOI 10.1016/S0163-4453(86)94138-1; Reilly L, 2006, AACN ADV CRIT CARE, V17, P272, DOI 10.1097/01256961-200607000-00007; Robinson Sherry, 2007, Medsurg Nurs, V16, P157; Rosh AJ, SUPRAPUBIC ASPIRATIO; Rothfeld AF, 2010, AM J INFECT CONTROL, V38, P568, DOI 10.1016/j.ajic.2009.12.017; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 1999, ARCH INTERN MED, V159, P800, DOI 10.1001/archinte.159.8.800; Saint S, 2005, JT COMM J QUAL PATIE, V31, P455, DOI 10.1016/S1553-7250(05)31059-2; Saint S, 2006, J AM GERIATR SOC, V54, P1055, DOI 10.1111/j.1532-5415.2006.00785.x; Saint S, 2013, JAMA INTERN MED, V173, P874, DOI 10.1001/jamainternmed.2013.101; Schlamovitz GZ, SUPRAPUBIC CATHETERI; Schultz P, 2011, CRIT CARE NURSE, V31, pE42; Schumm K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004013.pub3; Seguin P, 2010, INTENS CARE MED, V36, P1202, DOI 10.1007/s00134-010-1829-1; Shekelle P G, 1999, J Spinal Cord Med, V22, P258; Smith JoAnn Mercer, 2003, Ostomy Wound Manage, V49, P34; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; Stephan F, 2006, CLIN INFECT DIS, V42, P1544, DOI 10.1086/503837; Tang MWS, 2006, MATURITAS, V53, P274, DOI 10.1016/j.maturitas.2005.05.014; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; The National Pressure Ulcer Advisory Panel, 2009, NPUAP PRESS ULC STAG; Titsworth WL, 2012, J NEUROSURG, V116, P911, DOI 10.3171/2011.11.JNS11974; Topal J, 2005, AM J MED QUAL, V20, P121, DOI 10.1177/1062860605276074; Torres-Salazar J, 2008, REV MEX UROL, V683, P170; Treatment of Pressure Ulcers Guideline Panel, 1994, 950652 AG HLTH CAR P; Trovillion E, 2011, SHEA 2011 ANN SCI M; Turi Mubasher H, 2006, J Pak Med Assoc, V56, P401; Umscheid CA, 2010, AM J INFECT CONTROL, V38, P264, DOI 10.1016/j.ajic.2009.12.005; van den Broek PJ, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-10; Vickrey B G, 1999, Evid Rep Technol Assess (Summ), P1; Voss AB, 2009, J GERONTOL NURS, V35, P35, DOI 10.3928/00989134-20090428-05; Warren J W, 1987, Infect Dis Clin North Am, V1, P823; Warren JW, 1997, INFECT DIS CLIN N AM, V11, P609, DOI 10.1016/S0891-5520(05)70376-7; Wein, 2009, INCONTINENCE, P1519; Weitzel Tina, 2008, Nursing, V38, P20, DOI 10.1097/01.NURSE.0000309715.59679.a5; Weld KJ, 2000, J UROLOGY, V163, P768, DOI 10.1016/S0022-5347(05)67800-7; Wenger JE, 2010, AM J NURS, V110, P40, DOI 10.1097/01.NAJ.0000387691.47746.b5; Wong E S, 1983, Am J Infect Control, V11, P28, DOI 10.1016/S0196-6553(83)80012-1; Wong ES., 1981, GUIDELINE PREVENTION; Wound Ostomy Continence Nurses Society, 2010, GUID PREV MAN PRESS	123	59	60	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9		S			S1	S34		10.7326/M14-1304	http://dx.doi.org/10.7326/M14-1304			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI8IA	25938928				2022-12-28	WOS:000355014300001
J	Bernstein, R				Bernstein, Rachel			From war to science paradise	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					602	602		10.1126/science.348.6234.602	http://dx.doi.org/10.1126/science.348.6234.602			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931563				2022-12-28	WOS:000353778100047
J	Miao, JW; Ishikawa, T; Robinson, IK; Murnane, MM				Miao, Jianwei; Ishikawa, Tetsuya; Robinson, Ian K.; Murnane, Margaret M.			Beyond crystallography: Diffractive imaging using coherent x-ray light sources	SCIENCE			English	Review							FREE-ELECTRON LASER; 3-DIMENSIONAL STRUCTURE DETERMINATION; MICROSCOPY; RESOLUTION; NANOSCALE; PROTEIN; NANOCRYSTALS; REFLECTION; DYNAMICS; OBJECTS	X-ray crystallography has been central to the development of many fields of science over the past century. It has now matured to a point that as long as good-quality crystals are available, their atomic structure can be routinely determined in three dimensions. However, many samples in physics, chemistry, materials science, nanoscience, geology, and biology are noncrystalline, and thus their three-dimensional structures are not accessible by traditional x-ray crystallography. Overcoming this hurdle has required the development of new coherent imaging methods to harness new coherent x-ray light sources. Here we review the revolutionary advances that are transforming x-ray sources and imaging in the 21st century.	[Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Ishikawa, Tetsuya] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Robinson, Ian K.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Robinson, Ian K.] Res Complex Harwell, Oxford OX11 0DE, England; [Murnane, Margaret M.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Murnane, Margaret M.] NIST, Boulder, CO 80309 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN; University of London; University College London; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Ishikawa, Tetsuya/I-4775-2012; Robinson, Ian/A-4906-2010	Ishikawa, Tetsuya/0000-0002-6906-9909; Robinson, Ian/0000-0003-4897-5221	Defense Advanced Research Projects Agency PULSE program through a grant from AMRDEC; NSF [DMR-1437263]; NSF; DOE; SRC; ERC "Advanced" grant; BBSRC [BB/H022597/1] Funding Source: UKRI; EPSRC [EP/I022562/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022597/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I022562/1] Funding Source: researchfish	Defense Advanced Research Projects Agency PULSE program through a grant from AMRDEC; NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); SRC; ERC "Advanced" grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Pellegrini and J. M. Rodenburg for stimulating discussions and H. Jiang, J. Zhou, Y. Yang, and D. Adams for help with the figures and references. J. M. and M. M. M. acknowledge support from the Defense Advanced Research Projects Agency PULSE program through a grant from AMRDEC. J. M. thanks support from NSF (grant DMR-1437263). M. M. M. thanks support from NSF, DOE, and SRC. I.K.R. acknowledges support from an ERC "Advanced" grant. The University of Colorado and the University of Michigan have patents coauthored by M. M. M. in the area of high harmonic sources: U.S. Patent 8,462,824 (2013) and U.S. Patent 6151155 (2000).	Barty A, 2008, NAT PHOTONICS, V2, P415, DOI 10.1038/nphoton.2008.128; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Ekeberg T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.098102; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Gallagher-Jones M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4798; Hantke MF, 2014, NAT PHOTONICS, V8, P943, DOI [10.1038/nphoton.2014.270, 10.1038/NPHOTON.2014.270]; Hernandez-Garcia C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.033002; Hoogeboom-Pot KM, 2015, P NATL ACAD SCI USA, V112, P4846, DOI 10.1073/pnas.1503449112; Huang XJ, 2009, OPT EXPRESS, V17, P13541, DOI 10.1364/OE.17.013541; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Jiang HD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.205501; Jiang HD, 2010, P NATL ACAD SCI USA, V107, P11234, DOI 10.1073/pnas.1000156107; Jiang HD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038103; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kfir O, 2015, NAT PHOTONICS, V9, P99, DOI [10.1038/nphoton.2014.293, 10.1038/NPHOTON.2014.293]; Kimura T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4052; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Maiden AM, 2009, ULTRAMICROSCOPY, V109, P1256, DOI 10.1016/j.ultramic.2009.05.012; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088303; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Miao JW, 2001, P NATL ACAD SCI USA, V98, P6641, DOI 10.1073/pnas.111083998; Nelson J, 2010, P NATL ACAD SCI USA, V107, P7235, DOI 10.1073/pnas.0910874107; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Newton MC, 2010, NAT MATER, V9, P120, DOI [10.1038/nmat2607, 10.1038/NMAT2607]; Nicolas JD, 2014, J APPL CRYSTALLOGR, V47, P1596, DOI 10.1107/S1600576714016896; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Pfeifer MA, 2006, NATURE, V442, P63, DOI 10.1038/nature04867; Popmintchev T, 2012, SCIENCE, V336, P1287, DOI 10.1126/science.1218497; Raines KS, 2010, NATURE, V463, P214, DOI 10.1038/nature08705; Robinson IK, 1999, PHYS REV B, V60, P9965, DOI 10.1103/PhysRevB.60.9965; Robinson IK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195505; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Roy S, 2011, NAT PHOTONICS, V5, P243, DOI 10.1038/NPHOTON.2011.11; Rudolf D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2029; Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267; Seaberg MD, 2014, OPTICA, V1, P39, DOI 10.1364/OPTICA.1.000039; Seaberg MD, 2011, OPT EXPRESS, V19, P22470, DOI 10.1364/OE.19.022470; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Shapiro DA, 2014, NAT PHOTONICS, V8, P765, DOI [10.1038/NPHOTON.2014.207, 10.1038/nphoton.2014.207]; Siemens ME, 2010, NAT MATER, V9, P26, DOI [10.1038/NMAT2568, 10.1038/nmat2568]; Song CY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.025504; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Sun T, 2012, NAT PHOTONICS, V6, P586, DOI [10.1038/nphoton.2012.178, 10.1038/NPHOTON.2012.178]; Szameit A, 2012, NAT MATER, V11, P455, DOI [10.1038/NMAT3289, 10.1038/nmat3289]; Takahashi Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214102; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Tripathi A, 2011, P NATL ACAD SCI USA, V108, P13393, DOI 10.1073/pnas.1104304108; Turgut E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.197201; Williams GJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025506; Xu R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5061	61	440	448	14	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					530	535		10.1126/science.aaa1394	http://dx.doi.org/10.1126/science.aaa1394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931551	Green Submitted			2022-12-28	WOS:000353778100031
J	O'Connor, JE; Duda, JJ; Grant, GE				O'Connor, J. E.; Duda, J. J.; Grant, G. E.			1000 dams down and counting	SCIENCE			English	Editorial Material							REMOVAL; RIVER		[O'Connor, J. E.] US Geol Survey, Portland, OR 97201 USA; [Duda, J. J.] US Geol Survey, Seattle, WA USA; [Grant, G. E.] US Forest Serv, USDA, Corvallis, OR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service	O'Connor, JE (corresponding author), US Geol Survey, Portland, OR 97201 USA.	oconnor@usgs.gov	Duda, Jeffrey J./A-7132-2009	Duda, Jeffrey J./0000-0001-7431-8634				Bellmore JR, 2015, USGS DAM REMOVAL SCI; Burroughs BA, 2009, GEOMORPHOLOGY, V110, P96, DOI 10.1016/j.geomorph.2009.03.019; Downs PW, 2009, INT J RIVER BASIN MA, V7, P433, DOI 10.1080/15715124.2009.9635401; East AE, 2015, GEOMORPHOLOGY, V228, P765, DOI 10.1016/j.geomorph.2014.08.028; Grant GE, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 3: RIVER BASINS, RESERVOIR SEDIMENTATION AND WATER RESOURCES, P31, DOI 10.1007/978-3-319-09054-2_7; Hitt NP, 2012, T AM FISH SOC, V141, P1171, DOI 10.1080/00028487.2012.675918; Hogg R, 2013, T AM FISH SOC, V142, P1381, DOI 10.1080/00028487.2013.811103; Kornis MS, 2015, AQUAT SCI, V77, P465, DOI 10.1007/s00027-014-0391-2; Lejon AGC, 2009, ECOL SOC, V14; Major J.J., 2012, GEOMORPHIC RESPONSE, DOI [10.3133/pp1792, DOI 10.3133/PP1792]; Orr CH, 2008, RIVER RES APPL, V24, P804, DOI 10.1002/rra.1084; Pearson A. J., 2009, WATER RESOUR RES, V47; Tullos DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108091; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	14	189	193	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					496	497		10.1126/science.aaa9204	http://dx.doi.org/10.1126/science.aaa9204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931537				2022-12-28	WOS:000353778100018
J	Castro, VM; McCoy, TH; Cagan, A; Rosenfield, HR; Murphy, SN; Churchill, SE; Kohane, IS; Perlis, RH				Castro, Victor M.; McCoy, Thomas H.; Cagan, Andrew; Rosenfield, Hannah R.; Murphy, Shawn N.; Churchill, Susanne E.; Kohane, Isaac S.; Perlis, Roy H.			Stratification of risk for hospital admissions for injury related to fall: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLDER-PEOPLE; COSTS; CARE; BALANCE; ABILITY; SCALE; RECLASSIFICATION; ASSOCIATION; STATISTICS; ENTERPRISE	Objective To determine whether the ability to stratify an individual patient's hazard for falling could facilitate development of focused interventions aimed at reducing these adverse outcomes. Design Clinical and sociodemographic data from electronic health records were utilized to derive multiple logistic regression models of hospital readmissions for injuries related to falls. Drugs used at admission were summarized based on reported adverse effect frequencies in published drug labeling. Setting Two large academic medical centers in New England, United States. Participants The model was developed with 25 924 individuals age >= 40 with an initial hospital discharge. The resulting model was then tested in an independent set of 13 032 inpatients drawn from the same hospital and 36 588 individuals discharged from a second large hospital during the same period. Main outcome measure Hospital readmissions for injury related to falls. Results Among 25 924 discharged individuals, 680 (2.6%) were evaluated in the emergency department or admitted to hospital for a fall within 30 days of discharge, 1635 (6.3%) within 180 days of discharge, 2360 (9.1%) within one year, and 3465 (13.4%) within two years. Older age, female sex, white or African-American race, public insurance, greater number of drugs taken on discharge, and score for burden of adverse effects were each independently associated with hazard for fall. For drug burden, presence of a drug with a frequency of adverse effects related to fall of 10% was associated with 3.5% increase in odds of falling over the next two years (odds ratio 1.04, 95% confidence interval 1.02 to 1.05). In an independent testing set, the area under the receiver operating characteristics curve was 0.65 for a fall within two years based on cross sectional data and 0.72 with the addition of prior utilization data including age adjusted Charlson comorbidity index. Portability was promising, with area under the curve of 0.71 for the longitudinal model in a second hospital system. Conclusions It is potentially useful to stratify risk of falls based on clinical features available as artifacts of routine clinical care. A web based tool can be used to calculate and visualize risk associated with drug treatment to facilitate further investigation and application.	[Castro, Victor M.; McCoy, Thomas H.; Cagan, Andrew; Rosenfield, Hannah R.; Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Ctr Expt Drugs & Diagnost, Boston, MA 02114 USA; [Castro, Victor M.; Cagan, Andrew; Murphy, Shawn N.] Partners HealthCare Syst, Partners Res Comp, Boston, MA 02129 USA; [Castro, Victor M.; Cagan, Andrew; Murphy, Shawn N.] Massachusetts Gen Hosp, Lab Comp Sci, Boston, MA 02114 USA; [Castro, Victor M.; Cagan, Andrew; Murphy, Shawn N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [McCoy, Thomas H.; Rosenfield, Hannah R.; Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Ctr Expt Drugs & Diagnost, Boston, MA 02114 USA; [Churchill, Susanne E.] Partners HealthCare Syst, Informat Syst, Natl Ctr Biomed Comp I2b2, Boston, MA 02115 USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Natl Ctr Biomed Comp I2b2, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Perlis, RH (corresponding author), Simches Res Bldg MGH,185 Cambridge St,6th Floor, Boston, MA 02114 USA.	rperlis@partners.org	Castro, Victor M/CAF-9395-2022; Castro, Victor M/CAH-3428-2022	Castro, Victor M/0000-0001-7390-6354; Castro, Victor M/0000-0001-7390-6354; McCoy, Thomas/0000-0002-5624-0439				AMBLER G, 2012, HOSMER LEMESHOW GOOD; Baetens T, 2011, J REHABIL MED, V43, P876, DOI 10.2340/16501977-0873; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bohl AA, 2012, GERONTOLOGIST, V52, P664, DOI 10.1093/geront/gnr151; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; *CDC, 2013, PREV FALLS OLD AD 20; Chaudhuri S, 2014, J GERIATR PHYS THER, V37, P178, DOI 10.1519/JPT.0b013e3182abe779; Clements CC, 2015, MOL PSYCHIATR, V20, P727, DOI 10.1038/mp.2014.90; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; da Costa BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041061; Duran CE, 2013, EUR J CLIN PHARMACOL, V69, P1485, DOI 10.1007/s00228-013-1499-3; Goodwin VA, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-15; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Liston MB, 2014, CLIN REHABIL, V28, P784, DOI 10.1177/0269215514521042; Mangoni AA, 2013, AM J GERIAT PSYCHIAT, V21, P785, DOI 10.1016/j.jagp.2013.01.012; Emilio EJML, 2014, J SPORT SCI MED, V13, P349; McCart JA, 2013, J AM MED INFORM ASSN, V20, P906, DOI 10.1136/amiajnl-2012-001334; Medical Advisory Secretariat, 2008, Ont Health Technol Assess Ser, V8, P1; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy Shawn N, 2007, AMIA Annu Symp Proc, P548; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Nystrom A, 2013, CLIN REHABIL, V27, P473, DOI 10.1177/0269215512464703; Pasina L, 2013, DRUG AGING, V30, P103, DOI 10.1007/s40266-012-0044-x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Ryan JJ, 2011, J GERIATR PHYS THER, V34, P19, DOI 10.1519/JPT.0b013e31820aa829; Sterke CS, 2012, GAIT POSTURE, V36, P95, DOI 10.1016/j.gaitpost.2012.01.012; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Sundstrom J, 2011, SCAND J PUBLIC HEALT, V39, P439, DOI 10.1177/1403494810396556; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377	34	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g5863	10.1136/bmj.g5863	http://dx.doi.org/10.1136/bmj.g5863			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OI	25954985	Green Published, hybrid			2022-12-28	WOS:000343768700001
J	Tong, YG; Shi, WF; Liu, D; Qian, J; Liang, L; Bo, XC; Liu, J; Ren, HG; Fan, H; Ni, M; Sun, Y; Jin, Y; Teng, Y; Li, Z; Kargbo, D; Dafae, F; Kanu, A; Chen, CC; Lan, ZH; Jiang, H; Luo, Y; Lu, HJ; Zhang, XG; Yang, F; Hu, Y; Cao, YX; Deng, YQ; Su, HX; Sun, Y; Liu, WS; Wang, Z; Wang, CY; Bu, ZY; Guo, ZD; Zhang, LB; Nie, WM; Bai, CQ; Sun, CH; An, XP; Xu, PS; Zhang, XLL; Huang, Y; Mi, ZQ; Yu, D; Yao, HW; Feng, Y; Xia, ZP; Zheng, XX; Yang, ST; Lu, B; Jiang, JF; Kargbo, B; He, FC; Gao, GF; Cao, WC				Tong, Yi-Gang; Shi, Wei-Feng; Liu, Di; Qian, Jun; Liang, Long; Bo, Xiao-Chen; Liu, Jun; Ren, Hong-Guang; Fan, Hang; Ni, Ming; Sun, Yang; Jin, Yuan; Teng, Yue; Li, Zhen; Kargbo, David; Dafae, Foday; Kanu, Alex; Chen, Cheng-Chao; Lan, Zhi-Heng; Jiang, Hui; Luo, Yang; Lu, Hui-Jun; Zhang, Xiao-Guang; Yang, Fan; Hu, Yi; Cao, Yu-Xi; Deng, Yong-Qiang; Su, Hao-Xiang; Sun, Yu; Liu, Wen-Sen; Wang, Zhuang; Wang, Cheng-Yu; Bu, Zhao-Yang; Guo, Zhen-Dong; Zhang, Liu-Bo; Nie, Wei-Min; Bai, Chang-Qing; Sun, Chun-Hua; An, Xiao-Ping; Xu, Pei-Song; Zhang, Xiang-Li-Lan; Huang, Yong; Mi, Zhi-Qiang; Yu, Dong; Yao, Hong-Wu; Feng, Yong; Xia, Zhi-Ping; Zheng, Xue-Xing; Yang, Song-Tao; Lu, Bing; Jiang, Jia-Fu; Kargbo, Brima; He, Fu-Chu; Gao, George F.; Cao, Wu-Chun		China Mobile Lab Testing Team	Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone	NATURE			English	Article							MOLECULAR EVOLUTION; INFERENCE	A novel Ebola virus (EBOV) first identified in March 2014 has infected more than 25,000 people in West Africa, resulting in more than 10,000 deaths(1,2). Preliminary analyses of genome sequences of 81 EBOV collected from March to June 2014 from Guinea and Sierra Leone suggest that the 2014 EBOV originated from an independent transmission event from its natural reservoir(3) followed by sustained human-to-human infections(4). It has been reported that the EBOV genome variation might have an effect on the efficacy of sequence-based virus detection and candidate therapeutics(5,6). However, only limited viral information has been available since July 2014, when the outbreak entered a rapid growth phase(7). Here we describe 175 full-length EBOV genome sequences from five severely stricken districts in Sierra Leone from 28 September to 11 November 2014. We found that the 2014 EBOV has become more phylogenetically and genetically diverse from July to November 2014, characterized by the emergence of multiple novel lineages. The substitution rate for the 2014 EBOV was estimated to be 1.23x10(-3) substitutions per site per year (95% highest posterior density interval, 1.04x10(-3) to 1.41x10(-3) substitutions per site per year), approximating to that observed between previous EBOV outbreaks. The sharp increase in genetic diversity of the 2014 EBOV warrants extensive EBOV surveillance in Sierra Leone, Guinea and Liberia to better understand the viral evolution and transmission dynamics of the ongoing outbreak. These data will facilitate the international efforts to develop vaccines and therapeutics.	[Tong, Yi-Gang; Liang, Long; Ren, Hong-Guang; Fan, Hang; Jin, Yuan; Teng, Yue; Hu, Yi; Deng, Yong-Qiang; Sun, Yu; Wang, Zhuang; Sun, Chun-Hua; An, Xiao-Ping; Zhang, Xiang-Li-Lan; Huang, Yong; Mi, Zhi-Qiang; Yu, Dong; Yao, Hong-Wu; Lu, Bing; Jiang, Jia-Fu; Cao, Wu-Chun] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Shi, Wei-Feng] Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China; [Liu, Di; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Bo, Xiao-Chen; Ni, Ming; Li, Zhen; Xu, Pei-Song] Beijing Key Lab New Mol Diagnost Technol, Beijing 100850, Peoples R China; [Qian, Jun; Sun, Yang; Lu, Hui-Jun; Liu, Wen-Sen; Wang, Cheng-Yu; Bu, Zhao-Yang; Guo, Zhen-Dong; Xia, Zhi-Ping; Zheng, Xue-Xing; Yang, Song-Tao] Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun 130122, Peoples R China; [Liu, Jun; Zhang, Xiao-Guang; Cao, Yu-Xi; Gao, George F.] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Kargbo, David; Dafae, Foday; Kargbo, Brima] Sierra Leone Minist Hlth & Sanitat, Freetown, Sierra Leone; [Kanu, Alex] Sierra Leone China Friendship Hosp, Freetown, Sierra Leone; [Chen, Cheng-Chao; Lan, Zhi-Heng; Jiang, Hui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Luo, Yang] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Yang, Fan; Su, Hao-Xiang] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Yang, Fan; Su, Hao-Xiang] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Liu-Bo] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safet, Beijing 100021, Peoples R China; [Nie, Wei-Min] 302 Hosp, Beijing 100039, Peoples R China; [Bai, Chang-Qing] 307 Hosp, Beijing 100071, Peoples R China; [Feng, Yong] Natl Hlth & Family Planning Commiss, Dept Int Cooperat, Beijing 100044, Peoples R China; [He, Fu-Chu] State Key Lab Prote, Beijing 102206, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Center for Disease Control & Prevention; Ministry of Health & Sanitation Sierra Leone; Beijing Genomics Institute (BGI); Wellcome Trust Sanger Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Chinese Center for Disease Control & Prevention	Cao, WC (corresponding author), State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	hefc@nic.bmi.ac.cn; gaof@im.ac.cn; caowc@bmi.ac.cn	Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021; Liu, Di/G-6135-2014; Fan, Hang/AAA-8489-2022; Yang, Fan/GYU-4249-2022	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; Fan, Hang/0000-0002-7927-1684; Yang, Fengtang/0000-0002-3573-2354; Yu, Dong/0000-0001-6089-4905; Ni, Ming/0000-0001-9465-2787; Bo, Xiao-chen/0000-0003-1911-7922; Tong, Yigang/0000-0002-8503-8045	special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences; China Mega-Project on Infectious Disease Prevention [2013ZX10004202-002, 2013ZX10004605]; China Mega-Project on Major Drug Development [2013ZX09304101]; National Hi-Tech Research and Development (863) Program of China [2014AA021402, 2014AA021501]; Innovative Research Group of the National Natural Science Foundation of China, NSFC [81321063]	special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences; China Mega-Project on Infectious Disease Prevention; China Mega-Project on Major Drug Development; National Hi-Tech Research and Development (863) Program of China; Innovative Research Group of the National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC))	We thank P. Lemey and S. Ho for technical assistance. This work is partially supported by the special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences. It was also supported by grants from the China Mega-Project on Infectious Disease Prevention (nos 2013ZX10004202-002, 2013ZX10004605), China Mega-Project on Major Drug Development (no. 2013ZX09304101) and the National Hi-Tech Research and Development (863) Program of China (nos 2014AA021402, 2014AA021501). We thank the government of Sierra Leone, the Sierra Leone Ministry of Health and Sanitation and the Chinese National Health and Family Planning Commission. We also thank the medical workers and volunteers in Sierra Leone. G.F.G. is a leading principal investigator of Innovative Research Group of the National Natural Science Foundation of China, NSFC) (grant no. 81321063).	[Anonymous], EBOLA RESPONSE ROADM; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Calvignac-Spencer S, 2014, PLOS CURR, V6; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dudas G., 2014, PLOS CURR; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090	17	117	131	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					93	U191		10.1038/nature14490	http://dx.doi.org/10.1038/nature14490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	25970247	hybrid			2022-12-28	WOS:000359002300038
J	Jairath, V; Kahan, BC; Gray, A; Dore, CJ; Mora, A; James, MW; Stanley, AJ; Everett, SM; Bailey, AA; Dallal, H; Greenaway, J; Le Jeune, I; Darwent, M; Church, N; Reckless, I; Hodge, R; Dyer, C; Meredith, S; Llewelyn, C; Palmer, KR; Logan, RF; Travis, SP; Walsh, TS; Murphy, MF				Jairath, Vipul; Kahan, Brennan C.; Gray, Alasdair; Dore, Caroline J.; Mora, Ana; James, Martin W.; Stanley, Adrian J.; Everett, Simon M.; Bailey, Adam A.; Dallal, Helen; Greenaway, John; Le Jeune, Ivan; Darwent, Melanie; Church, Nicholas; Reckless, Ian; Hodge, Renate; Dyer, Claire; Meredith, Sarah; Llewelyn, Charlotte; Palmer, Kelvin R.; Logan, Richard F.; Travis, Simon P.; Walsh, Timothy S.; Murphy, Michael F.			Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial	LANCET			English	Article							CELL TRANSFUSION; RISK; REQUIREMENTS; MULTICENTER; STRATEGIES; CONSENSUS; OUTCOMES	Background Transfusion thresholds for acute upper gastrointestinal bleeding are controversial. So far, only three small, underpowered studies and one single-centre trial have been done. Findings from the single-centre trial showed reduced mortality with restrictive red blood cell (RBC) transfusion. We aimed to assess whether a multicentre, cluster randomised trial is a feasible method to substantiate or refute this finding. Methods In this pragmatic, open-label, cluster randomised feasibility trial, done in six university hospitals in the UK, we enrolled all patients aged 18 years or older with new presentations of acute upper gastrointestinal bleeding, irrespective of comorbidity, except for exsanguinating haemorrhage. We randomly assigned hospitals (1: 1) with a computer-generated randomisation sequence (random permuted block size of 6, without stratification or matching) to either a restrictive (transfusion when haemoglobin concentration fell below 80 g/L) or liberal (transfusion when haemoglobin concentration fell below 100 g/L) RBC transfusion policy. Neither patients nor investigators were masked to treatment allocation. Feasibility outcomes were recruitment rate, protocol adherence, haemoglobin concentration, RBC exposure, selection bias, and information to guide design and economic evaluation of the phase 3 trial. Main exploratory clinical outcomes were further bleeding and mortality at day 28. We did analyses on all enrolled patients for whom an outcome was available. This trial is registered, ISRCTN85757829 and NCT02105532. Findings Between Sept 3, 2012, and March 1, 2013, we enrolled 936 patients across six hospitals (403 patients in three hospitals with a restrictive policy and 533 patients in three hospitals with a liberal policy). Recruitment rate was significantly higher for the liberal than for the restrictive policy (62% vs 55%; p=0.04). Despite some baseline imbalances, Rockall and Blatchford risk scores were identical between policies. Protocol adherence was 96% (SD 10) in the restrictive policy vs 83% (25) in the liberal policy (difference 14%; 95% CI 7-21; p=0.005). Mean last recorded haemoglobin concentration was 116 (SD 24) g/L for patients on the restrictive policy and 118 (20) g/L for those on the liberal policy (diff erence -2.0 [95% CI -12.0 to 7.0]; p=0.50). Fewer patients received RBCs on the restrictive policy than on the liberal policy (restrictive policy 133 [33%] vs liberal policy 247 [46%]; diff erence -12% [95% CI -35 to 11]; p=0.23), with fewer RBC units transfused (mean 1.2 [SD 2.1] vs 1.9 [2.8]; diff erence -0.7 [-1.6 to 0.3]; p=0.12), although these differences were not significant. We noted no significant diff erence in clinical outcomes. Interpretation A cluster randomised design led to rapid recruitment, high protocol adherence, separation in degree of anaemia between groups, and non-significant reduction in RBC transfusion in the restrictive policy. A large cluster randomised trial to assess the effectiveness of transfusion strategies for acute upper gastrointestinal bleeding is both feasible and essential before clinical practice guidelines change to recommend restrictive transfusion for all patients with acute upper gastrointestinal bleeding.	[Jairath, Vipul; Murphy, Michael F.] NHS Blood & Transplant, Oxford, England; [Jairath, Vipul; Bailey, Adam A.; Travis, Simon P.] Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England; [Kahan, Brennan C.; Dore, Caroline J.; Meredith, Sarah] UCL, MRC, Clin Trials Unit, London, England; [Gray, Alasdair] Royal Edinburgh Infirm, Dept Emergency Med, Edinburgh, Midlothian, Scotland; [Church, Nicholas] Royal Edinburgh Infirm, Dept Gastroenterol, Edinburgh, Midlothian, Scotland; [Mora, Ana; Hodge, Renate; Dyer, Claire; Llewelyn, Charlotte] NHS Blood & Transplant Clin Trials Unit, Cambridge, England; [James, Martin W.; Logan, Richard F.] Nottingham Univ Hosp NHS Trust, Natl Inst Hlth Res, Nottingham Digest Dis Biomed Res Unit, Nottingham, England; [Le Jeune, Ivan] Nottingham Univ Hosp NHS Trust, Dept Res & Educ Emergency Med Acute Med & Trauma, Nottingham, England; [Stanley, Adrian J.] Glasgow Royal Infirm, Gastroenterol Unit, Glasgow G4 0SF, Lanark, Scotland; [Everett, Simon M.] St James Univ Hosp, Dept Gastroenterol, Leeds, W Yorkshire, England; [Dallal, Helen; Greenaway, John] James Cook Univ Hosp, Dept Gastroenterol, Middlesbrough, Cleveland, England; [Reckless, Ian] Oxford Univ Hosp NHS Trust, Dept Acute Gen Med, Dept Emergency Med, Oxford, England; [Palmer, Kelvin R.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Walsh, Timothy S.] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Murphy, Michael F.] Oxford Univ Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England	University of Oxford; Medical Research Council Clinical Trials Unit; University of London; University College London; Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; Nottingham University Hospital NHS Trust; University of Nottingham; Nottingham University Hospital NHS Trust; University of Glasgow; Saint James's University Hospital; James Cook University Hospital; Oxford University Hospitals NHS Foundation Trust; University of Edinburgh; University of Edinburgh; University of Oxford	Jairath, V (corresponding author), Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	vipul.jairath@nhsbt.nhs.uk	Jairath, Vipul/GLS-6449-2022; Dore, Caroline J/J-4716-2012	Dore, Caroline J/0000-0001-9796-4970; Stanley, Adrian/0000-0002-9761-9795; Travis, Simon/0000-0002-2690-4361; Bailey, Adam/0000-0002-8371-2147	NHS Blood and Transplant Research and Development; NHS Blood and Transplant Research and Development [10-09-CSU]; National Institute for Health Research Clinical Research Networks; Medical Research Council [MC_U122870183] Funding Source: researchfish; MRC [MC_U122870183] Funding Source: UKRI	NHS Blood and Transplant Research and Development; NHS Blood and Transplant Research and Development; National Institute for Health Research Clinical Research Networks; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NHS Blood and Transplant Research and Development.; This study was funded by NHS Blood and Transplant Research and Development (grant number 10-09-CSU) and run by the NHS Blood and Transplant Clinical Trials Unit (formerly NHS Blood and Transplant/Medical Research Council Clinical Trials Unit). The views and opinions expressed herein are those of the authors and do not necessarily represent those of NHS Blood and Transplant. The trial was supported by the National Institute for Health Research Clinical Research Networks. We thank the independent members of the Trial Steering Committee and independent data monitoring committee, members of the lay focus group and patient panel who contributed to trial design, and Age UK Abingdon for allowing us to run a focus group with members of the public. We thank all clinical teams in participating centres for their support and following the transfusion policies.	Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; British Society of Gastroenterology, 2007, UK COMP AUD UPP GAST; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub2; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Crooks C, 2011, GASTROENTEROLOGY, V141, P62, DOI 10.1053/j.gastro.2011.03.048; Crooks CJ, 2013, GASTROENTEROLOGY, V144, P1384, DOI 10.1053/j.gastro.2013.02.040; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Elizalde JI, 1998, J HEPATOL, V29, P789, DOI 10.1016/S0168-8278(98)80260-2; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hayes RJ, 2009, INTERD STAT, P3; Hearnshaw SA, 2010, ALIMENT PHARM THER, V32, P215, DOI 10.1111/j.1365-2036.2010.04348.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jairath V, 2013, TRANSFUSION MED, V23, P139, DOI 10.1111/tme.12048; Jairath V, 2010, COCHRANE DB SYST REV, V9; Jairath V, 2013, TRANSFUS MED REV, V27, P146, DOI 10.1016/j.tmrv.2013.04.001; Jairath V, 2011, TRANSFUSION, V51, P1940, DOI 10.1111/j.1537-2995.2011.03119.x; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kahan BC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-206; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Restellini S, 2013, ALIMENT PHARM THER, V37, P316, DOI 10.1111/apt.12170; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Tinegate H, 2013, TRANSFUSION, V53, P483, DOI 10.1111/j.1537-2995.2012.03782.x; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Villarejo F., 1999, Acta Gastroenterologica Latinoamericana, V29, P261; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Walsh TS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4408	31	143	152	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					137	144		10.1016/S0140-6736(14)61999-1	http://dx.doi.org/10.1016/S0140-6736(14)61999-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	25956718	Green Submitted			2022-12-28	WOS:000357742200030
J	Blumenthal, D; Abrams, M; Nuzum, R				Blumenthal, David; Abrams, Melinda; Nuzum, Rachel			The Affordable Care Act at 5 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSIONS		[Blumenthal, David; Abrams, Melinda; Nuzum, Rachel] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Agency for Healthcare Research and Quality, 2014, INT UPD 2013 ANN HOS; Agency for Healthcare Research and Quality, 2014, 2013 NAT HEALTHC QUA; [Anonymous], 2015, GROGR VAR PUBL US FI; [Anonymous], CMS INN CTR MOD PART; Brennan N., 2014, FINDINGS RECENT CMS; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Carman KG, 2014, CHANGES HLTH INSURAN; Cavanaugh S., 2014, ACOS MOVING AHEAD; Centers for Medicare and Medicaid Services, 2015, MED CHIP DEC 2014 MO; Centers for Medicare and Medicaid Services, 2015, 2015 VAL MOD RES; Clemans-Cope L, 2015, QUICKTAKE HLTH INSUR; Collins SR, 2015, RISE HLTH CARE COVER; Congressional Budget Office, 2010, BUDG EC OUTL FISC YE; Congressional Budget Office, 2015, UPD BUDG PROJ 2015 2; Conway P, 2015, BUILDING SUCCESS ACO; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Long S.K., 2014, TAKING STOCK HLTH IN; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Medicaid and CHIP Payment and Access Commission, 2020, JUN 2020 REP C MED C; Nyweide D. J., 2015, JAMA; Office of the Assistant Secretary for Planning and Evaluation, 2015, HLTH INS MARK 2015 O; Office of the Assistant Secretary for Planning and Evaluation Department of Health & Human Services, 2014, MAN IND MIGHT HAV MA; Polsky D, 2015, NEW ENGL J MED, V372, P537, DOI 10.1056/NEJMsa1413299; Roehrig C, 2015, WHAT IS POSTRECESSIO; Snyder L, 2014, ACA PRIMARY CARE INC; Taylor E. F., 2015, EVALUATION COMPREHEN	27	158	158	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2451	2458		10.1056/NEJMhpr1503614	http://dx.doi.org/10.1056/NEJMhpr1503614			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK6RF	25946142				2022-12-28	WOS:000356354600013
J	Klomp, J; Athy, D; Kwan, CW; Bloch, NI; Sandmann, T; Lemke, S; Schmidt-Ott, U				Klomp, Jeff; Athy, Derek; Kwan, Chun Wai; Bloch, Natasha I.; Sandmann, Thomas; Lemke, Steffen; Schmidt-Ott, Urs			A cysteine-clamp gene drives embryo polarity in the midge Chironomus	SCIENCE			English	Article							EARLY DROSOPHILA EMBRYO; BICOID PROTEIN; ANTERIOR; ORTHODENTICLE; MORPHOGEN; TRIBOLIUM; POSTERIOR; TAILLESS; PATTERN; EGG	In the fruit fly Drosophila, head formation is driven by a single gene, bicoid, which generates head-to-tail polarity of the main embryonic axis. Bicoid deficiency results in embryos with tail-to-tail polarity and no head. However, most insects lack bicoid, and the molecular mechanism for establishing head-to-tail polarity is poorly understood. We have identified a gene that establishes head-to-tail polarity of the mosquito-like midge, Chironomus riparius. This gene, named panish, encodes a cysteine-clamp DNA binding domain and operates through a different mechanism than bicoid. This finding, combined with the observation that the phylogenetic distributions of panish and bicoid are limited to specific families of flies, reveals frequent evolutionary changes of body axis determinants and a remarkable opportunity to study gene regulatory network evolution.	[Klomp, Jeff; Athy, Derek; Kwan, Chun Wai; Bloch, Natasha I.; Lemke, Steffen; Schmidt-Ott, Urs] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sandmann, Thomas] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany	University of Chicago; Helmholtz Association; German Cancer Research Center (DKFZ)	Schmidt-Ott, U (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	uschmid@uchicago.edu	Lemke, Steffen/A-2463-2017	Sandmann, Thomas/0000-0002-6601-8890; Schmidt-Ott, Urs/0000-0002-1351-9472; Klomp, Jeffrey/0000-0002-5243-6987; Bloch, Natasha I/0000-0002-4769-1027	Cell Networks Cluster of Excellence grant [EXC81]; NIH [1R03HD67700-01A1]; NSF [IOS-1121211, IOS-1355057]; University of Chicago; Division Of Integrative Organismal Systems [1121211, 1355057] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD067700] Funding Source: NIH RePORTER	Cell Networks Cluster of Excellence grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Chicago(University of Chicago); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Transcriptomic data are available at the National Center for Biotechnology Information Sequence Read Archive (PRJNA229141). We thank G. K. Bergtrom for Chironomus culture and equipment; T. Hankeln, F. Ripp, L. Wieslander, and N. Visa for chironomid sequence data; J. E. Klomp for technical advice and discussions; M. Ludwig, S. Lott, M. Kim, C. Avila, A. Barnett, E. Davydova, T. Uchanski, C. Martinez, and Y. Yoon for technical help; J. Reinitz, M. Long, P. Rice, P. Faber, A. Ruthenberg, and C. Martinez for discussions; and C. Ferguson and M. Feder for laboratory equipment. Supported by Cell Networks Cluster of Excellence grant EXC81 (T. S.), NIH grant 1R03HD67700-01A1, NSF grants IOS-1121211 and IOS-1355057, and the University of Chicago.	Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Brent AE, 2007, SCIENCE, V315, P1841, DOI 10.1126/science.1137528; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1990, DEVELOPMENT, V109, P811; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; DRIEVER W, 1993, DEV DROSOPHILA MELAN, V1, P301; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; KALTHOFF K, 1971, DEV BIOL, V25, P119, DOI 10.1016/0012-1606(71)90022-4; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kotkamp K, 2010, DEVELOPMENT, V137, P1853, DOI 10.1242/dev.047043; Lemke S, 2010, DEVELOPMENT, V137, P1709, DOI 10.1242/dev.046649; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Moran E, 2006, MOL CELL BIOL, V26, P3446, DOI 10.1128/MCB.26.9.3446-3454.2006; Rosenberg MI, 2009, BBA-GENE REGUL MECH, V1789, P333, DOI 10.1016/j.bbagrm.2008.09.007; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; STRECKER TR, 1988, DEVELOPMENT, V102, P721; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; YAJIMA H, 1964, J EMBRYOL EXP MORPH, V12, P89	22	28	29	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1040	1042		10.1126/science.aaa7105	http://dx.doi.org/10.1126/science.aaa7105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25953821	Green Accepted			2022-12-28	WOS:000355276600050
J	DiLillo, DJ; Ravetch, JV				DiLillo, David J.; Ravetch, Jeffrey V.			Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect	CELL			English	Article							IN-VIVO; ANTI-CD20 ANTIBODY; ADAPTIVE IMMUNITY; GAMMA RECEPTORS; DENDRITIC CELLS; TUMOR-IMMUNITY; MOUSE MODEL; CANCER; IMMUNOTHERAPY; RITUXIMAB	Passively administered anti-tumor monoclonal antibodies (mAbs) rapidly kill tumor targets via Fc gamma R-mediated cytotoxicity (ADCC), a short-term process. However, anti-tumor mAb treatment can also induce a vaccinal effect, in which mAb-mediated tumor death induces a long-term anti-tumor cellular immune response. To determine how such responses are generated, we utilized a murine model of an anti-tumor vaccinal effect against a model neoantigen. We demonstrate that Fc gamma R expression by CD11c(+) antigen-presenting cells is required to generate antitumor T cell responses upon ADCC-mediated tumor clearance. Using Fc gamma R-humanized mice, we demonstrate that anti-tumor human (h)IgG1 must engage hFc gamma RIIIA on macrophages to mediate ADCC, but also engage hFc gamma RIIA, the sole hFc gamma R expressed by human dendritic cells (DCs), to generate a potent vaccinal effect. Thus, while next-generation antitumor antibodies with enhanced binding to only hFc gamma RIIIA are now in clinical use, ideal anti-tumor antibodies must be optimized for both cytotoxic effects as well as hFc gamma RIIA engagement on DCs to stimulate long-term anti-tumor cellular immunity.	[DiLillo, David J.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041	National Cancer Institute of the NIH [R01CA080757]; Melanoma Research Alliance; Harry J. Lloyd Charitable Trust; Cancer Research Institute CLIP award; Rockefeller University; New York Community Trust Grants for Blood Disorder Research, Francis Florio Fund; Leukemia and Lymphoma Society of America; NATIONAL CANCER INSTITUTE [R01CA080757, R35CA196620] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance; Harry J. Lloyd Charitable Trust; Cancer Research Institute CLIP award; Rockefeller University; New York Community Trust Grants for Blood Disorder Research, Francis Florio Fund; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Patrick Smith and Stylianos Bournazos for assistance with these studies. We are grateful to Oliver Press (Fred Hutchinson Cancer Research Center, Seattle, WA) and Josee Golay (Ospedali Riuniti di Bergamo, Bergamo, Italy) for providing EL4-hCD20 cells, and to Andrew Chan (Genentech, San Francisco, CA) for providing hCD20-Tg mice. Research reported in this publication was supported by the National Cancer Institute of the NIH under Award Number R01CA080757 to J.V.R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Support was also provided in part by the Melanoma Research Alliance, the Harry J. Lloyd Charitable Trust, and the Cancer Research Institute CLIP award (to J.V.R), as well from the Rockefeller University. This work was also supported by funding from the New York Community Trust Grants for Blood Disorder Research, Francis Florio Fund (to D.J.D.). D.J.D. received a postdoctoral career development fellowship from the Leukemia and Lymphoma Society of America.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Abu-Shakra M, 2001, ANN RHEUM DIS, V60, P433, DOI 10.1136/ard.60.5.433; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Berlyn KA, 2001, CLIN IMMUNOL, V101, P276, DOI 10.1006/clim.2001.5115; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bournazos S, 2014, CURR TOP MICROBIOL, V382, P237, DOI 10.1007/978-3-319-07911-0_11; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; de Bono JS, 2004, ANN ONCOL, V15, P1825, DOI 10.1093/annonc/mdh472; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311; Gadri Z, 2009, J IMMUNOTHER, V32, P333, DOI 10.1097/CJI.0b013e31819b7c17; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kimby E, 2008, LEUKEMIA LYMPHOMA, V49, P102, DOI 10.1080/10428190701704647; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; McKenzie SE, 1999, J IMMUNOL, V162, P4311; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Selenko N, 2002, J CLIN IMMUNOL, V22, P124, DOI 10.1023/A:1015463811683; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221	47	182	192	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1035	1045		10.1016/j.cell.2015.04.016	http://dx.doi.org/10.1016/j.cell.2015.04.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25976835	Green Accepted, Bronze			2022-12-28	WOS:000355152600012
J	Lunt, S; Parry, J				Lunt, Susie; Parry, Jane			CORRUPTION End of the gold rush for China's drugs market?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												susie_lunt@yahoo.com						Jourdan A., UPDATE 1 BITTER PILL; Jourdan A., 2014, REUTERS; Le Deu F, 2012, MCKINSEY CO	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2015	350								h2756	10.1136/bmj.h2756	http://dx.doi.org/10.1136/bmj.h2756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZD	25997641				2022-12-28	WOS:000355129300004
J	Schmidt, AG; Therkelsen, MD; Stewart, S; Kepler, TB; Liao, HX; Moody, MA; Haynes, BF; Harrison, SC				Schmidt, Aaron G.; Therkelsen, Matthew D.; Stewart, Shaun; Kepler, Thomas B.; Liao, Hua-Xin; Moody, M. Anthony; Haynes, Barton F.; Harrison, Stephen C.			Viral Receptor-Binding Site Antibodies with Diverse Germline Origins	CELL			English	Article							MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUSES; GLOBULAR HEAD; H1N1 VIRUS; HIV-1; NEUTRALIZATION; RECOGNITION; BROAD; VACCINE; DESIGN	Vaccines for rapidly evolving pathogens will confer lasting immunity if they elicit antibodies recognizing conserved epitopes, such as a receptor-binding site (RBS). From characteristics of an influenza-virus RBS-directed antibody, we devised a signature motif to search for similar antibodies. We identified, from three vaccinees, over 100 candidates encoded by 11 different V-H genes. Crystal structures show that antibodies in this class engage the hemagglutinin RBS and mimic binding of the receptor, sialic acid, by supplying a critical dipeptide on their projecting, heavy-chain third complementarity determining region. They share contacts with conserved, receptor-binding residues but contact different residues on the RBS periphery, limiting the likelihood of viral escape when several such antibodies are present. These data show that related modes of RBS recognition can arise from different germline origins and mature through diverse affinity maturation pathways. Immunogens focused on an RBS-directed response will thus have a broad range of B cell targets.	[Schmidt, Aaron G.; Therkelsen, Matthew D.; Harrison, Stephen C.] Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA; [Stewart, Shaun] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Liao, Hua-Xin; Moody, M. Anthony; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Novartis; Boston University; Duke University; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Moody, M/AAB-6947-2020	Moody, M/0000-0002-3890-5855	NIH [P01AI089618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Harrison Laboratory for discussions. We thank the beamline staff at Advanced Light Source 8.2.2 and Advanced Photon Source NE-CAT ID-24E. The work at Harvard Medical School and Boston Children's Hospital was supported by NIH Grant P01AI089618. S.C.H. is an investigator of the Howard Hughes Medical Institute. The authors note that S.C.H., A.G.S., B.F.H., H.X.L., M.A.M., and T.B.K. hold a patent on CH65 lineage antibodies.	BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Okada J, 2011, J GEN VIROL, V92, P326, DOI 10.1099/vir.0.026419-0; Okada J, 2010, VIROLOGY, V397, P322, DOI 10.1016/j.virol.2009.11.025; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu HF, 2015, PROTEINS, V83, P771, DOI 10.1002/prot.24745; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500	37	105	105	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1026	1034		10.1016/j.cell.2015.04.028	http://dx.doi.org/10.1016/j.cell.2015.04.028			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959776	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000355152600011
J	Barbosa, JS; Sanchez-Gonzalez, R; Di Giaimo, R; Baumgart, EV; Theis, FJ; Gotz, M; Ninkovic, J				Barbosa, Joana S.; Sanchez-Gonzalez, Rosario; Di Giaimo, Rossella; Baumgart, Emily Violette; Theis, Fabian J.; Goetz, Magdalena; Ninkovic, Jovica			Live imaging of adult neural stem cell behavior in the intact and injured zebrafish brain	SCIENCE			English	Article							TELENCEPHALON; REGENERATION; NEUROGENESIS; DIFFERENTIATION; QUIESCENCE; FOREBRAIN; MODEL; ZONE	Adult neural stem cells are the source for restoring injured brain tissue. We used repetitive imaging to follow single stem cells in the intact and injured adult zebrafish telencephalon in vivo and found that neurons are generated by both direct conversions of stem cells into postmitotic neurons and via intermediate progenitors amplifying the neuronal output. We observed an imbalance of direct conversion consuming the stem cells and asymmetric and symmetric self-renewing divisions, leading to depletion of stem cells over time. After brain injury, neuronal progenitors are recruited to the injury site. These progenitors are generated by symmetric divisions that deplete the pool of stem cells, a mode of neurogenesis absent in the intact telencephalon. Our analysis revealed changes in the behavior of stem cells underlying generation of additional neurons during regeneration.	[Barbosa, Joana S.; Sanchez-Gonzalez, Rosario; Di Giaimo, Rossella; Baumgart, Emily Violette; Goetz, Magdalena; Ninkovic, Jovica] Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany; [Barbosa, Joana S.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Program Biomed & Expt Biol BEB, Coimbra, Portugal; [Di Giaimo, Rossella] Univ Naples Federico II, Dept Biol, Naples, Italy; [Theis, Fabian J.] Helmholtz Ctr Munich, Inst Computat Biol, Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Inst Math Sci, Garching, Germany; [Goetz, Magdalena; Ninkovic, Jovica] Univ Munich, Biomed Ctr, Munich, Germany; [Goetz, Magdalena] Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universidade de Coimbra; University of Naples Federico II; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich	Ninkovic, J (corresponding author), Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany.	ninkovic@helmholtz-muenchen.de	Di Giaimo, Rossella/A-3521-2014; Theis, Fabian J/ABD-5212-2021; Ninkovic, Jovica/AAH-5220-2019	Di Giaimo, Rossella/0000-0003-3604-3697; Theis, Fabian J/0000-0002-2419-1943; Ninkovic, Jovica/0000-0002-4381-0041	German Research foundation (DFG) [Sonderforschungsbereich (SFB) 870]; Schwerpunktprogramm "Integrative analysis of olfaction"; DFG [SFB 870]; Leibniz Prize; Helmholtz Alliance ICEMED; European Research Council grant ChroNeuroRepair [340793]; Fundacao para a Ciencia e Tecnologia, Portugal (FCT); European Research Council; Bavarian ministry of education and research	German Research foundation (DFG)(German Research Foundation (DFG)); Schwerpunktprogramm "Integrative analysis of olfaction"; DFG(German Research Foundation (DFG)); Leibniz Prize(German Research Foundation (DFG)); Helmholtz Alliance ICEMED; European Research Council grant ChroNeuroRepair; Fundacao para a Ciencia e Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); European Research Council(European Research Council (ERC)European Commission); Bavarian ministry of education and research	We thank P. Raymonds for sharing the Tg(gfap:GFP)mi2001 fish line. We also thank T. Ozturk, A. Steiner-Mazzardi, and S. Hubinger for excellent technical help; A. Lepier for the viral vector production; S. Hake for the help with intracellular FACS; and P. Alexandre, V. Borrell, P. Chapouton, L. Dimou, and L. Godinho for critical reading of the manuscript. We acknowledge funding to J.N. from the German Research foundation (DFG) by the Sonderforschungsbereich (SFB) 870 and Schwerpunktprogramm "Integrative analysis of olfaction"; to M.G. from the DFG by the SFB 870, the Leibniz Prize, the Helmholtz Alliance ICEMED, and the European Research Council grant ChroNeuroRepair: Grant Agreement no. 340793; and to J.S.B. from the Fundacao para a Ciencia e Tecnologia, Portugal (FCT); to F.T. from European Research Council grant LatentCauses and a BioSysNet grant by the Bavarian ministry of education and research. Supplementary materials contain additional data.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bestman JE, 2012, J COMP NEUROL, V520, P401, DOI 10.1002/cne.22795; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Edelmann K, 2013, J COMP NEUROL, V521, P3099, DOI 10.1002/cne.23347; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mchedlishvili L, 2012, P NATL ACAD SCI USA, V109, pE2258, DOI 10.1073/pnas.1116738109; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156	20	117	120	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					789	793		10.1126/science.aaa2729	http://dx.doi.org/10.1126/science.aaa2729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977550				2022-12-28	WOS:000354428700041
J	Hofmann, W; Wisneski, DC; Brandt, MJ; Skitka, LJ				Hofmann, Wilhelm; Wisneski, Daniel C.; Brandt, Mark J.; Skitka, Linda J.			Response to Comment on "Morality in everyday life"	SCIENCE			English	Letter													Skitka, Linda/P-4085-2019	Skitka, Linda/0000-0002-7078-0650; Brandt, Mark/0000-0002-7185-7031					0	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					767	767		10.1126/science.aaa3053	http://dx.doi.org/10.1126/science.aaa3053			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977545				2022-12-28	WOS:000354428700031
J	Huckman, RS; Raman, A				Huckman, Robert S.; Raman, Ananth			Medicine's Continuous Improvement Imperative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Huckman, Robert S.; Raman, Ananth] Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Huckman, RS (corresponding author), Harvard Univ, Sch Business, 435 Morgan Hall, Boston, MA 02163 USA.	rhuckman@hbs.edu						American Hospital Association, FAST FACTS US HOSP; [Anonymous], FACTS MAN; Chassin MR, 2013, MILBANK Q, V91, P459, DOI 10.1111/1468-0009.12023; Kempen PM, 2012, J AM PHYS SURG, V17, P12; Tierney C., 2004, DETROIT NEWS    0222	5	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1811	1812		10.1001/jama.2015.4619	http://dx.doi.org/10.1001/jama.2015.4619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965220				2022-12-28	WOS:000354391000015
J	Amundson, R; Berhe, AA; Hopmans, JW; Olson, C; Sztein, AE; Sparks, DL				Amundson, Ronald; Berhe, Asmeret Asefaw; Hopmans, Jan W.; Olson, Carolyn; Sztein, A. Ester; Sparks, Donald L.			Soil and human security in the 21st century	SCIENCE			English	Review							ORGANIC-CARBON STOCKS; EARTH SYSTEM MODELS; LAND-USE; EROSION; CLIMATE; BIODIVERSITY; FUTURE; IMPACT; CYCLE	Human security has and will continue to rely on Earth's diverse soil resources. Yet we have now exploited the planet's most productive soils. Soil erosion greatly exceeds rates of production in many agricultural regions. Nitrogen produced by fossil fuel and geological reservoirs of other fertilizers are headed toward possible scarcity, increased cost, and/or geopolitical conflict. Climate change is accelerating the microbial release of greenhouse gases from soil organic matter and will likely play a large role in our near-term climate future. In this Review, we highlight challenges facing Earth's soil resources in the coming century. The direct and indirect response of soils to past and future human activities will play a major role in human prosperity and survival.	[Amundson, Ronald] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Berhe, Asmeret Asefaw] Univ Calif, Life & Environm Sci Unit, Merced, CA 95343 USA; [Hopmans, Jan W.] Land Air & Water Resources, Davis, CA 95616 USA; [Olson, Carolyn] USDA, Climate Change Program Off, Off Chief Economist, Washington, DC 20013 USA; [Sztein, A. Ester] Natl Acad Sci, Board Int Sci Org, Washington, DC 20001 USA; [Sparks, Donald L.] Univ Delaware, Plant & Soil Sci, Chem & Biochem, Civil & Environm Engn, Newark, DE 19716 USA; [Sparks, Donald L.] Univ Delaware, Marine Sci & Policy, Newark, DE 19716 USA	University of California System; University of California Berkeley; University of California System; University of California Merced; United States Department of Agriculture (USDA); National Academies of Sciences, Engineering & Medicine; University of Delaware; University of Delaware	Amundson, R (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	earthy@berkeley.edu	Berhe, Asmeret Asefaw/D-4179-2011; Amundson, Ronald/E-2654-2015; hopmans, jan w/P-6225-2018	Berhe, Asmeret Asefaw/0000-0002-6986-7943; Amundson, Ronald/0000-0003-1510-7313; Olson, Carolyn/0000-0002-4198-6158; Hopmans, Jan/0000-0002-4807-2172	ICER [1441845] Funding Source: National Science Foundation; Office of Integrative Activities [1301765] Funding Source: National Science Foundation	ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))		Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Amundson R, 2003, ECOSYSTEMS, V6, P470, DOI 10.1007/s10021-002-0160-2; [Anonymous], 2013, WORLD POPULATION PRO; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Burke EJ, 2012, CRYOSPHERE, V6, P1063, DOI 10.5194/tc-6-1063-2012; Cao L, 2010, P NATL ACAD SCI USA, V107, P9513, DOI 10.1073/pnas.0913000107; Center for International Earth Science Information Network (CIESIN) Columbia University; International Food Policy Research Institute (IFPRI); the World Bank; and Centro Internacional de Agricultura Tropical (CIAT), 2011, VERS 1 GRUMPV1 URB E; Center for Sustainability and the Global Environment (SAGE) Nelson Institute for Environmental Studies at the University of Wisconsin-Madison, ATL BIOSPH; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Doetterl S, 2012, EARTH SURF PROC LAND, V37, P642, DOI 10.1002/esp.3198; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; FAO, 2011, FAO 21 CENT ENS FOOD; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gottschalk P, 2012, BIOGEOSCIENCES, V9, P3151, DOI 10.5194/bg-9-3151-2012; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Guo YY, 2003, GEODERMA, V117, P99, DOI 10.1016/S0016-7061(03)00137-X; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Jenny H., 1994, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones DL, 2013, J APPL ECOL, V50, P851, DOI 10.1111/1365-2664.12089; KIRKBY MJ, 1967, J GEOL, V75, P359, DOI 10.1086/627267; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Koch A, 2013, GLOB POLICY, V4, P434, DOI 10.1111/1758-5899.12096; Koven CD, 2013, BIOGEOSCIENCES, V10, P7109, DOI 10.5194/bg-10-7109-2013; Lal R, 2008, SCIENCE, V319, P1040, DOI 10.1126/science.319.5866.1040; LIETH H, 1973, HUM ECOL, V1, P303, DOI 10.1007/BF01536729; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; National Research Council, 2010, AM CLIM CHOIC PAN AD; Odelman L. R., 1991, GLOBAL ASSESSMENT SO; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Ramankutty N., 2010, GLOBAL AGR LANDS PAS; Ruddiman WF, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000207; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Schuur EAG, 2013, CLIMATIC CHANGE, V119, P359, DOI 10.1007/s10584-013-0730-7; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Smil V., 2011, WORLD AGR, V2, P9; Smith P, 2005, EUR J SOIL SCI, V56, P673, DOI 10.1111/j.1365-2389.2005.00708.x; Smith P, 2007, CLIMATE CHANGE 2007; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; Sposito G, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2013.02.0041; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Sun WY, 2014, CATENA, V121, P151, DOI 10.1016/j.catena.2014.05.009; SUNDQUIST ET, 1993, SCIENCE, V259, P934, DOI 10.1126/science.259.5097.934; Tennesen M, 2014, SCIENCE, V346, P692, DOI 10.1126/science.346.6210.692; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1; Yang X., 2014, GLOBAL GRIDDED SOIL, DOI http://dx.doi.org/	61	562	603	91	889	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235							1261071	10.1126/science.1261071	http://dx.doi.org/10.1126/science.1261071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954014	Green Published			2022-12-28	WOS:000354045700035
J	Geden, O				Geden, Oliver			Climate advisers must maintain integrity	NATURE			English	Editorial Material									German Inst Int & Secur Affairs, EU Res Div, Berlin, Germany		Geden, O (corresponding author), German Inst Int & Secur Affairs, EU Res Div, Berlin, Germany.	oliver.geden@swp-berlin.org						Brunsson N., 2007, CONSEQUENCES DECISIO; Edenhofer O, 2015, ENVIRON SCI POLICY, V51, P56, DOI 10.1016/j.envsci.2015.03.017; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Geden O., 2013, MODIFYING 2 C TARGET; Geden O, 2014, NAT CLIM CHANGE, V4, P747, DOI 10.1038/nclimate2309; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Lentsch J., 2011, POLITICS SCI ADVICE, P3; Pielke R.A.J., 2007, HONEST BROKER MAKING; Tavoni M, 2013, CLIMATIC CHANGE, V118, P1, DOI 10.1007/s10584-013-0757-9; Victor DG, 2014, NAT CLIM CHANGE, V4, P853, DOI 10.1038/nclimate2396	10	65	66	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					27	28		10.1038/521027a	http://dx.doi.org/10.1038/521027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH4YS	25951268	Bronze			2022-12-28	WOS:000354040900013
J	Heyn, H; Esteller, M				Heyn, Holger; Esteller, Manel			An Adenine Code for DNA: A Second Life for N6-Methyladenine	CELL			English	Review							SINGLE-MOLECULE; METHYLATION; METHYLOMES; WIDE	DNA N6-methyladenine (6mA) protects against restriction enzymes in bacteria. However, isolated reports have suggested additional activities and its presence in other organisms, such as unicellular eukaryotes. New data now find that 6mA may have a gene regulatory function in green alga, worm, and fly, suggesting m6A as a potential "epigenetic'' mark.	[Heyn, Holger; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona 08036, Catalonia, Spain; [Esteller, Manel] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093; Heyn, Holger/0000-0002-3276-1889	ICREA Funding Source: Custom	ICREA(ICREA)		ACHWAL CW, 1983, FEBS LETT, V158, P353, DOI 10.1016/0014-5793(83)80612-7; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; GOMMERSAMPT JH, 1995, FASEB J, V9, P1034, DOI 10.1096/fasebj.9.11.7649402; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350	15	112	116	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					710	713		10.1016/j.cell.2015.04.021	http://dx.doi.org/10.1016/j.cell.2015.04.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936836	Bronze			2022-12-28	WOS:000354175200006
J	Sorrells, TR; Johnson, AD				Sorrells, Trevor R.; Johnson, Alexander D.			Making Sense of Transcription Networks	CELL			English	Review							GENE REGULATORY NETWORKS; DNA-BINDING SPECIFICITY; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; DEVELOPMENTAL EVOLUTION; COOPERATIVE BINDING; DIRECT CONVERSION; RAPID EVOLUTION; YEAST	When transcription regulatory networks are compared among distantly related eukaryotes, a number of striking similarities are observed: a larger-than-expected number of genes, extensive overlapping connections, and an apparently high degree of functional redundancy. It is often assumed that the complexity of these networks represents optimized solutions, precisely sculpted by natural selection; their common features are often asserted to be adaptive. Here, we discuss support for an alternative hypothesis: the common structural features of transcription networks arise from evolutionary trajectories of "least resistance''-that is, the relative ease with which certain types of network structures are formed during their evolution.	[Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, Tetrad Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ajohnson@cgl.ucsf.edu		Sorrells, Trevor/0000-0002-3527-8622	NIH [R01 GM037049]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Nobile, E. Mancera, S. Coyle, and V. Hanson-Smith for helpful comments on the manuscript. We also thank K. Carniol and two anonymous reviewers for providing critical feedback on the content and language. Work from the authors' laboratory was supported by grant R01 GM037049 from the NIH. T.R.S. was supported by a Graduate Research Fellowship from the National Science Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Chan S. S.-K., 2013, STEM CELL RES THER; Cordero OX, 2006, MOL BIOL EVOL, V23, P1931, DOI 10.1093/molbev/msl060; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Force A, 1999, GENETICS, V151, P1531; Frankel N, 2012, P NATL ACAD SCI USA, V109, P20975, DOI 10.1073/pnas.1207715109; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HAYES TE, 1988, GENE DEV, V2, P1713, DOI 10.1101/gad.2.12b.1713; Hernday AD, 2013, MOL MICROBIOL, V90, P22, DOI 10.1111/mmi.12329; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Kielbasa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003210; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li H, 2010, CURR BIOL, V20, pR746, DOI 10.1016/j.cub.2010.06.056; Liang ZC, 1998, DEVELOPMENT, V125, P4471; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Lynch M, 2014, P NATL ACAD SCI USA, V111, P16990, DOI 10.1073/pnas.1415861111; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; MASTICK GS, 1995, GENETICS, V139, P349; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monteiro A, 2012, BIOESSAYS, V34, P181, DOI 10.1002/bies.201100160; Mosch HU, 1997, GENETICS, V145, P671; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Paixao T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000848; Pavlicev M, 2012, TRENDS ECOL EVOL, V27, P316, DOI 10.1016/j.tree.2012.01.016; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; PTASHNE M, 2002, GENES SIGNALS; Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017; Raff R.A., 1983, EMBRYOS GENES EVOLUT; Reece-Hoyes JS, 2013, MOL CELL, V51, P116, DOI 10.1016/j.molcel.2013.05.018; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ruths T, 2013, P NATL ACAD SCI USA, V110, P7754, DOI 10.1073/pnas.1217630110; Ruths T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-159; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagner A., 2003, SCI STKE, V2003, pPE41; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Ward JJ, 2007, PLOS COMPUT BIOL, V3, P1993, DOI 10.1371/journal.pcbi.0030198; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256; Zuckerkandl E, 1997, J MOL EVOL, V44, pS2, DOI 10.1007/PL00000048	90	92	92	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					714	723		10.1016/j.cell.2015.04.014	http://dx.doi.org/10.1016/j.cell.2015.04.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957680	Green Accepted, Bronze			2022-12-28	WOS:000354175200007
J	Muir, AJ; Poordad, F; Lalezari, J; Everson, G; Dore, GJ; Herring, R; Sheikh, A; Kwo, P; Hezode, C; Pockros, PJ; Tran, A; Yozviak, J; Reau, N; Ramji, A; Stuart, K; Thompson, AJ; Vierling, J; Freilich, B; Cooper, J; Ghesquiere, W; Yang, R; McPhee, F; Hughes, EA; Swenson, ES; Yin, PD				Muir, Andrew J.; Poordad, Fred; Lalezari, Jacob; Everson, Gregory; Dore, Gregory J.; Herring, Robert; Sheikh, Aasim; Kwo, Paul; Hezode, Christophe; Pockros, Paul J.; Tran, Albert; Yozviak, Joseph; Reau, Nancy; Ramji, Alnoor; Stuart, Katherine; Thompson, Alexander J.; Vierling, John; Freilich, Bradley; Cooper, James; Ghesquiere, Wayne; Yang, Rong; McPhee, Fiona; Hughes, Eric A.; Swenson, E. Scott; Yin, Philip D.			Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; PEGYLATED INTERFERON; PLUS RIBAVIRIN; SOFOSBUVIR; SIMEPREVIR; BOCEPREVIR; LEDIPASVIR; EFFICACY; PHASE-3	IMPORTANCE Effective and well-tolerated, interferon-free regimens are needed for treatment of patients with chronic hepatitis C virus (HCV) infection and cirrhosis. OBJECTIVE All-oral therapy with daclatasvir (nonstructural protein 5A [NS5A] inhibitor), asunaprevir (NS3 protease inhibitor), and beclabuvir (nonnucleoside NS5B inhibitor), with or without ribavirin, was evaluated in patients with HCV genotype 1 infection and compensated cirrhosis. DESIGN, SETTING, AND PARTICIPANTS The UNITY-2 study was conducted between December 2013 and October 2014 at 49 outpatient sites in the United States, Canada, France, and Australia. Patients were treated for 12 weeks, with 24 weeks of follow-up after completion of treatment. Adult patients with cirrhosis were enrolled in 2 cohorts: HCV treatment-naive or HCV treatment-experienced. Statistical analyses were based on historical controls; there were no internal controls. INTERVENTIONS All patients received twice-daily treatment with the fixed-dose combination of daclatasvir (30 mg), asunaprevir (200 mg), and beclabuvir (75 mg). In addition, patients within each cohort were stratified according to HCV genotype 1 subtype (1a or 1b) and randomly assigned (1:1) to receive double-blinded weight-based ribavirin (1000-1200 mg/d) or matching placebo. MAIN OUTCOMES AND MEASURES Sustained virologic response at posttreatment week 12 (SVR12). RESULTS One hundred twelve patients in the treatment-naive group and 90 patients in the treatment-experienced group were treated and included in the analysis. Enrolled patients were 88% white with a median age of 58 years (treatment-naive group) or 60 years (treatment-experienced group); 74% had genotype 1a infection. SVR12 rates were 98% (97.5% CI, 88.9%-100%) for patients in the treatment-naive group and 93%(97.5% CI, 85.0%-100.0%) for those in the treatment-experienced group when ribavirin was included in the regimen. With the fixed-dose combination alone, response rates were 93%(97.5% CI, 85.4%-100.0%) for patients in the treatment-naive group and 87%(97.5% CI, 75.3%-98.0%) for those in the treatment-experienced group. Three serious adverse events were considered to be treatment related and there were 4 adverse event-related discontinuations. Treatment-emergent grade 3 or 4 alanine aminotransferase elevations were observed in 4 patients, of which 1 had concomitant total bilirubin elevation. CONCLUSIONS AND RELEVANCE In this open-label uncontrolled study, patients with chronic HCV genotype 1 infection and cirrhosis who received a 12-week oral fixed-dose regimen of daclatasvir, asunaprevir, and beclabuvir, with or without ribavirin, achieved high rates of SVR12. Copyright 2015 American Medical Association. All rights reserved.	[Muir, Andrew J.] Duke Univ, Duke Clin Res Inst, Durham, NC 27710 USA; [Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Lalezari, Jacob] Quest Clin Res, San Francisco, CA USA; [Everson, Gregory] Univ Colorado, Sch Med, Denver, CO USA; [Dore, Gregory J.] Univ New S Wales, Kirby Inst, Kensington, NSW 2033, Australia; [Dore, Gregory J.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Herring, Robert] Qual Med Res, Nashville, TN USA; [Sheikh, Aasim] Gastrointestinal Specialists Georgia, Marietta, GA USA; [Kwo, Paul] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hezode, Christophe] Univ Paris Est, Hop Henri Mondor, AP HP, INSERM,U955, Creteil, France; [Pockros, Paul J.] Scripps Clin, La Jolla, CA 92037 USA; [Tran, Albert] Fac Med Nice, INSERM, U1065, Team 8,Hepat Complicat Obes, F-06034 Nice, France; [Tran, Albert] CHU Nice, Digest Ctr, F-06202 Nice, France; [Yozviak, Joseph] Lehigh Valley Hlth Network, Allentown, PA USA; [Reau, Nancy] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Ramji, Alnoor] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Stuart, Katherine] Gallipoli Med Res Fdn, Greenslopes Private Hosp, Brisbane, Qld, Australia; [Thompson, Alexander J.] St Vincents Hosp, Melbourne, Vic, Australia; [Thompson, Alexander J.] Univ Melbourne, Melbourne, Vic, Australia; [Vierling, John] Baylor Coll Med, Houston, TX 77030 USA; [Freilich, Bradley] Kansas City Res Inst, Kansas City, MO USA; [Cooper, James] Inova Fairfax Hosp, Falls Church, VA USA; [Ghesquiere, Wayne] Univ British Columbia, Victoria, BC, Canada; [Yang, Rong; Hughes, Eric A.] Bristol Myers Squibb Co, Princeton, NJ USA; [McPhee, Fiona; Swenson, E. Scott; Yin, Philip D.] Bristol Myers Squibb Co, Wallingford, CT 06492 USA	Duke University; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Indiana University System; Indiana University Bloomington; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Lehigh Valley Health Network; University of Chicago; University of Chicago Medical Center; University of British Columbia; St Vincent's Hospital Melbourne; University of Melbourne; Baylor College of Medicine; Inova Fairfax Hospital; University of British Columbia; Bristol-Myers Squibb; Bristol-Myers Squibb	Muir, AJ (corresponding author), Duke Univ, Med Ctr 3913, Duke Clin Res Inst, Durham, NC 27710 USA.	andrew.muir@duke.edu	Hezode, Christophe/U-4659-2018; Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Albert, TRAN/0000-0003-0003-5361	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Akhtar E, 2015, LIVER INT, V35, P30, DOI 10.1111/liv.12576; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bronowicki JP, 2014, J HEPATOL, V61, P1220, DOI 10.1016/j.jhep.2014.07.011; Bruno S, 2013, J HEPATOL, V58, P479, DOI 10.1016/j.jhep.2012.11.020; Bruno S, 2010, HEPATOLOGY, V51, P388, DOI 10.1002/hep.23340; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Di Bisceglie AM, 2000, HEPATOLOGY, V31, P1014, DOI 10.1053/he.2000.5762; Everson GT, 2013, 64 ANN M AM ASS STUD; Hezode C, 2015, GUT, V64, P948, DOI 10.1136/gutjnl-2014-307498; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; McPhee F, 2012, J HEPATOL, V56, pS473; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P3670, DOI 10.1128/AAC.00308-12; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011	20	108	110	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1736	1744		10.1001/jama.2015.3868	http://dx.doi.org/10.1001/jama.2015.3868			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25942724	Green Published, Bronze			2022-12-28	WOS:000353921000019
J	Insel, TR; Cuthbert, BN				Insel, Thomas R.; Cuthbert, Bruce N.			Brain disorders? Precisely	SCIENCE			English	Editorial Material							RESEARCH DOMAIN CRITERIA; MENTAL-DISORDERS; MEDICINE; HEALTH		[Insel, Thomas R.; Cuthbert, Bruce N.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov						Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crocker LD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00261; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Goodkind M., 2015, JAMA PSYCHIAT, DOI [10.1001/jamapsychiatry.2014.2206, DOI 10.1001/JAMAPSYCHIATRY.2014.2206]; Hall BS, 2015, NEUROBIOL STRESS, V1, P174, DOI 10.1016/j.ynstr.2014.10.008; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Karalunas SL, 2014, JAMA PSYCHIAT, V71, P1015, DOI 10.1001/jamapsychiatry.2014.763; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; McCoy TH, 2015, AM J PSYCHIAT, V172, P316, DOI 10.1176/appi.ajp.2014.14091177; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Schumann G, 2014, EUR NEUROPSYCHOPHARM, V24, P5, DOI 10.1016/j.euroneuro.2013.09.010; Tamminga CA, 2014, SCHIZOPHRENIA BULL, V40, pS131, DOI 10.1093/schbul/sbt179; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization, 2014, PREV SUIC PREV SUIC	15	385	392	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					499	500		10.1126/science.aab2358	http://dx.doi.org/10.1126/science.aab2358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931539				2022-12-28	WOS:000353778100020
J	Lambers, JHR				Lambers, Janneke Hille Ris			Extinction risks from climate change	SCIENCE			English	Editorial Material									Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Lambers, JHR (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jhrl@uw.edu						Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Ryan ME, 2014, FRONT ECOL ENVIRON, V12, P232, DOI 10.1890/130145; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Stocker T. F., 2013, PHYS SCI BASIS CONTR; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984	11	39	42	5	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					501	502		10.1126/science.aab2057	http://dx.doi.org/10.1126/science.aab2057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931540				2022-12-28	WOS:000353778100021
J	Silvestri, GA; Vachani, A; Whitney, D; Elashoff, M; Smith, KP; Ferguson, JS; Parsons, E; Mitra, N; Brody, J; Lenburg, ME; Spira, A				Silvestri, Gerard A.; Vachani, Anil; Whitney, Duncan; Elashoff, Michael; Smith, Kate Porta; Ferguson, J. Scott; Parsons, Ed; Mitra, Nandita; Brody, Jerome; Lenburg, Marc E.; Spira, Avrum		AEGIS Study Team	A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-COLLEGE; GENE-EXPRESSION; NODULES; MANAGEMENT; PREDICTION; GUIDELINES; BIOPSY	BACKGROUND Bronchoscopy is frequently nondiagnostic in patients with pulmonary lesions suspected to be lung cancer. This often results in additional invasive testing, although many lesions are benign. We sought to validate a bronchial-airway gene-expression classifier that could improve the diagnostic performance of bronchoscopy. METHODS Current or former smokers undergoing bronchoscopy for suspected lung cancer were enrolled at 28 centers in two multicenter prospective studies (AEGIS-1 and AEGIS-2). A gene-expression classifier was measured in epithelial cells collected from the normal-appearing mainstem bronchus to assess the probability of lung cancer. RESULTS A total of 639 patients in AEGIS-1 (298 patients) and AEGIS-2 (341 patients) met the criteria for inclusion. A total of 43% of bronchoscopic examinations were nondiagnostic for lung cancer, and invasive procedures were performed after bronchoscopy in 35% of patients with benign lesions. In AEGIS-1, the classifier had an area under the receiver-operating-characteristic curve (AUC) of 0.78 (95% confidence interval [CI], 0.73 to 0.83), a sensitivity of 88% (95% CI, 83 to 92), and a specificity of 47% (95% CI, 37 to 58). In AEGIS-2, the classifier had an AUC of 0.74 (95% CI, 0.68 to 0.80), a sensitivity of 89% (95% CI, 84 to 92), and a specificity of 47% (95% CI, 36 to 59). The combination of the classifier plus bronchoscopy had a sensitivity of 96% (95% CI, 93 to 98) in AEGIS-1 and 98% (95% CI, 96 to 99) in AEGIS-2, independent of lesion size and location. In 101 patients with an intermediate pretest probability of cancer, the negative predictive value of the classifier was 91% (95% CI, 75 to 98) among patients with a nondiagnostic bronchoscopic examination. CONCLUSIONS The gene-expression classifier improved the diagnostic performance of bronchoscopy for the detection of lung cancer. In intermediate-risk patients with a nondiagnostic bronchoscopic examination, a negative classifier score provides support for a more conservative diagnostic approach.	[Silvestri, Gerard A.] Med Univ S Carolina, Charleston, SC USA; [Vachani, Anil; Mitra, Nandita] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Whitney, Duncan; Smith, Kate Porta; Parsons, Ed] Allegro Diagnost, Maynard, MA USA; [Brody, Jerome; Lenburg, Marc E.; Spira, Avrum] Boston Univ, Sch Med, Boston, MA 02118 USA; [Whitney, Duncan; Smith, Kate Porta] Veracyte, San Francisco, CA USA; [Elashoff, Michael] Elashoff Consulting, Redwood City, CA USA; [Ferguson, J. Scott] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	Medical University of South Carolina; University of Pennsylvania; Boston University; University of Wisconsin System; University of Wisconsin Madison	Spira, A (corresponding author), Boston Univ, Med Ctr, Div Computat Biomed, Dept Med, 715 Albany St, Boston, MA 02118 USA.	silvestr@musc.edu; aspira@bu.edu	Mehrad, Borna/D-9363-2015; Mehrad, Borna/AAC-9876-2019; Lenburg, Marc/B-8027-2008; Weder, Max/AAO-4265-2021	Mehrad, Borna/0000-0001-5198-065X; Mehrad, Borna/0000-0001-5198-065X; Lenburg, Marc/0000-0002-5760-4708; Dhand, Rajiv/0000-0002-3621-2422; Rafeq, Samaan/0000-0003-1573-1896; Hsia, David/0000-0002-9655-781X; Scherb, Hagen/0000-0002-2730-5619	Allegro Diagnostics; National Institutes of Health (NIH) [NIH 1R44CA139803]; Department of Defense [DOD W81XWH-11-2-0161]; National Cancer Institute, NIH as part of the Early Detection Research Network [NIH/NCI U01 CA152751]; NATIONAL CANCER INSTITUTE [U01CA152751, P30CA016520, R44CA139803] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Allegro Diagnostics; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute, NIH as part of the Early Detection Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by Allegro Diagnostics and by grants from the National Institutes of Health (NIH) (NIH 1R44CA139803); the Department of Defense (DOD W81XWH-11-2-0161); and the National Cancer Institute, NIH (NIH/NCI U01 CA152751), as part of the Early Detection Research Network.	Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Grogan EL, 2011, J THORAC ONCOL, V6, P1720, DOI 10.1097/JTO.0b013e318226b48a; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLIN SM, 1959, AM REV TUBERC PULM, V79, P427; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; LILLINGTON GA, 1991, DM-DIS MON, V37, P274; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Tukey MH, 2012, RESP MED, V106, P1559, DOI 10.1016/j.rmed.2012.08.008; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Whitney DH, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0091-3; Wiener Renda Soylemez, 2013, Clin Pulm Med, V20, P29; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	24	168	175	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					243	251		10.1056/NEJMoa1504601	http://dx.doi.org/10.1056/NEJMoa1504601			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	25981554	Green Accepted			2022-12-28	WOS:000357956200007
J	Boggild, AK; Esposito, DH; Kozarsky, PE; Ansdell, V; Beeching, NJ; Campion, D; Castelli, F; Caumes, E; Chappuis, F; Cramer, JP; Gkrania-Klotsas, E; Grobusch, MP; Hagmann, SHF; Hynes, NA; Lim, PL; Lopez-Velez, R; Malvy, DJM; Mendelson, M; Parola, P; Sotir, MJ; Wu, HM; Hamer, DH				Boggild, Andrea K.; Esposito, Douglas H.; Kozarsky, Phyllis E.; Ansdell, Vernon; Beeching, Nicholas J.; Campion, Daniel; Castelli, Francesco; Caumes, Eric; Chappuis, Francois; Cramer, Jakob P.; Gkrania-Klotsas, Effrossyni; Grobusch, Martin P.; Hagmann, Stefan H. F.; Hynes, Noreen A.; Lim, Poh Lian; Lopez-Velez, Rogelio; Malvy, Denis J. M.; Mendelson, Marc; Parola, Philippe; Sotir, Mark J.; Wu, Henry M.; Hamer, Davidson H.		GeoSentinel Surveillance Network	Differential Diagnosis of Illness in Travelers Arriving From Sierra Leone, Liberia, or Guinea: A Cross-sectional Study From the GeoSentinel Surveillance Network	ANNALS OF INTERNAL MEDICINE			English	Article							EBOLA-VIRUS DISEASE; HEMORRHAGIC-FEVER; RETURNED TRAVELERS; AFRICA; VACCINE	Background: The largest-ever outbreak of Ebola virus disease (EVD), ongoing in West Africa since late 2013, has led to export of cases to Europe and North America. Clinicians encountering ill travelers arriving from countries with widespread Ebola virus transmission must be aware of alternate diagnoses associated with fever and other nonspecific symptoms. Objective: To define the spectrum of illness observed in persons returning from areas of West Africa where EVD transmission has been widespread. Design: Descriptive, using GeoSentinel records. Setting: 57 travel or tropical medicine clinics in 25 countries. Patients: 805 ill returned travelers and new immigrants from Sierra Leone, Liberia, or Guinea seen between September 2009 and August 2014. Measurements: Frequencies of demographic and travel-related characteristics and illnesses reported. Results: The most common specific diagnosis among 770 non-immigrant travelers was malaria (n = 310 [40.3%]), with Plasmodium falciparum or severe malaria in 267 (86%) and non-P. falciparum malaria in 43 (14%). Acute diarrhea was the second most common diagnosis among nonimmigrant travelers (n = 95 [12.3%]). Such common diagnoses as upper respiratory tract infection, urinary tract infection, and influenza-like illness occurred in only 26, 9, and 7 returning travelers, respectively. Few instances of typhoid fever (n = 8), acute HIV infection (n = 5), and dengue (n = 2) were encountered. Limitation: Surveillance data collected by specialist clinics may not be representative of all ill returned travelers. Conclusion: Although EVD may currently drive clinical evaluation of ill travelers arriving from Sierra Leone, Liberia, and Guinea, clinicians must be aware of other more common, potentially fatal diseases. Malaria remains a common diagnosis among travelers seen at GeoSentinel sites. Prompt exclusion of malaria and other life-threatening conditions is critical to limiting morbidity and mortality.	Univ Toronto, Toronto Gen Hosp, Trop Dis Unit, Toronto, ON M5G 1L7, Canada; Publ Hlth Ontario Lab, Toronto, ON, Canada; Ctr Dis Control & Prevent, Atlanta, GA USA; Emory Univ, Atlanta, GA 30322 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; InterHlth Worldwide, London, England; Univ Brescia, Brescia, Italy; Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; Univ Hosp Geneva, Geneva, Switzerland; Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Cambridge, Cambridge, England; Univ Amsterdam, Amsterdam, Netherlands; Bronx Lebanon Hosp Ctr, Bronx, NY 10456 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Tan Tock Seng Hosp, Singapore, Singapore; Lee Kong Chian Sch Med, Singapore, Singapore; Hosp Ramon & Cajal, E-28034 Madrid, Spain; Univ Bordeaux, Bordeaux, France; Univ Cape Town, ZA-7925 Cape Town, South Africa; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Aix Marseille Univ, Marseille, France; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Centers for Disease Control & Prevention - USA; Emory University; University of Hawaii System; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Geneva; Bernhard Nocht Institut fur Tropenmedizin; University of Cambridge; University of Amsterdam; BronxCare Health System; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Hospital Universitario Ramon y Cajal; UDICE-French Research Universities; Universite de Bordeaux; University of Cape Town; University of Cape Town; UDICE-French Research Universities; Aix-Marseille Universite; Boston University; Boston University	Hamer, DH (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Crosstown 3rd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.	dhamer@bu.edu	MALVY, Denis/T-7930-2019; Parola, Philippe/AAY-4346-2021; Hamer, Davidson Howes/J-2020-2019; Mockenhaupt, Frank P/U-9824-2017; Beeching, Nicholas J/L-5363-2017; Lopez-Velez, Rogelio/AAV-1782-2021; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Hynes, Noreen/AAA-2550-2020; Gautret, Philippe/AAY-5126-2021	Parola, Philippe/0000-0002-1061-1927; Hamer, Davidson Howes/0000-0002-4700-1495; Mockenhaupt, Frank P/0000-0002-8117-5421; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Gautret, Philippe/0000-0002-1664-958X; Beeching, Nicholas/0000-0002-7019-8791; Chen, Lin/0000-0002-5684-8436; McCarthy, Anne/0000-0001-7195-6366; Campion, Daniel/0000-0002-6093-8418; Chappuis, Francois/0000-0003-0442-7610; Ursing, Johan/0000-0002-5508-9327; Schlagenhauf, Patricia/0000-0002-1075-7010; Mendelson, Marc/0000-0001-6668-3893; Castelli, Francesco/0000-0001-9161-7804; Kain, Kevin/0000-0001-6068-1272	Centers for Disease Control and Prevention; CDC [U50/CCU412347]; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections; University of Liverpool; Liverpool School of Tropical Medicine; Public Health England; MRC [G0701652] Funding Source: UKRI	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections; University of Liverpool; Liverpool School of Tropical Medicine; Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Centers for Disease Control and Prevention.; GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine, is supported by cooperative agreement U50/CCU412347 from the CDC. Dr. Gkrania-Klotsas was supported by the National Institute for Health Research Cambridge Biomedical Research Centre. Dr. Beeching was funded in part by the National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, a partnership among the University of Liverpool, the Liverpool School of Tropical Medicine, and Public Health England.	Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; [Anonymous], EB CLIN CAR GUID GUI; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Beeching NJ, 2010, INT J ANTIMICROB AG, V36, pS26, DOI 10.1016/j.ijantimicag.2010.06.017; Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Centers for Disease Control and Prevention, 2015, KEY MESS EB VIR DIS; Centers for Disease Control and Prevention, 2014, KEY MESS EB VIR DIS; Centers for Disease Control and Prevention, 2014, THINK EB EARL REC CR; Centers for Disease Control and Prevention, 2014, ID IS INF AMB CAR EV; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; European Centre for Disease Prevention and Control, 2015, MED EV; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Gonsalves G, 2014, NEW ENGL J MED, V371, P2348, DOI 10.1056/NEJMp1413425; Inglis T, 2014, NATURE, V514, P537, DOI 10.1038/514537a; Johnston V, 2009, J INFECTION, V59, P1, DOI 10.1016/j.jinf.2009.05.005; Karwowski MP, 2014, MMWR-MORBID MORTAL W, V63, P1175; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Marti F, 2008, EXPERT REV VACCINES, V7, P679, DOI 10.1586/14760584.7.5.679; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6555; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Roddy P, 2011, J INFECT DIS, V204, pS791, DOI 10.1093/infdis/jir297; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090015, 10.3201/eid1508.090051]; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; World Health Organization, 2014, EB VIR DIS GUIN; World Health Organization, 2014, CAS DEF REC EB MARB; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036	40	31	31	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					757	764		10.7326/M15-0074	http://dx.doi.org/10.7326/M15-0074			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25961811	Green Accepted			2022-12-28	WOS:000355572300003
J	DeWeerdt, S				DeWeerdt, Sarah			The beeline	NATURE			English	Editorial Material																			0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					S50	S51		10.1038/521S50a	http://dx.doi.org/10.1038/521S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25992671	Bronze			2022-12-28	WOS:000354816500067
J	DeCarli, C				DeCarli, Charles			Blood Pressure Control and Cognitive Performance Something to Think About With Aging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; ADULTS; HYPERTENSION; ASSOCIATION; DECLINE	IMPORTANCE Hypertension is a treatable potential cause of cognitive decline and dementia, but its greatest influence on cognition may occur in middle age. OBJECTIVE To evaluate the association between midlife (48-67 years of age) hypertension and the 20-year change in cognitive performance. DESIGN, SETTING, AND PARTICIPANTS The Atherosclerosis Risk in Communities cohort (1990-1992 through 2011-2013) underwent evaluation at field centers in Washington County, Maryland, Forsyth County, North Carolina, Jackson, Mississippi, and the Minneapolis, Minnesota, suburbs. Of 13 476 African American and white participants with baseline cognitive data, 58.0% of living participants completed the 20-year cognitive follow-up. EXPOSURES Hypertension, prehypertension, or normal blood pressure (BP) at visit 2 (1990-1992) constituted the primary exposure. Systolic BP at visit 2 or 5 (2011-2013) and indication for treatment at visit 2 based on the Eighth Joint National Committee (JNC-8) hypertension guidelines constituted the secondary exposures. MAIN OUTCOMES AND MEASURES Prespecified outcomes included the 20-year change in scores on the Delayed Word Recall Test, Digit Symbol Substitution Test, and Word Fluency Test and in global cognition. RESULTS During 20 years, baseline hypertension was associated with an additional decline of 0.056 global z score points (95% CI, -0.100 to -0.012) and prehypertension was associated nonsignificantly with 0.040 more global z score points of decline (95% CI, -0.085 to 0.005) compared with normal BP. Individuals with hypertension who used antihypertensives had less decline during the 20 years than untreated individuals with hypertension (-0.050 [95% CI, -0.003 to -0.097] vs -0.079 [95% CI, -0.156 to -0.002] global z score points). Having a JNC-8-specified indication for initiating antihypertensive treatment at baseline was associated with a greater 20-year decline (-0.044 [95% CI, -0.085 to -0.003] global z score points) than not having an indication. We observed effect modification by race for the continuous systolic BP analyses (P =.01), with each 20-mm Hg increment at baseline associated with an additional decline of 0.048 (95% CI, -0.074 to -0.022) points in global cognitive z score in whites but not in African Americans (decline, -0.020 [95% CI, -0.026 to 0.066] points). Systolic BP at the end of follow-up was not associated with the preceding 20 years of cognitive change in either group. Methods to account for bias owing to attrition strengthened the magnitude of some associations. CONCLUSIONS AND RELEVANCE Midlife hypertension and elevated midlife but not late-life systolic BP was associated with more cognitive decline during the 20 years of the study. Greater decline is found with higher midlife BP in whites than in African Americans.	Univ Calif Davis, Dept Neurol, 4860 Y St,Ste 3700, Sacramento, CA 95817 USA	University of California System; University of California Davis	DeCarli, C (corresponding author), Univ Calif Davis, Dept Neurol, 4860 Y St,Ste 3700, Sacramento, CA 95817 USA.	cdecarli@ucdavis.edu	DeCarli, Charles/B-5541-2009		NIA NIH HHS [P30 AG10129, R01 AG012975, R01 AG008122, P30 AG010129, R01 AG08122, R01 AG021028, R01 AG047827] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012975, R01AG047827, R01AG008122, R01AG021028, P30AG010129] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; INZITARI D, 1987, ARCH NEUROL-CHICAGO, V44, P42, DOI 10.1001/archneur.1987.00520130034014; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986	8	4	5	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1963	+		10.1001/jama.2015.3113	http://dx.doi.org/10.1001/jama.2015.3113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988465	Green Accepted			2022-12-28	WOS:000354691200017
J	Harder, B; Comarow, A				Harder, Ben; Comarow, Avery			Hospital Quality Reporting by US News & World Report Why, How, and What's Ahead	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Harder, Ben; Comarow, Avery] US News & World Report, Washington, DC 20007 USA		Harder, B (corresponding author), US News & World Report, 1050 Thomas Jefferson St NW, Washington, DC 20007 USA.	bharder@usnews.com						COMAROW A, US NEWS WORLD REPORT; Comarow A, 2015, US NEWS WORLD REPORT; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Harder B, US NEWS HOSP RANKING; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; National Quality Forum, 2014, RISK ADJ SOC STAT OT; Olmsted MG, 2014, US NEWS WORLD REPORT	7	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1903	1904		10.1001/jama.2015.4566	http://dx.doi.org/10.1001/jama.2015.4566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988456				2022-12-28	WOS:000354691200006
J	Lip, GYH; Lane, DA				Lip, Gregory Y. H.; Lane, Deirdre A.			Stroke Prevention in Atrial Fibrillation A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NET CLINICAL BENEFIT; ADHERENT ANTITHROMBOTIC TREATMENT; BLEEDING RISK-ASSESSMENT; RHYTHM ASSOCIATION EHRA; VON-WILLEBRAND-FACTOR; EURO HEART SURVEY; HAS-BLED SCORE; ISCHEMIC-STROKE; CHA(2)DS(2)-VASC SCORE; ORAL ANTICOAGULATION	IMPORTANCE Atrial fibrillation (AF) is associated with an increase in mortality and morbidity, with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF are associated with higher mortality, greater disability, longer hospital stays, and lower chance of being discharged home than strokes unrelated to AF. OBJECTIVE To provide an overview of current concepts and recent developments in stroke prevention in AF, with suggestions for practical management. EVIDENCE REVIEW A comprehensive structured literature search was performed using MEDLINE for studies published through March 11, 2015, that reported on AF and stroke, bleeding risk factors, and stroke prevention. FINDINGS The risk of stroke in AF is reduced by anticoagulant therapy. Thromboprophylaxis can be obtained with vitamin K antagonists (VKA, eg, warfarin) or a non-VKA oral anticoagulant (NOAC). Major guidelines emphasize the important role of oral anticoagulation (OAC) for effective stroke prevention in AF. Initially, clinicians should identify low-risk AF patients who do not require antithrombotic therapy (ie, CHA(2)DS(2)-VASc score, 0 for men; 1 for women). Subsequently, patients with at least 1 stroke risk factor (except when the only risk is being a woman) should be offered OAC. A patient's individual risk of bleeding from antithrombotic therapy should be assessed, and modifiable risk factors for bleeding should be addressed (blood pressure control, discontinuing unnecessary medications such as aspirin or nonsteroidal anti-inflammatory drugs). The international normalized ratio should be tightly controlled for patients receiving VKAs. CONCLUSIONS AND RELEVANCE Stroke prevention is central to the management of AF, irrespective of a rate or rhythm control strategy. Following the initial focus on identifying low-risk patients, all others with 1 or more stroke risk factors should be offered OAC.	[Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	University of Birmingham; Aalborg University	Lip, GYH (corresponding author), Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk	Lane, Deirdre/AAX-1866-2020	Lane, Deirdre/0000-0002-5604-9378	Bayer Healthcare; Boehringer Ingelheim	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim)	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lip reported that he has served as a consultant for Bayer Healthcare, Merck, AstraZeneca, sanofi-aventis, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim, and has been on the speaker bureaus for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and sanofi-aventis. Dr Lane reported that she has received an investigator initiated educational grants from Bayer Healthcare and Boehringer Ingelheim and has been on the speakers bureau for Boehringer Ingelheim, Bayer, and Bristol-Myers Squibb/Pfizer.	Anandasundaram B, 2013, J THROMB HAEMOST, V11, P975, DOI 10.1111/jth.12177; Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552; Apostolakis S, 2013, J AM COLL CARDIOL, V61, P386, DOI 10.1016/j.jacc.2012.10.010; Azoulay L, 2014, EUR HEART J, V35, P1881, DOI 10.1093/eurheartj/eht499; Banerjee A, 2014, AM J MED, V127, P972, DOI 10.1016/j.amjmed.2014.05.035; Banerjee A, 2014, THROMB HAEMOSTASIS, V111, P549, DOI 10.1160/TH13-12-1033; Banerjee A, 2012, THROMB HAEMOSTASIS, V107, P584, DOI 10.1160/TH11-11-0784; Bernard A, 2013, THROMB HAEMOSTASIS, V110, P560, DOI 10.1160/TH13-04-0351; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Bjorck S, 2013, STROKE, V44, P3103, DOI 10.1161/STROKEAHA.113.002329; Bonde AN, 2014, J AM COLL CARDIOL, V64, P2471, DOI 10.1016/j.jacc.2014.09.051; Camm AJ, 2012, EUR HEART J, V33; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; Chao TF, 2014, J AM COLL CARDIOL, V64, P1658, DOI 10.1016/j.jacc.2014.06.1203; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Devereaux PJ, 2001, BMJ-BRIT MED J, V323, P1218, DOI 10.1136/bmj.323.7323.1218; Donze J, 2012, AM J MED, V125, P773, DOI 10.1016/j.amjmed.2012.01.033; Douketis JD, 2015, THROMB HAEMOSTASIS, V113, P625, DOI 10.1160/TH14-04-0305; Douketis JD, 2012, CHEST S, V141; Eckman MH, 2014, CIRC-CARDIOVASC QUAL, V7, P680, DOI 10.1161/CIRCOUTCOMES.114.001163; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062; Friberg Leif, 2012, BMJ, V344, pe3522, DOI 10.1136/bmj.e3522; Friberg L, 2015, EUR HEART J, V36, P297, DOI 10.1093/eurheartj/ehu139; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gallego P, 2014, AM J MED, V127, P1083, DOI 10.1016/j.amjmed.2014.05.023; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Guo YT, 2013, INT J CARDIOL, V168, P904, DOI 10.1016/j.ijcard.2012.10.052; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Huang D, 2014, PACE, V37, P1442, DOI 10.1111/pace.12445; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Karthikeyan G, 2010, THROMB HAEMOSTASIS, V104, P45, DOI 10.1160/TH09-11-0757; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; LaHaye S, 2014, THROMB HAEMOSTASIS, V111, P465, DOI 10.1160/TH13-05-0424; Lane DA, 2014, THROMB HAEMOSTASIS, V111, P381, DOI 10.1160/TH14-01-0063; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lip GYH, 2006, STROKE, V37, P2294, DOI 10.1161/01.STR.0000236840.00467.84; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; Lip GYH, 2015, CAN J CARDIOL, V31, P24, DOI 10.1016/j.cjca.2014.10.018; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lip GYH, 2014, CHEST, V146, P1337, DOI 10.1378/chest.14-0533; Lip GYH, 2014, CHEST, V146, P719, DOI 10.1378/chest.13-2976; Lip GYH, 2014, THROMB HAEMOSTASIS, V111, P933, DOI 10.1160/TH13-09-0734; Lip GYH, 2013, CHEST, V144, P1839, DOI 10.1378/chest.13-1635; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lip GYH, 2012, CIRC-ARRHYTHMIA ELEC, V5, P941, DOI 10.1161/CIRCEP.112.972869; Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Marcucci M, 2014, AM J MED, V127, P979, DOI 10.1016/j.amjmed.2014.05.003; Meier B, 2014, EUROPACE, V16, P1397, DOI 10.1093/europace/euu174; Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x; Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546; National Institute for Health and Care Excellence, 2014, NICE CLIN GUID; Ng KP, 2013, AM J KIDNEY DIS, V62, P615, DOI 10.1053/j.ajkd.2013.02.381; Nielsen PB, 2015, THROMB HAEMOSTASIS, V113, P1170, DOI 10.1160/TH15-03-0210; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Olesen JB, 2015, THROMB HAEMOST, V113; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen JB, 2012, CHEST, V141, P147, DOI 10.1378/chest.11-0862; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Omran H, 2012, THROMB HAEMOSTASIS, V108, P65, DOI 10.1160/TH11-12-0827; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Pisters R, 2013, THROMB HAEMOSTASIS, V109, P328, DOI 10.1160/TH12-08-0539; Pisters R, 2012, CIRC J, V76, P2289, DOI 10.1253/circj.CJ-12-1036; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2014, INTERN EMERG MED, V9, P443, DOI 10.1007/s11739-014-1065-8; Proietti M, EUR HEART J; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Abumuaileq RRY, 2015, EUROPACE, V17, P711, DOI 10.1093/europace/euu353; Roldan V, 2013, J AM COLL CARDIOL, V62, P2199, DOI 10.1016/j.jacc.2013.08.1623; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Rubboli A, 2014, THROMB HAEMOSTASIS, V112, P1080, DOI 10.1160/TH14-08-0681; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Senoo K, 2015, INT J CARDIOL, V181, P247, DOI 10.1016/j.ijcard.2014.11.196; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000250; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021; Skjoth F, 2014, THROMB HAEMOSTASIS, V111, P981, DOI 10.1160/TH14-02-0118; Skjoth F, 2012, THROMB HAEMOSTASIS, V108, P405, DOI 10.1160/TH12-06-0438; Smith JG, 2012, EUROINTERVENTION, V8, P672, DOI 10.4244/EIJV8I6A105; Steinberg BA, 2015, CIRCULATION, V131, P488, DOI 10.1161/CIRCULATIONAHA.114.011777; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; Taillandier S, 2012, J CARDIOVASC ELECTR, V23, P708, DOI 10.1111/j.1540-8167.2011.02257.x; The-Stroke-Prevention-in-Atrial-Fibrillation-Investigators, 1993, J STROKE CEREBROVASC, V3, P181; van Walraven C, 2003, ARCH INTERN MED, V163, P936, DOI 10.1001/archinte.163.8.936; van Walraven C, 2009, STROKE, V40, P1410, DOI 10.1161/STROKEAHA.108.526988; Verdecchia P, 2015, EXPERT OPIN DRUG SAF, V14, P7, DOI 10.1517/14740338.2014.971009; Verdecchia P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100478; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Wagstaff AJ, 2014, QJM-INT J MED, V107, P955, DOI 10.1093/qjmed/hcu054; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005; Zhu WG, 2015, TEX HEART I J, V42, P6, DOI 10.14503/THIJ-14-4353	120	210	216	3	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1950	1962		10.1001/jama.2015.4369	http://dx.doi.org/10.1001/jama.2015.4369			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988464				2022-12-28	WOS:000354691200016
J	Smith, JM				Smith, Jeanette M.			Bird's Nest and Ferns Fidelia Bridges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		HILL MB, 1981, F BRIDGES AM PRERAPH, P1	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1890	1891		10.1001/jama.2014.11751	http://dx.doi.org/10.1001/jama.2014.11751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25988448				2022-12-28	WOS:000354691200028
J	Voelkle, MC				Voelkle, Manuel C.			Comment on "Morality in everyday life"	SCIENCE			English	Letter																			0	3	3	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					767	767		10.1126/science.aaa2409	http://dx.doi.org/10.1126/science.aaa2409			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25977544				2022-12-28	WOS:000354428700030
J	Lee, VS				Lee, Vivian S.			Redesigning Metrics to Integrate Professionalism Into the Governance of Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Utah, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Lee, VS (corresponding author), Univ Utah, 175 N Med Dr,Fifth Floor, Salt Lake City, UT 84132 USA.	vivian.lee@utah.edu						Berenson RA, ACHIEVING POTENTIAL; Kaplan RS, 2011, HARVARD BUS REV, V89, P46; Kaplan RS, 2011, HARVARD BUS REV, V89, P54; Kaplan RS, 2011, HARVARD BUS REV, V89, P56; Kawamoto K, 2015, J AM MED INFORM ASSN, V22, P223, DOI 10.1136/amiajnl-2013-002511; Lee TH, HARVARD BUSINESS REV; National Quality Forum, PAT REP OUTC PROS PE; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939	9	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1815	1816		10.1001/jama.2015.4062	http://dx.doi.org/10.1001/jama.2015.4062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH9XW	25965222				2022-12-28	WOS:000354391000017
J	Levey, NN				Levey, Noam N.			Medical Professionalism and the Future of Public Trust in Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Los Angeles Times Tribune Washington Bur, Washington, DC 20005 USA		Levey, NN (corresponding author), Los Angeles Times Tribune Washington Bur, 1100 Vermont Ave NW,Ninth Floor, Washington, DC 20005 USA.	noam.levey@latimes.com						Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Gallup, HON ETH PROF; Gallup, PUBL FAITH C FALLS A; Gawande A, 2014, BEING MORTAL MED WHA; National Public Radio; Robert Wood Johnson Foundation; Harvard School of Public Health, SICK IN AM; Sagara E, DOLLARS DOCS IND DOL; Scanlon DP, ARE HEALTHCARE QUALI; Schlesinger M, 2002, MILBANK Q, V80, P185, DOI 10.1111/1468-0009.t01-1-00010	8	14	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2015	313	18					1827	1828		10.1001/jama.2015.4172	http://dx.doi.org/10.1001/jama.2015.4172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH9XW	25965228				2022-12-28	WOS:000354391000023
J	Blaikie, AJ; Dutton, GN				Blaikie, Andrew J.; Dutton, Gordon N.			PRACTICE POINTER How to assess eyes and vision in infants and preschool children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBLYOPIA		[Blaikie, Andrew J.] Fife Acute Hosp Trust, Queen Margaret Hosp, Dept Ophthalmol, Paediat Serv, Dunfermline KY12 0SU, Fife, Scotland; [Dutton, Gordon N.] Glasgow Caledonian Univ, Visual Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Dutton, GN (corresponding author), Glasgow Caledonian Univ, Visual Sci, Glasgow G4 0BA, Lanark, Scotland.	dutton@duttonhome.com		Blaikie, Andrew/0000-0001-7913-6872; Dutton, Gordon N/0000-0003-2516-5795				Anna, 2017, PEDIAT OPHTHALMOLOGY, P746; Atkinson J., 2000, OXFORD PSYCHOL SERIE, V32, P44; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Bowman R, 2010, BRIT J OPHTHALMOL, V94, P882, DOI 10.1136/bjo.2009.162750; Goddard AG, 1999, BRIT J OPHTHALMOL, V83, P1320, DOI 10.1136/bjo.83.12.1320; Horwood A, 2003, BRIT J OPHTHALMOL, V87, P1146, DOI 10.1136/bjo.87.9.1146; Papageorgiou E, 2014, PEDIATR NEONATOL, V55, P341, DOI 10.1016/j.pedneo.2014.02.007; Russell HC, 2010, J PEDIATR OPHTHALMOL, V1, P1; Salt A, 2014, ARCH DIS CHILD, V99, P1163, DOI 10.1136/archdischild-2013-305267; Stein A, 2014, J PEDIATR-US, V165, P820, DOI 10.1016/j.jpeds.2014.06.053; Zihl J, 2014, CEREBRAL VISUAL IMPA	11	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2015	350								h1716	10.1136/bmj.h1716	http://dx.doi.org/10.1136/bmj.h1716			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GJ	25952683				2022-12-28	WOS:000354414800001
J	Chawla, DS				Chawla, Dalmeet Singh			'Living figures' make their debut	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					112	112		10.1038/521112a	http://dx.doi.org/10.1038/521112a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951287				2022-12-28	WOS:000354040900045
J	Foster, CL; Mould, K; Reynolds, P; Simonian, PL; Erlandson, KM				Foster, Clayton L.; Mould, Kara; Reynolds, Paul; Simonian, Philip L.; Erlandson, Kristine M.			Sick as a Dog	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN PLAGUE; YERSINIA-PESTIS; NEW-MEXICO		[Foster, Clayton L.; Erlandson, Kristine M.] Univ Colorado, Dept Med, Div Infect Dis, Aurora, CO 80045 USA; [Mould, Kara; Simonian, Philip L.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Reynolds, Paul] Univ Colorado Hosp, Dept Clin Pharm, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Hospital	Erlandson, KM (corresponding author), Univ Colorado, Dept Med, Div Infect Dis, 12700 E 19th Ave,Mailstop B168, Aurora, CO 80045 USA.	kristine.erlandson@ucdenver.edu	Reynolds, Paul/ABH-3561-2020; Reynolds, Paul/ABD-9094-2020	Reynolds, Paul/0000-0002-7159-0517; Mould, Kara/0000-0003-2967-2778				Boulanger LL, 2004, CLIN INFECT DIS, V38, P663, DOI 10.1086/381545; BUTLER T, 1972, AM J MED, V53, P268, DOI 10.1016/0002-9343(72)90168-4; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; CAMPBELL GL, 1995, ANN INTERN MED, V122, P151, DOI 10.7326/0003-4819-122-2-199501150-00014; Dennis D. T, 1999, WHOCDSCSREDC992; Gage KL, 2000, CLIN INFECT DIS, V30, P893, DOI 10.1086/313804; Gould LH, 2008, ZOONOSES PUBLIC HLTH, V55, P448, DOI 10.1111/j.1863-2378.2008.01132.x; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; POLLITZER R, 1953, Bull World Health Organ, V9, P59; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Runfola JK, 2014, MMWR MORB M IN PRESS; Siegel JD, 2007, 2007 GUIDELINES ISOL; Tourdjman M, 2012, CLIN INFECT DIS, V55, pE58, DOI 10.1093/cid/cis578; Wong JD, 2000, ANTIMICROB AGENTS CH, V44, P1995, DOI 10.1128/AAC.44.7.1995-1996.2000	15	3	3	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1845	1850		10.1056/NEJMcps1411346	http://dx.doi.org/10.1056/NEJMcps1411346			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25946284				2022-12-28	WOS:000353974700011
J	Koster, MJE; Snel, B; Timmers, HTM				Koster, Maria J. E.; Snel, Berend; Timmers, H. Th. Marc			Genesis of Chromatin and Transcription Dynamics in the Origin of Species	CELL			English	Review							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; DNA-BINDING; CRYSTAL-STRUCTURE; IN-VITRO; DEVELOPMENTAL REGULATION; REMODELING COMPLEXES; TRYPANOSOMA-BRUCEI	Histone proteins compact and stabilize the genomes of Eukarya and Archaea. By forming nucleosome(-like) structures they restrict access of DNA-binding transcription regulators to cis-regulatory DNA elements. Dynamic competition between histones and transcription factors is facilitated by different classes of proteins including ATP-dependent remodeling enzymes that control assembly, access, and editing of chromatin. Here, we summarize the knowledge on dynamics underlying transcriptional regulation across the domains of life with a focus on ATP-dependent enzymes in chromatin structure or in TATA-binding protein activity. These insights suggest directions for future studies on the evolution of transcription regulation and chromatin dynamics.	[Koster, Maria J. E.; Timmers, H. Th. Marc] Univ Med Ctr Utrecht, Mol Canc Res, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands; [Snel, Berend] Univ Utrecht, Theoret Biol & Bioinformat, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Timmers, HTM (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res, Ctr Mol Med, Univ 100, NL-3584 CG Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl	Snel, Berend/B-8886-2011	Snel, Berend/0000-0002-5804-8547	Netherlands Organization for Scientific Research (NWO) through ALW [820.02.013]	Netherlands Organization for Scientific Research (NWO) through ALW(Netherlands Organization for Scientific Research (NWO))	We are grateful to Geert Kops and members of the Timmers lab for discussion and insightful comments. We thank the anonymous reviewers for their astute comments. We thank Koen Dreijerink, Laszlo Tora, Finn Werner and Carl Wu for critical reading of the manuscript. The work is supported by the Netherlands Organization for Scientific Research (NWO) through ALW (grant #820.02.013 to HTMT).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akhtar W, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-23; Ammar R, 2012, ELIFE, V1, DOI 10.7554/eLife.00078; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Brindefalk B, 2013, NUCLEIC ACIDS RES, V41, P2832, DOI 10.1093/nar/gkt045; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Delgadillo RF, 2009, BIOCHEMISTRY-US, V48, P1801, DOI 10.1021/bi8018724; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dobzhansky T., 1973, AM BIOL TEACH, V35, P126; Duttke SHC, 2014, GENE DEV, V28, P2071, DOI 10.1101/gad.250563.114; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gazdag E, 2007, REPRODUCTION, V134, P51, DOI 10.1530/REP-06-0337; Gentry M, 2014, EXP CELL RES, V321, P40, DOI 10.1016/j.yexcr.2013.11.010; Gietl A, 2014, NUCLEIC ACIDS RES, V42, P6219, DOI 10.1093/nar/gku273; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Grohmann D, 2011, CURR OPIN MICROBIOL, V14, P328, DOI 10.1016/j.mib.2011.04.012; Guillebault D, 2002, J BIOL CHEM, V277, P40881, DOI 10.1074/jbc.M205624200; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Hoopes BC, 1998, J MOL BIOL, V277, P1015, DOI 10.1006/jmbi.1998.1651; Hope R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005234; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Jun SH, 2011, CRIT REV BIOCHEM MOL, V46, P27, DOI 10.3109/10409238.2010.538662; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kedmi A, 2014, GENE DEV, V28, P2163, DOI 10.1101/gad.245670.114; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Klejman MP, 2005, NUCLEIC ACIDS RES, V33, P5426, DOI 10.1093/nar/gki850; Koike H, 2004, STRUCTURE, V12, P157, DOI 10.1016/j.str.2003.12.003; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-21; Koster MJE, 2014, NUCLEIC ACIDS RES, V42, P4220, DOI 10.1093/nar/gkt1398; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lorch Y, 2014, GENE DEV, V28, P2492, DOI 10.1101/gad.250704.114; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Maruyama H, 2013, EMBO REP, V14, P711, DOI 10.1038/embor.2013.94; Meissner M, 2005, MICROBES INFECT, V7, P1376, DOI 10.1016/j.micinf.2005.04.019; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Moshkin YM, 2012, MOL CELL BIOL, V32, P675, DOI 10.1128/MCB.06365-11; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; NEIGEBORN L, 1984, GENETICS, V108, P845; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pointner J, 2012, EMBO J, V31, P4388, DOI 10.1038/emboj.2012.289; POON D, 1994, J BIOL CHEM, V269, P23135; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Ruan JP, 2004, MOL CELL BIOL, V24, P9610, DOI 10.1128/MCB.24.21.9610-9618.2004; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shinzato C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00336; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Spedale G, 2012, NUCLEIC ACIDS RES, V40, P996, DOI 10.1093/nar/gkr784; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; TIMMERS HTM, 1991, GENE DEV, V5, P1946, DOI 10.1101/gad.5.11.1946; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Torres-Padilla ME, 2007, EMBO REP, V8, P1016, DOI 10.1038/sj.embor.7401093; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yamamoto T, 2006, PROTEIN SCI, V15, P152, DOI 10.1110/ps.051788906; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zentner GE, 2013, MOL CELL BIOL, V33, P4996, DOI 10.1128/MCB.01218-13	123	52	52	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					724	736		10.1016/j.cell.2015.04.033	http://dx.doi.org/10.1016/j.cell.2015.04.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957681	Bronze			2022-12-28	WOS:000354175200008
J	Ahmed, SH; Ewins, DL; Nair, S; Joseph, F				Ahmed, S. H.; Ewins, David L.; Nair, Sunil; Joseph, Franklin			CASE REVIEW Spontaneous hypokalaemia in a man with treated hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY ALDOSTERONISM		[Ahmed, S. H.; Ewins, David L.; Nair, Sunil; Joseph, Franklin] Chester Hosp, Dept Endocrinol & Diabet, Diabet & Endocrinol, Chester CH2 1UL, Cheshire, England		Ahmed, SH (corresponding author), Chester Hosp, Dept Endocrinol & Diabet, Diabet & Endocrinol, Chester CH2 1UL, Cheshire, England.	drharis_76@yahoo.co.uk						Celen O, 1996, ARCH SURG-CHICAGO, V131, P646; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Sawka AM, 2001, ANN INTERN MED, V135, P258, DOI 10.7326/0003-4819-135-4-200108210-00010	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2015	350								h2154	10.1136/bmj.h2154	http://dx.doi.org/10.1136/bmj.h2154			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UU	25929782				2022-12-28	WOS:000353956800003
